-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WAu8FxJs3mWlZfboeY2jbRCVJsdIvqi2vl5BU9r0y0FpeCyqgj45wPGY2bkBIYH/ fgG+qpid/a8kpes2coIpyg== 0000950123-05-000221.txt : 20050111 0000950123-05-000221.hdr.sgml : 20050111 20050111092033 ACCESSION NUMBER: 0000950123-05-000221 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20050108 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050111 DATE AS OF CHANGE: 20050111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WYETH CENTRAL INDEX KEY: 0000005187 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 132526821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01225 FILM NUMBER: 05522279 BUSINESS ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9736605000 MAIL ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HOME PRODUCTS CORP DATE OF NAME CHANGE: 20020308 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HOME PRODUCTS CORP DATE OF NAME CHANGE: 19920703 8-K 1 y00311e8vk.txt WYETH UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2005 WYETH (Exact name of registrant as specified in its charter) Delaware 1-1225 13-2526821 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) Five Giralda Farms, Madison, New Jersey 07940 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 973-660-5000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 1.01. Entry into a Material Definitive Agreement. On January 10, 2005, the Company confirmed in a press release that it would support the proposed Seventh Amendment to the National Diet Drug Settlement. The Company's right to withdraw from the proposed Seventh Amendment expired on January 8, 2005. Pursuant to the terms of the proposed Seventh Amendment, potentially affected class members had until November 9, 2004 to decide whether to be subject to the Seventh Amendment or to opt out. More than 95% of such class members are participating in the proposed Seventh Amendment. Implementation of the proposed Seventh Amendment remains subject to final approval by the U.S. District Court for the Eastern District of Pennslyvania. There can be no assurance that it will be approved by the court and upheld if challenged on appeal. A fairness hearing before Judge Harvey Bartle III of the Eastern District of Pennsylvania is scheduled for January 18, 2005. The Company is evaluating potential additional charges relating to the diet drug litigation in connection with the preparation of its year-end financial statements. The material terms of the proposed Seventh Amendment are described in the Company's Quarterly Report on Form 10-Q for period ended September 30, 2004 and in the Company's press release confirming its support of the proposed Seventh Amendment (attached hereto as Exhibit 99), which descriptions are incorporated by reference into this Item 1.01. Such descriptions are qualified in their entirety by reference to the full text of the proposed Seventh Amendment (attached hereto as Exhibit 10.1), which is incorporated by reference into this Item 1.01. Item 9.01. Financial Statements and Exhibits (c) Exhibits. 10.1 Seventh Amendment to the Nationwide Class Action Settlement Agreement with American Home Products Corporation (now Wyeth), dated July 21, 2004. 99 Wyeth Press Release Confirming its Support for the Proposed Seventh Amendment to the National Diet Drug Settlement. Page 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 10, 2005 WYETH By: /s/ Douglas A. Dworkin --------------------------------------------- Name: Douglas A. Dworkin Title: Vice President and Deputy General Counsel Page 3 Exhibit Index Exhibit No. Description 10.1 Seventh Amendment to the Nationwide Class Action Settlement Agreement withAmerican Home Products Corporation (now Wyeth), dated July 21, 2004. 99 Wyeth Press Release Confirming its Support for the Proposed Seventh Amendment to the National Diet Drug Settlement. EX-10.1 2 y00311exv10w1.txt SEVENTH AMENDMENT TO NATIONWIDE CLASS ACTION SETTLEMENT AGREEMENT Exhibit 10.1 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA - ------------------------------------------ IN RE: DIET DRUGS (PHENTERMINE/FENFLURAMINE/ DEXFENFLURAMINE) PRODUCTS LIABILITY MDL NO. 1203 LITIGATION - ------------------------------------------ THIS DOCUMENT RELATES TO: SHEILA BROWN, ET AL. V. AMERICAN HOME CIVIL ACTION PRODUCTS CORPORATION No. 99-20593 - ------------------------------------------ SEVENTH AMENDMENT TO THE NATIONWIDE CLASS ACTION SETTLEMENT AGREEMENT WITH AMERICAN HOME PRODUCTS CORPORATION Dated July 21, 2004 TABLE OF CONTENTS I. DEFINITIONS.................................................................................... 1 A. Incorporation of Settlement Agreement Definitions and Section References........................................................... 1 B. Additional Defined Terms..................................................... 2 II. SEVENTH AMENDMENT ............................................................................. 20 III. CLASS MEMBERS SUBJECT TO THIS SEVENTH AMENDMENT................................................ 21 A. Categories of Class Members.................................................. 21 B. Derivative Claimants......................................................... 23 C. Progression During Pendency of the Seventh Amendment.................................................................... 24 IV. APPOINTMENT OF THE FUND ADMINISTRATOR, ESCROW AGENT, MEDICAL REVIEW CONSULTING COMMITTEE, AND THE SALC............................................................. 26 A. The Fund Administrator....................................................... 26 B. The Escrow Agent............................................................. 26 C. The Medical Review Coordinating Committee.................................... 27 D. The Seventh Amendment Liaison Committee...................................... 27 E. Immunity From Liability...................................................... 28 V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS.............................................................. 31 A. Supplemental Class Settlement Fund........................................... 31
i B. Use of Funds Before Final Judicial Approval of the Seventh Amendment............................................................ 33 C. Notice....................................................................... 33 D. Return of Funds.............................................................. 34 E. Impact of Final Judicial Approval of the Seventh Amendment.................................................................... 34 F. Compensatory Damages......................................................... 35 G. Authorization Applications................................................... 35 H. Authorization Orders ........................................................ 36 VI. SECURITY ARRANGEMENTS RELATING TO THE SEVENTH AMENDMENT........................................ 37 A. Seventh Amendment Security Fund.............................................. 37 B. Purpose of the Seventh Amendment Security Fund .............................. 37 C. Impact of No Final Judicial Approval ........................................ 37 D. Withdrawals by Wyeth from the Seventh Amendment Security Fund................................................................ 37 E. Security for Wyeth's Guarantee............................................... 38 VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS........................................................ 39 A. Benefits Subject to Medical Review........................................... 39 B. Minimum Payment Amount ...................................................... 44 C. Category Two Election by a Category One Class Member....................................................................... 45
ii D. Timing and Condition of Payments ............................................ 46 VIII. BENEFITS FOR CATEGORY TWO CLASS MEMBERS........................................................ 47 A. Category Two Payment......................................................... 47 B. Administration of Category Two Payments...................................... 47 C. Timing of Category Two Payments.............................................. 49 D. Condition of Category Two Payments........................................... 49 IX. BENEFITS FOR CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS......................... 51 A. Seventh Amendment Matrix Compensation Benefits............................... 51 B. Funding for Seventh Amendment Matrix Compensation Benefits, Effect on MAFBA, and Guarantee by Wyeth............................ 53 C. Funding of Supplemental Claims When MAFBA Reaches $255,000,000................................................................. 54 D. Eligibility List............................................................. 54 E. No Preclusion................................................................ 54 X. EFFECT OF THE SEVENTH AMENDMENT ON CASH/MEDICAL SERVICES BENEFITS OF CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS.................................................................................. 56 A. Category One Class Members................................................... 56 B. Category Two Election by Category One Class Member........................... 57 C. Category Two Class Members .................................................. 57
iii D. Category One Class Members and Category Two Class Members Who Do Not Qualify for Cash/Medical Services Benefits................ 58 XI. OTHER EFFECTS OF THE SEVENTH AMENDMENT. ....................................................... 59 A. Termination of Opt-Out Rights................................................ 59 B. Matrix Compensation Benefits Under the Seventh Amendment.................................................................... 59 C. Release and Covenant Not to Sue.............................................. 60 D. Credits...................................................................... 61 XII. SEVENTH AMENDMENT OPT-OUT...................................................................... 62 A. Seventh Amendment Opt-Out.................................................... 62 B. Method of Exercise........................................................... 62 C. Effect of Opt-Out............................................................ 62 D. Derivative Claimants ........................................................ 63 E. Revocation of Seventh Amendment Opt-Out ..................................... 63 F. Seventh Amendment Opt-Out List............................................... 63 XIII. SEVENTH AMENDMENT WALKAWAY RIGHT............................................................... 65 A. Walkaway Period.............................................................. 65 B. Walkaway Right .............................................................. 65 C. Method of Exercise........................................................... 65
iv XIV. PROCEDURES TO BECOME ELIGIBLE FOR INCLUSION IN CATEGORY ONE AFTER THE EXECUTION DATE........... 66 A. Initial Category One Class List.............................................. 66 B. Class Members who Previously Exercised Initial, Intermediate, or Back-End Opt-Outs........................................... 66 C. Inclusion in Category One After the Execution Date ......................... 67 D. Amended and Final Category One Class List.................................... 68 E. Disputes..................................................................... 69 XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND............................................................. 70 A. General...................................................................... 70 B. Proof Requirements........................................................... 70 C. Access to Trust Files........................................................ 73 D. Access to Trust Database..................................................... 74 E. Trust Cooperation............................................................ 74 F. Technical Deficiencies....................................................... 74 G. Proof of Diet Drug Use....................................................... 74 H. Echocardiograms.............................................................. 75 I. Qualified Cardiology Centers................................................. 75 J. Role of the MRCC............................................................. 75
v K. Challenges................................................................... 76 L. No Contact with Participating Physicians or the MRCC......................... 76 M. Medical Review............................................................... 76 N. Category One Class Members Found Payable by the Trust........................................................................ 77 O. Relative Payment Value....................................................... 77 P. Interim Distributions........................................................ 77 Q. Payment of Interim Distributions............................................. 78 R. Individual Payment Amount.................................................... 78 S. Distribution of Proceeds..................................................... 79 T. Attorneys' Fees.............................................................. 80 U. Distribution of Category Two Payment ........................................ 81 V. Distribution of Minimum Payment Amount....................................... 81 W. Subrogation and Other Third Party Payor Claims............................... 81 XVI. REMEDIES IN THE EVENT OF A BREACH BY WYETH..................................................... 85 A. Notice of Default............................................................ 85 B. Order of Default............................................................. 85 XVII. PRELIMINARY APPROVAL; STAY OF PROCEEDINGS DURING THE OBJECTION/OPT-OUT PERIOD.................. 86 A. Preliminary Approval Order................................................... 86
vi B. Stay of Appeals. ........................................................... 90 XVIII. JURISDICTION, EFFECT ON OTHER PROCEEDINGS, AND REMEDIES.............................................................................. 91 A. Dismissals of Proceedings.................................................... 91 B. Enforcement Actions.......................................................... 91 C. Conditions................................................................... 91 D. Retained Jurisdiction ....................................................... 94 XIX. OTHER PROVISIONS............................................................................... 95 A. Method of Transmission of Notices............................................ 95 B. Recipients of Notices........................................................ 95 C. Change in Recipients ........................................................ 97 D. Confidential Information..................................................... 97 E. No Admissions................................................................ 97 F. Wyeth Cooperation............................................................ 97 G. Access by Wyeth ............................................................. 97 H. Survival of Terms............................................................ 98 I. Administrative Deadlines..................................................... 98 J. Seventh Amendment Term Sheet................................................. 98 K. Headings..................................................................... 98 L. Counterparts................................................................. 99
vii TABLE OF EXHIBITS
DESCRIPTION EXHIBIT ----------- ------- Seventh Amendment Term Sheet A Initial Category One Class List B Seventh Amendment Security Fund Agreement C Notice Regarding Endorsements on Payments D Category Two Election Form E Release and Covenant Not To Sue F Seventh Amendment Opt-Out Form G Matters Subject to Stays in District Court H Matters Subject to Stays in the Court of Appeals I Pre-Stay Payable PADL Order J Parallel Processing Program K Notice to Class Members L Motion and Memorandum to Extend Stays in Court of Appeals M
viii SEVENTH AMENDMENT TO THE NATIONWIDE CLASS ACTION SETTLEMENT AGREEMENT WITH AMERICAN HOME PRODUCTS CORPORATION Class Counsel and Wyeth (the "Parties") agree that the Nationwide Class Action Settlement Agreement with American Home Products Corporation, as previously amended (the "Settlement Agreement"), is further amended by this Seventh Amendment, subject to the conditions, and effective at such time as, set forth below. I. DEFINITIONS. A. INCORPORATION OF SETTLEMENT AGREEMENT DEFINITIONS AND SECTION REFERENCES. 1. When used in the Seventh Amendment, the capitalized terms used in the Settlement Agreement shall have the same meaning as in the Settlement Agreement. ======================================= I. DEFINITIONS. 1 2. References to a "Section" refer to Sections of the Seventh Amendment, unless otherwise specified. B. ADDITIONAL DEFINED TERMS. For purposes of the Seventh Amendment, these capitalized terms shall have these meanings: 1. "Additional Post-FJA Deposit(s)" is defined in Section V.A.4. 2. "Age at First Diagnosis" means the age of the Diet Drug Recipient (whose condition forms the basis of the claim) as of the date that a High Threshold Condition or Low Threshold Condition is first diagnosed. 3. "Alternative Causation Factors" means, for claims seeking Benefits Subject to Medical Review: a. With respect to a Matrix Claim (or any part of a Matrix Claim) based on the aortic valve: (1) Any of the following congenital aortic valve abnormalities: unicuspid, bicuspid or quadricuspid aortic valve, ventricular septal defect associated with aortic regurgitation; (2) Aortic dissection involving the aortic root and/or aortic valve; (3) Aortic sclerosis in people who are > or = 60 years old as of the time they are first diagnosed as FDA Positive; (4) Aortic root dilatation > 5.0 cm; (5) Aortic stenosis with an aortic valve area < 1.0 square centimeter by the Continuity Equation. ======================================= I. DEFINITIONS. 2 b. With respect to a Matrix Claim (or any part of a Matrix Claim) based on the mitral valve: (1) Any of these congenital mitral valve abnormalities: parachute valve, and/or cleft of the mitral valve associated with atrial septal defect; (2) Mitral Valve Prolapse; (3) Chordae tendineae rupture or papillary muscle rupture, or acute myocardial infarction associated with acute mitral regurgitation; (4) Mitral annular calcification; (5) M-Mode and 2-D echocardiographic evidence of rheumatic mitral valves (doming of the anterior leaflet and/or anterior motion of the posterior leaflet and/or commissural fusion); and/or (6) Diagnosis of Mild Mitral Regurgitation and not Moderate Mitral Regurgitation or Severe Mitral Regurgitation by the end of the Screening Period. c. With respect to Matrix Claims based in whole or in part on the aortic and/or mitral valve(s): heart valve surgery prior to Diet Drug use on the valve that is the basis of the Matrix Claim (or any part of the Matrix Claim), as determined from a review of the Relevant Echocardiogram. The presence or absence of the medical conditions contained in this definition of Alternative Causation Factors is to be determined solely by review of the Class Member's echocardiographic evidence. Such factors as age and dates of relevant events may be determined from other information submitted by the Class Member. ======================================= I. DEFINITIONS. 3 4. "Amended and Final Category One Class List" is the final list of Diet Drug Recipients (or their Representative Claimants) who have been determined to be Category One Class Members after the close of the Seventh Amendment Opt-Out/Objection Period. 5. "Attesting Physician" means the physician who signed Part II of the Green Form as part of a Matrix Claim by or on behalf of a Class Member. 6. "Audit" shall mean the medical evaluation of claims by a Trust Auditing Cardiologist pursuant to section VI.E of the Settlement Agreement. 7. "Authorization Application" is defined in Section V.G. 8. "Authorization Order" is defined in Section V.H. 9. "Balance of the Individual Payment Amount" is defined in Section XV.R.3. 10. "Benefits Subject to Medical Review" means those benefits described in Sections VII.A.1-7, which may be payable to Category One Class Members based on the Medical Review process described in Section XV. 11. "Cash/Medical Services Benefit" means the Additional Medical Services or Cash benefit described in section IV.A.1.c and/or section IV.A.2.c of the Settlement Agreement. 12. "Category One" is defined in Section III.A.1. 13. "Category One Class Member(s)" means Class Members who meet the criteria for inclusion in Category One. 14. "Category Two" is defined in Section III.A.2. ======================================= I. DEFINITIONS. 4 15. "Category Two Class Member(s)" means Class Members who meet the criteria for inclusion in Category Two, as defined in Sections III.A.2.a-g. 16. "Category Two Election Amount" means an amount equal to $2,000 multiplied by the number of Diet Drug Recipients (or Representative Claimants) identified on the Category Two Election Certification. In the event that more than 6,400 Diet Drug Recipients (or Representative Claimants) are identified on the Category Two Election Certification, then the Category Two Election Amount shall include an additional amount computed by multiplying $5,500 times the number of Diet Drug Recipients (or Representative Claimants) identified on the Category Two Election Certification and then subtracting $35,000,000 from the product of such multiplication. 17. "Category Two Election Certification" is defined in Section VII.C.3. 18. "Category Two Election Form" is defined in Section VII.C.2. 19. "Category Two Payment" means the $2,000 payment to eligible Category Two Class Members as set forth in Section VIII.A.1. 20. "Category Two Payment List" is defined in Section VIII.B.1. 21. "Common Benefit Percentage" means the percentage, if any, determined by the Court on a preliminary basis (to facilitate distribution of the Individual Payment Amounts without awaiting full adjudication of any fee application or dispute) or final basis before final distribution pursuant to Section XV.R, of the Individual Payment Amounts payable to Category One Class Members who are entitled to receive Benefits Subject to Medical Review: a. Which the Court determines should be allocated and/or paid as common benefit fees to attorneys for professional ======================================= I. DEFINITIONS. 5 services that are found by the Court to be of "common benefit" to Category One Class Members; and b. Which may represent an allocable share of or reimbursement to the Fund B Attorneys' Fees Account, a percentage of the Supplemental Class Settlement Fund, or both, as determined by the Court in accordance with applicable law. 22. "Common Benefit Percentage Amount" is defined in Section XV.R.1. 23. "Eligibility List" is defined in Section IX.D. 24. "Enforcement Actions" means civil actions by the Trust, Wyeth, their successors and/or assigns, against any person or entity, including, without limitation, Attesting Physicians, claimants' attorneys, and Class Members, to recover benefits, including, without limitation, Matrix Compensation Benefits paid by the Trust on or before the Execution Date and/or on a Pre-Stay Payable PADL, costs of administration and investigation, and any compensatory and/or punitive damages with respect to the payment and/or processing of Matrix Compensation Benefits paid by the Trust on or before the Execution Date and/or with respect to any Pre-Stay Payable PADL claims made to and/or processed by the Trust. Use of evidence regarding Matrix Compensation Benefits paid by the Trust on or before the Execution Date and/or on a Pre-Stay Payable PADL in any action or proceeding other than an Enforcement Action shall not be considered as within this definition of Enforcement Actions. Actions that are based on or arise from (i) claims submitted by Class Members who have exercised a Seventh Amendment Opt-Out; (ii) claims for Seventh Amendment Matrix Compensation Benefits; and (iii) Supplemental Claims do not constitute Enforcement Actions as defined in this Seventh Amendment. Without limiting the generality of the foregoing, Enforcement Actions include the ======================================= I. DEFINITIONS. 6 civil actions entitled AHP Settlement Trust v. Linda Crouse, M.D., et al., Civil Action No. 03-5252 (E.D. Pa.), and AHP Settlement Trust v. Richard L. Mueller, M.D., Civil Action No. 03-6163 (E.D. Pa.). 25. "Escrow Agent" is defined in Section IV.B. 26. "Examining Physician" means a Board-Certified Cardiologist, a Board-Certified Cardiothoracic Surgeon, or a Qualified Physician, who (i) has treated the Diet Drug Recipient for any of the conditions that form the basis of the Matrix Claim or (ii) demonstrates to the Trust the same familiarity with the Diet Drug Recipient's medical condition, and applying normal clinical practice standards, as a physician who has treated the Diet Drug Recipient for any of the conditions that form the basis of the Matrix Claim. 27. "Execution Date" means July 21, 2004. 28. "Final Judicial Approval of the Seventh Amendment" refers to the approval of the Seventh Amendment by the Court and such approval becoming final by the exhaustion of all appeals (including petitions for writ of certiorari to the United States Supreme Court), if any, without substantial modification of the order or orders granting such approval. Final Judicial Approval of the Seventh Amendment shall be deemed not to have been obtained if Trial Court Approval of the Seventh Amendment is denied and the period for appealing such denial has expired without any such appeal having been taken. 29. "Fund Administrator" means the person appointed by the Court to process benefit claims by Category One Class Members under the Seventh Amendment, as defined in Section IV.A. 30. "High Matrix Level Qualifying Factors" is defined as the original requirements of section IV.B.2.c(3), (4) and (5) of the ======================================= I. DEFINITIONS. 7 Settlement Agreement, except as modified and/or clarified as follows: a. With respect to any claim for Matrix Level III, IV, or V benefits that is based, in whole or in part, on surgery to repair or replace the aortic and/or mitral valve(s), "High Matrix Level Qualifying Factors" means that the Diet Drug Recipient actually had surgery to repair or replace the valve or valves that were found to have FDA Positive regurgitation or Mild Mitral Regurgitation before the end of the Screening Period and that is/are the basis of the claim. b. With respect to any claim for Matrix Level IV or V benefits that is based, in whole or in part, on ineligibility due to medical reasons for surgery to repair or replace the aortic and/or mitral valve(s), "High Matrix Level Qualifying Factors" means that the Diet Drug Recipient had ACC/AHA Class I indications for surgery as described in the Settlement Agreement, but was ineligible for surgery due to medical reasons (other than acute conditions that merely require a postponement of surgery), as documented contemporaneously in the Diet Drug Recipient's medical records by the attending Board-Certified Cardiothoracic Surgeon or Board-Certified Cardiologist and certified to under penalty of perjury by an Examining Physician. The valve or valves that is/are the basis for the Matrix Level IV or V claim must have been found to have FDA Positive regurgitation or Mild Mitral Regurgitation before the end of the Screening Period. c. "High Matrix Level Qualifying Factors" do not include the circumstances described in section IV.B.2.c(3)(b) of the Settlement Agreement except to the extent necessary to qualify for Matrix Compensation Benefits at Matrix ======================================= I. DEFINITIONS. 8 Level IV or Matrix Level V, as limited by Section I.B.30.b. d. For any claim for Matrix Level III, IV, or V benefits that is based on complications of left atrial enlargement with chronic atrial fibrillation, "High Matrix Level Qualifying Factors" means: (1) Left atrial supero-inferior systolic dimension > 5.3 cm (apical four chamber view) or an abnormal left atrial antero-posterior systolic dimension > 4.0 cm (parasternal long axis view) measured by 2-D directed M-mode or 2-D echocardiography using sites of measurement recommended by the American Society of Echocardiography; (2) Chronic atrial fibrillation; and (3) A statement under penalty of perjury from an Examining Physician, along with contemporaneous medical records, that establish to a reasonable degree of medical certainty and to the reasonable satisfaction of a Trust Auditing Cardiologist, that the Diet Drug Recipient's left atrial enlargement and chronic atrial fibrillation/flutter were a direct consequence of Moderate Mitral Regurgitation or Severe Mitral Regurgitation. e. For any claim on Matrix Level V(c) under section IV.B.2.c(5)(c) of the Settlement Agreement, "High Matrix Level Qualifying Factors" means, in addition to the requirements of section IV.B.2.c(5)(c), that the conditions of the Diet Drug Recipient would have qualified for Matrix Compensation Benefits under Matrix Level I or II as defined in the Settlement Agreement as it existed before the Execution Date, ======================================= I. DEFINITIONS. 9 and/or under the requirements of Matrix Level III, IV, or V, as modified and/or clarified in this Section I.B.30. f. For any claim for Matrix Level III, IV, or V benefits, "High Matrix Level Qualifying Factors" means that the Echocardiogram Tape or Disk relied upon by the Class Member to qualify the claim complies with the criteria and requirements for Echocardiograms provided in the Settlement Agreement as it existed before the Execution Date, including the requirements that any copy of the Echocardiogram Tape or Disk: (1) Must be of sufficient quality that a Cardiologist with Level 2 or 3 competency in echocardiography can reliably ascertain the presence or absence of each of the factors that is relevant to the claim; and (2) With respect to any claim based on Mitral Regurgitation, the copy must comply with the requirements set forth in Section XV.B.2.b(2). g. If a copy of any Echocardiogram Tape or Disk that supports a claim for Seventh Amendment Matrix Compensation Benefits complies with Section I.B.30.f, the existence of those "High Matrix Level Qualifying Factors" that depend on echocardiographic evidence shall be determined in Audit based on such Echocardiogram Tape(s) or Disk(s) without regard to: (i) whether the Echocardiogram Tape or Disk (or any copy thereof) was allegedly obtained without adequate physician supervision; (ii) the identity of the person or entity that performed the Echocardiogram; or (iii) the identity of the attorney(s) representing the claimant; provided, however, that nothing contained in this Section shall prevent the Trust from contesting the validity of any Echocardiogram Tape or Disk where there is substantial evidence that such Tape or Disk constitutes ======================================= I. DEFINITIONS. 10 or contains a material misrepresentation of fact under section VI.E of the Settlement Agreement. Lack of adequate physician supervision with respect to an Echocardiogram Tape or Disk shall not constitute a material misrepresentation of fact for this purpose. 31. "High Threshold Condition" means: a. Moderate Aortic Regurgitation with one or more of the following complicating factors: (1) Abnormal left ventricular end-systolic dimension > 50 mm by M-mode or 2-D echocardiography or abnormal left ventricular end-diastolic dimension > 70 mm as measured by M-mode or 2-D echocardiography; and/or (2) Ejection fraction of < 50%; and/or b. Severe Aortic Regurgitation; and/or c. Severe Mitral Regurgitation with one or more of the following complicating factors: (1) Pulmonary hypertension secondary to valvular heart disease with peak systolic pulmonary artery pressure > 40 mm Hg measured by cardiac catheterization or with a peak systolic pulmonary artery pressure > 45 mm Hg measured by Doppler echocardiography, at rest, utilizing standard procedures described in section IV.B.2.c(2)(a)(i) of the Settlement Agreement and assuming a right atrial pressure of 10 mm Hg; (2) Abnormal left ventricular end-systolic dimension > or = 45 mm by M-mode or 2-D Echocardiogram; and/or - ======================================= I. DEFINITIONS. 11 (3) Ejection fraction of < 50%. 32. "Individual Payment Amount" is defined in Section VII.A.7. 33. "Initial Category One Class List" is the list appended as Exhibit "B" to this Seventh Amendment and defined in Section XIV.A. 34. "Initial Deposit" is defined in Section V.A.1. 35. "Initial Post-FJA Deposit" is defined in Section V.A.3. 36. "Initial Review" is defined in Section XV.M. 37. "Interim Distribution" is defined in Section XV.P. 38. "Intermediate Deposit" is defined in Section V.A.2. 39. "Low Threshold Condition" means one or more of the following: a. Severe Mitral Regurgitation and no High Threshold complicating factors as defined in Section I.B.31.c; b. FDA Positive valvular regurgitation with bacterial endocarditis contracted after commencement of Diet Drug use; c. Moderate Mitral Regurgitation with one or more of the following: (1) Pulmonary hypertension secondary to valvular heart disease with peak systolic pulmonary artery pressure > 40 mm Hg measured by cardiac catheterization or with a peak systolic pulmonary artery pressure > 45 mm Hg measured by Doppler echocardiography, at rest, utilizing standard ======================================= I. DEFINITIONS. 12 procedures and assuming a right atrial pressure of 10 mm Hg; or (2) Abnormal left atrial supero-inferior systolic dimension > 5.3 cm (apical four chamber view) or abnormal left atrial antero-posterior systolic dimension > 4.0 cm (parasternal long axis view) measured by 2-D directed M-mode or 2-D echocardiography with normal sinus rhythm using sites of measurement recommended by the American Society of Echocardiography; or (3) Abnormal left ventricular end-systolic dimension > or = 45 mm by M-mode or 2-D Echocardiogram; and/or - (4) Ejection fraction of < or = 60%. 40. "Matrix Claim" means a claim of a Class Member seeking Matrix Compensation Benefits under section IV.B of the Settlement Agreement. 41. "Matrix Election Payment" is defined in Section VII.C.5. 42. "Medical Review" is described in Section XV.M. 43. "Medical Review Coordinating Committee" or "MRCC" is defined in Section IV.C. 44. "Minimum Payment Amount" means $2,000, as further defined in Section VII.B.1. 45. "Moderate Aortic Regurgitation" or " Moderate AR" means FDA Positive regurgitation of the aortic heart valve in which the ratio between the regurgitant jet height and the left ventricular outflow tract height (JH/LVOTH) is > or = 25% and < or = 49%, as determined by color flow Doppler echocardiography ======================================= I. DEFINITIONS. 13 using the methods described by Singh(1), and as further described in the Settlement Agreement. 46. "Moderate Mitral Regurgitation" or "Moderate MR" means FDA Positive regurgitation of the mitral heart valve in which the ratio between the regurgitant jet area and the left atrial area (RJA/LAA) is > or = 20% and < or = 40%, as determined by color flow Doppler echocardiography using the methods described by Singh, and as further described in the Settlement Agreement. 47. "Net Matrix Amount" is defined in Section IX.A.2. 48. "Net Supplemental Class Settlement Fund Amount" is defined in Section VII.A.7. 49. "Notice of Default" is the notice that the Fund Administrator and/or the Trust is required to provide to Wyeth under Section XVI.A in the event of a default in Wyeth's obligation to deposit security under Section VI. 50. "Participating Physicians" is defined in Section XV.I. 51. "Preliminary Approval" means the entry of an order in conformity with Section XVII.A. 52. "Pre-Stay Payable PADL" means a Post-Audit Determination Letter issued pursuant to Rules 12 through 17 of the Rules for the Audit of Matrix Compensation Claims approved by the Court in Pretrial Order No. 2807, a notice issued pursuant to paragraph 6 of Court Approved Procedure ("CAP") No. 4, and/or a Post-Audit Determination Letter issued pursuant to section IV.A or IV.B of the Policies and Procedures for Audit - --------------------- (1) J. P. Singh, et al., Prevalence of Clinical Determinants of Mitral, Tricuspid and Aortic Regurgitation (The Framingham Heart Study), 83 AM. J. CARDIOLOGY 897, 898 (1999) (hereinafter "Singh"). ======================================= I. DEFINITIONS. 14 and Disposition of Matrix Compensation Claims in Audit approved by the Court in Pretrial Order No. 2457, which meets all of the following criteria: a. It was issued by the Trust on or before May 6, 2004; b. It was issued after a Trust Audit in which the Auditing Cardiologist determined that there was a reasonable medical basis for a Matrix Claim; c. It was issued with respect to a claim for Matrix Level I or Matrix Level II benefits; and d. The affected Class Member(s) has not received any payment based on the Audit outcome with respect to the Matrix Claim as of the Execution Date. 53. "QCC Report" is defined in Section XV.I. 54. "Qualified Cardiology Centers" is defined in Section XV.I. 55. "Relative Payment Grid" is defined in Section VII.A.2. 56. "Relative Payment Grid Levels" are described in Sections VII.A.3-4. 57. "Relative Payment Value" is defined in Sections VII.A.5-6. 58. "Releasing Parties" means each Category One Class Member and each Category Two Class Member, including Derivative Claimants, who does not timely and properly exercise a Seventh Amendment Opt-Out, individually and for his or her heirs, beneficiaries, agents, estates, executors, administrators, personal representatives, attorneys, successors and assigns (and/or if the Class Member is a legal representative of another person, in that capacity). ======================================= I. DEFINITIONS. 15 59. "Relevant Echocardiogram" means an Echocardiogram: a. Performed before the end of the Screening Period, which demonstrates FDA Positive regurgitation or Mild Mitral Regurgitation; b. On the Diet Drug Recipient whose medical condition forms the basis of the Matrix Claim; c. After the Diet Drug Recipient's ingestion of Diet Drugs; d. As the single Echocardiogram on which the Class Member has based a claim that a Diet Drug Recipient had the Matrix Level condition claimed by the Attesting Physician in Part II of the Green Form submitted in support of the Matrix Claim. Where a Class Member has had an Echocardiogram performed after Diet Drug use and before the end of the Screening Period which demonstrates FDA Positive regurgitation or Mild Mitral Regurgitation but which does not otherwise demonstrate either a High Threshold Condition or a Low Threshold Condition, then solely for purposes of determining whether a Category One Class Member is entitled to Benefits Subject to Medical Review, a "Relevant Echocardiogram" also includes the single additional Echocardiogram that purportedly demonstrates the remaining elements of either a High Threshold Condition or a Low Threshold Condition, provided that such Echocardiogram complies with Section I.B.59.b and c. 60. "Revoked Opt-Out" means an Initial Opt-Out, Intermediate Opt-Out, and/or Back-End Opt-Out of a Class Member who has requested that Wyeth consent to revocation of the opt-out, and whose request Wyeth has granted by written notice to the Class Member. ======================================= I. DEFINITIONS. 16 61. "Second Review" is defined in Section XV.M. 62. "Settlement Agreement" means the Nationwide Class Action Settlement Agreement with American Home Products Corporation (now Wyeth by corporate name change as of March 11, 2002), as amended through and including the Sixth Amendment approved by the Court on March 12, 2003, in PTO No. 2778. 63. "Seventh Amendment Liaison Committee" or "SALC" is defined in Section IV.D. 64. "Seventh Amendment Matrix Compensation Benefits" means those Matrix Compensation Benefits which may be paid or claimed for High Matrix Level Qualifying Factors to or by Category One Class Members or Category Two Class Members in accordance with the terms of the Seventh Amendment. 65. "Seventh Amendment Opt-Out/Objection Period" means the 60-day period, or such other period established by the Court, within which Category One Class Members and Category Two Class Members may object to or opt out of this Seventh Amendment, as defined in Section XII. 66. "Seventh Amendment Security Fund" is defined in Section VI. 67. "Seventh Amendment Walkaway Right" is defined in Section XIII.B. 68. "Severe Aortic Regurgitation" or "Severe AR" means FDA Positive regurgitation of the aortic heart valve, in which the ratio between the regurgitant jet height and the left ventricular outflow tract height (JH/LVOTH) is > 49%, as determined by color flow Doppler echocardiography using the methods described by Singh, and as further described in the Settlement Agreement. ======================================= I. DEFINITIONS. 17 69. "Severe Mitral Regurgitation" or "Severe MR" means FDA Positive regurgitation of the mitral heart valve in which the ratio between the regurgitant jet area and the left atrial area (RJA/LAA) is > 40% as determined by color flow Doppler echocardiography using the methods described by Singh, and as further described in the Settlement Agreement. 70. "Supplemental Claim" means a claim for incremental Matrix Compensation Benefits under section IV.C.3 of the Settlement Agreement by a Class Member (other than a Category One Class Member or a Category Two Class Member) who was paid Matrix Compensation Benefits on any Matrix Level by the Trust. 71. "Supplemental Class Settlement Fund" is defined in Section V.A. 72. "Third Party Payor" is defined in Section XV.W. 73. "Trial Court Approval of the Seventh Amendment" means entry of an order or orders by the Court approving the Seventh Amendment, which satisfy the conditions specified in Section XVIII.C.7. 74. "Trust" means the AHP Settlement Trust established pursuant to the Settlement Agreement and also shall mean "Trustees and/or Claims Administrator." 75. "Trust Determination Denying Matrix Benefits" means that as of May 6, 2004, the Trust had issued a Post-Audit Determination Letter and/or a Final Post-Audit Determination Letter on a Matrix Claim (under the Audit Rules approved by PTO No. 2457 and/or by PTO No. 2807), informing the Class Member that the Trust had determined that the Class Member is not entitled to payment of any Matrix Compensation Benefits regardless of whether as of May 6, 2004: (i) the time for the Class Member to Contest a Post-Audit Determination Letter ======================================= I. DEFINITIONS. 18 had expired; (ii) the claim was subject to a Contest by the Class Member; (iii) the time for the Class Member to dispute a Final Post-Audit Determination Letter had expired; (iv) the claim was subject to dispute by the Class Member; (v) the claim was the subject of an Application for Show Cause Order; and/or (vi) the claim was the subject of an Order to Show Cause. 76. "Walkaway Period" is defined in Section XIII.A. ======================================= I. DEFINITIONS. 19 II. SEVENTH AMENDMENT. Immediately upon Final Judicial Approval of the Seventh Amendment, it shall become effective as the Seventh Amendment to the Settlement Agreement. ======================================= II. SEVENTH AMENDMENT. 20 III. CLASS MEMBERS SUBJECT TO THIS SEVENTH AMENDMENT. A. CATEGORIES OF CLASS MEMBERS. This Seventh Amendment applies to two categories of Diet Drug Recipients (or their Representative Claimants), as follows: 1. "Category One" consists of all Diet Drug Recipients (or their Representative Claimants) who: a. Have signed a Pink Form, a Blue Form, and/or Part I of a Green Form, and submitted it to the Trust on or before May 3, 2003, and/or on whose behalf a Green Form Part II was substantially completed as further described in Section III.A.1.b(2), signed and submitted by an Attesting Physician to the Trust on or before May 3, 2003; and b. (i) In the case of any Class Members who have exercised an Initial, Intermediate, or Back-End Opt-Out right under the Settlement Agreement, have submitted a Green Form to the Trust before May 6, 2004, and (ii) in the case of any other Class Member, have submitted a Green Form to the Trust, or pursuant to Section XIV.C.4, submits a Green Form to the Trust before the end of the Seventh Amendment Opt-Out/Objection Period: (1) In which Part I was signed by the Class Member and in which Part II was signed by an Attesting Physician; and (2) In which the unaudited answers provided by the Attesting Physician in Part II of the Green Form contain sufficient information on medical conditions to support a claim for Matrix Compensation Benefits on Matrix Level I and/or Matrix Level II of the Settlement Agreement, but which do not support a claim on Matrix Level III, ======================================= III. CLASS MEMBERS SUBJECT TO THIS SEVENTH AMENDMENT. 21 Matrix Level IV, or Matrix Level V of the Settlement Agreement; and c. Have not received payment of any Matrix Compensation Benefits from the Trust; and d. Have not received, on or before the Execution Date, a Trust Determination Denying Matrix Benefits on the Green Form referred to in Section III.A.1.b; and e. Have not been the subject of a Pre-Stay Payable PADL; and f. Have not signed an individual release of claims arising from the use of Diet Drugs, and/or have not been the subject of a final order dismissing with prejudice an action relating to injuries arising from the use of Diet Drugs, unless such order expressly preserves the Class Member's ability to seek benefits under the Settlement Agreement. 2. "Category Two" consists of all Diet Drug Recipients (or their Representative Claimants) who: a. Have submitted a signed Pink Form, Blue Form, Green Form Part I, Green Form Part II, and/or Gray Form to the Trust on or before May 3, 2003, or who presently have a good faith belief that they timely registered for benefits under the Settlement Agreement and are determined by the Court to have been timely registered for benefits under the terms of the Settlement Agreement as it existed before the Seventh Amendment; and b. Have been diagnosed as having Mild Mitral Regurgitation or FDA Positive regurgitation after Diet Drug use and by the end of the Screening Period; and ======================================= III. CLASS MEMBERS SUBJECT TO THIS SEVENTH AMENDMENT. 22 c. Have not filed a Green Form Part II with the Trust on or before the end of the Seventh Amendment Opt-Out/Objection Period in which the unaudited answers provided by the Attesting Physician in the Green Form Part II contain sufficient information on medical conditions to support a claim for Matrix Compensation Benefits on Matrix Level III, Matrix Level IV, or Matrix Level V of the Settlement Agreement; and d. Have not received payment of any Matrix Compensation Benefits from the Trust; and e. Are not members of Category One; and f. Have not exercised or attempted to exercise an Initial Opt-Out, Intermediate Opt-Out, or Back-End Opt-Out, unless that opt-out is a Revoked Opt-Out; and g. Have not signed an individual release of claims arising from the use of Diet Drugs, and/or have not been the subject of a final order dismissing with prejudice an action relating to injuries arising from the use of Diet Drugs, unless such order expressly preserves the Class Member's ability to seek benefits under the Settlement Agreement. B. DERIVATIVE CLAIMANTS. The Derivative Claimants of Diet Drug Recipients (or their Representative Claimants) in Category One or Category Two shall receive benefits from Category One or Category Two only: (i) if they would have been eligible for Matrix Compensation Benefits under the Settlement Agreement; and if so, (ii) only as expressly provided in this Seventh Amendment. As to all actions under the Seventh Amendment, the Diet Drug Recipient's (or the Representative Claimant's) action or failure to act shall be binding on the associated Derivative Claimant(s) of that Diet Drug Recipient (or Representative Claimant). ======================================= III. CLASS MEMBERS SUBJECT TO THIS SEVENTH AMENDMENT. 23 C. PROGRESSION DURING PENDENCY OF THE SEVENTH AMENDMENT. 1. If the valvular heart disease of a Diet Drug Recipient who is a Category One Class Member or Category Two Class Member progresses such that the Diet Drug Recipient becomes qualified for payment of Matrix Compensation Benefits on Matrix Level III, Matrix Level IV, or Matrix Level V of the Settlement Agreement and demonstrates High Matrix Level Qualifying Factors after the Execution Date but before Final Judicial Approval of the Seventh Amendment, then the Diet Drug Recipient's claim shall be processed pursuant to this Section III.C. 2. For this purpose, notwithstanding any stay on Trust processing of Matrix Claims submitted by Category One Class Members or Category Two Class Members pending Final Judicial Approval of the Seventh Amendment, the Trust shall process claims by Category One Class Members or Category Two Class Members who submit to the Trust a Green Form Part II signed by an Attesting Physician, in which the unaudited answers by the Attesting Physician contain sufficient information on medical conditions to support a claim for Matrix Compensation Benefits on Matrix Level III, Matrix Level IV, or Matrix Level V of the Settlement Agreement, with High Matrix Level Qualifying Factors. If the Trust determines that the Diet Drug Recipient satisfies these conditions and is eligible for Matrix Compensation Benefits on Matrix Level III, Matrix Level IV, or Matrix Level V of the Settlement Agreement, with High Matrix Level Qualifying Factors, the Trust shall pay such benefits from the Settlement Fund in accordance with the Settlement Agreement. If the Trust determines that the Diet Drug Recipient does not satisfy these conditions, the claim shall return to its classification before submission of a claim for Matrix Level III, IV, or V benefits, as a Category One Class Member or a Category Two Class Member claim. ======================================= III. CLASS MEMBERS SUBJECT TO THIS SEVENTH AMENDMENT. 24 3. Upon Final Judicial Approval of the Seventh Amendment, the Fund Administrator shall subject to the Medical Review process the claim of each Class Member whose claim is determined by the Trust to satisfy the conditions in Section III.C.2. If the Fund Administrator determines that such Class Member is eligible for Benefits Subject to Medical Review, the Fund Administrator shall calculate the Individual Payment Amount that such Class Member would have received from the Fund Administrator as a Category One Class Member and remit that amount to the Trust. For this purpose: a. The Trust shall furnish a copy of the Relevant Echocardiogram for each such Class Member to the Fund Administrator together with a copy of the claim file maintained by the Trust with respect to such Class Member; b. The Medical Review process shall consist of a review of the Relevant Echocardiogram furnished by the Trust to the Fund Administrator; and c. The Fund Administrator shall determine whether such Class Member is eligible for Benefits Subject to Medical Review based on the results of such review process and the information contained in the claim file furnished to the Fund Administrator by the Trust. Class Members are not required to provide information to the Fund Administrator unless specifically requested by the Fund Administrator to do so. ======================================= III. CLASS MEMBERS SUBJECT TO THIS SEVENTH AMENDMENT. 25 IV. APPOINTMENT OF THE FUND ADMINISTRATOR, ESCROW AGENT, MEDICAL REVIEW CONSULTING COMMITTEE, AND THE SALC. A. THE FUND ADMINISTRATOR. 1. Within 14 days after the Execution Date, Class Counsel and the SALC jointly shall nominate Heffler, Radetich & Saitta, L.L.P., for appointment by the Court to serve as "Fund Administrator" for purposes of administering the terms of the Seventh Amendment pursuant to the terms of a Fund Administrator Agreement to be approved by the Court. 2. If Heffler, Radetich & Saitta, L.L.P., is not appointed as Fund Administrator or becomes unable or unwilling to serve, then Class Counsel and the SALC jointly shall recommend appointment of another natural person, corporation, or other entity to serve as Fund Administrator, and upon appointment by the Court, such natural person, corporation, or other entity thereafter shall serve as Fund Administrator. 3. Except as set forth in Section IV.A.2, the Fund Administrator may be removed or replaced only by order of the Court for good cause shown. B. THE ESCROW AGENT. 1. Within 14 days after the Execution Date, Class Counsel and the SALC jointly shall nominate PNC Bank, N.A., for appointment by the Court to serve as "Escrow Agent" for purposes of receiving, investing, and disbursing the Supplemental Class Settlement Fund (as defined in Section V.A) pursuant to the terms of an escrow agreement in a form approved by the Court. 2. If PNC Bank, N.A., is not appointed as Escrow Agent or becomes unable or unwilling to serve, then Class Counsel and the SALC jointly shall recommend appointment of another ======================================= IV. APPOINTMENT OF THE FUND ADMINISTRATOR, ESCROW AGENT, MEDICAL REVIEW CONSULTING COMMITTEE, AND THE SALC. 26 financial institution to serve as Escrow Agent, and upon appointment by the Court, such financial institution thereafter shall serve as Escrow Agent. 3. Except as set forth in Section IV.B.2, the Escrow Agent may be removed or replaced only by order of the Court for good cause shown. C. THE MEDICAL REVIEW COORDINATING COMMITTEE. 1. The Medical Review Coordinating Committee ("MRCC") shall consist of three Board-Certified Cardiologists with Level 3 training in echocardiography, who shall be appointed by the Court. Within 14 days after the Execution Date, Class Counsel and the SALC jointly shall nominate Dean Karalis, M.D., F.A.C.C., Gregg Reis, M.D., F.A.C.C., and Frank Silvestry, M.D., F.A.C.C., jointly to serve as members of the MRCC pursuant to the terms of an agreement in a form approved by the Court. 2. If any physician proposed for membership in the MRCC is not appointed or if any physician appointed to the MRCC becomes unable or unwilling to serve on the MRCC, then Class Counsel and the SALC jointly shall recommend appointment of another Board-Certified Cardiologist with Level 3 training in echocardiography and, upon appointment by the Court, such physician thereafter shall serve as a member of the MRCC. 3. Except as set forth in Section IV.C.2, the members of the MRCC may be removed or replaced only by order of the Court for good cause shown. D. THE SEVENTH AMENDMENT LIAISON COMMITTEE. 1. The Seventh Amendment Liaison Committee ("SALC") shall assist in the implementation of this Seventh Amendment as ======================================= IV. APPOINTMENT OF THE FUND ADMINISTRATOR, ESCROW AGENT, MEDICAL REVIEW CONSULTING COMMITTEE, AND THE SALC. 27 liaison between counsel for Category One Class Members and Category Two Class Members, on the one hand, and Class Counsel, Wyeth and the Court, on the other hand. Subject to approval of the Court, the SALC shall consist of the following attorneys, all of whom represent Category One Class Members and Category Two Class Members and who assisted in the negotiation and finalization of the Seventh Amendment: Jerry Alexander, Esquire; James Doyle, Esquire; Tony Martinez, Esquire; Ellen Presby, Esquire; and Wayne Spivey, Esquire, who shall serve as chair of the Committee. 2. A member of the SALC may be removed or replaced only by order of the Court for good cause shown. 3. The members of the SALC shall be entitled to participate in any common benefit fee which may be awarded by the Court with respect to activities of common benefit in creating, negotiating, obtaining Trial Court Approval of the Seventh Amendment and Final Judicial Approval of the Seventh Amendment, and administering and otherwise implementing the Seventh Amendment. 4. The Parties explicitly acknowledge that the SALC does not act in a representative capacity on behalf of the Class. E. IMMUNITY FROM LIABILITY. 1. The Fund Administrator, the Escrow Agent, the MRCC, and the Participating Physicians (as defined in Section XV.I) shall have no liability to any person for any act or transaction taken by them in good faith pursuant to the terms of this Seventh Amendment and/or any procedure, document, rule, or agreement arising from this Seventh Amendment, and shall be entitled to qualified judicial immunity for any action reported to the Court in an Authorization Application (as defined in ======================================= IV. APPOINTMENT OF THE FUND ADMINISTRATOR, ESCROW AGENT, MEDICAL REVIEW CONSULTING COMMITTEE, AND THE SALC. 28 Section V.G) and approved by the Court in an Authorization Order (as defined in Section V.H). 2. The Fund Administrator, the Escrow Agent, the MRCC and the Participating Physicians shall be indemnified by the Supplemental Class Settlement Fund with respect to the costs of defending against, and with respect to any and all liability based on, any claim arising from any act, omission or transaction by them in good faith pursuant to the terms of this Seventh Amendment and/or any procedure, document, rule, or agreement arising from this Seventh Amendment. 3. Wyeth shall have no liability or responsibility for any of the actions or omissions of the Fund Administrator, the Escrow Agent, the MRCC, the Participating Physicians, the SALC, Class Counsel, or any agent or contractor of the Supplemental Class Settlement Fund, and none of the foregoing shall have any recourse against Wyeth for any claim against them based upon such actions or omissions. 4. The Fund Administrator shall use its best efforts to procure and maintain commercially reasonable amounts and types of insurance against any liability asserted against or incurred by the Fund Administrator, the Escrow Agent, the MRCC, and the Participating Physicians, in such capacities or arising from their status under the Seventh Amendment, and to provide the indemnification required under this Section IV.E. Such insurance shall be maintained for a period of time at least equal to any statute of limitations periods applicable to potential claims against these parties. The Fund Administrator shall apply to the Court for an order approving the amount and type of coverage it intends to obtain. In the event that the Fund Administrator is unable to obtain such insurance by a date which is 30 days after the date of Trial Court Approval of the Seventh Amendment, then the Fund Administrator shall apply to the Court for an order permitting it to proceed without ======================================= IV. APPOINTMENT OF THE FUND ADMINISTRATOR, ESCROW AGENT, MEDICAL REVIEW CONSULTING COMMITTEE, AND THE SALC. 29 obtaining insurance. Wyeth shall have the right to be heard in connection with any application to the Court pertaining to such insurance. 5. If the Supplemental Class Settlement Fund has insufficient funds to satisfy any uninsured or underinsured indemnity obligation to the Fund Administrator, the Escrow Agent, the MRCC, and the Participating Physicians pursuant to Section IV.E.2, then upon application and good cause shown, the Court may authorize the Settlement Fund to indemnify them with respect to the costs of defending against, and with respect to any and all liability based on, any claim arising from any act or failure to act, in good faith, pursuant to the terms of this Seventh Amendment and/or any procedure, document, rule, or agreement arising from this Seventh Amendment. Wyeth and the Trust shall have the right to be heard in connection with any such good cause application to the Court. 6. The order(s) appointing the Fund Administrator, the Escrow Agent, and the MRCC shall include terms sufficient to effectuate the provisions of Section IV.E. ======================================= IV. APPOINTMENT OF THE FUND ADMINISTRATOR, ESCROW AGENT, MEDICAL REVIEW CONSULTING COMMITTEE, AND THE SALC. 30 V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS. A. SUPPLEMENTAL CLASS SETTLEMENT FUND. A "Supplemental Class Settlement Fund" shall be established to receive a total amount of $1,275,000,000 for the benefit of Category One Class Members, to be paid by Wyeth to the Escrow Agent subject to the conditions set forth in this Seventh Amendment, as follows: 1. Within ten Business Days after the date of Preliminary Approval of the Seventh Amendment, Wyeth shall pay to the Escrow Agent an "Initial Deposit" in the amount of $5,000,000. 2. Within five Business Days after the date of Trial Court Approval of the Seventh Amendment, Wyeth shall pay to the Escrow Agent an "Intermediate Deposit" in the amount of $20,000,000. If needed by the Fund Administrator (for the purposes identified in Section V.B) after payment by Wyeth of the Intermediate Deposit and before payment by Wyeth of the Initial Post-FJA Deposit (under Section V.A.3), Wyeth shall pay to the Escrow Agent, within five Business Days after Wyeth's receipt of a written request by the Fund Administrator, such amounts as are reasonably requested by the Fund Administrator, up to a total amount of $25,000,000, in addition to the Initial Deposit and the Intermediate Deposit. 3. Within five Business Days after the date of Final Judicial Approval of the Seventh Amendment, Wyeth shall pay to the Escrow Agent an "Initial Post-FJA Deposit" of $400,000,000. 4. After payment of the Initial Post-FJA Deposit, Wyeth shall pay the Escrow Agent "Additional Post-FJA Deposits," up to a total of $1,275,000,000, less the Initial Deposit, the Intermediate Deposit, the Initial Post-FJA Deposit, and any other amounts previously paid by Wyeth to the Escrow Agent under this ======================================= V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS. 31 Seventh Amendment, and less the Category Two Election Amount, in such installments as the Fund Administrator shall reasonably request, to fund the payment of benefits to Category One Class Members and associated costs of administration, subject to the terms of this Seventh Amendment, with such payments to be made to the Escrow Agent within five Business Days after Wyeth's receipt of a written request by the Fund Administrator for payment of such an Additional Post-FJA Deposit. Prior to making such written request, the Fund Administrator shall determine the Category Two Election Amount and inform Wyeth of the credit to which it is entitled as a result thereof. 5. The Initial Deposit, Intermediate Deposit, Initial Post-FJA Deposit, Additional Post-FJA Deposits, and any other payments made by Wyeth to the Escrow Agent under Section V.A, collectively, shall comprise the Supplemental Class Settlement Fund and shall be available and shall be used to pay those benefits to which Category One Class Members are entitled under this Seventh Amendment (and all deductions from or payments relating to such benefits), and the associated costs of administration of such benefits. 6. Wyeth's payment of funds to the Escrow Agent under this Section V.A shall be in addition to any of its payment obligations under section III.C of the Settlement Agreement and shall not reduce the Maximum Available Fund B Amount under section I.1 of the Settlement Agreement. 7. Wyeth shall have no financial obligations to the Supplemental Class Settlement Fund other than as explicitly set forth in Section V.A. 8. Wyeth shall have no responsibility for the management or administration of the Supplemental Class Settlement Fund or any liability to any Class Members arising from the processing ======================================= V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS. 32 of claims by the Fund Administrator and/or the management of the Supplemental Class Settlement Fund. 9. All payments by Wyeth to the Escrow Agent under Section V.A shall be made by wire transfer. B. USE OF FUNDS BEFORE FINAL JUDICIAL APPROVAL OF THE SEVENTH AMENDMENT. Before Final Judicial Approval of the Seventh Amendment, the funds paid by Wyeth to the Escrow Agent under Section V.A may be used to: 1. Pay such expenses as may be reasonably necessary to establish a mechanism to administer the payment of benefits to Category One Class Members, including payment of appropriate professional fees to attorneys, accountants, health care providers, insurers, consultants, and other vendors and service providers; and 2. Establish Qualified Cardiology Centers (as defined in Section XV.I), to receive and process information and Relevant Echocardiograms from Category One Class Members, to have such information and Echocardiograms reviewed by the Qualified Cardiology Centers, to obtain QCC Reports (as defined in Section XV.I) and to perform all other administrative activities described in Section XV so that Benefits Subject to Medical Review (as defined in Section I.B.10) may promptly be paid to eligible Class Members as soon after Final Judicial Approval of the Seventh Amendment as is reasonably practicable; and 3. Pay all state and federal income and other taxes or fees of any kind applicable to the Supplemental Class Settlement Fund. C. NOTICE. 1. The Parties shall carry out the printing and mailing of a Notice of the Seventh Amendment, in a form approved by the Court, ======================================= V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS. 33 to all Class Members who have ever registered or purported to register with the Trust or who have submitted any type of form to the Trust (including Class Members who have exercised or attempted to exercise any right of opt-out) and to all known attorneys representing such Class Members, at the addresses reflected in the most recent version of the Trust's database made available to the Parties at the time Notice is disseminated. 2. Where an attorney represents more than one registered Class Member, it shall be sufficient to provide that attorney with a single copy of the Notice. 3. The Notice shall also be posted on the website maintained by the Trust and the official MDL 1203 website. 4. The Trust shall pay the costs of any such Notice out of the Settlement Fund. D. RETURN OF FUNDS. If: (i) Wyeth exercises its Seventh Amendment Walkaway Right (as defined in Section XIII.B); (ii) Trial Court Approval of the Seventh Amendment does not occur; or (iii) Final Judicial Approval of the Seventh Amendment does not occur, then within 30 days after such an event, the Escrow Agent shall return to Wyeth a sum equal to the Initial and Intermediate Deposits, and any other payments by Wyeth to the Escrow Agent before such event, together with the interest and other income accrued thereon, less all expenses reasonably paid or incurred before such event by the Fund Administrator pursuant to Section V.B. E. IMPACT OF FINAL JUDICIAL APPROVAL OF THE SEVENTH AMENDMENT. If Final Judicial Approval of the Seventh Amendment occurs: 1. Immediately upon the date of Final Judicial Approval of the Seventh Amendment, the Supplemental Class Settlement Fund shall become non-reversionary and all funds paid by Wyeth to the Escrow Agent by such time shall become irrevocable and not subject to repayment to Wyeth, in whole or in part. ======================================= V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS. 34 2. The Supplemental Class Settlement Fund shall be structured and managed to qualify as a Qualified Settlement Fund under section 468B of the Internal Revenue Code of 1986, as Amended (the "Code"), and related regulations, and the documents establishing the Supplemental Class Settlement Fund shall contain customary provisions for such funds, including the obligation to make tax filings and to provide to Wyeth information to permit Wyeth to report properly for tax purposes. 3. All income earned on monies held by the Escrow Agent on behalf of the Supplemental Class Settlement Fund shall remain the property of the Supplemental Class Settlement Fund. The Supplemental Class Settlement Fund shall be responsible for the reporting and payment of all state and federal income and other taxes or fees of any kind applicable to the Supplemental Class Settlement Fund. Wyeth shall have no responsibility for any such matters. F. COMPENSATORY DAMAGES. The Parties agree that all of the amounts paid to Class Members from the Supplemental Class Settlement Fund will be paid as alleged damages (other than punitive damages) on account of personal physical injuries or physical sickness of Class Members as described in section 104(a)(2) of the Code. G. AUTHORIZATION APPLICATIONS. The Fund Administrator shall not at any time pay any expenses or make any benefit distributions to Category One Class Members without prior approval by the Court. At such intervals as the Fund Administrator determines are appropriate or as otherwise directed by the Court, the Fund Administrator shall prepare and submit to the Court an application for authorization ("Authorization Application") to pay the reasonable expenses incurred for the administration of this Seventh Amendment and to distribute the benefits (including any Interim Distributions) determined to be due to Category One Class Members under the terms of this Seventh Amendment, and in such application shall set forth the basis for the action for which authorization is sought. In addition, the Fund Administrator shall prepare and submit such an ======================================= V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS. 35 Authorization Application to the Court before incurring any obligation relating to administration costs for payments to any single person or entity, which are reasonably expected to total more than $1,000,000 in the aggregate. The Fund Administrator shall serve a copy of each Authorization Application on Class Counsel, Wyeth, and the SALC. H. AUTHORIZATION ORDERS. The Escrow Agent shall make payments and distributions from the Supplemental Class Settlement Fund to the extent expressly ordered by the Court ("Authorization Order") in response to the Authorization Applications submitted by the Fund Administrator. ======================================= V. THE SUPPLEMENTAL CLASS SETTLEMENT FUND; WYETH'S ADDITIONAL FINANCIAL OBLIGATIONS; AND OTHER PROVISIONS. 36 VI. SECURITY ARRANGEMENTS RELATING TO THE SEVENTH AMENDMENT. A. SEVENTH AMENDMENT SECURITY FUND. Within ten Business Days after the date of Trial Court Approval of the Seventh Amendment, Wyeth shall establish and thereafter maintain a Seventh Amendment Security Fund consisting of cash and/or Permitted Investments in an amount that is equal to that portion of the Supplemental Class Settlement Fund that remains unpaid by Wyeth as of such date, pursuant to the terms of the Seventh Amendment Security Fund Agreement, substantially in the form attached as Exhibit "C" to this Seventh Amendment, with such changes as agreed upon by the Parties. B. PURPOSE OF THE SEVENTH AMENDMENT SECURITY FUND. The Seventh Amendment Security Fund shall secure Wyeth's obligation to make deposits into the Supplemental Class Settlement Fund as required in Section V.A and to make deposits to fund the payment of Seventh Amendment Matrix Compensation Benefits pursuant to the provisions of Section IX. C. IMPACT OF NO FINAL JUDICIAL APPROVAL. If Final Judicial Approval of the Seventh Amendment does not occur for any reason, the Seventh Amendment Security Fund shall be terminated and all cash and Permitted Investments, and retained income thereon, if any, shall be returned to Wyeth. D. WITHDRAWALS BY WYETH FROM THE SEVENTH AMENDMENT SECURITY FUND. If at any time the balance of the Seventh Amendment Security Fund is greater than 100% of the amount of Wyeth's unpaid obligation to the Supplemental Class Settlement Fund under Section V.A, Wyeth may withdraw, at its option, free of any lien, cash and/or Permitted Investments from the Seventh Amendment Security Fund, provided that: 1. The balance in the Seventh Amendment Security Fund must at all times equal or exceed 100% of the amount of Wyeth's unpaid obligation to the Supplemental Class Settlement Fund under Section V.A; 2. Wyeth may make such withdrawals no more frequently than once monthly; and ======================================= VI. SECURITY ARRANGEMENTS RELATING TO THE SEVENTH AMENDMENT. 37 3. At any time that the balance of the Seventh Amendment Security Fund is equal to or less than $255,000,000, no further withdrawals by Wyeth shall be permitted. Wyeth shall maintain the Seventh Amendment Security Fund balance at $255,000,000 and replenish the balance to such level if it should fall below $255,000,000 for any reason. The provisions of this Section shall apply until termination of the Seventh Amendment Security Fund under Section VI.E.2. E. SECURITY FOR WYETH'S GUARANTEE. 1. At such time as the Fund Administrator has substantially completed the distribution of the Supplemental Class Settlement Fund to Category One Class Members, the Trust shall have a non-subordinated, perfected security interest in the assets on deposit in the Seventh Amendment Security Fund to secure Wyeth's deposit obligations to fund payment of Seventh Amendment Matrix Compensation Benefits pursuant to Section IX. 2. The security required by this Section VI and the lien of the Supplemental Class Settlement Fund and/or the Trust shall terminate entirely on June 30, 2012, and any amounts remaining in the Seventh Amendment Security Fund for this purpose at that time shall be returned to Wyeth. ======================================= VI. SECURITY ARRANGEMENTS RELATING TO THE SEVENTH AMENDMENT. 38 VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. A. BENEFITS SUBJECT TO MEDICAL REVIEW. Subject to all provisions of this Seventh Amendment, Category One Class Members shall be eligible to receive Benefits Subject to Medical Review as follows: 1. Each Category One Class Member shall receive monetary benefits from the Supplemental Class Settlement Fund in accordance with the medical condition of the Diet Drug Recipient whose medical condition forms the basis of the claim as determined by the Medical Review process specified in Section XV. 2. For purposes of determining what portion of the Supplemental Class Settlement Fund is payable to Category One Class Members who are entitled to payment of Benefits Subject to Medical Review, a "Relative Payment Grid" is established as follows: ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 39
> or = 61 DAYS OF DIET DRUG USE < or = 60 DAYS OF DIET DRUG USE A ---------------------------------------- -------------------------------------- G HIGH THRESHOLD LOW THRESHOLD HIGH THRESHOLD LOW THRESHOD E GRID LEVEL GRID LEVEL GRID LEVEL GRID LEVE ALPHA (SYMBOL) BETA (SYMBOL) DELTA (SYMBOL) EPSILON (SYMBOL) A T < or = 24 100.00 33.54 20.00 6.71 F I 25-29 95.00 31.87 19.00 6.37 R S 30-34 90.25 30.27 18.05 6.05 T 35-39 85.74 28.76 17.15 5.75 D I 40-44 81.45 27.32 16.29 5.46 A G 45-49 77.38 25.95 15.48 5.19 N O 50-54 73.51 24.66 14.70 4.93 S I 55-59 69.83 23.42 13.97 4.68 S 60-64 66.34 22.25 13.27 4.45 65-69 59.71 20.03 11.94 4.01 70-79 29.85 10.01 5.97 2.00
3. This Relative Payment Grid describes the relative value of the claims of Category One Class Members based on the level of severity of the Diet Drug Recipient's medical condition, whether the Diet Drug Recipient used Diet Drugs for 61 days or more, and the Age at First Diagnosis of the Diet Drug Recipient for each "Relative Payment Grid Level." ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 40 4. The Relative Payment Grid Levels, the medical conditions, and the period of Diet Drug use that determine which Relative Payment Grid Level is applicable to a Category One Class Member are as follows: a. Relative Payment Grid Level "Alpha" (SYMBOL) is the Level applicable to each Category One Class Member whose claim is based on the ingestion of Diet Drugs by a Diet Drug Recipient: (1) Who ingested Diet Drugs for 61 days or more; (2) Whose Relevant Echocardiogram (or other qualifying medical procedure) demonstrates one or more High Threshold Conditions; and (3) Whose claim is not subject to any Alternative Causation Factor. b. Relative Payment Grid Level "Beta" (SYMBOL) is the Level applicable to each Category One Class Member whose claim is based on the ingestion of Diet Drugs by a Diet Drug Recipient: (1) Who ingested Diet Drugs for 61 days or more; (2) Whose Relevant Echocardiogram (or other qualifying medical procedure) demonstrates one or more Low Threshold Conditions; and (3) Whose claim is not subject to any Alternative Causation Factor. c. Relative Payment Grid Level "Delta" (SYMBOL) is the Level applicable to each Category One Class Member whose claim is based on the ingestion of Diet Drugs by a Diet Drug Recipient: ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 41 (1) Who ingested Diet Drugs for fewer than 61 days and/or whose claim is subject to one or more Alternative Causation Factors; and (2) Whose Relevant Echocardiogram (or other qualifying medical procedure) demonstrates one or more High Threshold Conditions. d. Relative Payment Grid Level "Epsilon" (SYMBOL) is the Level applicable to each Category One Class Member whose claim is based on the ingestion of Diet Drugs by a Diet Drug Recipient: (1) Who ingested Diet Drugs for fewer than 61 days and/or whose claim is subject to one or more Alternative Causation Factors; and (2) Whose Relevant Echocardiogram (or other qualifying medical procedure) demonstrates one or more Low Threshold Conditions. 5. Based upon the Medical Review process, the Fund Administrator shall determine the Relative Payment Grid Level and Age at First Diagnosis for each Category One Class Member who has been found eligible to receive Benefits Subject to Medical Review, and shall fix the Relative Payment Value for each such Class Member at the amount specified by the Relative Payment Grid in the cell formed by the intersection between the Relative Payment Grid Level and Age at First Diagnosis as determined for each such Class Member, as further defined in Sections VII.A.2-4. 6. Where the medical condition of a Diet Drug Recipient, as determined in the Medical Review process, satisfies the criteria for more than one Grid Level, then the Relative Payment Value for claims arising from the medical condition of that Diet Drug Recipient shall be the single highest value on the Relative ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 42 Payment Grid for which the Class Member qualifies and shall exclude all lower values for which the Class Member qualifies on the Relative Payment Grid. 7. Each Category One Class Member who is a Diet Drug Recipient (or Representative Claimant) and who is eligible to receive Benefits Subject to Medical Review shall receive from the Supplemental Class Settlement Fund an amount of money - the "Individual Payment Amount" - determined by applying to the Net Supplemental Class Settlement Fund Amount (as defined in this Section) a fraction, the numerator of which is the Relative Payment Value determined for that Class Member and the denominator of which is the total of all Relative Payment Values for all Category One Class Members whom the Fund Administrator has determined are entitled to receive Benefits Subject to Medical Review and Category One Class Members who progress during the pendency of the Seventh Amendment pursuant to Section III.C. Payment of each Individual Payment Amount shall be subject to the provisions of Section XV, including the provisions for deductions for payments of counsel fees, common benefit fees, reimbursements of out-of-pocket expenses advanced by counsel, subrogation claims, payments to Derivative Claimants and the like. For purposes of this Section, the "Net Supplemental Class Settlement Fund Amount" is $1,275,000,000, plus any interest accrued on the Supplemental Class Settlement Fund, and less the following amounts: a. The costs and expenses reasonably incurred by the Fund Administrator to administer the benefits provided for in this Seventh Amendment, including the payment of any applicable taxes and an appropriate reserve for any potential uninsured or underinsured liabilities, as well as for costs and expenses that the Fund Administrator reasonably expects to incur after the date on which the Net Supplemental Class Settlement Fund Amount is finally determined; and ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 43 b. All amounts that have been paid and/or reserved for payment of Minimum Payment Amounts (as defined in Section VII.B) and all amounts that have been paid and/or reserved for payment under Section III.C.2 and 3; and c. The Category Two Election Amount. 8. In connection with the filing of any Authorization Application that is based in whole or in part on the computation of the Net Supplemental Class Settlement Fund Amount, Wyeth shall have an opportunity to be heard before the Court concerning any matter related to the computation of that amount. B. MINIMUM PAYMENT AMOUNT. 1. The Fund Administrator shall pay from the Supplemental Class Settlement Fund the sum of $2,000 as the "Minimum Payment Amount" to any Category One Class Member (other than a Derivative Claimant) who has furnished to the Fund Administrator proof of Diet Drug use in accordance with section VI.C.2.d of the Settlement Agreement, but who is found by the Fund Administrator to be ineligible to receive Benefits Subject to Medical Review as a result of the Medical Review process, a failure timely to submit or complete a claim, or otherwise. Category One Class Members who receive the Minimum Payment Amount shall not be entitled to any other payment from the Supplemental Class Settlement Fund. Derivative Claimants shall not be entitled to a Minimum Payment Amount or any portion of a Minimum Payment Amount. 2. When transmitting a Minimum Payment Amount to a Category One Class Member, the Fund Administrator shall notify the Category One Class Member, using the form of notice attached as Exhibit "D" to this Seventh Amendment, that the endorsement of the payment instrument constitutes agreement ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 44 to the release, subrogation and other provisions of this Seventh Amendment, and the Fund Administrator shall place a legend on each payment instrument advising that endorsement constitutes agreement to such terms, as follows: "Endorsement of this check confirms the release of claims and covenant not to sue in accordance with the Seventh Amendment to the Settlement Agreement." C. CATEGORY TWO ELECTION BY A CATEGORY ONE CLASS MEMBER. 1. A Diet Drug Recipient (or Representative Claimant) who is identified on the Initial Category One Class List or who otherwise qualified for inclusion on such list as of the Execution Date and who elects, at any time before a date which is 120 days after the end of the Seventh Amendment Opt-Out/Objection Period, to withdraw the Matrix Claim that placed the Class Member in Category One, shall receive benefits as a Category Two Class Member. 2. This election is to be made by completing, executing, and delivering to the Fund Administrator the Category Two Election Form appended as Exhibit "E" to this Seventh Amendment. 3. Within 30 days after Trial Court Approval of the Seventh Amendment, the Fund Administrator shall provide to Wyeth and the Trust a written certification identifying each Diet Drug Recipient (or Representative Claimant) who is a Category One Class Member and who has executed a Category Two Election Form ("Category Two Election Certification"). 4. Within 30 days after Final Judicial Approval of the Seventh Amendment, Wyeth shall pay the Trust, for deposit into the Settlement Fund, an amount equal to $2,000 multiplied by the number of Diet Drug Recipients (or Representative Claimants) identified on the Category Two Election Certification. The payment of that amount by Wyeth to the Trust shall not operate ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 45 to reduce or otherwise be credited in reduction of the Maximum Available Fund B Amount. 5. Within 30 days after receiving the deposit of the payment referenced in Section VII.C.4, the Trust shall pay to each Diet Drug Recipient (or Representative Claimant) identified in the Category Two Election Certification the sum of $2,000 as a "Matrix Election Payment." Class Members who receive the Matrix Election Payment shall not receive a Category Two Payment. Derivative Claimants shall not be entitled to a Matrix Election Payment or any portion of a Matrix Election Payment. 6. When transmitting a Matrix Election Payment (defined in Section VII.C.5) to a Category One Class Member, the Trust shall notify the Category One Class Member, using the form of notice attached as Exhibit "D" to this Seventh Amendment, that the endorsement of the payment instrument constitutes agreement to the release, subrogation and other provisions of this Seventh Amendment, and the Trust shall place a legend on each payment instrument advising that endorsement constitutes agreement to such terms, as follows: "Endorsement of this check confirms the release of claims and covenant not to sue in accordance with the Seventh Amendment to the Settlement Agreement." 7. Wyeth shall receive a credit against its payment obligations to the Supplemental Class Settlement Fund under Section V.A in an amount equal to the Category Two Election Amount. D. TIMING AND CONDITION OF PAYMENTS. No payments may be paid by the Supplemental Class Settlement Fund to Category One Class Members until after Final Judicial Approval of the Seventh Amendment. After Final Judicial Approval of the Seventh Amendment, no payments other than the Minimum Payment Amount may be made by the Supplemental Class Settlement Fund to Category One Class Members unless the Fund Administrator has received from the Category One Class Member a properly executed Release and Covenant Not to Sue in the form attached as Exhibit "F." ======================================= VII. BENEFITS FOR CATEGORY ONE CLASS MEMBERS. 46 VIII. BENEFITS FOR CATEGORY TWO CLASS MEMBERS. A. CATEGORY TWO PAYMENT. 1. Each Diet Drug Recipient (or Representative Claimant) who is a Category Two Class Member shall be entitled to receive a "Category Two Payment" of $2,000 from the Trust upon submission to the Trust of: (i) proof of Diet Drug use in accordance with section VI.C.2.d of the Settlement Agreement; and (ii) a properly completed Gray Form or Green Form (including a copy of the Tape or Disk of the Echocardiogram on which the claim is based) demonstrating that such Diet Drug Recipient was diagnosed by a Qualified Physician as FDA Positive or as having Mild Mitral Regurgitation by an Echocardiogram performed after the commencement of Diet Drug use and before the end of the Screening Period. Derivative Claimants shall not be entitled to a Category Two Payment or any portion of a Category Two Payment. 2. The Category Two Payment amount shall be in addition to the Cash/Medical Services Benefit, if any, to which the Diet Drug Recipient (or Representative Claimant) may be entitled or may have received. B. ADMINISTRATION OF CATEGORY TWO PAYMENTS. 1. Within 30 days after Final Judicial Approval of the Seventh Amendment, Wyeth shall furnish to the Trust, Class Counsel, and the SALC a list that identifies, by the unique Trust-assigned identification number ("DDR Number") and by claimant name, all the Class Members who appear to be Category Two Class Members as of the date of the list and who appear to qualify for the Category Two Payment (the "Category Two Payment List"), based upon Wyeth's review of the most recent version of the database that the Trust has made available to the Parties, and the underlying documents and other relevant information. Within ten days after its receipt of the Category ======================================= VIII. BENEFITS FOR CATEGORY TWO CLASS MEMBERS. 47 Two Payment List, the Trust shall redact the names but not the DDR Numbers of Class Members from the list and shall post the list, without claimant names, on the Trust's website, in a manner that can be read and printed. 2. No later than 60 days after Final Judicial Approval of the Seventh Amendment, the Trust shall pay a Category Two Payment to each Category Two Class Member identified on the Category Two Payment List. 3. No later than 60 days after Final Judicial Approval of the Settlement Agreement, the Trust shall transmit a notice to every potential Category Two Class Member whose name does not appear on the Category Two Payment List, which informs such Class Members that if they are not on the list and believe they are eligible to receive a Category Two Payment from the Trust, they will not receive the Category Two Payment unless such Class Member submits or has submitted to the Trust no later than seven months after the date of Final Judicial Approval of the Seventh Amendment, all of the following: a. An Echocardiogram Tape or Disk for the relevant Diet Drug Recipient, conducted after Diet Drug use and by the end of the Screening Period, and in compliance with the Settlement Agreement, showing FDA Positive regurgitation or Mild Mitral Regurgitation; b. A properly completed and signed Green Form or Gray Form documenting a diagnosis of FDA Positive regurgitation or Mild Mitral Regurgitation based upon such Echocardiogram; and c. Proof of Diet Drug use in accordance with section VI.C.2.d of the Settlement Agreement. This notice shall also advise Category Two Class Members that if they have already furnished such information to the Trust, ======================================= VIII. BENEFITS FOR CATEGORY TWO CLASS MEMBERS. 48 they should either furnish another copy of the information to the Trust or inform the Trust, in writing, that the information has been provided previously. 4. Within 60 days after receiving a submission or other information from a Category Two Class Member in response to any notice sent under Section VIII.B.3, the Trust shall: (i) determine the completeness of the claim and eligibility for the Category Two Payment; (ii) resolve any claims by Class Members that they have previously furnished materials described in Section VIII.B.3; and (iii) pay the Category Two Payment to each Category Two Class Member determined to be eligible for such payment. 5. If a Diet Drug Recipient fails timely to comply with the notice from the Trust sent under Section VIII.B.3, the Trust shall have no further obligation to process the Diet Drug Recipient's claim for a Category Two Payment, and that Diet Drug Recipient's claim for this benefit shall be extinguished. 6. After Final Judicial Approval of the Seventh Amendment, the Trust shall include in its Settlement Fund Quarterly Notices (or such other notices as agreed upon by the Parties pursuant to section III.C.4.e of the Settlement Agreement) funds sufficient to make Category Two Payments to all Category Two Class Members determined by the Trust to be entitled to such payments by such time. Wyeth shall include such amounts in its Fund B Deposit in response to such Notice. Amounts deposited by Wyeth into the Settlement Fund for this purpose shall not reduce the Maximum Available Fund B Amount. C. TIMING OF CATEGORY TWO PAYMENTS. No Category Two Payments may be paid to Category Two Class Members until after Final Judicial Approval of the Seventh Amendment. D. CONDITION OF CATEGORY TWO PAYMENTS. When transmitting a Category Two Payment to a Category Two Class Member, the Trust shall notify ======================================= VIII. BENEFITS FOR CATEGORY TWO CLASS MEMBERS. 49 the Category Two Class Member, using the form of notice attached as Exhibit "D" to this Seventh Amendment, that the endorsement of the payment instrument constitutes agreement to the release, subrogation and other provisions of this Seventh Amendment, and the Trust shall place a legend on each payment instrument advising that endorsement constitutes agreement to such terms, as follows: "Endorsement of this check confirms the release of claims and covenant not to sue in accordance with the Seventh Amendment to the Settlement Agreement." ======================================= VIII. BENEFITS FOR CATEGORY TWO CLASS MEMBERS. 50 IX. BENEFITS FOR CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. A. SEVENTH AMENDMENT MATRIX COMPENSATION BENEFITS. Each Category One Class Member and each Category Two Class Member shall be entitled to receive from the Trust payment of Seventh Amendment Matrix Compensation Benefits, if the Class Member qualifies as follows: 1. Seventh Amendment Matrix Compensation Benefits shall be payable to a Category One Class Member or a Category Two Class Member if, but only if, the Trust determines after Audit of the claim and in accordance with standards and procedures then in effect under the Settlement Agreement and all applicable Court orders that: a. The Diet Drug Recipient whose condition forms the basis for the claim has or had High Matrix Level Qualifying Factors that were diagnosed and occurred by the earlier of: (i) December 31, 2011; or (ii) 15 years after the date of the Diet Drug Recipient's last ingestion of Diet Drugs (as established by the proof of Diet Drug use submitted to the Trust in accordance with section VI.C.2.d of the Settlement Agreement); and b. The Class Member making the claim (i) has submitted a properly completed Green Form and other documentation and materials necessary to support a claim for Seventh Amendment Matrix Compensation Benefits; (ii) qualifies for the payment of benefits on Matrix Levels III, IV or V under the terms of the Settlement Agreement as it existed before the Execution Date; and (iii) qualifies as having the High Matrix Level Qualifying Factors on the same Matrix Level for which the Class Member qualifies for benefits under the Settlement Agreement as it existed before the Execution Date. ======================================= IX. BENEFITS FOR CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 51 2. For each Category One Class Member or Category Two Class Member found to be eligible for Seventh Amendment Matrix Compensation Benefits, the Trust shall calculate as a Net Matrix Amount a sum equal to the gross amount payable to the Diet Drug Recipient or Representative Claimant and their associated Derivative Claimants, if any, on the applicable Matrix under section IV.B.2 of the Settlement Agreement, less Individual Payment Amounts, Minimum Payment Amounts, Matrix Election Payments and/or Category Two Payments paid or payable to the Class Member under the Seventh Amendment. The Trust shall distribute the Net Matrix Amount in accordance with the provisions of section VI.C.4.g of the Settlement Agreement and Section XV.W. 3. No Category One Class Member or Category Two Class Member shall be eligible for or shall receive Seventh Amendment Matrix Compensation Benefits for any conditions that were diagnosed or occurred after the earlier of: (i) December 31, 2011; or (ii) 15 years after the date of the Diet Drug Recipient's last ingestion of Diet Drugs (as established by the proof of Diet Drug use submitted to the Trust in accordance with section VI.C.2.d of the Settlement Agreement). 4. Where the validity of a Class Member's Green Form (as distinguished from the underlying echocardiographic or medical evidence) is contested, the Class Member may submit a substitute Green Form attested to by a different Attesting Physician, under such reasonable conditions as the Trust shall prescribe, based on an Echocardiogram that otherwise complies with the requirements of the Settlement Agreement, as modified by the Seventh Amendment. ======================================= IX. BENEFITS FOR CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 52 B. FUNDING FOR SEVENTH AMENDMENT MATRIX COMPENSATION BENEFITS, EFFECT ON MAFBA, AND GUARANTEE BY WYETH. 1. The Trust shall include in its Settlement Fund Quarterly Notices (or such other notices as agreed upon by the Parties pursuant to section III.C.4.e of the Settlement Agreement) the amounts that it is required to pay as Seventh Amendment Matrix Compensation Benefits to Category One Class Members and Category Two Class Members pursuant to Section IX.A, as well as the reasonable costs of administering claims for such benefits, and Wyeth shall include such amounts in the Fund B Deposits that it is required to make under the terms of the Settlement Agreement. 2. Amounts included in Fund B Deposits into the Settlement Fund by Wyeth for payment of Seventh Amendment Matrix Compensation Benefits to Category One Class Members or Category Two Class Members, or for the reasonable costs of administration of such benefits, shall reduce the Maximum Available Fund B Amount under section I.1 of the Settlement Agreement. Notwithstanding the foregoing, if at any time the Maximum Available Fund B Amount has been reduced to $255,000,000, Wyeth shall continue to deposit funds into the Settlement Fund to pay Seventh Amendment Matrix Compensation Benefits to eligible Category One Class Members and Category Two Class Members, and for the reasonable costs of administration of such benefits, in accordance with this Seventh Amendment, regardless of the Maximum Available Fund B Amount at such time, and such deposits shall not reduce the Maximum Available Fund B Amount. ======================================= IX. BENEFITS FOR CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 53 C. FUNDING OF SUPPLEMENTAL CLAIMS WHEN MAFBA REACHES $255,000,000. 1. At any time that the Maximum Available Fund B Amount is $255,000,000 or less, the Trust shall pay Matrix Compensation Benefits only with respect to claims for Seventh Amendment Matrix Compensation Benefits (to be funded in accordance with Section IX.B.2) and Supplemental Claims (to be funded in accordance with this Section). 2. Deposits by Wyeth into the Settlement Fund for purposes of paying Matrix Compensation Benefits on Supplemental Claims and the reasonable costs of administering such benefits, shall reduce the Maximum Available Fund B Amount under section I.1 of the Settlement Agreement, regardless of whether the Maximum Available Fund B Amount is $255,000,000 or less. D. ELIGIBILITY LIST. The Fund Administrator shall create and maintain an "Eligibility List" containing the names and DDR Numbers of all Class Members who are entitled to receive or have received Benefits Subject to Medical Review and Minimum Payment Amounts pursuant to the terms of this Seventh Amendment, and the amount of the benefits paid or expected to be paid by the Fund Administrator to each such person, and shall assure that the Eligibility List is current and accurate and that the Trust has access to the list on an ongoing basis. E. NO PRECLUSION. The Trust, in computing the amount to be paid to a Category One Class Member or Category Two Class Member in relation to a claim for Seventh Amendment Matrix Compensation Benefits, is required to deduct amounts paid to such Class Members as Benefits Subject to Medical Review, Minimum Payment Amounts, Matrix Election Payments or Category Two Payments. Otherwise, the determinations and actions of the Fund Administrator on any aspect of the claim of a Category One Class Member shall have no preclusive or precedential effect of any kind on the Trust in the administration of claims for Matrix Compensation Benefits of Class Members who have exercised Seventh Amendment Opt-Outs or of claims for Seventh Amendment Matrix Compensation Benefits. The determinations and actions of the Trust on any ======================================= IX. BENEFITS FOR CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 54 aspect of a claim for Cash/Medical Services Benefits of a Category One Class Member or Category Two Class Member, or on any claim for the Matrix Election Payment, or on any claim of a Category Two Class Member for the Category Two Payment, shall have no preclusive or precedential effect of any kind on the Trust in the administration of claims for Matrix Compensation Benefits of Class Members who have exercised Seventh Amendment Opt-Outs or of claims for Seventh Amendment Matrix Compensation Benefits. ======================================= IX. BENEFITS FOR CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 55 X. EFFECT OF THE SEVENTH AMENDMENT ON CASH/MEDICAL SERVICES BENEFITS OF CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. A. CATEGORY ONE CLASS MEMBERS. If not paid by the Trust on or before Final Judicial Approval of the Seventh Amendment, the payment of the Cash/Medical Services Benefit to Category One Class Members, if otherwise eligible under the Settlement Agreement, is subject to the following: 1. Category One Class Members found eligible for Benefits Subject to Medical Review: A Diet Drug Recipient who is a Category One Class Member and whom the Fund Administrator has determined, after the Medical Review process, to be entitled to receive Benefits Subject to Medical Review from the Supplemental Class Settlement Fund, shall not receive the Cash/Medical Services Benefit from the Trust. 2. Category One Class Members found after the Medical Review process not eligible for Benefits Subject to Medical Review: Where the Fund Administrator has determined, as a result of the Medical Review process, that a Diet Drug Recipient who is a Category One Class Member (i) does not qualify to receive Benefits Subject to Medical Review, but (ii) the Relevant Echocardiogram for such Diet Drug Recipient demonstrates FDA Positive regurgitation before the end of the Screening Period, such a Category One Class Member shall be entitled to receive the Cash/Medical Services Benefit from the Trust. The Fund Administrator shall certify to the Trust in writing every 30 days the identity of such Category One Class Members who are not qualified to receive Benefits Subject to Medical Review but who have a Relevant Echocardiogram that demonstrates FDA Positive regurgitation before the end of the Screening Period. Within 30 days after receiving such certification, the Trust shall pay the Cash/Medical Services Benefit to each such Category One Class Member, based upon the proof of Diet Drug use submitted by such Category One Class Member to the ======================================= X. EFFECT OF THE SEVENTH AMENDMENT ON CASH/MEDICAL SERVICES BENEFITS OF CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 56 Trust in accordance with section VI.C.2.d of the Settlement Agreement, and without further Medical Review or Audit of the claim by the Trust. A Category One Class Member as to whom the Fund Administrator has determined as a result of the Medical Review process that the Relevant Echocardiogram does not show FDA Positive regurgitation before the end of the Screening Period, shall not receive the Cash/Medical Services Benefit, and the Trust shall not process or pay the Cash/Medical Services Benefit for any such Category One Class Member. B. CATEGORY TWO ELECTION BY CATEGORY ONE CLASS MEMBER. If otherwise eligible under the Settlement Agreement, a Diet Drug Recipient who is a Category One Class Member and who makes a Category Two Election shall be eligible as follows to receive Cash/Medical Services Benefits from the Trust if such Diet Drug Recipient has not previously been paid such Cash/Medical Services Benefits by the Trust. The Fund Administrator shall certify in writing, every 30 days to the Trust, the Diet Drug Recipients in Category One who make a Category Two Election. Within 60 days after Final Judicial Approval of the Seventh Amendment, the Trust shall determine the eligibility of such Class Members for the Cash/Medical Services Benefit based upon proof of Diet Drug use in accordance with section VI.C.2.d of the Settlement Agreement and a properly completed Gray Form or Green Form (including submission of an Echocardiogram Tape or Disk) demonstrating that such Class Members have FDA Positive regurgitation before the end of the Screening Period, without further Medical Review or Audit of the claim by the Trust, and either pay the Cash/Medical Services Benefit to the Class Member or inform the Class Member that the Class Member is not eligible for Cash/Medical Services Benefits. C. CATEGORY TWO CLASS MEMBERS. If otherwise eligible under the Settlement Agreement, a Diet Drug Recipient who is a Category Two Class Member shall be eligible as follows to receive Cash/Medical Services Benefits from the Trust if such Diet Drug Recipient has not previously been paid such Cash/Medical Services Benefits by the Trust. The Trust shall, subject to the Audit provisions of section VI.F.2 of the Settlement Agreement, determine the eligibility of such Class Members for the Cash/Medical Services Benefit based upon proof of ======================================= X. EFFECT OF THE SEVENTH AMENDMENT ON CASH/MEDICAL SERVICES BENEFITS OF CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 57 Diet Drug use in accordance with section VI.C.2.d of the Settlement Agreement and a properly completed Gray Form or Green Form (including submission of an Echocardiogram Tape or Disk) demonstrating that such Class Members have FDA Positive regurgitation before the end of the Screening Period, and either pay the Cash/Medical Services Benefit to the Class Member or inform the Class Member that the Class Member is not eligible for Cash/Medical Services Benefits. D. CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS WHO DO NOT QUALIFY FOR CASH/MEDICAL SERVICES BENEFITS. Category One Class Members and Category Two Class Members who do not qualify to receive the Cash/Medical Services Benefit under Sections X.A.2, X.B, and X.C, are not eligible to receive the Cash/Medical Services Benefits. ======================================= X. EFFECT OF THE SEVENTH AMENDMENT ON CASH/MEDICAL SERVICES BENEFITS OF CATEGORY ONE CLASS MEMBERS AND CATEGORY TWO CLASS MEMBERS. 58 XI. OTHER EFFECTS OF THE SEVENTH AMENDMENT. A. TERMINATION OF OPT-OUT RIGHTS. Upon Final Judicial Approval of the Seventh Amendment, any rights that any Category One Class Members and/or Category Two Class Members (who have not timely and properly opted-out of the Seventh Amendment) may have had to exercise a right of: (i) Intermediate Opt-Out under section IV.D.3 of the Settlement Agreement; (ii) Back-End Opt-Out under section IV.D.4 of the Settlement Agreement; (iii) Sixth Amendment Opt-Out under section IV.D.5 of the Settlement Agreement; and/or (iv) Financial Insecurity Opt-Out under section III.E.9 of the Settlement Agreement, and to pursue any opt-out claims against Wyeth and/or any Released Party in litigation or in any manner, are terminated, relinquished, permanently barred, and forever discharged. B. MATRIX COMPENSATION BENEFITS UNDER THE SEVENTH AMENDMENT. Upon Final Judicial Approval of the Seventh Amendment, any rights of Category One Class Members and Category Two Class Members (who have not timely and properly opted-out of the Seventh Amendment) relating to Matrix Compensation Benefits under, or otherwise arising from, section IV.B of the Settlement Agreement as it existed prior to Final Judicial Approval of the Seventh Amendment, are terminated, relinquished, permanently barred, and forever discharged, except as specifically provided in this Seventh Amendment. Upon Final Judicial Approval of the Seventh Amendment, no Class Member may pursue or receive Matrix Compensation Benefits on Matrix Level I or Matrix Level II from the Trust unless such Class Member: (i) received Matrix Compensation Benefits on Matrix Level I before the Execution Date and is pursuing a Supplemental Claim for progression to Matrix Level II; or (ii) has timely and properly exercised a Seventh Amendment Opt-Out (that has not been revoked). Upon Final Judicial Approval of the Seventh Amendment, no Category One Class Member or Category Two Class Member (except a Class Member who has timely and properly exercised a Seventh Amendment Opt-Out) may pursue or receive Matrix Compensation Benefits at Matrix Levels III, IV or V, except as provided in Section IX.A. Receipt of an Individual Payment Amount (or any Interim Distribution) and/or of Seventh Amendment Matrix Compensation Benefits shall constitute receiving "settlement benefits from Fund B" for purposes of claims based on PPH in section I.53 of the Settlement Agreement. ======================================= XI. OTHER EFFECTS OF THE SEVENTH AMENDMENT. 59 C. RELEASE AND COVENANT NOT TO SUE. 1. Upon Final Judicial Approval of the Seventh Amendment, the following claims of each Releasing Party are hereby released and forever discharged: all Settled Claims against any Released Party; all claims against any Released Party arising from any acts or omissions of the Trust, its officers, agents, employees, attorneys and all other persons acting or purporting to act on the Trust's behalf; and all claims arising out of Wyeth's role in drafting, negotiating, obtaining approval of, or the administration of the Settlement Agreement. Further, each Releasing Party shall be deemed to have reaffirmed each and every release previously provided for the benefit of each and every Released Party from each and every Settled Claim, notwithstanding any event, act, transaction or thing from the beginning of the world until the Execution Date, including, without limitation, the manner in which the Settlement Agreement was negotiated, the alleged inadequacy of representation provided to Class Members in connection with the negotiation of the Settlement Agreement, the alleged inadequacy of notice provided to the Class in connection with the Settlement Agreement, the process by which the Settlement Agreement was approved, the payment of claims to Class Members not qualified to receive benefits under the Settlement Agreement, and any alleged inadequacy of funds available to the Trust to pay all claims for Matrix Compensation Benefits. This Release and Covenant Not to Sue is solely for the benefit of the Released Parties. 2. Upon Final Judicial Approval of the Seventh Amendment, each Releasing Party shall not initiate, assert, maintain or prosecute any legal action against any Trustee, officer or employee of the Trust arising from the performance of their duties under the Settlement Agreement, as to which the Trustee and/or Trust officer or employee may have a right of indemnity from the Settlement Fund or against the Trust with respect to any such claims; provided, however, that nothing contained herein shall ======================================= XI. OTHER EFFECTS OF THE SEVENTH AMENDMENT. 60 preclude any Releasing Party from recovering benefits due under the Settlement Agreement as amended by the Seventh Amendment. 3. Upon Final Judicial Approval of the Seventh Amendment, each Releasing Party shall not initiate, assert, maintain or prosecute any claim released by the foregoing clauses, seek to enforce any such right or claim, including by action, motion, appeal or any other manner, or attempt to establish a right not to be bound by the Settlement Agreement. Each Releasing Party waives and relinquishes any right under any applicable law not to be bound by the Settlement Agreement, which might be established on behalf of Class Members by action taken by any other person. 4. Nothing in Section XI.C shall be interpreted as depriving any Category One Class Member or Category Two Class Member of the right to assert and/or enforce by appropriate legal action rights expressly provided to that Class Member by the Settlement Agreement, as amended by this Seventh Amendment. 5. The releases and covenants contained in this Section XI.C shall become effective when the Seventh Amendment becomes effective, without any further action by the Releasing Party, notwithstanding the delivery of, or failure to deliver, the confirming individual Class Member releases and covenants not to sue, or the failure of a Class Member to negotiate or endorse the payment instrument on any payment under this Seventh Amendment. D. CREDITS. Upon Final Judicial Approval of the Seventh Amendment, Wyeth shall not be entitled to any Credits against the Maximum Available Fund B Amount under sections VI.D and VII.A of the Settlement Agreement, and those sections of the Settlement Agreement shall be completely void, inoperative, and of no force and effect. ======================================= XI. OTHER EFFECTS OF THE SEVENTH AMENDMENT. 61 XII. SEVENTH AMENDMENT OPT-OUT. A. SEVENTH AMENDMENT OPT-OUT. Any Diet Drug Recipient (or Representative Claimant) who is a Category One Class Member or Category Two Class Member may elect not to be subject to the Seventh Amendment by exercising an opt-out from the Seventh Amendment ("Seventh Amendment Opt-Out") and thereby remain subject to the terms of the Settlement Agreement as they existed before the Execution Date. Persons who exercise a Seventh Amendment Opt-Out shall remain members of the Class, and the effect of such an election shall be only as set forth in Section XII.C. B. METHOD OF EXERCISE. To exercise a Seventh Amendment Opt-Out, a Diet Drug Recipient (or Representative Claimant) in Category One or Category Two must notify Wyeth of the intention to do so in a notice postmarked or delivered to Wyeth (c/o BrownGreer PLC, P.O. Box 85006, Richmond, VA 23285-5006) no later than the last day of the Seventh Amendment Opt-Out/Objection Period. To be effective, such notice must (i) clearly identify the name of the Class Member exercising the Seventh Amendment Opt-Out right, the Class Member's address, DDR Number and Social Security number, and the attorney for such Class Member, if any; (ii) unequivocally state the Class Member's intention to opt-out of the Seventh Amendment; and (iii) be signed by the Diet Drug Recipient (or Representative Claimant). Class Members may use the form attached as Exhibit "G," which shall be considered sufficient for this purpose. Within five days after Preliminary Approval of the Seventh Amendment, the Trust shall make the Seventh Amendment Opt-Out Form available on the Trust's official website in a manner that can be read and printed. C. EFFECT OF OPT-OUT. Any Class Member who timely and properly exercises a Seventh Amendment Opt-Out shall not be bound by the terms of this Seventh Amendment. Such Class Members remain members of the Class and subject to the terms of the Settlement Agreement as they existed before the Execution Date. Any Category One Class Member or Category Two Class Member who fails timely and properly to exercise a Seventh Amendment Opt-Out shall be bound by all the terms of the Settlement Agreement and of this Seventh Amendment. ======================================= XII. SEVENTH AMENDMENT OPT-OUT. 62 D. DERIVATIVE CLAIMANTS. As to all Class Members who have exercised a Seventh Amendment Opt-Out, where there is both a Diet Drug Recipient or a Representative Claimant and one or more Derivative Claimants, the Diet Drug Recipient's or the Representative Claimant's exercise or failure to exercise an opt-out shall be binding on the associated Derivative Claimant(s). E. REVOCATION OF SEVENTH AMENDMENT OPT-OUT. At any time prior to the end of the Walkaway Period, a Class Member who has exercised a Seventh Amendment Opt-Out may revoke that opt-out by transmitting written notice of such revocation to Wyeth (c/o BrownGreer PLC, P.O. Box 85006, Richmond, VA 23285-5006). Thereafter, a Class Member who has exercised a Seventh Amendment Opt-Out may request that Wyeth consent to revocation of that opt-out, and Wyeth may grant or deny such request in its sole discretion. For revocations that occur prior to the end of the Walkaway Period, the Class Member shall be considered either a Category One Class Member or a Category Two Class Member, depending upon the Class Member's eligibility. If a revocation occurs after the end of the Walkaway Period, the Class Member shall be considered a Category Two Class Member, if otherwise eligible for inclusion in either Category One or Category Two. F. SEVENTH AMENDMENT OPT-OUT LIST. 1. Wyeth shall preserve and retain the Seventh Amendment Opt-Out notices that it receives. 2. No less than once per week during the Seventh Amendment Opt-Out/Objection Period, Wyeth shall furnish the Fund Administrator, Class Counsel, and the SALC with a complete and current list stating the name, DDR Number (if any) and principal attorney for each person who exercised or purported to exercise a Seventh Amendment Opt-Out, which is complete as of 5:00 p.m. of the Friday before the list is furnished. 3. Within 30 days after the end of the Walkaway Period, Wyeth shall prepare a list identifying by name and DDR Number (if any) each Class Member who has timely and properly exercised a Seventh Amendment Opt-Out, and shall furnish an electronic ======================================= XII. SEVENTH AMENDMENT OPT-OUT. 63 copy of that list and of the Seventh Amendment Opt-Out notices to the Court and the Trust. The Trust shall be entitled to rely upon that list for purposes of administering the claims of Class Members who have opted out of the Seventh Amendment ("the Seventh Amendment Opt-Out List"). 4. Wyeth periodically shall supplement the Seventh Amendment Opt-Out List with information concerning the identity of Class Members who have properly revoked their Seventh Amendment Opt-Outs and the date on which each such revocation occurred. 5. All disputes concerning whether a Class Member has timely and properly opted out of the Seventh Amendment, including disputes concerning inclusion on or exclusion from the Seventh Amendment Opt-Out List, and including the purported exercise or continued effect of an Intermediate Opt-Out, a Back-End Opt-Out or a Sixth Amendment Opt-Out by a Class Member who did not exercise a Seventh Amendment Opt-Out, shall be decided by the Court or a Special Master appointed by the Court for that purpose. ======================================= XII. SEVENTH AMENDMENT OPT-OUT. 64 XIII. SEVENTH AMENDMENT WALKAWAY RIGHT. A. WALKAWAY PERIOD. A "Walkaway Period" is hereby established as the period that ends 60 days after the end of the Seventh Amendment Opt-Out/ Objection Period. Upon the agreement of Class Counsel, Wyeth, and the SALC (acting by majority vote), the Court may extend the Walkway Period. B. WALKAWAY RIGHT. Until the end of the Walkaway Period, Wyeth shall have the option to terminate and withdraw from this Seventh Amendment for any reason in its sole discretion ("Seventh Amendment Walkaway Right"). C. METHOD OF EXERCISE. If Wyeth elects to exercise this Seventh Amendment Walkaway Right, it must do so by written notice of that election to the Court, Class Counsel, and the SALC by 5:00 p.m. ET on the last day of the Walkaway Period. If Wyeth fails to do so, its Walkaway Right shall be terminated, void, and of no further force or effect. For this purpose, the Parties agree that time is of the essence. ======================================= XIII. SEVENTH AMENDMENT WALKAWAY RIGHT. 65 XIV. PROCEDURES TO BECOME ELIGIBLE FOR INCLUSION IN CATEGORY ONE AFTER THE EXECUTION DATE. A. INITIAL CATEGORY ONE CLASS LIST. The "Initial Category One Class List" appended as Exhibit "B" to this Seventh Amendment identifies by DDR Number all of the Class Members who appear to be Category One Class Members as of the Execution Date, as determined by the Parties based on a review of the most recent version of the database that the Trust has made available to the Parties. A copy of the Initial Category One Class List identifying the names and addresses corresponding to the DDR Numbers on Exhibit "B" and identifying the name and address of the principal attorney for each such person, if known, shall be delivered to and maintained by the Fund Administrator subject to the confidentiality provisions of PTO No. 2683, as modified pursuant to Section XVII.A.13. The Fund Administrator shall treat each person identified on the Initial Category One Class List as a Category One Class Member. B. CLASS MEMBERS WHO PREVIOUSLY EXERCISED INITIAL, INTERMEDIATE, OR BACK-END OPT-OUTS. 1. Each Class Member who exercised an Initial, Intermediate, or Back-End Opt-Out, but who satisfied the criteria for inclusion in Category One as of May 6, 2004 (as further described in Section III.A.1) is deemed to have effectively revoked any prior opt-out and to be a member of Category One unless such person exercises a Seventh Amendment Opt-Out pursuant to Section XII. 2. Each Class Member who opted out of the Settlement as an Initial, Intermediate, or Back-End Opt-Out, but who did not satisfy each and every one of the criteria for inclusion in Category One as of May 6, 2004 (as further described in Section III.A.1) is ineligible for inclusion in Category One even if such Class Member effectively revokes the Class Member's opt-out and/or even if such Class Member purports to comply with Section XIV.C. Such a Class Member may be a ======================================= XIV. PROCEDURES TO BECOME ELIGIBLE FOR INCLUSION IN CATEGORY ONE AFTER THE EXECUTION DATE. 66 Category Two Class Member if the Class Member otherwise meets the criteria for inclusion in Category Two. C. INCLUSION IN CATEGORY ONE AFTER THE EXECUTION DATE. 1. Within ten days after the date of Preliminary Approval of the Seventh Amendment, the Trust shall post the Initial Category One Class List on the official Settlement website in a manner that permits the list to be read and printed for use by Class Members and shall maintain the list on the website until Final Judicial Approval of the Seventh Amendment. 2. Each Class Member to whom Notice of the Seventh Amendment is mailed has the duty to determine whether the Class Member is a Category One Class Member or a Category Two Class Member. 3. Subject to the express limitations set forth in Sections III.A.1.b and XIV.B (with respect to Class Members who previously exercised an Initial, Intermediate or Back-End Opt-Out), a Class Member who is not listed on the Initial Category One Class List or otherwise is not within the definition of Category One as of the Execution Date may become a Category One Class Member and eligible for Category One Benefits under this Seventh Amendment, if the Class Member: a. Signed a Pink Form, a Blue Form, and/or Part I of a Green Form, and submitted it to the Trust on or before May 3, 2003, and/or had a substantially completed Green Form Part II signed by an Attesting Physician and submitted on his or her behalf to the Trust on or before May 3, 2003; b. Is a Diet Drug Recipient or the Representative Claimant of a Diet Drug Recipient who had an Echocardiogram after Diet Drug use and before the end of the Screening ======================================= XIV. PROCEDURES TO BECOME ELIGIBLE FOR INCLUSION IN CATEGORY ONE AFTER THE EXECUTION DATE. 67 Period that demonstrated Mild Mitral Regurgitation or FDA Positive valvular regurgitation, and had an Echocardiogram that demonstrates a Matrix Level I or Matrix Level II condition; c. Has not timely and properly exercised a Seventh Amendment Opt-Out (that has not been revoked); and d. Satisfies the requirements of Section XIV.C.4. 4. Class Members who satisfy all of the criteria of Section XIV.C.3 and Section III.A.1 except for the criteria of Section III.A.1.b, shall be included as Category One Class Members and eligible to receive Category One Benefits if they submit the following documents to Wyeth, with copies to the Fund Administrator, by the end of the Seventh Amendment Opt-Out/Objection Period: a. Proof of Diet Drug use in accordance with section VI.C.2.d of the Settlement Agreement or Section XV.B.1; and b. A Green Form in which: (i) Part I has been signed by the Class Member; (ii) Part II has been signed by a Board-Certified Cardiologist with Level 2 or greater training in echocardiography; and (iii) and the unaudited answers in Part II contain sufficient information on medical conditions to support a claim on Matrix Level I or Matrix Level II; and c. The Relevant Echocardiogram Tape or Disk. D. AMENDED AND FINAL CATEGORY ONE CLASS LIST. Within 120 days after the end of the Seventh Amendment Opt-Out/Objection Period, Wyeth, the SALC, and the Fund Administrator shall review the submissions made pursuant to the preceding Section, shall determine whether each such person should be included ======================================= XIV. PROCEDURES TO BECOME ELIGIBLE FOR INCLUSION IN CATEGORY ONE AFTER THE EXECUTION DATE. 68 as an additional Category One Class Member, shall notify all persons who made submissions pursuant to the preceding Section of such determination, and shall include all persons who have been determined to be additional Category One Class Members in an "Amended and Final Category One Class List." Any Class Member not included in Category One as a result of the process described in this Section XIV shall be considered a Category Two Class Member, if otherwise eligible for inclusion in Category Two. E. DISPUTES. Any disputes between or among a Class Member, Class Counsel, Wyeth, the SALC, and/or the Fund Administrator as to whether a Class Member is or should be treated as a Category One Class Member shall be resolved by the Court or a Special Master designated by the Court for that purpose. ======================================= XIV. PROCEDURES TO BECOME ELIGIBLE FOR INCLUSION IN CATEGORY ONE AFTER THE EXECUTION DATE. 69 XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. A. GENERAL. The Fund Administrator, in consultation with Class Counsel, the SALC, and the MRCC shall establish rules, forms and procedures for use in administering benefit claims by Category One Class Members under the Seventh Amendment. B. PROOF REQUIREMENTS. At a minimum, the Fund Administrator shall require that within six months after the end of the Walkaway Period: 1. All Category One Class Members who claim benefits under this Seventh Amendment shall provide proof of Diet Drug use in accordance with the proof requirements specified in section VI.C.2.d of the Settlement Agreement, except as follows: a. For Class Members who claim benefits based on fewer than 61 days of Diet Drug use, the Class Member must only furnish proof of Diet Drug use and need not furnish proof of duration of use; and b. For Class Members who claim benefits based on 61 or more days of Diet Drug use, such Class Members need not prove with specificity the exact amount of Diet Drug use by the Diet Drug Recipient whose Diet Drug ingestion forms the basis for the claim, so long as they provide proof satisfactory to the Fund Administrator that such Diet Drug Recipient used Diet Drugs for 61 days or longer. 2. All Category One Class Members who claim Benefits Subject to Medical Review (except Derivative Claimants) shall provide to the Fund Administrator a copy of the Relevant Echocardiogram Tape or Disk, which must comply with the following minimum criteria: ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 70 a. The copy must be of sufficient quality that a competent Cardiologist with Level 2 training in echocardiography can reliably ascertain the presence or absence of each of the factors that is relevant to a determination of the Grid Payment Level applicable to the claim; and b. The copy must reflect an echocardiographic study that was conducted and recorded in accordance with the following minimum technical criteria, which are not intended to change the technical requirements set forth in the Settlement Agreement and are intended to adopt the Court's interpretations regarding the assessment and measurement of Mitral Regurgitation under the Settlement Agreement as set forth in PTO No. 2640: (1) The Echocardiogram was conducted in accordance with the requirements of Feigenbaum(2) or Weyman(3); and (2) With respect to any claim based on Mitral Regurgitation, the study meets the following technical requirements: (a) The regurgitant jet must clearly originate from the mitral valve (i.e., there is no black space or apparent void between the valve and the jet); (b) The regurgitant jet must follow the QRS complex and be sustained during systole so - ------------------------ (2) Harvey Feigenbaum, ECHOCARDIOGRAPHY, 68-113 (5th ed. 1994). (3) Arthur E. Weyman, PRINCIPLES AND PRACTICE OF ECHOCARDIOGRAPHY, 75-97 (2nd ed. 1994). ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 71 that it is > than 1/10th of a second, and present for more than 2 frames; (c) The regurgitant jet must be seen in multiple beats spreading into the left atrium during systole; (d) The regurgitant jet must be seen as aliasing in multiple beats, evidencing high velocity and turbulence in the jet; and (e) The freeze frame evidence shows an aliasing jet with a corresponding loop in real time. (3) Where the Class Member directly submits a copy of an Echocardiogram Tape or Disk to the Fund Administrator to support the claim, the Class Member must provide a statement signed under oath subject to the penalties of perjury that the Echocardiogram Tape or Disk submitted to the Fund Administrator is the Relevant Echocardiogram for the claim, as defined in Section I.B.59. c. All Category One Class Members who claim Benefits Subject to Medical Review (except Derivative Claimants) shall furnish the Fund Administrator with a statement signed under oath subject to the penalties of perjury: (1) Setting forth the date of birth for the Diet Drug Recipient whose medical condition forms the basis for the claim; ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 72 (2) Stating the date on which the Relevant Echocardiogram was performed; (3) Furnishing sufficient medical proof that the Diet Drug Recipient has suffered bacterial endocarditis, where such endocarditis is the basis for the claim; and (4) Stating whether the Class Member has previously received any payment of Matrix Benefits from the Trust, or received a Trust Determination Denying Matrix Benefits. 3. If a Category One Class Member does not have possession of a copy of the Relevant Echocardiogram Tape or Disk or proof of Diet Drug use, the Class Member may request in writing, delivered to the Trust in such a manner as to generate a written return receipt, that the Trust provide a copy of such Tape or Disk and/or proof of Diet Drug use to the Fund Administrator. Each person making such a request shall pay the Trust a service fee to cover the cost of providing such copies in the amount of $50.00 in the case of a request for copies of documents and in the amount of $100.00 in the case of a request for copies of the Relevant Echocardiogram Tape or Disk. Within 30 days of receipt of such a request and payment, the Trust shall provide to the Fund Administrator a copy of the requested Tape or Disk, clearly labeled with the applicable Diet Drug Recipient's name and DDR Number (if any) and/or the proof of Diet Drug use originally submitted to the Trust and shall supply written confirmation to the Class Member or the Class Member's attorney that it has done so. C. ACCESS TO TRUST FILES. The Trust shall make its electronic files reflecting images of all documents filed by any Class Member available for unlimited access by Wyeth and the Fund Administrator and, upon written request, ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 73 shall promptly furnish the Fund Administrator with copies of any documents previously submitted by any Category One Class Member to the Trust. D. ACCESS TO TRUST DATABASE. To the extent that its "JTS Database" contains information concerning Category One Class Members and the claims made by them, the Trust shall make that entire database available to Wyeth and the Fund Administrator in a format that will permit the Fund Administrator to import the data into its own information processing system. E. TRUST COOPERATION. The Trust shall fully cooperate with the Fund Administrator and the Parties to assure that the Seventh Amendment may be administered as expeditiously as is reasonably possible. F. TECHNICAL DEFICIENCIES. If the Fund Administrator finds that there are technical deficiencies by a Class Member in compliance with any of the conditions to the processing or payment of claims under this Seventh Amendment, including deficiencies in the Relevant Echocardiogram Tape or Disk that render it uninterpretable, the Fund Administrator shall notify the Class Member or his/her counsel, if represented, of the technical deficiencies by a notice of deficiency and shall allow the otherwise eligible claimant 60 days from the date of receipt of such notice to correct the deficiencies. This notification shall be in writing and delivered by overnight courier or mail in such a manner as to require written acknowledgment of receipt by the addressee. An Echocardiogram performed after the end of the Screening Period may not be relied upon to correct any such deficiencies. If the deficiencies are not corrected within the 60-day period, the Fund Administrator shall reject the claim with prejudice, after which the Class Member will not be provided any further opportunity to qualify for Benefits Subject to Medical Review, and the Class Member shall not be entitled to receive any payment from the Fund Administrator other than the Minimum Payment Amount, distributed as specified in Section XV.V. G. PROOF OF DIET DRUG USE. If a Category One Class Member does not timely submit to the Fund Administrator the proof of Diet Drug use required in Section XV.B.1, then that Class Member shall not be entitled to receive any payment from the Supplemental Class Settlement Fund. ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 74 H. ECHOCARDIOGRAMS. If a Category One Class Member does not timely submit or cause the Trust to submit to the Fund Administrator the certifications under oath required in Sections XV.B.2.c and a copy of a Relevant Echocardiogram Tape or Disk that meets the requirements of Section XV.B.2.a and b, then the Class Member shall not be entitled to any Benefits Subject to Medical Review under this Seventh Amendment, and the Class Member shall not be entitled to receive any payment from the Fund Administrator other than the Minimum Payment Amount, distributed as specified in Section XV.V. I. QUALIFIED CARDIOLOGY CENTERS. The Fund Administrator, with the assistance of the MRCC, Class Counsel, and the SALC shall establish "Qualified Cardiology Centers" which utilize the services of Cardiologists with Level 2 or greater training in echocardiography ("Participating Physicians") for purposes of reviewing the Relevant Echocardiograms to determine the existence or non-existence of each of the medical criteria described herein for each Relative Payment Grid Level. The Participating Physicians shall report the results of that review in a report, the form of which shall be prescribed by the Fund Administrator (the "QCC Report"). J. ROLE OF THE MRCC. The MRCC shall: 1. Assist in recruiting Qualified Cardiology Centers; 2. Develop and implement a protocol to train Participating Physicians as to how to employ accepted principles and practices of Cardiology to review the Relevant Echocardiograms to determine and report on: a. Compliance with the criteria specified in Section XV.B.2; and b. The existence or non-existence of each of the medical criteria described herein for each Relative Payment Grid Level; ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 75 3. Assist the Fund Administrator in the development and implementation of quality control procedures to secure, to the extent reasonably possible, uniform application of the medical criteria specified by the Seventh Amendment. K. CHALLENGES. In the absence of actual fraud, Class Members shall have no right to challenge any action taken by the MRCC and the Fund Administrator to establish and implement the Medical Review process. L. NO CONTACT WITH PARTICIPATING PHYSICIANS OR THE MRCC. Neither Category One Class Members, their counsel, nor anyone acting on their behalf shall have any communication or contact with any Participating Physician or the MRCC with respect to any of their functions under this Seventh Amendment except that Class Counsel and the SALC, acting jointly, in their official capacities, and without reference to any specific claims that may be subject to Medical Review under this Seventh Amendment, may assist the MRCC in performing those activities specified in Section XV.J. An injunction directing compliance with this subparagraph shall be included in any order granting Preliminary Approval of the Seventh Amendment, Trial Court Approval of the Seventh Amendment and Final Judicial Approval of the Seventh Amendment. M. MEDICAL REVIEW. The Fund Administrator shall submit the Relevant Echocardiogram for Medical Review by a Qualified Cardiology Center to determine whether the Relevant Echocardiogram demonstrates or does not demonstrate each of the medical factors that determine the Relative Payment Value applicable to a given Diet Drug Recipient as specified in Section XV.O and shall obtain the QCC Report from the Qualified Cardiology Center concerning the results of its evaluation for each such Class Member (each an "Initial Review"). Within 30 days after receiving the QCC Report, the Fund Administrator shall provide a copy of that report to counsel for the Class Member to whom the report relates or directly to the Class Member, if unrepresented. A Diet Drug Recipient or Representative Claimant may obtain a Second Review of the Relevant Echocardiogram by a different Qualified Cardiology Center than the one that conducted the Initial Review by making a written request for such a Second Review and paying the Fund Administrator a non-refundable fee not to exceed $2,500 within the time specified by the Fund Administrator to make a request for a ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 76 "Second Review." When a Second Review is requested and conducted in conformity with this provision, the Relative Payment Value applicable to the Class Member who requested a Second Review shall be determined in accordance with the QCC Report submitted by the Qualified Cardiology Center that conducted the Second Review. N. CATEGORY ONE CLASS MEMBERS FOUND PAYABLE BY THE TRUST. A Category One Class Member who, on or before the Execution Date, was found by a Trust Auditing Cardiologist to have a Matrix Level condition on Matrix Level I or Matrix Level II, but whose claim was not, as of the Execution Date, the subject of a Post-Audit Determination Letter issued by the Trust under Audit Rule 12 or 15 of the Rules for the Audit of Matrix Claims approved by the Court in PTO No. 2807 or a CAP 4 notice under Rule 13 of such Audit Rules, and who otherwise qualifies for inclusion in Category One, shall be considered by the Fund Administrator to have been found to demonstrate the medical factors necessary for eligibility for Benefits Subject to Medical Review, without undergoing the Medical Review process, except that the Fund Administrator, with the MRCC as needed, shall determine whether the Class Member's condition constitutes a High Threshold Condition or a Low Threshold Condition and, under appropriate circumstances, whether there was a fraudulent manipulation of the Echocardiogram Tape or Disk, which shall disqualify the Class Member from receiving Benefits Subject to Medical Review. O. RELATIVE PAYMENT VALUE. The Fund Administrator shall determine the Relative Payment Value applicable to each Category One Class Member who has timely completed a claim for Benefits Subject to Medical Review in accordance with the Fund Administrator's evaluation of the evidence of duration of Diet Drug use submitted in connection with the claim, the sworn affidavit or declaration of the Class Member submitted under Section XV.B.2.c and the applicable QCC Report. This determination shall be final, binding and, in the absence of actual fraud, shall not be subject to appeal, challenge before, or review of any kind by, any court, agency, arbitrator, mediator or otherwise. P. INTERIM DISTRIBUTIONS. After the Fund Administrator has completed the Medical Review process for at least 50% of the claims of Category One Class Members, which appear to qualify for the Medical Review process, the Fund ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 77 Administrator may distribute to eligible Category One Class Members a portion of the Category One Class Member's estimated Individual Payment Amount ("Interim Distribution"). Interim Distributions to a Category One Class Member shall not exceed, in the aggregate, 40% of that Category One Class Member's estimated Individual Payment Amount. No Interim Distribution may be paid unless: (i) the Fund Administrator has determined that such distribution will not put the Supplemental Class Settlement Fund at risk of not being able to pay all Individual Payment Amounts in full to all eligible Category One Class Members; (ii) the Fund Administrator has made an Authorization Application setting forth the grounds for the Fund Administrator's position that it has met its burden prescribed in (i); and (iii) the Court has determined that the Fund Administrator has satisfied its burden of establishing that such distribution should be made. Wyeth shall have the right to be heard before the Court regarding any such Authorization Application, except as to matters pertaining to individual claims or the application of the Medical Review process to individual claims. Q. PAYMENT OF INTERIM DISTRIBUTIONS. Interim Distributions shall be made by the Escrow Agent pursuant to an Authorization Order by check made jointly payable to each Class Member entitled to participate in the claim proceeds and the Class Member's attorney(s), if applicable, provided that attorneys may recover from such interim reimbursements only: 1. Reimbursement for reasonable out-of-pocket costs expended on their client's behalf; and 2. An attorneys' fee that is equal to the smaller of the percentage specified under the applicable contingent fee agreement or 40% of the Interim Distribution. R. INDIVIDUAL PAYMENT AMOUNT. After (i) Final Judicial Approval of the Seventh Amendment and (ii) the Fund Administrator has completed the Medical Review process for Category One Class Members who have timely completed claims for Benefits Subject to Medical Review and has complied with all applicable provisions of the Seventh Amendment, the Fund Administrator shall calculate the Individual Payment Amount for each Class Member qualified to receive distribution of an Individual Payment Amount and shall determine the ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 78 portion of the Individual Payment Amount to be paid to such Class Members as follows: 1. The Fund Administrator shall first deduct from the Individual Payment Amount an amount equal to the Individual Payment Amount multiplied by the Common Benefit Percentage, if any (the "Common Benefit Percentage Amount"); 2. The Fund Administrator shall next deduct all Interim Distributions previously made to the Class Members and their attorneys; 3. The balance of the Individual Payment Amount remaining after the deduction of the Common Benefit Percentage Amount, the Interim Distributions, and any other deductions required under this Seventh Amendment ("Balance of the Individual Payment Amount"), shall be paid by the Escrow Agent, upon entry of an appropriate Authorization Order, by a check made jointly payable to each Class Member entitled to participate in the claim proceeds and the Class Member's attorney(s), if applicable. S. DISTRIBUTION OF PROCEEDS. When a Class Member is represented by an attorney who is named as a joint payee on any check tendered by the Escrow Agent in payment of the Balance of the Individual Payment Amount, the attorney shall hold the proceeds of the check in the attorney's client escrow and/or trust account and shall distribute such proceeds to persons entitled to participate in such proceeds, including: 1. Any Derivative Claimants to the extent of 2% of the Individual Payment Amount; 2. Any amounts which the Class Member is obligated to pay to any Third Party Payor pursuant to Section XV.W; and ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 79 3. Any other persons having a legally recognized right to participate in the settlement proceeds. Category One Class Members who are not represented by their own counsel shall distribute the proceeds of their check for Benefits Subject to Medical Review to the same groups, if any, identified in Section XV.S.1-3. T. ATTORNEYS' FEES. When a Class Member is represented by an attorney who is named as a joint payee on any check tendered by the Escrow Agent in payment of the Balance of the Individual Payment Amount, the attorney shall distribute the portion of the recovery payable to any and all attorneys as follows: 1. Payment to attorneys shall be in accordance with the terms of any applicable contingent fee contract and applicable law, provided that: a. The attorney or attorneys may not charge or collect a contingent fee that is, in the aggregate, larger than 40% of the total Individual Payment Amount, for all Class Members entitled to participate in the distribution of such Individual Payment Amount, as computed before deduction of the Common Benefit Percentage Amount; b. The Common Benefit Percentage Amount, if any, shall be deducted from the amount of fees to which such attorneys are entitled (as limited in Section XV.T.1.a) and shall not be deducted from the client's share of the recovery; and c. Each such attorney, by making such a distribution, agrees to and shall indemnify and hold harmless the Fund Administrator, the Escrow Agent, Wyeth, Class Counsel, and the members of the SALC, with respect to any and all liability for, and the actual costs of defending against, any and all claims that are or may be made that relate to the distribution of the proceeds by that attorney. ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 80 U. DISTRIBUTION OF CATEGORY TWO PAYMENT. For every Category Two Class Member who is entitled to receive the Category Two Payment, the Trust shall distribute the amount as follows: 1. If the Class Member is represented by counsel, the Trust shall pay the Class Member's attorney an amount not to exceed $650 as full compensation for all attorneys' fees and costs to which such counsel are entitled; and 2. The Trust shall make payment of the balance remaining after deduction of such payment to the Class Member's attorney, or the sum of $2,000 in those instances where the Class Member is unrepresented, to the Diet Drug Recipient whose drug ingestion forms the basis of the claim or to the applicable Representative Claimant(s). V. DISTRIBUTION OF MINIMUM PAYMENT AMOUNT. For Category One Class Members the Minimum Payment Amount shall be distributed as follows: 1. If the Class Member is represented by counsel, the Class Member's attorney shall be entitled to receive an amount not to exceed $650 as full compensation for all attorneys' fees and costs to which such counsel are entitled; and 2. The balance remaining after deduction of such payment to the Class Member's attorney or the sum of $2,000 in those instances where the Class Member is unrepresented, shall be paid to the Diet Drug Recipient whose drug ingestion forms the basis of the claim or to the applicable Representative Claimant(s). W. SUBROGATION AND OTHER THIRD PARTY PAYOR CLAIMS. 1. Each Category One Class Member and Category Two Class Member, and their attorney(s) if represented, covenants that any lawful outstanding liens or claims, whether asserted or ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 81 unasserted, for reimbursement of medical expenses, including the cost of medical services, by any private subrogee or government entity, including any claims for reimbursement of medical expenses paid by Medicare, shall be satisfied after receipt of payment from the Fund Administrator or the Trust. All such private subrogees and government entities shall be "Third Party Payors" for purposes of this Section. 2. Each Class Member who receives Benefits Subject to Medical Review (other than the Minimum Payment Amount) and/or Seventh Amendment Matrix Compensation Benefits shall be obligated to indemnify and hold harmless the Fund Administrator, the Trust, and Wyeth from and against any claims, suits or demands asserted by any Third Party Payor arising out of or relating to the payment of medical expenses or provision of medical services by such Third Party Payor or the failure of the Fund Administrator or Wyeth to pay the Third Party Payor, including the cost of investigating and defending against such claims, suits or demands, and including any settlement thereof. Each such Class Member shall be obligated to cooperate as reasonably requested by the indemnitee in such investigation and defense. Each Class Member acknowledges that the Medicare Secondary Payer Act, 42 U.S.C. Section 1395y(b)(2), may permit recovery of double the amount of such expenses paid by Medicare, and each Class Member agrees that the foregoing indemnity includes the amount of any such double recovery or any other penalty or interest imposed. 3. The Court shall have the power to enforce the obligations under this Section XV.W pursuant to the Court's reserved power to enforce the Settlement Agreement. In addition, the reserve of $7,000,000 maintained by the Trust pursuant to PTO No. 1823 shall be available to Wyeth from which Wyeth may obtain a further indemnity from and against all such claims, suits or demands, and Wyeth shall be credited from that reserve with any amount the Court authorizes to be credited, upon a ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 82 showing by Wyeth that such a claim, suit or demand has resulted in a payment or expenditure by Wyeth, including any settlement and cost of defense, arising from such claim, suit or demand. 4. This Section XV.W shall be the exclusive method for securing the resolution by the Trust of all liens or claims, whether asserted or unasserted, of Third Party Payors with respect to Seventh Amendment Matrix Compensation Benefits for Class Members who are represented by counsel. Section VII.D of the Settlement Agreement and sections VI.C.4.c(3), VI.C.4.e(4) and (5), VI.C.4.f, and VI.C.4.g-o of the Settlement Agreement, to the extent that they relate to subrogation and reimbursement liens or claims of Third Party Payors, shall be inoperative and of no further force and effect as to claims for Seventh Amendment Matrix Compensation Benefits of Class Members who are represented by counsel. 5. Any check issued by the Trust for the amount due to a Class Member who is represented by counsel as Seventh Amendment Matrix Compensation Benefits (after payment of all sums due to the individual attorney for the Class Member for payment of counsel fees and reimbursement of litigation expenses under section VI.C.4.n of the Settlement Agreement) shall be made jointly payable to the Class Member and the Class Member's primary attorney for purposes of securing appropriate payment of the lawful outstanding liens or claims of Third Party Payors that are referred to in Section XV.W.1. Such attorney shall hold the proceeds of such check in the attorney's client escrow and/or trust account and shall pay any such lawful outstanding liens or claims to the Third Party Payor(s). 6. Section VII.D of the Settlement Agreement and sections VI.C.4.c(3), VI.C.4.e(4) and (5), VI.C.4.f, and VI.C.4.g-o of the Settlement Agreement, to the extent that they relate to subrogation and reimbursement liens or claims of Third Party ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 83 Payors, shall continue to apply to Class Members who are not represented by their own counsel and who are entitled to Seventh Amendment Matrix Compensation Benefits. 7. The terms of this Section XV.W are without prejudice to the legal rights of Wyeth, the Fund Administrator, the Trust, and Class Members in any legal proceeding regarding the subrogation and reimbursement liens or claims of Third Party Payors. ======================================= XV. ADMINISTRATION OF BENEFIT CLAIMS PAYABLE FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. 84 XVI. REMEDIES IN THE EVENT OF A BREACH BY WYETH. A. NOTICE OF DEFAULT. If Wyeth fails timely to establish or maintain the Seventh Amendment Security Fund or the balance in the Security Fund required by Section VI, the Fund Administrator or the Trust shall transmit a "Notice of Default" to Wyeth advising Wyeth of the default and demanding the correction of the security issue. B. ORDER OF DEFAULT. If Wyeth fails to cure the default by taking the action demanded in the Notice of Default within five Business Days after its receipt of the Notice of Default, the Fund Administrator or the Trust, Class Counsel or the SALC may apply to the Court for an order determining that Wyeth is in default. In ruling upon such an application, the Court shall determine whether Wyeth failed timely to establish, maintain, or replenish the Seventh Amendment Security Fund or the balance in the Security Fund required by Section VI and whether that default remained uncured after receiving a Notice of Default. If the Court adjudicates Wyeth in material default of such obligations, Wyeth shall have ten days to cure such default. If the Court finds that Wyeth has failed to cure such default timely, then notwithstanding any other provision of the Seventh Amendment, Wyeth shall be considered in material breach of the terms of the Seventh Amendment, and the affected Class Members shall be entitled to such remedies as the Court shall determine are appropriate under applicable law, preserving all appellate rights and remedies of all parties. ======================================= XVI. REMEDIES IN THE EVENT OF A BREACH BY WYETH. 85 XVII. PRELIMINARY APPROVAL; STAY OF PROCEEDINGS DURING THE OBJECTION/OPT-OUT PERIOD. A. PRELIMINARY APPROVAL ORDER. Within 15 days after the Execution Date, the Parties shall apply to the Court for an order or orders: 1. Granting Preliminary Approval of the Seventh Amendment; 2. Staying the Claims Integrity Program, all Enforcement Actions, and all Show Cause Proceedings as to any claim that is a Pre-Stay Payable PADL until such time as the Court determines whether to approve the Seventh Amendment unless the Court has already entered an order directing disposition of the Pre-Stay Payable PADLs; 3. Establishing a period of not less than 60 days and not more than 90 days for Category One Class Members and Category Two Class Members either to opt out of or object to the Seventh Amendment and providing that Class Members who wish to object to the Seventh Amendment must file with the Court and serve on Class Counsel (c/o Arnold Levin, 510 Walnut Street, Ste. 500, Philadelphia, PA 19106) and Wyeth (c/o BrownGreer PLC, P.O. Box 85006, Richmond, VA 23285-5006) detailed and specific objections and a memorandum of law in support of those objections by the end of the Seventh Amendment Opt-Out/Objection Period; 4. Scheduling a hearing to determine whether to approve the terms of the Seventh Amendment under the same standard that would be applicable under Fed.R.Civ.P. 23(e); 5. Approving the appointment of the Fund Administrator, the Escrow Agent, the SALC, and the MRCC, pursuant to Section IV; ======================================= XVII. PRELIMINARY APPROVAL; STAY OF PROCEEDINGS DURING THE OBJECTION/OPT-OUT PERIOD. 86 6. Approving a written Notice substantially in a form attached as Exhibit "L" to this Seventh Amendment; 7. Directing the Parties to serve such Notice by first-class mail, postage prepaid on all Class Members as specified in Section V.C, and directing the Trust to pay all costs of such Notice; 8. Staying consideration of each of the motions and other matters included and described in Exhibit "H"; 9. Staying the operation of the Trust's Claims Integrity Program and all discovery, motion practice, and other proceedings with respect to claims by Category One Class Members and Category Two Class Members until the end of the Seventh Amendment Opt-Out/Objection Period as to all such Class Members and thereafter staying the operation of the Trust's Claims Integrity Program and all discovery, motion practice and other proceedings with respect to claims by Category One Class Members and Category Two Class Members who have not opted out of the Seventh Amendment, until such time as Wyeth exercises its Walkaway Right or it is determined that the Seventh Amendment will not obtain Trial Court Approval or it is judicially determined that the Seventh Amendment will not obtain Final Judicial Approval, provided, however, that the Trust will have the right to investigate whether there has been any material misrepresentations of fact made in connection with claims for Seventh Amendment Matrix Compensation Benefits at Matrix Levels III, IV and V. For this purpose and for purposes of any Enforcement Action specified in Section XVIII.B.1, an investigation, claim or assertion of material misrepresentation shall not be based solely on: (i) whether the Echocardiogram Tape or Disk (or any copy thereof) was allegedly obtained without adequate physician supervision; (ii) the identity of the person or entity that performed the Echocardiogram; or (iii) the identity of the attorney(s) representing the claimant, and lack of adequate physician ======================================= XVII. PRELIMINARY APPROVAL; STAY OF PROCEEDINGS DURING THE OBJECTION/OPT-OUT PERIOD. 87 supervision with respect to an Echocardiogram Tape or Disk shall not constitute a material misrepresentation of fact. 10. Staying the initiation or prosecution of all Enforcement Actions, with such stay to remain in place until such time as Wyeth exercises its Seventh Amendment Walkaway Right, or it is determined that the Seventh Amendment will not obtain Trial Court Approval, or it is judicially determined that the Seventh Amendment will not obtain Final Judicial Approval; 11. Staying the processing of all claims for Matrix Level I and Matrix Level II Benefits under the Settlement Agreement, except claims subject to a Trust Determination Denying Matrix Benefits, until the end of the Seventh Amendment Opt-Out/Objection Period and thereafter staying the processing of all claims for Matrix Level I and Matrix Level II benefits under the Settlement Agreement with respect to claims by Category One Class Members and Category Two Class Members who have not opted out of the Seventh Amendment until such time as Wyeth exercises its Seventh Amendment Walkaway Right, or it is determined that the Seventh Amendment will not obtain Trial Court Approval, or it is judicially determined that the Seventh Amendment will not obtain Final Judicial Approval, provided that such stays shall not prevent Class Members from completing claims pursuant to Sections VII, VIII and XIV or from making claims pursuant to Section III.C; 12. Restraining and enjoining Category One Class Members, their counsel, and anyone acting on their behalf from having any communication or contact of any kind with any Participating Physician and the MRCC with respect to any of their functions under the Seventh Amendment, except to the extent that Class Counsel and the SALC, acting jointly, in their official capacities, and without reference to any specific claims that will be subject to Medical Review under the Seventh ======================================= XVII. PRELIMINARY APPROVAL; STAY OF PROCEEDINGS DURING THE OBJECTION/OPT-OUT PERIOD. 88 Amendment, may assist the MRCC in performing those activities specified in Section XV.J; 13. Designating the SALC, the Fund Administrator, the Escrow Agent, the MRCC and the Participating Physicians as "Authorized Persons" entitled to receive Confidential Information under PTO No. 2683; 14. Authorizing indemnity and immunity for the Fund Administrator, the MRCC, and the Participating Physicians as provided in Section IV.E; 15. Permanently restraining and enjoining, except insofar as is necessary to implement or enforce the Seventh Amendment, each Party to the Seventh Amendment and every Class Member, including without limitation, Class Members who have exercised an Intermediate Opt-Out, a Back-End Opt-Out, a Sixth Amendment Opt-Out or a Seventh Amendment Opt-Out, (i) from seeking to use or using any statement, transaction or proceeding in connection with the negotiation, execution, approval or implementation of the Seventh Amendment or any term or provision thereof for the purpose of seeking to establish or dispute that, under the terms of the Settlement Agreement as it existed prior to the Seventh Amendment, any person is eligible to exercise an Intermediate Opt-Out, Back-End Opt-Out or Sixth Amendment Opt-Out, is entitled to compensation in a judicial proceeding or is eligible for Matrix Compensation Benefits; (ii) from offering and/or introducing any statement, transaction or proceeding in connection with the negotiation, execution, approval or implementation of the Seventh Amendment or any term or provision thereof in any judicial proceeding to support a claim that Wyeth is or is not or should be or should not be found culpable or liable for any Settled Claim; and ======================================= XVII. PRELIMINARY APPROVAL; STAY OF PROCEEDINGS DURING THE OBJECTION/OPT-OUT PERIOD. 89 16. Directing the Trust to provide all Diet Drug Recipients, within 30 days after a written request, a copy of an Echocardiogram conducted on such Diet Drug Recipient in the Trust's Screening Program, if not previously provided by the Trust. B. STAY OF APPEALS. Within ten days after the Execution Date, the Parties shall apply to the United States Court of Appeals for the Third Circuit for further orders staying consideration of all appeals listed on Exhibit "I" to this Seventh Amendment by filing a motion and memorandum substantially in the form attached as Exhibit "M," until such time as Wyeth exercises its Walkaway Right, or it is determined that the Seventh Amendment will not obtain Trial Court Approval, or it is judicially determined that the Seventh Amendment will not obtain Final Judicial approval. Class Counsel, the SALC, and all Class Members shall cooperate with Wyeth to effect these stays. ======================================= XVII. PRELIMINARY APPROVAL; STAY OF PROCEEDINGS DURING THE OBJECTION/OPT-OUT PERIOD. 90 XVIII. JURISDICTION, EFFECT ON OTHER PROCEEDINGS, AND REMEDIES. A. DISMISSALS OF PROCEEDINGS. Upon Final Judicial Approval of the Seventh Amendment, the Parties shall take all reasonable steps to dismiss or otherwise discontinue with prejudice each of the appeals, motions, and other matters included and described in Exhibits "H" and "I" and to obtain an order from the Court directing the Trust permanently to discontinue the operation of the Trust's Claims Integrity Program insofar as it includes claims by Category One Class Members and Category Two Class Members who have not opted out of the Seventh Amendment. Class Counsel, the SALC, and all Class Members shall cooperate with Wyeth to effect these dismissals. B. ENFORCEMENT ACTIONS. 1. In light of the cost of Enforcement Actions, the likely collectable recoveries therein, and the objectives of the Seventh Amendment to reduce the burden of collateral litigation on the Parties and the Court and to preserve the assets of the Trust for the benefit of eligible Class Members, upon Final Judicial Approval of the Seventh Amendment, the Trust and Wyeth shall not initiate, prosecute, or maintain any Enforcement Action based on or arising out of any claim submitted to the Trust. 2. The terms of the Seventh Amendment are without prejudice to the rights of any person to cooperate in providing evidence to appropriate law enforcement agencies and other appropriate government agencies and officers. C. CONDITIONS. The Parties' respective obligations under this Seventh Amendment, are subject to all of the following conditions: 1. Entry of an order or orders by the Court ordering Notice in accordance with Section XVII.A.6 and 7. ======================================= XVIII. JURISDICTION, EFFECT ON OTHER PROCEEDINGS, AND REMEDIES. 91 2. Entry of an order on or before the date of Preliminary Approval of the Seventh Amendment in accordance with Section XVII.A, substantially in the form appended to this Seventh Amendment as Exhibit "J," establishing the procedures to be followed in the adjudication and payment of claims that are subject to Pre-Stay Payable PADLs. 3. Entry of an order or orders granting stays in accordance with Section XVII.A. 4. Entry of an order or orders on or before the date of Preliminary Approval of the Seventh Amendment in accordance with Section XVII.A, authorizing the Parties to engage in the Parallel Processing Program described in Exhibit "K" to this Seventh Amendment and requiring the Trust to cooperate in administering Matrix Compensation Benefits through that program. 5. Entry of an order or orders following Final Judicial Approval of the Seventh Amendment dismissing or otherwise discontinuing with prejudice each of the appeals, motions, and other matters included and described in Exhibits "H" and "I," and directing the Trust permanently to discontinue the operation of the Trust's Claims Integrity Program in accordance with the provisions of Section XVII.A.9 insofar as it includes claims by Category One Class Members and Category Two Class Members who have not opted out of the Seventh Amendment. 6. Entry of an order or orders permanently restraining and enjoining Category One Class Members, their counsel, and anyone acting on their behalf from having any communication or contact of any kind with any Participating Physician or the MRCC with respect to any of their functions under the Seventh Amendment, except to the extent that Class Counsel and the SALC, acting jointly, in their official capacities, and without ======================================= XVIII. JURISDICTION, EFFECT ON OTHER PROCEEDINGS, AND REMEDIES. 92 reference to any specific claims that will be subject to Medical Review under the Seventh Amendment, assist the MRCC in performing those activities specified in Section XV.J. 7. Except as to actions required by this Seventh Amendment to occur before such time, Trial Court Approval of the Seventh Amendment, which approval order or orders shall: a. Approve this Seventh Amendment in its entirety under the standard which would be applicable under Fed.R.Civ.P. 23(e) as fair, reasonable, adequate, and non-collusive; b. Require compliance with the terms of the Seventh Amendment; c. Bar and enjoin Category One Class Members and Category Two Class Members from pursuing any litigation based on the exercise or purported exercise of any Initial Opt-Out, Intermediate Opt-Out, Back-End Opt-Out, Sixth Amendment Opt-Out, and/or Financial Insecurity Opt-Out; d. Subject to Final Judicial Approval of the Seventh Amendment, permanently restrain and enjoin Wyeth and the Trust from initiating, prosecuting or maintaining any Enforcement Action precluded by Section XVIII.B.1; and e. Subject to Final Judicial Approval of the Seventh Amendment, permanently restrain and enjoin every Class Member, who has not timely and properly exercised a Seventh Amendment Opt-Out, from initiating, prosecuting, or maintaining any claim precluded by Section XI.C. ======================================= XVIII. JURISDICTION, EFFECT ON OTHER PROCEEDINGS, AND REMEDIES. 93 8. Except as to actions required by this Seventh Amendment to occur before such time, Final Judicial Approval of this Seventh Amendment. D. RETAINED JURISDICTION. The Court shall have original and exclusive jurisdiction over the interpretation and enforcement of this Seventh Amendment incident to its exclusive, retained jurisdiction under section VIII.B.1 of the Settlement Agreement and Paragraph 11 of PTO No. 1415 entered by the Court on August 28, 2000. ======================================= XVIII. JURISDICTION, EFFECT ON OTHER PROCEEDINGS, AND REMEDIES. 94 XIX. OTHER PROVISIONS. A. METHOD OF TRANSMISSION OF NOTICES. Whenever this instrument requires delivery of a document by a date certain, such execution and delivery shall be deemed to have taken place either: 1. As of the date of the postmark placed on the envelope in which the document is delivered, provided that the document was deposited in the United States mail, with postage prepaid and properly addressed to the intended recipient thereof; or 2. As of the date on which the document is actually delivered, by private courier or hand delivery, to the intended recipient. B. RECIPIENTS OF NOTICES. Any notice, request, instruction or other document to be given to Wyeth, BrownGreer, the Fund Administrator, Class Counsel, the SALC, or the Trust, shall be in writing and delivered personally or sent as follows: 1. If to Wyeth, in care of: Peter L. Zimroth, Esquire ARNOLD & PORTER, L.L.P. 399 Park Avenue New York, NY 10022 and Lawrence V. Stein, Esquire Senior Vice President and General Counsel WYETH Five Giralda Farms Madison, NJ 07940 ======================================= XIX. OTHER PROVISIONS. 95 2. If to BrownGreer, PLC: Orran L. Brown, Esquire BROWNGREER, PLC 115 South 15th Street Suite 1400 Richmond, VA 23219-4209 3. If to the Fund Administrator, at such address as the Fund Administrator shall announce upon his or her appointment. 4. If to Class Counsel, in care of: Michael D. Fishbein, Esquire Laurence S. Berman, Esquire LEVIN, FISHBEIN, SEDRAN, & BERMAN 510 Walnut Street Suite 500 Philadelphia, PA 19106 5. If to the SALC, in care of: Wayne R. Spivey, Esquire SHRAGER, SPIVEY & SACHS Two Commerce Square, 32nd Floor 2001 Market Street Philadelphia, PA 19103 6. If to the Trust, in care of: Andrew A. Chirls, Esquire WOLF, BLOCK, SCHORR & SOLIS-COHEN 1650 Arch Street 22nd Floor Philadelphia, PA 19103 ======================================= XIX. OTHER PROVISIONS. 96 C. CHANGE IN RECIPIENTS. Any party listed in Section XIX.B may change the identity and/or address or the person to receive notice for that party by written notice given in conformity with Section XIX.B. D. CONFIDENTIAL INFORMATION. Any information possessed by the Supplemental Class Settlement Fund regarding a Category One Class Member and Category Two Class Member pursuant to this Seventh Amendment shall be considered Confidential Information under PTO No. 2683 (and any subsequent order of the Court concerning such information). E. NO ADMISSIONS. Neither this Seventh Amendment nor any exhibit, document or instrument delivered under this Seventh Amendment, nor any of the statements in the Notice documents appended to this Seventh Amendment or in connection with it, nor any statement, transaction or proceeding in connection with the negotiation, execution or implementation of this Seventh Amendment, nor any term or provision hereof, is intended to be or shall be construed as or deemed to be evidence of an admission or concession by Wyeth or the Released Parties of any liability or wrongdoing or of the truth of any allegations asserted by any Class Member against it or them, or with respect to the Settlement Agreement, or as an admission by the Class Representatives or members of the Settlement Class of any lack of merit in their claims. Nothing contained in this Seventh Amendment will be deemed to make admissible any evidence that is otherwise inadmissible under applicable law. F. WYETH COOPERATION. Wyeth shall cooperate, as reasonably requested, with the Fund Administrator, the Escrow Agent, Class Counsel, and the SALC to facilitate the administration of the benefits that are subject to this Amendment. G. ACCESS BY WYETH. 1. Wyeth shall have the right, upon reasonable request, to obtain from the Fund Administrator payment information regarding the disposition of claims of Category One Class Members and to obtain copies (and/or the originals, if requested) of any Release and Covenant Not to Sue, payment instruments and ======================================= XIX. OTHER PROVISIONS. 97 communications transmitting payments relating to a Category One Class Member. 2. Wyeth shall have access to any and all information of the Trust pertaining to claims of Category One Class Members and Category Two Class Members. H. SURVIVAL OF TERMS. Except as expressly modified in this Seventh Amendment, all terms and provisions of the Settlement Agreement remain in full force and effect. I. ADMINISTRATIVE DEADLINES. Upon good cause shown after a motion filed before the expiration of any time period prescribed by the Settlement Agreement and/or this Seventh Amendment for the administration of claims, the Court may extend such time period as the Court deems appropriate. The failure by the Fund Administrator or the Trust to comply with any such administrative time period shall not be considered a breach by Wyeth of the Settlement Agreement or this Seventh Amendment and shall not render a Class Member eligible for any benefit for which the Class Member is not otherwise eligible. If the Fund Administrator or the Trust fails to comply with an administrative time period prescribed by the Settlement Agreement and/or this Seventh Amendment for the administration of claims, the Class Member may seek from the Court specific performance of the Settlement Agreement and/or this Seventh Amendment, and the Court may grant such specific performance and such other relief as determined appropriate by the Court to afford the Class Member and the Parties the benefits of the Settlement Agreement and/or this Seventh Amendment. J. SEVENTH AMENDMENT TERM SHEET. The terms and provisions of this Seventh Amendment shall supercede and any and all terms of the Seventh Amendment Term Sheet, appended to this Seventh Amendment as Exhibit "A." K. HEADINGS. The headings of the Sections of this Seventh Amendment are included for convenience only and shall not be deemed to constitute part of this Amendment or affect its construction. ======================================= XIX. OTHER PROVISIONS. 98 L. COUNTERPARTS. This Seventh Amendment may be executed in counterparts by facsimile signature and each such counterpart shall be effective as part of a fully executed original Seventh Amendment. IN WITNESS WHEREOF, the Parties have duly executed this Seventh Amendment to the Settlement Agreement between Wyeth and the Class Representatives, by their respective counsel as set forth below, as of July 21, 2004. WYETH By: _____________________________________ Douglas A. Dworkin Vice President and Deputy General Counsel Date: ___________________ 99 CLASS COUNSEL ___________________________________ _______________________________ Arnold Levin, Esquire Gene Locks, Esquire LEVIN, FISHBEIN, SEDRAN & BERMAN LOCKS LAW FIRM 510 Walnut Street, Suite 500 1500 Walnut Street Philadelphia, PA 19106 Philadelphia, PA 19102 Date:_______________ Date:_______________ ___________________________________ _______________________________ Michael D. Fishbein, Esquire Sol H. Weiss, Esquire LEVIN, FISHBEIN, SEDRAN & BERMAN ANAPOL, SCHWARTZ, WEISS, COHAN, 510 Walnut Street, Suite 500 FELDMAN & SMALLEY, P.C. Philadelphia, PA 19106 1900 Delancey Place Philadelphia, PA 19103 Date:________________ Date:________________ ___________________________________ _______________________________ Stanley Chesley, Esquire Charles R. Parker, Esquire WAITE, SCHNEIDER, BAYLESS & LOCKE, LIDDELL & SAPP, LLP CHESLEY 3400 JP Morgan Chase Tower 1513 Central Trust Tower 600 Travis Fourth & Vine Sts. Houston, TX 77002 Cincinnati, Ohio 45202 Date:__________________ Date:_________________ 100 ___________________________________ John J. Cummings, Esquire CUMMINGS, CUMMINGS & DUDENHEFER 416 Gravier Street New Orleans, LA 70130 Date:_________________ 101 SEVENTH AMENDMENT LIAISON COMMITTEE Each of the initial members of the Seventh Amendment Liaison Committee hereby accepts membership on that Committee and agrees to fulfill the responsibilities imposed on that Committee and to carry out the powers and functions accorded to that Committee by the terms of this Seventh Amendment for the purpose of implementing this Seventh Amendment. ___________________________________ _______________________________ Jerry Alexander, Esquire James Doyle, Esquire ALEXANDER & ASSOCIATES, P.C. FLEMING & ASSOCIATES, LLP Historic Inns of Court Building 1330 Post Oak Boulevard 619 North 90th Street Suite 3030 Omaha, NE 68114 Houston, TX 77056 Date:_____________ Date:_____________ ___________________________________ _______________________________ Tony Martinez, Esquire Ellen Presby, Esquire MARTINEZ, BARRERA & MARTINEZ, LLP BARON & BUDD, PC 1201 East Van Buren The Centrum Brownsville, TX 78520 3102 Oaklawn Avenue Suite 1100 Date:______________ Dallas, TX 75215 Date:_____________ ___________________________________ Wayne Spivey, Esquire SHRAGER, SPIVEY & SACHS Two Commerce Square, 32nd Floor 2001 Market Street Philadelphia, PA 19103 Date:______________ 102 PROPOSED SEVENTH AMENDMENT TO SETTLEMENT AGREEMENT I. CATEGORIES OF CLAIMS COVERED BY THE SEVENTH AMENDMENT. A. CATEGORY ONE: All Class Members with a substantially complete Green Form on file as of a fixed date, in which the unaudited responses in Part II support a claim for Matrix Level I or Matrix Level II benefits. Category One does not include: (a) Class Members who have received Matrix Compensation Benefits; (b) Class Members who have received (before a date specified in the Seventh Amendment) a Post-Audit Determination indicating eligibility for Matrix Compensation Benefits; (c) Class Members who have submitted Green Forms in which the unaudited responses in Part II support a claim for Matrix Level III, Matrix Level IV, or Matrix Level V; and (d) Class Members who have received a final Trust determination denying Matrix Compensation Benefits. B. CATEGORY TWO: All Class Members who are not in Category One but who were diagnosed as FDA Positive or Mild Mitral by the close of the Screening Period and who have filed a Pink or Blue Form with the Trust, or any other Form that constitutes registration for benefits. Category Two does not include: (a) Class Members who have received Matrix Compensation Benefits; and (b) Class Members who have received (before a date specified in the Seventh Amendment) a Post-Audit Determination indicating eligibility for Matrix Compensation Benefits. II. BENEFITS AVAILABLE TO CLASS MEMBERS COVERED BY THE SEVENTH AMENDMENT. A. CATEGORY ONE: 1) Wyeth shall pay $1.275 billion to fund a new Alternate Facility, headed by a Claims Administrator. Subject to Section II.D below, Wyeth shall deposit such funds into the Alternate Facility after Final Judicial Approval of the Seventh Amendment on this schedule: (a) within 10 Business Days after Final Judicial Approval, an amount sufficient to place $400 million in the Alternate Facility; (b) thereafter, as funds are distributed by the Alternate Facility, within 10 Business Days after a written request from the Claims Administrator of the Alternate Facility, such amount as is necessary to restore the amount in the Alternate Facility to $400 million, until the total of $1.275 billion has been deposited into the Alternate Facility. Subject to Section II.D below, Wyeth shall have no reversionary rights in amounts it has deposited in the Alternate Facility under the Seventh Amendment, nor any right to participate in the administration of benefits payable from the fund. 2) Claims shall go through medical review by Board-Certified Cardiologists retained by the Claims Administrator to determine if they qualify for payment. 3) The reviewing Cardiologist shall determine if the claim qualifies for benefits on one of two injury levels: (a) High Threshold: Class Members with conditions in the categories described in Attachment A. EXHIBIT A 1 (b) Low Threshold: Class Members who qualify on Matrix Levels I or II in the existing Settlement Agreement and who do not qualify on the High Threshold above. 4) Payments to qualifying Class Members shall be made on a pro rata basis and shall vary depending upon: the number of Class Members who participate in the Seventh Amendment and who qualify for payment, and upon the claimant's injury level, duration of drug use, and age at the time of diagnosis. Each injury threshold shall have a basic payment grid (Grid A) and a reduced payment grid (Grid B) that is 20% of Grid A. Class Members with <61 days of drug use, a reduction factor (as defined in the Settlement Agreement) present on an Echocardiogram tape, and/or valve surgery before use of the Diet Drugs, shall recover based on Grid B of each Injury Threshold. 5) Considering the types of Green Form claims now on file with the existing Trust and assumptions about how many claims will pass medical review and be found payable by the Alternate Facility, we have attempted to project the potential payments by the Alternate Facility to eligible Class Members in Category One. For example, if 90% of the approximately 42,200 Green Forms now on file with the Trust that appear to document a claim on Matrix Level I or II assert injuries on the Low Threshold, and using a hypothetical rate of 45% of those claims passing medical review, the payment to a claimant in the 50-54 age group on Grid A of the Low Threshold could total approximately $68,000. Also depending upon these variables, persons who qualify after medical review to be paid on the High Threshold could receive total payments of approximately three times the amount payable on the Low Threshold. 6) The Claims Administrator shall make payments to eligible Class Members in such a manner and in such amounts so that, based upon the status and progress of the medical review of claims, and in a method specified in the Seventh Amendment and approved by the Court, all eligible Class Members shall receive a proportionate share of available funds. 7) Any claimant in Category One who chooses not to have the medical review, or who does not qualify on one of the above Injury Thresholds after medical review, shall be paid $2,000 by the Alternate Facility. For this benefit, attorneys' fees and costs reimbursements payable to each individual claimant's personal attorney(s) shall not exceed $650 per claim. 8) Any claimant in Category One may submit a claim to the existing Trust if he/she progresses to Matrix Level III with actual surgery, or progresses to Matrix Level IV or V (with verified precursor medical events), within the earlier of seven years from the date of the Seventh Amendment or 15 years after his/her last Diet Drug use. If eligible after Audit, these Class Members shall be paid these Level III-V amounts out of the existing Trust, less amounts previously received from the Alternate Facility or the existing Trust. If the existing Settlement Fund is exhausted, Wyeth shall guarantee the payment of these Level III-V benefits to eligible Class Members. EXHIBIT A 2 B. CATEGORY TWO: 1) Class Members in Category Two who properly document a timely FDA Positive or Mild Mitral diagnosis shall be paid $2,000 out of the existing Trust, without any medical review. With respect to this payment, attorneys' fees and costs reimbursements payable to each individual claimant's personal attorney(s) shall not exceed $650 per claim. 2) Such a claimant may also submit a claim to the existing Trust if he/she progresses to Matrix Level III with actual surgery, or progresses to Matrix Level IV or V (with verified precursor medical events), within the earlier of seven years from the date of the Seventh Amendment or 15 years after his/her last Diet Drug use. If eligible after Audit, these Class Members shall be paid these Level III-V amounts out of the existing Trust, less amounts previously received from the Alternate Facility or the existing Trust. If the existing Settlement Fund is exhausted, Wyeth shall guarantee the payment of these Level III-V benefits to eligible Class Members. C. PROOF OF DRUG USE: All payments to Category One and Category Two Class Members shall be contingent upon submission of satisfactory proof of Diet Drug use, as set forth in the Seventh Amendment. D. EFFECT OF THE SEVENTH AMENDMENT ON EXISTING RIGHTS: All Class Members covered by the Seventh Amendment relinquish claims to Level I and II benefits from the existing Trust, and shall not have future opt-out rights. E. TIMING OF PAYMENTS: As soon as the Court preliminarily approves the Seventh Amendment, Wyeth would advance funds (in an agreed amount) to provide Notice to the Class Members subject to the Seventh Amendment and for the initial set up of the Alternate Facility. Upon Trial Court Approval, Wyeth would advance, as needed, a further agreed amount to the Alternate Facility to begin processing claims so that claims could be ready for payment as soon after Final Judicial Approval of the Seventh Amendment as is reasonably practicable. If Final Judicial Approval of the Seventh Amendment is not obtained for any reason, any funds remaining in the Alternate Facility shall, after payment of expenses incurred by the Alternate Facility, be returned to Wyeth. F. STAY OF CLAIMS AND PROCEEDINGS: If there appears to be sufficient support for the Seventh Amendment, Wyeth, Class Counsel, and, to the extent necessary, the law firms indicated in Section IV below, jointly shall ask the Court to stay, for a period of approximately three weeks, all Trust processing, Audit and payment of Level I and II claims, and the implementation of Section 11 of the Trust's Operations Program, and shall take all steps necessary to stay all proceedings in the Trial Court and in the Court of Appeals for the Third Circuit, on matters relating to Trust administration, Matrix claims, and any other aspects of the Settlement Agreement not involving opt-out cases, to allow the parties to complete drafting and execution of the Seventh Amendment. If the parties seeking the initial stay thereafter submit the Seventh Amendment to the Trial Court for preliminary approval and for authorization to send notice to Class Members covered by the Seventh Amendment, they shall at that time ask the Court to continue such stay through the date of Final Judicial Approval of the Seventh Amendment. EXHIBIT A 3 These stays shall be lifted at the end of the opt-out/objection period as to any Class Member who opts out of the Seventh Amendment. If Wyeth exercises its walk-away right, or the Trial Court does not approve the Seventh Amendment, all stays shall be lifted as to all Category One and Category Two members. If Final Judicial Approval of the Seventh Amendment occurs, the stays imposed by this paragraph shall become permanent and all such motions and appeals shall be dismissed with prejudice. G. SECURITY FROM WYETH: Before Final Judicial Approval, Wyeth shall post appropriate security for its obligation to the Alternate Facility, in an amount and in the manner set forth in the Seventh Amendment. After Final Judicial Approval, Wyeth shall post security to the extent of any unpaid obligation to the Alternate Facility. H. CLAIMANTS COMMITTEE: A Claimants Committee shall be formed to assist in the administration of the Seventh Amendment in accordance with the Agreement attached hereto. III. OPT-OUT AND OBJECTION RIGHTS, AND WYETH WALK-AWAY RIGHT. A. NOTICE AND OPT-OUT/OBJECTION PERIOD: Class Members covered by the Seventh Amendment shall be mailed a Notice explaining that the Class Member shall have 60 days to: (a) object to the Seventh Amendment at an approval hearing; or (b) opt out of the Seventh Amendment and remain in the existing Settlement Agreement. Such Notice shall advise Class Members that they have this 60-day period to submit sufficiently completed claims to qualify to participate in Category One. Class Members electing to opt out of the Seventh Amendment shall also be notified that they will be foregoing the following: 1) All guaranteed payments for progression, including Level III surgery benefits, Level IV, or Level V benefits; 2) Any right to payment pursuant to the Seventh Amendment; 3) Benefits following exhaustion of the Maximum Available Fund B Amount; and 4) The benefit of all judicial stays with respect to pending motions, discovery, and the Section 11 of the Trust's Operations Plan as to that Class Member's claim. The Notice shall contain such other information as agreed by the parties and approved by the Court. B. WYETH WALK-AWAY: Until a date that is a specified number of days after the close of the Opt-Out/objection period, Wyeth may, at its sole discretion, at any time terminate the entire Seventh Amendment. If Wyeth exercises this right, the Claims Integrity Program, Trust Audit of Level I and II claims, and the processing and payment of Trust claims shall resume immediately. IV. ASSURANCES OF PARTICIPATION A. PARTICIPATION IN THE SEVENTH AMENDMENT: The law firms signing below represent Class Members who are eligible to participate in the Seventh Amendment. These law firms believe that the Seventh Amendment is in their clients' best interests and therefore commit that they EXHIBIT A 4 shall recommend that all their clients elect to participate in the Seventh Amendment, and not object to the Seventh Amendment or opt out of it to remain in the existing Settlement Agreement. B. FURTHER ASSURANCES: 1) Such law firms further commit that they shall: (a) use their best efforts and take all reasonable steps necessary to obtain Final Judicial Approval of the Seventh Amendment and the stays referred to in Section II.F above; (b) recommend that each of their clients accept the terms of the Seventh Amendment and refrain from opting out of it or objecting to its terms; (c) not engage in any action to frustrate Trial Court Approval and Final Judicial Approval of the Seventh Amendment; (d) not solicit the representation of claimants who have opted out of the Seventh Amendment to remain in the existing Settlement Agreement or to object to the Seventh Amendment. 2) In recognition of the conflict inherent in representing Class Members who wish to participate in the Seventh Amendment program while simultaneously representing others who object to it or whose election to opt out of the Seventh Amendment and remain in the existing Settlement Agreement could cause Wyeth to terminate the Seventh Amendment, such law firms shall, until Final Judicial Approval and for such additional period after Final Judicial Approval during which such a conflict would exist: (a) take all lawful measures to withdraw from representing in this or any substantially related matter any client who opts out of or objects to the Seventh Amendment, and not seek to cure any conflict covered by this Section 2) through waiver or similar act by any one or more clients; (b) irrevocably waive and relinquish any fee or other financial interest in relation to the claim of any client (whether represented directly or in association with other attorneys) who opts out of the Seventh Amendment to remain in the existing Settlement Agreement or objects to the Seventh Amendment; (c) decline to accept as a new client any person who is eligible to participate in the Seventh Amendment program but who seeks representation in order to opt out of or object to the Seventh Amendment, and whose representation will therefore pose a conflict for the law firm; provided that any such law firm may accept as a new client, if the firm so chooses, any person who is eligible to participate in the Seventh Amendment program and who seeks representation by the law firm in order to do so, and whose representation therefore does not pose a conflict for the law firm; and EXHIBIT A 5 (d) not support or provide any assistance to any lawyer who is representing claimants who have opted out of the Seventh Amendment to remain in the existing Settlement Agreement or to object to the Seventh Amendment, provided that each law firm may deliver to any successor counsel to a former client all file materials and client information, at the direction of the former client. 3) Such law firms agree to the exclusive jurisdiction and venue of the Trial Court to enforce these covenants and undertakings, and agree that the Court may order such relief as is appropriate for their breach, including a decree of specific performance, an award of compensatory damages, and payment of counsel fees and costs to the substantially prevailing party. IN MY/OUR CAPACITY AS COUNSEL TO DIET DRUG CLAIMANTS AND ON BEHALF OF THE LAW FIRM IDENTIFIED BELOW AND ANY OTHER FIRM(S) THAT JOINTLY REPRESENT SUCH CLAIMANTS, I/WE AGREE TO ALL THE TERMS ABOVE, AS AN INDUCEMENT TO WYETH TO ENTER INTO A SEVENTH AMENDMENT TO THE SETTLEMENT AGREEMENT: Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________
EXHIBIT A 6 Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________ Name: ________________________ Law Firm: ________________________ Date: __________
EXHIBIT A 7 HIGH THRESHOLD CRITERIA A. CLAIMS BASED ON THE AORTIC VALVE. (i) Severe AR (>49% JH/LVOTH); or (ii) Moderate AR (25% - 49% JH/LVOTH) with one or more of the following: a. Abnormal left ventricular end-systolic dimension > 50 mm by M-mode or 2-D Echocardiography or abnormal left ventricular end-diastolic dimension > 70 mm as measured by M-mode or 2-D Echocardiography; or b. Ejection fraction of < 50%. B. CLAIMS BASED ON THE MITRAL VALVE. Severe mitral regurgitation, as defined in the existing Settlement Agreement (>40% RJA/LAA), with one or more of the following complicating factors: i) Pulmonary hypertension secondary to valvular heart disease with peak systolic pulmonary artery pressure > 40 mm Hg measured by cardiac catheterization or with a peak systolic pulmonary artery pressure > 45 mm Hg measured by Doppler Echocardiography, at rest; ii) Abnormal left ventricular end-systolic dimension > or = 45 mm by M-mode or 2-D Echocardiogram; or iii) Ejection fraction of <50%. EXHIBIT A 8 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 21147 101238 161257 197665 293381 421032 22400 101394 161927 198911 298877 421321 26997 101493 161992 198978 299206 421586 31245 102004 162834 199141 299453 422493 32193 102038 163139 201012 300434 422568 35923 102681 163222 201053 302513 423905 37432 102947 163451 201996 302976 424671 40121 104562 163543 202085 304113 425282 41202 105049 165258 202442 304162 426494 43166 105082 165746 202572 304782 427096 43752 105338 165779 202705 305201 427658 44107 107821 167114 202772 306102 428052 44446 108381 167346 202846 307306 428417 44867 109462 168385 202911 307553 428839 45476 109637 168674 204982 308684 429639 48934 110122 168872 206367 309641 430298 52746 110272 168932 206732 310326 431429 53538 110379 169011 206847 312629 432062 54007 110841 169367 207712 316273 432443 54619 111583 169425 208769 316349 433722 54635 112482 169706 209072 317743 434621 55162 113159 171348 209462 339978 437162 56028 115055 171371 209866 366344 438408 56374 115212 171843 211623 381285 438671 58016 115642 172942 212027 393702 439471 58586 115873 173815 212142 394528 439812 58818 116913 174177 212482 395301 440511 59568 118398 175562 212722 395426 441568 59683 120113 176149 212902 395475 441907 61184 121376 176735 213264 396028 442699 61242 121509 177444 214189 396226 443036 61713 122945 177667 214445 396499 443416 62539 123622 178053 214825 396614 443721 77545 127597 178202 217166 396879 445114 77701 128538 178723 217604 397091 445692 78949 128884 178798 217844 398982 446138 79004 129643 179077 218008 399089 446997 80481 131235 179796 218073 399675 448472 85209 134338 180018 219162 400101 449777 87841 134742 180067 219172 400754 450924 88542 135475 180372 220079 402156 451312 89367 135657 180414 220162 404459 452029 89492 135681 180762 221226 405605 452839 89623 136283 181461 221879 405928 453258 89789 139412 181552 225193 406264 464958 89797 140145 181602 225615 406512 465252 89805 140301 182527 225656 406579 465781 89953 140353 184986 226225 407502 467183 90118 141697 185282 226555 408104 467672 90142 142695 185348 226639 408161 468637 90522 142992 186338 227116 409052 468884 91389 143123 187393 227942 409623 468983 92304 143842 187427 229583 409821 471078 93502 144667 188292 231951 409961 471565 94253 146654 188326 232751 412702 472381 95067 148254 189829 251702 412783 473512 95323 148379 190561 276428 413344 473629 95679 148643 191528 279265 413453 473843 95943 148767 191635 285478 414565 474437 97048 151118 191924 287227 414805 475012 97261 152421 192351 289522 415034 475251 97279 153817 192393 289777 415059 475467 97808 153924 192453 289793 415356 475855 98244 156192 192922 290759 416867 476721 99267 156513 193524 291013 417162 476754 99598 157859 193532 291161 417741 477711 99838 157883 193821 292342 417857 478529 100042 158055 194175 292656 419192 479436 100487 158428 196412 293043 419632 479741 100867 159673 196436 293308 420752 481044
EXHIBIT B 1 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 481101 585216 633222 701144 756197 829093 484386 587022 633545 702217 757724 829366 484477 587832 633586 703116 757856 829622 485268 588335 633776 703926 759357 830836 486647 588814 634469 704783 759886 831107 488221 589424 635045 704908 760892 831644 489401 590174 635078 705202 760942 832493 494161 591412 638445 705541 761957 834598 495812 593707 638702 705592 762195 835033 497461 593822 639534 705962 762781 835314 497628 594077 640938 705996 764134 836082 498105 595066 641001 706481 764282 838722 500736 595348 641464 706929 765042 838748 501322 595439 642256 707224 765206 838888 501395 598193 642579 707935 765545 839613 501429 598326 642793 708099 765917 839647 501932 598391 642868 709725 766147 840181 502062 598649 643189 710673 766535 840736 502567 599175 643221 710782 766725 840853 502658 599258 643668 710848 767194 841619 502932 599381 643981 711226 767632 843292 509109 599779 644054 715078 767814 843995 520452 599787 644708 715094 768754 846006 523423 600056 646091 715276 768846 847509 532457 602375 647149 716342 770537 849109 539460 602771 647214 716555 770586 849513 556373 603381 647438 716928 771063 849604 556415 604142 650598 717785 771675 849812 557157 606194 650861 718494 773507 850321 557223 606592 652248 720062 773648 850925 557934 607202 652826 720235 773812 851378 557983 608166 653675 720243 773937 851741 558759 608953 653733 720722 773952 851774 560169 609396 655118 720763 776773 853457 560862 609404 655357 721142 780635 853929 561292 610121 655423 721225 781138 854448 562132 610683 655498 721399 782557 854661 562736 611087 655605 721753 782922 854695 563007 611186 655902 722902 783613 856344 563825 611426 656561 724716 784231 857037 564262 613554 656637 724856 785238 859512 564385 614693 656652 725101 785832 859652 564849 615005 656902 726117 786863 860171 565077 615484 659466 727248 787572 862482 566612 615724 660746 729848 789008 862492 566893 615732 660928 730838 789461 862599 567768 616151 663351 730937 789941 862682 568402 617324 664128 732255 790378 862938 570101 618132 664542 732602 790543 863647 570135 619874 664847 732792 791269 864272 570226 621136 665588 733982 791681 864611 572255 621748 667881 736272 791988 865212 572917 622134 668087 738328 795179 868927 573362 623512 671271 739078 795336 871293 573709 624684 678649 739492 795708 874982 573782 624734 680132 739672 796409 875815 574368 625202 684464 740019 797092 876193 574822 627067 684654 740118 798231 877787 575053 627513 688392 741306 804112 878282 575266 627901 689232 741712 809582 878322 576207 628182 690651 742171 811802 881813 579821 628222 692038 742544 813022 882332 580258 629602 692202 742759 815068 883694 580415 630426 692897 743054 820662 883827 580985 631226 693442 751297 824474 884197 581306 631846 695478 754713 826232 887786 581926 632596 695536 754804 826289 888271 582361 632745 695643 755142 827337 888487 584922 632802 699553 755405 827956 900225 585091 632836 699991 755694 828848 901579
EXHIBIT B 2 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 902411 997015 1120955 1262468 1314897 1361286 902718 998963 1121062 1262591 1315672 1361453 903692 999253 1122647 1262633 1316959 1361559 904342 999896 1123298 1262724 1317494 1361609 907196 1000967 1124171 1262849 1317676 1362425 920835 1000975 1127463 1263474 1318146 1362979 921106 1001262 1139195 1266725 1318195 1363126 921411 1001288 1149004 1266741 1318658 1363571 921452 1002435 1149699 1270404 1319938 1363722 921957 1002815 1196104 1272871 1320738 1363829 921981 1003276 1199249 1273085 1322437 1364348 921999 1003482 1205772 1273416 1322775 1364702 922641 1003698 1218726 1274448 1322973 1364736 923722 1003979 1220888 1274588 1323692 1364983 928069 1005081 1221886 1275932 1324542 1365842 933392 1005422 1222496 1276153 1325307 1366368 937672 1005511 1223577 1277037 1325455 1367632 938837 1005909 1224278 1277409 1325604 1367903 939942 1011063 1224682 1277425 1326289 1369032 940668 1011097 1225408 1278001 1326768 1369495 941005 1016609 1225978 1279751 1327311 1369941 941146 1020114 1226067 1283449 1328848 1370444 942888 1021443 1227537 1283746 1328939 1371046 942912 1021502 1228329 1286228 1331396 1371251 943266 1026509 1230093 1287143 1332469 1371517 943332 1026806 1230655 1288281 1333368 1371608 944298 1027168 1231432 1288638 1335522 1371921 945402 1034438 1231521 1289669 1341619 1372713 946913 1038512 1231638 1290253 1341882 1372911 947176 1041342 1231762 1290527 1342096 1374511 949802 1041672 1232032 1290758 1342476 1374537 950352 1042381 1232753 1290949 1342502 1374594 950477 1043249 1233188 1291301 1342708 1377944 950808 1047786 1233485 1291475 1343201 1379346 951038 1050186 1234715 1291533 1343334 1379858 951194 1056308 1235894 1291657 1343524 1379882 952432 1071851 1235969 1294982 1346261 1380724 954727 1079912 1236033 1295419 1346949 1380856 957902 1087337 1237114 1295708 1347996 1380922 959098 1087519 1238815 1295864 1348143 1381524 959512 1087741 1240985 1295955 1348416 1381706 959551 1088061 1244607 1296474 1349133 1382407 959668 1088152 1245281 1297282 1349762 1382795 960104 1088301 1246727 1298298 1349953 1383853 960781 1088905 1247295 1299072 1351022 1383991 961128 1089275 1247626 1300417 1351261 1384015 963282 1091073 1248079 1301167 1351865 1384429 964239 1091461 1248111 1301183 1351931 1385988 965178 1092014 1249153 1301449 1352095 1387042 965939 1092253 1249226 1302314 1352913 1387315 966202 1093806 1249366 1302488 1352921 1389592 967315 1093996 1249564 1302884 1353671 1389881 967562 1102748 1251263 1302902 1354604 1391582 971515 1102847 1252154 1303619 1354679 1392471 971754 1105873 1252774 1305259 1355031 1392539 974808 1107523 1252832 1306141 1355296 1392877 974982 1108166 1252899 1306208 1356229 1393081 979161 1109776 1253251 1307099 1357193 1393693 980185 1110048 1253327 1307248 1357409 1397058 983346 1110345 1253608 1307305 1357417 1397645 983437 1112051 1254994 1307372 1357631 1398379 983627 1113893 1255637 1308873 1357995 1398437 987644 1114222 1256528 1309855 1358449 1399559 988006 1114495 1257237 1311034 1358555 1399815 990119 1115245 1257724 1311224 1359231 1399849 990713 1115302 1259159 1313519 1359728 1399898 990846 1115666 1259696 1313667 1359801 1400712 995852 1117159 1260025 1313907 1360973 1401892 996066 1117274 1260092 1314319 1360981 1401902 996272 1119908 1260215 1314782 1361153 1401918
EXHIBIT B 3 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 1402197 1439108 1474949 1518877 1558378 1602994 1402272 1439322 1475656 1519487 1559212 1603307 1402809 1439348 1476829 1520808 1560275 1603356 1403088 1439662 1478312 1520873 1560366 1603521 1403765 1439694 1479500 1521731 1560432 1603612 1404821 1439902 1480375 1522689 1561414 1604594 1405232 1442334 1482587 1522697 1562859 1604909 1406933 1442672 1482926 1523192 1563222 1605039 1407741 1442748 1482959 1523398 1564756 1605138 1408277 1443134 1483338 1523778 1565035 1605575 1408392 1443571 1483551 1524602 1565365 1607860 1409077 1443654 1483702 1524669 1565912 1609684 1409153 1445758 1484211 1525312 1567452 1609783 1409408 1446152 1484294 1526367 1570233 1609940 1409564 1446194 1484435 1527837 1570662 1610724 1410554 1449578 1484534 1527845 1571561 1614445 1410794 1450113 1484559 1528421 1572866 1615046 1411263 1450436 1484732 1528868 1573146 1616101 1412055 1451137 1484815 1529262 1573328 1617141 1412899 1452945 1485184 1529924 1573906 1617224 1414325 1453372 1486133 1532472 1574409 1617331 1414861 1453786 1489293 1532803 1575794 1618651 1415454 1454305 1489467 1534023 1575901 1618826 1415512 1454867 1489772 1534601 1576612 1618982 1415652 1455072 1489988 1534635 1577303 1621408 1416114 1455252 1490153 1534684 1578038 1621457 1416619 1455351 1490499 1534783 1578087 1621739 1417692 1455732 1490632 1536267 1578467 1622406 1417922 1456516 1491604 1536317 1579234 1623651 1418516 1456532 1492354 1536473 1580075 1624063 1418706 1457053 1492628 1537117 1580083 1624758 1418797 1457266 1493576 1537953 1580737 1627553 1418839 1457292 1495514 1538396 1580901 1627678 1419571 1458712 1495852 1538586 1581933 1627868 1419928 1458967 1496009 1538644 1582741 1628528 1420389 1459585 1496157 1538776 1582865 1628643 1420561 1459692 1496199 1538802 1583061 1629237 1422203 1460013 1496942 1539329 1583782 1629476 1422393 1460096 1497072 1539337 1584101 1629591 1422559 1463918 1497635 1540335 1584119 1629641 1422914 1464114 1497866 1540723 1585314 1630722 1423276 1464783 1497924 1541069 1585405 1632546 1424944 1464932 1498120 1543412 1585678 1633122 1425198 1465541 1498534 1543974 1586577 1633338 1426238 1467091 1501139 1544089 1587377 1634773 1427277 1467762 1502228 1544857 1587658 1635242 1427426 1467919 1503887 1546084 1587807 1635598 1427574 1468182 1504382 1546167 1588409 1636083 1429729 1468289 1505569 1546308 1588748 1636562 1429762 1468503 1506575 1546482 1589324 1636604 1430232 1468818 1508001 1546589 1589548 1636661 1430271 1468834 1508662 1547744 1590363 1637370 1430941 1468891 1509371 1547819 1592096 1637701 1431105 1468925 1509603 1549997 1592237 1638055 1431352 1469022 1510114 1551373 1592989 1639335 1431691 1470756 1510272 1552066 1594225 1639392 1431725 1470798 1510361 1552124 1594696 1640556 1432376 1470848 1510379 1552132 1594985 1640614 1433143 1470897 1510817 1553809 1595297 1641422 1434554 1471366 1511781 1554419 1595628 1641521 1434729 1471739 1512607 1554674 1596527 1642073 1434828 1471796 1512748 1554882 1596642 1642164 1434893 1472547 1513993 1555036 1599083 1645084 1435015 1472943 1514157 1555564 1599901 1645993 1435551 1473131 1514991 1555788 1600154 1646017 1435593 1473214 1515485 1556299 1600683 1646181 1436377 1474222 1515592 1556992 1601061 1646371 1436567 1474329 1515709 1557131 1601343 1646413 1437516 1474337 1516632 1557636 1602671 1647015 1438142 1474394 1517671 1558188 1602770 1647072
EXHIBIT B 4 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 1648591 1681014 1730878 1776533 1818574 1873603 1648872 1681519 1730969 1776723 1818830 1874064 1650340 1682533 1731140 1777580 1820315 1874270 1650480 1682772 1731157 1777697 1820406 1874668 1650613 1683846 1732049 1777721 1820778 1874759 1650647 1684661 1732106 1778208 1820968 1875202 1650910 1684679 1732155 1778372 1821149 1876077 1651462 1685080 1732783 1778802 1823319 1876549 1651835 1686161 1732817 1779040 1823681 1877299 1652114 1686898 1733245 1779586 1824291 1878313 1652189 1687128 1733302 1779693 1824416 1878701 1652502 1687631 1733849 1779883 1825835 1879279 1653377 1688175 1734482 1780642 1825942 1879733 1653849 1688282 1734516 1780733 1827260 1879915 1654839 1689934 1735547 1781061 1828581 1880368 1655372 1690023 1735927 1781129 1829217 1880459 1655877 1690031 1736834 1781236 1829555 1880756 1655893 1690155 1737279 1783398 1829910 1881127 1656057 1693597 1738400 1783562 1829936 1881275 1656503 1694470 1738467 1787167 1830314 1881663 1656602 1694934 1739762 1788660 1831619 1882034 1656644 1695402 1739879 1789247 1831825 1882596 1656685 1695642 1740380 1789924 1832294 1882794 1657436 1695915 1742105 1790500 1832542 1883768 1658178 1696418 1743152 1791532 1832773 1883867 1658277 1698505 1743277 1793173 1834530 1883933 1658459 1698778 1743285 1793264 1835131 1884576 1659580 1699560 1743798 1793306 1835362 1884733 1661016 1701879 1744366 1793330 1835693 1885524 1661503 1703206 1744614 1793439 1836808 1886159 1662444 1703214 1745322 1793561 1837038 1886662 1662998 1703909 1745967 1793579 1838978 1886837 1663061 1704816 1746213 1793678 1839422 1887413 1663541 1704907 1746429 1793694 1839737 1889005 1664010 1705110 1747880 1793744 1840503 1889682 1665462 1705607 1748177 1794023 1841956 1890128 1665520 1705615 1750322 1794197 1843432 1890334 1665959 1705706 1750934 1794270 1843978 1891571 1666023 1706688 1751163 1794510 1843994 1893221 1666718 1707710 1751338 1795558 1844018 1893445 1666726 1707751 1751841 1796895 1845486 1894385 1667476 1707835 1752187 1798065 1845841 1896380 1668441 1707918 1752260 1798206 1849611 1896810 1668821 1708262 1752633 1799014 1849983 1897354 1669290 1708288 1752716 1799634 1851849 1897784 1669357 1708387 1753920 1799964 1851864 1899087 1669936 1711282 1754027 1801422 1852235 1899426 1670314 1711936 1754365 1802057 1853084 1901172 1670645 1712546 1754688 1802883 1856772 1901354 1670801 1714864 1755958 1803444 1858265 1902527 1671841 1717438 1756972 1806421 1858299 1903244 1671973 1718444 1759570 1807023 1858414 1903970 1673011 1719251 1762483 1809649 1861806 1904473 1673391 1720648 1762608 1810233 1862556 1905504 1673896 1720960 1763051 1811355 1862606 1906031 1674290 1721505 1763564 1811892 1862705 1906056 1674928 1722396 1763598 1813575 1862762 1906684 1675065 1723634 1764414 1813799 1863042 1907021 1675164 1724319 1766047 1814177 1863075 1908037 1676170 1724624 1767615 1814698 1863851 1908177 1677095 1724855 1767763 1815018 1863885 1908466 1677665 1725597 1768530 1815067 1864537 1908599 1677970 1727882 1769231 1815331 1865856 1909167 1678069 1728682 1770692 1815984 1866425 1909324 1678218 1728815 1772599 1816149 1866755 1909993 1679745 1729490 1772862 1816354 1867936 1910553 1680008 1729508 1773357 1816388 1868868 1911817 1680016 1729516 1773696 1816735 1869486 1912724 1680248 1729623 1774355 1817733 1870666 1912914 1680321 1730449 1775675 1817790 1873512 1913318
EXHIBIT B 5 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 1913334 1950542 1982545 2019347 2064269 2111805 1915040 1950799 1983725 2020329 2065217 2114023 1915123 1952019 1983832 2020451 2067064 2114452 1916196 1952522 1984152 2020634 2067908 2115301 1916493 1952605 1984319 2020881 2068336 2115467 1916634 1953686 1988054 2021046 2069532 2115566 1916774 1953710 1988211 2021111 2069888 2116218 1916790 1953785 1988419 2021319 2070670 2116812 1916949 1953959 1988617 2021715 2071058 2118453 1917186 1954163 1989458 2022671 2071082 2119238 1917228 1954296 1989540 2023034 2071207 2119436 1919976 1954528 1990175 2023406 2071694 2120293 1921170 1954833 1991371 2023497 2072080 2120475 1922194 1955277 1992791 2023877 2072916 2121556 1922764 1955301 1992858 2024677 2073443 2123495 1923622 1955483 1993104 2024693 2074359 2125474 1924067 1955608 1993625 2025211 2074441 2127421 1924208 1955822 1994482 2025237 2075646 2128809 1924257 1955848 1995802 2025609 2077378 2129385 1924315 1956358 1996222 2026391 2078418 2129401 1924323 1957059 1997162 2026953 2079424 2129427 1924612 1957927 1997436 2027118 2080232 2129757 1926062 1957950 1997576 2028272 2080885 2129831 1927888 1958032 1999028 2028991 2081248 2131977 1928761 1958073 1999853 2029056 2081321 2133080 1929009 1958339 2000180 2030278 2082170 2133312 1929116 1958735 2000271 2031995 2082386 2135242 1931625 1958859 2000651 2033132 2082436 2135598 1931948 1958917 2002061 2033413 2084333 2136109 1932102 1959279 2002095 2033959 2084507 2136448 1932185 1959873 2002764 2034114 2084846 2138485 1932706 1960228 2003275 2034635 2086262 2138535 1932771 1961929 2003309 2036010 2086445 2138972 1933340 1962257 2003697 2036564 2086452 2139020 1933449 1962356 2003762 2037281 2086510 2139137 1934322 1962455 2004091 2039394 2087740 2139558 1934520 1964816 2004117 2040392 2089084 2140077 1934942 1965615 2004562 2040608 2089951 2140432 1935089 1965706 2004646 2040681 2090744 2140531 1935550 1966746 2004760 2040822 2091007 2141430 1935972 1967025 2005577 2041937 2091098 2142230 1936335 1967082 2006021 2042745 2091254 2143477 1937044 1967116 2006195 2043750 2091494 2145480 1937432 1967124 2006500 2043800 2091643 2145530 1938018 1968254 2007490 2046563 2096295 2146272 1938190 1968692 2008027 2047397 2096576 2146470 1938216 1968767 2008365 2047504 2097053 2146611 1938356 1969518 2008845 2047512 2100113 2149367 1939404 1969625 2009447 2048676 2100162 2149946 1940170 1969849 2009538 2048866 2100212 2151132 1941269 1970037 2010643 2049823 2100394 2151629 1941764 1970276 2010668 2051027 2101442 2151736 1942036 1970532 2011005 2052645 2102689 2151900 1942622 1971282 2011542 2052884 2104057 2151918 1942887 1971431 2011690 2053627 2104461 2152072 1943448 1971894 2011765 2054146 2104578 2152510 1945856 1976778 2012680 2054732 2105245 2152650 1946524 1977198 2013019 2055184 2106458 2153880 1946623 1977222 2013258 2056885 2107530 2154029 1946979 1977255 2013761 2056992 2107886 2154334 1947423 1977321 2013779 2057511 2107944 2154425 1947464 1977503 2014108 2057842 2108165 2154672 1948355 1977610 2014181 2058105 2108215 2155075 1948454 1977636 2015097 2058113 2108421 2155281 1948546 1977651 2016665 2058170 2108835 2156040 1948751 1980259 2016988 2058402 2109031 2156206 1948785 1980457 2017812 2060077 2109387 2156479 1950203 1980812 2018166 2060846 2110047 2156529 1950278 1981471 2018174 2061364 2110104 2157840 1950302 1981984 2019289 2062578 2110328 2158319
EXHIBIT B 6 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 2158731 2187375 2228286 2267052 2307916 2354280 2158749 2187987 2229490 2267557 2307924 2354363 2159184 2188456 2229573 2268183 2308476 2354462 2159630 2190155 2229920 2268761 2308518 2354959 2159853 2190866 2230308 2269470 2309839 2355147 2160133 2193191 2231439 2269652 2310431 2355543 2160323 2193647 2231454 2271807 2310795 2356889 2160331 2194223 2232163 2273001 2311306 2356921 2161297 2194645 2232569 2273449 2313369 2357739 2161636 2195956 2232809 2273803 2314383 2357903 2161701 2196731 2232981 2273910 2315190 2358166 2162113 2197002 2233567 2274298 2315406 2359891 2162246 2197556 2234227 2274678 2315414 2359990 2163954 2198851 2234821 2274710 2316131 2360048 2164283 2199081 2234854 2274728 2317261 2362465 2164655 2199586 2234946 2275790 2317758 2363646 2165306 2199941 2235257 2276319 2318798 2365740 2165413 2200301 2235695 2276525 2319556 2367076 2165488 2201135 2235919 2276814 2320174 2367886 2165652 2201283 2236099 2277267 2320257 2367951 2165785 2202968 2236602 2278240 2321909 2368454 2166080 2203339 2236701 2278331 2322170 2369429 2166429 2203495 2237410 2279560 2322246 2369486 2167567 2204030 2238616 2279727 2322402 2370351 2168557 2204378 2238657 2280154 2322931 2371235 2170439 2204683 2238863 2282960 2323269 2372159 2171221 2206209 2238988 2283745 2323376 2372795 2171361 2207397 2239044 2284784 2323574 2373033 2171460 2207835 2239572 2285963 2323822 2373207 2171502 2208296 2239705 2286904 2324374 2373520 2173342 2208395 2240281 2288058 2325009 2374692 2173482 2209708 2241248 2288645 2326650 2375046 2173623 2209716 2242139 2289221 2327146 2375350 2174639 2210029 2242402 2289494 2327278 2375574 2174944 2210508 2243319 2290013 2327773 2375772 2175065 2211050 2243624 2290203 2328284 2376168 2175917 2211514 2243657 2291078 2328698 2376390 2176238 2211977 2243681 2293702 2328722 2378206 2176246 2212173 2243855 2293793 2328839 2378404 2176485 2212520 2244069 2293983 2329522 2380699 2178036 2212546 2245033 2295129 2330421 2380749 2178200 2212983 2246528 2295608 2330728 2381135 2178259 2213031 2246619 2295715 2331981 2381358 2178390 2213130 2246817 2296812 2332740 2382109 2178408 2214013 2248425 2296903 2333250 2382133 2178465 2214542 2249910 2298826 2336279 2382182 2178861 2214575 2251445 2299253 2336642 2382828 2179042 2214831 2252278 2299345 2337855 2383800 2179620 2216547 2254472 2299642 2339919 2383834 2179695 2218683 2255024 2299691 2339950 2385839 2180065 2219343 2255180 2299832 2340891 2386555 2180883 2219483 2256543 2300002 2341279 2386654 2181022 2219848 2257947 2300705 2341352 2386753 2181253 2220440 2258093 2300887 2342236 2386886 2181477 2221430 2258549 2300978 2342418 2388544 2181642 2221968 2258739 2301059 2342715 2388932 2181709 2222461 2259109 2301182 2343242 2391209 2182160 2222651 2261295 2301471 2343325 2391258 2182822 2223881 2262616 2301653 2344190 2391548 2182830 2224210 2264018 2302123 2344539 2391902 2182855 2224939 2264109 2302255 2344604 2392025 2183291 2225464 2264166 2303444 2345023 2392231 2183754 2225647 2264497 2304509 2345825 2392306 2184018 2226181 2265338 2304665 2346492 2392348 2184539 2226751 2265452 2304673 2347888 2392983 2185064 2227031 2265734 2304962 2348274 2393106 2185247 2227080 2265882 2305076 2348621 2393247 2185338 2227460 2265890 2305167 2350122 2393445 2187292 2227882 2265999 2307189 2352250 2393577 2187359 2228252 2266922 2307312 2353951 2393858
EXHIBIT B 7 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 2394534 2430098 2470490 2521011 2555324 2605228 2394880 2430189 2470847 2521045 2555621 2605376 2395226 2431492 2471043 2521144 2556330 2606093 2395267 2432045 2471803 2522043 2556421 2606465 2395960 2432656 2471894 2523090 2556470 2607091 2396679 2433597 2472769 2523314 2558658 2607620 2396711 2433753 2472819 2523421 2559516 2607687 2397578 2434652 2473205 2523983 2560423 2607935 2397925 2435030 2473635 2525368 2562502 2608271 2399038 2435824 2474385 2526184 2562577 2609303 2399483 2435865 2476190 2526614 2564516 2609758 2399681 2436301 2476216 2526648 2564821 2609964 2399855 2436590 2476554 2527141 2564920 2610087 2401800 2436616 2476794 2527174 2565208 2610970 2402402 2436632 2477495 2527299 2566610 2611929 2402469 2436889 2479194 2527406 2566891 2612513 2402741 2437150 2479681 2528313 2567659 2612943 2402824 2437226 2480473 2529139 2568012 2613503 2403343 2437549 2480515 2530640 2568376 2613990 2403731 2437820 2481281 2531150 2570133 2614485 2403905 2439347 2481331 2531309 2570240 2614535 2404325 2439891 2481612 2531598 2570521 2614675 2405181 2440287 2482198 2531622 2571636 2615151 2405439 2441111 2482800 2531986 2572568 2615300 2405769 2442861 2483931 2532422 2575132 2616159 2405868 2443992 2484095 2532869 2575983 2616936 2405900 2444909 2485100 2533107 2577104 2617512 2406601 2445344 2485704 2533222 2578516 2618510 2407336 2445393 2485761 2533982 2578524 2619203 2407575 2446425 2486090 2534261 2578714 2619344 2408029 2447233 2486405 2534584 2579134 2620201 2408417 2447324 2487353 2535904 2579241 2620227 2410223 2448454 2488054 2536498 2579522 2620607 2411551 2448702 2488690 2536530 2580389 2621019 2411767 2450138 2489342 2536928 2580488 2622363 2412476 2451698 2489862 2537785 2581254 2622983 2412575 2452761 2491538 2538023 2583441 2623171 2413193 2453439 2492981 2539120 2584399 2623221 2414639 2453926 2493823 2539625 2584514 2623270 2415677 2454114 2493906 2539658 2585891 2623338 2416923 2455335 2494284 2540078 2586337 2623932 2417483 2456515 2495281 2540177 2589224 2624195 2417491 2456820 2496859 2540722 2589273 2625051 2417814 2457240 2497501 2540938 2589562 2625184 2418465 2458057 2499036 2541159 2591089 2625291 2418564 2458149 2499341 2542462 2592145 2625531 2419414 2458719 2503852 2542546 2593077 2625812 2421147 2458842 2504769 2543585 2594588 2626083 2421220 2459162 2504983 2543643 2594596 2626224 2422046 2461739 2505816 2546984 2594638 2626448 2422095 2461887 2506509 2547917 2596351 2626703 2423093 2461960 2506822 2547941 2596450 2626752 2423374 2462364 2506913 2547990 2596559 2627370 2423408 2463529 2508232 2548022 2596625 2627479 2423507 2463693 2508455 2548071 2597078 2627826 2423846 2463800 2508752 2548865 2597565 2628212 2424083 2464261 2509685 2549061 2597995 2628444 2424109 2465011 2510170 2549368 2598720 2628568 2424802 2465235 2510964 2549400 2598878 2629053 2425817 2465821 2513653 2549525 2601110 2629913 2425916 2466126 2513760 2549939 2601169 2631026 2426211 2466530 2514198 2550028 2601946 2631042 2427383 2466597 2514404 2550523 2602241 2631059 2428076 2466605 2514511 2551786 2602316 2632198 2428100 2467314 2515062 2552156 2602332 2632511 2428530 2467850 2515765 2552552 2602472 2633386 2429496 2468072 2516466 2552594 2602761 2633469 2429637 2469161 2517605 2553360 2602779 2633642 2429728 2470003 2518454 2554319 2603207 2633733 2429827 2470292 2518512 2554772 2604999 2633741
EXHIBIT B 8 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 2633790 2668481 2708956 2757797 2793222 2840866 2634384 2670107 2708998 2758118 2793446 2841435 2634434 2670412 2709673 2758373 2793594 2841450 2634509 2670628 2710051 2759116 2793883 2843068 2634640 2671188 2710499 2759223 2794832 2844173 2635019 2671246 2710531 2759330 2795839 2844256 2635217 2672368 2711174 2759439 2795888 2845568 2635233 2672434 2712024 2760536 2799401 2845618 2635274 2672863 2712776 2760874 2799963 2845907 2635308 2673051 2713865 2761195 2800811 2845923 2635324 2673127 2715555 2761724 2801447 2846285 2635365 2673309 2717114 2761732 2803575 2846681 2635688 2673390 2717296 2761849 2804771 2846715 2636041 2674810 2717791 2762029 2805521 2847168 2636231 2675338 2717924 2762268 2805760 2847283 2638005 2676518 2719136 2763175 2806552 2847424 2639276 2676849 2719284 2763563 2808202 2847549 2639508 2677821 2719367 2763944 2808723 2848133 2639722 2680791 2720118 2764496 2808897 2848380 2639888 2680957 2722288 2764561 2809291 2848604 2640019 2681047 2722973 2764660 2810976 2848901 2640134 2681641 2723294 2765535 2812287 2849149 2640225 2682227 2724607 2765774 2813665 2849263 2640464 2682698 2725497 2765840 2814192 2849305 2640746 2682714 2726305 2766301 2814762 2849529 2640779 2682763 2726354 2766848 2815496 2850022 2640928 2682771 2726461 2767747 2815876 2850501 2641538 2683852 2726495 2768646 2816049 2851103 2642072 2683894 2726768 2768653 2816213 2851616 2643237 2684165 2727659 2769792 2816593 2852184 2643328 2684215 2727774 2770097 2817914 2852424 2643757 2684348 2728269 2770667 2818615 2852473 2649150 2684678 2728509 2770956 2820074 2852614 2650430 2685592 2729242 2772713 2820090 2854453 2651214 2687929 2729689 2773455 2820124 2854800 2651255 2688109 2729721 2773638 2820157 2854826 2651933 2688273 2730091 2774149 2821783 2854933 2655751 2689537 2730844 2774529 2821908 2855336 2656924 2690055 2731271 2774610 2822328 2855567 2657047 2690147 2732105 2774685 2822997 2855955 2658961 2690170 2732154 2775351 2823508 2856250 2659068 2690774 2732840 2775377 2823888 2856961 2660090 2690782 2733293 2775385 2824415 2857761 2660140 2690873 2733681 2775799 2824928 2858181 2660413 2691178 2734945 2776128 2826758 2858934 2661007 2691236 2735355 2776169 2827087 2859007 2661064 2691335 2735843 2776300 2828259 2859189 2661288 2691426 2737914 2776367 2828408 2859486 2661981 2691574 2738748 2778116 2828424 2859627 2662120 2691814 2738987 2778827 2829331 2859890 2662146 2692945 2739399 2779627 2830529 2860096 2662187 2693141 2740389 2780963 2830586 2860963 2662302 2694347 2741577 2782464 2831444 2862241 2662526 2694461 2742765 2784031 2831535 2864163 2662682 2694800 2743649 2784478 2832160 2864858 2662708 2695559 2743698 2784742 2832467 2865798 2662823 2695716 2744126 2786739 2832491 2865962 2663334 2696169 2744761 2787026 2832905 2866101 2663722 2697290 2745768 2787455 2832921 2866747 2664472 2697936 2746642 2787596 2833028 2867778 2664662 2698512 2746931 2789378 2834018 2868537 2665156 2700086 2747715 2789865 2835007 2868578 2665768 2702744 2748168 2789923 2835320 2868594 2666048 2703072 2749463 2790129 2835981 2868917 2666428 2703767 2752103 2790418 2836948 2869014 2666857 2706158 2752806 2791051 2837722 2869501 2667897 2706992 2753457 2791283 2838183 2869691 2668044 2707180 2754232 2791556 2839009 2869857 2668135 2707206 2754448 2791754 2839314 2870160 2668416 2707412 2754885 2792174 2839553 2870459
EXHIBIT B 9 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 2870715 2918852 2968733 3018546 3062346 3113966 2870756 2920783 2969269 3018975 3063005 3114006 2871192 2920940 2970218 3018991 3063104 3114121 2871655 2921005 2970457 3019767 3063856 3115037 2871713 2922383 2970812 3020021 3066628 3115656 2871796 2922862 2971091 3020120 3066941 3116209 2874824 2923464 2971273 3021607 3067626 3116241 2874881 2923514 2971729 3021615 3068012 3116456 2876357 2927812 2971893 3021789 3068038 3116803 2876712 2929297 2974004 3022266 3069093 3117868 2877157 2929313 2975050 3022829 3069820 3119252 2877421 2929487 2976835 3023884 3070323 3119773 2877587 2930204 2976843 3024007 3070901 3120979 2877702 2930436 2977866 3024668 3073806 3122652 2877991 2932069 2978765 3024700 3074317 3122926 2879070 2932408 2979011 3024718 3074895 3125903 2879286 2933794 2979284 3025053 3075124 3127636 2880862 2934412 2982023 3025129 3075496 3128865 2880912 2935187 2982692 3025624 3076536 3129491 2881175 2936110 2982791 3027042 3076593 3130986 2881803 2937167 2983781 3027067 3076619 3131034 2882058 2937563 2984391 3029725 3077518 3131216 2883650 2937639 2984623 3030392 3077773 3131554 2884757 2938223 2984813 3030749 3078144 3131927 2885820 2938835 2986602 3031267 3078573 3133170 2886141 2939262 2987238 3031408 3079423 3133261 2886190 2941128 2987782 3032158 3079696 3134194 2886554 2941573 2988285 3035136 3080884 3134947 2887560 2941763 2989390 3035649 3081528 3135944 2887651 2943843 2990489 3036050 3081544 3137585 2888022 2945459 2990968 3036100 3082039 3138021 2888840 2945772 2990976 3036811 3083979 3138245 2891265 2946127 2991073 3037496 3084274 3138815 2891828 2946960 2991115 3038387 3085511 3139193 2891844 2947505 2991198 3038577 3086634 3141694 2892131 2947539 2992303 3039047 3089000 3142726 2892479 2947737 2993590 3040177 3090644 3143526 2893451 2947786 2993608 3040482 3090982 3143633 2894285 2947844 2993830 3040789 3091089 3143658 2894533 2947950 2993897 3041282 3091782 3143807 2895290 2948263 2993939 3041589 3093804 3144201 2896132 2948875 2994283 3041613 3094141 3144433 2896942 2949170 2995579 3041746 3094745 3144938 2898625 2949857 2996882 3042033 3095239 3145299 2898898 2950319 2996965 3043023 3096179 3145471 2899862 2951424 2997351 3043502 3097110 3145505 2901114 2951671 2998979 3043551 3097441 3145638 2903185 2953255 2999688 3043767 3097821 3146446 2903599 2953776 3001468 3043957 3099611 3146818 2903946 2954139 3001542 3044468 3099850 3147816 2905370 2954196 3001716 3045077 3101086 3148160 2906196 2954253 3001781 3045465 3101375 3150729 2907962 2954287 3002466 3045598 3101573 3151511 2908291 2955813 3002763 3045770 3101946 3151628 2909935 2955961 3003589 3045861 3102571 3153269 2910586 2956126 3003720 3046620 3103751 3154523 2912194 2956456 3003928 3047065 3103876 3155116 2913994 2957298 3004140 3048329 3103934 3158193 2914604 2957942 3004520 3050333 3103942 3158334 2914976 2958635 3005865 3050945 3105129 3159225 2915544 2959872 3008091 3051844 3105517 3159431 2915601 2960896 3011830 3052305 3109147 3159589 2915908 2962439 3011947 3052545 3109568 3160363 2916427 2962454 3012028 3055043 3109865 3160991 2916443 2962520 3012606 3056959 3110459 3162047 2917342 2964237 3012804 3057528 3111077 3162062 2918001 2965754 3013166 3058211 3112042 3162484 2918290 2965895 3013620 3058740 3113131 3162625 2918449 2966406 3013893 3058997 3113230 3163417 2918761 2968337 3016011 3060027 3113834 3163573
EXHIBIT B 10 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 3163797 3210283 3256484 3312923 3362654 3405602 3164209 3210416 3257656 3313897 3362696 3406220 3164944 3211687 3258241 3314952 3363579 3407764 3166444 3212099 3259520 3315561 3363645 3407954 3166642 3212107 3259652 3318391 3364320 3408986 3166832 3212438 3259686 3319209 3364619 3409158 3167590 3213964 3260940 3321023 3365152 3409893 3169596 3215894 3262003 3321270 3366069 3410032 3169802 3216546 3262557 3321361 3367364 3410354 3170313 3217353 3262813 3321544 3367760 3410826 3171956 3217684 3264090 3323938 3369774 3411451 3172228 3217932 3264751 3324456 3370228 3412939 3172392 3218260 3265477 3325198 3370541 3413671 3173432 3218344 3266632 3327137 3370806 3413796 3173937 3219243 3267440 3327194 3370871 3414000 3175320 3219649 3268000 3327319 3371044 3414018 3175452 3220381 3268307 3328325 3375714 3414059 3176708 3220761 3270352 3328564 3376225 3415635 3176807 3221926 3271426 3329018 3377363 3418191 3178167 3223039 3272085 3329687 3377447 3418514 3178431 3223492 3272507 3330263 3379716 3419553 3179108 3223567 3273174 3330297 3380938 3420452 3180452 3224433 3273844 3330982 3382413 3420593 3181039 3227360 3275807 3331006 3382702 3421039 3181468 3227857 3276276 3333184 3383205 3422011 3183050 3227980 3278207 3334109 3383544 3422235 3183662 3228004 3278892 3335155 3383700 3422342 3183910 3230331 3279254 3335262 3385309 3422359 3183969 3230372 3279783 3336385 3385325 3422409 3184009 3230752 3281243 3336401 3386067 3422912 3184702 3232352 3281482 3337151 3386836 3424157 3185766 3232964 3283983 3337524 3387362 3424165 3186350 3234572 3284056 3337862 3387719 3424256 3186590 3235496 3286218 3338837 3388501 3426608 3187325 3236296 3286390 3338878 3388915 3426822 3187440 3236536 3286648 3339140 3389350 3428844 3189099 3237096 3286929 3339249 3389947 3428869 3189727 3237146 3287182 3339959 3389962 3429412 3189818 3237328 3287414 3341054 3390234 3429461 3190022 3238086 3288743 3342011 3390788 3430055 3193810 3238268 3291481 3342904 3390846 3430717 3194156 3238516 3292638 3343167 3391224 3431640 3194404 3238599 3292653 3343514 3392693 3432507 3194453 3238912 3292968 3343530 3393246 3433208 3195922 3239803 3293636 3344959 3393972 3433745 3196474 3239969 3294725 3347200 3394350 3434297 3196599 3240322 3296126 3347366 3394384 3434628 3196813 3240454 3296688 3347663 3394814 3434701 3196920 3243367 3297058 3347747 3394863 3434727 3196953 3244464 3299120 3347986 3394905 3434818 3197027 3244985 3299179 3348315 3396488 3434875 3197340 3245511 3300241 3348596 3397148 3434958 3198462 3245834 3301124 3349925 3397254 3434974 3199080 3245859 3301231 3350733 3397692 3435013 3199106 3246196 3302247 3350790 3397817 3435088 3201035 3246774 3302908 3351384 3399300 3435484 3201332 3248424 3303021 3352200 3400835 3435518 3201381 3249091 3303088 3352978 3402054 3435526 3202090 3249323 3304367 3353208 3402138 3435559 3202884 3249505 3304946 3353273 3402435 3435567 3203098 3250008 3305075 3353455 3403490 3435617 3203288 3250123 3305463 3353497 3403524 3436169 3203650 3251295 3305471 3354024 3403854 3436219 3207560 3251410 3305653 3356383 3404076 3436532 3207818 3251519 3306735 3359031 3404209 3437050 3207917 3251584 3307519 3359643 3404266 3437266 3208758 3253309 3309903 3359767 3404480 3437779 3208774 3254133 3310265 3360914 3404902 3438314 3209798 3254828 3311677 3361250 3405354 3438454 3210150 3255015 3312147 3361706 3405578 3438967
EXHIBIT B 11 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 3439007 3458791 3475555 3504651 3534963 3559341 3439015 3458916 3476140 3504776 3535002 3559382 3439023 3459393 3476348 3504826 3535044 3559432 3439445 3459526 3476934 3505161 3535150 3559549 3439478 3460599 3477007 3505690 3535507 3559721 3440021 3460987 3477254 3506573 3536299 3560240 3440146 3461803 3477437 3506615 3536935 3560349 3440401 3461845 3477494 3506664 3537057 3561586 3440492 3461985 3477510 3506672 3537503 3561685 3440989 3462041 3477551 3507936 3538709 3562113 3441144 3462066 3477890 3509569 3539194 3562410 3442019 3462181 3479359 3509635 3539772 3562428 3442431 3462199 3479656 3509718 3540358 3562675 3442969 3462215 3480209 3510658 3540366 3562741 3443033 3462223 3481926 3510757 3540390 3562873 3443173 3462231 3481975 3511904 3541513 3563277 3443538 3462256 3482155 3512514 3541901 3564093 3443835 3462371 3482692 3512795 3542214 3564234 3444403 3462413 3482932 3512977 3542347 3564762 3444437 3462488 3483864 3513017 3542644 3564937 3444593 3462496 3484094 3513140 3542651 3565603 3445061 3462611 3484235 3514700 3542800 3566221 3445095 3462645 3484359 3514726 3543014 3566353 3445566 3462660 3484631 3515475 3543147 3566734 3445723 3462686 3484987 3515921 3543386 3567492 3445863 3462694 3485646 3516275 3543915 3567732 3446416 3462843 3485745 3516705 3544426 3568490 3446473 3462892 3485992 3517661 3544434 3569134 3447182 3462942 3486420 3517745 3544442 3569712 3447265 3462991 3487071 3518479 3544558 3569787 3447877 3463015 3488111 3518735 3546181 3570058 3448180 3463080 3488251 3518834 3546223 3570090 3448628 3463197 3488301 3518941 3546348 3570272 3448800 3463239 3488400 3519915 3546991 3570652 3449220 3463270 3488491 3521051 3547361 3570694 3449550 3463288 3488756 3521291 3547411 3570744 3449667 3463304 3488772 3521739 3547460 3570926 3449881 3463353 3488830 3522034 3547973 3570975 3449964 3463403 3489028 3522141 3548021 3571742 3450210 3463411 3489135 3523156 3548062 3571916 3451259 3463429 3489275 3524303 3548500 3571957 3451317 3463593 3489309 3524329 3548740 3572013 3451499 3463783 3490042 3525318 3549045 3572047 3451671 3463809 3491321 3526514 3550076 3573128 3451747 3463833 3491727 3527306 3551538 3573375 3452026 3463866 3491818 3527561 3551587 3574092 3452331 3463932 3492147 3527710 3551744 3574613 3452638 3463965 3492949 3528171 3552056 3574647 3452646 3464005 3494911 3528429 3552122 3575248 3452810 3464328 3495132 3528890 3552213 3575289 3453883 3464344 3495272 3529070 3552312 3575297 3454022 3464401 3495520 3529153 3552346 3575339 3454071 3464468 3496122 3530144 3552445 3575446 3454568 3464559 3496734 3530250 3552890 3576220 3454584 3467644 3497609 3530490 3552957 3576691 3454618 3468105 3499712 3530722 3553278 3577855 3454733 3468378 3499720 3530763 3553542 3578523 3456217 3468436 3500501 3530870 3553583 3578622 3456969 3468675 3502135 3531464 3554730 3579380 3457363 3468774 3502663 3531621 3554854 3579489 3457595 3468931 3502770 3531936 3555141 3579505 3457868 3471356 3503083 3532140 3555794 3579604 3457967 3471455 3503794 3532959 3555810 3579679 3458031 3471638 3503802 3533130 3556388 3580115 3458148 3473097 3503885 3533767 3556461 3580172 3458312 3473410 3504263 3534153 3556768 3580354 3458486 3474103 3504503 3534377 3557774 3580990 3458502 3474251 3504545 3534583 3557964 3581709 3458692 3474426 3504628 3534815 3558640 3582202 3458775 3474590 3504636 3534955 3558723 3582475
EXHIBIT B 12 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 3584182 3612918 3631231 3659059 3680196 8000154 3584695 3612967 3631306 3659109 3680246 8000172 3584703 3613080 3631876 3659232 3680428 8000187 3584810 3613197 3632619 3659901 3680691 8000229 3584828 3613304 3632759 3660206 3680758 8000231 3584950 3613346 3633054 3660891 3680865 8000235 3584968 3613353 3633450 3661048 3680881 8000236 3584976 3613395 3634128 3661758 3680899 8000237 3585312 3613510 3635026 3661782 3680972 8000255 3585437 3613528 3637741 3662947 3681103 8000261 3585635 3613577 3637758 3663481 3681137 8000264 3585809 3613601 3638400 3663895 3681186 8000285 3586005 3613650 3639176 3664414 3681277 8000294 3586781 3613726 3639192 3664471 3681558 8000296 3586914 3613791 3639663 3664786 3682069 8000297 3587482 3613809 3640695 3664810 3682218 8000309 3587888 3613825 3641107 3664828 3682325 8000311 3588126 3613858 3641313 3665742 3683463 8000317 3588209 3613908 3642121 3666310 3683968 8000328 3588688 3613957 3642162 3667029 3684099 8000334 3589074 3614351 3642386 3667060 3684412 8000335 3589371 3614468 3642592 3667623 3684503 8000338 3589843 3614666 3642956 3667722 3685609 8000357 3590072 3614757 3643079 3667730 3685625 8000395 3590254 3614971 3644549 3668084 3685740 8000464 3590270 3615002 3644861 3668100 3686045 8000471 3590635 3615234 3644887 3668530 3686102 8000482 3590775 3615648 3645041 3668613 3686631 8000502 3590809 3616091 3645736 3668969 3686664 8000527 3591864 3616596 3645884 3669074 3686789 8000529 3592003 3616620 3645918 3669611 3686797 8000574 3592854 3616638 3645934 3669645 3686912 8000584 3592920 3616661 3646676 3669660 3686946 8000610 3592938 3616786 3646783 3669934 3687167 8000664 3593662 3616794 3646809 3669942 3687704 8000670 3594686 3616885 3647161 3669975 3687720 8000677 3596913 3616893 3647732 3671211 3687886 8000681 3597143 3617941 3648417 3671237 3688454 8000682 3597192 3619715 3648532 3671443 3688520 8000697 3597242 3619954 3648797 3672102 3688538 8000701 3597259 3620077 3648888 3672144 3688546 8000707 3597317 3620473 3649035 3672151 3688553 8000716 3597622 3620879 3649605 3672318 3688744 8000719 3597846 3621380 3649647 3672573 3688751 8000721 3599156 3621687 3649662 3672722 3689270 8000722 3599297 3622008 3649795 3672847 3689452 8000723 3599651 3622065 3650306 3672862 3689759 8000724 3599917 3622339 3650520 3673118 3690674 8000733 3600400 3622453 3650934 3673498 8000002 8000760 3601176 3622461 3651320 3674058 8000004 8000767 3602463 3622685 3651429 3674389 8000012 8000791 3605482 3623709 3651791 3674710 8000015 8000843 3605631 3624335 3651817 3674934 8000016 8000889 3605805 3624533 3651874 3675253 8000083 8000895 3605946 3625100 3651924 3675535 8000085 8000896 3606902 3625670 3651973 3677085 8000086 8000941 3607108 3625696 3652732 3677093 8000088 8000970 3608890 3625779 3653805 3677119 8000090 8000980 3608940 3625886 3654100 3677150 8000093 8001094 3609567 3625894 3654464 3677283 8000118 8001096 3610326 3627486 3654555 3677382 8000127 8001099 3610516 3628740 3654985 3677416 8000128 8001185 3610599 3629391 3656139 3677440 8000129 8001189 3610904 3629409 3656162 3677556 8000135 8001196 3611019 3629953 3656188 3678265 8000137 8001197 3611423 3630076 3656733 3679065 8000138 8001201 3611779 3630506 3657319 3679131 8000139 8001202 3611829 3630696 3658283 3679446 8000142 8001214 3612520 3630753 3658465 3679917 8000146 8001223 3612579 3630894 3658549 3680097 8000148 8001226
EXHIBIT B 13 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8001227 8002323 8003450 8005269 8006433 8007542 8001252 8002334 8003472 8005271 8006448 8007543 8001256 8002365 8003506 8005273 8006453 8007545 8001274 8002372 8003556 8005325 8006460 8007562 8001279 8002386 8003602 8005326 8006470 8007570 8001282 8002406 8003658 8005338 8006477 8007577 8001283 8002410 8003672 8005348 8006487 8007582 8001302 8002421 8003720 8005371 8006490 8007586 8001307 8002425 8003741 8005377 8006500 8007589 8001320 8002426 8003894 8005384 8006501 8007596 8001325 8002432 8003986 8005389 8006502 8007604 8001373 8002439 8004018 8005393 8006503 8007608 8001441 8002443 8004037 8005396 8006505 8007668 8001442 8002447 8004129 8005399 8006524 8007671 8001477 8002451 8004219 8005400 8006537 8007673 8001480 8002457 8004278 8005401 8006617 8007699 8001502 8002460 8004291 8005403 8006621 8007713 8001516 8002461 8004308 8005409 8006648 8007718 8001536 8002462 8004343 8005414 8006666 8007724 8001539 8002502 8004349 8005415 8006668 8007727 8001597 8002588 8004355 8005435 8006672 8007733 8001603 8002592 8004395 8005450 8006681 8007740 8001609 8002611 8004433 8005454 8006691 8007765 8001618 8002616 8004476 8005456 8006720 8007776 8001673 8002622 8004542 8005457 8006725 8007806 8001720 8002629 8004563 8005459 8006796 8007809 8001738 8002643 8004566 8005508 8006839 8007812 8001749 8002663 8004575 8005515 8006859 8007816 8001758 8002671 8004577 8005601 8006948 8007847 8001766 8002684 8004585 8005628 8006952 8007884 8001770 8002747 8004589 8005696 8007012 8007909 8001774 8002762 8004669 8005782 8007023 8007912 8001776 8002777 8004732 8005794 8007024 8007948 8001780 8002809 8004741 8005807 8007059 8007952 8001782 8002817 8004748 8005814 8007060 8007975 8001783 8002843 8004755 8005818 8007112 8007976 8001784 8002853 8004761 8005820 8007190 8007983 8001891 8002855 8004769 8005835 8007199 8007985 8001898 8002857 8004774 8005839 8007208 8007988 8001899 8002912 8004782 8005846 8007210 8008086 8001929 8002919 8004785 8005855 8007234 8008096 8001939 8002927 8004788 8005868 8007245 8008123 8001974 8002934 8004792 8005881 8007251 8008128 8001985 8002944 8004793 8005887 8007265 8008133 8001999 8002967 8004794 8005888 8007272 8008192 8002067 8002973 8004800 8005890 8007273 8008195 8002089 8003002 8004805 8005918 8007275 8008203 8002120 8003016 8004808 8005925 8007276 8008235 8002134 8003105 8004814 8005994 8007277 8008262 8002139 8003119 8004815 8006070 8007278 8008264 8002142 8003127 8004885 8006075 8007350 8008272 8002145 8003136 8004919 8006149 8007412 8008283 8002147 8003140 8004949 8006223 8007413 8008300 8002148 8003159 8004960 8006236 8007424 8008304 8002171 8003173 8004983 8006240 8007428 8008318 8002180 8003175 8004986 8006277 8007446 8008327 8002201 8003178 8004990 8006281 8007458 8008351 8002213 8003181 8005066 8006291 8007459 8008375 8002218 8003183 8005096 8006292 8007469 8008377 8002224 8003197 8005103 8006302 8007471 8008382 8002228 8003198 8005108 8006307 8007479 8008423 8002249 8003210 8005134 8006344 8007483 8008425 8002254 8003234 8005152 8006359 8007485 8008570 8002259 8003253 8005165 8006368 8007487 8008571 8002287 8003260 8005175 8006377 8007491 8008573 8002289 8003271 8005204 8006384 8007497 8008596 8002291 8003275 8005226 8006386 8007502 8008600 8002292 8003279 8005238 8006387 8007526 8008603 8002293 8003298 8005248 8006389 8007534 8008604 8002300 8003352 8005264 8006419 8007541 8008608
EXHIBIT B 14 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8008609 8009872 8010578 8011401 8012473 8013458 8008610 8009900 8010579 8011428 8012554 8013466 8008627 8009908 8010637 8011436 8012627 8013468 8008639 8009917 8010676 8011441 8012648 8013490 8008644 8009920 8010679 8011445 8012662 8013502 8008716 8009923 8010681 8011463 8012696 8013531 8008725 8009927 8010684 8011534 8012726 8013536 8008741 8009932 8010694 8011549 8012729 8013566 8008749 8009935 8010697 8011679 8012732 8013572 8008785 8009939 8010705 8011694 8012739 8013579 8008792 8009986 8010706 8011697 8012746 8013586 8008815 8009991 8010707 8011709 8012759 8013590 8008834 8009993 8010708 8011742 8012764 8013594 8008870 8009995 8010713 8011782 8012778 8013679 8008959 8009998 8010716 8011793 8012782 8013705 8008964 8010003 8010717 8011796 8012785 8013711 8008969 8010005 8010719 8011800 8012786 8013720 8008978 8010009 8010734 8011807 8012807 8013748 8008979 8010011 8010767 8011834 8012809 8013758 8008981 8010013 8010768 8011865 8012864 8013771 8008986 8010025 8010774 8011881 8012867 8013786 8009005 8010034 8010784 8011883 8012925 8013825 8009009 8010043 8010797 8011887 8012951 8013843 8009017 8010065 8010802 8011890 8012955 8013880 8009040 8010075 8010817 8011896 8012957 8013899 8009048 8010080 8010825 8011905 8012975 8013917 8009084 8010086 8010842 8011912 8013001 8013919 8009096 8010091 8010848 8011916 8013010 8013926 8009117 8010092 8010854 8011941 8013014 8013953 8009120 8010094 8010859 8011948 8013016 8013955 8009142 8010100 8010865 8011953 8013017 8013959 8009159 8010104 8010898 8011954 8013019 8013966 8009161 8010107 8010907 8011960 8013020 8013974 8009171 8010113 8010930 8011963 8013041 8013994 8009179 8010122 8010935 8011968 8013051 8014005 8009186 8010130 8010970 8011976 8013054 8014015 8009190 8010133 8010987 8011981 8013055 8014020 8009196 8010174 8010990 8012018 8013093 8014024 8009206 8010190 8010992 8012022 8013103 8014033 8009220 8010228 8011009 8012026 8013109 8014035 8009222 8010237 8011021 8012030 8013116 8014038 8009225 8010251 8011041 8012048 8013117 8014043 8009229 8010258 8011046 8012055 8013118 8014052 8009235 8010267 8011060 8012056 8013122 8014056 8009351 8010283 8011068 8012057 8013125 8014062 8009363 8010306 8011080 8012063 8013128 8014083 8009378 8010307 8011102 8012076 8013132 8014086 8009391 8010320 8011114 8012147 8013134 8014135 8009475 8010327 8011127 8012187 8013140 8014137 8009557 8010333 8011146 8012221 8013152 8014155 8009608 8010348 8011160 8012238 8013156 8014162 8009618 8010366 8011175 8012240 8013157 8014168 8009629 8010368 8011177 8012260 8013164 8014169 8009640 8010371 8011179 8012275 8013168 8014174 8009644 8010395 8011189 8012288 8013169 8014175 8009654 8010404 8011213 8012290 8013180 8014177 8009671 8010425 8011224 8012293 8013203 8014226 8009700 8010431 8011263 8012305 8013211 8014239 8009701 8010462 8011292 8012310 8013254 8014241 8009719 8010471 8011301 8012315 8013310 8014260 8009728 8010476 8011307 8012328 8013325 8014265 8009761 8010489 8011311 8012340 8013346 8014268 8009781 8010500 8011341 8012342 8013387 8014281 8009789 8010506 8011348 8012348 8013421 8014284 8009795 8010522 8011356 8012365 8013430 8014319 8009797 8010559 8011364 8012417 8013435 8014329 8009801 8010564 8011379 8012420 8013440 8014339 8009822 8010565 8011382 8012427 8013445 8014373 8009855 8010572 8011386 8012446 8013453 8014380 8009868 8010574 8011395 8012463 8013457 8014395
EXHIBIT B 15 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8014400 8014975 8015432 8015920 8016732 8017547 8014418 8014985 8015435 8015930 8016741 8017549 8014426 8014995 8015437 8015953 8016754 8017551 8014462 8014998 8015443 8015956 8016766 8017563 8014466 8015001 8015449 8015959 8016770 8017564 8014475 8015002 8015474 8015970 8016779 8017571 8014479 8015004 8015475 8015971 8016837 8017597 8014481 8015006 8015478 8015974 8016844 8017601 8014483 8015007 8015486 8015982 8016849 8017616 8014490 8015011 8015490 8015991 8016850 8017617 8014492 8015014 8015494 8016012 8016854 8017621 8014521 8015018 8015496 8016015 8016860 8017624 8014529 8015025 8015511 8016024 8016873 8017628 8014546 8015026 8015517 8016035 8016879 8017630 8014564 8015032 8015518 8016039 8016880 8017631 8014586 8015041 8015523 8016040 8016891 8017641 8014594 8015046 8015524 8016083 8016918 8017647 8014597 8015049 8015537 8016118 8016923 8017649 8014604 8015057 8015538 8016175 8016945 8017659 8014609 8015061 8015541 8016183 8016948 8017668 8014618 8015075 8015544 8016187 8016952 8017678 8014623 8015081 8015545 8016189 8016962 8017681 8014627 8015089 8015552 8016193 8016969 8017684 8014654 8015107 8015556 8016199 8016980 8017692 8014666 8015123 8015563 8016208 8017014 8017696 8014667 8015160 8015566 8016209 8017037 8017701 8014668 8015163 8015570 8016232 8017050 8017705 8014670 8015169 8015576 8016275 8017056 8017708 8014693 8015174 8015577 8016294 8017063 8017711 8014697 8015196 8015579 8016300 8017082 8017727 8014702 8015197 8015580 8016306 8017103 8017744 8014714 8015198 8015585 8016307 8017105 8017748 8014717 8015203 8015589 8016314 8017121 8017760 8014719 8015207 8015596 8016326 8017161 8017761 8014725 8015220 8015597 8016366 8017168 8017767 8014730 8015224 8015602 8016375 8017169 8017782 8014731 8015233 8015607 8016376 8017174 8017792 8014736 8015237 8015618 8016384 8017189 8017798 8014737 8015243 8015622 8016397 8017210 8017799 8014746 8015253 8015633 8016402 8017226 8017807 8014748 8015255 8015635 8016406 8017238 8017809 8014749 8015257 8015650 8016427 8017249 8017811 8014763 8015267 8015655 8016446 8017261 8017812 8014765 8015279 8015659 8016453 8017277 8017814 8014775 8015281 8015667 8016457 8017298 8017837 8014781 8015283 8015673 8016461 8017308 8017858 8014782 8015286 8015674 8016462 8017311 8017886 8014799 8015293 8015678 8016467 8017328 8017923 8014823 8015295 8015696 8016472 8017357 8017957 8014827 8015322 8015711 8016474 8017373 8017959 8014828 8015326 8015719 8016488 8017374 8017965 8014835 8015331 8015769 8016520 8017400 8017988 8014844 8015339 8015785 8016528 8017406 8018003 8014846 8015341 8015799 8016540 8017411 8018016 8014851 8015349 8015802 8016547 8017418 8018020 8014852 8015354 8015814 8016553 8017422 8018022 8014858 8015355 8015826 8016561 8017428 8018025 8014899 8015359 8015828 8016575 8017444 8018028 8014901 8015361 8015829 8016580 8017456 8018035 8014909 8015367 8015830 8016582 8017460 8018133 8014910 8015375 8015838 8016585 8017490 8018141 8014913 8015378 8015846 8016596 8017500 8018182 8014926 8015386 8015855 8016601 8017510 8018246 8014929 8015389 8015861 8016650 8017512 8018294 8014936 8015391 8015865 8016655 8017515 8018297 8014949 8015401 8015870 8016678 8017523 8018300 8014950 8015410 8015876 8016685 8017528 8018314 8014961 8015419 8015879 8016700 8017535 8018317 8014962 8015430 8015887 8016719 8017542 8018320 8014970 8015431 8015904 8016721 8017543 8018323
EXHIBIT B 16 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8018346 8018854 8019408 8019827 8020160 8020929 8018350 8018858 8019409 8019835 8020174 8020935 8018375 8018870 8019410 8019837 8020202 8020964 8018388 8018884 8019411 8019839 8020223 8020981 8018424 8018886 8019416 8019849 8020224 8020982 8018430 8018888 8019418 8019850 8020226 8020984 8018445 8018890 8019420 8019855 8020228 8020988 8018500 8018899 8019424 8019858 8020229 8020996 8018519 8018903 8019428 8019861 8020231 8021000 8018522 8018932 8019433 8019862 8020236 8021002 8018525 8018936 8019437 8019863 8020245 8021008 8018529 8018939 8019440 8019873 8020258 8021009 8018534 8018962 8019443 8019875 8020261 8021017 8018546 8018968 8019448 8019896 8020266 8021018 8018552 8019031 8019451 8019898 8020269 8021019 8018553 8019037 8019453 8019904 8020296 8021020 8018567 8019055 8019456 8019931 8020311 8021024 8018569 8019057 8019458 8019935 8020314 8021025 8018571 8019060 8019465 8019938 8020315 8021028 8018573 8019061 8019468 8019945 8020322 8021033 8018574 8019065 8019475 8019946 8020337 8021040 8018575 8019078 8019481 8019971 8020339 8021046 8018578 8019101 8019485 8019984 8020365 8021050 8018584 8019108 8019490 8019995 8020389 8021054 8018593 8019110 8019498 8019996 8020397 8021060 8018596 8019181 8019501 8019998 8020413 8021065 8018612 8019184 8019518 8019999 8020429 8021069 8018624 8019196 8019593 8020000 8020439 8021080 8018625 8019218 8019610 8020001 8020441 8021084 8018628 8019239 8019619 8020005 8020449 8021091 8018636 8019256 8019620 8020009 8020456 8021096 8018657 8019278 8019627 8020010 8020465 8021102 8018660 8019283 8019631 8020011 8020473 8021110 8018661 8019284 8019635 8020012 8020479 8021111 8018673 8019286 8019638 8020022 8020492 8021115 8018677 8019295 8019639 8020024 8020525 8021117 8018681 8019300 8019646 8020025 8020544 8021121 8018688 8019304 8019648 8020026 8020570 8021122 8018689 8019311 8019688 8020029 8020588 8021125 8018694 8019313 8019704 8020030 8020590 8021131 8018703 8019315 8019716 8020033 8020593 8021135 8018716 8019316 8019723 8020037 8020596 8021137 8018733 8019317 8019724 8020039 8020603 8021145 8018740 8019320 8019732 8020040 8020608 8021172 8018745 8019323 8019734 8020041 8020612 8021187 8018746 8019325 8019736 8020048 8020614 8021201 8018755 8019326 8019742 8020057 8020618 8021207 8018759 8019328 8019744 8020059 8020634 8021209 8018762 8019330 8019745 8020062 8020635 8021210 8018767 8019344 8019747 8020064 8020636 8021211 8018775 8019348 8019748 8020066 8020659 8021215 8018776 8019349 8019751 8020069 8020661 8021218 8018778 8019353 8019755 8020075 8020665 8021223 8018783 8019357 8019757 8020078 8020669 8021225 8018791 8019367 8019761 8020079 8020678 8021232 8018804 8019372 8019765 8020080 8020698 8021234 8018807 8019375 8019767 8020101 8020705 8021237 8018810 8019379 8019776 8020103 8020734 8021238 8018811 8019385 8019784 8020107 8020755 8021239 8018813 8019386 8019792 8020108 8020771 8021240 8018816 8019391 8019793 8020123 8020819 8021250 8018817 8019392 8019795 8020124 8020821 8021257 8018820 8019395 8019798 8020127 8020826 8021263 8018829 8019396 8019801 8020129 8020827 8021271 8018839 8019399 8019804 8020133 8020845 8021273 8018841 8019400 8019805 8020135 8020860 8021286 8018842 8019401 8019808 8020147 8020878 8021294 8018843 8019403 8019813 8020156 8020893 8021313 8018844 8019405 8019825 8020158 8020926 8021314 8018845 8019407 8019826 8020159 8020928 8021323
EXHIBIT B 17 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8021335 8021816 8022061 8022485 8023168 8023800 8021346 8021819 8022076 8022493 8023175 8023801 8021356 8021821 8022083 8022504 8023178 8023804 8021360 8021825 8022091 8022506 8023185 8023808 8021364 8021829 8022124 8022512 8023188 8023810 8021370 8021830 8022134 8022519 8023199 8023811 8021373 8021834 8022143 8022524 8023201 8023816 8021381 8021837 8022147 8022528 8023202 8023819 8021385 8021841 8022148 8022533 8023209 8023820 8021387 8021847 8022149 8022538 8023210 8023821 8021419 8021848 8022159 8022555 8023211 8023828 8021422 8021851 8022160 8022569 8023214 8023840 8021425 8021852 8022163 8022582 8023216 8023846 8021427 8021853 8022169 8022585 8023218 8023852 8021432 8021855 8022186 8022591 8023242 8023854 8021434 8021856 8022206 8022601 8023245 8023855 8021435 8021866 8022212 8022607 8023253 8023870 8021437 8021868 8022241 8022613 8023255 8023872 8021438 8021872 8022247 8022621 8023259 8023880 8021440 8021878 8022249 8022627 8023264 8023881 8021441 8021883 8022260 8022650 8023276 8023882 8021444 8021892 8022263 8022657 8023277 8023883 8021447 8021898 8022268 8022659 8023285 8023884 8021453 8021904 8022275 8022664 8023287 8023886 8021456 8021908 8022279 8022674 8023290 8023887 8021458 8021911 8022284 8022680 8023291 8023888 8021460 8021928 8022289 8022688 8023294 8023891 8021468 8021932 8022295 8022694 8023295 8023895 8021470 8021936 8022304 8022709 8023296 8023913 8021497 8021937 8022305 8022718 8023298 8023934 8021500 8021940 8022310 8022723 8023300 8023951 8021515 8021941 8022313 8022727 8023305 8023954 8021518 8021944 8022318 8022732 8023311 8023960 8021525 8021946 8022321 8022738 8023315 8023962 8021526 8021947 8022323 8022742 8023323 8023965 8021528 8021948 8022324 8022760 8023327 8023969 8021540 8021951 8022327 8022799 8023328 8023976 8021542 8021952 8022333 8022804 8023332 8023982 8021562 8021955 8022336 8022814 8023334 8023984 8021582 8021960 8022345 8022822 8023336 8023994 8021607 8021963 8022349 8022849 8023341 8023998 8021613 8021964 8022358 8022878 8023342 8024000 8021619 8021966 8022363 8022920 8023344 8024001 8021632 8021967 8022368 8022923 8023363 8024003 8021638 8021968 8022370 8022940 8023376 8024004 8021640 8021969 8022373 8022947 8023381 8024005 8021644 8021970 8022375 8022970 8023384 8024011 8021650 8021973 8022379 8023002 8023386 8024015 8021658 8021976 8022381 8023015 8023388 8024017 8021668 8021978 8022383 8023022 8023439 8024020 8021674 8021983 8022386 8023025 8023455 8024025 8021678 8021987 8022393 8023029 8023462 8024029 8021681 8021991 8022397 8023035 8023499 8024033 8021687 8021994 8022399 8023042 8023511 8024036 8021695 8021998 8022405 8023050 8023534 8024040 8021698 8022000 8022415 8023063 8023552 8024041 8021703 8022005 8022425 8023066 8023610 8024042 8021721 8022008 8022427 8023078 8023627 8024043 8021727 8022012 8022431 8023100 8023631 8024059 8021732 8022013 8022433 8023102 8023687 8024075 8021738 8022014 8022435 8023106 8023694 8024084 8021741 8022015 8022438 8023108 8023701 8024098 8021746 8022016 8022441 8023125 8023704 8024112 8021756 8022017 8022443 8023132 8023709 8024121 8021762 8022022 8022445 8023134 8023733 8024140 8021765 8022024 8022447 8023140 8023744 8024141 8021768 8022028 8022451 8023147 8023754 8024168 8021776 8022045 8022456 8023150 8023757 8024174 8021811 8022051 8022457 8023155 8023783 8024176 8021814 8022052 8022459 8023166 8023799 8024178
EXHIBIT B 18 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8024181 8024505 8024956 8025198 8025592 8026192 8024187 8024507 8024958 8025200 8025600 8026210 8024191 8024511 8024961 8025202 8025603 8026213 8024248 8024515 8024969 8025204 8025607 8026219 8024252 8024518 8024972 8025206 8025612 8026225 8024257 8024522 8024978 8025207 8025614 8026234 8024258 8024524 8024998 8025209 8025621 8026239 8024262 8024528 8024999 8025226 8025623 8026261 8024263 8024535 8025002 8025231 8025626 8026266 8024265 8024539 8025003 8025232 8025650 8026271 8024266 8024543 8025004 8025233 8025658 8026283 8024267 8024544 8025010 8025234 8025672 8026304 8024270 8024548 8025019 8025236 8025673 8026307 8024274 8024550 8025021 8025239 8025700 8026308 8024277 8024553 8025023 8025240 8025702 8026318 8024285 8024556 8025030 8025241 8025728 8026322 8024288 8024558 8025034 8025242 8025789 8026328 8024297 8024562 8025037 8025245 8025803 8026333 8024299 8024567 8025038 8025247 8025817 8026339 8024300 8024568 8025039 8025248 8025820 8026343 8024307 8024569 8025041 8025250 8025828 8026344 8024308 8024571 8025042 8025252 8025833 8026362 8024310 8024572 8025044 8025255 8025834 8026366 8024313 8024575 8025046 8025256 8025835 8026383 8024315 8024584 8025048 8025260 8025837 8026400 8024317 8024591 8025052 8025264 8025838 8026403 8024325 8024600 8025053 8025274 8025841 8026416 8024328 8024608 8025058 8025279 8025842 8026431 8024352 8024613 8025060 8025292 8025843 8026432 8024364 8024616 8025064 8025293 8025845 8026434 8024374 8024626 8025066 8025312 8025847 8026493 8024383 8024629 8025068 8025315 8025848 8026499 8024388 8024654 8025078 8025316 8025849 8026504 8024392 8024657 8025080 8025317 8025855 8026508 8024395 8024683 8025083 8025318 8025857 8026516 8024400 8024694 8025084 8025323 8025859 8026521 8024402 8024714 8025085 8025324 8025861 8026523 8024403 8024723 8025091 8025326 8025866 8026525 8024407 8024725 8025102 8025329 8025867 8026574 8024412 8024731 8025105 8025330 8025869 8026603 8024414 8024734 8025109 8025334 8025887 8026611 8024426 8024735 8025111 8025341 8025893 8026619 8024433 8024736 8025113 8025359 8025917 8026620 8024436 8024742 8025115 8025361 8025926 8026636 8024437 8024753 8025119 8025387 8025949 8026637 8024438 8024758 8025122 8025391 8025984 8026655 8024442 8024760 8025125 8025395 8026001 8026656 8024443 8024766 8025134 8025403 8026008 8026670 8024447 8024770 8025144 8025404 8026017 8026671 8024451 8024783 8025147 8025406 8026024 8026696 8024456 8024786 8025149 8025423 8026040 8026698 8024458 8024793 8025153 8025459 8026041 8026699 8024462 8024795 8025154 8025463 8026046 8026704 8024463 8024835 8025159 8025464 8026062 8026707 8024464 8024846 8025160 8025467 8026076 8026708 8024469 8024848 8025162 8025486 8026087 8026714 8024472 8024857 8025165 8025496 8026090 8026716 8024474 8024860 8025167 8025508 8026096 8026719 8024479 8024869 8025173 8025509 8026103 8026729 8024480 8024874 8025174 8025512 8026105 8026730 8024481 8024876 8025177 8025517 8026115 8026740 8024482 8024878 8025179 8025518 8026118 8026752 8024483 8024882 8025181 8025536 8026120 8026758 8024486 8024884 8025183 8025545 8026123 8026766 8024489 8024904 8025184 8025551 8026132 8026782 8024494 8024916 8025185 8025552 8026148 8026790 8024496 8024932 8025189 8025555 8026158 8026792 8024501 8024951 8025190 8025563 8026166 8026804 8024502 8024952 8025192 8025571 8026181 8026812 8024503 8024955 8025194 8025581 8026183 8026814
EXHIBIT B 19 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8026829 8027736 8029035 8029389 8029846 8030913 8026834 8027769 8029041 8029391 8029854 8030914 8026840 8027777 8029049 8029398 8029859 8030920 8026866 8027792 8029050 8029403 8029870 8030937 8026878 8027795 8029058 8029404 8029873 8030975 8026902 8027807 8029059 8029411 8029874 8030981 8026905 8027847 8029065 8029414 8029875 8030989 8026924 8027850 8029067 8029418 8029879 8030990 8026957 8027879 8029068 8029420 8029880 8031007 8026958 8027904 8029069 8029427 8029882 8031008 8026974 8027909 8029070 8029430 8029888 8031014 8027017 8027940 8029074 8029434 8029890 8031016 8027050 8027952 8029080 8029435 8029894 8031021 8027066 8027977 8029081 8029437 8029899 8031040 8027071 8027981 8029096 8029438 8029921 8031047 8027083 8027984 8029100 8029439 8029923 8031048 8027097 8027986 8029105 8029444 8029935 8031054 8027098 8027995 8029112 8029448 8029936 8031063 8027099 8028002 8029118 8029451 8029944 8031068 8027100 8028007 8029120 8029453 8029951 8031084 8027106 8028024 8029134 8029457 8029955 8031085 8027113 8028035 8029136 8029461 8029961 8031096 8027140 8028048 8029144 8029462 8029963 8031112 8027167 8028051 8029148 8029464 8029970 8031116 8027183 8028062 8029165 8029465 8029971 8031119 8027203 8028070 8029166 8029468 8030016 8031140 8027212 8028081 8029168 8029469 8030140 8031148 8027219 8028157 8029170 8029470 8030240 8031161 8027223 8028250 8029173 8029472 8030366 8031171 8027241 8028252 8029179 8029473 8030394 8031174 8027308 8028259 8029184 8029474 8030458 8031186 8027331 8028265 8029186 8029475 8030474 8031194 8027339 8028266 8029187 8029477 8030482 8031197 8027342 8028275 8029194 8029478 8030495 8031202 8027344 8028276 8029195 8029479 8030504 8031205 8027348 8028284 8029196 8029480 8030505 8031211 8027362 8028291 8029197 8029481 8030531 8031212 8027365 8028301 8029198 8029483 8030551 8031216 8027369 8028304 8029200 8029484 8030557 8031219 8027375 8028312 8029201 8029485 8030575 8031223 8027378 8028321 8029206 8029487 8030639 8031226 8027380 8028322 8029208 8029488 8030641 8031231 8027386 8028337 8029225 8029491 8030645 8031232 8027394 8028400 8029228 8029493 8030670 8031234 8027398 8028402 8029234 8029501 8030702 8031237 8027401 8028478 8029239 8029502 8030711 8031243 8027403 8028482 8029245 8029503 8030715 8031251 8027407 8028489 8029251 8029504 8030719 8031258 8027411 8028505 8029257 8029579 8030729 8031264 8027412 8028515 8029266 8029587 8030730 8031270 8027418 8028538 8029269 8029594 8030787 8031272 8027422 8028581 8029275 8029601 8030791 8031281 8027426 8028595 8029277 8029607 8030796 8031287 8027430 8028596 8029279 8029673 8030814 8031302 8027435 8028683 8029280 8029680 8030818 8031304 8027440 8028717 8029287 8029693 8030823 8031310 8027504 8028757 8029292 8029704 8030827 8031331 8027515 8028890 8029294 8029711 8030833 8031350 8027532 8028931 8029306 8029719 8030838 8031362 8027566 8028948 8029325 8029725 8030839 8031375 8027582 8028968 8029334 8029727 8030877 8031382 8027650 8028985 8029337 8029732 8030878 8031467 8027661 8028996 8029346 8029740 8030882 8031483 8027671 8029003 8029359 8029758 8030883 8031511 8027682 8029006 8029367 8029760 8030889 8031533 8027684 8029014 8029370 8029778 8030893 8031552 8027695 8029018 8029373 8029794 8030899 8031568 8027714 8029022 8029378 8029796 8030902 8031592 8027717 8029024 8029383 8029815 8030903 8031610 8027727 8029027 8029386 8029831 8030910 8031616
EXHIBIT B 20 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8031654 8033150 8033626 8033842 8034244 8034961 8031706 8033161 8033629 8033845 8034259 8034974 8031722 8033162 8033633 8033848 8034264 8034975 8031763 8033163 8033638 8033850 8034271 8034977 8031833 8033169 8033640 8033852 8034281 8034979 8031869 8033173 8033643 8033854 8034285 8034986 8031960 8033176 8033652 8033855 8034288 8034995 8031989 8033184 8033655 8033858 8034290 8034998 8032004 8033186 8033656 8033868 8034291 8035007 8032084 8033188 8033658 8033870 8034294 8035016 8032100 8033193 8033659 8033871 8034295 8035020 8032114 8033198 8033663 8033876 8034300 8035027 8032152 8033201 8033666 8033878 8034301 8035028 8032201 8033206 8033670 8033879 8034304 8035033 8032285 8033210 8033674 8033884 8034329 8035037 8032299 8033234 8033679 8033891 8034330 8035054 8032383 8033244 8033680 8033892 8034337 8035080 8032389 8033245 8033682 8033899 8034344 8035088 8032408 8033255 8033684 8033900 8034345 8035093 8032643 8033257 8033687 8033901 8034348 8035099 8032750 8033260 8033694 8033903 8034370 8035106 8032753 8033263 8033707 8033906 8034381 8035126 8032760 8033267 8033708 8033909 8034392 8035134 8032770 8033275 8033709 8033910 8034400 8035156 8032774 8033281 8033716 8033913 8034413 8035166 8032785 8033289 8033721 8033914 8034414 8035170 8032791 8033332 8033722 8033917 8034420 8035177 8032801 8033386 8033723 8033918 8034431 8035189 8032805 8033404 8033729 8033920 8034457 8035190 8032809 8033409 8033730 8033926 8034476 8035202 8032817 8033415 8033734 8033928 8034503 8035208 8032820 8033429 8033735 8033929 8034506 8035211 8032826 8033449 8033736 8033931 8034558 8035215 8032828 8033450 8033738 8033938 8034576 8035216 8032843 8033454 8033739 8033939 8034580 8035217 8032860 8033465 8033741 8033940 8034614 8035223 8032872 8033468 8033742 8033945 8034643 8035235 8032875 8033478 8033744 8033950 8034660 8035246 8032884 8033481 8033745 8033956 8034680 8035250 8032890 8033484 8033747 8033957 8034682 8035252 8032892 8033489 8033751 8033958 8034688 8035264 8032903 8033494 8033754 8033966 8034691 8035266 8032916 8033499 8033755 8033968 8034702 8035322 8032925 8033507 8033758 8033973 8034714 8035326 8032938 8033510 8033761 8034007 8034727 8035335 8032939 8033511 8033763 8034008 8034744 8035351 8032942 8033520 8033765 8034015 8034756 8035357 8032965 8033533 8033770 8034020 8034761 8035358 8032979 8033536 8033771 8034027 8034762 8035360 8032989 8033541 8033777 8034030 8034765 8035372 8033001 8033544 8033782 8034032 8034772 8035383 8033003 8033548 8033783 8034035 8034776 8035399 8033004 8033552 8033785 8034040 8034778 8035400 8033017 8033556 8033790 8034048 8034781 8035408 8033021 8033558 8033795 8034051 8034787 8035426 8033023 8033562 8033805 8034063 8034792 8035441 8033030 8033568 8033807 8034065 8034795 8035447 8033033 8033569 8033809 8034076 8034799 8035459 8033036 8033573 8033814 8034077 8034808 8035467 8033052 8033574 8033815 8034097 8034811 8035469 8033072 8033577 8033818 8034109 8034821 8035500 8033081 8033579 8033819 8034122 8034822 8035509 8033091 8033581 8033820 8034144 8034826 8035511 8033093 8033582 8033824 8034164 8034849 8035516 8033110 8033584 8033828 8034170 8034884 8035525 8033119 8033585 8033829 8034180 8034885 8035527 8033128 8033595 8033832 8034209 8034899 8035537 8033130 8033610 8033835 8034210 8034923 8035548 8033144 8033617 8033839 8034235 8034937 8035556 8033149 8033623 8033841 8034240 8034953 8035566
EXHIBIT B 21 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8035581 8036325 8036621 8037176 8037474 8037839 8035588 8036335 8036623 8037178 8037480 8037846 8035599 8036337 8036627 8037183 8037491 8037850 8035604 8036343 8036636 8037184 8037500 8037855 8035616 8036356 8036640 8037186 8037502 8037861 8035631 8036358 8036651 8037193 8037506 8037872 8035637 8036360 8036657 8037208 8037516 8037883 8035648 8036375 8036659 8037222 8037527 8037886 8035659 8036379 8036665 8037226 8037541 8037893 8035661 8036384 8036677 8037229 8037548 8037899 8035668 8036392 8036697 8037235 8037552 8037902 8035674 8036393 8036707 8037244 8037553 8037905 8035676 8036395 8036724 8037251 8037566 8037910 8035683 8036409 8036748 8037257 8037574 8037913 8035686 8036417 8036750 8037267 8037586 8037921 8035692 8036419 8036775 8037269 8037595 8037948 8035693 8036421 8036777 8037274 8037598 8037975 8035694 8036433 8036783 8037277 8037601 8037987 8035705 8036435 8036803 8037278 8037604 8038037 8035707 8036436 8036810 8037281 8037605 8038062 8035708 8036440 8036815 8037284 8037609 8038071 8035726 8036445 8036826 8037285 8037614 8038090 8035740 8036446 8036830 8037292 8037622 8038093 8035744 8036457 8036846 8037293 8037628 8038096 8035751 8036465 8036849 8037296 8037629 8038101 8035757 8036468 8036861 8037302 8037640 8038103 8035763 8036474 8036868 8037305 8037641 8038109 8035767 8036477 8036872 8037307 8037643 8038118 8035768 8036478 8036875 8037310 8037648 8038125 8035773 8036486 8036878 8037318 8037649 8038131 8035792 8036487 8036880 8037321 8037653 8038133 8035810 8036498 8036882 8037323 8037655 8038135 8035864 8036500 8036887 8037325 8037660 8038139 8035876 8036502 8036891 8037326 8037666 8038140 8035884 8036510 8036893 8037334 8037668 8038143 8035903 8036513 8036897 8037337 8037678 8038148 8035921 8036516 8036903 8037340 8037686 8038149 8035933 8036517 8036904 8037343 8037690 8038155 8035937 8036519 8036913 8037344 8037694 8038158 8035981 8036521 8036914 8037347 8037707 8038159 8035990 8036525 8036922 8037348 8037714 8038161 8036032 8036526 8036924 8037351 8037715 8038165 8036050 8036530 8036933 8037353 8037716 8038166 8036099 8036531 8036935 8037355 8037723 8038168 8036116 8036534 8036946 8037356 8037725 8038169 8036133 8036537 8036975 8037358 8037731 8038170 8036171 8036538 8036976 8037366 8037735 8038172 8036173 8036541 8036986 8037369 8037737 8038177 8036220 8036542 8037012 8037370 8037740 8038180 8036229 8036547 8037035 8037373 8037748 8038181 8036238 8036548 8037051 8037382 8037756 8038182 8036242 8036549 8037072 8037389 8037757 8038187 8036244 8036551 8037074 8037391 8037758 8038192 8036247 8036552 8037075 8037392 8037759 8038199 8036248 8036554 8037090 8037398 8037760 8038203 8036253 8036555 8037110 8037400 8037765 8038204 8036256 8036557 8037115 8037419 8037766 8038208 8036259 8036559 8037117 8037427 8037768 8038218 8036262 8036560 8037120 8037428 8037773 8038220 8036268 8036562 8037124 8037431 8037776 8038223 8036272 8036567 8037128 8037433 8037778 8038226 8036275 8036568 8037135 8037437 8037782 8038230 8036277 8036575 8037142 8037440 8037784 8038239 8036285 8036579 8037144 8037441 8037794 8038247 8036296 8036584 8037148 8037446 8037804 8038286 8036304 8036588 8037150 8037449 8037806 8038309 8036307 8036592 8037159 8037457 8037808 8038315 8036316 8036603 8037162 8037458 8037815 8038321 8036319 8036611 8037164 8037465 8037819 8038324 8036324 8036613 8037174 8037469 8037828 8038325
EXHIBIT B 22 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8038327 8038793 8039517 8039978 8040269 8040946 8038329 8038799 8039518 8039980 8040270 8041031 8038340 8038816 8039519 8039984 8040271 8041082 8038346 8038818 8039552 8039989 8040272 8041089 8038359 8038821 8039589 8039990 8040275 8041102 8038364 8038824 8039617 8039994 8040276 8041108 8038365 8038832 8039634 8039998 8040282 8041109 8038374 8038856 8039636 8040003 8040283 8041121 8038377 8038881 8039654 8040010 8040285 8041122 8038378 8038883 8039658 8040016 8040288 8041125 8038380 8038889 8039683 8040020 8040289 8041126 8038381 8038899 8039689 8040023 8040292 8041132 8038387 8038906 8039692 8040026 8040294 8041133 8038389 8038918 8039697 8040028 8040296 8041144 8038391 8038923 8039707 8040030 8040298 8041154 8038394 8038925 8039711 8040034 8040305 8041156 8038396 8038945 8039716 8040038 8040310 8041162 8038400 8038965 8039717 8040039 8040314 8041163 8038401 8038970 8039719 8040045 8040379 8041173 8038404 8038974 8039722 8040053 8040395 8041174 8038405 8038977 8039724 8040055 8040419 8041176 8038407 8038992 8039726 8040058 8040427 8041183 8038416 8039011 8039729 8040064 8040436 8041186 8038417 8039014 8039730 8040067 8040472 8041187 8038421 8039020 8039735 8040069 8040511 8041198 8038427 8039026 8039736 8040075 8040528 8041202 8038428 8039031 8039744 8040077 8040533 8041213 8038430 8039062 8039752 8040081 8040537 8041238 8038431 8039067 8039764 8040085 8040541 8041258 8038435 8039071 8039772 8040086 8040549 8041298 8038440 8039074 8039783 8040095 8040554 8041325 8038444 8039092 8039784 8040106 8040561 8041329 8038455 8039100 8039785 8040108 8040568 8041347 8038460 8039103 8039787 8040110 8040576 8041348 8038462 8039131 8039788 8040124 8040585 8041351 8038468 8039151 8039798 8040137 8040586 8041372 8038477 8039162 8039815 8040138 8040598 8041373 8038492 8039176 8039836 8040142 8040626 8041374 8038493 8039188 8039842 8040143 8040629 8041386 8038495 8039189 8039850 8040146 8040647 8041395 8038497 8039201 8039851 8040153 8040659 8041405 8038500 8039209 8039856 8040157 8040662 8041409 8038508 8039214 8039865 8040163 8040669 8041412 8038525 8039216 8039871 8040169 8040677 8041413 8038536 8039219 8039875 8040175 8040688 8041425 8038543 8039220 8039880 8040176 8040689 8041432 8038547 8039232 8039890 8040177 8040693 8041449 8038550 8039243 8039895 8040188 8040697 8041453 8038554 8039253 8039897 8040190 8040702 8041471 8038574 8039261 8039898 8040191 8040704 8041486 8038588 8039283 8039901 8040198 8040708 8041492 8038598 8039292 8039902 8040200 8040710 8041493 8038617 8039320 8039914 8040204 8040714 8041495 8038627 8039365 8039916 8040210 8040721 8041501 8038632 8039394 8039922 8040215 8040722 8041507 8038659 8039435 8039931 8040222 8040725 8041512 8038683 8039456 8039934 8040226 8040739 8041518 8038685 8039468 8039935 8040230 8040755 8041524 8038692 8039478 8039941 8040231 8040765 8041528 8038694 8039479 8039942 8040232 8040770 8041531 8038696 8039481 8039946 8040239 8040778 8041533 8038703 8039487 8039950 8040243 8040799 8041545 8038704 8039490 8039952 8040244 8040848 8041549 8038708 8039492 8039956 8040255 8040863 8041558 8038717 8039495 8039960 8040260 8040875 8041561 8038724 8039507 8039961 8040261 8040887 8041562 8038732 8039509 8039968 8040262 8040889 8041563 8038742 8039510 8039969 8040263 8040896 8041578 8038782 8039512 8039973 8040266 8040924 8041591 8038789 8039514 8039976 8040267 8040938 8041596
EXHIBIT B 23 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8041610 8041997 8042530 8043178 8043973 8044727 8041616 8041998 8042534 8043206 8043989 8044732 8041622 8042003 8042538 8043222 8044045 8044736 8041627 8042006 8042543 8043227 8044066 8044737 8041629 8042010 8042546 8043235 8044084 8044738 8041631 8042011 8042553 8043238 8044100 8044739 8041633 8042018 8042558 8043239 8044113 8044741 8041641 8042020 8042573 8043243 8044137 8044742 8041650 8042023 8042580 8043244 8044181 8044744 8041653 8042025 8042581 8043247 8044185 8044746 8041655 8042030 8042587 8043250 8044201 8044749 8041659 8042031 8042593 8043254 8044225 8044752 8041660 8042035 8042600 8043267 8044248 8044753 8041661 8042044 8042602 8043274 8044259 8044756 8041664 8042050 8042613 8043281 8044273 8044758 8041667 8042054 8042617 8043293 8044293 8044759 8041675 8042057 8042649 8043300 8044333 8044760 8041684 8042060 8042704 8043317 8044362 8044761 8041702 8042067 8042721 8043335 8044370 8044763 8041727 8042079 8042739 8043337 8044381 8044769 8041741 8042080 8042741 8043342 8044384 8044770 8041743 8042091 8042748 8043343 8044405 8044775 8041753 8042094 8042752 8043382 8044424 8044779 8041765 8042100 8042755 8043390 8044434 8044782 8041766 8042103 8042758 8043395 8044441 8044799 8041767 8042111 8042761 8043398 8044451 8044810 8041768 8042116 8042765 8043418 8044457 8044821 8041782 8042127 8042767 8043427 8044462 8044832 8041794 8042135 8042790 8043434 8044463 8044841 8041795 8042139 8042798 8043444 8044466 8044878 8041798 8042142 8042803 8043452 8044468 8044887 8041804 8042155 8042805 8043458 8044475 8044905 8041822 8042160 8042807 8043464 8044482 8044920 8041831 8042164 8042815 8043478 8044485 8044935 8041837 8042166 8042836 8043514 8044488 8044944 8041845 8042185 8042841 8043542 8044491 8044958 8041847 8042204 8042849 8043555 8044492 8044980 8041855 8042227 8042856 8043589 8044495 8045004 8041856 8042282 8042857 8043593 8044499 8045006 8041858 8042284 8042859 8043597 8044506 8045013 8041868 8042291 8042870 8043606 8044507 8045039 8041871 8042296 8042877 8043607 8044508 8045044 8041880 8042304 8042880 8043610 8044517 8045062 8041882 8042309 8042888 8043612 8044531 8045068 8041888 8042311 8042915 8043632 8044553 8045075 8041902 8042326 8042919 8043651 8044563 8045084 8041905 8042338 8042921 8043653 8044575 8045089 8041906 8042355 8042922 8043654 8044576 8045092 8041911 8042376 8042933 8043677 8044579 8045101 8041914 8042397 8042941 8043678 8044580 8045115 8041915 8042399 8042952 8043731 8044617 8045116 8041923 8042404 8042962 8043735 8044630 8045129 8041927 8042405 8042966 8043760 8044641 8045140 8041932 8042413 8042969 8043761 8044651 8045148 8041934 8042417 8042970 8043769 8044655 8045152 8041939 8042420 8042978 8043778 8044656 8045154 8041946 8042430 8042996 8043786 8044663 8045213 8041951 8042437 8042997 8043796 8044669 8045239 8041953 8042438 8043002 8043818 8044679 8045262 8041954 8042443 8043013 8043831 8044682 8045273 8041958 8042452 8043029 8043837 8044685 8045282 8041966 8042464 8043032 8043847 8044690 8045318 8041967 8042471 8043033 8043859 8044693 8045328 8041970 8042475 8043054 8043876 8044697 8045330 8041975 8042484 8043079 8043895 8044703 8045342 8041980 8042489 8043094 8043905 8044707 8045351 8041981 8042509 8043097 8043918 8044714 8045355 8041989 8042522 8043118 8043920 8044716 8045365 8041992 8042525 8043136 8043951 8044718 8045394 8041995 8042526 8043150 8043971 8044720 8045426
EXHIBIT B 24 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8045432 8045979 8046589 8047081 8047799 8048618 8045434 8045985 8046590 8047084 8047808 8048620 8045436 8045998 8046591 8047093 8047816 8048627 8045454 8046001 8046599 8047101 8047827 8048636 8045488 8046030 8046609 8047107 8047836 8048641 8045494 8046036 8046610 8047108 8047837 8048667 8045503 8046040 8046616 8047123 8047844 8048678 8045511 8046049 8046644 8047124 8047857 8048695 8045520 8046055 8046676 8047130 8047863 8048697 8045531 8046056 8046680 8047133 8047870 8048705 8045537 8046061 8046682 8047136 8047871 8048715 8045552 8046099 8046694 8047141 8047875 8048724 8045557 8046100 8046697 8047146 8047878 8048727 8045569 8046101 8046700 8047155 8047886 8048733 8045571 8046118 8046715 8047159 8047891 8048740 8045580 8046127 8046725 8047174 8047894 8048749 8045597 8046134 8046730 8047178 8047912 8048756 8045607 8046146 8046746 8047190 8047916 8048783 8045626 8046148 8046752 8047198 8047917 8048801 8045627 8046160 8046755 8047227 8047933 8048833 8045649 8046176 8046757 8047238 8047941 8048864 8045652 8046198 8046764 8047241 8047948 8048875 8045659 8046214 8046767 8047242 8047965 8048889 8045663 8046222 8046771 8047257 8047989 8048961 8045666 8046238 8046773 8047262 8047990 8048984 8045683 8046250 8046776 8047270 8048073 8048995 8045687 8046275 8046781 8047271 8048082 8049006 8045688 8046285 8046784 8047280 8048088 8049116 8045700 8046288 8046786 8047284 8048096 8049140 8045711 8046290 8046791 8047288 8048103 8049151 8045717 8046293 8046809 8047293 8048121 8049157 8045736 8046301 8046813 8047298 8048124 8049208 8045739 8046328 8046816 8047299 8048146 8049221 8045758 8046339 8046823 8047302 8048172 8049230 8045759 8046341 8046827 8047314 8048191 8049243 8045760 8046349 8046831 8047316 8048203 8049248 8045775 8046350 8046841 8047323 8048231 8049397 8045777 8046353 8046844 8047328 8048242 8049425 8045781 8046360 8046858 8047334 8048243 8049449 8045788 8046370 8046866 8047342 8048269 8049471 8045799 8046380 8046867 8047352 8048285 8049497 8045815 8046391 8046874 8047355 8048291 8049508 8045816 8046397 8046882 8047372 8048301 8049562 8045821 8046400 8046898 8047375 8048307 8049596 8045824 8046404 8046901 8047398 8048309 8049598 8045826 8046408 8046906 8047405 8048326 8049610 8045832 8046422 8046918 8047413 8048330 8049631 8045833 8046442 8046937 8047418 8048366 8049675 8045835 8046443 8046941 8047436 8048380 8049678 8045836 8046446 8046945 8047439 8048398 8049686 8045837 8046456 8046961 8047480 8048402 8049688 8045844 8046459 8046973 8047490 8048409 8049707 8045856 8046470 8046974 8047492 8048425 8049708 8045858 8046475 8046988 8047500 8048434 8049714 8045866 8046476 8046989 8047512 8048447 8049727 8045869 8046478 8046995 8047520 8048461 8049730 8045875 8046489 8046998 8047524 8048473 8049743 8045876 8046492 8047003 8047566 8048475 8049747 8045880 8046497 8047004 8047651 8048487 8049751 8045882 8046506 8047006 8047738 8048497 8049754 8045888 8046525 8047014 8047747 8048503 8049765 8045891 8046529 8047023 8047752 8048516 8049766 8045902 8046539 8047025 8047754 8048561 8049774 8045910 8046542 8047039 8047755 8048564 8049823 8045935 8046557 8047042 8047756 8048579 8049878 8045937 8046566 8047045 8047764 8048586 8049897 8045940 8046570 8047058 8047768 8048601 8049951 8045957 8046576 8047062 8047774 8048606 8049964 8045958 8046582 8047071 8047789 8048612 8049999 8045973 8046584 8047073 8047797 8048617 8050051
EXHIBIT B 25 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8050102 8050901 8051161 8051560 8052031 8053534 8050105 8050917 8051165 8051571 8052052 8053571 8050109 8050918 8051169 8051576 8052061 8053574 8050173 8050919 8051170 8051582 8052070 8053665 8050178 8050929 8051171 8051589 8052082 8053715 8050221 8050932 8051177 8051591 8052084 8053796 8050287 8050936 8051180 8051598 8052086 8053868 8050295 8050943 8051189 8051610 8052094 8053941 8050306 8050950 8051190 8051617 8052095 8053969 8050315 8050955 8051203 8051619 8052096 8053974 8050319 8050959 8051206 8051620 8052097 8053993 8050321 8050964 8051213 8051621 8052101 8054010 8050325 8050966 8051218 8051627 8052104 8054031 8050329 8050967 8051220 8051629 8052111 8054059 8050332 8050970 8051224 8051635 8052116 8054076 8050335 8050971 8051237 8051645 8052120 8054098 8050339 8050976 8051240 8051648 8052127 8054124 8050343 8050979 8051242 8051653 8052137 8054134 8050345 8050980 8051251 8051657 8052141 8054186 8050356 8050986 8051253 8051658 8052150 8054250 8050389 8050989 8051258 8051662 8052152 8054317 8050394 8050994 8051259 8051675 8052153 8054348 8050401 8050995 8051260 8051682 8052165 8054355 8050416 8050996 8051262 8051685 8052169 8054369 8050423 8051000 8051264 8051686 8052194 8054382 8050429 8051001 8051273 8051690 8052206 8054398 8050431 8051002 8051291 8051692 8052217 8054433 8050432 8051004 8051298 8051696 8052260 8054457 8050461 8051011 8051300 8051700 8052263 8054467 8050481 8051014 8051302 8051703 8052273 8054482 8050543 8051020 8051304 8051709 8052314 8054483 8050547 8051023 8051313 8051726 8052352 8054506 8050555 8051029 8051317 8051731 8052360 8054518 8050557 8051031 8051319 8051749 8052398 8054531 8050566 8051037 8051326 8051756 8052412 8054533 8050572 8051039 8051336 8051766 8052429 8054554 8050579 8051046 8051339 8051783 8052545 8054563 8050593 8051048 8051341 8051787 8052556 8054603 8050597 8051050 8051364 8051799 8052565 8054669 8050608 8051052 8051367 8051807 8052596 8054688 8050616 8051062 8051377 8051822 8052606 8054699 8050618 8051068 8051381 8051841 8052609 8054702 8050640 8051069 8051393 8051859 8052704 8054710 8050644 8051071 8051400 8051869 8052771 8054717 8050656 8051072 8051410 8051887 8052784 8054719 8050661 8051075 8051422 8051892 8052833 8054741 8050671 8051078 8051433 8051906 8052864 8054743 8050673 8051085 8051456 8051908 8052905 8054751 8050685 8051090 8051459 8051916 8052915 8054785 8050721 8051091 8051469 8051917 8052918 8054825 8050737 8051092 8051471 8051924 8052929 8054827 8050741 8051095 8051474 8051931 8052942 8054831 8050755 8051098 8051478 8051934 8052943 8054834 8050761 8051100 8051488 8051940 8052967 8054846 8050766 8051101 8051499 8051942 8052977 8054859 8050776 8051103 8051502 8051946 8053017 8054862 8050792 8051106 8051503 8051952 8053030 8054868 8050801 8051109 8051505 8051960 8053056 8054884 8050812 8051110 8051511 8051964 8053059 8054889 8050815 8051111 8051517 8051965 8053179 8054911 8050823 8051114 8051522 8051973 8053255 8054914 8050831 8051119 8051524 8051983 8053303 8054940 8050839 8051120 8051527 8051992 8053305 8054969 8050867 8051128 8051531 8051995 8053319 8054975 8050871 8051132 8051532 8051996 8053325 8054982 8050878 8051135 8051536 8052008 8053350 8054985 8050881 8051136 8051542 8052009 8053378 8054987 8050884 8051140 8051550 8052015 8053449 8054992 8050885 8051141 8051552 8052020 8053472 8054994 8050899 8051150 8051559 8052024 8053520 8054997
EXHIBIT B 26 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8054998 8056096 8057157 8058022 8058491 8059558 8054999 8056100 8057163 8058024 8058492 8059561 8055003 8056108 8057164 8058035 8058517 8059574 8055007 8056111 8057174 8058038 8058520 8059586 8055009 8056116 8057185 8058040 8058542 8059617 8055017 8056122 8057220 8058044 8058547 8059653 8055030 8056163 8057236 8058049 8058551 8059662 8055032 8056181 8057265 8058050 8058565 8059697 8055033 8056213 8057282 8058057 8058569 8059699 8055052 8056255 8057298 8058060 8058596 8059710 8055091 8056279 8057301 8058069 8058627 8059715 8055112 8056289 8057353 8058070 8058638 8059718 8055132 8056319 8057365 8058073 8058650 8059734 8055299 8056325 8057370 8058081 8058661 8059738 8055348 8056336 8057373 8058088 8058728 8059743 8055380 8056373 8057380 8058093 8058790 8059756 8055439 8056404 8057384 8058096 8058794 8059765 8055451 8056405 8057386 8058097 8058815 8059766 8055455 8056422 8057394 8058103 8058824 8059769 8055462 8056423 8057395 8058104 8058826 8059784 8055473 8056425 8057399 8058105 8058842 8059793 8055475 8056428 8057411 8058109 8058862 8059796 8055531 8056429 8057413 8058112 8058863 8059808 8055550 8056437 8057417 8058116 8058882 8059809 8055586 8056442 8057431 8058124 8058897 8059813 8055613 8056466 8057462 8058127 8058957 8059828 8055647 8056472 8057463 8058132 8058988 8059835 8055659 8056473 8057484 8058139 8058991 8059846 8055660 8056475 8057492 8058155 8059013 8059855 8055665 8056479 8057495 8058158 8059085 8059856 8055681 8056483 8057522 8058162 8059094 8059859 8055683 8056487 8057528 8058166 8059102 8059867 8055687 8056490 8057537 8058176 8059121 8059873 8055696 8056493 8057552 8058180 8059146 8059896 8055715 8056495 8057561 8058181 8059148 8059898 8055736 8056508 8057566 8058191 8059151 8059899 8055750 8056552 8057598 8058192 8059158 8059921 8055751 8056597 8057600 8058195 8059167 8059957 8055753 8056630 8057601 8058203 8059170 8060013 8055760 8056636 8057667 8058209 8059184 8060021 8055777 8056670 8057674 8058216 8059195 8060038 8055788 8056672 8057679 8058217 8059214 8060043 8055802 8056702 8057716 8058231 8059218 8060060 8055808 8056705 8057729 8058240 8059255 8060073 8055831 8056708 8057769 8058241 8059269 8060081 8055847 8056726 8057775 8058245 8059282 8060086 8055851 8056727 8057794 8058247 8059291 8060105 8055852 8056745 8057838 8058248 8059298 8060142 8055853 8056753 8057843 8058252 8059309 8060162 8055856 8056778 8057850 8058259 8059311 8060163 8055867 8056800 8057856 8058267 8059318 8060181 8055885 8056815 8057862 8058268 8059321 8060214 8055904 8056831 8057866 8058276 8059324 8060238 8055914 8056837 8057878 8058278 8059325 8060255 8055917 8056902 8057882 8058281 8059328 8060280 8055918 8056934 8057903 8058292 8059332 8060282 8055941 8056951 8057913 8058293 8059336 8060285 8055972 8056989 8057916 8058296 8059341 8060309 8055976 8057049 8057946 8058309 8059362 8060317 8055989 8057072 8057952 8058331 8059366 8060320 8055991 8057073 8057959 8058346 8059379 8060329 8056001 8057083 8057969 8058358 8059383 8060353 8056013 8057101 8057978 8058382 8059387 8060392 8056022 8057110 8057979 8058389 8059412 8060394 8056024 8057118 8057984 8058410 8059430 8060417 8056039 8057130 8057992 8058426 8059447 8060425 8056041 8057132 8057996 8058434 8059451 8060432 8056043 8057140 8058009 8058463 8059453 8060438 8056055 8057148 8058015 8058479 8059510 8060442 8056086 8057149 8058016 8058482 8059554 8060450
EXHIBIT B 27 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8060458 8061017 8061799 8062864 8063723 8064478 8060462 8061028 8061810 8062868 8063726 8064485 8060471 8061039 8061820 8062895 8063730 8064493 8060479 8061043 8061823 8062901 8063732 8064499 8060486 8061059 8061839 8062906 8063733 8064513 8060494 8061063 8061859 8062956 8063735 8064558 8060496 8061074 8061884 8062957 8063741 8064577 8060523 8061080 8061889 8062961 8063755 8064685 8060537 8061083 8061897 8062967 8063765 8064691 8060544 8061088 8061904 8063040 8063793 8064693 8060564 8061100 8061930 8063048 8063794 8064725 8060575 8061115 8061937 8063066 8063808 8064739 8060581 8061128 8061945 8063070 8063811 8064742 8060609 8061135 8061953 8063073 8063812 8064750 8060621 8061142 8061957 8063074 8063818 8064819 8060629 8061150 8061969 8063090 8063824 8064832 8060637 8061155 8061978 8063096 8063827 8064841 8060680 8061165 8062004 8063107 8063829 8064857 8060686 8061166 8062026 8063110 8063848 8064863 8060710 8061176 8062032 8063134 8063861 8064877 8060722 8061197 8062036 8063137 8063863 8064901 8060725 8061200 8062056 8063144 8063868 8064910 8060730 8061207 8062077 8063160 8063874 8064929 8060733 8061231 8062119 8063162 8063877 8064950 8060750 8061239 8062125 8063165 8063878 8064951 8060753 8061242 8062188 8063180 8063888 8064996 8060758 8061249 8062200 8063188 8063892 8065002 8060762 8061263 8062210 8063189 8063894 8065028 8060783 8061264 8062225 8063207 8063899 8065038 8060790 8061270 8062228 8063208 8063901 8065044 8060795 8061272 8062255 8063214 8063909 8065055 8060806 8061293 8062269 8063220 8063915 8065077 8060810 8061301 8062272 8063233 8063933 8065080 8060822 8061303 8062282 8063244 8063938 8065086 8060825 8061308 8062313 8063246 8063939 8065103 8060828 8061316 8062328 8063256 8063958 8065107 8060830 8061322 8062336 8063267 8063964 8065118 8060831 8061351 8062352 8063270 8063968 8065124 8060833 8061371 8062354 8063278 8063987 8065144 8060834 8061377 8062368 8063296 8063988 8065172 8060836 8061390 8062402 8063309 8063999 8065194 8060840 8061409 8062403 8063332 8064007 8065224 8060845 8061416 8062424 8063353 8064023 8065233 8060848 8061440 8062439 8063394 8064038 8065239 8060850 8061441 8062450 8063396 8064040 8065252 8060856 8061453 8062454 8063428 8064068 8065259 8060869 8061458 8062466 8063463 8064092 8065273 8060871 8061460 8062469 8063466 8064104 8065294 8060874 8061463 8062471 8063490 8064130 8065326 8060885 8061479 8062475 8063495 8064156 8065379 8060893 8061482 8062479 8063501 8064168 8065411 8060896 8061484 8062488 8063502 8064202 8065418 8060915 8061487 8062499 8063504 8064215 8065442 8060921 8061497 8062502 8063513 8064217 8065470 8060928 8061518 8062505 8063522 8064228 8065491 8060929 8061525 8062519 8063561 8064252 8065496 8060935 8061527 8062540 8063578 8064270 8065591 8060938 8061546 8062572 8063586 8064285 8065609 8060944 8061566 8062575 8063595 8064286 8065649 8060955 8061595 8062598 8063607 8064298 8065727 8060957 8061602 8062602 8063629 8064313 8065739 8060959 8061626 8062639 8063635 8064316 8065771 8060960 8061640 8062675 8063640 8064319 8065781 8060974 8061652 8062679 8063643 8064330 8065792 8060976 8061660 8062703 8063679 8064387 8065843 8060980 8061683 8062791 8063690 8064401 8065897 8060990 8061715 8062804 8063698 8064413 8065972 8061002 8061752 8062805 8063704 8064429 8065974 8061006 8061758 8062838 8063709 8064434 8065997 8061010 8061795 8062857 8063719 8064435 8066012
EXHIBIT B 28 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8066023 8067021 8067977 8068367 8069121 8070389 8066035 8067029 8067986 8068387 8069126 8070437 8066037 8067033 8067988 8068389 8069147 8070484 8066053 8067065 8067994 8068399 8069155 8070504 8066068 8067066 8067996 8068400 8069162 8070520 8066083 8067088 8068004 8068411 8069166 8070528 8066087 8067104 8068005 8068417 8069178 8070543 8066096 8067132 8068008 8068424 8069179 8070551 8066130 8067160 8068010 8068430 8069213 8070567 8066173 8067163 8068019 8068438 8069245 8070569 8066203 8067179 8068020 8068439 8069288 8070580 8066227 8067186 8068021 8068446 8069316 8070592 8066236 8067207 8068024 8068447 8069333 8070599 8066248 8067213 8068034 8068456 8069336 8070624 8066259 8067236 8068035 8068467 8069378 8070627 8066268 8067239 8068038 8068470 8069385 8070663 8066270 8067253 8068046 8068480 8069387 8070684 8066279 8067256 8068049 8068482 8069392 8070689 8066292 8067261 8068052 8068492 8069393 8070697 8066293 8067291 8068057 8068503 8069410 8070705 8066298 8067301 8068063 8068514 8069417 8070733 8066309 8067306 8068071 8068515 8069427 8070734 8066317 8067312 8068077 8068522 8069433 8070741 8066320 8067321 8068084 8068526 8069438 8070763 8066324 8067330 8068085 8068561 8069449 8070767 8066329 8067334 8068092 8068575 8069458 8070775 8066345 8067339 8068093 8068596 8069485 8070778 8066348 8067345 8068102 8068607 8069494 8070789 8066350 8067356 8068108 8068618 8069509 8070794 8066360 8067365 8068114 8068628 8069511 8070838 8066370 8067390 8068130 8068632 8069515 8070851 8066374 8067407 8068133 8068641 8069522 8070886 8066385 8067415 8068134 8068646 8069546 8070897 8066387 8067418 8068137 8068673 8069549 8070921 8066391 8067451 8068138 8068679 8069550 8070930 8066426 8067452 8068139 8068683 8069565 8070956 8066428 8067466 8068150 8068685 8069578 8070957 8066430 8067467 8068152 8068686 8069589 8070975 8066439 8067484 8068159 8068697 8069608 8070980 8066441 8067499 8068168 8068700 8069621 8070983 8066444 8067515 8068175 8068710 8069649 8070996 8066469 8067527 8068177 8068713 8069662 8071030 8066489 8067541 8068186 8068742 8069703 8071039 8066507 8067559 8068190 8068749 8069704 8071058 8066528 8067563 8068195 8068756 8069712 8071073 8066542 8067566 8068200 8068761 8069736 8071084 8066560 8067579 8068203 8068763 8069740 8071090 8066569 8067600 8068205 8068783 8069742 8071111 8066598 8067609 8068213 8068787 8069801 8071152 8066617 8067617 8068215 8068810 8069802 8071157 8066624 8067624 8068216 8068812 8069814 8071182 8066656 8067640 8068225 8068833 8069864 8071196 8066660 8067650 8068228 8068871 8069874 8071206 8066674 8067690 8068230 8068891 8069885 8071230 8066681 8067691 8068237 8068893 8069889 8071231 8066682 8067695 8068244 8068916 8069895 8071254 8066719 8067731 8068257 8068921 8069989 8071281 8066726 8067795 8068267 8068937 8070030 8071284 8066738 8067815 8068278 8068943 8070092 8071351 8066742 8067861 8068280 8068964 8070093 8071367 8066749 8067863 8068283 8068968 8070111 8071372 8066757 8067865 8068286 8068987 8070117 8071383 8066794 8067885 8068299 8069018 8070240 8071404 8066864 8067903 8068303 8069026 8070247 8071415 8066877 8067921 8068314 8069035 8070261 8071419 8066920 8067936 8068318 8069051 8070267 8071425 8066979 8067937 8068333 8069070 8070291 8071489 8066987 8067949 8068336 8069072 8070296 8071491 8066990 8067953 8068342 8069091 8070327 8071501 8067018 8067975 8068354 8069117 8070383 8071509
EXHIBIT B 29 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8071538 8073092 8075637 8077940 8079836 8081350 8071572 8073109 8075668 8077961 8079860 8081382 8071580 8073123 8075676 8077982 8079874 8081386 8071582 8073136 8075716 8078033 8079951 8081404 8071599 8073142 8075780 8078039 8079956 8081425 8071606 8073164 8075799 8078070 8079975 8081427 8071658 8073188 8075814 8078082 8080042 8081431 8071664 8073200 8075840 8078159 8080105 8081434 8071676 8073204 8075844 8078229 8080147 8081438 8071697 8073222 8075867 8078241 8080194 8081444 8071720 8073257 8075915 8078295 8080201 8081477 8071727 8073272 8075920 8078335 8080223 8081515 8071745 8073309 8075929 8078339 8080225 8081517 8071757 8073312 8075995 8078404 8080270 8081548 8071766 8073324 8076005 8078432 8080288 8081550 8071771 8073349 8076052 8078442 8080290 8081588 8071787 8073359 8076059 8078449 8080313 8081591 8071795 8073375 8076098 8078502 8080316 8081597 8071807 8073386 8076137 8078538 8080328 8081626 8071825 8073400 8076193 8078547 8080333 8081715 8071833 8073403 8076197 8078573 8080382 8081718 8071879 8073418 8076219 8078592 8080386 8081746 8071943 8073438 8076230 8078645 8080438 8081751 8071963 8073486 8076240 8078650 8080444 8081760 8071984 8073512 8076245 8078670 8080457 8081820 8072004 8073583 8076249 8078684 8080482 8081842 8072040 8073649 8076306 8078705 8080502 8081852 8072114 8073825 8076331 8078773 8080572 8081871 8072177 8073875 8076351 8078840 8080618 8081872 8072190 8074002 8076362 8078911 8080620 8081931 8072208 8074029 8076368 8078912 8080631 8081943 8072227 8074097 8076379 8078934 8080654 8081996 8072231 8074149 8076393 8078938 8080682 8081999 8072240 8074176 8076410 8078989 8080708 8082019 8072242 8074190 8076426 8079018 8080730 8082028 8072317 8074277 8076442 8079033 8080773 8082034 8072332 8074317 8076449 8079053 8080798 8082039 8072333 8074324 8076461 8079101 8080802 8082055 8072356 8074372 8076494 8079112 8080834 8082059 8072426 8074406 8076569 8079124 8080872 8082083 8072428 8074456 8076581 8079126 8080883 8082158 8072433 8074504 8076625 8079131 8080885 8082168 8072494 8074548 8076644 8079153 8080888 8082191 8072504 8074553 8076697 8079157 8080915 8082215 8072508 8074564 8076714 8079191 8080916 8082221 8072530 8074593 8076749 8079199 8080981 8082248 8072540 8074599 8076819 8079206 8080990 8082264 8072544 8074606 8076822 8079255 8080993 8082268 8072600 8074654 8076877 8079279 8081005 8082289 8072666 8074667 8076878 8079289 8081012 8082291 8072671 8074718 8076889 8079301 8081025 8082292 8072706 8074824 8076915 8079315 8081051 8082310 8072858 8074888 8076966 8079316 8081104 8082316 8072877 8074899 8077081 8079354 8081107 8082325 8072893 8074923 8077102 8079382 8081137 8082336 8072917 8074982 8077107 8079429 8081161 8082339 8072935 8075108 8077119 8079453 8081164 8082355 8072957 8075135 8077172 8079585 8081169 8082371 8072959 8075141 8077210 8079590 8081202 8082411 8072966 8075143 8077294 8079695 8081206 8082419 8072996 8075211 8077470 8079703 8081251 8082451 8072997 8075222 8077516 8079704 8081252 8082472 8073005 8075227 8077537 8079726 8081261 8082507 8073007 8075388 8077603 8079730 8081265 8082521 8073019 8075524 8077617 8079734 8081276 8082529 8073042 8075550 8077657 8079745 8081311 8082568 8073050 8075592 8077708 8079751 8081313 8082577 8073064 8075594 8077743 8079761 8081314 8082582 8073069 8075598 8077910 8079791 8081334 8082585 8073082 8075615 8077915 8079796 8081338 8082587
EXHIBIT B 30 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8082607 8083619 8085422 8087805 8090238 8091411 8082641 8083630 8085442 8087807 8090259 8091427 8082642 8083650 8085682 8087839 8090262 8091462 8082665 8083662 8085820 8087868 8090275 8091470 8082675 8083678 8085870 8087895 8090284 8091503 8082677 8083706 8085906 8087901 8090335 8091510 8082704 8083724 8086083 8087913 8090358 8091529 8082710 8083739 8086118 8087953 8090364 8091531 8082732 8083757 8086179 8087975 8090442 8091532 8082748 8083771 8086237 8088048 8090455 8091557 8082767 8083829 8086239 8088067 8090456 8091570 8082780 8083834 8086241 8088133 8090471 8091576 8082817 8083874 8086304 8088175 8090476 8091580 8082823 8083887 8086338 8088187 8090479 8091612 8082827 8083891 8086362 8088192 8090522 8091616 8082857 8083910 8086368 8088224 8090550 8091667 8082872 8083923 8086377 8088330 8090555 8091673 8082882 8083965 8086400 8088405 8090571 8091677 8082885 8083992 8086495 8088415 8090575 8091692 8082908 8083993 8086497 8088508 8090578 8091715 8082929 8083998 8086538 8088669 8090585 8091718 8082947 8084019 8086539 8088848 8090645 8091750 8082968 8084027 8086550 8088860 8090651 8091784 8082973 8084031 8086584 8088870 8090656 8091786 8083014 8084054 8086590 8088951 8090657 8091788 8083018 8084058 8086596 8088965 8090669 8091826 8083028 8084079 8086626 8088996 8090680 8091838 8083042 8084103 8086670 8089054 8090760 8091848 8083061 8084135 8086677 8089069 8090799 8091859 8083094 8084139 8086695 8089095 8090818 8091879 8083097 8084171 8086699 8089148 8090835 8091889 8083126 8084197 8086708 8089182 8090836 8091893 8083134 8084251 8086736 8089196 8090839 8091901 8083143 8084252 8086768 8089205 8090846 8091930 8083146 8084274 8086791 8089216 8090851 8091935 8083168 8084356 8086793 8089279 8090864 8091954 8083197 8084370 8086797 8089286 8090892 8091975 8083214 8084377 8086801 8089291 8090916 8091976 8083215 8084384 8086835 8089295 8090931 8091997 8083228 8084429 8086850 8089687 8090933 8091999 8083234 8084441 8086858 8089699 8090957 8092011 8083242 8084476 8086896 8089700 8090968 8092038 8083251 8084481 8087111 8089721 8091003 8092040 8083268 8084495 8087156 8089736 8091006 8092045 8083275 8084521 8087173 8089748 8091038 8092066 8083290 8084533 8087188 8089762 8091067 8092072 8083307 8084592 8087209 8089767 8091069 8092075 8083321 8084600 8087247 8089771 8091073 8092081 8083326 8084617 8087296 8089809 8091081 8092102 8083327 8084652 8087326 8089854 8091085 8092104 8083333 8084668 8087369 8089862 8091104 8092116 8083348 8084767 8087390 8089877 8091139 8092130 8083362 8084826 8087489 8089884 8091167 8092166 8083369 8084880 8087536 8089885 8091216 8092174 8083371 8084915 8087559 8089893 8091225 8092231 8083383 8084960 8087571 8089913 8091232 8092261 8083413 8084993 8087578 8089916 8091237 8092297 8083422 8084997 8087619 8089949 8091244 8092303 8083428 8085050 8087624 8089975 8091265 8092305 8083444 8085119 8087628 8089987 8091266 8092313 8083449 8085131 8087648 8089994 8091275 8092317 8083461 8085155 8087660 8090014 8091307 8092321 8083476 8085175 8087666 8090047 8091319 8092342 8083482 8085205 8087670 8090053 8091335 8092345 8083503 8085219 8087674 8090059 8091339 8092374 8083519 8085237 8087703 8090070 8091361 8092377 8083534 8085244 8087745 8090124 8091365 8092401 8083535 8085247 8087748 8090129 8091372 8092403 8083537 8085287 8087758 8090147 8091391 8092411 8083599 8085324 8087778 8090187 8091400 8092414
EXHIBIT B 31 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8092443 8094291 8095656 8096611 8097494 8098987 8092469 8094309 8095693 8096613 8097502 8099051 8092502 8094330 8095720 8096621 8097510 8099093 8092505 8094341 8095721 8096624 8097516 8099126 8092521 8094448 8095734 8096632 8097530 8099164 8092570 8094463 8095748 8096645 8097605 8099166 8092615 8094552 8095752 8096647 8097628 8099181 8092616 8094553 8095761 8096688 8097773 8099187 8092644 8094578 8095765 8096690 8097774 8099201 8092651 8094596 8095800 8096710 8097786 8099208 8092678 8094631 8095822 8096714 8097797 8099280 8092692 8094632 8095848 8096718 8097816 8099317 8092702 8094656 8095851 8096721 8097831 8099321 8092729 8094691 8095877 8096726 8097850 8099324 8092746 8094700 8095883 8096728 8097877 8099332 8092752 8094711 8095898 8096747 8097889 8099338 8092757 8094725 8095899 8096764 8097899 8099343 8092781 8094736 8095916 8096817 8097962 8099345 8092820 8094804 8095919 8096822 8097977 8099348 8092845 8094882 8095925 8096823 8097986 8099353 8092910 8094922 8095929 8096846 8097995 8099354 8092927 8094927 8095940 8096849 8098046 8099360 8092966 8094929 8095946 8096862 8098057 8099368 8092979 8094930 8095953 8096878 8098061 8099376 8092996 8094952 8095955 8096880 8098069 8099390 8093096 8094954 8095970 8096918 8098072 8099402 8093160 8094973 8095974 8097005 8098101 8099414 8093234 8095035 8095986 8097011 8098104 8099426 8093236 8095041 8096007 8097015 8098106 8099435 8093272 8095048 8096009 8097022 8098119 8099448 8093273 8095059 8096013 8097062 8098139 8099454 8093301 8095061 8096028 8097063 8098201 8099459 8093304 8095082 8096032 8097089 8098225 8099468 8093319 8095094 8096040 8097118 8098228 8099474 8093369 8095101 8096045 8097126 8098241 8099484 8093393 8095117 8096068 8097127 8098251 8099500 8093403 8095137 8096073 8097130 8098256 8099587 8093430 8095147 8096087 8097145 8098272 8099599 8093439 8095149 8096088 8097146 8098278 8099609 8093498 8095170 8096146 8097148 8098285 8099615 8093503 8095176 8096154 8097155 8098316 8099628 8093516 8095188 8096163 8097178 8098322 8099738 8093526 8095194 8096229 8097188 8098325 8099758 8093640 8095197 8096241 8097190 8098327 8099847 8093706 8095210 8096255 8097200 8098352 8099853 8093756 8095218 8096257 8097211 8098390 8099858 8093770 8095253 8096273 8097237 8098400 8099865 8093771 8095298 8096277 8097247 8098408 8099871 8093842 8095304 8096287 8097266 8098418 8099893 8093910 8095333 8096306 8097267 8098432 8099915 8093926 8095337 8096317 8097271 8098433 8099920 8093928 8095353 8096327 8097291 8098441 8099925 8093935 8095374 8096330 8097296 8098442 8099989 8093939 8095386 8096334 8097303 8098473 8100020 8093951 8095411 8096335 8097334 8098487 8100027 8093958 8095419 8096356 8097340 8098495 8100059 8093995 8095420 8096357 8097343 8098502 8100063 8093998 8095427 8096362 8097358 8098504 8100110 8094000 8095440 8096394 8097379 8098512 8100125 8094010 8095477 8096405 8097383 8098534 8100152 8094027 8095484 8096426 8097393 8098547 8100186 8094037 8095506 8096429 8097398 8098561 8100233 8094041 8095510 8096447 8097411 8098590 8100281 8094071 8095517 8096470 8097412 8098657 8100283 8094102 8095536 8096472 8097417 8098715 8100294 8094122 8095552 8096513 8097430 8098720 8100333 8094136 8095601 8096590 8097445 8098727 8100355 8094161 8095620 8096592 8097461 8098731 8100426 8094174 8095624 8096608 8097481 8098824 8100478 8094289 8095641 8096610 8097490 8098839 8100500
EXHIBIT B 32 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8100512 8102167 8103328 8104995 8106781 8107920 8100531 8102178 8103330 8105006 8106784 8107925 8100552 8102204 8103333 8105008 8106804 8107948 8100579 8102227 8103355 8105160 8106808 8107956 8100602 8102230 8103383 8105161 8106835 8107957 8100686 8102245 8103404 8105198 8106878 8107965 8100690 8102266 8103409 8105314 8106882 8108015 8100701 8102267 8103457 8105378 8106902 8108029 8100707 8102269 8103468 8105470 8106920 8108049 8100772 8102283 8103487 8105518 8106926 8108064 8100779 8102298 8103520 8105537 8106934 8108086 8100781 8102314 8103557 8105571 8106942 8108097 8100792 8102319 8103589 8105578 8106952 8108110 8100802 8102334 8103644 8105581 8106964 8108118 8100805 8102348 8103664 8105679 8106969 8108132 8100827 8102355 8103672 8105721 8106980 8108149 8100846 8102380 8103720 8105785 8106986 8108152 8100895 8102389 8103754 8105786 8106995 8108175 8100954 8102390 8103757 8105806 8107002 8108180 8100963 8102401 8103767 8105844 8107030 8108183 8100989 8102403 8103777 8105850 8107036 8108187 8100999 8102413 8103852 8105917 8107044 8108189 8101004 8102427 8103857 8105932 8107045 8108213 8101018 8102453 8103889 8105944 8107070 8108234 8101079 8102470 8103898 8105960 8107071 8108246 8101103 8102486 8103929 8105972 8107083 8108267 8101120 8102499 8103936 8105984 8107105 8108285 8101138 8102523 8103944 8105989 8107132 8108288 8101167 8102534 8103950 8106027 8107147 8108290 8101180 8102556 8103998 8106047 8107154 8108317 8101199 8102557 8104023 8106048 8107163 8108324 8101263 8102578 8104027 8106081 8107166 8108345 8101293 8102649 8104040 8106084 8107168 8108368 8101308 8102650 8104050 8106112 8107177 8108379 8101320 8102667 8104066 8106114 8107210 8108391 8101364 8102673 8104125 8106136 8107261 8108420 8101365 8102677 8104135 8106138 8107281 8108423 8101368 8102704 8104142 8106172 8107284 8108444 8101401 8102726 8104153 8106174 8107320 8108458 8101402 8102779 8104161 8106191 8107345 8108462 8101436 8102814 8104199 8106233 8107349 8108467 8101444 8102818 8104210 8106245 8107369 8108470 8101507 8102822 8104217 8106282 8107390 8108543 8101544 8102896 8104225 8106301 8107405 8108560 8101620 8102912 8104306 8106339 8107421 8108590 8101656 8102929 8104309 8106372 8107458 8108610 8101672 8102952 8104345 8106373 8107480 8108634 8101714 8102972 8104359 8106417 8107482 8108643 8101842 8102986 8104368 8106425 8107497 8108650 8101878 8102997 8104452 8106448 8107509 8108677 8101898 8103002 8104475 8106451 8107537 8108678 8101904 8103034 8104481 8106469 8107565 8108683 8101946 8103117 8104487 8106480 8107567 8108692 8101962 8103149 8104548 8106495 8107612 8108695 8101990 8103155 8104549 8106498 8107622 8108697 8101998 8103165 8104551 8106521 8107647 8108708 8102001 8103178 8104566 8106533 8107666 8108723 8102014 8103181 8104575 8106546 8107672 8108731 8102038 8103197 8104585 8106555 8107701 8108734 8102043 8103213 8104587 8106569 8107723 8108741 8102054 8103220 8104590 8106598 8107732 8108753 8102068 8103223 8104640 8106605 8107757 8108770 8102071 8103234 8104674 8106623 8107763 8108775 8102084 8103242 8104758 8106637 8107766 8108785 8102097 8103261 8104809 8106647 8107776 8108793 8102103 8103270 8104834 8106684 8107830 8108809 8102104 8103275 8104934 8106699 8107835 8108824 8102127 8103278 8104947 8106710 8107849 8108825 8102136 8103305 8104984 8106728 8107870 8108853 8102156 8103312 8104991 8106770 8107882 8108882
EXHIBIT B 33 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8108889 8110437 8112370 8114164 8115358 8116694 8108907 8110449 8112381 8114172 8115382 8116706 8108912 8110465 8112492 8114176 8115397 8116717 8108915 8110504 8112500 8114178 8115398 8116731 8108916 8110509 8112542 8114181 8115410 8116761 8108937 8110549 8112563 8114182 8115451 8116769 8108973 8110663 8112585 8114185 8115458 8116780 8108996 8110689 8112589 8114197 8115486 8116786 8109041 8110747 8112615 8114198 8115539 8116798 8109045 8110852 8112632 8114200 8115547 8116800 8109054 8110866 8112874 8114218 8115548 8116815 8109106 8110930 8112921 8114222 8115561 8116818 8109113 8111007 8112928 8114237 8115573 8116831 8109124 8111036 8112939 8114241 8115582 8116835 8109136 8111057 8112967 8114367 8115626 8116855 8109153 8111067 8113053 8114378 8115658 8116903 8109187 8111109 8113063 8114392 8115668 8116924 8109188 8111114 8113089 8114405 8115672 8116927 8109237 8111128 8113177 8114426 8115719 8116984 8109252 8111147 8113196 8114470 8115729 8116990 8109278 8111153 8113225 8114479 8115752 8117009 8109280 8111196 8113248 8114480 8115762 8117135 8109323 8111275 8113356 8114504 8115868 8117161 8109324 8111292 8113366 8114518 8116009 8117180 8109327 8111325 8113373 8114519 8116024 8117198 8109342 8111347 8113405 8114521 8116033 8117215 8109344 8111409 8113415 8114522 8116055 8117287 8109347 8111452 8113424 8114523 8116082 8117308 8109372 8111506 8113433 8114544 8116083 8117329 8109399 8111525 8113448 8114546 8116170 8117336 8109400 8111554 8113653 8114558 8116171 8117351 8109410 8111576 8113660 8114565 8116181 8117352 8109422 8111607 8113685 8114582 8116203 8117369 8109471 8111613 8113698 8114609 8116208 8117391 8109488 8111640 8113699 8114626 8116239 8117411 8109491 8111645 8113704 8114651 8116253 8117419 8109502 8111648 8113752 8114665 8116263 8117423 8109519 8111658 8113786 8114674 8116268 8117498 8109531 8111660 8113839 8114700 8116272 8117548 8109563 8111674 8113855 8114720 8116277 8117564 8109576 8111679 8113887 8114737 8116282 8117567 8109578 8111706 8113889 8114748 8116306 8117714 8109580 8111720 8113890 8114751 8116348 8117764 8109581 8111725 8113902 8114768 8116356 8117828 8109591 8111728 8113907 8114771 8116370 8117835 8109605 8111741 8113927 8114787 8116378 8117996 8109641 8111755 8113935 8114799 8116396 8118032 8109672 8111763 8113938 8114814 8116416 8118069 8109692 8111788 8113944 8114818 8116424 8118118 8109694 8111795 8113955 8114826 8116459 8118147 8109706 8111803 8113962 8114856 8116467 8118154 8109710 8111838 8113970 8114891 8116483 8118203 8109724 8111867 8113978 8114897 8116498 8118330 8109729 8111875 8113985 8114898 8116527 8118332 8109740 8111911 8113989 8114908 8116531 8118386 8109788 8111936 8113999 8114967 8116534 8118397 8109798 8111984 8114018 8114971 8116552 8118477 8109821 8111991 8114027 8114977 8116556 8118582 8109960 8111995 8114037 8115009 8116566 8118593 8110077 8112072 8114054 8115022 8116573 8118626 8110155 8112175 8114059 8115033 8116591 8118647 8110163 8112205 8114070 8115102 8116604 8118688 8110171 8112211 8114091 8115136 8116608 8118740 8110176 8112213 8114104 8115207 8116613 8118773 8110225 8112271 8114106 8115217 8116615 8118863 8110308 8112279 8114116 8115233 8116628 8118907 8110312 8112280 8114124 8115238 8116641 8118920 8110332 8112305 8114141 8115326 8116651 8118942 8110397 8112350 8114151 8115337 8116677 8118995 8110428 8112353 8114162 8115352 8116693 8119168
EXHIBIT B 34 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8119201 8121631 8123246 8124942 8126654 8128797 8119277 8121686 8123255 8124976 8126660 8128805 8119335 8121693 8123262 8124981 8126684 8128876 8119434 8121705 8123281 8125008 8126691 8128919 8119525 8121723 8123325 8125029 8126778 8128921 8119550 8121772 8123353 8125057 8126816 8128941 8119561 8121788 8123373 8125082 8126831 8129048 8119601 8121801 8123407 8125108 8126846 8129055 8119708 8121814 8123429 8125124 8126867 8129172 8119763 8121819 8123430 8125287 8126892 8129193 8119857 8121837 8123441 8125316 8126971 8129210 8119879 8121871 8123458 8125350 8127031 8129227 8119894 8121920 8123588 8125398 8127045 8129266 8119982 8121941 8123609 8125440 8127112 8129276 8120025 8121972 8123613 8125451 8127150 8129299 8120052 8121984 8123634 8125465 8127190 8129337 8120059 8122014 8123812 8125494 8127193 8129376 8120071 8122054 8123831 8125503 8127198 8129378 8120134 8122096 8123857 8125506 8127199 8129392 8120154 8122105 8123861 8125550 8127210 8129419 8120198 8122144 8123877 8125557 8127217 8129434 8120213 8122150 8123880 8125669 8127233 8129450 8120223 8122163 8123899 8125708 8127257 8129452 8120277 8122166 8123912 8125746 8127311 8129480 8120326 8122181 8123941 8125795 8127320 8129482 8120390 8122187 8123952 8125800 8127349 8129489 8120438 8122195 8123991 8125834 8127389 8129500 8120467 8122228 8123999 8125866 8127483 8129547 8120517 8122255 8124031 8125879 8127491 8129562 8120519 8122272 8124054 8125918 8127518 8129572 8120529 8122295 8124084 8125993 8127531 8129601 8120537 8122316 8124092 8126054 8127533 8129619 8120585 8122349 8124119 8126164 8127535 8129630 8120619 8122429 8124148 8126212 8127589 8129675 8120650 8122437 8124164 8126225 8127614 8129682 8120666 8122446 8124175 8126292 8127619 8129688 8120708 8122465 8124221 8126310 8127647 8129709 8120714 8122471 8124265 8126311 8127677 8129712 8120734 8122497 8124310 8126353 8127685 8129763 8120766 8122529 8124343 8126388 8127707 8129795 8120836 8122585 8124353 8126406 8127735 8129802 8120982 8122586 8124360 8126426 8127738 8129876 8121019 8122635 8124361 8126440 8127753 8129877 8121046 8122642 8124375 8126467 8127768 8129922 8121080 8122649 8124419 8126477 8127805 8129924 8121146 8122671 8124426 8126486 8127858 8129989 8121176 8122673 8124428 8126507 8127866 8129998 8121208 8122720 8124450 8126538 8127898 8130000 8121210 8122750 8124462 8126545 8127901 8130005 8121242 8122756 8124472 8126552 8127904 8130034 8121270 8122768 8124492 8126560 8127968 8130121 8121274 8122770 8124517 8126565 8127996 8130140 8121276 8122817 8124544 8126570 8128000 8130160 8121279 8122838 8124547 8126577 8128060 8130176 8121302 8122844 8124586 8126580 8128131 8130182 8121394 8122869 8124595 8126584 8128141 8130188 8121396 8122905 8124599 8126589 8128160 8130225 8121405 8122927 8124629 8126592 8128188 8130315 8121429 8122933 8124630 8126600 8128195 8130317 8121447 8122945 8124693 8126604 8128213 8130361 8121449 8122989 8124708 8126613 8128254 8130362 8121467 8123000 8124731 8126618 8128307 8130392 8121474 8123072 8124770 8126620 8128313 8130494 8121475 8123079 8124801 8126627 8128314 8130520 8121484 8123089 8124818 8126631 8128386 8130578 8121544 8123120 8124827 8126632 8128649 8130586 8121557 8123125 8124847 8126639 8128728 8130626 8121559 8123153 8124913 8126641 8128739 8130688 8121609 8123175 8124921 8126643 8128760 8130694 8121620 8123189 8124924 8126653 8128776 8130875
EXHIBIT B 35 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8130879 8133089 8135749 8138287 8140485 8143254 8130914 8133124 8135789 8138308 8140512 8143278 8131064 8133169 8135804 8138345 8140524 8143362 8131127 8133173 8135838 8138355 8140531 8143380 8131165 8133200 8135840 8138358 8140538 8143393 8131179 8133208 8135864 8138367 8140578 8143395 8131219 8133242 8135917 8138372 8140614 8143437 8131229 8133247 8135956 8138380 8140626 8143441 8131233 8133291 8135986 8138393 8140630 8143456 8131238 8133415 8136002 8138428 8140673 8143489 8131239 8133449 8136188 8138452 8140745 8143492 8131247 8133471 8136190 8138453 8140829 8143494 8131327 8133573 8136240 8138467 8140864 8143502 8131329 8133608 8136264 8138507 8140926 8143507 8131348 8133633 8136307 8138533 8140990 8143520 8131387 8133903 8136322 8138545 8141023 8143541 8131389 8133970 8136413 8138663 8141102 8143576 8131392 8134005 8136457 8138673 8141141 8143625 8131399 8134035 8136488 8138795 8141161 8143651 8131413 8134048 8136507 8138808 8141174 8143679 8131477 8134084 8136544 8138825 8141176 8143686 8131492 8134145 8136548 8138827 8141240 8143761 8131498 8134191 8136583 8138948 8141242 8143778 8131560 8134231 8136587 8138999 8141289 8143810 8131575 8134261 8136597 8139061 8141351 8143814 8131576 8134353 8136683 8139082 8141393 8143833 8131594 8134387 8136716 8139085 8141426 8143904 8131636 8134401 8136749 8139100 8141450 8143958 8131696 8134483 8136815 8139102 8141455 8143970 8131719 8134488 8136838 8139111 8141530 8143973 8131775 8134497 8136937 8139112 8141572 8144029 8131782 8134572 8137004 8139200 8141573 8144074 8131843 8134585 8137033 8139239 8141672 8144123 8131940 8134600 8137048 8139277 8141681 8144126 8131943 8134668 8137114 8139293 8141708 8144200 8131944 8134745 8137117 8139311 8141730 8144254 8131954 8134761 8137211 8139315 8141731 8144340 8131971 8134778 8137218 8139332 8141791 8144356 8131981 8134784 8137226 8139358 8141801 8144357 8131991 8134813 8137253 8139375 8141811 8144379 8132005 8134887 8137287 8139411 8141825 8144419 8132026 8134925 8137301 8139428 8141945 8144441 8132032 8134952 8137316 8139444 8142013 8144442 8132058 8134960 8137318 8139458 8142302 8144472 8132097 8135001 8137326 8139460 8142378 8144482 8132165 8135011 8137327 8139494 8142413 8144523 8132177 8135014 8137354 8139519 8142494 8144525 8132192 8135021 8137375 8139530 8142530 8144551 8132201 8135051 8137471 8139532 8142565 8144582 8132245 8135054 8137505 8139559 8142655 8144588 8132263 8135118 8137513 8139607 8142693 8144590 8132271 8135168 8137516 8139652 8142695 8144630 8132323 8135179 8137527 8139670 8142729 8144640 8132402 8135211 8137549 8139696 8142747 8144660 8132421 8135234 8137552 8139723 8142760 8144666 8132433 8135275 8137588 8139756 8142811 8144675 8132473 8135277 8137639 8139799 8142856 8144690 8132493 8135303 8137710 8139850 8142872 8144692 8132551 8135388 8137718 8139939 8142877 8144710 8132568 8135421 8137722 8139949 8142951 8144712 8132593 8135434 8137800 8139985 8142957 8144735 8132661 8135443 8137930 8139993 8142968 8144866 8132702 8135476 8137957 8140022 8143005 8144908 8132714 8135599 8137980 8140064 8143038 8144910 8132755 8135640 8138000 8140081 8143060 8144924 8132784 8135648 8138005 8140127 8143086 8144928 8132790 8135664 8138210 8140178 8143107 8144945 8132807 8135718 8138243 8140205 8143164 8144952 8132811 8135742 8138255 8140397 8143168 8144983 8133054 8135743 8138283 8140460 8143199 8144993
EXHIBIT B 36 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8145003 8146097 8149149 8150902 8152846 8154264 8145033 8146107 8149177 8150927 8152864 8154287 8145058 8146139 8149178 8150940 8152903 8154291 8145066 8146149 8149235 8150947 8152915 8154325 8145076 8146178 8149244 8150957 8152930 8154367 8145098 8146240 8149301 8150964 8152940 8154368 8145106 8146259 8149325 8150970 8152943 8154388 8145119 8146365 8149344 8150971 8152949 8154395 8145125 8146433 8149378 8150991 8152963 8154428 8145128 8146446 8149391 8151053 8152977 8154440 8145178 8146460 8149411 8151057 8152979 8154464 8145183 8146467 8149428 8151064 8152988 8154481 8145197 8146498 8149441 8151099 8153003 8154527 8145205 8146514 8149450 8151143 8153018 8154552 8145210 8146569 8149489 8151162 8153049 8154573 8145227 8146620 8149497 8151167 8153094 8154585 8145240 8146646 8149522 8151168 8153128 8154596 8145249 8146658 8149554 8151176 8153136 8154611 8145251 8146716 8149581 8151205 8153153 8154623 8145285 8146758 8149620 8151226 8153177 8154644 8145298 8146778 8149628 8151283 8153196 8154650 8145301 8146799 8149682 8151313 8153226 8154653 8145341 8146914 8149755 8151330 8153266 8154661 8145359 8146931 8149805 8151332 8153281 8154718 8145363 8147018 8149807 8151424 8153285 8154779 8145373 8147036 8149832 8151439 8153328 8154802 8145374 8147059 8149850 8151451 8153352 8154840 8145379 8147079 8149935 8151482 8153355 8154864 8145399 8147199 8149964 8151580 8153364 8154974 8145422 8147289 8150003 8151673 8153369 8155012 8145426 8147327 8150006 8151691 8153426 8155034 8145435 8147475 8150043 8151707 8153478 8155037 8145436 8147545 8150069 8151804 8153489 8155052 8145461 8147641 8150103 8151826 8153496 8155092 8145465 8147662 8150142 8151859 8153505 8155125 8145473 8147722 8150149 8151864 8153568 8155137 8145482 8147743 8150152 8151888 8153571 8155139 8145501 8147772 8150158 8151902 8153576 8155173 8145534 8147801 8150164 8151944 8153602 8155183 8145538 8147815 8150173 8151952 8153609 8155215 8145599 8147950 8150182 8151955 8153610 8155228 8145600 8148006 8150200 8151981 8153647 8155229 8145617 8148037 8150233 8151983 8153654 8155245 8145649 8148119 8150263 8152017 8153668 8155259 8145661 8148134 8150265 8152075 8153706 8155267 8145674 8148189 8150269 8152114 8153734 8155277 8145696 8148207 8150280 8152151 8153747 8155293 8145706 8148263 8150303 8152194 8153767 8155349 8145728 8148275 8150358 8152195 8153790 8155380 8145772 8148374 8150397 8152231 8153798 8155398 8145813 8148383 8150446 8152363 8153813 8155423 8145823 8148408 8150453 8152376 8153873 8155433 8145860 8148430 8150469 8152384 8153875 8155441 8145878 8148478 8150488 8152387 8153898 8155448 8145886 8148594 8150504 8152388 8153939 8155453 8145888 8148595 8150537 8152394 8153954 8155464 8145897 8148600 8150538 8152407 8153991 8155470 8145919 8148674 8150572 8152415 8154018 8155523 8145932 8148686 8150600 8152428 8154026 8155552 8145946 8148718 8150631 8152448 8154048 8155650 8145966 8148754 8150640 8152519 8154083 8155681 8145974 8148827 8150710 8152520 8154088 8155798 8146002 8148830 8150745 8152588 8154092 8155810 8146004 8148902 8150779 8152590 8154125 8155890 8146005 8148903 8150810 8152591 8154128 8155919 8146011 8148920 8150819 8152593 8154155 8155920 8146054 8149056 8150838 8152603 8154208 8155925 8146063 8149098 8150844 8152609 8154216 8155999 8146093 8149120 8150846 8152694 8154230 8156083 8146094 8149145 8150879 8152786 8154232 8156203
EXHIBIT B 37 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8156257 8158309 8160209 8161677 8163107 8163962 8156298 8158310 8160248 8161714 8163116 8163969 8156330 8158321 8160297 8161729 8163126 8163976 8156342 8158353 8160339 8161742 8163127 8163987 8156368 8158363 8160383 8161758 8163142 8163992 8156393 8158391 8160386 8161763 8163147 8164011 8156395 8158444 8160390 8161776 8163150 8164014 8156399 8158468 8160396 8161787 8163168 8164027 8156410 8158492 8160419 8161801 8163181 8164028 8156415 8158577 8160426 8161836 8163204 8164034 8156419 8158633 8160439 8161849 8163232 8164042 8156440 8158674 8160442 8161866 8163247 8164044 8156448 8158688 8160452 8161880 8163249 8164047 8156505 8158707 8160461 8161894 8163258 8164049 8156583 8158710 8160476 8161914 8163267 8164071 8156599 8158772 8160486 8161927 8163272 8164092 8156657 8158776 8160500 8161933 8163288 8164098 8156695 8158790 8160507 8161958 8163292 8164105 8156747 8158805 8160514 8161967 8163296 8164107 8156750 8158828 8160527 8161975 8163308 8164115 8156778 8158839 8160547 8161992 8163309 8164119 8156807 8158903 8160584 8162046 8163319 8164120 8156845 8158912 8160635 8162173 8163339 8164138 8156880 8158950 8160654 8162278 8163347 8164142 8156909 8159014 8160717 8162283 8163378 8164145 8156940 8159015 8160730 8162361 8163385 8164152 8156964 8159070 8160749 8162370 8163408 8164153 8157005 8159103 8160764 8162398 8163409 8164159 8157142 8159107 8160785 8162403 8163421 8164175 8157188 8159130 8160791 8162434 8163427 8164188 8157191 8159184 8160848 8162439 8163428 8164192 8157200 8159263 8160863 8162463 8163451 8164198 8157314 8159278 8160878 8162504 8163454 8164205 8157343 8159369 8160901 8162511 8163457 8164217 8157349 8159387 8160913 8162520 8163475 8164227 8157476 8159390 8160950 8162526 8163480 8164230 8157491 8159391 8160965 8162561 8163482 8164236 8157497 8159405 8160978 8162568 8163492 8164240 8157520 8159414 8160982 8162570 8163507 8164241 8157526 8159420 8160985 8162571 8163515 8164264 8157552 8159425 8160991 8162629 8163559 8164274 8157559 8159438 8160995 8162631 8163572 8164284 8157634 8159482 8161004 8162637 8163578 8164293 8157660 8159493 8161034 8162643 8163588 8164309 8157701 8159510 8161083 8162651 8163597 8164311 8157709 8159518 8161106 8162678 8163630 8164318 8157737 8159533 8161119 8162698 8163669 8164322 8157748 8159563 8161122 8162732 8163685 8164332 8157844 8159572 8161162 8162738 8163702 8164333 8157887 8159595 8161245 8162745 8163705 8164341 8157893 8159606 8161335 8162747 8163723 8164346 8157930 8159609 8161342 8162763 8163732 8164357 8157971 8159613 8161347 8162790 8163741 8164358 8158003 8159617 8161358 8162792 8163797 8164365 8158014 8159640 8161363 8162837 8163798 8164368 8158084 8159641 8161387 8162840 8163801 8164376 8158085 8159645 8161390 8162865 8163813 8164389 8158113 8159701 8161391 8162868 8163814 8164399 8158141 8159723 8161396 8162916 8163858 8164436 8158161 8159749 8161406 8162918 8163878 8164468 8158185 8159755 8161421 8162937 8163881 8164473 8158212 8159814 8161425 8162976 8163886 8164474 8158221 8159816 8161449 8162997 8163903 8164483 8158230 8159819 8161455 8163010 8163906 8164484 8158239 8159900 8161522 8163027 8163918 8164493 8158253 8159968 8161541 8163067 8163921 8164497 8158256 8160001 8161601 8163072 8163936 8164499 8158263 8160043 8161638 8163073 8163939 8164504 8158283 8160061 8161648 8163092 8163958 8164505 8158306 8160126 8161659 8163101 8163959 8164512
EXHIBIT B 38 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8164533 8165434 8165963 8167087 8167952 8168566 8164535 8165457 8165989 8167090 8167954 8168590 8164542 8165462 8165991 8167093 8167988 8168597 8164584 8165480 8165993 8167120 8168029 8168623 8164600 8165488 8166001 8167129 8168046 8168626 8164610 8165491 8166016 8167155 8168067 8168630 8164613 8165498 8166019 8167157 8168086 8168639 8164625 8165503 8166022 8167169 8168096 8168648 8164663 8165508 8166029 8167176 8168101 8168655 8164672 8165509 8166043 8167180 8168110 8168657 8164679 8165516 8166055 8167198 8168119 8168673 8164684 8165517 8166056 8167205 8168120 8168681 8164693 8165520 8166086 8167212 8168121 8168691 8164697 8165525 8166103 8167226 8168128 8168699 8164712 8165526 8166113 8167257 8168131 8168713 8164724 8165544 8166122 8167262 8168137 8168721 8164742 8165547 8166131 8167279 8168146 8168730 8164815 8165548 8166143 8167302 8168161 8168745 8164817 8165552 8166145 8167310 8168170 8168751 8164824 8165572 8166150 8167346 8168200 8168758 8164825 8165578 8166171 8167348 8168224 8168763 8164856 8165585 8166177 8167352 8168228 8168774 8164913 8165588 8166185 8167356 8168230 8168781 8164923 8165594 8166189 8167358 8168245 8168792 8164940 8165595 8166229 8167360 8168274 8168799 8164946 8165620 8166312 8167384 8168275 8168813 8164949 8165627 8166356 8167438 8168280 8168843 8164954 8165633 8166374 8167439 8168303 8168860 8164973 8165638 8166429 8167452 8168315 8168862 8164975 8165640 8166445 8167453 8168318 8168865 8164978 8165648 8166452 8167463 8168327 8168879 8164979 8165650 8166473 8167465 8168335 8168883 8165021 8165654 8166485 8167504 8168339 8168884 8165022 8165670 8166492 8167518 8168346 8168886 8165043 8165678 8166521 8167522 8168349 8168892 8165064 8165681 8166547 8167533 8168353 8168898 8165069 8165695 8166557 8167534 8168359 8168900 8165073 8165706 8166560 8167561 8168371 8168907 8165083 8165707 8166572 8167569 8168372 8168917 8165085 8165709 8166595 8167570 8168400 8168920 8165112 8165716 8166596 8167578 8168401 8168923 8165116 8165717 8166606 8167592 8168404 8168933 8165128 8165722 8166634 8167596 8168421 8168952 8165147 8165740 8166650 8167613 8168430 8168962 8165150 8165763 8166660 8167619 8168431 8168964 8165152 8165770 8166679 8167624 8168432 8168974 8165159 8165784 8166702 8167650 8168433 8168981 8165167 8165788 8166742 8167668 8168442 8168988 8165188 8165814 8166792 8167692 8168452 8168990 8165198 8165823 8166809 8167698 8168454 8168993 8165209 8165828 8166817 8167723 8168458 8169001 8165214 8165831 8166835 8167732 8168459 8169003 8165233 8165838 8166839 8167735 8168460 8169006 8165253 8165844 8166856 8167747 8168469 8169008 8165260 8165847 8166860 8167749 8168474 8169023 8165262 8165851 8166864 8167756 8168475 8169028 8165276 8165863 8166887 8167772 8168481 8169033 8165300 8165874 8166943 8167775 8168489 8169034 8165301 8165886 8166957 8167793 8168490 8169047 8165311 8165894 8166962 8167824 8168494 8169048 8165329 8165898 8166974 8167843 8168503 8169060 8165340 8165899 8166993 8167855 8168513 8169069 8165343 8165908 8166996 8167859 8168526 8169072 8165351 8165915 8167018 8167878 8168528 8169080 8165352 8165925 8167035 8167888 8168533 8169085 8165377 8165929 8167046 8167890 8168534 8169091 8165388 8165947 8167050 8167895 8168538 8169093 8165393 8165949 8167058 8167901 8168540 8169098 8165418 8165952 8167074 8167915 8168551 8169111 8165433 8165957 8167076 8167933 8168564 8169115
EXHIBIT B 39 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8169125 8169445 8169649 8169865 8170048 8170208 8169139 8169446 8169651 8169871 8170050 8170211 8169145 8169448 8169659 8169874 8170052 8170212 8169159 8169449 8169661 8169875 8170057 8170225 8169166 8169452 8169662 8169880 8170059 8170231 8169171 8169460 8169672 8169881 8170060 8170233 8169177 8169469 8169677 8169884 8170062 8170237 8169184 8169475 8169679 8169885 8170064 8170239 8169187 8169478 8169680 8169892 8170066 8170244 8169192 8169480 8169685 8169896 8170067 8170247 8169195 8169486 8169686 8169897 8170068 8170249 8169196 8169488 8169689 8169898 8170073 8170250 8169201 8169490 8169697 8169903 8170074 8170254 8169202 8169491 8169699 8169904 8170079 8170264 8169208 8169495 8169706 8169909 8170081 8170274 8169209 8169500 8169716 8169911 8170082 8170275 8169221 8169511 8169721 8169912 8170083 8170281 8169224 8169516 8169722 8169913 8170087 8170283 8169227 8169519 8169724 8169914 8170089 8170285 8169231 8169521 8169726 8169917 8170090 8170286 8169235 8169523 8169727 8169918 8170091 8170287 8169241 8169525 8169728 8169924 8170096 8170292 8169242 8169527 8169729 8169927 8170097 8170295 8169244 8169528 8169732 8169937 8170098 8170296 8169246 8169538 8169737 8169938 8170100 8170301 8169248 8169539 8169739 8169940 8170101 8170304 8169250 8169543 8169741 8169943 8170102 8170305 8169251 8169544 8169742 8169944 8170103 8170307 8169265 8169546 8169743 8169945 8170104 8170310 8169268 8169551 8169747 8169953 8170105 8170313 8169270 8169554 8169751 8169956 8170106 8170318 8169271 8169555 8169755 8169961 8170111 8170319 8169279 8169559 8169757 8169963 8170112 8170326 8169280 8169560 8169765 8169972 8170113 8170329 8169286 8169561 8169766 8169974 8170117 8170338 8169288 8169563 8169769 8169975 8170120 8170339 8169303 8169565 8169779 8169977 8170121 8170343 8169305 8169567 8169780 8169983 8170122 8170344 8169306 8169569 8169781 8169989 8170123 8170352 8169312 8169573 8169783 8169990 8170124 8170354 8169314 8169574 8169786 8169995 8170125 8170355 8169316 8169578 8169787 8169996 8170127 8170360 8169317 8169580 8169790 8169997 8170128 8170362 8169328 8169581 8169793 8169999 8170129 8170368 8169335 8169582 8169796 8170002 8170130 8170369 8169339 8169583 8169801 8170003 8170131 8170373 8169348 8169584 8169804 8170005 8170132 8170376 8169349 8169585 8169805 8170007 8170135 8170378 8169358 8169587 8169807 8170009 8170136 8170379 8169359 8169589 8169812 8170014 8170138 8170381 8169363 8169591 8169814 8170015 8170142 8170385 8169366 8169596 8169816 8170016 8170145 8170386 8169371 8169599 8169822 8170017 8170150 8170387 8169376 8169601 8169824 8170018 8170153 8170398 8169377 8169604 8169826 8170019 8170159 8170402 8169380 8169608 8169832 8170021 8170160 8170403 8169389 8169609 8169834 8170022 8170161 8170404 8169396 8169610 8169835 8170024 8170165 8170406 8169398 8169611 8169837 8170029 8170167 8170407 8169399 8169617 8169838 8170030 8170168 8170408 8169404 8169618 8169840 8170031 8170169 8170413 8169409 8169621 8169841 8170033 8170172 8170414 8169420 8169624 8169846 8170035 8170178 8170415 8169422 8169625 8169847 8170036 8170180 8170417 8169430 8169632 8169848 8170038 8170181 8170421 8169431 8169634 8169850 8170042 8170184 8170424 8169436 8169637 8169852 8170043 8170186 8170425 8169437 8169640 8169861 8170044 8170196 8170428 8169441 8169647 8169862 8170046 8170204 8170429 8169442 8169648 8169863 8170047 8170206 8170433
EXHIBIT B 40 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8170435 8170670 8170903 8171113 8171304 8171459 8170437 8170671 8170904 8171114 8171306 8171460 8170439 8170672 8170905 8171115 8171308 8171464 8170443 8170677 8170907 8171116 8171311 8171466 8170445 8170678 8170908 8171119 8171312 8171468 8170448 8170680 8170909 8171123 8171313 8171469 8170451 8170684 8170910 8171124 8171318 8171475 8170452 8170691 8170912 8171128 8171320 8171479 8170454 8170694 8170913 8171129 8171322 8171480 8170456 8170701 8170914 8171133 8171323 8171481 8170461 8170702 8170924 8171140 8171324 8171482 8170462 8170703 8170925 8171141 8171325 8171485 8170465 8170705 8170929 8171142 8171328 8171486 8170469 8170710 8170931 8171144 8171331 8171489 8170470 8170711 8170934 8171146 8171332 8171492 8170475 8170717 8170940 8171147 8171336 8171493 8170481 8170719 8170945 8171149 8171337 8171495 8170483 8170727 8170946 8171153 8171343 8171496 8170494 8170728 8170947 8171156 8171344 8171498 8170496 8170729 8170949 8171158 8171347 8171499 8170497 8170733 8170951 8171161 8171348 8171506 8170498 8170735 8170954 8171164 8171353 8171511 8170499 8170744 8170965 8171167 8171354 8171512 8170500 8170747 8170966 8171169 8171356 8171513 8170502 8170748 8170967 8171170 8171362 8171515 8170508 8170749 8170973 8171177 8171364 8171517 8170509 8170768 8170976 8171182 8171366 8171520 8170517 8170769 8170977 8171184 8171367 8171521 8170520 8170771 8170982 8171192 8171368 8171522 8170524 8170777 8170983 8171200 8171373 8171523 8170527 8170782 8170999 8171201 8171376 8171524 8170534 8170784 8171000 8171203 8171377 8171528 8170536 8170789 8171001 8171204 8171379 8171530 8170540 8170795 8171004 8171210 8171381 8171531 8170546 8170807 8171007 8171211 8171385 8171533 8170547 8170814 8171009 8171213 8171386 8171536 8170556 8170815 8171017 8171214 8171388 8171537 8170559 8170825 8171019 8171220 8171389 8171543 8170561 8170831 8171020 8171221 8171391 8171545 8170568 8170833 8171021 8171223 8171394 8171546 8170571 8170834 8171023 8171224 8171398 8171547 8170573 8170835 8171024 8171226 8171402 8171548 8170576 8170839 8171031 8171227 8171403 8171553 8170581 8170845 8171032 8171230 8171405 8171558 8170585 8170848 8171039 8171231 8171406 8171559 8170587 8170849 8171042 8171233 8171408 8171560 8170590 8170852 8171048 8171237 8171411 8171562 8170594 8170853 8171049 8171240 8171412 8171565 8170595 8170855 8171052 8171242 8171416 8171569 8170596 8170857 8171054 8171243 8171418 8171570 8170598 8170862 8171057 8171246 8171419 8171572 8170604 8170865 8171061 8171248 8171421 8171575 8170608 8170866 8171064 8171249 8171423 8171577 8170614 8170871 8171065 8171251 8171424 8171578 8170621 8170874 8171066 8171254 8171426 8171581 8170623 8170877 8171070 8171258 8171431 8171582 8170629 8170878 8171071 8171259 8171432 8171583 8170633 8170879 8171073 8171260 8171433 8171584 8170641 8170882 8171074 8171264 8171434 8171586 8170642 8170883 8171076 8171274 8171435 8171587 8170646 8170886 8171079 8171276 8171439 8171589 8170647 8170887 8171081 8171279 8171440 8171592 8170651 8170889 8171086 8171281 8171443 8171593 8170652 8170890 8171090 8171283 8171444 8171594 8170654 8170891 8171093 8171288 8171445 8171595 8170658 8170893 8171094 8171291 8171446 8171597 8170660 8170895 8171096 8171294 8171450 8171603 8170661 8170897 8171098 8171295 8171451 8171605 8170665 8170899 8171100 8171299 8171453 8171607 8170668 8170901 8171108 8171300 8171456 8171608
EXHIBIT B 41 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8171609 8171752 8171962 8172203 8172471 8172609 8171612 8171757 8171966 8172212 8172473 8172610 8171614 8171761 8171967 8172219 8172474 8172611 8171615 8171765 8171969 8172222 8172475 8172612 8171616 8171767 8171974 8172236 8172477 8172613 8171619 8171771 8171977 8172241 8172479 8172618 8171621 8171774 8171980 8172243 8172480 8172619 8171622 8171776 8171982 8172246 8172482 8172620 8171624 8171777 8171984 8172249 8172483 8172622 8171626 8171778 8171985 8172259 8172485 8172626 8171628 8171783 8171987 8172260 8172486 8172627 8171629 8171786 8171990 8172262 8172488 8172629 8171630 8171787 8171992 8172266 8172490 8172631 8171633 8171789 8171998 8172271 8172491 8172632 8171634 8171794 8172000 8172276 8172495 8172633 8171636 8171796 8172004 8172285 8172504 8172634 8171641 8171798 8172016 8172287 8172506 8172636 8171642 8171799 8172019 8172289 8172508 8172637 8171645 8171804 8172020 8172291 8172510 8172638 8171646 8171807 8172021 8172296 8172513 8172639 8171648 8171808 8172022 8172302 8172514 8172640 8171649 8171810 8172024 8172306 8172517 8172641 8171650 8171811 8172026 8172308 8172518 8172642 8171652 8171818 8172028 8172310 8172520 8172643 8171654 8171820 8172029 8172313 8172521 8172645 8171656 8171821 8172034 8172314 8172522 8172648 8171658 8171825 8172036 8172316 8172525 8172649 8171661 8171826 8172038 8172320 8172531 8172650 8171663 8171829 8172048 8172325 8172532 8172651 8171664 8171832 8172049 8172329 8172535 8172652 8171665 8171834 8172050 8172331 8172536 8172653 8171667 8171836 8172053 8172332 8172538 8172656 8171669 8171838 8172057 8172337 8172539 8172657 8171670 8171840 8172061 8172342 8172542 8172658 8171673 8171848 8172065 8172348 8172543 8172660 8171674 8171852 8172071 8172349 8172545 8172661 8171677 8171856 8172076 8172354 8172547 8172663 8171680 8171862 8172078 8172357 8172548 8172664 8171682 8171863 8172080 8172358 8172549 8172665 8171684 8171867 8172082 8172361 8172550 8172666 8171687 8171872 8172085 8172362 8172551 8172667 8171688 8171874 8172088 8172366 8172552 8172671 8171691 8171877 8172089 8172372 8172554 8172672 8171693 8171884 8172093 8172375 8172555 8172673 8171695 8171886 8172096 8172385 8172562 8172675 8171700 8171891 8172097 8172387 8172563 8172676 8171701 8171892 8172100 8172391 8172564 8172679 8171703 8171896 8172102 8172393 8172565 8172680 8171712 8171899 8172103 8172400 8172572 8172682 8171713 8171901 8172105 8172405 8172573 8172683 8171716 8171902 8172107 8172407 8172575 8172684 8171717 8171903 8172109 8172408 8172576 8172685 8171718 8171904 8172110 8172415 8172577 8172686 8171720 8171907 8172115 8172416 8172579 8172689 8171721 8171908 8172118 8172422 8172581 8172690 8171725 8171914 8172119 8172424 8172583 8172691 8171726 8171917 8172123 8172430 8172584 8172692 8171730 8171920 8172125 8172431 8172585 8172694 8171731 8171923 8172130 8172440 8172588 8172695 8171732 8171928 8172136 8172442 8172589 8172697 8171733 8171930 8172137 8172445 8172590 8172698 8171735 8171932 8172140 8172450 8172591 8172699 8171737 8171937 8172146 8172451 8172594 8172701 8171739 8171943 8172151 8172454 8172596 8172705 8171740 8171947 8172154 8172456 8172597 8172706 8171741 8171948 8172156 8172460 8172599 8172708 8171744 8171952 8172159 8172462 8172600 8172710 8171745 8171954 8172161 8172464 8172603 8172712 8171746 8171955 8172175 8172465 8172604 8172713 8171749 8171957 8172185 8172467 8172605 8172714
EXHIBIT B 42 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8172715 8172887 8173045 8173202 8173433 8173593 8172719 8172891 8173046 8173214 8173438 8173595 8172722 8172892 8173048 8173216 8173439 8173597 8172723 8172897 8173049 8173217 8173441 8173598 8172726 8172899 8173051 8173225 8173449 8173600 8172727 8172900 8173052 8173230 8173452 8173608 8172732 8172901 8173053 8173231 8173454 8173611 8172734 8172902 8173057 8173233 8173455 8173612 8172736 8172905 8173058 8173242 8173459 8173618 8172737 8172906 8173059 8173244 8173460 8173621 8172739 8172908 8173064 8173245 8173462 8173623 8172742 8172909 8173066 8173250 8173468 8173624 8172743 8172911 8173068 8173254 8173471 8173626 8172744 8172912 8173069 8173262 8173479 8173627 8172755 8172915 8173071 8173263 8173480 8173631 8172764 8172917 8173072 8173264 8173481 8173632 8172767 8172918 8173075 8173266 8173484 8173633 8172768 8172919 8173076 8173273 8173486 8173635 8172769 8172920 8173077 8173275 8173487 8173637 8172771 8172922 8173078 8173276 8173488 8173641 8172774 8172923 8173080 8173278 8173491 8173642 8172776 8172924 8173081 8173280 8173492 8173645 8172777 8172929 8173082 8173288 8173494 8173649 8172781 8172932 8173083 8173290 8173495 8173651 8172782 8172933 8173086 8173293 8173497 8173653 8172783 8172940 8173088 8173296 8173500 8173656 8172784 8172943 8173089 8173297 8173502 8173658 8172787 8172945 8173091 8173298 8173503 8173662 8172788 8172948 8173092 8173299 8173505 8173663 8172789 8172952 8173093 8173301 8173507 8173666 8172790 8172953 8173095 8173304 8173508 8173670 8172792 8172955 8173097 8173305 8173510 8173674 8172793 8172957 8173100 8173309 8173515 8173675 8172795 8172958 8173103 8173312 8173516 8173677 8172796 8172959 8173104 8173315 8173518 8173680 8172801 8172961 8173106 8173318 8173520 8173685 8172802 8172964 8173107 8173321 8173522 8173687 8172806 8172967 8173108 8173330 8173527 8173691 8172808 8172973 8173109 8173331 8173529 8173693 8172809 8172974 8173111 8173332 8173531 8173700 8172810 8172975 8173117 8173333 8173532 8173703 8172811 8172976 8173118 8173336 8173533 8173706 8172813 8172977 8173119 8173338 8173534 8173714 8172815 8172980 8173122 8173345 8173535 8173715 8172817 8172986 8173125 8173350 8173540 8173716 8172818 8172987 8173128 8173353 8173541 8173718 8172819 8172988 8173129 8173356 8173542 8173729 8172820 8172991 8173131 8173357 8173543 8173735 8172821 8172996 8173134 8173359 8173545 8173742 8172822 8172998 8173138 8173363 8173546 8173748 8172826 8172999 8173140 8173368 8173548 8173749 8172834 8173004 8173144 8173370 8173549 8173751 8172835 8173005 8173146 8173373 8173551 8173766 8172837 8173008 8173147 8173374 8173552 8173767 8172843 8173009 8173151 8173375 8173554 8173769 8172848 8173010 8173153 8173383 8173555 8173772 8172849 8173015 8173154 8173384 8173559 8173776 8172861 8173021 8173156 8173392 8173562 8173778 8172862 8173029 8173161 8173393 8173563 8173792 8172863 8173030 8173164 8173396 8173565 8173793 8172867 8173031 8173166 8173401 8173567 8173800 8172869 8173032 8173168 8173408 8173571 8173818 8172871 8173033 8173170 8173413 8173572 8173820 8172872 8173035 8173177 8173415 8173573 8173821 8172874 8173036 8173178 8173417 8173574 8173828 8172876 8173037 8173182 8173419 8173580 8173837 8172878 8173038 8173183 8173420 8173581 8173842 8172880 8173040 8173184 8173421 8173583 8173844 8172883 8173041 8173190 8173428 8173585 8173845 8172886 8173042 8173197 8173431 8173588 8173846
EXHIBIT B 43 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8173853 8174158 8174382 8174523 8174673 8174922 8173855 8174159 8174384 8174525 8174674 8174925 8173859 8174164 8174385 8174526 8174675 8174927 8173865 8174166 8174386 8174528 8174681 8174928 8173867 8174170 8174387 8174529 8174683 8174931 8173870 8174171 8174389 8174530 8174684 8174935 8173871 8174174 8174392 8174531 8174686 8174936 8173873 8174176 8174394 8174533 8174689 8174941 8173874 8174177 8174395 8174537 8174690 8174942 8173875 8174183 8174405 8174538 8174694 8174945 8173876 8174186 8174406 8174540 8174695 8174948 8173879 8174191 8174407 8174542 8174696 8174953 8173885 8174193 8174411 8174545 8174697 8174955 8173899 8174194 8174412 8174546 8174705 8174956 8173908 8174195 8174416 8174548 8174709 8174957 8173922 8174198 8174417 8174550 8174714 8174958 8173925 8174200 8174418 8174552 8174716 8174959 8173943 8174206 8174419 8174553 8174718 8174961 8173963 8174207 8174423 8174555 8174720 8174963 8173964 8174210 8174425 8174558 8174730 8174966 8173971 8174211 8174428 8174559 8174733 8174969 8173980 8174216 8174430 8174560 8174734 8174970 8173981 8174223 8174431 8174563 8174742 8174972 8173986 8174228 8174434 8174564 8174743 8174973 8173990 8174229 8174435 8174565 8174753 8174974 8174000 8174230 8174441 8174569 8174754 8174978 8174026 8174231 8174442 8174570 8174756 8174979 8174029 8174234 8174446 8174579 8174764 8174980 8174035 8174236 8174448 8174581 8174773 8174981 8174041 8174242 8174450 8174582 8174786 8174982 8174043 8174249 8174453 8174585 8174797 8174987 8174044 8174259 8174457 8174587 8174800 8174988 8174052 8174260 8174458 8174589 8174808 8174990 8174053 8174266 8174459 8174590 8174809 8174991 8174055 8174267 8174460 8174597 8174811 8174992 8174056 8174277 8174461 8174600 8174814 8174994 8174070 8174279 8174463 8174601 8174818 8174995 8174072 8174284 8174465 8174602 8174819 8174996 8174075 8174290 8174467 8174606 8174821 8174999 8174077 8174298 8174470 8174607 8174823 8175000 8174078 8174299 8174472 8174612 8174824 8175003 8174081 8174301 8174476 8174614 8174827 8175004 8174082 8174302 8174477 8174615 8174832 8175007 8174085 8174308 8174479 8174617 8174835 8175008 8174086 8174309 8174480 8174621 8174838 8175010 8174088 8174317 8174481 8174622 8174841 8175011 8174090 8174318 8174482 8174623 8174845 8175013 8174092 8174319 8174483 8174624 8174850 8175014 8174093 8174323 8174486 8174627 8174851 8175018 8174095 8174324 8174489 8174629 8174855 8175024 8174097 8174325 8174490 8174630 8174857 8175026 8174098 8174329 8174491 8174636 8174860 8175027 8174099 8174331 8174495 8174637 8174866 8175030 8174100 8174333 8174496 8174638 8174872 8175031 8174101 8174334 8174499 8174641 8174873 8175032 8174103 8174339 8174502 8174643 8174874 8175034 8174106 8174342 8174503 8174645 8174878 8175035 8174108 8174346 8174504 8174647 8174880 8175036 8174117 8174350 8174505 8174648 8174883 8175041 8174120 8174351 8174507 8174649 8174884 8175042 8174124 8174355 8174509 8174655 8174887 8175045 8174127 8174360 8174510 8174658 8174891 8175048 8174133 8174364 8174514 8174659 8174899 8175050 8174134 8174365 8174515 8174660 8174901 8175052 8174137 8174366 8174516 8174662 8174903 8175056 8174143 8174368 8174517 8174664 8174910 8175057 8174146 8174371 8174518 8174665 8174914 8175058 8174148 8174374 8174519 8174669 8174917 8175059 8174155 8174376 8174520 8174670 8174918 8175061 8174156 8174381 8174521 8174672 8174920 8175063
EXHIBIT B 44 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8175066 8175191 8175413 8175622 8175747 8175939 8175068 8175195 8175414 8175623 8175748 8175942 8175069 8175197 8175415 8175629 8175751 8175944 8175074 8175199 8175419 8175631 8175752 8175947 8175079 8175200 8175422 8175632 8175753 8175951 8175081 8175203 8175424 8175633 8175756 8175953 8175083 8175206 8175429 8175634 8175758 8175955 8175084 8175210 8175433 8175635 8175759 8175957 8175087 8175212 8175434 8175640 8175762 8175959 8175090 8175217 8175435 8175641 8175764 8175962 8175094 8175218 8175436 8175642 8175767 8175965 8175095 8175220 8175438 8175643 8175770 8175966 8175097 8175221 8175443 8175647 8175771 8175967 8175098 8175222 8175446 8175650 8175773 8175975 8175099 8175224 8175449 8175652 8175782 8175976 8175101 8175225 8175450 8175654 8175784 8175977 8175106 8175232 8175452 8175655 8175793 8175978 8175107 8175234 8175454 8175659 8175796 8175980 8175108 8175239 8175460 8175660 8175803 8175982 8175115 8175243 8175462 8175661 8175804 8175985 8175116 8175244 8175463 8175664 8175806 8175989 8175117 8175251 8175464 8175665 8175809 8175990 8175118 8175255 8175466 8175667 8175813 8175991 8175119 8175261 8175469 8175669 8175815 8175997 8175120 8175264 8175473 8175671 8175818 8175998 8175121 8175267 8175475 8175672 8175819 8175999 8175124 8175271 8175477 8175674 8175821 8176000 8175125 8175276 8175479 8175676 8175823 8176003 8175129 8175278 8175480 8175677 8175825 8176004 8175130 8175282 8175481 8175678 8175828 8176007 8175131 8175284 8175486 8175679 8175830 8176008 8175133 8175291 8175489 8175680 8175832 8176009 8175134 8175292 8175490 8175681 8175836 8176010 8175135 8175294 8175494 8175682 8175838 8176011 8175139 8175295 8175499 8175683 8175840 8176012 8175140 8175302 8175504 8175688 8175843 8176013 8175141 8175303 8175505 8175689 8175845 8176014 8175142 8175311 8175507 8175694 8175846 8176015 8175143 8175313 8175510 8175695 8175850 8176017 8175144 8175321 8175512 8175696 8175851 8176018 8175147 8175329 8175520 8175697 8175854 8176019 8175148 8175337 8175521 8175699 8175856 8176020 8175149 8175340 8175523 8175701 8175859 8176022 8175150 8175342 8175525 8175703 8175862 8176025 8175152 8175345 8175526 8175704 8175864 8176031 8175154 8175349 8175529 8175705 8175869 8176035 8175157 8175351 8175530 8175707 8175871 8176041 8175158 8175363 8175534 8175708 8175875 8176043 8175160 8175366 8175539 8175710 8175876 8176044 8175161 8175370 8175540 8175711 8175880 8176045 8175163 8175371 8175544 8175712 8175884 8176046 8175164 8175373 8175550 8175713 8175886 8176048 8175166 8175374 8175552 8175714 8175888 8176050 8175168 8175375 8175554 8175715 8175889 8176052 8175170 8175376 8175555 8175719 8175896 8176053 8175172 8175378 8175556 8175720 8175897 8176061 8175173 8175379 8175565 8175723 8175899 8176066 8175174 8175380 8175568 8175725 8175900 8176068 8175175 8175382 8175569 8175727 8175907 8176071 8175177 8175384 8175571 8175728 8175908 8176074 8175179 8175387 8175572 8175732 8175910 8176075 8175180 8175390 8175574 8175736 8175913 8176076 8175181 8175392 8175580 8175737 8175914 8176078 8175182 8175397 8175586 8175738 8175917 8176081 8175183 8175398 8175587 8175739 8175919 8176082 8175184 8175400 8175597 8175740 8175922 8176085 8175185 8175406 8175603 8175741 8175925 8176086 8175186 8175407 8175608 8175742 8175928 8176087 8175187 8175408 8175610 8175743 8175934 8176090 8175190 8175412 8175611 8175744 8175935 8176091
EXHIBIT B 45 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8176093 8176221 8176352 8176458 8176616 8176837 8176095 8176222 8176353 8176459 8176618 8176838 8176096 8176223 8176354 8176461 8176620 8176839 8176100 8176224 8176355 8176463 8176621 8176842 8176101 8176225 8176357 8176465 8176623 8176846 8176102 8176226 8176359 8176469 8176624 8176847 8176103 8176228 8176361 8176470 8176628 8176849 8176104 8176230 8176362 8176471 8176629 8176852 8176106 8176232 8176364 8176476 8176634 8176856 8176108 8176233 8176365 8176477 8176637 8176858 8176111 8176234 8176366 8176481 8176638 8176859 8176112 8176237 8176368 8176486 8176639 8176861 8176114 8176239 8176371 8176488 8176644 8176862 8176116 8176242 8176372 8176489 8176650 8176866 8176118 8176243 8176373 8176491 8176660 8176868 8176119 8176244 8176374 8176493 8176661 8176869 8176120 8176247 8176376 8176494 8176664 8176870 8176121 8176248 8176379 8176495 8176671 8176871 8176123 8176250 8176380 8176501 8176681 8176875 8176124 8176251 8176381 8176502 8176690 8176878 8176125 8176253 8176382 8176503 8176691 8176879 8176127 8176255 8176386 8176505 8176694 8176880 8176131 8176259 8176388 8176509 8176701 8176881 8176133 8176261 8176391 8176514 8176703 8176885 8176136 8176267 8176392 8176515 8176704 8176886 8176137 8176270 8176393 8176518 8176705 8176892 8176138 8176272 8176395 8176519 8176707 8176900 8176141 8176275 8176396 8176520 8176708 8176901 8176142 8176276 8176397 8176523 8176709 8176903 8176143 8176277 8176398 8176529 8176713 8176906 8176144 8176280 8176399 8176531 8176719 8176907 8176145 8176283 8176400 8176533 8176720 8176914 8176146 8176286 8176402 8176534 8176721 8176915 8176148 8176287 8176403 8176537 8176724 8176920 8176151 8176289 8176405 8176540 8176726 8176923 8176153 8176292 8176406 8176542 8176733 8176926 8176154 8176294 8176408 8176544 8176734 8176928 8176157 8176295 8176411 8176547 8176735 8176931 8176158 8176297 8176412 8176549 8176737 8176933 8176160 8176298 8176413 8176551 8176746 8176935 8176163 8176299 8176414 8176554 8176752 8176937 8176164 8176302 8176415 8176555 8176753 8176939 8176165 8176303 8176418 8176556 8176757 8176940 8176166 8176305 8176419 8176560 8176758 8176943 8176171 8176306 8176420 8176562 8176762 8176949 8176172 8176307 8176421 8176565 8176763 8176950 8176174 8176309 8176424 8176566 8176764 8176953 8176175 8176312 8176425 8176573 8176767 8176955 8176176 8176313 8176426 8176576 8176771 8176957 8176181 8176315 8176427 8176577 8176774 8176964 8176182 8176316 8176428 8176578 8176775 8176968 8176184 8176318 8176429 8176579 8176777 8176971 8176186 8176321 8176432 8176581 8176779 8176972 8176188 8176323 8176435 8176582 8176786 8176974 8176189 8176325 8176436 8176585 8176788 8176978 8176191 8176326 8176437 8176586 8176790 8176980 8176193 8176327 8176438 8176587 8176792 8176983 8176194 8176328 8176439 8176590 8176796 8176984 8176200 8176330 8176440 8176591 8176798 8176985 8176202 8176332 8176443 8176595 8176805 8176986 8176204 8176336 8176445 8176597 8176806 8176989 8176205 8176338 8176446 8176598 8176810 8176991 8176208 8176339 8176448 8176600 8176812 8176995 8176209 8176340 8176449 8176601 8176819 8176996 8176211 8176341 8176450 8176602 8176820 8176998 8176212 8176344 8176451 8176604 8176823 8177004 8176214 8176345 8176452 8176607 8176825 8177005 8176215 8176346 8176453 8176608 8176827 8177006 8176217 8176347 8176456 8176611 8176828 8177008 8176219 8176349 8176457 8176612 8176835 8177011
EXHIBIT B 46 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8177015 8177181 8177353 8177514 8177724 8178001 8177016 8177182 8177355 8177515 8177725 8178003 8177017 8177183 8177356 8177519 8177726 8178007 8177024 8177187 8177358 8177522 8177732 8178014 8177027 8177189 8177361 8177525 8177733 8178025 8177030 8177193 8177363 8177526 8177738 8178027 8177032 8177196 8177364 8177527 8177739 8178028 8177033 8177206 8177365 8177531 8177742 8178031 8177034 8177209 8177366 8177533 8177743 8178034 8177037 8177214 8177367 8177535 8177744 8178038 8177038 8177215 8177370 8177541 8177745 8178042 8177042 8177217 8177372 8177550 8177746 8178047 8177044 8177218 8177375 8177551 8177752 8178053 8177045 8177219 8177379 8177554 8177753 8178054 8177049 8177220 8177383 8177557 8177758 8178061 8177052 8177222 8177384 8177560 8177760 8178062 8177053 8177230 8177385 8177564 8177764 8178068 8177055 8177233 8177387 8177566 8177765 8178072 8177056 8177238 8177388 8177568 8177768 8178074 8177057 8177241 8177389 8177581 8177770 8178075 8177060 8177243 8177390 8177582 8177778 8178079 8177061 8177247 8177394 8177586 8177785 8178080 8177062 8177250 8177399 8177587 8177786 8178081 8177063 8177255 8177400 8177594 8177788 8178087 8177064 8177258 8177404 8177596 8177793 8178088 8177068 8177263 8177409 8177608 8177813 8178095 8177070 8177268 8177410 8177612 8177819 8178098 8177073 8177269 8177414 8177615 8177825 8178101 8177074 8177279 8177415 8177618 8177827 8178102 8177076 8177280 8177418 8177620 8177836 8178103 8177078 8177281 8177422 8177622 8177841 8178104 8177079 8177282 8177423 8177624 8177842 8178106 8177080 8177285 8177424 8177627 8177850 8178112 8177082 8177288 8177427 8177631 8177858 8178119 8177083 8177289 8177428 8177633 8177863 8178121 8177084 8177292 8177431 8177634 8177874 8178123 8177085 8177294 8177432 8177635 8177876 8178124 8177091 8177295 8177435 8177639 8177888 8178125 8177095 8177299 8177437 8177642 8177889 8178126 8177097 8177300 8177439 8177643 8177894 8178133 8177100 8177301 8177444 8177644 8177896 8178137 8177101 8177302 8177448 8177645 8177897 8178140 8177103 8177303 8177449 8177647 8177900 8178141 8177105 8177304 8177456 8177649 8177907 8178143 8177106 8177306 8177460 8177652 8177908 8178144 8177109 8177309 8177462 8177653 8177909 8178145 8177110 8177310 8177463 8177655 8177915 8178147 8177114 8177311 8177465 8177663 8177916 8178152 8177118 8177316 8177466 8177665 8177924 8178156 8177119 8177317 8177467 8177673 8177925 8178163 8177122 8177319 8177471 8177677 8177933 8178164 8177123 8177322 8177474 8177678 8177940 8178165 8177126 8177323 8177475 8177680 8177945 8178166 8177131 8177324 8177476 8177681 8177948 8178168 8177133 8177325 8177477 8177683 8177953 8178169 8177136 8177326 8177478 8177685 8177967 8178172 8177137 8177327 8177479 8177688 8177968 8178175 8177140 8177330 8177480 8177691 8177970 8178177 8177142 8177331 8177486 8177693 8177976 8178181 8177144 8177332 8177487 8177694 8177978 8178185 8177149 8177334 8177488 8177697 8177979 8178189 8177152 8177336 8177497 8177699 8177982 8178195 8177153 8177338 8177500 8177706 8177985 8178196 8177166 8177339 8177502 8177707 8177987 8178203 8177168 8177341 8177503 8177711 8177991 8178204 8177170 8177343 8177506 8177712 8177992 8178206 8177171 8177344 8177508 8177715 8177994 8178208 8177173 8177345 8177509 8177717 8177995 8178212 8177174 8177349 8177510 8177718 8177996 8178215 8177180 8177350 8177512 8177722 8177997 8178218
EXHIBIT B 47 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8178219 8178456 8178698 8178901 8179139 8179291 8178220 8178458 8178705 8178902 8179144 8179292 8178226 8178465 8178710 8178903 8179148 8179294 8178231 8178469 8178719 8178904 8179149 8179297 8178234 8178470 8178723 8178913 8179150 8179300 8178238 8178473 8178725 8178919 8179151 8179301 8178240 8178474 8178728 8178920 8179157 8179302 8178242 8178480 8178730 8178924 8179159 8179303 8178246 8178485 8178733 8178925 8179160 8179305 8178247 8178490 8178736 8178931 8179162 8179306 8178250 8178493 8178741 8178937 8179164 8179308 8178258 8178496 8178742 8178939 8179167 8179310 8178265 8178499 8178744 8178940 8179170 8179311 8178279 8178503 8178749 8178941 8179172 8179316 8178280 8178506 8178752 8178943 8179173 8179317 8178281 8178507 8178753 8178945 8179174 8179322 8178282 8178511 8178756 8178948 8179178 8179323 8178283 8178512 8178758 8178949 8179185 8179326 8178292 8178513 8178760 8178954 8179186 8179327 8178293 8178515 8178765 8178958 8179188 8179331 8178294 8178520 8178766 8178959 8179192 8179337 8178295 8178521 8178782 8178963 8179193 8179348 8178301 8178528 8178784 8178965 8179194 8179354 8178302 8178530 8178786 8178968 8179197 8179355 8178305 8178532 8178791 8178969 8179198 8179360 8178307 8178533 8178792 8178973 8179205 8179365 8178310 8178534 8178798 8178979 8179206 8179366 8178312 8178539 8178799 8178981 8179210 8179370 8178316 8178540 8178800 8178986 8179212 8179371 8178317 8178544 8178803 8178987 8179214 8179375 8178318 8178545 8178804 8178995 8179215 8179378 8178319 8178546 8178811 8179001 8179216 8179383 8178320 8178550 8178812 8179007 8179218 8179391 8178326 8178551 8178813 8179010 8179227 8179396 8178327 8178553 8178818 8179016 8179230 8179398 8178330 8178554 8178819 8179023 8179231 8179404 8178331 8178555 8178820 8179027 8179232 8179411 8178333 8178557 8178821 8179030 8179233 8179413 8178334 8178563 8178824 8179032 8179235 8179414 8178335 8178566 8178830 8179040 8179236 8179418 8178337 8178574 8178831 8179042 8179241 8179420 8178339 8178575 8178837 8179044 8179243 8179427 8178340 8178577 8178838 8179049 8179248 8179438 8178342 8178579 8178843 8179056 8179249 8179442 8178344 8178580 8178844 8179058 8179250 8179444 8178346 8178584 8178846 8179060 8179252 8179453 8178347 8178587 8178847 8179063 8179254 8179455 8178358 8178589 8178848 8179066 8179255 8179456 8178359 8178595 8178850 8179069 8179256 8179460 8178361 8178596 8178853 8179075 8179257 8179468 8178365 8178597 8178854 8179082 8179258 8179470 8178369 8178599 8178855 8179085 8179260 8179474 8178373 8178600 8178856 8179089 8179264 8179477 8178376 8178601 8178859 8179091 8179265 8179479 8178385 8178602 8178860 8179094 8179267 8179487 8178386 8178603 8178862 8179100 8179268 8179494 8178387 8178607 8178863 8179105 8179270 8179499 8178395 8178619 8178866 8179108 8179272 8179501 8178396 8178630 8178867 8179109 8179273 8179512 8178397 8178641 8178868 8179111 8179275 8179516 8178401 8178642 8178870 8179112 8179276 8179517 8178407 8178646 8178871 8179116 8179278 8179524 8178411 8178652 8178875 8179119 8179279 8179526 8178415 8178658 8178877 8179122 8179280 8179532 8178424 8178659 8178878 8179123 8179281 8179540 8178427 8178667 8178879 8179126 8179282 8179547 8178435 8178678 8178882 8179128 8179286 8179549 8178444 8178684 8178890 8179130 8179287 8179552 8178446 8178688 8178897 8179133 8179289 8179555 8178447 8178697 8178898 8179138 8179290 8179556
EXHIBIT B 48 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8179558 8179864 8180094 8180416 8180657 8180803 8179579 8179866 8180099 8180421 8180659 8180804 8179585 8179869 8180110 8180430 8180661 8180809 8179588 8179870 8180126 8180432 8180662 8180813 8179590 8179876 8180133 8180435 8180666 8180836 8179591 8179879 8180144 8180444 8180667 8180838 8179597 8179890 8180147 8180447 8180670 8180840 8179599 8179892 8180148 8180455 8180671 8180843 8179602 8179900 8180165 8180456 8180673 8180845 8179606 8179909 8180177 8180458 8180675 8180846 8179609 8179914 8180186 8180463 8180676 8180847 8179610 8179916 8180200 8180467 8180677 8180848 8179616 8179921 8180209 8180478 8180679 8180850 8179617 8179923 8180217 8180482 8180680 8180853 8179621 8179927 8180222 8180487 8180681 8180855 8179622 8179931 8180226 8180492 8180682 8180856 8179623 8179935 8180232 8180495 8180683 8180860 8179627 8179936 8180235 8180496 8180686 8180863 8179629 8179941 8180236 8180502 8180687 8180867 8179631 8179942 8180237 8180504 8180690 8180870 8179633 8179943 8180238 8180505 8180691 8180873 8179634 8179951 8180240 8180507 8180692 8180874 8179642 8179952 8180243 8180511 8180697 8180876 8179647 8179955 8180250 8180512 8180699 8180877 8179655 8179956 8180251 8180513 8180703 8180882 8179657 8179960 8180253 8180520 8180705 8180883 8179662 8179962 8180256 8180523 8180708 8180890 8179666 8179964 8180259 8180527 8180710 8180893 8179669 8179965 8180262 8180528 8180713 8180895 8179676 8179967 8180265 8180534 8180714 8180896 8179678 8179976 8180266 8180535 8180720 8180897 8179685 8179977 8180267 8180536 8180723 8180898 8179690 8179980 8180270 8180541 8180725 8180899 8179692 8179982 8180273 8180546 8180726 8180900 8179696 8179985 8180274 8180553 8180727 8180901 8179699 8179988 8180277 8180554 8180734 8180903 8179701 8179990 8180281 8180559 8180739 8180904 8179706 8179992 8180283 8180571 8180743 8180906 8179707 8179993 8180284 8180576 8180744 8180909 8179710 8179995 8180286 8180585 8180745 8180910 8179714 8179996 8180295 8180587 8180746 8180911 8179716 8179998 8180299 8180590 8180747 8180912 8179717 8179999 8180300 8180592 8180750 8180914 8179720 8180000 8180306 8180594 8180752 8180915 8179724 8180003 8180310 8180595 8180755 8180916 8179725 8180005 8180313 8180601 8180756 8180919 8179734 8180006 8180315 8180604 8180759 8180922 8179742 8180008 8180316 8180605 8180761 8180923 8179744 8180009 8180320 8180606 8180763 8180931 8179748 8180018 8180331 8180607 8180764 8180933 8179752 8180019 8180343 8180609 8180768 8180934 8179765 8180020 8180364 8180611 8180770 8180935 8179767 8180022 8180366 8180612 8180773 8180936 8179772 8180023 8180368 8180614 8180775 8180937 8179773 8180024 8180369 8180615 8180779 8180938 8179780 8180025 8180370 8180621 8180782 8180941 8179781 8180029 8180375 8180625 8180783 8180944 8179782 8180032 8180376 8180629 8180784 8180947 8179788 8180037 8180379 8180633 8180788 8180948 8179789 8180040 8180380 8180635 8180789 8180951 8179798 8180048 8180381 8180636 8180790 8180954 8179818 8180054 8180386 8180637 8180791 8180955 8179822 8180056 8180389 8180639 8180793 8180959 8179827 8180061 8180390 8180643 8180794 8180960 8179833 8180067 8180391 8180645 8180795 8180963 8179838 8180072 8180392 8180647 8180796 8180970 8179850 8180079 8180394 8180648 8180797 8180972 8179857 8180082 8180410 8180651 8180798 8180973 8179858 8180083 8180411 8180653 8180801 8180978 8179861 8180086 8180415 8180655 8180802 8180979
EXHIBIT B 49 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8180980 8181337 8181671 8182070 8182288 8182660 8180983 8181339 8181673 8182071 8182289 8182664 8180984 8181355 8181674 8182079 8182290 8182667 8180987 8181367 8181675 8182081 8182294 8182670 8180989 8181372 8181678 8182082 8182295 8182671 8180991 8181382 8181681 8182083 8182297 8182672 8180993 8181388 8181682 8182097 8182298 8182673 8180995 8181407 8181708 8182098 8182300 8182677 8180998 8181423 8181710 8182101 8182302 8182679 8180999 8181428 8181712 8182102 8182303 8182681 8181003 8181435 8181714 8182106 8182305 8182683 8181005 8181442 8181716 8182108 8182306 8182687 8181008 8181446 8181725 8182117 8182311 8182697 8181012 8181449 8181736 8182119 8182313 8182698 8181031 8181453 8181739 8182123 8182314 8182704 8181035 8181455 8181746 8182125 8182316 8182710 8181036 8181459 8181747 8182130 8182318 8182711 8181041 8181464 8181749 8182136 8182319 8182714 8181043 8181471 8181752 8182137 8182322 8182715 8181045 8181493 8181756 8182140 8182326 8182718 8181047 8181497 8181759 8182144 8182335 8182719 8181055 8181506 8181760 8182145 8182339 8182722 8181056 8181508 8181764 8182148 8182341 8182725 8181058 8181516 8181767 8182153 8182342 8182730 8181059 8181520 8181774 8182155 8182349 8182733 8181067 8181526 8181806 8182157 8182362 8182746 8181074 8181527 8181810 8182159 8182373 8182753 8181075 8181529 8181812 8182160 8182375 8182757 8181084 8181531 8181813 8182172 8182377 8182761 8181089 8181543 8181814 8182174 8182382 8182766 8181094 8181547 8181816 8182177 8182390 8182774 8181096 8181551 8181820 8182178 8182396 8182782 8181098 8181553 8181825 8182180 8182398 8182783 8181106 8181557 8181830 8182181 8182410 8182790 8181108 8181562 8181832 8182188 8182425 8182794 8181110 8181564 8181835 8182191 8182448 8182831 8181114 8181565 8181836 8182192 8182464 8182873 8181115 8181566 8181841 8182193 8182475 8182877 8181118 8181567 8181845 8182198 8182482 8182882 8181123 8181570 8181847 8182199 8182489 8182885 8181124 8181572 8181849 8182200 8182492 8182886 8181130 8181573 8181851 8182205 8182497 8182891 8181133 8181576 8181852 8182208 8182503 8182893 8181135 8181580 8181853 8182210 8182505 8182896 8181137 8181585 8181855 8182213 8182506 8182909 8181140 8181592 8181856 8182215 8182517 8182916 8181142 8181594 8181857 8182217 8182521 8182921 8181152 8181596 8181859 8182219 8182523 8182927 8181158 8181598 8181860 8182222 8182535 8182940 8181174 8181599 8181862 8182223 8182539 8182942 8181184 8181601 8181868 8182225 8182547 8182944 8181189 8181604 8181874 8182228 8182556 8182947 8181192 8181608 8181883 8182229 8182562 8182949 8181194 8181615 8181902 8182231 8182572 8182957 8181205 8181617 8181903 8182233 8182576 8182960 8181208 8181618 8181904 8182235 8182577 8182964 8181213 8181619 8181906 8182240 8182578 8182968 8181219 8181622 8181916 8182241 8182579 8182969 8181227 8181623 8181929 8182242 8182596 8182979 8181228 8181625 8181953 8182243 8182631 8182994 8181231 8181626 8181964 8182249 8182633 8182999 8181238 8181630 8182014 8182250 8182635 8183010 8181247 8181636 8182023 8182257 8182644 8183015 8181254 8181642 8182027 8182259 8182646 8183016 8181263 8181643 8182028 8182261 8182648 8183026 8181267 8181646 8182031 8182267 8182649 8183031 8181275 8181649 8182035 8182269 8182650 8183032 8181278 8181661 8182037 8182275 8182652 8183037 8181299 8181667 8182047 8182278 8182658 8183038 8181318 8181668 8182068 8182282 8182659 8183040
EXHIBIT B 50 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8183044 8183343 8183662 8184131 8184329 8184488 8183046 8183344 8183664 8184134 8184330 8184489 8183052 8183353 8183669 8184136 8184335 8184495 8183058 8183358 8183671 8184143 8184336 8184507 8183059 8183363 8183675 8184151 8184339 8184510 8183069 8183365 8183678 8184170 8184340 8184521 8183070 8183369 8183681 8184173 8184341 8184542 8183073 8183374 8183689 8184174 8184342 8184544 8183082 8183379 8183695 8184176 8184344 8184545 8183093 8183381 8183697 8184178 8184345 8184546 8183096 8183385 8183699 8184179 8184347 8184547 8183103 8183391 8183703 8184185 8184348 8184563 8183111 8183392 8183704 8184188 8184349 8184570 8183114 8183393 8183705 8184191 8184350 8184574 8183118 8183400 8183706 8184193 8184351 8184580 8183124 8183408 8183707 8184196 8184353 8184584 8183128 8183439 8183709 8184197 8184354 8184596 8183130 8183445 8183710 8184214 8184357 8184599 8183141 8183461 8183711 8184216 8184365 8184600 8183144 8183463 8183712 8184219 8184368 8184601 8183148 8183469 8183713 8184221 8184369 8184602 8183151 8183472 8183716 8184222 8184379 8184612 8183152 8183482 8183717 8184223 8184382 8184616 8183153 8183498 8183718 8184239 8184386 8184623 8183170 8183499 8183719 8184240 8184388 8184628 8183171 8183505 8183720 8184241 8184389 8184641 8183173 8183509 8183722 8184242 8184392 8184651 8183174 8183519 8183731 8184243 8184394 8184660 8183175 8183522 8183736 8184246 8184399 8184664 8183180 8183523 8183737 8184248 8184401 8184687 8183182 8183526 8183749 8184250 8184404 8184691 8183183 8183530 8183750 8184251 8184405 8184695 8183186 8183532 8183753 8184252 8184406 8184696 8183213 8183533 8183755 8184254 8184410 8184698 8183216 8183536 8183756 8184256 8184411 8184703 8183227 8183544 8183758 8184258 8184413 8184706 8183230 8183551 8183790 8184263 8184414 8184709 8183233 8183554 8183802 8184266 8184415 8184711 8183236 8183568 8183808 8184268 8184416 8184712 8183238 8183573 8183812 8184276 8184417 8184713 8183248 8183586 8183816 8184282 8184422 8184714 8183249 8183588 8183820 8184288 8184425 8184715 8183252 8183592 8183835 8184289 8184433 8184718 8183254 8183594 8183866 8184292 8184437 8184723 8183259 8183599 8183867 8184294 8184441 8184726 8183263 8183601 8183892 8184298 8184442 8184729 8183269 8183605 8183932 8184299 8184443 8184730 8183272 8183607 8183941 8184300 8184446 8184731 8183275 8183610 8183948 8184301 8184447 8184734 8183280 8183612 8183960 8184303 8184451 8184736 8183282 8183615 8184009 8184304 8184454 8184737 8183284 8183616 8184013 8184305 8184457 8184738 8183285 8183617 8184021 8184306 8184459 8184759 8183290 8183618 8184036 8184307 8184462 8184780 8183292 8183623 8184042 8184308 8184463 8184786 8183296 8183625 8184053 8184310 8184464 8184788 8183298 8183626 8184077 8184311 8184466 8184794 8183303 8183627 8184079 8184312 8184468 8184798 8183304 8183628 8184081 8184313 8184472 8184806 8183308 8183630 8184082 8184314 8184473 8184808 8183310 8183631 8184083 8184316 8184474 8184817 8183316 8183632 8184084 8184317 8184475 8184820 8183323 8183633 8184085 8184318 8184478 8184822 8183326 8183645 8184087 8184319 8184479 8184825 8183328 8183647 8184089 8184320 8184481 8184830 8183329 8183649 8184091 8184322 8184483 8184831 8183330 8183655 8184093 8184323 8184484 8184832 8183335 8183656 8184094 8184325 8184485 8184833 8183337 8183657 8184125 8184326 8184486 8184835 8183341 8183661 8184129 8184328 8184487 8184836
EXHIBIT B 51 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8184837 8185274 8185578 8186054 8186354 8186585 8184839 8185283 8185579 8186055 8186355 8186588 8184849 8185288 8185580 8186061 8186356 8186589 8184851 8185290 8185583 8186062 8186357 8186590 8184854 8185291 8185584 8186066 8186359 8186591 8184881 8185294 8185596 8186067 8186363 8186593 8184882 8185295 8185601 8186071 8186364 8186594 8184885 8185297 8185603 8186078 8186366 8186596 8184888 8185299 8185604 8186080 8186369 8186598 8184897 8185301 8185605 8186081 8186371 8186599 8184898 8185305 8185611 8186088 8186375 8186604 8184900 8185312 8185630 8186091 8186379 8186609 8184904 8185314 8185686 8186092 8186382 8186610 8184906 8185339 8185694 8186098 8186383 8186615 8184925 8185342 8185699 8186100 8186384 8186616 8184941 8185347 8185706 8186101 8186385 8186621 8184950 8185354 8185711 8186104 8186393 8186622 8184956 8185358 8185714 8186114 8186398 8186628 8184969 8185360 8185760 8186120 8186399 8186629 8184970 8185363 8185856 8186128 8186406 8186630 8184974 8185365 8185858 8186131 8186410 8186632 8184975 8185366 8185879 8186133 8186411 8186633 8184987 8185369 8185894 8186137 8186414 8186635 8185002 8185372 8185899 8186142 8186415 8186636 8185033 8185374 8185905 8186148 8186417 8186637 8185037 8185376 8185909 8186151 8186420 8186638 8185051 8185377 8185913 8186182 8186421 8186640 8185052 8185380 8185918 8186196 8186426 8186641 8185054 8185385 8185921 8186197 8186432 8186642 8185057 8185386 8185923 8186204 8186433 8186643 8185058 8185393 8185925 8186210 8186436 8186644 8185060 8185397 8185930 8186213 8186450 8186646 8185068 8185402 8185935 8186251 8186452 8186648 8185072 8185404 8185938 8186252 8186455 8186649 8185075 8185407 8185947 8186255 8186462 8186650 8185078 8185410 8185948 8186259 8186465 8186651 8185079 8185417 8185950 8186260 8186466 8186653 8185080 8185425 8185953 8186276 8186468 8186654 8185091 8185430 8185954 8186287 8186486 8186655 8185093 8185431 8185955 8186288 8186487 8186656 8185131 8185443 8185957 8186297 8186491 8186657 8185135 8185447 8185959 8186298 8186492 8186658 8185152 8185451 8185964 8186303 8186493 8186659 8185155 8185456 8185966 8186305 8186503 8186660 8185170 8185466 8185970 8186309 8186511 8186661 8185183 8185473 8185972 8186310 8186515 8186664 8185189 8185488 8185975 8186313 8186518 8186666 8185195 8185490 8185979 8186314 8186521 8186667 8185198 8185497 8185987 8186318 8186530 8186669 8185207 8185507 8185988 8186320 8186533 8186670 8185209 8185509 8185992 8186321 8186540 8186671 8185227 8185512 8185996 8186323 8186545 8186674 8185230 8185514 8186004 8186324 8186546 8186675 8185236 8185517 8186009 8186325 8186552 8186676 8185240 8185518 8186012 8186326 8186554 8186677 8185241 8185521 8186019 8186328 8186555 8186681 8185242 8185526 8186021 8186330 8186557 8186682 8185245 8185528 8186023 8186334 8186560 8186685 8185249 8185529 8186025 8186336 8186562 8186686 8185252 8185537 8186026 8186340 8186565 8186693 8185255 8185543 8186028 8186342 8186569 8186694 8185257 8185545 8186031 8186344 8186570 8186696 8185260 8185551 8186032 8186345 8186571 8186697 8185261 8185563 8186034 8186346 8186574 8186699 8185264 8185564 8186037 8186347 8186575 8186701 8185268 8185566 8186041 8186348 8186577 8186703 8185270 8185568 8186043 8186349 8186578 8186706 8185271 8185571 8186047 8186350 8186580 8186708 8185272 8185576 8186049 8186351 8186582 8186709 8185273 8185577 8186053 8186352 8186583 8186713
EXHIBIT B 52 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8186715 8186853 8187191 8187470 8187714 8188111 8186718 8186855 8187192 8187476 8187716 8188116 8186719 8186856 8187193 8187481 8187718 8188119 8186722 8186860 8187197 8187485 8187723 8188120 8186727 8186861 8187198 8187486 8187726 8188122 8186728 8186863 8187202 8187487 8187731 8188123 8186732 8186866 8187203 8187490 8187738 8188125 8186735 8186869 8187205 8187493 8187743 8188127 8186737 8186875 8187206 8187500 8187747 8188130 8186738 8186879 8187207 8187502 8187758 8188131 8186739 8186903 8187212 8187503 8187760 8188132 8186741 8186907 8187214 8187506 8187763 8188137 8186742 8186910 8187217 8187513 8187769 8188141 8186743 8186912 8187220 8187522 8187771 8188146 8186744 8186914 8187226 8187526 8187773 8188149 8186746 8186915 8187227 8187534 8187775 8188150 8186747 8186917 8187231 8187539 8187779 8188155 8186753 8186923 8187234 8187540 8187781 8188176 8186754 8186924 8187240 8187542 8187787 8188179 8186755 8186929 8187241 8187543 8187801 8188181 8186759 8186930 8187242 8187544 8187807 8188185 8186762 8186934 8187249 8187545 8187826 8188187 8186764 8186935 8187253 8187552 8187835 8188190 8186765 8186937 8187256 8187554 8187841 8188192 8186766 8186942 8187260 8187555 8187842 8188196 8186768 8186952 8187267 8187556 8187850 8188201 8186771 8186956 8187271 8187558 8187859 8188203 8186774 8186961 8187285 8187560 8187869 8188208 8186775 8186992 8187298 8187561 8187874 8188212 8186776 8186998 8187302 8187563 8187877 8188215 8186783 8187002 8187310 8187565 8187897 8188216 8186785 8187007 8187322 8187566 8187902 8188218 8186789 8187011 8187324 8187567 8187911 8188222 8186792 8187032 8187330 8187569 8187927 8188225 8186793 8187038 8187335 8187570 8187932 8188226 8186796 8187042 8187336 8187571 8187937 8188228 8186803 8187046 8187346 8187572 8187952 8188232 8186805 8187048 8187352 8187574 8187953 8188235 8186808 8187055 8187354 8187575 8187961 8188236 8186809 8187057 8187361 8187580 8187963 8188241 8186811 8187060 8187364 8187581 8187968 8188243 8186812 8187063 8187365 8187587 8187969 8188245 8186813 8187067 8187367 8187588 8187975 8188246 8186816 8187072 8187370 8187595 8187976 8188247 8186817 8187077 8187371 8187598 8187980 8188248 8186818 8187080 8187373 8187604 8187984 8188250 8186819 8187089 8187376 8187609 8187997 8188251 8186820 8187090 8187377 8187632 8188000 8188257 8186821 8187093 8187379 8187646 8188002 8188259 8186822 8187094 8187391 8187653 8188006 8188261 8186826 8187099 8187393 8187660 8188024 8188263 8186827 8187103 8187394 8187663 8188031 8188264 8186830 8187105 8187402 8187665 8188037 8188265 8186831 8187108 8187404 8187669 8188069 8188266 8186832 8187111 8187408 8187670 8188076 8188267 8186834 8187113 8187409 8187673 8188078 8188268 8186835 8187118 8187412 8187676 8188080 8188271 8186836 8187119 8187414 8187677 8188088 8188273 8186837 8187122 8187419 8187679 8188089 8188276 8186838 8187128 8187420 8187680 8188091 8188278 8186839 8187144 8187424 8187684 8188094 8188279 8186840 8187146 8187425 8187689 8188097 8188281 8186842 8187154 8187428 8187697 8188098 8188283 8186844 8187157 8187430 8187701 8188099 8188284 8186845 8187164 8187432 8187703 8188101 8188286 8186846 8187181 8187434 8187704 8188105 8188287 8186847 8187182 8187438 8187705 8188106 8188290 8186848 8187185 8187449 8187706 8188107 8188291 8186849 8187186 8187454 8187708 8188109 8188292 8186850 8187188 8187461 8187711 8188110 8188294
EXHIBIT B 53 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8188296 8188484 8188631 8188946 8189400 8189692 8188297 8188485 8188638 8188947 8189407 8189697 8188298 8188486 8188639 8188948 8189411 8189700 8188300 8188487 8188640 8188949 8189413 8189701 8188301 8188489 8188641 8188950 8189415 8189702 8188303 8188493 8188642 8188952 8189416 8189703 8188305 8188494 8188644 8188955 8189420 8189705 8188308 8188496 8188647 8188961 8189423 8189706 8188309 8188497 8188648 8188975 8189424 8189708 8188312 8188503 8188650 8189011 8189427 8189709 8188314 8188504 8188654 8189013 8189429 8189710 8188315 8188506 8188657 8189025 8189432 8189714 8188317 8188507 8188658 8189028 8189435 8189715 8188318 8188509 8188667 8189033 8189441 8189717 8188319 8188512 8188671 8189038 8189445 8189719 8188321 8188515 8188673 8189049 8189448 8189722 8188323 8188516 8188675 8189072 8189452 8189724 8188324 8188518 8188737 8189075 8189458 8189727 8188325 8188520 8188739 8189079 8189464 8189730 8188328 8188523 8188742 8189091 8189475 8189743 8188329 8188525 8188745 8189125 8189479 8189746 8188331 8188526 8188747 8189130 8189483 8189751 8188332 8188528 8188751 8189139 8189492 8189756 8188333 8188531 8188758 8189140 8189496 8189759 8188335 8188532 8188768 8189146 8189501 8189760 8188339 8188533 8188776 8189154 8189521 8189761 8188343 8188534 8188780 8189155 8189524 8189762 8188344 8188535 8188783 8189159 8189525 8189770 8188345 8188536 8188784 8189165 8189530 8189789 8188350 8188537 8188788 8189170 8189534 8189790 8188353 8188538 8188792 8189172 8189537 8189791 8188355 8188540 8188793 8189175 8189541 8189793 8188357 8188541 8188795 8189181 8189544 8189795 8188358 8188542 8188796 8189184 8189547 8189799 8188365 8188544 8188806 8189190 8189550 8189802 8188381 8188545 8188813 8189194 8189551 8189803 8188383 8188548 8188835 8189196 8189552 8189804 8188386 8188549 8188843 8189203 8189553 8189805 8188390 8188550 8188854 8189205 8189554 8189807 8188394 8188552 8188860 8189206 8189555 8189808 8188396 8188554 8188865 8189211 8189556 8189810 8188401 8188556 8188872 8189213 8189558 8189813 8188402 8188559 8188875 8189215 8189561 8189814 8188403 8188560 8188879 8189218 8189580 8189816 8188406 8188562 8188881 8189220 8189582 8189817 8188408 8188566 8188882 8189221 8189584 8189818 8188416 8188567 8188884 8189228 8189586 8189819 8188420 8188569 8188885 8189235 8189593 8189821 8188424 8188570 8188907 8189240 8189594 8189823 8188425 8188576 8188908 8189246 8189597 8189825 8188426 8188577 8188912 8189253 8189600 8189828 8188427 8188580 8188913 8189255 8189603 8189831 8188428 8188581 8188919 8189258 8189604 8189833 8188429 8188582 8188922 8189260 8189605 8189834 8188430 8188586 8188923 8189268 8189606 8189837 8188432 8188593 8188924 8189270 8189609 8189839 8188433 8188594 8188926 8189276 8189610 8189846 8188434 8188595 8188927 8189281 8189614 8189852 8188435 8188597 8188929 8189286 8189616 8189862 8188436 8188598 8188930 8189291 8189619 8189865 8188437 8188602 8188932 8189302 8189620 8189866 8188441 8188604 8188933 8189309 8189657 8189867 8188443 8188608 8188934 8189313 8189658 8189871 8188444 8188614 8188935 8189323 8189661 8189872 8188447 8188615 8188936 8189330 8189668 8189874 8188451 8188617 8188937 8189348 8189670 8189875 8188467 8188622 8188939 8189361 8189682 8189878 8188471 8188624 8188942 8189364 8189685 8189879 8188474 8188627 8188944 8189384 8189689 8189883 8188477 8188628 8188945 8189393 8189690 8189889
EXHIBIT B 54 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8189890 8190238 8190886 8191761 8193108 8194028 8189893 8190240 8190911 8191781 8193110 8194046 8189896 8190242 8190914 8191798 8193118 8194047 8189900 8190245 8190960 8191807 8193139 8194055 8189902 8190249 8190965 8191838 8193141 8194063 8189907 8190254 8190966 8191840 8193147 8194066 8189910 8190279 8190972 8191849 8193161 8194070 8189914 8190286 8191021 8191909 8193177 8194109 8189915 8190287 8191040 8191933 8193193 8194136 8189917 8190289 8191095 8191967 8193196 8194142 8189919 8190378 8191102 8191973 8193197 8194159 8189921 8190388 8191113 8191994 8193198 8194166 8189932 8190412 8191121 8192011 8193235 8194213 8189933 8190416 8191159 8192013 8193248 8194230 8189935 8190419 8191165 8192016 8193255 8194231 8189939 8190420 8191170 8192019 8193268 8194234 8189942 8190422 8191174 8192049 8193282 8194235 8189945 8190433 8191176 8192089 8193283 8194237 8189950 8190434 8191186 8192092 8193288 8194239 8189975 8190440 8191191 8192102 8193292 8194381 8189976 8190441 8191196 8192123 8193296 8194387 8189977 8190454 8191210 8192155 8193299 8194395 8189978 8190459 8191216 8192158 8193356 8194411 8189981 8190469 8191262 8192164 8193361 8194443 8189992 8190470 8191263 8192174 8193370 8194448 8190017 8190477 8191267 8192175 8193377 8194469 8190019 8190506 8191270 8192191 8193488 8194484 8190020 8190512 8191271 8192198 8193500 8194577 8190022 8190516 8191296 8192206 8193535 8194581 8190024 8190520 8191304 8192207 8193588 8194583 8190025 8190528 8191311 8192236 8193598 8194618 8190026 8190532 8191320 8192239 8193599 8194639 8190027 8190542 8191325 8192254 8193600 8194723 8190029 8190547 8191329 8192256 8193620 8194729 8190032 8190548 8191339 8192294 8193628 8194797 8190048 8190553 8191344 8192388 8193631 8194820 8190052 8190557 8191357 8192389 8193632 8194824 8190056 8190561 8191371 8192436 8193636 8194856 8190057 8190563 8191375 8192442 8193640 8195013 8190059 8190572 8191382 8192466 8193644 8195022 8190060 8190584 8191384 8192487 8193645 8195130 8190062 8190588 8191391 8192494 8193651 8195178 8190063 8190597 8191396 8192511 8193659 8195190 8190064 8190600 8191403 8192530 8193677 8195194 8190065 8190601 8191411 8192571 8193680 8195196 8190075 8190614 8191416 8192680 8193683 8195207 8190077 8190616 8191423 8192701 8193702 8195227 8190078 8190618 8191429 8192741 8193720 8195230 8190080 8190619 8191430 8192745 8193726 8195233 8190081 8190622 8191434 8192752 8193735 8195234 8190082 8190623 8191437 8192809 8193738 8195242 8190094 8190635 8191440 8192891 8193739 8195245 8190096 8190641 8191443 8192893 8193741 8195247 8190103 8190646 8191451 8192897 8193746 8195250 8190109 8190649 8191455 8192901 8193754 8195260 8190113 8190652 8191460 8192904 8193788 8195262 8190118 8190657 8191462 8192907 8193801 8195266 8190122 8190662 8191467 8192913 8193821 8195271 8190129 8190677 8191471 8193045 8193829 8195286 8190134 8190681 8191482 8193052 8193834 8195288 8190136 8190689 8191494 8193058 8193836 8195297 8190165 8190690 8191577 8193064 8193841 8195303 8190174 8190691 8191620 8193066 8193847 8195310 8190179 8190706 8191666 8193072 8193852 8195312 8190187 8190709 8191676 8193081 8193858 8195323 8190188 8190729 8191687 8193083 8193863 8195325 8190199 8190745 8191699 8193087 8193868 8195328 8190228 8190790 8191717 8193088 8193869 8195332 8190232 8190854 8191720 8193096 8193927 8195337 8190236 8190871 8191726 8193101 8194013 8195344
EXHIBIT B 55 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8195346 8195859 8196289 8196442 8196566 8196775 8195350 8195864 8196291 8196445 8196567 8196791 8195354 8195867 8196292 8196451 8196568 8196794 8195358 8195871 8196294 8196456 8196570 8196801 8195361 8195873 8196298 8196457 8196571 8196813 8195364 8195874 8196299 8196458 8196572 8196856 8195371 8195875 8196300 8196459 8196573 8196868 8195374 8195877 8196301 8196460 8196574 8196877 8195376 8195878 8196305 8196461 8196575 8196883 8195392 8195882 8196306 8196464 8196576 8196893 8195395 8195884 8196308 8196467 8196578 8196896 8195399 8195885 8196310 8196468 8196579 8196897 8195408 8195887 8196313 8196469 8196580 8196901 8195414 8195893 8196316 8196471 8196581 8196903 8195421 8195896 8196317 8196472 8196585 8196912 8195424 8195902 8196319 8196473 8196588 8196918 8195426 8195903 8196320 8196474 8196589 8196920 8195433 8195905 8196324 8196475 8196590 8196921 8195434 8195926 8196325 8196477 8196592 8196922 8195439 8195934 8196329 8196479 8196593 8196960 8195442 8195963 8196330 8196482 8196594 8196962 8195448 8195972 8196335 8196483 8196595 8196976 8195482 8195989 8196341 8196484 8196597 8196994 8195496 8195998 8196347 8196488 8196598 8197000 8195503 8196018 8196349 8196490 8196599 8197003 8195506 8196022 8196350 8196491 8196601 8197008 8195524 8196026 8196351 8196492 8196603 8197011 8195525 8196042 8196356 8196494 8196605 8197013 8195532 8196061 8196357 8196497 8196609 8197014 8195539 8196066 8196358 8196498 8196621 8197015 8195568 8196080 8196359 8196500 8196625 8197016 8195594 8196094 8196361 8196501 8196627 8197022 8195597 8196107 8196366 8196502 8196628 8197023 8195606 8196109 8196369 8196503 8196629 8197024 8195609 8196122 8196370 8196504 8196632 8197026 8195610 8196127 8196372 8196506 8196633 8197027 8195617 8196134 8196375 8196507 8196635 8197028 8195619 8196136 8196376 8196508 8196639 8197029 8195627 8196164 8196379 8196510 8196645 8197031 8195644 8196195 8196381 8196511 8196648 8197033 8195652 8196196 8196384 8196514 8196653 8197035 8195658 8196199 8196387 8196516 8196656 8197040 8195667 8196201 8196390 8196518 8196660 8197041 8195718 8196203 8196391 8196519 8196661 8197042 8195727 8196207 8196392 8196525 8196668 8197046 8195731 8196210 8196395 8196526 8196671 8197047 8195733 8196216 8196396 8196527 8196674 8197048 8195734 8196217 8196398 8196530 8196675 8197052 8195735 8196224 8196399 8196533 8196676 8197057 8195739 8196228 8196404 8196534 8196679 8197058 8195742 8196234 8196405 8196536 8196683 8197059 8195744 8196238 8196407 8196539 8196684 8197062 8195750 8196244 8196408 8196540 8196695 8197063 8195756 8196245 8196409 8196541 8196703 8197066 8195757 8196246 8196411 8196542 8196710 8197067 8195760 8196251 8196413 8196544 8196716 8197068 8195777 8196252 8196419 8196545 8196724 8197069 8195785 8196263 8196420 8196546 8196725 8197071 8195791 8196265 8196421 8196547 8196729 8197074 8195796 8196266 8196424 8196549 8196732 8197075 8195797 8196269 8196425 8196550 8196734 8197076 8195799 8196272 8196426 8196552 8196735 8197077 8195804 8196273 8196427 8196553 8196736 8197078 8195807 8196275 8196432 8196554 8196739 8197079 8195809 8196277 8196433 8196555 8196743 8197080 8195832 8196279 8196434 8196557 8196744 8197083 8195833 8196280 8196435 8196559 8196748 8197084 8195843 8196281 8196438 8196560 8196749 8197088 8195849 8196284 8196439 8196562 8196751 8197090 8195854 8196287 8196440 8196564 8196767 8197091
EXHIBIT B 56 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8197092 8197235 8197385 8197591 8197796 8198104 8197094 8197244 8197386 8197594 8197798 8198105 8197097 8197247 8197387 8197595 8197803 8198108 8197098 8197249 8197389 8197596 8197804 8198109 8197099 8197254 8197392 8197599 8197808 8198110 8197102 8197258 8197393 8197600 8197813 8198111 8197107 8197261 8197394 8197601 8197814 8198112 8197109 8197262 8197396 8197603 8197818 8198113 8197114 8197263 8197398 8197604 8197829 8198114 8197115 8197266 8197400 8197613 8197844 8198116 8197117 8197268 8197404 8197619 8197850 8198117 8197118 8197272 8197405 8197621 8197868 8198118 8197124 8197274 8197406 8197623 8197874 8198119 8197128 8197275 8197408 8197624 8197885 8198120 8197129 8197277 8197411 8197627 8197892 8198122 8197131 8197278 8197415 8197629 8197904 8198124 8197132 8197281 8197416 8197630 8197967 8198125 8197140 8197282 8197420 8197632 8197971 8198126 8197148 8197283 8197421 8197633 8197981 8198127 8197153 8197284 8197423 8197636 8197984 8198129 8197155 8197285 8197426 8197638 8197988 8198130 8197156 8197288 8197427 8197640 8197991 8198131 8197160 8197289 8197430 8197643 8197998 8198137 8197161 8197290 8197433 8197646 8198000 8198139 8197162 8197291 8197434 8197651 8198001 8198140 8197165 8197292 8197435 8197653 8198006 8198141 8197168 8197293 8197437 8197657 8198008 8198144 8197169 8197294 8197439 8197658 8198010 8198145 8197171 8197295 8197442 8197662 8198012 8198147 8197174 8197296 8197445 8197664 8198013 8198148 8197175 8197299 8197450 8197666 8198015 8198149 8197177 8197306 8197466 8197667 8198017 8198150 8197178 8197307 8197469 8197668 8198019 8198151 8197181 8197308 8197471 8197669 8198025 8198152 8197182 8197309 8197472 8197684 8198026 8198153 8197183 8197310 8197487 8197685 8198029 8198154 8197184 8197313 8197488 8197686 8198032 8198155 8197187 8197314 8197495 8197690 8198035 8198156 8197189 8197315 8197496 8197691 8198036 8198159 8197190 8197316 8197501 8197694 8198038 8198160 8197191 8197317 8197508 8197695 8198043 8198162 8197192 8197320 8197516 8197696 8198049 8198163 8197193 8197322 8197520 8197697 8198057 8198164 8197195 8197323 8197522 8197701 8198061 8198166 8197201 8197324 8197525 8197703 8198062 8198167 8197202 8197327 8197528 8197706 8198063 8198171 8197203 8197329 8197529 8197709 8198065 8198173 8197204 8197331 8197532 8197710 8198066 8198175 8197205 8197336 8197546 8197711 8198067 8198176 8197207 8197337 8197548 8197712 8198068 8198177 8197208 8197338 8197549 8197714 8198070 8198178 8197209 8197340 8197550 8197715 8198071 8198179 8197211 8197341 8197552 8197716 8198073 8198180 8197212 8197345 8197553 8197717 8198076 8198181 8197213 8197347 8197554 8197718 8198077 8198182 8197216 8197351 8197555 8197719 8198079 8198183 8197217 8197353 8197557 8197720 8198080 8198184 8197218 8197354 8197563 8197721 8198082 8198185 8197219 8197355 8197568 8197724 8198083 8198186 8197220 8197358 8197569 8197726 8198084 8198190 8197221 8197359 8197571 8197729 8198086 8198194 8197223 8197362 8197577 8197731 8198087 8198199 8197224 8197365 8197578 8197737 8198089 8198200 8197225 8197371 8197580 8197740 8198091 8198208 8197227 8197375 8197581 8197741 8198092 8198211 8197228 8197376 8197584 8197748 8198094 8198212 8197229 8197377 8197585 8197755 8198096 8198214 8197230 8197379 8197586 8197776 8198099 8198216 8197231 8197383 8197588 8197784 8198102 8198217 8197232 8197384 8197589 8197790 8198103 8198218
EXHIBIT B 57 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8198219 8198323 8198470 8198688 8198789 8198884 8198220 8198324 8198472 8198689 8198792 8198886 8198223 8198325 8198474 8198691 8198802 8198887 8198224 8198326 8198477 8198693 8198803 8198888 8198225 8198327 8198482 8198694 8198804 8198889 8198226 8198328 8198486 8198695 8198806 8198890 8198227 8198329 8198491 8198696 8198807 8198891 8198229 8198330 8198495 8198698 8198808 8198892 8198231 8198331 8198497 8198699 8198809 8198893 8198233 8198332 8198505 8198701 8198810 8198895 8198234 8198334 8198508 8198702 8198811 8198897 8198235 8198335 8198510 8198703 8198812 8198898 8198236 8198339 8198511 8198705 8198813 8198899 8198237 8198346 8198512 8198707 8198814 8198900 8198238 8198350 8198513 8198712 8198815 8198902 8198241 8198351 8198514 8198713 8198816 8198904 8198242 8198352 8198515 8198715 8198817 8198905 8198243 8198353 8198516 8198718 8198818 8198906 8198245 8198354 8198517 8198719 8198819 8198908 8198246 8198355 8198518 8198721 8198821 8198909 8198247 8198356 8198519 8198723 8198822 8198910 8198248 8198357 8198520 8198729 8198823 8198911 8198249 8198361 8198521 8198731 8198824 8198913 8198250 8198363 8198522 8198737 8198825 8198914 8198252 8198364 8198523 8198738 8198826 8198915 8198255 8198365 8198525 8198739 8198827 8198916 8198256 8198367 8198526 8198740 8198828 8198917 8198260 8198369 8198527 8198741 8198829 8198918 8198262 8198371 8198528 8198742 8198830 8198920 8198263 8198373 8198530 8198743 8198831 8198921 8198265 8198374 8198531 8198744 8198832 8198922 8198267 8198375 8198532 8198745 8198833 8198925 8198268 8198376 8198534 8198746 8198834 8198927 8198270 8198379 8198535 8198747 8198835 8198928 8198271 8198381 8198536 8198748 8198836 8198929 8198272 8198382 8198542 8198749 8198837 8198932 8198273 8198383 8198545 8198750 8198838 8198935 8198275 8198384 8198556 8198751 8198840 8198937 8198276 8198388 8198559 8198752 8198841 8198938 8198277 8198391 8198562 8198754 8198842 8198943 8198279 8198396 8198571 8198755 8198843 8198944 8198280 8198397 8198579 8198756 8198844 8198948 8198283 8198407 8198586 8198757 8198845 8198949 8198287 8198410 8198593 8198760 8198846 8198951 8198288 8198411 8198601 8198761 8198847 8198952 8198290 8198417 8198603 8198762 8198848 8198953 8198292 8198422 8198606 8198763 8198849 8198954 8198294 8198428 8198608 8198764 8198850 8198957 8198296 8198429 8198614 8198765 8198851 8198958 8198300 8198431 8198615 8198766 8198852 8198959 8198301 8198432 8198617 8198767 8198853 8198960 8198302 8198434 8198620 8198768 8198854 8198962 8198303 8198438 8198623 8198769 8198855 8198963 8198304 8198443 8198626 8198770 8198857 8198964 8198306 8198444 8198633 8198772 8198860 8198965 8198307 8198445 8198635 8198773 8198861 8198966 8198308 8198449 8198647 8198774 8198862 8198967 8198309 8198451 8198648 8198775 8198863 8198968 8198310 8198453 8198650 8198776 8198865 8198970 8198311 8198454 8198654 8198777 8198866 8198971 8198313 8198455 8198655 8198778 8198867 8198972 8198314 8198456 8198656 8198779 8198868 8198976 8198315 8198457 8198658 8198780 8198870 8198977 8198316 8198459 8198660 8198781 8198872 8198978 8198317 8198463 8198671 8198782 8198873 8198981 8198318 8198464 8198675 8198783 8198876 8198982 8198319 8198465 8198678 8198784 8198877 8198983 8198320 8198466 8198682 8198785 8198879 8198985 8198321 8198467 8198684 8198786 8198882 8198986 8198322 8198469 8198686 8198787 8198883 8198987
EXHIBIT B 58 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8198988 8199081 8199193 8199307 8199570 8199741 8198989 8199082 8199194 8199308 8199572 8199742 8198990 8199083 8199196 8199310 8199579 8199743 8198991 8199084 8199198 8199311 8199580 8199744 8198992 8199085 8199200 8199313 8199583 8199745 8198993 8199086 8199201 8199315 8199587 8199747 8198995 8199087 8199202 8199316 8199594 8199749 8198998 8199088 8199203 8199318 8199596 8199750 8198999 8199089 8199204 8199319 8199598 8199752 8199001 8199090 8199205 8199321 8199600 8199753 8199002 8199091 8199206 8199323 8199601 8199755 8199004 8199092 8199207 8199329 8199604 8199757 8199005 8199093 8199208 8199335 8199606 8199758 8199006 8199094 8199209 8199336 8199608 8199760 8199008 8199097 8199210 8199341 8199609 8199761 8199011 8199098 8199211 8199343 8199613 8199762 8199012 8199099 8199212 8199346 8199614 8199763 8199013 8199100 8199213 8199347 8199615 8199764 8199014 8199103 8199214 8199351 8199620 8199766 8199017 8199104 8199215 8199353 8199632 8199768 8199018 8199106 8199216 8199357 8199635 8199769 8199019 8199108 8199217 8199358 8199637 8199770 8199020 8199109 8199218 8199363 8199638 8199771 8199022 8199110 8199220 8199366 8199639 8199772 8199023 8199111 8199221 8199367 8199644 8199773 8199024 8199113 8199222 8199370 8199646 8199774 8199025 8199114 8199223 8199371 8199649 8199777 8199026 8199118 8199225 8199373 8199653 8199779 8199027 8199119 8199226 8199376 8199655 8199780 8199028 8199122 8199228 8199386 8199656 8199782 8199030 8199125 8199229 8199390 8199659 8199783 8199031 8199126 8199230 8199402 8199664 8199784 8199032 8199132 8199232 8199404 8199665 8199786 8199033 8199133 8199233 8199409 8199666 8199788 8199034 8199150 8199234 8199413 8199668 8199789 8199035 8199151 8199235 8199414 8199669 8199790 8199036 8199153 8199236 8199416 8199671 8199791 8199037 8199154 8199237 8199418 8199673 8199792 8199038 8199155 8199239 8199422 8199675 8199794 8199039 8199156 8199240 8199426 8199676 8199795 8199040 8199157 8199241 8199428 8199678 8199796 8199041 8199158 8199242 8199431 8199681 8199797 8199042 8199159 8199243 8199434 8199685 8199798 8199043 8199160 8199244 8199451 8199688 8199799 8199044 8199161 8199245 8199452 8199691 8199801 8199046 8199162 8199246 8199459 8199697 8199802 8199048 8199164 8199247 8199464 8199704 8199806 8199049 8199165 8199248 8199465 8199708 8199807 8199050 8199166 8199249 8199466 8199709 8199808 8199052 8199167 8199251 8199480 8199713 8199812 8199053 8199168 8199252 8199482 8199714 8199813 8199054 8199169 8199253 8199485 8199716 8199814 8199055 8199171 8199254 8199488 8199717 8199815 8199056 8199172 8199255 8199492 8199720 8199816 8199057 8199173 8199256 8199501 8199721 8199817 8199059 8199174 8199257 8199512 8199722 8199818 8199060 8199175 8199258 8199514 8199723 8199819 8199061 8199176 8199259 8199517 8199727 8199821 8199064 8199178 8199261 8199522 8199728 8199822 8199065 8199180 8199269 8199524 8199730 8199823 8199067 8199181 8199270 8199529 8199731 8199824 8199069 8199182 8199271 8199532 8199732 8199825 8199071 8199185 8199272 8199537 8199733 8199826 8199072 8199186 8199273 8199547 8199734 8199827 8199075 8199187 8199274 8199551 8199735 8199828 8199076 8199188 8199279 8199552 8199736 8199829 8199077 8199189 8199299 8199553 8199737 8199830 8199078 8199190 8199302 8199554 8199738 8199831 8199079 8199191 8199304 8199565 8199739 8199832 8199080 8199192 8199305 8199567 8199740 8199833
EXHIBIT B 59 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8199834 8199928 8200036 8200141 8200264 8200381 8199835 8199929 8200037 8200143 8200269 8200382 8199837 8199931 8200038 8200144 8200270 8200383 8199838 8199932 8200039 8200145 8200273 8200384 8199839 8199933 8200040 8200146 8200275 8200385 8199840 8199934 8200041 8200149 8200276 8200386 8199842 8199935 8200042 8200155 8200278 8200387 8199843 8199937 8200043 8200156 8200279 8200388 8199844 8199938 8200044 8200157 8200282 8200389 8199845 8199939 8200045 8200158 8200283 8200390 8199848 8199940 8200046 8200161 8200284 8200391 8199849 8199942 8200047 8200163 8200286 8200392 8199850 8199943 8200048 8200164 8200289 8200393 8199851 8199944 8200049 8200165 8200290 8200395 8199852 8199948 8200051 8200167 8200293 8200396 8199853 8199949 8200052 8200168 8200296 8200397 8199854 8199952 8200053 8200171 8200297 8200398 8199856 8199956 8200054 8200173 8200298 8200399 8199857 8199958 8200056 8200174 8200299 8200400 8199858 8199960 8200057 8200178 8200300 8200401 8199859 8199962 8200058 8200180 8200301 8200402 8199860 8199963 8200060 8200182 8200302 8200403 8199862 8199965 8200063 8200183 8200303 8200404 8199863 8199967 8200064 8200186 8200307 8200406 8199865 8199968 8200066 8200187 8200310 8200407 8199868 8199970 8200068 8200189 8200311 8200408 8199870 8199971 8200070 8200190 8200312 8200411 8199872 8199972 8200071 8200193 8200314 8200412 8199873 8199973 8200074 8200194 8200315 8200413 8199874 8199975 8200076 8200197 8200317 8200414 8199875 8199976 8200077 8200198 8200319 8200415 8199876 8199980 8200080 8200202 8200322 8200417 8199877 8199981 8200082 8200203 8200323 8200418 8199878 8199982 8200084 8200205 8200326 8200419 8199879 8199983 8200085 8200206 8200327 8200420 8199882 8199984 8200090 8200207 8200332 8200421 8199887 8199987 8200092 8200208 8200333 8200422 8199888 8199989 8200096 8200209 8200334 8200423 8199890 8199991 8200097 8200210 8200335 8200424 8199893 8199992 8200099 8200212 8200339 8200425 8199894 8199994 8200100 8200213 8200341 8200426 8199895 8199995 8200102 8200214 8200344 8200427 8199896 8199997 8200105 8200215 8200347 8200428 8199897 8199998 8200107 8200217 8200349 8200429 8199898 8199999 8200109 8200218 8200350 8200430 8199899 8200001 8200111 8200220 8200351 8200432 8199900 8200002 8200112 8200221 8200352 8200434 8199901 8200003 8200113 8200222 8200353 8200437 8199902 8200005 8200114 8200226 8200354 8200438 8199903 8200006 8200115 8200228 8200355 8200440 8199904 8200008 8200119 8200229 8200356 8200442 8199905 8200010 8200120 8200230 8200357 8200443 8199906 8200011 8200121 8200231 8200358 8200444 8199909 8200013 8200122 8200232 8200359 8200445 8199910 8200016 8200123 8200233 8200361 8200446 8199911 8200018 8200124 8200238 8200363 8200447 8199912 8200019 8200125 8200244 8200364 8200449 8199913 8200021 8200126 8200245 8200365 8200450 8199914 8200022 8200127 8200246 8200367 8200451 8199915 8200024 8200128 8200248 8200370 8200452 8199916 8200026 8200129 8200249 8200371 8200455 8199917 8200027 8200130 8200252 8200372 8200456 8199919 8200028 8200131 8200253 8200373 8200457 8199920 8200029 8200132 8200255 8200374 8200458 8199921 8200030 8200133 8200257 8200375 8200459 8199923 8200031 8200134 8200258 8200376 8200460 8199924 8200032 8200136 8200259 8200377 8200461 8199925 8200033 8200138 8200261 8200378 8200462 8199926 8200034 8200139 8200262 8200379 8200463 8199927 8200035 8200140 8200263 8200380 8200466
EXHIBIT B 60 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8200467 8200581 8200687 8200837 8200997 8201126 8200468 8200584 8200688 8200838 8200999 8201127 8200470 8200585 8200689 8200840 8201000 8201129 8200471 8200587 8200692 8200841 8201008 8201131 8200473 8200588 8200693 8200842 8201014 8201133 8200476 8200590 8200694 8200843 8201015 8201135 8200477 8200592 8200701 8200847 8201017 8201136 8200478 8200593 8200702 8200849 8201019 8201137 8200479 8200595 8200706 8200852 8201021 8201139 8200481 8200596 8200708 8200853 8201023 8201140 8200482 8200597 8200713 8200855 8201024 8201143 8200483 8200599 8200716 8200857 8201025 8201146 8200484 8200600 8200720 8200859 8201026 8201147 8200485 8200601 8200722 8200860 8201028 8201149 8200486 8200603 8200724 8200864 8201030 8201150 8200489 8200604 8200726 8200867 8201031 8201151 8200490 8200605 8200728 8200869 8201033 8201152 8200491 8200607 8200730 8200870 8201034 8201153 8200492 8200608 8200732 8200871 8201036 8201161 8200493 8200611 8200735 8200878 8201038 8201163 8200494 8200612 8200737 8200879 8201039 8201164 8200495 8200615 8200740 8200880 8201040 8201166 8200496 8200617 8200741 8200881 8201042 8201167 8200498 8200619 8200746 8200884 8201047 8201169 8200499 8200620 8200747 8200887 8201049 8201170 8200500 8200621 8200749 8200890 8201050 8201171 8200501 8200622 8200750 8200891 8201051 8201172 8200503 8200623 8200755 8200895 8201054 8201173 8200504 8200624 8200760 8200899 8201055 8201174 8200505 8200626 8200761 8200904 8201056 8201175 8200506 8200628 8200762 8200905 8201058 8201176 8200507 8200629 8200765 8200908 8201059 8201179 8200508 8200631 8200766 8200911 8201060 8201180 8200510 8200634 8200767 8200912 8201063 8201182 8200511 8200635 8200769 8200914 8201065 8201184 8200512 8200636 8200771 8200917 8201070 8201185 8200513 8200637 8200773 8200922 8201072 8201186 8200516 8200638 8200774 8200924 8201073 8201187 8200518 8200639 8200775 8200925 8201078 8201188 8200519 8200640 8200778 8200926 8201079 8201191 8200520 8200641 8200779 8200927 8201082 8201192 8200522 8200653 8200780 8200928 8201083 8201193 8200524 8200654 8200786 8200929 8201086 8201195 8200525 8200655 8200787 8200930 8201089 8201196 8200526 8200656 8200790 8200931 8201090 8201198 8200528 8200658 8200792 8200933 8201091 8201199 8200529 8200659 8200794 8200937 8201096 8201200 8200531 8200660 8200797 8200941 8201098 8201202 8200532 8200662 8200799 8200942 8201099 8201203 8200534 8200663 8200800 8200945 8201100 8201204 8200535 8200664 8200801 8200946 8201101 8201205 8200536 8200665 8200802 8200948 8201102 8201209 8200538 8200666 8200804 8200949 8201103 8201211 8200540 8200667 8200807 8200952 8201104 8201212 8200541 8200668 8200810 8200954 8201106 8201214 8200542 8200669 8200811 8200955 8201107 8201215 8200544 8200670 8200812 8200956 8201109 8201216 8200547 8200671 8200815 8200958 8201110 8201218 8200549 8200672 8200817 8200959 8201111 8201219 8200551 8200673 8200818 8200960 8201112 8201222 8200552 8200674 8200819 8200961 8201114 8201223 8200553 8200675 8200822 8200962 8201115 8201224 8200555 8200676 8200823 8200963 8201116 8201225 8200559 8200678 8200825 8200964 8201117 8201226 8200562 8200679 8200826 8200965 8201118 8201230 8200564 8200680 8200827 8200971 8201119 8201231 8200569 8200681 8200829 8200973 8201120 8201232 8200571 8200683 8200831 8200976 8201122 8201234 8200574 8200684 8200835 8200986 8201123 8201235 8200576 8200685 8200836 8200992 8201125 8201238
EXHIBIT B 61 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8201240 8201358 8201465 8201609 8201751 8201863 8201241 8201360 8201466 8201611 8201753 8201864 8201242 8201362 8201467 8201612 8201756 8201867 8201243 8201363 8201468 8201614 8201757 8201875 8201245 8201364 8201470 8201615 8201758 8201880 8201246 8201365 8201471 8201616 8201764 8201884 8201248 8201366 8201473 8201617 8201772 8201888 8201249 8201367 8201474 8201618 8201774 8201890 8201251 8201368 8201477 8201619 8201776 8201892 8201255 8201372 8201478 8201620 8201777 8201893 8201256 8201377 8201479 8201621 8201779 8201900 8201257 8201378 8201481 8201622 8201782 8201902 8201258 8201383 8201484 8201624 8201783 8201903 8201259 8201384 8201486 8201625 8201786 8201905 8201261 8201387 8201487 8201628 8201787 8201907 8201262 8201388 8201490 8201629 8201789 8201909 8201264 8201391 8201496 8201630 8201791 8201910 8201267 8201393 8201497 8201636 8201792 8201918 8201268 8201394 8201501 8201638 8201793 8201921 8201269 8201397 8201503 8201643 8201794 8201929 8201271 8201398 8201505 8201645 8201795 8201937 8201273 8201399 8201506 8201649 8201797 8201940 8201277 8201400 8201513 8201651 8201798 8201942 8201278 8201401 8201519 8201652 8201800 8201948 8201284 8201402 8201522 8201654 8201801 8201949 8201285 8201403 8201524 8201655 8201802 8201950 8201290 8201405 8201527 8201657 8201804 8201951 8201292 8201406 8201529 8201658 8201805 8201952 8201295 8201407 8201531 8201660 8201807 8201953 8201296 8201408 8201533 8201661 8201808 8201954 8201297 8201409 8201534 8201664 8201809 8201955 8201301 8201410 8201537 8201666 8201810 8201957 8201303 8201412 8201538 8201669 8201811 8201958 8201304 8201413 8201540 8201670 8201813 8201959 8201305 8201416 8201543 8201672 8201815 8201960 8201306 8201417 8201548 8201673 8201817 8201962 8201309 8201418 8201549 8201674 8201818 8201964 8201312 8201419 8201552 8201677 8201820 8201965 8201313 8201420 8201553 8201679 8201821 8201966 8201314 8201422 8201556 8201681 8201824 8201967 8201316 8201423 8201573 8201682 8201825 8201968 8201318 8201424 8201575 8201683 8201827 8201970 8201319 8201425 8201576 8201685 8201828 8201971 8201320 8201426 8201577 8201686 8201829 8201972 8201321 8201427 8201578 8201688 8201830 8201983 8201323 8201428 8201579 8201689 8201831 8201985 8201325 8201429 8201581 8201691 8201833 8201989 8201326 8201430 8201582 8201693 8201834 8201991 8201327 8201431 8201583 8201694 8201836 8201992 8201329 8201432 8201584 8201696 8201839 8201994 8201330 8201433 8201586 8201698 8201840 8201995 8201331 8201435 8201588 8201699 8201841 8201998 8201332 8201436 8201589 8201700 8201842 8202001 8201334 8201438 8201591 8201703 8201843 8202003 8201335 8201439 8201592 8201707 8201844 8202004 8201336 8201440 8201593 8201710 8201845 8202006 8201338 8201442 8201594 8201717 8201846 8202007 8201341 8201443 8201595 8201718 8201847 8202014 8201344 8201448 8201596 8201720 8201848 8202015 8201347 8201450 8201597 8201723 8201849 8202019 8201348 8201451 8201598 8201725 8201850 8202026 8201349 8201453 8201599 8201731 8201851 8202028 8201350 8201454 8201601 8201733 8201852 8202031 8201351 8201455 8201602 8201736 8201853 8202033 8201352 8201457 8201603 8201739 8201854 8202034 8201353 8201458 8201604 8201740 8201855 8202035 8201354 8201459 8201605 8201741 8201856 8202036 8201355 8201461 8201606 8201744 8201859 8202037 8201356 8201462 8201607 8201745 8201860 8202038 8201357 8201463 8201608 8201748 8201861 8202040
EXHIBIT B 62 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8202045 8202302 8202434 8202613 8202722 8202862 8202048 8202303 8202436 8202616 8202723 8202863 8202049 8202305 8202440 8202617 8202724 8202865 8202053 8202306 8202442 8202618 8202727 8202866 8202056 8202313 8202447 8202619 8202728 8202867 8202057 8202316 8202452 8202621 8202729 8202868 8202058 8202321 8202453 8202625 8202731 8202872 8202059 8202322 8202454 8202627 8202734 8202873 8202060 8202325 8202455 8202629 8202741 8202874 8202063 8202326 8202456 8202632 8202742 8202875 8202086 8202327 8202458 8202634 8202744 8202876 8202088 8202329 8202459 8202636 8202749 8202877 8202089 8202330 8202460 8202637 8202750 8202882 8202091 8202332 8202463 8202640 8202758 8202884 8202093 8202334 8202468 8202641 8202759 8202885 8202094 8202335 8202472 8202642 8202762 8202886 8202101 8202336 8202473 8202643 8202763 8202887 8202102 8202339 8202474 8202644 8202764 8202888 8202103 8202340 8202475 8202645 8202765 8202890 8202105 8202341 8202476 8202646 8202766 8202891 8202106 8202342 8202478 8202647 8202770 8202892 8202109 8202343 8202480 8202648 8202771 8202893 8202110 8202344 8202484 8202649 8202774 8202894 8202114 8202345 8202487 8202651 8202775 8202895 8202116 8202346 8202488 8202652 8202780 8202897 8202120 8202347 8202495 8202653 8202782 8202898 8202121 8202348 8202498 8202654 8202799 8202899 8202132 8202349 8202503 8202655 8202800 8202900 8202136 8202351 8202504 8202656 8202802 8202903 8202137 8202357 8202508 8202658 8202804 8202904 8202139 8202359 8202509 8202659 8202805 8202906 8202142 8202361 8202512 8202660 8202806 8202907 8202143 8202362 8202516 8202661 8202808 8202908 8202144 8202366 8202522 8202662 8202809 8202909 8202145 8202367 8202524 8202663 8202810 8202910 8202148 8202372 8202526 8202664 8202811 8202911 8202154 8202374 8202529 8202666 8202812 8202913 8202155 8202376 8202530 8202667 8202814 8202914 8202166 8202378 8202536 8202669 8202815 8202915 8202173 8202379 8202539 8202670 8202816 8202917 8202192 8202380 8202540 8202671 8202817 8202918 8202197 8202381 8202544 8202672 8202819 8202919 8202201 8202383 8202549 8202673 8202820 8202921 8202206 8202385 8202550 8202677 8202821 8202922 8202209 8202386 8202553 8202678 8202822 8202923 8202213 8202389 8202558 8202680 8202824 8202924 8202215 8202390 8202559 8202681 8202826 8202925 8202221 8202391 8202560 8202683 8202827 8202926 8202224 8202392 8202562 8202684 8202829 8202927 8202228 8202393 8202563 8202685 8202830 8202928 8202231 8202394 8202564 8202687 8202831 8202929 8202236 8202395 8202566 8202692 8202833 8202930 8202238 8202397 8202568 8202695 8202834 8202931 8202239 8202398 8202569 8202698 8202836 8202933 8202242 8202400 8202570 8202699 8202837 8202934 8202247 8202401 8202572 8202700 8202838 8202935 8202250 8202404 8202573 8202701 8202841 8202938 8202252 8202405 8202574 8202702 8202843 8202939 8202256 8202407 8202578 8202703 8202844 8202940 8202264 8202410 8202580 8202704 8202846 8202941 8202269 8202414 8202581 8202705 8202847 8202942 8202271 8202417 8202585 8202706 8202848 8202944 8202277 8202418 8202586 8202708 8202851 8202947 8202282 8202419 8202593 8202711 8202854 8202948 8202285 8202421 8202594 8202712 8202855 8202949 8202290 8202422 8202596 8202714 8202856 8202952 8202293 8202426 8202603 8202715 8202857 8202954 8202294 8202427 8202604 8202717 8202859 8202955 8202298 8202431 8202609 8202718 8202860 8202957 8202300 8202433 8202610 8202720 8202861 8202958
EXHIBIT B 63 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8202965 8203094 8203215 8203401 8203750 8203956 8202969 8203096 8203216 8203402 8203753 8203959 8202971 8203103 8203217 8203404 8203755 8203961 8202976 8203104 8203218 8203409 8203756 8203964 8202979 8203105 8203219 8203412 8203757 8203969 8202980 8203107 8203220 8203422 8203762 8203973 8202985 8203110 8203221 8203435 8203763 8203981 8202988 8203111 8203222 8203440 8203765 8203982 8202990 8203112 8203224 8203444 8203767 8203985 8202993 8203114 8203225 8203447 8203768 8203987 8202996 8203115 8203226 8203451 8203771 8203989 8202997 8203117 8203227 8203454 8203772 8203992 8203000 8203118 8203228 8203463 8203774 8203994 8203002 8203119 8203230 8203466 8203775 8203999 8203006 8203121 8203232 8203485 8203776 8204001 8203007 8203122 8203233 8203489 8203778 8204003 8203008 8203124 8203234 8203496 8203779 8204005 8203012 8203125 8203235 8203497 8203782 8204009 8203013 8203127 8203237 8203501 8203784 8204010 8203014 8203128 8203239 8203504 8203785 8204014 8203015 8203129 8203240 8203508 8203786 8204018 8203018 8203131 8203241 8203512 8203792 8204022 8203019 8203133 8203242 8203522 8203793 8204023 8203021 8203134 8203243 8203536 8203795 8204024 8203022 8203135 8203250 8203537 8203796 8204030 8203023 8203138 8203252 8203540 8203797 8204031 8203024 8203139 8203254 8203576 8203799 8204033 8203025 8203140 8203258 8203594 8203806 8204035 8203027 8203143 8203259 8203599 8203812 8204036 8203028 8203144 8203260 8203607 8203813 8204038 8203029 8203146 8203262 8203623 8203816 8204041 8203030 8203147 8203263 8203631 8203820 8204042 8203031 8203148 8203265 8203635 8203824 8204043 8203032 8203149 8203266 8203647 8203827 8204045 8203033 8203150 8203267 8203648 8203831 8204046 8203034 8203151 8203269 8203650 8203839 8204049 8203035 8203152 8203270 8203652 8203840 8204050 8203036 8203153 8203279 8203655 8203841 8204057 8203037 8203155 8203282 8203656 8203846 8204060 8203038 8203156 8203283 8203658 8203847 8204063 8203039 8203158 8203286 8203661 8203849 8204064 8203041 8203159 8203289 8203665 8203851 8204066 8203042 8203161 8203293 8203666 8203853 8204067 8203044 8203162 8203296 8203669 8203856 8204069 8203046 8203163 8203301 8203671 8203857 8204072 8203047 8203164 8203303 8203672 8203859 8204076 8203049 8203165 8203308 8203675 8203861 8204080 8203050 8203166 8203310 8203676 8203862 8204082 8203051 8203167 8203313 8203679 8203863 8204084 8203052 8203181 8203317 8203680 8203865 8204086 8203053 8203182 8203319 8203684 8203866 8204088 8203054 8203183 8203320 8203686 8203867 8204093 8203055 8203184 8203322 8203693 8203870 8204095 8203056 8203185 8203323 8203697 8203873 8204097 8203061 8203186 8203324 8203700 8203882 8204098 8203063 8203187 8203325 8203705 8203891 8204104 8203066 8203189 8203338 8203706 8203901 8204108 8203071 8203190 8203342 8203710 8203904 8204110 8203075 8203192 8203348 8203716 8203908 8204111 8203076 8203193 8203350 8203722 8203912 8204114 8203079 8203194 8203352 8203723 8203913 8204117 8203081 8203195 8203364 8203727 8203918 8204121 8203084 8203196 8203378 8203729 8203921 8204123 8203085 8203204 8203381 8203733 8203924 8204125 8203088 8203208 8203385 8203737 8203929 8204130 8203089 8203209 8203387 8203738 8203930 8204135 8203090 8203210 8203393 8203740 8203933 8204140 8203091 8203212 8203395 8203743 8203940 8204148 8203092 8203213 8203397 8203744 8203943 8204149 8203093 8203214 8203399 8203749 8203953 8204152
EXHIBIT B 64 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8204154 8204438 8204672 8204874 8205050 8205153 8204156 8204441 8204673 8204875 8205051 8205154 8204160 8204443 8204674 8204882 8205052 8205155 8204164 8204444 8204684 8204884 8205053 8205156 8204165 8204445 8204691 8204892 8205054 8205157 8204166 8204446 8204696 8204894 8205055 8205158 8204167 8204451 8204698 8204897 8205056 8205159 8204169 8204454 8204707 8204903 8205057 8205160 8204173 8204456 8204709 8204905 8205058 8205162 8204175 8204459 8204713 8204909 8205060 8205163 8204182 8204461 8204714 8204911 8205064 8205164 8204189 8204464 8204716 8204912 8205068 8205165 8204195 8204469 8204718 8204916 8205069 8205166 8204198 8204471 8204722 8204917 8205073 8205167 8204200 8204476 8204723 8204920 8205078 8205168 8204203 8204483 8204725 8204924 8205079 8205169 8204204 8204484 8204727 8204925 8205083 8205170 8204208 8204489 8204729 8204926 8205085 8205171 8204216 8204493 8204733 8204927 8205086 8205172 8204219 8204495 8204735 8204928 8205087 8205174 8204224 8204496 8204736 8204931 8205089 8205175 8204236 8204501 8204737 8204933 8205090 8205176 8204238 8204502 8204739 8204935 8205091 8205177 8204243 8204503 8204740 8204937 8205092 8205178 8204245 8204504 8204742 8204938 8205094 8205179 8204249 8204519 8204743 8204940 8205096 8205180 8204257 8204520 8204745 8204941 8205097 8205181 8204259 8204523 8204746 8204942 8205098 8205182 8204262 8204524 8204748 8204943 8205099 8205183 8204264 8204525 8204749 8204944 8205100 8205184 8204266 8204531 8204750 8204945 8205101 8205185 8204267 8204533 8204755 8204948 8205103 8205186 8204270 8204536 8204756 8204950 8205104 8205187 8204279 8204539 8204758 8204953 8205106 8205189 8204283 8204540 8204760 8204954 8205107 8205190 8204286 8204543 8204762 8204957 8205109 8205191 8204287 8204544 8204763 8204958 8205110 8205192 8204288 8204545 8204764 8204962 8205111 8205193 8204290 8204546 8204765 8204966 8205112 8205194 8204291 8204547 8204766 8204968 8205113 8205195 8204293 8204548 8204767 8204969 8205114 8205196 8204296 8204549 8204769 8204971 8205115 8205198 8204297 8204550 8204770 8204972 8205116 8205200 8204307 8204551 8204772 8204975 8205118 8205201 8204312 8204552 8204775 8204976 8205120 8205202 8204338 8204553 8204780 8204982 8205121 8205203 8204339 8204554 8204787 8204983 8205123 8205207 8204343 8204555 8204789 8204985 8205125 8205209 8204351 8204558 8204796 8204986 8205126 8205211 8204359 8204560 8204799 8204991 8205127 8205216 8204361 8204561 8204808 8204997 8205128 8205218 8204367 8204563 8204811 8205001 8205129 8205220 8204379 8204565 8204812 8205002 8205130 8205222 8204383 8204566 8204817 8205006 8205132 8205224 8204390 8204571 8204822 8205009 8205133 8205226 8204394 8204573 8204830 8205010 8205134 8205228 8204396 8204574 8204832 8205014 8205135 8205231 8204401 8204575 8204836 8205016 8205136 8205232 8204404 8204577 8204839 8205022 8205137 8205251 8204410 8204578 8204840 8205023 8205138 8205254 8204416 8204579 8204844 8205029 8205140 8205255 8204418 8204580 8204848 8205034 8205141 8205257 8204420 8204581 8204849 8205037 8205142 8205258 8204422 8204584 8204852 8205038 8205143 8205260 8204423 8204588 8204853 8205039 8205145 8205262 8204425 8204600 8204854 8205042 8205146 8205266 8204429 8204603 8204858 8205043 8205147 8205267 8204430 8204618 8204863 8205045 8205150 8205269 8204433 8204620 8204869 8205047 8205151 8205270 8204436 8204626 8204870 8205049 8205152 8205271
EXHIBIT B 65 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8205274 8205448 8205561 8205704 8205867 8206662 8205283 8205454 8205565 8205706 8205871 8206680 8205291 8205456 8205566 8205707 8205876 8206681 8205294 8205460 8205567 8205709 8205877 8206690 8205297 8205462 8205569 8205713 8205878 8206711 8205300 8205464 8205573 8205714 8205880 8206717 8205301 8205466 8205575 8205718 8205882 8206727 8205303 8205468 8205578 8205719 8205887 8206738 8205306 8205469 8205584 8205721 8205892 8206782 8205309 8205470 8205586 8205722 8205893 8206807 8205310 8205471 8205592 8205723 8205894 8206810 8205312 8205473 8205595 8205726 8205895 8206846 8205317 8205474 8205599 8205727 8205899 8206865 8205319 8205476 8205608 8205728 8205900 8206868 8205320 8205478 8205612 8205729 8205903 8206896 8205322 8205479 8205616 8205731 8205905 8206902 8205323 8205480 8205617 8205732 8205907 8207028 8205324 8205481 8205620 8205734 8205908 8207161 8205325 8205483 8205623 8205736 8205911 8207162 8205326 8205486 8205629 8205737 8205912 8207167 8205327 8205488 8205633 8205741 8205916 8207179 8205328 8205489 8205636 8205743 8205919 8207183 8205329 8205491 8205637 8205746 8205921 8207184 8205331 8205493 8205639 8205748 8205925 8207185 8205332 8205494 8205642 8205750 8205935 8207189 8205333 8205495 8205644 8205752 8206005 8207190 8205335 8205498 8205646 8205753 8206008 8207213 8205336 8205499 8205647 8205754 8206009 8207245 8205339 8205500 8205648 8205755 8206013 8207260 8205340 8205501 8205650 8205757 8206017 8207288 8205342 8205502 8205652 8205758 8206022 8207316 8205343 8205503 8205653 8205759 8206025 8207321 8205344 8205504 8205654 8205761 8206029 8207327 8205345 8205505 8205655 8205763 8206036 8207334 8205346 8205507 8205656 8205765 8206040 8207340 8205347 8205508 8205657 8205768 8206042 8207345 8205348 8205510 8205658 8205770 8206047 8207346 8205349 8205512 8205659 8205771 8206051 8207349 8205351 8205514 8205660 8205773 8206052 8207357 8205353 8205515 8205661 8205776 8206056 8207362 8205354 8205517 8205662 8205777 8206057 8207374 8205356 8205518 8205663 8205785 8206058 8207377 8205358 8205520 8205664 8205789 8206062 8207380 8205362 8205521 8205665 8205792 8206063 8207383 8205371 8205524 8205666 8205795 8206065 8207390 8205373 8205525 8205670 8205796 8206071 8207391 8205375 8205526 8205672 8205797 8206074 8207392 8205376 8205528 8205673 8205801 8206075 8207396 8205378 8205530 8205674 8205805 8206076 8207399 8205379 8205532 8205676 8205812 8206077 8207402 8205384 8205533 8205677 8205819 8206081 8207407 8205390 8205534 8205678 8205823 8206088 8207409 8205395 8205535 8205679 8205824 8206092 8207413 8205397 8205536 8205680 8205829 8206127 8207429 8205398 8205537 8205682 8205835 8206130 8207435 8205401 8205538 8205683 8205840 8206158 8207438 8205404 8205540 8205685 8205841 8206186 8207443 8205405 8205541 8205686 8205846 8206204 8207446 8205410 8205543 8205688 8205849 8206259 8207466 8205411 8205544 8205689 8205851 8206269 8207505 8205414 8205545 8205691 8205852 8206282 8207513 8205416 8205546 8205692 8205853 8206294 8207522 8205418 8205547 8205695 8205855 8206315 8207524 8205420 8205548 8205696 8205856 8206477 8207542 8205426 8205550 8205697 8205858 8206532 8207549 8205431 8205551 8205698 8205859 8206548 8207560 8205433 8205554 8205700 8205860 8206564 8207595 8205437 8205556 8205701 8205862 8206575 8207601 8205438 8205558 8205702 8205863 8206608 8207606 8205440 8205560 8205703 8205865 8206615 8207614
EXHIBIT B 66 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8207618 8207903 8208364 8208479 8208626 8208751 8207620 8207907 8208365 8208481 8208629 8208753 8207622 8207935 8208366 8208483 8208633 8208754 8207625 8207942 8208370 8208487 8208637 8208755 8207642 8207948 8208373 8208489 8208643 8208758 8207649 8207955 8208382 8208490 8208649 8208759 8207653 8207971 8208383 8208494 8208652 8208760 8207655 8207974 8208384 8208495 8208653 8208761 8207657 8207976 8208387 8208497 8208654 8208763 8207659 8207982 8208388 8208498 8208657 8208764 8207660 8207986 8208389 8208500 8208658 8208765 8207664 8207989 8208390 8208502 8208659 8208766 8207665 8207996 8208391 8208503 8208660 8208768 8207666 8208017 8208393 8208505 8208662 8208771 8207667 8208030 8208394 8208506 8208664 8208773 8207670 8208036 8208395 8208509 8208665 8208777 8207671 8208043 8208397 8208510 8208666 8208779 8207695 8208056 8208398 8208511 8208667 8208780 8207700 8208059 8208399 8208513 8208668 8208784 8207710 8208066 8208401 8208514 8208670 8208786 8207711 8208067 8208403 8208516 8208671 8208788 8207713 8208073 8208404 8208517 8208674 8208790 8207716 8208077 8208405 8208520 8208675 8208791 8207721 8208086 8208408 8208525 8208677 8208792 8207722 8208097 8208409 8208527 8208678 8208793 8207765 8208111 8208410 8208528 8208679 8208794 8207786 8208113 8208411 8208529 8208682 8208795 8207791 8208116 8208413 8208530 8208683 8208799 8207794 8208118 8208414 8208532 8208684 8208800 8207796 8208129 8208415 8208533 8208685 8208802 8207798 8208138 8208416 8208534 8208686 8208803 8207812 8208142 8208418 8208538 8208687 8208806 8207816 8208148 8208420 8208540 8208689 8208808 8207817 8208159 8208422 8208541 8208692 8208809 8207821 8208166 8208423 8208545 8208693 8208811 8207825 8208172 8208424 8208546 8208695 8208812 8207826 8208179 8208426 8208547 8208697 8208815 8207828 8208183 8208427 8208549 8208698 8208817 8207829 8208188 8208428 8208551 8208701 8208819 8207832 8208202 8208429 8208552 8208702 8208821 8207835 8208207 8208431 8208553 8208704 8208822 8207836 8208208 8208432 8208555 8208705 8208823 8207838 8208210 8208436 8208556 8208706 8208825 8207840 8208214 8208437 8208562 8208708 8208826 8207841 8208219 8208438 8208563 8208709 8208827 8207846 8208239 8208440 8208564 8208710 8208828 8207848 8208247 8208441 8208565 8208712 8208831 8207850 8208250 8208443 8208570 8208719 8208834 8207851 8208253 8208444 8208574 8208720 8208835 8207853 8208265 8208445 8208578 8208722 8208838 8207854 8208276 8208447 8208579 8208723 8208840 8207860 8208277 8208448 8208581 8208724 8208841 8207861 8208279 8208449 8208584 8208727 8208842 8207862 8208283 8208450 8208586 8208730 8208844 8207864 8208285 8208452 8208587 8208733 8208845 8207865 8208299 8208454 8208589 8208734 8208847 8207866 8208306 8208455 8208590 8208735 8208850 8207867 8208309 8208456 8208591 8208737 8208851 8207869 8208314 8208457 8208593 8208738 8208853 8207873 8208318 8208458 8208594 8208739 8208854 8207878 8208325 8208460 8208595 8208740 8208857 8207882 8208326 8208462 8208597 8208741 8208858 8207884 8208333 8208464 8208599 8208743 8208862 8207886 8208334 8208465 8208603 8208744 8208865 8207887 8208340 8208466 8208604 8208745 8208866 8207892 8208346 8208468 8208605 8208746 8208867 8207894 8208350 8208469 8208614 8208747 8208868 8207896 8208354 8208471 8208618 8208748 8208871 8207900 8208355 8208472 8208621 8208749 8208875 8207901 8208357 8208475 8208624 8208750 8208878
EXHIBIT B 67 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8208879 8209041 8209144 8209262 8209453 8209548 8208881 8209045 8209145 8209263 8209454 8209554 8208882 8209046 8209148 8209264 8209455 8209555 8208884 8209047 8209149 8209265 8209458 8209557 8208885 8209051 8209150 8209266 8209459 8209558 8208886 8209054 8209155 8209267 8209460 8209559 8208889 8209055 8209156 8209270 8209461 8209561 8208893 8209056 8209158 8209271 8209465 8209564 8208894 8209057 8209160 8209274 8209468 8209565 8208895 8209061 8209162 8209275 8209469 8209568 8208896 8209063 8209163 8209276 8209470 8209570 8208897 8209064 8209164 8209278 8209471 8209572 8208900 8209067 8209166 8209279 8209472 8209584 8208903 8209068 8209167 8209281 8209473 8209590 8208904 8209069 8209169 8209283 8209474 8209594 8208906 8209070 8209175 8209286 8209475 8209596 8208908 8209071 8209176 8209291 8209476 8209598 8208910 8209072 8209180 8209296 8209477 8209603 8208913 8209073 8209184 8209298 8209478 8209604 8208916 8209074 8209185 8209299 8209479 8209605 8208917 8209078 8209186 8209301 8209480 8209607 8208919 8209079 8209187 8209308 8209481 8209610 8208923 8209080 8209188 8209309 8209482 8209612 8208924 8209081 8209189 8209310 8209483 8209614 8208925 8209082 8209192 8209315 8209484 8209619 8208926 8209084 8209193 8209321 8209485 8209622 8208928 8209085 8209194 8209322 8209486 8209624 8208931 8209086 8209196 8209323 8209487 8209625 8208934 8209087 8209198 8209324 8209488 8209628 8208935 8209088 8209199 8209327 8209489 8209629 8208939 8209089 8209202 8209336 8209490 8209631 8208940 8209091 8209203 8209343 8209491 8209632 8208946 8209092 8209204 8209344 8209492 8209633 8208947 8209093 8209205 8209350 8209494 8209634 8208952 8209094 8209206 8209359 8209495 8209638 8208958 8209095 8209207 8209362 8209496 8209639 8208963 8209096 8209211 8209365 8209498 8209641 8208969 8209098 8209214 8209367 8209499 8209642 8208973 8209099 8209215 8209368 8209500 8209644 8208974 8209100 8209216 8209370 8209501 8209647 8208977 8209102 8209218 8209371 8209503 8209652 8208978 8209103 8209219 8209373 8209504 8209655 8208982 8209104 8209221 8209376 8209505 8209656 8208983 8209105 8209222 8209377 8209506 8209660 8208986 8209106 8209224 8209378 8209507 8209662 8208987 8209107 8209225 8209381 8209511 8209663 8208989 8209108 8209226 8209384 8209512 8209668 8208990 8209109 8209228 8209386 8209513 8209671 8208992 8209110 8209229 8209387 8209514 8209672 8208995 8209111 8209232 8209389 8209515 8209673 8208996 8209114 8209233 8209395 8209517 8209677 8208998 8209117 8209234 8209397 8209518 8209681 8208999 8209118 8209235 8209398 8209520 8209682 8209001 8209120 8209236 8209400 8209521 8209686 8209002 8209122 8209237 8209402 8209522 8209687 8209006 8209125 8209239 8209408 8209524 8209688 8209007 8209127 8209240 8209412 8209525 8209690 8209009 8209128 8209241 8209416 8209527 8209693 8209010 8209129 8209244 8209421 8209528 8209697 8209012 8209130 8209249 8209422 8209530 8209701 8209016 8209131 8209250 8209426 8209531 8209703 8209019 8209132 8209251 8209428 8209533 8209708 8209021 8209134 8209252 8209429 8209536 8209711 8209022 8209135 8209253 8209435 8209537 8209715 8209023 8209136 8209254 8209439 8209538 8209716 8209025 8209137 8209255 8209440 8209539 8209722 8209028 8209138 8209256 8209444 8209541 8209725 8209030 8209139 8209257 8209445 8209542 8209726 8209032 8209140 8209259 8209447 8209544 8209730 8209038 8209142 8209260 8209449 8209546 8209732
EXHIBIT B 68 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8209733 8209988 8210315 8210589 8210739 8210826 8209736 8209990 8210316 8210591 8210740 8210828 8209738 8209993 8210318 8210592 8210741 8210829 8209742 8209998 8210320 8210593 8210743 8210830 8209743 8210002 8210325 8210594 8210744 8210831 8209744 8210010 8210329 8210595 8210745 8210832 8209746 8210011 8210330 8210596 8210746 8210833 8209747 8210013 8210333 8210598 8210747 8210834 8209748 8210021 8210334 8210599 8210749 8210835 8209752 8210022 8210337 8210602 8210751 8210836 8209755 8210023 8210339 8210604 8210752 8210837 8209756 8210035 8210340 8210606 8210753 8210838 8209762 8210051 8210343 8210609 8210754 8210839 8209764 8210052 8210344 8210610 8210755 8210842 8209769 8210060 8210351 8210611 8210756 8210843 8209771 8210065 8210352 8210612 8210757 8210844 8209774 8210073 8210353 8210615 8210759 8210846 8209778 8210082 8210354 8210617 8210760 8210847 8209784 8210085 8210358 8210619 8210762 8210848 8209789 8210112 8210359 8210622 8210764 8210851 8209794 8210118 8210360 8210631 8210766 8210852 8209797 8210121 8210361 8210633 8210767 8210854 8209801 8210135 8210362 8210636 8210768 8210855 8209804 8210147 8210363 8210637 8210769 8210856 8209805 8210153 8210364 8210641 8210771 8210858 8209811 8210154 8210366 8210643 8210772 8210859 8209817 8210161 8210368 8210645 8210774 8210861 8209820 8210165 8210371 8210646 8210775 8210862 8209833 8210178 8210372 8210647 8210776 8210863 8209835 8210179 8210374 8210649 8210778 8210864 8209840 8210187 8210404 8210650 8210779 8210865 8209848 8210193 8210406 8210651 8210780 8210867 8209852 8210198 8210412 8210653 8210782 8210868 8209860 8210205 8210416 8210654 8210783 8210869 8209863 8210206 8210420 8210655 8210786 8210871 8209864 8210212 8210423 8210656 8210787 8210874 8209869 8210215 8210435 8210660 8210788 8210875 8209872 8210218 8210458 8210662 8210789 8210876 8209873 8210221 8210466 8210664 8210790 8210877 8209874 8210233 8210467 8210666 8210792 8210878 8209875 8210237 8210469 8210667 8210793 8210879 8209887 8210245 8210475 8210668 8210794 8210882 8209892 8210253 8210477 8210672 8210795 8210883 8209895 8210259 8210480 8210673 8210796 8210884 8209901 8210262 8210489 8210682 8210797 8210887 8209903 8210263 8210490 8210683 8210798 8210889 8209905 8210265 8210492 8210685 8210799 8210890 8209906 8210267 8210496 8210691 8210800 8210891 8209907 8210269 8210497 8210693 8210801 8210892 8209908 8210270 8210499 8210697 8210803 8210894 8209909 8210271 8210501 8210698 8210804 8210895 8209914 8210274 8210502 8210704 8210805 8210896 8209915 8210275 8210505 8210707 8210807 8210898 8209918 8210276 8210509 8210708 8210808 8210899 8209919 8210277 8210516 8210712 8210809 8210900 8209921 8210278 8210519 8210714 8210810 8210901 8209924 8210279 8210520 8210718 8210811 8210902 8209926 8210280 8210525 8210720 8210812 8210904 8209931 8210283 8210527 8210721 8210813 8210905 8209940 8210285 8210528 8210722 8210814 8210906 8209942 8210287 8210545 8210723 8210815 8210907 8209953 8210290 8210548 8210724 8210816 8210908 8209958 8210291 8210549 8210725 8210817 8210909 8209959 8210292 8210557 8210727 8210818 8210910 8209963 8210294 8210558 8210729 8210819 8210911 8209968 8210302 8210564 8210730 8210820 8210912 8209974 8210306 8210577 8210732 8210821 8210913 8209976 8210312 8210580 8210735 8210822 8210916 8209978 8210313 8210581 8210737 8210823 8210918 8209987 8210314 8210587 8210738 8210825 8210919
EXHIBIT B 69 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8210922 8211024 8211105 8211190 8211307 8211709 8210923 8211025 8211107 8211191 8211308 8211731 8210924 8211026 8211109 8211192 8211310 8211743 8210927 8211028 8211111 8211193 8211311 8211748 8210928 8211029 8211113 8211194 8211312 8211754 8210929 8211030 8211114 8211195 8211314 8211761 8210930 8211032 8211115 8211196 8211315 8211774 8210932 8211033 8211116 8211197 8211319 8211784 8210935 8211034 8211117 8211198 8211320 8211791 8210936 8211035 8211118 8211199 8211323 8211796 8210937 8211036 8211121 8211203 8211324 8211800 8210939 8211037 8211122 8211205 8211327 8211804 8210940 8211038 8211123 8211208 8211330 8211805 8210942 8211039 8211124 8211209 8211331 8211811 8210945 8211040 8211126 8211210 8211333 8211813 8210947 8211041 8211128 8211214 8211337 8211814 8210948 8211042 8211130 8211217 8211340 8211817 8210949 8211043 8211131 8211218 8211345 8211827 8210951 8211044 8211133 8211221 8211348 8211840 8210952 8211045 8211134 8211223 8211351 8211844 8210953 8211046 8211136 8211224 8211357 8211848 8210954 8211047 8211137 8211231 8211366 8211853 8210956 8211048 8211138 8211232 8211381 8211855 8210957 8211049 8211139 8211233 8211383 8211860 8210958 8211051 8211140 8211234 8211386 8211863 8210959 8211052 8211141 8211235 8211391 8211868 8210960 8211053 8211142 8211236 8211399 8211873 8210961 8211054 8211143 8211239 8211400 8211876 8210962 8211055 8211144 8211240 8211401 8211888 8210965 8211056 8211145 8211244 8211402 8211901 8210967 8211057 8211146 8211245 8211403 8211913 8210968 8211058 8211147 8211246 8211404 8211936 8210969 8211059 8211148 8211248 8211405 8211954 8210970 8211061 8211149 8211249 8211406 8211975 8210971 8211062 8211150 8211250 8211407 8211979 8210972 8211063 8211151 8211254 8211408 8211997 8210973 8211064 8211152 8211256 8211409 8212010 8210974 8211065 8211153 8211257 8211410 8212016 8210975 8211066 8211154 8211259 8211411 8212048 8210976 8211068 8211155 8211260 8211412 8212057 8210977 8211069 8211156 8211261 8211413 8212062 8210978 8211070 8211157 8211262 8211418 8212066 8210980 8211072 8211158 8211263 8211419 8212069 8210981 8211073 8211159 8211266 8211426 8212074 8210982 8211075 8211161 8211267 8211428 8212077 8210983 8211077 8211162 8211269 8211433 8212087 8210984 8211078 8211163 8211270 8211434 8212104 8210987 8211079 8211164 8211272 8211441 8212105 8210988 8211080 8211165 8211274 8211451 8212107 8210989 8211082 8211166 8211275 8211466 8212112 8210990 8211083 8211167 8211276 8211469 8212113 8210991 8211084 8211168 8211278 8211477 8212116 8210992 8211085 8211169 8211279 8211479 8212119 8210994 8211086 8211170 8211282 8211551 8212122 8210995 8211087 8211171 8211283 8211576 8212126 8210996 8211088 8211172 8211284 8211606 8212130 8210997 8211089 8211173 8211285 8211620 8212134 8210999 8211090 8211175 8211286 8211625 8212137 8211001 8211091 8211176 8211287 8211629 8212138 8211003 8211093 8211177 8211288 8211632 8212140 8211004 8211094 8211178 8211289 8211637 8212142 8211007 8211095 8211180 8211290 8211639 8212143 8211012 8211096 8211182 8211291 8211646 8212145 8211015 8211097 8211183 8211292 8211650 8212148 8211016 8211098 8211184 8211295 8211656 8212149 8211017 8211099 8211185 8211298 8211664 8212151 8211018 8211100 8211186 8211299 8211665 8212152 8211020 8211102 8211187 8211301 8211669 8212153 8211022 8211103 8211188 8211304 8211692 8212154 8211023 8211104 8211189 8211305 8211701 8212156
EXHIBIT B 70 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8212158 8212426 8212685 8212991 8213141 8213289 8212159 8212428 8212691 8212993 8213142 8213293 8212160 8212431 8212695 8212996 8213144 8213294 8212161 8212433 8212696 8213000 8213147 8213296 8212164 8212435 8212697 8213002 8213150 8213301 8212166 8212440 8212698 8213005 8213152 8213302 8212167 8212442 8212699 8213006 8213153 8213311 8212170 8212445 8212704 8213008 8213155 8213319 8212171 8212447 8212705 8213009 8213159 8213321 8212172 8212460 8212709 8213010 8213162 8213330 8212174 8212466 8212723 8213014 8213165 8213331 8212178 8212472 8212725 8213016 8213171 8213339 8212180 8212483 8212734 8213017 8213173 8213340 8212183 8212501 8212743 8213018 8213177 8213343 8212186 8212503 8212748 8213021 8213179 8213344 8212187 8212506 8212752 8213025 8213180 8213345 8212191 8212513 8212754 8213026 8213181 8213352 8212196 8212514 8212777 8213027 8213182 8213354 8212197 8212520 8212779 8213030 8213185 8213356 8212200 8212521 8212781 8213031 8213188 8213358 8212201 8212524 8212784 8213034 8213189 8213364 8212202 8212526 8212791 8213037 8213191 8213368 8212206 8212530 8212795 8213039 8213193 8213372 8212207 8212531 8212803 8213041 8213197 8213373 8212211 8212535 8212804 8213042 8213198 8213376 8212214 8212536 8212813 8213047 8213199 8213378 8212215 8212539 8212816 8213049 8213200 8213379 8212217 8212540 8212817 8213054 8213201 8213382 8212218 8212544 8212818 8213055 8213204 8213388 8212220 8212546 8212829 8213056 8213206 8213391 8212224 8212547 8212830 8213057 8213207 8213395 8212225 8212550 8212839 8213058 8213210 8213398 8212232 8212551 8212845 8213064 8213211 8213399 8212233 8212553 8212849 8213065 8213212 8213400 8212238 8212559 8212854 8213068 8213213 8213402 8212240 8212563 8212857 8213069 8213214 8213403 8212243 8212564 8212863 8213073 8213217 8213405 8212247 8212568 8212869 8213074 8213219 8213411 8212250 8212569 8212870 8213075 8213221 8213413 8212256 8212573 8212874 8213078 8213222 8213415 8212258 8212578 8212877 8213081 8213224 8213416 8212271 8212584 8212879 8213084 8213225 8213417 8212283 8212587 8212881 8213086 8213234 8213418 8212287 8212591 8212884 8213088 8213236 8213419 8212302 8212597 8212889 8213091 8213237 8213420 8212312 8212598 8212893 8213093 8213242 8213421 8212318 8212599 8212895 8213097 8213243 8213423 8212322 8212603 8212896 8213100 8213245 8213424 8212329 8212606 8212897 8213101 8213246 8213425 8212331 8212607 8212899 8213105 8213247 8213426 8212332 8212609 8212900 8213107 8213249 8213427 8212334 8212611 8212902 8213108 8213250 8213429 8212335 8212614 8212906 8213109 8213251 8213431 8212365 8212616 8212907 8213111 8213253 8213433 8212370 8212619 8212910 8213112 8213255 8213434 8212371 8212621 8212916 8213116 8213256 8213435 8212382 8212625 8212919 8213117 8213257 8213436 8212386 8212631 8212921 8213118 8213260 8213437 8212389 8212634 8212923 8213120 8213263 8213438 8212397 8212637 8212928 8213123 8213267 8213440 8212399 8212642 8212932 8213124 8213268 8213442 8212402 8212645 8212935 8213128 8213272 8213443 8212404 8212648 8212941 8213129 8213274 8213445 8212406 8212652 8212944 8213130 8213277 8213446 8212411 8212661 8212947 8213133 8213280 8213448 8212413 8212667 8212952 8213134 8213281 8213449 8212417 8212674 8212978 8213135 8213283 8213450 8212418 8212676 8212980 8213137 8213284 8213453 8212419 8212681 8212986 8213138 8213285 8213457 8212421 8212682 8212987 8213139 8213287 8213458
EXHIBIT B 71 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8213459 8213645 8213844 8214129 8214331 8214589 8213463 8213649 8213846 8214131 8214332 8214594 8213465 8213653 8213850 8214135 8214334 8214595 8213466 8213656 8213855 8214136 8214335 8214598 8213468 8213658 8213858 8214140 8214336 8214600 8213470 8213659 8213864 8214143 8214341 8214603 8213471 8213661 8213873 8214144 8214342 8214604 8213476 8213665 8213875 8214146 8214343 8214605 8213477 8213669 8213890 8214150 8214345 8214607 8213479 8213672 8213938 8214152 8214346 8214609 8213480 8213675 8213942 8214153 8214348 8214610 8213484 8213678 8213948 8214157 8214349 8214614 8213485 8213683 8213950 8214159 8214350 8214615 8213487 8213684 8213963 8214162 8214354 8214616 8213489 8213686 8213967 8214165 8214356 8214621 8213492 8213687 8213969 8214167 8214358 8214623 8213494 8213688 8213971 8214168 8214359 8214624 8213501 8213689 8213973 8214170 8214360 8214625 8213504 8213691 8213975 8214171 8214361 8214628 8213505 8213693 8213981 8214172 8214366 8214629 8213506 8213694 8213984 8214174 8214369 8214631 8213510 8213697 8213986 8214175 8214373 8214632 8213512 8213698 8213988 8214176 8214374 8214635 8213516 8213699 8213992 8214178 8214375 8214638 8213517 8213700 8213994 8214180 8214378 8214642 8213520 8213701 8213997 8214181 8214379 8214645 8213523 8213702 8214001 8214185 8214381 8214646 8213524 8213703 8214006 8214186 8214383 8214650 8213525 8213704 8214007 8214189 8214386 8214653 8213527 8213708 8214008 8214191 8214399 8214658 8213535 8213713 8214011 8214192 8214404 8214659 8213538 8213714 8214014 8214193 8214406 8214660 8213547 8213715 8214018 8214197 8214407 8214662 8213548 8213716 8214021 8214198 8214409 8214666 8213553 8213717 8214024 8214199 8214410 8214667 8213558 8213720 8214025 8214203 8214415 8214669 8213560 8213722 8214028 8214204 8214417 8214673 8213562 8213730 8214029 8214205 8214419 8214679 8213566 8213731 8214035 8214208 8214421 8214681 8213567 8213732 8214037 8214209 8214426 8214684 8213568 8213734 8214041 8214211 8214428 8214687 8213570 8213737 8214042 8214235 8214430 8214690 8213575 8213738 8214044 8214240 8214439 8214699 8213577 8213739 8214051 8214241 8214440 8214700 8213579 8213743 8214055 8214243 8214442 8214720 8213580 8213745 8214057 8214259 8214447 8214723 8213581 8213747 8214068 8214264 8214454 8214728 8213583 8213748 8214072 8214273 8214458 8214732 8213584 8213749 8214080 8214274 8214461 8214735 8213586 8213760 8214083 8214282 8214462 8214738 8213588 8213762 8214084 8214283 8214468 8214743 8213589 8213764 8214091 8214286 8214472 8214746 8213595 8213767 8214093 8214290 8214476 8214748 8213596 8213769 8214094 8214291 8214479 8214750 8213598 8213771 8214096 8214292 8214485 8214759 8213600 8213772 8214099 8214295 8214490 8214765 8213602 8213773 8214102 8214297 8214492 8214768 8213606 8213777 8214103 8214303 8214493 8214773 8213609 8213780 8214105 8214307 8214499 8214775 8213610 8213787 8214108 8214309 8214503 8214779 8213611 8213796 8214109 8214310 8214515 8214781 8213612 8213798 8214114 8214311 8214517 8214783 8213613 8213801 8214115 8214313 8214519 8214784 8213614 8213803 8214119 8214314 8214530 8214798 8213632 8213804 8214120 8214319 8214541 8214801 8213635 8213806 8214123 8214320 8214548 8214803 8213638 8213807 8214124 8214324 8214553 8214808 8213639 8213813 8214125 8214325 8214556 8214815 8213642 8213831 8214126 8214326 8214567 8214823 8213644 8213840 8214128 8214330 8214568 8214825
EXHIBIT B 72 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8214826 8215169 8215458 8215746 8216001 8216291 8214831 8215171 8215460 8215751 8216007 8216295 8214832 8215174 8215465 8215754 8216009 8216296 8214835 8215176 8215466 8215757 8216016 8216300 8214838 8215181 8215486 8215759 8216017 8216302 8214849 8215183 8215491 8215762 8216021 8216305 8214850 8215186 8215498 8215774 8216030 8216306 8214855 8215188 8215499 8215779 8216031 8216307 8214857 8215189 8215502 8215785 8216033 8216308 8214861 8215190 8215504 8215786 8216041 8216309 8214865 8215194 8215507 8215788 8216042 8216310 8214866 8215197 8215509 8215789 8216049 8216311 8214869 8215201 8215510 8215790 8216054 8216312 8214870 8215204 8215512 8215791 8216056 8216313 8214875 8215207 8215513 8215796 8216068 8216314 8214878 8215210 8215514 8215800 8216077 8216315 8214881 8215214 8215515 8215808 8216114 8216317 8214885 8215217 8215516 8215812 8216115 8216318 8214892 8215218 8215518 8215816 8216117 8216319 8214894 8215220 8215520 8215820 8216118 8216320 8214897 8215221 8215523 8215826 8216122 8216321 8214899 8215224 8215524 8215828 8216123 8216322 8214901 8215227 8215525 8215830 8216124 8216324 8214908 8215229 8215528 8215833 8216126 8216326 8214909 8215233 8215529 8215837 8216127 8216328 8214922 8215234 8215531 8215838 8216130 8216330 8214923 8215239 8215532 8215841 8216134 8216332 8214928 8215241 8215533 8215844 8216137 8216341 8214930 8215242 8215535 8215846 8216145 8216343 8214933 8215246 8215536 8215850 8216156 8216346 8214940 8215247 8215537 8215859 8216167 8216347 8214944 8215251 8215544 8215863 8216168 8216354 8214957 8215252 8215545 8215865 8216173 8216357 8214959 8215253 8215546 8215869 8216179 8216362 8214965 8215258 8215548 8215874 8216181 8216368 8214968 8215263 8215555 8215875 8216182 8216370 8214970 8215264 8215558 8215879 8216184 8216373 8214973 8215265 8215560 8215880 8216185 8216380 8214975 8215271 8215570 8215886 8216187 8216382 8214981 8215275 8215576 8215887 8216191 8216386 8214982 8215311 8215582 8215893 8216196 8216389 8214985 8215320 8215585 8215894 8216201 8216390 8214986 8215353 8215587 8215895 8216204 8216393 8214987 8215375 8215591 8215896 8216205 8216394 8214993 8215377 8215592 8215899 8216214 8216395 8214996 8215379 8215595 8215901 8216218 8216397 8215004 8215390 8215602 8215903 8216219 8216399 8215007 8215393 8215610 8215906 8216223 8216400 8215008 8215396 8215612 8215907 8216237 8216405 8215011 8215398 8215617 8215909 8216240 8216406 8215034 8215403 8215619 8215911 8216243 8216407 8215043 8215405 8215634 8215912 8216248 8216408 8215068 8215406 8215637 8215913 8216250 8216409 8215071 8215409 8215643 8215916 8216252 8216410 8215072 8215410 8215662 8215918 8216255 8216411 8215073 8215413 8215665 8215923 8216258 8216415 8215078 8215415 8215667 8215924 8216259 8216416 8215079 8215416 8215670 8215929 8216263 8216417 8215083 8215431 8215676 8215931 8216268 8216418 8215090 8215433 8215680 8215932 8216269 8216421 8215098 8215434 8215682 8215938 8216274 8216422 8215122 8215437 8215689 8215940 8216275 8216423 8215132 8215439 8215697 8215945 8216277 8216424 8215139 8215440 8215716 8215951 8216279 8216425 8215146 8215444 8215718 8215961 8216280 8216440 8215149 8215449 8215721 8215964 8216281 8216444 8215159 8215451 8215723 8215972 8216284 8216445 8215160 8215452 8215731 8215974 8216285 8216472 8215161 8215453 8215739 8215976 8216287 8216476 8215164 8215455 8215740 8216000 8216288 8216491
EXHIBIT B 73 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8216493 8216683 8216893 8217353 8217616 8218142 8216494 8216684 8216894 8217354 8217618 8218153 8216497 8216687 8216907 8217355 8217622 8218165 8216498 8216693 8216916 8217358 8217626 8218204 8216499 8216695 8216922 8217361 8217628 8218209 8216504 8216697 8216927 8217362 8217629 8218210 8216505 8216698 8216928 8217363 8217630 8218215 8216506 8216701 8216931 8217370 8217634 8218220 8216508 8216702 8216951 8217372 8217636 8218258 8216510 8216704 8216954 8217375 8217638 8218269 8216511 8216706 8216958 8217377 8217642 8218278 8216513 8216708 8216979 8217381 8217643 8218284 8216515 8216709 8217016 8217382 8217644 8218291 8216516 8216710 8217022 8217390 8217651 8218299 8216517 8216711 8217031 8217391 8217654 8218301 8216518 8216714 8217034 8217395 8217659 8218306 8216519 8216715 8217040 8217399 8217661 8218310 8216522 8216716 8217044 8217401 8217662 8218317 8216523 8216719 8217049 8217402 8217663 8218323 8216524 8216720 8217054 8217406 8217665 8218331 8216525 8216721 8217072 8217415 8217666 8218384 8216527 8216725 8217127 8217417 8217667 8218395 8216529 8216726 8217128 8217425 8217670 8218408 8216530 8216729 8217130 8217432 8217675 8218444 8216534 8216734 8217139 8217438 8217698 8218447 8216535 8216735 8217140 8217444 8217700 8218459 8216536 8216737 8217142 8217450 8217703 8218461 8216537 8216739 8217149 8217452 8217707 8218467 8216538 8216743 8217167 8217463 8217713 8218472 8216539 8216747 8217168 8217466 8217735 8218475 8216540 8216748 8217175 8217469 8217742 8218485 8216541 8216753 8217177 8217471 8217752 8218489 8216542 8216760 8217180 8217473 8217768 8218496 8216543 8216764 8217192 8217486 8217781 8218504 8216544 8216765 8217194 8217490 8217790 8218507 8216546 8216767 8217198 8217495 8217801 8218517 8216547 8216768 8217201 8217496 8217804 8218523 8216551 8216773 8217209 8217499 8217808 8218533 8216560 8216774 8217213 8217502 8217813 8218549 8216561 8216776 8217217 8217504 8217816 8218598 8216565 8216779 8217218 8217505 8217817 8218603 8216569 8216780 8217220 8217506 8217818 8218641 8216570 8216788 8217223 8217507 8217819 8218665 8216576 8216790 8217226 8217509 8217820 8218682 8216580 8216793 8217233 8217513 8217821 8218750 8216584 8216796 8217237 8217514 8217837 8218768 8216587 8216797 8217242 8217516 8217840 8218775 8216588 8216800 8217243 8217520 8217860 8218781 8216589 8216801 8217244 8217525 8217893 8218783 8216591 8216802 8217248 8217529 8217901 8218787 8216592 8216807 8217250 8217531 8217913 8218788 8216596 8216812 8217251 8217542 8217921 8218793 8216598 8216815 8217255 8217543 8217931 8218797 8216600 8216817 8217269 8217550 8217935 8218799 8216602 8216818 8217272 8217554 8217938 8218804 8216610 8216819 8217273 8217573 8217946 8218805 8216614 8216828 8217277 8217574 8217954 8218812 8216615 8216831 8217278 8217578 8217996 8218815 8216618 8216833 8217293 8217581 8217999 8218821 8216622 8216834 8217301 8217583 8218002 8218838 8216631 8216838 8217307 8217584 8218007 8218851 8216634 8216839 8217308 8217590 8218009 8218868 8216635 8216846 8217310 8217591 8218023 8218880 8216640 8216847 8217322 8217595 8218030 8218884 8216646 8216852 8217326 8217599 8218045 8218892 8216656 8216861 8217330 8217600 8218082 8218894 8216658 8216869 8217336 8217606 8218092 8218902 8216674 8216871 8217339 8217607 8218103 8218910 8216675 8216879 8217347 8217610 8218113 8218914 8216679 8216883 8217351 8217615 8218127 8218915
EXHIBIT B 74 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8218949 8219646 8220348 8220670 8220927 8221355 8218955 8219660 8220352 8220671 8220999 8221376 8218977 8219695 8220354 8220676 8221012 8221386 8218981 8219696 8220355 8220678 8221035 8221392 8218983 8219706 8220356 8220680 8221042 8221394 8218986 8219712 8220359 8220682 8221044 8221398 8218994 8219724 8220361 8220683 8221045 8221405 8219002 8219742 8220363 8220684 8221047 8221407 8219004 8219749 8220365 8220689 8221049 8221416 8219005 8219777 8220368 8220691 8221051 8221427 8219009 8219798 8220371 8220693 8221055 8221439 8219017 8219820 8220374 8220696 8221063 8221497 8219020 8219821 8220378 8220698 8221067 8221505 8219024 8219822 8220379 8220701 8221068 8221507 8219025 8219827 8220394 8220702 8221071 8221513 8219032 8219830 8220396 8220707 8221073 8221532 8219046 8219842 8220397 8220712 8221079 8221545 8219053 8219854 8220403 8220716 8221080 8221551 8219064 8219878 8220406 8220719 8221083 8221567 8219073 8219919 8220414 8220734 8221084 8221589 8219079 8219928 8220426 8220735 8221088 8221602 8219086 8219941 8220437 8220739 8221091 8221615 8219097 8219960 8220443 8220740 8221100 8221616 8219107 8219965 8220445 8220743 8221101 8221618 8219110 8219979 8220456 8220744 8221113 8221619 8219130 8219984 8220465 8220746 8221123 8221622 8219149 8220000 8220470 8220748 8221144 8221629 8219154 8220020 8220475 8220751 8221145 8221639 8219157 8220047 8220477 8220755 8221151 8221646 8219161 8220059 8220482 8220758 8221153 8221683 8219169 8220064 8220483 8220760 8221155 8221698 8219175 8220087 8220485 8220772 8221156 8221706 8219182 8220089 8220488 8220785 8221159 8221717 8219184 8220090 8220503 8220799 8221162 8221728 8219192 8220095 8220531 8220809 8221168 8221743 8219216 8220098 8220535 8220822 8221171 8221751 8219218 8220100 8220537 8220823 8221174 8221757 8219225 8220105 8220544 8220825 8221178 8221774 8219253 8220109 8220546 8220832 8221181 8221782 8219257 8220112 8220549 8220847 8221184 8221824 8219265 8220125 8220553 8220850 8221187 8221832 8219290 8220141 8220562 8220852 8221193 8221842 8219326 8220150 8220566 8220854 8221194 8221845 8219338 8220200 8220567 8220858 8221198 8221851 8219341 8220204 8220572 8220863 8221201 8221854 8219402 8220206 8220576 8220864 8221202 8221857 8219407 8220213 8220578 8220867 8221211 8221860 8219446 8220221 8220580 8220869 8221223 8221870 8219453 8220222 8220582 8220870 8221235 8221872 8219457 8220237 8220583 8220875 8221238 8221874 8219489 8220241 8220589 8220878 8221242 8221878 8219490 8220247 8220593 8220879 8221243 8221882 8219505 8220252 8220595 8220880 8221255 8221896 8219509 8220253 8220597 8220882 8221303 8221897 8219510 8220262 8220603 8220884 8221304 8221899 8219563 8220264 8220606 8220885 8221312 8221903 8219565 8220268 8220609 8220889 8221313 8221904 8219568 8220285 8220611 8220892 8221317 8221910 8219576 8220288 8220615 8220895 8221327 8221914 8219581 8220294 8220616 8220897 8221329 8221915 8219582 8220303 8220623 8220899 8221330 8221919 8219584 8220313 8220626 8220901 8221331 8221922 8219589 8220324 8220630 8220903 8221332 8221923 8219595 8220326 8220631 8220906 8221335 8221930 8219597 8220331 8220635 8220911 8221343 8221936 8219598 8220335 8220640 8220913 8221344 8221945 8219603 8220336 8220644 8220914 8221346 8221966 8219613 8220338 8220647 8220920 8221349 8221967 8219616 8220340 8220657 8220923 8221350 8221973 8219634 8220345 8220668 8220925 8221354 8221978
EXHIBIT B 75 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8221983 8222295 8222732 8223005 8223196 8223429 8221986 8222296 8222743 8223011 8223197 8223432 8221993 8222300 8222746 8223013 8223200 8223433 8221999 8222302 8222749 8223017 8223201 8223435 8222009 8222315 8222755 8223022 8223207 8223437 8222018 8222319 8222757 8223023 8223208 8223439 8222026 8222325 8222764 8223032 8223212 8223447 8222030 8222364 8222765 8223034 8223213 8223451 8222034 8222371 8222768 8223035 8223214 8223454 8222037 8222387 8222769 8223036 8223222 8223455 8222044 8222392 8222770 8223037 8223225 8223456 8222046 8222399 8222771 8223039 8223233 8223457 8222051 8222420 8222773 8223040 8223234 8223458 8222052 8222424 8222781 8223041 8223237 8223459 8222054 8222429 8222784 8223043 8223240 8223460 8222060 8222430 8222787 8223044 8223242 8223461 8222065 8222435 8222788 8223045 8223251 8223463 8222071 8222441 8222792 8223047 8223252 8223464 8222078 8222445 8222796 8223048 8223259 8223465 8222090 8222455 8222824 8223049 8223266 8223466 8222094 8222467 8222835 8223051 8223269 8223467 8222111 8222492 8222836 8223054 8223286 8223468 8222112 8222499 8222837 8223055 8223287 8223469 8222114 8222510 8222839 8223056 8223292 8223470 8222122 8222516 8222840 8223057 8223294 8223471 8222142 8222522 8222841 8223059 8223299 8223472 8222143 8222524 8222842 8223061 8223301 8223473 8222150 8222526 8222843 8223062 8223305 8223474 8222151 8222527 8222844 8223064 8223310 8223475 8222153 8222529 8222845 8223065 8223313 8223476 8222154 8222532 8222846 8223067 8223314 8223477 8222155 8222548 8222848 8223070 8223318 8223478 8222158 8222560 8222855 8223073 8223319 8223479 8222161 8222567 8222856 8223074 8223320 8223481 8222163 8222572 8222864 8223075 8223322 8223482 8222167 8222576 8222873 8223079 8223324 8223483 8222169 8222590 8222881 8223082 8223328 8223484 8222174 8222593 8222885 8223083 8223330 8223485 8222175 8222594 8222886 8223092 8223332 8223486 8222177 8222605 8222887 8223094 8223335 8223487 8222184 8222617 8222888 8223095 8223337 8223488 8222187 8222619 8222889 8223098 8223339 8223489 8222193 8222621 8222891 8223108 8223348 8223490 8222194 8222623 8222894 8223113 8223352 8223491 8222197 8222627 8222898 8223120 8223361 8223492 8222198 8222628 8222900 8223122 8223364 8223493 8222208 8222630 8222901 8223127 8223373 8223494 8222210 8222634 8222913 8223128 8223374 8223496 8222214 8222635 8222916 8223136 8223378 8223497 8222218 8222636 8222923 8223138 8223380 8223499 8222223 8222637 8222932 8223140 8223388 8223500 8222224 8222638 8222934 8223144 8223393 8223501 8222228 8222648 8222938 8223153 8223395 8223502 8222230 8222650 8222945 8223157 8223400 8223504 8222235 8222652 8222947 8223162 8223401 8223505 8222236 8222653 8222949 8223170 8223402 8223507 8222238 8222655 8222951 8223171 8223403 8223508 8222240 8222658 8222952 8223172 8223404 8223510 8222241 8222660 8222968 8223173 8223408 8223512 8222243 8222680 8222970 8223175 8223410 8223513 8222247 8222683 8222972 8223176 8223412 8223515 8222258 8222686 8222974 8223179 8223413 8223519 8222266 8222687 8222976 8223181 8223415 8223521 8222274 8222692 8222979 8223182 8223416 8223522 8222283 8222698 8222981 8223184 8223420 8223529 8222285 8222700 8222985 8223185 8223421 8223532 8222289 8222702 8222991 8223186 8223423 8223533 8222290 8222711 8222996 8223187 8223424 8223536 8222292 8222722 8222998 8223190 8223425 8223537 8222293 8222725 8223004 8223193 8223427 8223539
EXHIBIT B 76 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8223544 8223713 8224074 8224468 8225004 8225743 8223545 8223714 8224082 8224471 8225007 8225747 8223546 8223715 8224088 8224473 8225009 8225749 8223549 8223720 8224110 8224476 8225010 8225755 8223550 8223724 8224119 8224477 8225012 8225757 8223555 8223731 8224136 8224480 8225019 8225760 8223556 8223736 8224150 8224488 8225021 8225763 8223559 8223738 8224165 8224492 8225024 8225767 8223561 8223753 8224177 8224513 8225025 8225775 8223562 8223754 8224188 8224514 8225029 8225801 8223564 8223758 8224212 8224515 8225037 8225810 8223565 8223762 8224222 8224519 8225039 8225815 8223568 8223769 8224224 8224520 8225045 8225818 8223571 8223772 8224234 8224539 8225046 8225822 8223573 8223777 8224244 8224541 8225049 8225849 8223574 8223794 8224257 8224561 8225053 8225854 8223576 8223797 8224271 8224578 8225056 8225857 8223577 8223802 8224274 8224583 8225059 8225859 8223579 8223805 8224276 8224603 8225093 8225862 8223583 8223827 8224280 8224604 8225154 8225865 8223584 8223828 8224283 8224612 8225167 8225867 8223585 8223850 8224286 8224616 8225170 8225877 8223590 8223862 8224288 8224617 8225191 8225887 8223594 8223871 8224290 8224625 8225198 8225901 8223599 8223879 8224291 8224626 8225201 8225917 8223609 8223887 8224293 8224645 8225202 8225919 8223610 8223894 8224298 8224654 8225203 8225921 8223611 8223897 8224300 8224666 8225204 8225924 8223613 8223900 8224303 8224690 8225247 8225925 8223619 8223903 8224307 8224692 8225272 8225930 8223622 8223906 8224309 8224695 8225278 8225932 8223623 8223911 8224311 8224704 8225281 8225935 8223626 8223913 8224314 8224709 8225290 8225940 8223627 8223924 8224315 8224727 8225305 8225954 8223628 8223930 8224317 8224729 8225310 8225958 8223629 8223935 8224321 8224732 8225314 8225971 8223630 8223937 8224324 8224736 8225321 8225973 8223635 8223938 8224325 8224744 8225326 8225977 8223637 8223940 8224327 8224747 8225367 8225978 8223639 8223942 8224329 8224790 8225384 8225979 8223641 8223944 8224331 8224828 8225438 8225981 8223643 8223951 8224336 8224852 8225456 8225982 8223646 8223955 8224339 8224861 8225472 8225983 8223647 8223960 8224341 8224864 8225474 8225988 8223648 8223965 8224345 8224872 8225477 8225989 8223654 8223967 8224348 8224881 8225480 8225992 8223656 8223972 8224350 8224882 8225483 8225994 8223661 8223974 8224351 8224884 8225491 8226004 8223664 8223977 8224353 8224887 8225495 8226013 8223665 8223987 8224357 8224891 8225513 8226016 8223667 8223988 8224359 8224894 8225524 8226025 8223668 8224001 8224360 8224901 8225530 8226028 8223671 8224010 8224361 8224902 8225542 8226030 8223674 8224015 8224365 8224915 8225554 8226037 8223676 8224023 8224366 8224923 8225559 8226042 8223678 8224024 8224375 8224931 8225569 8226043 8223682 8224026 8224376 8224932 8225574 8226053 8223683 8224028 8224379 8224934 8225580 8226056 8223685 8224029 8224382 8224937 8225603 8226065 8223686 8224034 8224387 8224944 8225605 8226068 8223687 8224036 8224389 8224948 8225624 8226072 8223688 8224038 8224394 8224951 8225626 8226088 8223690 8224040 8224400 8224954 8225634 8226093 8223695 8224042 8224403 8224972 8225690 8226096 8223700 8224047 8224427 8224986 8225697 8226102 8223701 8224052 8224453 8224991 8225704 8226108 8223702 8224054 8224460 8224995 8225730 8226138 8223707 8224059 8224463 8224997 8225736 8226155 8223709 8224061 8224464 8225000 8225737 8226178 8223710 8224062 8224465 8225003 8225742 8226231
EXHIBIT B 77 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8226248 8226826 8227308 8227722 8228043 8228399 8226335 8226833 8227313 8227727 8228046 8228404 8226350 8226844 8227327 8227729 8228057 8228406 8226353 8226849 8227338 8227743 8228061 8228408 8226358 8226862 8227339 8227744 8228065 8228411 8226385 8226869 8227346 8227750 8228066 8228415 8226398 8226880 8227350 8227755 8228072 8228433 8226407 8226887 8227355 8227765 8228073 8228457 8226447 8226896 8227359 8227768 8228075 8228458 8226464 8226897 8227362 8227771 8228076 8228460 8226477 8226913 8227365 8227774 8228078 8228464 8226492 8226927 8227372 8227778 8228083 8228474 8226498 8226935 8227374 8227781 8228089 8228477 8226515 8226936 8227386 8227784 8228091 8228480 8226531 8226958 8227392 8227785 8228093 8228482 8226542 8226962 8227396 8227787 8228095 8228499 8226545 8226967 8227402 8227794 8228098 8228524 8226550 8226969 8227403 8227802 8228103 8228537 8226565 8226980 8227407 8227803 8228104 8228545 8226568 8226982 8227408 8227804 8228109 8228549 8226576 8226983 8227416 8227810 8228113 8228557 8226579 8226987 8227417 8227811 8228135 8228559 8226580 8226990 8227418 8227827 8228139 8228569 8226583 8227013 8227421 8227831 8228144 8228581 8226586 8227016 8227426 8227834 8228145 8228585 8226591 8227020 8227437 8227840 8228147 8228590 8226592 8227040 8227438 8227844 8228174 8228591 8226596 8227073 8227447 8227845 8228177 8228599 8226664 8227076 8227449 8227847 8228181 8228601 8226684 8227080 8227482 8227853 8228191 8228605 8226687 8227087 8227499 8227860 8228198 8228611 8226691 8227090 8227502 8227863 8228200 8228613 8226692 8227093 8227510 8227865 8228207 8228614 8226699 8227101 8227543 8227873 8228212 8228615 8226700 8227113 8227545 8227878 8228218 8228625 8226701 8227119 8227557 8227881 8228222 8228629 8226703 8227124 8227558 8227882 8228224 8228633 8226706 8227132 8227561 8227883 8228226 8228635 8226711 8227142 8227562 8227894 8228227 8228639 8226712 8227144 8227565 8227897 8228229 8228640 8226714 8227151 8227576 8227900 8228232 8228642 8226716 8227160 8227578 8227901 8228235 8228646 8226719 8227162 8227582 8227912 8228239 8228659 8226724 8227165 8227586 8227913 8228243 8228663 8226726 8227170 8227590 8227924 8228244 8228671 8226727 8227189 8227594 8227925 8228250 8228678 8226728 8227191 8227598 8227932 8228252 8228724 8226735 8227210 8227600 8227933 8228259 8228727 8226737 8227217 8227622 8227934 8228260 8228737 8226738 8227221 8227624 8227935 8228262 8228739 8226742 8227223 8227630 8227941 8228270 8228746 8226743 8227226 8227638 8227948 8228275 8228763 8226745 8227229 8227640 8227952 8228276 8228771 8226747 8227230 8227643 8227954 8228285 8228775 8226760 8227236 8227645 8227958 8228288 8228789 8226764 8227254 8227652 8227962 8228289 8228806 8226769 8227255 8227658 8227964 8228293 8228810 8226781 8227256 8227660 8227971 8228312 8228812 8226788 8227259 8227681 8227977 8228318 8228827 8226794 8227265 8227683 8227979 8228320 8228829 8226795 8227266 8227687 8227982 8228322 8228844 8226799 8227272 8227691 8227990 8228326 8228848 8226801 8227276 8227696 8227991 8228335 8228861 8226805 8227282 8227698 8227998 8228336 8228864 8226806 8227286 8227705 8228000 8228361 8228866 8226807 8227292 8227709 8228002 8228366 8228868 8226809 8227293 8227710 8228020 8228368 8228875 8226810 8227295 8227711 8228022 8228382 8228876 8226812 8227298 8227719 8228026 8228387 8228878 8226822 8227301 8227720 8228039 8228394 8228881
EXHIBIT B 78 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8228891 8229128 8229484 8229799 8230163 8230669 8228894 8229130 8229488 8229808 8230165 8230671 8228897 8229131 8229490 8229810 8230168 8230672 8228899 8229132 8229499 8229814 8230170 8230674 8228900 8229133 8229506 8229821 8230173 8230675 8228901 8229135 8229520 8229822 8230185 8230676 8228908 8229142 8229521 8229826 8230187 8230678 8228912 8229143 8229522 8229827 8230196 8230679 8228913 8229149 8229523 8229833 8230199 8230682 8228916 8229155 8229527 8229844 8230200 8230689 8228930 8229159 8229530 8229852 8230201 8230690 8228933 8229160 8229539 8229853 8230204 8230707 8228935 8229179 8229542 8229857 8230279 8230715 8228937 8229182 8229544 8229858 8230282 8230725 8228939 8229183 8229546 8229862 8230287 8230730 8228940 8229198 8229547 8229871 8230291 8230732 8228960 8229199 8229556 8229872 8230298 8230734 8228968 8229205 8229558 8229875 8230299 8230736 8228969 8229213 8229563 8229877 8230314 8230738 8228970 8229218 8229567 8229886 8230333 8230759 8228977 8229233 8229572 8229887 8230335 8230773 8228982 8229243 8229573 8229897 8230337 8230790 8228984 8229253 8229576 8229899 8230343 8230793 8228986 8229260 8229581 8229912 8230346 8230795 8228993 8229272 8229582 8229916 8230348 8230798 8228995 8229274 8229586 8229917 8230356 8230802 8229003 8229282 8229587 8229926 8230358 8230817 8229005 8229290 8229588 8229938 8230359 8230830 8229013 8229296 8229591 8229943 8230360 8230832 8229015 8229298 8229593 8229945 8230368 8230835 8229025 8229303 8229594 8229952 8230375 8230840 8229030 8229307 8229596 8229959 8230380 8230841 8229034 8229315 8229598 8229967 8230384 8230843 8229036 8229322 8229602 8229975 8230388 8230848 8229041 8229344 8229603 8229981 8230397 8230850 8229042 8229350 8229604 8229982 8230402 8230852 8229045 8229365 8229609 8229989 8230411 8230857 8229052 8229372 8229610 8229990 8230415 8230860 8229054 8229384 8229611 8229991 8230423 8230867 8229061 8229386 8229617 8229994 8230431 8230883 8229066 8229400 8229621 8229997 8230445 8230892 8229067 8229403 8229636 8229999 8230446 8230896 8229072 8229407 8229638 8230001 8230450 8230901 8229075 8229409 8229646 8230006 8230455 8230905 8229076 8229410 8229650 8230012 8230461 8230906 8229078 8229414 8229660 8230013 8230469 8230913 8229079 8229418 8229673 8230018 8230481 8230920 8229084 8229419 8229677 8230023 8230493 8230928 8229086 8229420 8229687 8230035 8230494 8230937 8229087 8229428 8229688 8230112 8230530 8230939 8229088 8229431 8229699 8230115 8230537 8230943 8229090 8229435 8229703 8230120 8230541 8230944 8229091 8229445 8229705 8230121 8230545 8230959 8229095 8229447 8229707 8230122 8230548 8230961 8229097 8229448 8229712 8230123 8230563 8230965 8229098 8229450 8229714 8230124 8230580 8230967 8229100 8229451 8229716 8230125 8230587 8230968 8229101 8229456 8229721 8230129 8230595 8230973 8229103 8229457 8229725 8230130 8230598 8230976 8229107 8229459 8229727 8230132 8230613 8230978 8229109 8229462 8229733 8230137 8230614 8230982 8229110 8229465 8229738 8230138 8230616 8230984 8229115 8229470 8229753 8230142 8230621 8230987 8229118 8229471 8229763 8230145 8230630 8230988 8229119 8229472 8229764 8230146 8230632 8230989 8229121 8229475 8229769 8230148 8230643 8230990 8229122 8229476 8229779 8230149 8230648 8230992 8229123 8229478 8229787 8230153 8230652 8230993 8229124 8229479 8229792 8230158 8230658 8230998 8229125 8229483 8229797 8230160 8230668 8231001
EXHIBIT B 79 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8231014 8231341 8231513 8231760 8231959 8232204 8231016 8231345 8231515 8231766 8231960 8232216 8231023 8231348 8231518 8231769 8231962 8232229 8231028 8231350 8231519 8231772 8231964 8232232 8231036 8231352 8231520 8231773 8231968 8232233 8231037 8231355 8231521 8231779 8231969 8232238 8231039 8231359 8231522 8231785 8231970 8232239 8231047 8231360 8231523 8231792 8231972 8232248 8231051 8231361 8231530 8231793 8231976 8232249 8231054 8231363 8231531 8231796 8231977 8232252 8231058 8231368 8231532 8231798 8231980 8232259 8231066 8231369 8231534 8231802 8231982 8232267 8231068 8231370 8231536 8231806 8231983 8232270 8231070 8231371 8231544 8231808 8231985 8232271 8231073 8231372 8231547 8231811 8231987 8232272 8231077 8231373 8231550 8231824 8231991 8232277 8231079 8231375 8231556 8231839 8231992 8232280 8231080 8231376 8231562 8231840 8231993 8232284 8231088 8231377 8231567 8231843 8231994 8232290 8231090 8231379 8231568 8231844 8231996 8232296 8231092 8231382 8231573 8231848 8231997 8232297 8231093 8231383 8231583 8231849 8232005 8232300 8231095 8231388 8231594 8231855 8232006 8232301 8231096 8231389 8231596 8231856 8232007 8232310 8231104 8231390 8231597 8231861 8232010 8232318 8231111 8231404 8231618 8231862 8232025 8232321 8231113 8231409 8231627 8231865 8232031 8232335 8231117 8231410 8231629 8231868 8232035 8232337 8231119 8231411 8231632 8231869 8232036 8232339 8231122 8231412 8231636 8231873 8232038 8232342 8231128 8231413 8231652 8231875 8232043 8232347 8231131 8231414 8231659 8231876 8232057 8232361 8231139 8231415 8231661 8231877 8232061 8232362 8231144 8231421 8231662 8231881 8232067 8232364 8231150 8231422 8231665 8231882 8232073 8232368 8231161 8231427 8231667 8231887 8232078 8232369 8231178 8231431 8231669 8231889 8232079 8232370 8231184 8231433 8231671 8231892 8232083 8232371 8231193 8231438 8231673 8231893 8232091 8232378 8231208 8231442 8231674 8231895 8232092 8232381 8231212 8231445 8231677 8231898 8232094 8232385 8231221 8231447 8231679 8231900 8232097 8232388 8231225 8231448 8231680 8231905 8232100 8232390 8231226 8231450 8231682 8231907 8232103 8232392 8231235 8231455 8231683 8231911 8232105 8232400 8231244 8231456 8231686 8231913 8232108 8232403 8231246 8231458 8231688 8231914 8232116 8232406 8231247 8231461 8231690 8231915 8232120 8232418 8231255 8231467 8231691 8231916 8232126 8232421 8231256 8231468 8231693 8231918 8232128 8232423 8231261 8231471 8231694 8231920 8232129 8232435 8231269 8231474 8231695 8231922 8232134 8232443 8231271 8231477 8231698 8231924 8232136 8232449 8231277 8231479 8231700 8231925 8232137 8232457 8231278 8231480 8231702 8231927 8232140 8232460 8231279 8231482 8231703 8231929 8232141 8232477 8231281 8231484 8231705 8231934 8232149 8232482 8231283 8231485 8231706 8231935 8232150 8232492 8231293 8231487 8231707 8231936 8232152 8232494 8231297 8231489 8231708 8231939 8232155 8232521 8231304 8231490 8231710 8231940 8232167 8232528 8231306 8231491 8231711 8231944 8232171 8232535 8231308 8231497 8231715 8231947 8232174 8232544 8231314 8231499 8231718 8231948 8232177 8232545 8231316 8231502 8231721 8231953 8232182 8232550 8231325 8231504 8231724 8231954 8232184 8232553 8231326 8231507 8231728 8231955 8232187 8232555 8231330 8231510 8231730 8231956 8232188 8232558 8231332 8231511 8231737 8231957 8232196 8232559 8231337 8231512 8231741 8231958 8232202 8232563
EXHIBIT B 80 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8232568 8232818 8233589 8234453 8235047 8235579 8232570 8232821 8233593 8234457 8235048 8235594 8232579 8232822 8233615 8234458 8235055 8235598 8232585 8232823 8233617 8234464 8235057 8235599 8232589 8232825 8233618 8234483 8235061 8235604 8232592 8232831 8233623 8234488 8235062 8235608 8232600 8232834 8233626 8234491 8235063 8235612 8232602 8232835 8233632 8234492 8235064 8235619 8232603 8232837 8233644 8234531 8235070 8235622 8232606 8232839 8233648 8234548 8235071 8235626 8232607 8232840 8233649 8234552 8235084 8235633 8232609 8232843 8233659 8234554 8235108 8235637 8232610 8232848 8233666 8234556 8235113 8235645 8232613 8232849 8233668 8234557 8235128 8235647 8232615 8232852 8233675 8234558 8235138 8235653 8232616 8232855 8233681 8234559 8235151 8235655 8232617 8232863 8233702 8234560 8235155 8235670 8232623 8232866 8233706 8234561 8235168 8235672 8232632 8232867 8233707 8234562 8235183 8235676 8232641 8232874 8233715 8234563 8235185 8235685 8232642 8232875 8233722 8234564 8235203 8235688 8232644 8232878 8233730 8234565 8235210 8235693 8232646 8232883 8233732 8234566 8235216 8235698 8232649 8232885 8233741 8234572 8235218 8235710 8232651 8232887 8233745 8234573 8235219 8235718 8232653 8232891 8233759 8234575 8235230 8235719 8232658 8232894 8233765 8234583 8235234 8235725 8232661 8232920 8233768 8234589 8235237 8235727 8232664 8232932 8233778 8234590 8235241 8235730 8232667 8232952 8233782 8234593 8235251 8235737 8232669 8232973 8233783 8234619 8235253 8235739 8232675 8232976 8233784 8234624 8235260 8235744 8232685 8232978 8233789 8234625 8235266 8235745 8232686 8233000 8233792 8234626 8235272 8235746 8232692 8233006 8233796 8234631 8235278 8235747 8232703 8233014 8233800 8234634 8235305 8235750 8232706 8233030 8233803 8234636 8235312 8235751 8232713 8233040 8233804 8234650 8235319 8235753 8232723 8233092 8233806 8234719 8235322 8235754 8232725 8233165 8233818 8234733 8235328 8235757 8232730 8233307 8233819 8234743 8235335 8235760 8232735 8233341 8233883 8234753 8235341 8235761 8232744 8233356 8233898 8234754 8235350 8235764 8232748 8233359 8233948 8234780 8235351 8235765 8232759 8233361 8233953 8234781 8235371 8235766 8232761 8233363 8233959 8234786 8235373 8235767 8232763 8233368 8233971 8234791 8235377 8235768 8232767 8233370 8233979 8234820 8235382 8235772 8232769 8233379 8234010 8234827 8235397 8235775 8232770 8233380 8234040 8234839 8235402 8235779 8232771 8233381 8234068 8234847 8235408 8235784 8232773 8233383 8234094 8234857 8235418 8235792 8232774 8233387 8234191 8234861 8235437 8235794 8232779 8233390 8234234 8234906 8235438 8235795 8232781 8233395 8234235 8234915 8235442 8235797 8232783 8233396 8234256 8234922 8235448 8235800 8232784 8233455 8234271 8234947 8235454 8235802 8232787 8233463 8234276 8234967 8235459 8235803 8232791 8233466 8234277 8234970 8235467 8235806 8232794 8233470 8234304 8234986 8235489 8235809 8232795 8233472 8234319 8234992 8235494 8235813 8232802 8233475 8234331 8235001 8235516 8235814 8232804 8233484 8234349 8235002 8235524 8235816 8232805 8233502 8234353 8235006 8235529 8235818 8232806 8233534 8234355 8235010 8235539 8235820 8232807 8233551 8234362 8235020 8235550 8235826 8232809 8233555 8234379 8235023 8235558 8235831 8232811 8233557 8234398 8235039 8235559 8235832 8232812 8233559 8234419 8235043 8235567 8235834 8232813 8233563 8234428 8235046 8235577 8235835
EXHIBIT B 81 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8235836 8236302 8236803 8237206 8237439 8237796 8235839 8236304 8236804 8237208 8237450 8237797 8235846 8236309 8236822 8237210 8237472 8237803 8235849 8236316 8236832 8237215 8237493 8237804 8235851 8236322 8236837 8237220 8237501 8237805 8235855 8236323 8236839 8237223 8237504 8237807 8235862 8236325 8236840 8237225 8237509 8237811 8235863 8236326 8236856 8237226 8237523 8237812 8235867 8236330 8236871 8237228 8237530 8237813 8235868 8236335 8236874 8237230 8237535 8237815 8235871 8236337 8236880 8237233 8237542 8237816 8235877 8236344 8236892 8237234 8237551 8237817 8235880 8236345 8236895 8237235 8237556 8237820 8235885 8236348 8236904 8237237 8237558 8237822 8235905 8236350 8236910 8237239 8237560 8237827 8235906 8236351 8236927 8237241 8237568 8237830 8235917 8236355 8236932 8237243 8237570 8237831 8235942 8236357 8236949 8237244 8237571 8237834 8235956 8236365 8236983 8237245 8237572 8237844 8235973 8236380 8236984 8237247 8237575 8237845 8235978 8236390 8236994 8237250 8237577 8237846 8235990 8236396 8236995 8237251 8237582 8237852 8236000 8236414 8237000 8237253 8237589 8237857 8236012 8236419 8237004 8237254 8237593 8237865 8236013 8236441 8237013 8237256 8237604 8237873 8236018 8236445 8237017 8237258 8237605 8237875 8236025 8236447 8237033 8237259 8237607 8237882 8236051 8236452 8237036 8237261 8237608 8237884 8236065 8236461 8237038 8237263 8237614 8237888 8236080 8236463 8237043 8237275 8237616 8237896 8236084 8236470 8237048 8237278 8237621 8237898 8236098 8236475 8237053 8237282 8237623 8237904 8236103 8236486 8237060 8237284 8237624 8237905 8236104 8236498 8237061 8237287 8237633 8237908 8236114 8236500 8237071 8237291 8237634 8237915 8236115 8236506 8237072 8237292 8237636 8237916 8236117 8236509 8237073 8237302 8237638 8237926 8236129 8236516 8237079 8237305 8237648 8237927 8236130 8236531 8237080 8237315 8237653 8237928 8236135 8236534 8237082 8237316 8237654 8237930 8236136 8236536 8237093 8237320 8237664 8237931 8236146 8236543 8237096 8237322 8237667 8237932 8236147 8236551 8237098 8237323 8237671 8237942 8236153 8236553 8237099 8237326 8237675 8237948 8236166 8236565 8237103 8237329 8237676 8237950 8236171 8236568 8237104 8237335 8237677 8237955 8236180 8236577 8237109 8237339 8237680 8237957 8236182 8236584 8237112 8237340 8237685 8237959 8236184 8236586 8237118 8237354 8237690 8237960 8236196 8236589 8237119 8237357 8237691 8237964 8236198 8236597 8237124 8237363 8237693 8237966 8236206 8236599 8237130 8237366 8237694 8237967 8236214 8236603 8237132 8237372 8237701 8237969 8236216 8236611 8237138 8237378 8237708 8237974 8236219 8236627 8237142 8237385 8237713 8237980 8236230 8236629 8237148 8237387 8237714 8237988 8236231 8236638 8237151 8237394 8237727 8237996 8236241 8236646 8237155 8237398 8237735 8238008 8236244 8236655 8237159 8237401 8237764 8238009 8236247 8236694 8237164 8237403 8237772 8238018 8236253 8236708 8237169 8237404 8237773 8238021 8236257 8236736 8237171 8237417 8237777 8238022 8236274 8236741 8237172 8237418 8237778 8238028 8236277 8236746 8237182 8237419 8237779 8238029 8236282 8236754 8237190 8237424 8237785 8238039 8236286 8236758 8237193 8237430 8237786 8238040 8236290 8236776 8237194 8237434 8237787 8238046 8236294 8236780 8237195 8237435 8237788 8238049 8236295 8236781 8237196 8237436 8237790 8238050 8236301 8236795 8237205 8237437 8237793 8238051
EXHIBIT B 82 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8238052 8238685 8239247 8239742 8240079 8240369 8238055 8238718 8239252 8239754 8240082 8240372 8238059 8238719 8239271 8239761 8240084 8240374 8238061 8238728 8239277 8239763 8240092 8240380 8238064 8238730 8239285 8239767 8240093 8240389 8238065 8238736 8239291 8239768 8240094 8240392 8238066 8238743 8239301 8239769 8240122 8240398 8238069 8238744 8239303 8239775 8240125 8240405 8238073 8238760 8239306 8239776 8240128 8240407 8238083 8238767 8239330 8239783 8240139 8240410 8238093 8238778 8239336 8239784 8240148 8240411 8238095 8238780 8239339 8239790 8240157 8240412 8238097 8238786 8239354 8239792 8240170 8240415 8238099 8238787 8239356 8239794 8240174 8240419 8238102 8238802 8239358 8239796 8240189 8240422 8238104 8238803 8239374 8239799 8240193 8240433 8238106 8238806 8239377 8239801 8240195 8240436 8238113 8238814 8239386 8239804 8240203 8240441 8238138 8238822 8239391 8239806 8240210 8240445 8238140 8238830 8239393 8239808 8240217 8240446 8238143 8238831 8239403 8239809 8240219 8240448 8238146 8238836 8239404 8239810 8240222 8240451 8238216 8238839 8239413 8239812 8240224 8240452 8238227 8238855 8239423 8239815 8240225 8240453 8238241 8238856 8239428 8239820 8240229 8240456 8238257 8238859 8239431 8239824 8240233 8240462 8238261 8238865 8239443 8239828 8240235 8240463 8238265 8238879 8239444 8239844 8240236 8240465 8238276 8238889 8239446 8239854 8240239 8240466 8238288 8238897 8239455 8239855 8240240 8240467 8238297 8238901 8239459 8239878 8240244 8240473 8238301 8238902 8239468 8239884 8240245 8240475 8238305 8238908 8239481 8239888 8240250 8240476 8238319 8238910 8239485 8239928 8240252 8240484 8238340 8238913 8239486 8239941 8240253 8240485 8238342 8238920 8239495 8239943 8240254 8240486 8238349 8238923 8239504 8239949 8240266 8240490 8238350 8238928 8239508 8239956 8240268 8240491 8238365 8238930 8239511 8239957 8240269 8240494 8238368 8238933 8239516 8239958 8240279 8240499 8238372 8238937 8239523 8239964 8240283 8240504 8238377 8238938 8239525 8239970 8240284 8240505 8238382 8238942 8239528 8239971 8240285 8240507 8238383 8238944 8239530 8239975 8240293 8240515 8238384 8238945 8239540 8239980 8240294 8240517 8238391 8238965 8239547 8239983 8240295 8240518 8238414 8238967 8239548 8239991 8240301 8240520 8238421 8238971 8239550 8239994 8240305 8240528 8238427 8239003 8239566 8240003 8240308 8240530 8238470 8239011 8239594 8240010 8240310 8240532 8238506 8239041 8239599 8240014 8240313 8240541 8238516 8239049 8239601 8240026 8240316 8240545 8238527 8239057 8239613 8240029 8240317 8240548 8238528 8239069 8239619 8240031 8240318 8240550 8238532 8239071 8239620 8240034 8240321 8240552 8238536 8239073 8239621 8240039 8240322 8240558 8238538 8239088 8239640 8240040 8240325 8240560 8238552 8239102 8239646 8240042 8240327 8240563 8238555 8239110 8239664 8240044 8240329 8240564 8238558 8239121 8239665 8240049 8240337 8240565 8238561 8239129 8239669 8240050 8240338 8240566 8238570 8239142 8239679 8240051 8240339 8240568 8238582 8239149 8239706 8240053 8240341 8240569 8238614 8239157 8239708 8240054 8240344 8240576 8238617 8239172 8239714 8240056 8240345 8240578 8238635 8239185 8239715 8240059 8240351 8240580 8238640 8239226 8239719 8240063 8240353 8240583 8238668 8239227 8239720 8240071 8240357 8240586 8238678 8239233 8239737 8240074 8240358 8240587 8238679 8239246 8239741 8240077 8240364 8240589
EXHIBIT B 83 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8240592 8240833 8241197 8241570 8241815 8242067 8240593 8240836 8241207 8241572 8241818 8242069 8240604 8240846 8241214 8241573 8241821 8242071 8240608 8240847 8241215 8241576 8241828 8242075 8240609 8240852 8241227 8241581 8241830 8242076 8240611 8240856 8241243 8241583 8241833 8242077 8240613 8240877 8241258 8241584 8241837 8242078 8240618 8240883 8241261 8241585 8241839 8242079 8240621 8240889 8241276 8241586 8241840 8242081 8240633 8240893 8241277 8241592 8241842 8242082 8240635 8240896 8241286 8241594 8241843 8242089 8240645 8240902 8241289 8241596 8241844 8242091 8240646 8240903 8241292 8241600 8241847 8242093 8240647 8240910 8241293 8241609 8241851 8242094 8240648 8240916 8241295 8241611 8241860 8242096 8240650 8240918 8241297 8241613 8241866 8242097 8240651 8240920 8241301 8241614 8241867 8242100 8240653 8240921 8241304 8241617 8241869 8242102 8240655 8240923 8241308 8241619 8241871 8242103 8240656 8240924 8241320 8241621 8241878 8242106 8240657 8240925 8241327 8241624 8241880 8242107 8240658 8240926 8241329 8241628 8241887 8242109 8240659 8240927 8241335 8241629 8241888 8242111 8240660 8240929 8241338 8241630 8241889 8242113 8240663 8240935 8241341 8241632 8241893 8242115 8240664 8240936 8241347 8241637 8241898 8242121 8240666 8240937 8241360 8241639 8241904 8242128 8240667 8240940 8241367 8241645 8241905 8242131 8240668 8240964 8241373 8241648 8241909 8242135 8240669 8240968 8241375 8241652 8241913 8242136 8240670 8240973 8241379 8241658 8241919 8242140 8240671 8240974 8241381 8241659 8241920 8242142 8240673 8240979 8241384 8241660 8241924 8242146 8240674 8240981 8241390 8241661 8241927 8242148 8240676 8240983 8241391 8241665 8241929 8242150 8240677 8240986 8241397 8241669 8241932 8242153 8240679 8240987 8241404 8241671 8241938 8242154 8240683 8240991 8241414 8241675 8241940 8242159 8240688 8240995 8241419 8241676 8241958 8242161 8240696 8241004 8241438 8241678 8241959 8242164 8240704 8241006 8241448 8241680 8241961 8242167 8240709 8241015 8241451 8241684 8241962 8242168 8240727 8241017 8241473 8241685 8241963 8242173 8240736 8241019 8241480 8241688 8241966 8242174 8240738 8241024 8241490 8241693 8241974 8242176 8240755 8241026 8241498 8241699 8241975 8242180 8240758 8241032 8241500 8241705 8241981 8242185 8240759 8241033 8241503 8241720 8241996 8242191 8240761 8241036 8241505 8241724 8242002 8242196 8240762 8241038 8241506 8241729 8242007 8242200 8240763 8241043 8241508 8241734 8242010 8242216 8240765 8241044 8241509 8241735 8242013 8242233 8240771 8241046 8241511 8241741 8242019 8242235 8240774 8241050 8241512 8241748 8242023 8242239 8240776 8241052 8241515 8241763 8242030 8242274 8240778 8241062 8241518 8241768 8242034 8242291 8240781 8241066 8241520 8241769 8242036 8242296 8240782 8241079 8241522 8241783 8242037 8242331 8240784 8241081 8241525 8241785 8242038 8242336 8240790 8241102 8241526 8241789 8242042 8242345 8240791 8241104 8241532 8241792 8242045 8242350 8240792 8241123 8241536 8241795 8242048 8242374 8240795 8241132 8241537 8241799 8242049 8242391 8240797 8241136 8241538 8241800 8242051 8242394 8240799 8241137 8241541 8241803 8242056 8242399 8240801 8241140 8241545 8241804 8242058 8242411 8240810 8241156 8241552 8241806 8242059 8242414 8240823 8241157 8241555 8241810 8242060 8242418 8240826 8241172 8241564 8241811 8242061 8242428 8240827 8241183 8241569 8241814 8242063 8242432
EXHIBIT B 84 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8242434 8242827 8243237 8243717 8244336 8244787 8242446 8242847 8243238 8243738 8244344 8244791 8242447 8242852 8243247 8243754 8244370 8244795 8242448 8242860 8243251 8243757 8244375 8244804 8242451 8242879 8243262 8243766 8244383 8244820 8242455 8242884 8243263 8243776 8244386 8244829 8242459 8242891 8243265 8243804 8244401 8244841 8242460 8242898 8243269 8243815 8244408 8244855 8242470 8242901 8243274 8243826 8244423 8244857 8242475 8242905 8243277 8243829 8244424 8244865 8242478 8242908 8243281 8243833 8244435 8244870 8242480 8242911 8243298 8243844 8244440 8244881 8242483 8242917 8243307 8243859 8244470 8244887 8242485 8242918 8243309 8243879 8244475 8244888 8242486 8242920 8243322 8243883 8244478 8244900 8242490 8242929 8243324 8243887 8244483 8244907 8242499 8242930 8243325 8243895 8244486 8244909 8242503 8242931 8243336 8243906 8244493 8244919 8242511 8242932 8243348 8243907 8244495 8244929 8242513 8242939 8243356 8243910 8244497 8244937 8242517 8242943 8243361 8243914 8244498 8244938 8242518 8242945 8243363 8243916 8244499 8244949 8242523 8242947 8243368 8243918 8244502 8244952 8242529 8242952 8243387 8243919 8244504 8244954 8242538 8242956 8243390 8243931 8244516 8244955 8242543 8242958 8243397 8243937 8244522 8244956 8242547 8242959 8243403 8243943 8244526 8244963 8242549 8242965 8243406 8243954 8244527 8244966 8242550 8242974 8243408 8243962 8244533 8244973 8242571 8242978 8243425 8243965 8244540 8244974 8242572 8242980 8243442 8243978 8244541 8244976 8242577 8242984 8243444 8243981 8244547 8244987 8242608 8242986 8243451 8243984 8244550 8244992 8242610 8242999 8243462 8243996 8244562 8244995 8242614 8243021 8243465 8244017 8244563 8244996 8242618 8243028 8243471 8244024 8244572 8244997 8242632 8243032 8243473 8244031 8244576 8245000 8242637 8243051 8243481 8244032 8244578 8245006 8242639 8243053 8243482 8244036 8244579 8245009 8242644 8243060 8243489 8244039 8244582 8245011 8242660 8243061 8243492 8244050 8244583 8245018 8242663 8243074 8243497 8244053 8244589 8245019 8242668 8243079 8243501 8244087 8244592 8245020 8242686 8243090 8243515 8244094 8244606 8245025 8242696 8243096 8243522 8244096 8244619 8245026 8242697 8243101 8243523 8244107 8244620 8245027 8242702 8243102 8243531 8244149 8244623 8245037 8242703 8243104 8243532 8244153 8244627 8245040 8242709 8243109 8243535 8244155 8244641 8245047 8242714 8243132 8243538 8244177 8244649 8245059 8242717 8243133 8243544 8244181 8244650 8245060 8242718 8243143 8243552 8244183 8244662 8245067 8242719 8243154 8243554 8244196 8244667 8245069 8242746 8243155 8243558 8244197 8244671 8245074 8242748 8243164 8243564 8244218 8244673 8245079 8242751 8243179 8243569 8244223 8244674 8245081 8242753 8243186 8243595 8244228 8244688 8245082 8242758 8243189 8243600 8244259 8244697 8245092 8242772 8243190 8243601 8244262 8244698 8245095 8242775 8243193 8243633 8244280 8244705 8245097 8242779 8243194 8243638 8244287 8244712 8245098 8242789 8243196 8243643 8244294 8244719 8245103 8242794 8243206 8243658 8244305 8244723 8245104 8242798 8243210 8243660 8244309 8244733 8245106 8242801 8243213 8243662 8244321 8244734 8245110 8242808 8243218 8243666 8244322 8244741 8245113 8242813 8243222 8243671 8244324 8244743 8245116 8242816 8243227 8243673 8244326 8244751 8245117 8242824 8243229 8243679 8244333 8244752 8245125 8242825 8243231 8243701 8244335 8244765 8245126
EXHIBIT B 85 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8245132 8245631 8246374 8246731 8247407 8248123 8245133 8245635 8246379 8246736 8247423 8248125 8245139 8245652 8246380 8246737 8247485 8248127 8245142 8245656 8246383 8246740 8247493 8248129 8245144 8245658 8246387 8246741 8247504 8248134 8245150 8245667 8246388 8246749 8247521 8248140 8245151 8245675 8246391 8246753 8247533 8248141 8245152 8245690 8246394 8246756 8247540 8248144 8245154 8245715 8246400 8246758 8247554 8248150 8245156 8245723 8246403 8246784 8247558 8248154 8245158 8245735 8246405 8246785 8247569 8248157 8245165 8245758 8246414 8246789 8247599 8248161 8245168 8245798 8246417 8246791 8247611 8248172 8245174 8245801 8246427 8246798 8247636 8248178 8245176 8245805 8246440 8246800 8247657 8248179 8245184 8245816 8246449 8246802 8247665 8248180 8245200 8245823 8246455 8246803 8247701 8248181 8245210 8245827 8246459 8246807 8247710 8248185 8245243 8245837 8246460 8246808 8247727 8248194 8245255 8245842 8246465 8246809 8247749 8248196 8245279 8245849 8246473 8246812 8247751 8248199 8245292 8245858 8246488 8246816 8247756 8248210 8245307 8245859 8246495 8246817 8247759 8248211 8245312 8245864 8246503 8246825 8247765 8248231 8245320 8245867 8246505 8246828 8247775 8248235 8245333 8245869 8246514 8246830 8247792 8248261 8245336 8245878 8246516 8246832 8247794 8248270 8245345 8245886 8246518 8246840 8247820 8248307 8245348 8245887 8246527 8246841 8247822 8248337 8245355 8245889 8246530 8246843 8247832 8248351 8245364 8245898 8246531 8246849 8247866 8248359 8245376 8245899 8246535 8246850 8247869 8248364 8245379 8245919 8246540 8246859 8247885 8248371 8245401 8245926 8246549 8246861 8247886 8248373 8245402 8245937 8246557 8246864 8247890 8248375 8245403 8245940 8246568 8246866 8247907 8248401 8245412 8245957 8246569 8246872 8247915 8248407 8245414 8245967 8246577 8246886 8247916 8248412 8245421 8245968 8246581 8246894 8247936 8248414 8245425 8245969 8246582 8246918 8247937 8248417 8245448 8245970 8246583 8246924 8247939 8248430 8245456 8245977 8246591 8246984 8247950 8248458 8245465 8245981 8246592 8247003 8247951 8248465 8245475 8245996 8246606 8247015 8247959 8248471 8245476 8245997 8246607 8247020 8247965 8248478 8245482 8246002 8246608 8247025 8247968 8248491 8245483 8246005 8246610 8247037 8247971 8248501 8245486 8246011 8246615 8247060 8247972 8248502 8245487 8246015 8246628 8247061 8247980 8248504 8245494 8246020 8246633 8247078 8247992 8248520 8245497 8246038 8246636 8247084 8247993 8248528 8245499 8246040 8246643 8247089 8247996 8248544 8245507 8246041 8246658 8247124 8248003 8248557 8245518 8246059 8246660 8247146 8248009 8248564 8245525 8246083 8246666 8247165 8248013 8248571 8245535 8246084 8246672 8247170 8248023 8248572 8245540 8246104 8246691 8247174 8248026 8248585 8245548 8246140 8246692 8247208 8248029 8248590 8245557 8246151 8246695 8247228 8248031 8248593 8245564 8246177 8246697 8247233 8248033 8248603 8245565 8246185 8246701 8247268 8248035 8248604 8245586 8246201 8246703 8247289 8248049 8248612 8245594 8246285 8246706 8247309 8248061 8248614 8245596 8246339 8246707 8247311 8248064 8248619 8245599 8246350 8246711 8247314 8248075 8248625 8245603 8246359 8246718 8247316 8248077 8248634 8245610 8246362 8246719 8247336 8248088 8248648 8245614 8246366 8246724 8247351 8248098 8248654 8245617 8246372 8246728 8247370 8248100 8248661 8245627 8246373 8246729 8247395 8248103 8248664
EXHIBIT B 86 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8248665 8249286 8249780 8250314 8250686 8251122 8248702 8249289 8249802 8250321 8250694 8251123 8248720 8249292 8249844 8250329 8250697 8251125 8248724 8249310 8249857 8250330 8250699 8251135 8248734 8249311 8249886 8250339 8250707 8251140 8248738 8249320 8249904 8250344 8250710 8251141 8248740 8249323 8249906 8250347 8250716 8251155 8248757 8249334 8249914 8250371 8250717 8251156 8248759 8249336 8249917 8250374 8250731 8251159 8248760 8249350 8249921 8250376 8250738 8251164 8248774 8249351 8249929 8250378 8250754 8251166 8248776 8249377 8249934 8250388 8250760 8251174 8248779 8249379 8249948 8250393 8250765 8251175 8248781 8249386 8249977 8250394 8250775 8251178 8248788 8249416 8249986 8250403 8250788 8251181 8248792 8249437 8249989 8250407 8250790 8251182 8248794 8249443 8249992 8250408 8250792 8251192 8248800 8249450 8249993 8250413 8250806 8251195 8248817 8249460 8250005 8250419 8250807 8251196 8248821 8249471 8250012 8250421 8250815 8251199 8248827 8249480 8250021 8250425 8250825 8251203 8248832 8249493 8250036 8250426 8250827 8251207 8248837 8249495 8250043 8250431 8250842 8251209 8248853 8249496 8250049 8250437 8250843 8251214 8248867 8249502 8250058 8250454 8250852 8251223 8248870 8249506 8250095 8250455 8250853 8251245 8248876 8249508 8250124 8250458 8250863 8251248 8248881 8249510 8250132 8250470 8250867 8251255 8248883 8249513 8250133 8250471 8250872 8251256 8248894 8249519 8250145 8250487 8250880 8251263 8248912 8249540 8250155 8250488 8250885 8251264 8248916 8249557 8250158 8250500 8250891 8251269 8248942 8249571 8250164 8250514 8250896 8251272 8248945 8249577 8250171 8250523 8250906 8251286 8248957 8249582 8250177 8250528 8250912 8251287 8248961 8249584 8250180 8250533 8250916 8251290 8248963 8249587 8250188 8250540 8250917 8251296 8248970 8249592 8250196 8250547 8250920 8251297 8248978 8249596 8250198 8250550 8250922 8251327 8248981 8249604 8250199 8250554 8250929 8251331 8248995 8249607 8250202 8250563 8250937 8251337 8249000 8249608 8250210 8250574 8250953 8251340 8249012 8249613 8250212 8250577 8250954 8251343 8249021 8249614 8250216 8250579 8250958 8251347 8249023 8249615 8250217 8250588 8250961 8251354 8249039 8249627 8250224 8250590 8250962 8251355 8249041 8249628 8250226 8250595 8250971 8251360 8249052 8249630 8250228 8250598 8250981 8251362 8249061 8249638 8250234 8250599 8250982 8251363 8249072 8249649 8250235 8250601 8250989 8251364 8249078 8249650 8250236 8250604 8251000 8251369 8249084 8249656 8250238 8250606 8251001 8251370 8249088 8249660 8250241 8250607 8251011 8251371 8249089 8249661 8250242 8250612 8251014 8251374 8249097 8249662 8250251 8250618 8251016 8251376 8249108 8249669 8250252 8250620 8251027 8251377 8249116 8249675 8250254 8250622 8251033 8251379 8249118 8249676 8250256 8250625 8251035 8251387 8249131 8249699 8250260 8250627 8251038 8251395 8249146 8249701 8250261 8250628 8251050 8251400 8249152 8249702 8250265 8250650 8251056 8251407 8249168 8249709 8250269 8250658 8251058 8251411 8249182 8249711 8250287 8250662 8251076 8251414 8249197 8249715 8250290 8250665 8251082 8251420 8249206 8249716 8250295 8250666 8251086 8251426 8249219 8249724 8250297 8250669 8251089 8251427 8249230 8249725 8250299 8250678 8251090 8251430 8249261 8249757 8250304 8250680 8251093 8251434 8249262 8249760 8250307 8250684 8251103 8251437 8249277 8249773 8250312 8250685 8251113 8251439
EXHIBIT B 87 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8251443 8251734 8252280 8253349 8254934 8255415 8251446 8251735 8252288 8253355 8254943 8255423 8251453 8251743 8252292 8253359 8254945 8255425 8251456 8251744 8252304 8253365 8254957 8255433 8251460 8251747 8252312 8253381 8254959 8255446 8251463 8251754 8252322 8253389 8254963 8255448 8251471 8251762 8252332 8253392 8254977 8255452 8251473 8251764 8252343 8253398 8254979 8255454 8251485 8251768 8252354 8253408 8255006 8255472 8251488 8251769 8252364 8253416 8255008 8255484 8251491 8251770 8252370 8253417 8255010 8255492 8251494 8251775 8252391 8253425 8255017 8255498 8251496 8251780 8252423 8253432 8255030 8255511 8251498 8251788 8252440 8253436 8255033 8255518 8251501 8251790 8252445 8253437 8255043 8255529 8251503 8251794 8252457 8253455 8255046 8255537 8251508 8251803 8252469 8253484 8255051 8255540 8251509 8251841 8252470 8253516 8255053 8255550 8251516 8251850 8252476 8253559 8255064 8255568 8251517 8251865 8252480 8253561 8255075 8255571 8251519 8251866 8252496 8253572 8255077 8255584 8251522 8251869 8252499 8253575 8255079 8255585 8251536 8251872 8252505 8253583 8255082 8255586 8251544 8251893 8252518 8253593 8255098 8255599 8251550 8251894 8252535 8253598 8255101 8255602 8251553 8251904 8252563 8253601 8255102 8255620 8251558 8251907 8252591 8253619 8255116 8255628 8251564 8251936 8252606 8253620 8255117 8255630 8251568 8251942 8252615 8253632 8255130 8255654 8251581 8251943 8252617 8253646 8255134 8255656 8251589 8251955 8252621 8253672 8255141 8255661 8251595 8251958 8252625 8253698 8255146 8255672 8251600 8251960 8252639 8253700 8255155 8255675 8251604 8251961 8252669 8253732 8255160 8255683 8251606 8251968 8252674 8253742 8255164 8255686 8251608 8251971 8252693 8253777 8255175 8255696 8251610 8251979 8252696 8253808 8255178 8255698 8251612 8251985 8252711 8253830 8255199 8255702 8251619 8251986 8252767 8253846 8255218 8255709 8251629 8251987 8252787 8253853 8255241 8255712 8251634 8251988 8252789 8253875 8255245 8255722 8251636 8251994 8252813 8254027 8255252 8255734 8251643 8252009 8252814 8254085 8255261 8255738 8251646 8252014 8252852 8254269 8255268 8255744 8251648 8252015 8252868 8254289 8255269 8255747 8251651 8252022 8253010 8254298 8255278 8255749 8251657 8252032 8253017 8254304 8255284 8255751 8251659 8252037 8253066 8254316 8255287 8255754 8251663 8252045 8253100 8254332 8255291 8255755 8251664 8252050 8253102 8254506 8255296 8255761 8251665 8252054 8253131 8254569 8255301 8255762 8251667 8252069 8253147 8254577 8255304 8255763 8251670 8252073 8253152 8254624 8255307 8255768 8251682 8252088 8253161 8254625 8255319 8255773 8251684 8252095 8253170 8254632 8255321 8255774 8251685 8252101 8253189 8254656 8255322 8255776 8251687 8252103 8253196 8254672 8255330 8255777 8251689 8252115 8253213 8254686 8255334 8255778 8251695 8252118 8253219 8254710 8255335 8255780 8251703 8252139 8253243 8254719 8255336 8255785 8251713 8252149 8253266 8254741 8255347 8255786 8251714 8252152 8253269 8254746 8255356 8255788 8251715 8252156 8253270 8254767 8255359 8255790 8251716 8252176 8253274 8254779 8255366 8255797 8251719 8252188 8253280 8254785 8255371 8255800 8251723 8252193 8253288 8254801 8255386 8255801 8251724 8252196 8253293 8254821 8255388 8255806 8251727 8252211 8253315 8254827 8255393 8255807 8251729 8252233 8253318 8254856 8255395 8255812 8251731 8252245 8253333 8254927 8255406 8255816
EXHIBIT B 88 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8255824 8256346 8256752 8257212 8257825 8258494 8255828 8256349 8256760 8257215 8257833 8258498 8255833 8256356 8256763 8257223 8257837 8258500 8255836 8256362 8256765 8257235 8257838 8258505 8255837 8256371 8256774 8257252 8257840 8258506 8255841 8256372 8256795 8257262 8257841 8258508 8255844 8256377 8256796 8257271 8257842 8258509 8255846 8256384 8256800 8257295 8257850 8258513 8255848 8256386 8256812 8257297 8257854 8258517 8255849 8256390 8256816 8257299 8257856 8258525 8255854 8256394 8256824 8257300 8257867 8258527 8255855 8256395 8256828 8257304 8257882 8258528 8255863 8256399 8256829 8257316 8257886 8258532 8255864 8256407 8256838 8257326 8257904 8258536 8255866 8256412 8256841 8257328 8257934 8258538 8255868 8256415 8256845 8257341 8257938 8258551 8255875 8256421 8256847 8257356 8257947 8258557 8255882 8256426 8256854 8257362 8257956 8258566 8255888 8256427 8256862 8257373 8257976 8258568 8255892 8256429 8256864 8257384 8257978 8258578 8255894 8256432 8256871 8257390 8257986 8258584 8255915 8256444 8256873 8257405 8257996 8258589 8255925 8256447 8256879 8257408 8258005 8258593 8255935 8256451 8256884 8257412 8258008 8258604 8255950 8256454 8256888 8257436 8258017 8258608 8255957 8256456 8256896 8257438 8258022 8258614 8255970 8256459 8256904 8257450 8258036 8258625 8255980 8256465 8256915 8257452 8258050 8258626 8255987 8256469 8256922 8257457 8258065 8258637 8256000 8256470 8256924 8257468 8258068 8258638 8256016 8256478 8256933 8257477 8258069 8258651 8256027 8256479 8256934 8257482 8258074 8258665 8256040 8256487 8256936 8257493 8258084 8258681 8256074 8256489 8256947 8257502 8258089 8258691 8256080 8256500 8256952 8257510 8258097 8258700 8256086 8256509 8256989 8257518 8258100 8258701 8256088 8256512 8256997 8257520 8258104 8258720 8256089 8256515 8257007 8257523 8258105 8258739 8256106 8256518 8257011 8257532 8258107 8258768 8256116 8256522 8257012 8257534 8258114 8258771 8256133 8256532 8257016 8257535 8258120 8258777 8256139 8256533 8257028 8257547 8258123 8258795 8256148 8256535 8257029 8257551 8258124 8258803 8256155 8256543 8257032 8257567 8258126 8258817 8256157 8256564 8257039 8257571 8258133 8258820 8256172 8256570 8257044 8257573 8258149 8258856 8256174 8256575 8257052 8257580 8258161 8258858 8256180 8256576 8257055 8257583 8258171 8258885 8256197 8256579 8257065 8257587 8258177 8258921 8256201 8256580 8257068 8257592 8258229 8258938 8256203 8256592 8257070 8257602 8258268 8258958 8256214 8256593 8257085 8257603 8258276 8258960 8256216 8256601 8257087 8257612 8258282 8258977 8256220 8256606 8257091 8257655 8258286 8258987 8256240 8256612 8257092 8257669 8258309 8258995 8256248 8256615 8257113 8257671 8258311 8259009 8256263 8256636 8257123 8257677 8258341 8259010 8256268 8256654 8257136 8257680 8258366 8259018 8256276 8256656 8257139 8257684 8258377 8259025 8256296 8256667 8257147 8257689 8258378 8259034 8256301 8256671 8257150 8257702 8258386 8259048 8256306 8256672 8257164 8257713 8258398 8259072 8256322 8256675 8257167 8257720 8258403 8259083 8256324 8256676 8257168 8257782 8258410 8259085 8256327 8256677 8257178 8257789 8258435 8259089 8256337 8256700 8257183 8257799 8258448 8259106 8256340 8256708 8257187 8257804 8258457 8259127 8256341 8256718 8257190 8257811 8258482 8259144 8256342 8256730 8257201 8257817 8258489 8259158 8256344 8256744 8257208 8257823 8258493 8259159
EXHIBIT B 89 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8259163 8259685 8260092 8260332 8260513 8260787 8259167 8259689 8260093 8260335 8260514 8260802 8259182 8259691 8260097 8260338 8260515 8260816 8259188 8259695 8260099 8260345 8260516 8260820 8259189 8259696 8260107 8260348 8260526 8260824 8259190 8259697 8260111 8260351 8260527 8260827 8259202 8259699 8260114 8260354 8260528 8260830 8259209 8259705 8260119 8260355 8260532 8260835 8259217 8259710 8260120 8260357 8260533 8260836 8259224 8259718 8260123 8260359 8260536 8260840 8259234 8259719 8260134 8260363 8260540 8260846 8259241 8259720 8260135 8260364 8260545 8260847 8259242 8259722 8260140 8260373 8260547 8260850 8259258 8259725 8260142 8260374 8260555 8260851 8259269 8259726 8260146 8260375 8260556 8260852 8259270 8259732 8260147 8260378 8260557 8260860 8259278 8259736 8260150 8260379 8260558 8260865 8259286 8259737 8260151 8260380 8260559 8260867 8259294 8259738 8260154 8260383 8260561 8260869 8259297 8259742 8260158 8260387 8260563 8260874 8259302 8259746 8260160 8260388 8260571 8260880 8259304 8259748 8260164 8260389 8260584 8260891 8259308 8259752 8260174 8260391 8260586 8260893 8259312 8259753 8260175 8260392 8260589 8260897 8259318 8259754 8260176 8260394 8260590 8260910 8259323 8259757 8260177 8260396 8260598 8260914 8259324 8259759 8260180 8260397 8260600 8260917 8259333 8259763 8260182 8260398 8260602 8260918 8259345 8259768 8260186 8260400 8260604 8260924 8259348 8259769 8260197 8260403 8260606 8260926 8259349 8259771 8260207 8260406 8260607 8260934 8259367 8259774 8260208 8260408 8260609 8260940 8259373 8259775 8260209 8260409 8260613 8260942 8259381 8259784 8260213 8260412 8260622 8260953 8259382 8259786 8260220 8260413 8260625 8260955 8259389 8259792 8260230 8260414 8260628 8260959 8259393 8259795 8260232 8260415 8260630 8260964 8259410 8259797 8260239 8260416 8260631 8260965 8259448 8259810 8260240 8260417 8260634 8260967 8259453 8259832 8260243 8260418 8260640 8260968 8259456 8259836 8260253 8260419 8260646 8260969 8259484 8259837 8260262 8260422 8260654 8260971 8259494 8259839 8260263 8260424 8260660 8260975 8259508 8259844 8260268 8260428 8260663 8260976 8259527 8259858 8260278 8260431 8260667 8260978 8259528 8259864 8260288 8260432 8260670 8260980 8259531 8259874 8260289 8260433 8260678 8260983 8259535 8259886 8260291 8260437 8260682 8260986 8259559 8259896 8260293 8260439 8260683 8260989 8259563 8259897 8260295 8260440 8260684 8260992 8259568 8259909 8260297 8260441 8260686 8261007 8259575 8259927 8260299 8260442 8260688 8261008 8259588 8259952 8260302 8260444 8260690 8261013 8259593 8259957 8260305 8260448 8260692 8261017 8259597 8259971 8260306 8260454 8260698 8261024 8259603 8259973 8260307 8260461 8260705 8261026 8259606 8259980 8260308 8260470 8260709 8261029 8259608 8259985 8260310 8260474 8260711 8261036 8259609 8259995 8260311 8260478 8260722 8261037 8259610 8260026 8260313 8260482 8260723 8261041 8259621 8260029 8260314 8260489 8260725 8261051 8259627 8260034 8260316 8260494 8260741 8261052 8259631 8260045 8260317 8260495 8260753 8261056 8259633 8260068 8260318 8260498 8260759 8261064 8259641 8260070 8260319 8260499 8260760 8261066 8259653 8260071 8260323 8260506 8260762 8261067 8259660 8260076 8260324 8260507 8260767 8261069 8259661 8260081 8260327 8260508 8260772 8261075 8259674 8260083 8260329 8260510 8260775 8261076 8259676 8260084 8260330 8260512 8260776 8261078
EXHIBIT B 90 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8261083 8261324 8261623 8261977 8262206 8262552 8261085 8261328 8261626 8261978 8262209 8262555 8261090 8261337 8261639 8261982 8262212 8262557 8261091 8261338 8261644 8261984 8262213 8262558 8261096 8261343 8261656 8261986 8262214 8262570 8261097 8261345 8261657 8261996 8262216 8262571 8261102 8261353 8261665 8261998 8262226 8262574 8261103 8261356 8261666 8262000 8262227 8262575 8261109 8261357 8261668 8262002 8262228 8262576 8261110 8261363 8261682 8262004 8262235 8262579 8261113 8261364 8261685 8262005 8262236 8262582 8261114 8261367 8261711 8262006 8262237 8262586 8261121 8261373 8261722 8262009 8262241 8262588 8261122 8261376 8261729 8262012 8262243 8262591 8261125 8261389 8261737 8262014 8262245 8262594 8261131 8261390 8261751 8262016 8262250 8262595 8261133 8261394 8261755 8262021 8262252 8262605 8261135 8261396 8261770 8262024 8262259 8262613 8261144 8261400 8261775 8262026 8262260 8262615 8261149 8261403 8261780 8262030 8262262 8262619 8261152 8261404 8261782 8262031 8262263 8262620 8261154 8261407 8261794 8262033 8262275 8262621 8261157 8261409 8261795 8262034 8262278 8262627 8261160 8261412 8261804 8262041 8262280 8262628 8261161 8261413 8261816 8262043 8262282 8262629 8261165 8261417 8261818 8262044 8262287 8262630 8261166 8261419 8261820 8262046 8262292 8262632 8261171 8261420 8261824 8262047 8262295 8262646 8261173 8261421 8261832 8262050 8262298 8262647 8261177 8261424 8261845 8262052 8262301 8262651 8261179 8261428 8261848 8262053 8262303 8262653 8261181 8261431 8261856 8262054 8262309 8262657 8261183 8261434 8261861 8262059 8262310 8262660 8261184 8261442 8261865 8262062 8262315 8262664 8261188 8261443 8261867 8262064 8262318 8262665 8261192 8261444 8261876 8262067 8262319 8262667 8261197 8261447 8261883 8262070 8262326 8262672 8261205 8261451 8261885 8262073 8262327 8262674 8261211 8261453 8261886 8262075 8262336 8262675 8261217 8261457 8261894 8262076 8262343 8262678 8261218 8261462 8261895 8262079 8262344 8262689 8261220 8261463 8261900 8262082 8262349 8262692 8261221 8261464 8261901 8262084 8262351 8262694 8261223 8261467 8261902 8262085 8262356 8262695 8261230 8261471 8261908 8262087 8262367 8262697 8261235 8261472 8261909 8262090 8262376 8262698 8261238 8261477 8261910 8262093 8262377 8262701 8261239 8261486 8261917 8262102 8262387 8262705 8261248 8261488 8261921 8262104 8262393 8262706 8261251 8261490 8261924 8262107 8262396 8262708 8261253 8261494 8261925 8262110 8262399 8262710 8261254 8261504 8261929 8262120 8262400 8262715 8261259 8261506 8261931 8262121 8262403 8262716 8261268 8261508 8261933 8262132 8262404 8262718 8261269 8261514 8261934 8262135 8262407 8262719 8261270 8261518 8261935 8262137 8262423 8262721 8261271 8261527 8261940 8262151 8262441 8262725 8261279 8261532 8261941 8262158 8262474 8262727 8261285 8261538 8261945 8262160 8262476 8262738 8261286 8261545 8261946 8262165 8262480 8262748 8261291 8261550 8261949 8262178 8262484 8262750 8261293 8261555 8261951 8262180 8262487 8262751 8261298 8261560 8261952 8262182 8262489 8262760 8261303 8261574 8261958 8262188 8262490 8262773 8261305 8261584 8261959 8262189 8262525 8262774 8261307 8261585 8261963 8262194 8262527 8262777 8261312 8261600 8261964 8262197 8262529 8262783 8261318 8261609 8261971 8262198 8262534 8262787 8261319 8261610 8261974 8262201 8262544 8262789 8261321 8261620 8261976 8262205 8262551 8262791
EXHIBIT B 91 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8262793 8263134 8263718 8264106 8264836 8265453 8262802 8263137 8263724 8264111 8264846 8265458 8262807 8263144 8263725 8264117 8264855 8265466 8262810 8263145 8263732 8264124 8264857 8265485 8262819 8263158 8263746 8264133 8264863 8265487 8262821 8263160 8263747 8264139 8264869 8265494 8262832 8263167 8263759 8264159 8264873 8265504 8262836 8263169 8263761 8264182 8264874 8265505 8262844 8263171 8263763 8264183 8264884 8265518 8262849 8263172 8263766 8264199 8264911 8265525 8262853 8263174 8263800 8264242 8264921 8265528 8262854 8263175 8263808 8264278 8264927 8265536 8262856 8263177 8263813 8264315 8264931 8265540 8262887 8263179 8263834 8264330 8264942 8265546 8262896 8263182 8263835 8264343 8264958 8265547 8262902 8263192 8263842 8264378 8264959 8265569 8262907 8263198 8263846 8264387 8264972 8265589 8262909 8263209 8263850 8264406 8264983 8265600 8262919 8263214 8263851 8264411 8264985 8265623 8262921 8263216 8263855 8264432 8264996 8265632 8262924 8263241 8263866 8264440 8265001 8265638 8262925 8263245 8263867 8264442 8265020 8265652 8262929 8263251 8263874 8264443 8265029 8265659 8262931 8263253 8263876 8264469 8265035 8265690 8262953 8263263 8263879 8264474 8265036 8265708 8262958 8263266 8263883 8264480 8265040 8265716 8262962 8263277 8263885 8264483 8265047 8265718 8262971 8263286 8263886 8264485 8265064 8265736 8262978 8263288 8263888 8264489 8265068 8265737 8262981 8263295 8263892 8264498 8265072 8265742 8262985 8263314 8263894 8264501 8265078 8265773 8262988 8263321 8263897 8264505 8265083 8265793 8262990 8263337 8263899 8264517 8265091 8265804 8262994 8263339 8263900 8264519 8265093 8265805 8263001 8263355 8263908 8264521 8265097 8265819 8263004 8263389 8263910 8264523 8265100 8265820 8263006 8263406 8263918 8264527 8265102 8265839 8263009 8263410 8263921 8264533 8265121 8265883 8263012 8263414 8263923 8264538 8265124 8265905 8263021 8263422 8263925 8264545 8265142 8265918 8263023 8263441 8263935 8264549 8265148 8265926 8263025 8263453 8263938 8264558 8265160 8265927 8263027 8263457 8263941 8264561 8265163 8265941 8263029 8263475 8263945 8264574 8265182 8265949 8263031 8263476 8263948 8264585 8265190 8265967 8263039 8263482 8263950 8264589 8265204 8265976 8263045 8263485 8263955 8264593 8265241 8265985 8263054 8263490 8263956 8264626 8265261 8265988 8263055 8263491 8263960 8264628 8265279 8266000 8263064 8263501 8263962 8264640 8265287 8266002 8263067 8263504 8263978 8264644 8265290 8266003 8263073 8263520 8263983 8264647 8265310 8266031 8263075 8263545 8263993 8264676 8265313 8266053 8263076 8263583 8264000 8264679 8265314 8266061 8263079 8263604 8264012 8264689 8265329 8266063 8263080 8263607 8264015 8264692 8265332 8266067 8263084 8263617 8264016 8264698 8265334 8266084 8263087 8263618 8264023 8264702 8265347 8266086 8263088 8263636 8264028 8264711 8265348 8266099 8263091 8263640 8264030 8264714 8265352 8266100 8263093 8263641 8264048 8264718 8265361 8266110 8263100 8263661 8264053 8264727 8265370 8266123 8263101 8263666 8264055 8264732 8265371 8266127 8263108 8263676 8264062 8264744 8265375 8266137 8263111 8263682 8264069 8264760 8265379 8266144 8263112 8263690 8264072 8264789 8265400 8266154 8263115 8263692 8264081 8264792 8265404 8266166 8263116 8263701 8264088 8264793 8265406 8266169 8263118 8263704 8264099 8264817 8265424 8266173 8263133 8263707 8264103 8264831 8265443 8266176
EXHIBIT B 92 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8266177 8266751 8267408 8268001 8268624 8269255 8266179 8266756 8267412 8268045 8268645 8269271 8266204 8266757 8267418 8268049 8268668 8269282 8266215 8266762 8267419 8268053 8268680 8269289 8266237 8266763 8267426 8268096 8268697 8269295 8266238 8266770 8267434 8268117 8268720 8269296 8266240 8266775 8267450 8268120 8268740 8269304 8266242 8266784 8267451 8268131 8268758 8269308 8266243 8266800 8267452 8268136 8268782 8269323 8266266 8266818 8267455 8268139 8268794 8269332 8266296 8266834 8267477 8268140 8268804 8269346 8266303 8266846 8267489 8268149 8268820 8269355 8266309 8266857 8267490 8268167 8268828 8269366 8266312 8266861 8267493 8268168 8268830 8269372 8266317 8266864 8267501 8268176 8268837 8269389 8266324 8266891 8267508 8268194 8268847 8269408 8266326 8266894 8267513 8268218 8268862 8269429 8266343 8266895 8267515 8268221 8268867 8269438 8266355 8266896 8267516 8268238 8268872 8269483 8266358 8266903 8267529 8268242 8268874 8269502 8266362 8266906 8267536 8268245 8268878 8269541 8266366 8266907 8267537 8268264 8268879 8269576 8266367 8266908 8267550 8268284 8268890 8269577 8266369 8266925 8267553 8268303 8268894 8269665 8266376 8266934 8267567 8268311 8268899 8269698 8266378 8266939 8267578 8268317 8268900 8269706 8266381 8266942 8267593 8268318 8268915 8269731 8266386 8266954 8267597 8268336 8268926 8269741 8266387 8266957 8267603 8268347 8268927 8269753 8266388 8266984 8267611 8268353 8268928 8269763 8266389 8267000 8267613 8268354 8268933 8269775 8266392 8267007 8267627 8268362 8268943 8269776 8266394 8267012 8267634 8268388 8268946 8269782 8266410 8267015 8267638 8268403 8268949 8269789 8266423 8267035 8267642 8268412 8268955 8269809 8266427 8267037 8267646 8268422 8268957 8269810 8266428 8267052 8267651 8268428 8268971 8269823 8266437 8267055 8267659 8268439 8268982 8269826 8266439 8267061 8267664 8268448 8268987 8269831 8266443 8267085 8267668 8268452 8268996 8269843 8266453 8267089 8267677 8268454 8269013 8269883 8266455 8267094 8267681 8268463 8269015 8269893 8266464 8267101 8267685 8268467 8269038 8269904 8266470 8267102 8267691 8268473 8269045 8269911 8266483 8267133 8267700 8268479 8269048 8269925 8266490 8267141 8267715 8268489 8269062 8269959 8266494 8267152 8267734 8268495 8269071 8269962 8266512 8267171 8267752 8268500 8269073 8269965 8266516 8267204 8267778 8268506 8269080 8269968 8266519 8267225 8267779 8268514 8269094 8269982 8266523 8267251 8267806 8268517 8269097 8269992 8266532 8267252 8267819 8268519 8269116 8269997 8266535 8267270 8267823 8268523 8269125 8270020 8266546 8267289 8267836 8268526 8269133 8270025 8266564 8267298 8267847 8268530 8269143 8270027 8266572 8267301 8267851 8268534 8269144 8270036 8266583 8267309 8267859 8268535 8269157 8270040 8266605 8267318 8267860 8268539 8269160 8270041 8266614 8267322 8267873 8268541 8269171 8270048 8266637 8267349 8267881 8268547 8269173 8270063 8266638 8267365 8267893 8268553 8269174 8270064 8266641 8267374 8267898 8268556 8269180 8270068 8266644 8267380 8267901 8268560 8269184 8270069 8266647 8267382 8267904 8268561 8269198 8270106 8266658 8267395 8267919 8268572 8269200 8270109 8266659 8267396 8267948 8268581 8269209 8270115 8266662 8267398 8267953 8268594 8269224 8270131 8266710 8267400 8267970 8268603 8269233 8270152 8266732 8267401 8267982 8268611 8269244 8270164 8266746 8267405 8267991 8268616 8269245 8270167
EXHIBIT B 93 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8270187 8270906 8271616 8271883 8272289 8272744 8270195 8270909 8271621 8271888 8272296 8272749 8270202 8270917 8271627 8271889 8272297 8272750 8270204 8270936 8271634 8271911 8272317 8272753 8270209 8270941 8271636 8271913 8272320 8272754 8270216 8270961 8271647 8271917 8272344 8272759 8270226 8270971 8271649 8271934 8272350 8272767 8270229 8270980 8271653 8271966 8272362 8272768 8270235 8270992 8271654 8271973 8272368 8272771 8270237 8271001 8271658 8271984 8272373 8272772 8270251 8271003 8271667 8271987 8272390 8272777 8270254 8271023 8271668 8271990 8272399 8272779 8270260 8271032 8271669 8271994 8272406 8272784 8270263 8271036 8271671 8272000 8272407 8272790 8270267 8271048 8271672 8272006 8272414 8272792 8270270 8271060 8271675 8272011 8272424 8272794 8270274 8271079 8271676 8272014 8272430 8272800 8270286 8271081 8271677 8272017 8272435 8272801 8270287 8271088 8271680 8272019 8272444 8272805 8270314 8271094 8271685 8272023 8272445 8272814 8270317 8271107 8271687 8272024 8272452 8272822 8270328 8271129 8271691 8272026 8272459 8272837 8270329 8271143 8271693 8272030 8272471 8272867 8270354 8271150 8271696 8272046 8272478 8272870 8270379 8271157 8271698 8272069 8272489 8272882 8270383 8271158 8271699 8272075 8272498 8272885 8270390 8271162 8271701 8272079 8272503 8272892 8270392 8271186 8271704 8272085 8272504 8272906 8270396 8271194 8271705 8272090 8272512 8272907 8270400 8271204 8271709 8272099 8272516 8272908 8270404 8271210 8271711 8272109 8272526 8272928 8270408 8271224 8271712 8272112 8272527 8272933 8270432 8271225 8271713 8272115 8272531 8272944 8270458 8271227 8271715 8272117 8272541 8272953 8270460 8271234 8271717 8272118 8272545 8272966 8270475 8271245 8271718 8272122 8272561 8272978 8270484 8271268 8271719 8272124 8272563 8272981 8270514 8271284 8271720 8272125 8272564 8272989 8270549 8271334 8271725 8272128 8272566 8272997 8270565 8271348 8271726 8272129 8272569 8273012 8270586 8271354 8271729 8272133 8272575 8273015 8270589 8271360 8271732 8272135 8272583 8273016 8270600 8271362 8271735 8272136 8272585 8273025 8270613 8271370 8271737 8272155 8272599 8273032 8270618 8271379 8271740 8272170 8272609 8273049 8270619 8271384 8271741 8272182 8272611 8273053 8270632 8271400 8271743 8272196 8272613 8273066 8270654 8271419 8271745 8272198 8272630 8273067 8270725 8271427 8271751 8272210 8272634 8273070 8270727 8271431 8271757 8272213 8272637 8273099 8270732 8271443 8271761 8272215 8272641 8273101 8270741 8271449 8271764 8272216 8272649 8273104 8270743 8271455 8271776 8272217 8272661 8273110 8270754 8271467 8271780 8272218 8272668 8273111 8270757 8271481 8271782 8272219 8272671 8273115 8270767 8271485 8271788 8272220 8272682 8273121 8270800 8271489 8271789 8272221 8272688 8273129 8270819 8271495 8271790 8272222 8272691 8273133 8270822 8271500 8271793 8272232 8272692 8273136 8270825 8271510 8271794 8272233 8272693 8273144 8270827 8271514 8271816 8272237 8272704 8273159 8270828 8271515 8271817 8272243 8272705 8273165 8270835 8271528 8271819 8272244 8272706 8273169 8270842 8271531 8271821 8272247 8272714 8273172 8270843 8271534 8271824 8272249 8272719 8273173 8270855 8271542 8271868 8272250 8272722 8273187 8270859 8271573 8271871 8272251 8272723 8273200 8270863 8271590 8271873 8272258 8272727 8273203 8270878 8271601 8271880 8272270 8272741 8273210 8270903 8271605 8271881 8272283 8272743 8273216
EXHIBIT B 94 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8273220 8274054 8274963 8275610 8276157 8276683 8273232 8274079 8274970 8275612 8276159 8276687 8273238 8274128 8274975 8275627 8276161 8276692 8273277 8274141 8274980 8275631 8276171 8276695 8273313 8274146 8274985 8275657 8276173 8276699 8273318 8274170 8274997 8275673 8276175 8276708 8273334 8274176 8275003 8275682 8276188 8276709 8273345 8274199 8275005 8275692 8276191 8276710 8273364 8274205 8275007 8275703 8276198 8276716 8273386 8274213 8275011 8275704 8276199 8276717 8273395 8274224 8275036 8275723 8276202 8276719 8273399 8274234 8275056 8275733 8276203 8276721 8273412 8274247 8275060 8275745 8276212 8276732 8273418 8274252 8275082 8275765 8276226 8276736 8273419 8274256 8275085 8275775 8276241 8276738 8273423 8274258 8275086 8275779 8276254 8276750 8273444 8274275 8275092 8275784 8276258 8276755 8273494 8274281 8275108 8275791 8276260 8276759 8273503 8274283 8275113 8275793 8276272 8276781 8273511 8274309 8275119 8275798 8276277 8276789 8273521 8274320 8275127 8275804 8276285 8276801 8273532 8274325 8275142 8275810 8276288 8276807 8273535 8274330 8275172 8275816 8276296 8276817 8273536 8274331 8275178 8275824 8276302 8276832 8273543 8274337 8275185 8275829 8276316 8276841 8273556 8274348 8275188 8275830 8276329 8276843 8273561 8274355 8275192 8275843 8276336 8276850 8273562 8274363 8275198 8275847 8276343 8276854 8273571 8274375 8275200 8275848 8276351 8276855 8273581 8274378 8275206 8275854 8276358 8276860 8273586 8274388 8275209 8275858 8276370 8276862 8273587 8274391 8275213 8275860 8276372 8276869 8273595 8274397 8275227 8275868 8276378 8276872 8273600 8274405 8275238 8275872 8276399 8276876 8273601 8274419 8275254 8275878 8276417 8276880 8273605 8274421 8275267 8275885 8276428 8276886 8273617 8274424 8275278 8275886 8276429 8276892 8273630 8274441 8275290 8275910 8276447 8276893 8273674 8274457 8275299 8275912 8276448 8276895 8273688 8274478 8275308 8275922 8276451 8276900 8273691 8274493 8275324 8275931 8276455 8276903 8273710 8274495 8275325 8275935 8276456 8276904 8273729 8274506 8275334 8275942 8276468 8276910 8273736 8274511 8275337 8275949 8276474 8276914 8273743 8274518 8275338 8275966 8276477 8276918 8273749 8274532 8275341 8275967 8276484 8276922 8273775 8274546 8275360 8275974 8276486 8276927 8273777 8274556 8275389 8275991 8276491 8276939 8273872 8274558 8275397 8276007 8276495 8276940 8273881 8274561 8275402 8276010 8276501 8276941 8273886 8274680 8275413 8276016 8276502 8276949 8273900 8274699 8275415 8276046 8276505 8276951 8273908 8274704 8275417 8276067 8276537 8276952 8273922 8274706 8275426 8276069 8276540 8276953 8273931 8274738 8275441 8276072 8276546 8276955 8273934 8274756 8275448 8276079 8276566 8276961 8273943 8274760 8275451 8276082 8276568 8276965 8273947 8274810 8275454 8276100 8276569 8276967 8273948 8274828 8275461 8276103 8276575 8276979 8273951 8274841 8275462 8276106 8276597 8276992 8273955 8274871 8275467 8276107 8276600 8277013 8273981 8274911 8275542 8276110 8276604 8277071 8274009 8274925 8275552 8276115 8276619 8277076 8274015 8274931 8275564 8276118 8276630 8277112 8274029 8274933 8275571 8276124 8276647 8277163 8274031 8274940 8275581 8276127 8276650 8277172 8274037 8274945 8275583 8276139 8276656 8277178 8274047 8274947 8275590 8276142 8276664 8277201 8274049 8274952 8275595 8276146 8276668 8277226 8274052 8274954 8275606 8276147 8276674 8277289
EXHIBIT B 95 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8277301 8278381 8279315 8280653 8281661 8283005 8277320 8278391 8279327 8280657 8281686 8283025 8277340 8278397 8279352 8280685 8281687 8283053 8277363 8278403 8279363 8280692 8281693 8283060 8277373 8278404 8279384 8280698 8281696 8283094 8277374 8278419 8279385 8280700 8281697 8283159 8277381 8278420 8279389 8280701 8281698 8283180 8277403 8278426 8279396 8280724 8281699 8283215 8277406 8278471 8279404 8280738 8281706 8283277 8277408 8278491 8279406 8280743 8281707 8283292 8277413 8278516 8279440 8280749 8281709 8283298 8277421 8278528 8279448 8280755 8281717 8283303 8277433 8278535 8279464 8280766 8281723 8283311 8277434 8278554 8279470 8280767 8281737 8283326 8277480 8278571 8279478 8280772 8281745 8283331 8277507 8278590 8279491 8280776 8281755 8283334 8277511 8278610 8279496 8280784 8281783 8283335 8277523 8278627 8279499 8280823 8281785 8283339 8277540 8278644 8279510 8280828 8281825 8283344 8277572 8278686 8279521 8280868 8281870 8283346 8277579 8278733 8279551 8280884 8281925 8283349 8277592 8278737 8279554 8280932 8281994 8283360 8277631 8278742 8279579 8280957 8282013 8283390 8277634 8278747 8279580 8280989 8282024 8283396 8277641 8278751 8279588 8280991 8282032 8283428 8277642 8278756 8279606 8280994 8282044 8283429 8277663 8278779 8279634 8280999 8282047 8283442 8277676 8278780 8279650 8281034 8282050 8283463 8277687 8278785 8279659 8281055 8282059 8283464 8277707 8278791 8279666 8281056 8282070 8283467 8277710 8278795 8279676 8281080 8282072 8283476 8277716 8278798 8279694 8281095 8282106 8283487 8277723 8278802 8279706 8281119 8282120 8283499 8277731 8278804 8279709 8281129 8282122 8283585 8277747 8278814 8279724 8281137 8282127 8283656 8277748 8278825 8279752 8281158 8282128 8283724 8277766 8278836 8279756 8281183 8282134 8283742 8277768 8278839 8279771 8281185 8282141 8283744 8277770 8278847 8279781 8281204 8282150 8283792 8277783 8278849 8279795 8281226 8282181 8283822 8277788 8278866 8279798 8281238 8282200 8283824 8277793 8278872 8279840 8281262 8282207 8283832 8277794 8278873 8279896 8281265 8282260 8283846 8277800 8278891 8279920 8281266 8282268 8283851 8277809 8278895 8279960 8281283 8282286 8283951 8277819 8278902 8279992 8281307 8282299 8283982 8277822 8278918 8280097 8281317 8282302 8283993 8277827 8278923 8280122 8281325 8282311 8283994 8277836 8278930 8280152 8281352 8282314 8283997 8277844 8278964 8280157 8281363 8282322 8284016 8277855 8279004 8280177 8281377 8282330 8284027 8277898 8279027 8280180 8281384 8282340 8284041 8277904 8279038 8280188 8281387 8282348 8284062 8277933 8279045 8280201 8281399 8282358 8284091 8277951 8279078 8280213 8281409 8282373 8284133 8277965 8279195 8280214 8281412 8282375 8284166 8277995 8279213 8280238 8281413 8282394 8284198 8277999 8279221 8280241 8281424 8282427 8284205 8278005 8279236 8280250 8281440 8282521 8284232 8278064 8279240 8280266 8281443 8282592 8284288 8278084 8279244 8280273 8281449 8282663 8284581 8278120 8279250 8280305 8281495 8282794 8284702 8278157 8279253 8280310 8281519 8282814 8284721 8278211 8279257 8280323 8281547 8282825 8284727 8278235 8279263 8280340 8281587 8282834 8284831 8278334 8279290 8280347 8281595 8282879 8284846 8278337 8279300 8280441 8281603 8282908 8284852 8278349 8279306 8280509 8281626 8282913 8284916 8278360 8279307 8280532 8281642 8282931 8284929 8278364 8279312 8280553 8281644 8282940 8284953
EXHIBIT B 96 INITIAL CATEGORY ONE CLASS LIST (based upon AHP Settlement Trust database) 8284989 9889046 9890898 8285056 9889047 9890900 8285094 9889059 9890907 8285100 9889068 9890922 8285103 9889079 9890929 8285110 9889130 9890931 8285131 9889134 9890949 8285177 9889153 9890955 8285214 9889179 9890958 8285251 9889318 9890960 8285255 9889395 9890999 8285266 9889468 9891042 8285303 9889508 9891115 8285417 9889540 9891159 8285451 9889700 9891168 8285452 9889710 9891178 8285479 9889714 9891189 8285480 9889719 9891214 8285482 9889729 9891229 8285484 9889737 9891240 8285501 9889741 9891348 8285515 9889754 9891350 8285522 9889826 9891407 8285554 9889830 9891514 8285558 9889854 9891699 8285561 9889870 9891711 8285563 9889884 9891720 8285564 9889909 9891725 8285574 9889912 9891729 8285580 9889917 9891735 8285610 9889936 9891740 8285612 9889991 9891751 8285759 9890029 9891806 8285779 9890054 9891814 8285786 9890133 9891859 8285798 9890149 9891867 8285809 9890177 9891894 8285810 9890194 9891917 8285818 9890221 9892002 8285845 9890273 9892026 8285879 9890281 9892059 8285894 9890316 9892106 8285900 9890320 9892123 8285919 9890325 9892155 8285942 9890329 9892168 8286108 9890330 9892175 8286161 9890335 9892195 8286175 9890351 9892202 9888730 9890371 9892208 9888737 9890374 9892209 9888742 9890402 9892213 9888749 9890451 9892218 9888772 9890481 9892221 9888904 9890495 9892226 9888922 9890500 9892229 9888926 9890515 9892230 9888932 9890555 9892235 9888939 9890636 9892242 9888962 9890645 9888965 9890658 9888968 9890696 9888971 9890717 9888973 9890760 9888974 9890843 9888993 9890861 9889007 9890874 9889014 9890877 9889028 9890888 9889035 9890893 9889039 9890894
EXHIBIT B 97 SEVENTH AMENDMENT SECURITY FUND AGREEMENT THIS SEVENTH AMENDMENT SECURITY FUND AGREEMENT dated as of __________, 2004, made by Wyeth, a corporation organized under the laws of Delaware ("Wyeth"), Heffler, Radetich and Saitta, L.L.P, a Pennsylvania limited liability partnership, as Fund Administrator (together with any successor Fund Administrator, the "Fund Administrator"), and Wilmington Trust Company, as escrow agent with respect to the Seventh Amendment Security Fund as hereinafter defined (together with any successor escrow agent, the "Security Fund Escrow Agent"), and Class Counsel, by Michael D. Fishbein. W I T N E S S E T H: WHEREAS, pursuant to a Nationwide Class Action Settlement Agreement with Wyeth (f/k/a American Home Products Corporation), dated November 18, 1999 (as the same has been amended through the Sixth Amendment, the "Existing Settlement Agreement"), Wyeth and the Class Representatives of the Class certified in Sheila Brown, et al. v. American Home Products Corporation, Civil Action No. 99-20593, pending in the United States District Court for the Eastern District of Pennsylvania (the "Court"), have entered into a class action settlement which resolves claims against Wyeth arising from the marketing, sale, distribution, and use of the Diet Drug(s); WHEREAS, the Settlement Trust was established pursuant to the Existing Settlement Agreement, to which Wyeth is required to make certain payments as provided for in the Existing Settlement Agreement; WHEREAS, the Existing Settlement Agreement required Wyeth to establish a security fund and to grant the Settlement Trust a perfected security interest in the security fund as collateral for Wyeth's financial obligations to the Settlement Trust under the Existing Settlement Agreement; WHEREAS, the Security Fund and such security interest were established and granted pursuant to the Amended and Restated Security Fund and Escrow Agreement dated as of January 31, 2003 (such Security Fund and Escrow Agreement, as amended from time to time, the "Security Agreement"); WHEREAS, the Parties thereto have further amended the Existing Settlement Agreement by the Seventh Amendment to Nationwide Class Action Settlement Agreement with Wyeth dated as of July 21, 2004 (the "Seventh Amendment"); WHEREAS, the Court has preliminarily approved the Seventh Amendment; WHEREAS, the Seventh Amendment, among other things, requires Wyeth to establish a "Supplemental Class Settlement Fund" in an aggregate amount of $1.275 billion to be administered by the Fund Administrator for the purposes described in the Seventh Amendment; WHEREAS, the Seventh Amendment also requires Wyeth to establish the Seventh Amendment Security Fund as collateral security for Wyeth's Payment Obligations and Seventh Amendment Matrix Obligations. EXHIBIT C NOW, THEREFORE, in consideration of the premises and of the mutual covenants and agreements contained herein, the parties hereto agree as follows: ARTICLE I DEFINITIONS Section 1.1 Incorporation of Existing Settlement Agreement and Seventh Amendment Definitions. Capitalized terms used in this Agreement, and not otherwise defined, shall have the meanings ascribed to them in the Existing Settlement Agreement and the Seventh Amendment. Section 1.2 Additional Definitions. In this Agreement, the following capitalized terms shall have the following meanings: (a) "Adverse Claim" means a Lien or other encumbrance or other type of preferential arrangement. (b) "Agreement" means this Seventh Amendment Security Fund Agreement, as the same may be amended or supplemented from time to time. (c) "Category One Claim" means a claim made by a Category One Class Member. (d) "Collateral" has the meaning specified in Section 3.1(c). (e) "Covered Claims" means Category One Claims. (f) "Covered Member" means a Class Member entitled to, and who has made, a Category One Claim. (g) "Lien", with respect to any property, means any mortgage, charge, lien, pledge or security interest with respect to such property. (h) "Moody's" means Moody's Investors Service, Inc. (i) "Notice of Nonpayment" means a written notice from the Fund Administrator to Wyeth (with a copy to the Security Fund Escrow Agent, Class Counsel, and the SALC) advising Wyeth that it has failed to meet in full any of its Payment Obligations and setting forth the amount of such obligation and calculation thereof, if applicable. (j) "Notice of Walkaway or Non-approval" means a written notice from Wyeth to the Settlement Fund Escrow Agent and the Security Fund Escrow Agent (with a copy to the Fund Administrator), countersigned by Class Counsel, certifying (i) that Wyeth has exercised its Seventh Amendment Walkaway Right, (ii) Trial Court Approval of the Seventh Amendment has not occurred, or (iii) Final Judicial Approval of the Seventh Amendment has not occurred. (k) "Payment Obligations" means Wyeth's obligations to make payments to or deposits into the Supplemental Class Settlement Fund, pursuant to and on the terms contained in Section V.A of the Seventh Amendment. EXHIBIT C - 2 - (l) "Permitted Assets" means any of the following (a) readily marketable direct obligations of the United States or any agency or instrumentality thereof or obligations unconditionally guaranteed by the full faith and credit of the United States, maturing within 365 days of purchase, (b) certificates of deposit of or time deposits maturing within 365 days of purchase with any commercial bank that (i) has deposits insured by the Federal Deposit Insurance Corporation, (ii) is organized under the laws of the United States or any state thereof, (iii) has a minimum long-term rating of "A-3" (or the then equivalent) by Moody's and a long-term rating of "A-" (or the then equivalent) by Standard & Poor's, and (iv) has combined capital and surplus of at least $10 billion, (c) commercial paper issued by any corporation organized under the laws of any state of the United States and rated at least "Prime-1" short-term (or the then equivalent grade) and A-3 long-term (or the then equivalent grade) by Moody's or "A-1" short-term (or the then equivalent grade) and "A-" long-term (or the then equivalent grade) by Standard & Poor's, in each case with a maturity of not more than 180 days from the date of acquisition thereof, and (d) investments, classified as current assets of Wyeth or any of its subsidiaries under GAAP, in money market investment programs registered under the Investment Company Act of 1940, as amended, which are administered by financial institutions that have the highest short-term rating obtainable from either Moody's or Standard & Poor's, and the portfolios of which are limited solely to assets of the character, quality and maturity described in clauses (a), (b) and (c) of this definition. (m) "Permitted Entitlement Order" has the meaning specified in Section 2.5(a). (n) "Person" means any individual, corporation, company, voluntary association, partnership, joint venture, trust, unincorporated organization or government (or any agency, instrumentality or political subdivision thereof). (o) "SALC" means the Seventh Amendment Liaison Committee constituted pursuant to Section IV.D of the Seventh Amendment. (p) "Security Fund" means the Security Fund established pursuant to and as defined in the Security Agreement. (q) "Settlement Fund Escrow Agent" means PNC Advisors, N.A., as account administrator and escrow agent with respect to the Supplemental Settlement Fund. (r) "Seventh Amendment Matrix Obligations" means Wyeth's obligation to make deposits to fund the payment of Seventh Amendment Matrix Compensation Benefits pursuant to the provisions of Section IX.B of the Seventh Amendment. (s) "Seventh Amendment Security Fund" means the escrow account bearing account number __________ maintained with the Security Fund Escrow Agent, which will secure Wyeth's Payment Obligations. (t) "Seventh Amendment Security Fund Amount" means the sum of the outstanding balance of cash, Permitted Assets and other property credited to the Seventh Amendment Security Fund on the date of determination. EXHIBIT C - 3 - (u) "Sixth Amendment" means the Sixth Amendment to the Nationwide Class Action Settlement Agreement with Wyeth (f/k/a American Home Products Corporation), approved by the Court on March 12, 2003 in PTO No. 2778. (v) "Standard & Poor's" means Standard & Poor's Ratings Services, a division of The McGraw-Hill Companies, Inc. (w) "UCC" means the Uniform Commercial Code as in effect in the State of Delaware, or any successor statute, or any comparable law, as the same may from time to time be amended, supplemented or otherwise modified and in effect in such jurisdiction. (x) "United States" and "U.S." each means United States of America. (y) "US$" and "$" each means United States dollars. Section 1.3 Interpretation. (a) Unless otherwise indicated to the contrary herein by the context or use thereof: (i) the words, "herein," "hereto," "hereof" and words of similar import refer to this Agreement as a whole and not to any particular Section or paragraph hereof; and (ii) words importing the singular shall also include the plural, and vice versa. (b) All accounting terms not specifically defined herein shall be construed in accordance with GAAP. All terms used in Article 1, 8, or 9 of the UCC and not specifically defined herein are used herein as defined in such Article 1, 8 or 9. ARTICLE II ESCROW AGENT Section 2.1 Appointment of Escrow Agent. (a) The Fund Administrator and Wyeth hereby appoint Wilmington Trust Company as escrow agent with respect to the Seventh Amendment Security Fund in accordance with the terms and conditions set forth herein for the purposes set forth herein and in Section VI of the Seventh Amendment, and Wilmington Trust Company hereby accepts such appointment for the benefit of the Supplemental Settlement Fund. The appointment of the Security Fund Escrow Agent herein shall be effective upon the approval of this Agreement by the Court. (b) The Security Fund Escrow Agent shall operate under the supervision of the Court and subject to the terms of the Seventh Amendment. The Court shall have continuing exclusive jurisdiction over the Seventh Amendment Security Fund and its operation, and shall have the exclusive authority to enforce and interpret the provisions hereof and of the Seventh Amendment. Section 2.2 Limited Responsibility of Escrow Agent. It is understood and agreed that: (a) The Security Fund Escrow Agent shall not be liable for any action taken or omitted in reliance upon any written notice, request, direction, instruction, certificate, or other EXHIBIT C - 4 - instrument or document (whether in its original or facsimile form) reasonably believed by it to be genuine and signed by the proper party or parties. (b) The Security Fund Escrow Agent shall be entitled to receive and to rely conclusively upon advice of counsel regularly retained by it in respect of escrow matters, and the Security Fund Escrow Agent shall not be liable for any action taken or omitted in good faith pursuant to such advice. (c) The Security Fund Escrow Agent shall be obligated to exercise reasonable care and diligence in carrying out the provisions of this Agreement (but in any event shall be liable only for its willful misconduct or gross negligence), provided that in no event shall the Security Fund Escrow Agent incur any liabilities if by reason of any provisions of any present law or regulation or order of the United States of America, or any state or political subdivision thereof or any court of competent jurisdiction, it shall be prevented or forbidden from doing or performing any act or thing that this Agreement provides shall be done or performed, nor shall it incur any liability by reason of any delay in the performance or non-performance of any act or thing, which this Agreement provides shall be done or performed, as a result of the aforesaid, except as such are caused by its own willful misconduct or gross negligence. In no event shall the Security Fund Escrow Agent be liable for special, indirect or consequential damages or lost profits or loss of business arising under or in connection with this Agreement. The Security Fund Escrow Agent shall not be obligated to take any action that it reasonably believes is contrary to such laws, regulations or orders. (d) The Security Fund Escrow Agent shall not be responsible for the title, validity or genuineness of any property or evidence of title thereto received by it or delivered by it pursuant to this Agreement. (e) If the Security Fund Escrow Agent should at any time be confronted with an Adverse Claim or any inconsistent claims or demands to the property held in escrow hereunder, the Security Fund Escrow Agent shall have the right to interplead the disputing parties in the United States District Court for the Eastern District of Pennsylvania and request that such court determine such respective rights of said parties with respect to this Agreement, and upon doing so, the Security Fund Escrow Agent automatically shall be released from any duties, obligations or liability of any kind as a consequence of any such claims or demands. (f) No provision of this Agreement shall require the Security Fund Escrow Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder. Section 2.3 Indemnity. The Security Fund Escrow Agent shall be indemnified and held harmless by Wyeth from and against all costs, damages, judgments, attorneys' fees, expenses (including expenses of interpleader referred to in Section 2.2(e)), obligations, and liabilities of every kind and nature which the Security Fund Escrow Agent may incur, sustain, or be required to pay in connection with or arising out of this Agreement, except any such costs, damages, judgments, attorneys' fees, expenses, obligations and liabilities which shall arise from or by reason of its willful misconduct or gross negligence. To secure such indemnification and EXHIBIT C - 5 - to satisfy its compensation hereunder, the Security Fund Escrow Agent is hereby given a first lien upon, and the right to reimbursement therefor out of, the Seventh Amendment Security Fund. The terms of this Section shall survive termination of this Agreement. Section 2.4 Resignation; Removal. (a) The Security Fund Escrow Agent may resign from this Agreement, and thereby become discharged from the obligations hereby created, by notice in writing given to the Fund Administrator, Wyeth, Class Counsel, the SALC and the Court not less than 60 days before such resignation is to take effect; provided, however that such resignation shall not be effective before the date a successor Security Fund Escrow Agent has been designated and qualified to serve. (b) The Security Fund Escrow Agent may be removed from this Agreement at any time and thereby become discharged from the obligations hereby created subsequent to the date of such discharge, by order of the Court for good cause shown. Section 2.5 Investments in Permitted Assets. (a) Subject to the limitations contained in Section 3.1(d) and unless and until the Security Fund Escrow Agent receives a Notice of Nonpayment from the Fund Administrator or a notice of default from the Trust pursuant to Section 3.4 directing the Security Fund Escrow Agent to transfer all or a portion of the Seventh Amendment Security Fund Amount to the Supplemental Settlement Fund or the Trust, as the case may be, the Security Fund Escrow Agent will comply with all written notifications or entitlement orders originated by Wyeth which direct the Security Fund Escrow Agent to invest or reinvest in Permitted Assets or to sell, transfer, or redeem any property in the Seventh Amendment Security Fund in connection with Wyeth's Payment Obligations (each a "Permitted Entitlement Order") without further consent by the Fund Administrator, the Trust or any other Person. To that end, the Security Fund Escrow Agent is directed to liquidate any securities and other property (other than cash) from the Seventh Amendment Security Fund and invest the proceeds thereof in Permitted Assets as directed by Wyeth. The Security Fund Escrow Agent may sell such investments from time to time as required to disburse funds in accordance with this Agreement. All such investments (including principal, interest, and sale proceeds) shall at all times constitute a part of the Seventh Amendment Security Fund Amount, and all income and profits on such investments shall be credited to, and losses thereon shall be charged against, the Seventh Amendment Security Fund. (b) Distributions by the Security Fund Escrow Agent to Wyeth pursuant to a Permitted Entitlement Order in accordance with Section 3.1(d) shall be made to Wyeth to its deposit account (account no. 123-000-123) maintained by JP Morgan Chase Bank or to such other account as shall be specified in such Permitted Entitlement Order. Section 2.6 Tax Reporting. (a) Title to all Permitted Assets and other property, including all income earned and other property distributed with respect thereto, held in the Seventh Amendment Security Fund by the Security Fund Escrow Agent shall reside in Wyeth. All items of income, gain, expense and loss recognized in the Seventh Amendment Security Fund shall be reported to the Internal Revenue Service and all relevant state and local taxing authorities under the name and taxpayer identification number of Wyeth, and Wyeth shall be EXHIBIT C - 6 - responsible for the payment of all federal, state and local taxes payable with respect to or on account of the Seventh Amendment Security Fund. The taxpayer identification number of Wyeth is 13-2526821. (b) All federal, state and local taxes attributable to the Seventh Amendment Security Fund Amount, whether payable by Wyeth or by the Seventh Amendment Security Fund, shall be paid from the Seventh Amendment Security Fund. The Security Fund Escrow Agent shall promptly pay, or reimburse Wyeth for, any and all federal, state and local taxes attributable to the Seventh Amendment Security Fund Amount out of the funds deposited in the Seventh Amendment Security Fund. Section 2.7 Segregated Account. (a) The Seventh Amendment Security Fund Amount held in the Seventh Amendment Security Fund shall be held separately from all other funds or accounts held by the Security Fund Escrow Agent. (b) For its services, the Security Fund Escrow Agent shall receive fees in accordance with a schedule to be agreed upon in writing by the parties hereto or, in the absence of any such agreement, approved by the Court. All such fees shall constitute a direct charge against the Seventh Amendment Security Fund. Section 2.8 Statements, Confirmations and Notices of Adverse Claims. The Security Fund Escrow Agent will send copies of all statements and confirmations concerning the Seventh Amendment Security Fund to Wyeth, the Fund Administrator, Class Counsel, the SALC and the Trust at their notice addresses set forth below. If any Person asserts any Adverse Claim against the Seventh Amendment Security Fund or in any Seventh Amendment Security Fund Amount carried therein, the Security Fund Escrow Agent will promptly notify the Fund Administrator and Wyeth thereof. The Security Fund Escrow Agent will promptly provide to Wyeth, Class Counsel, and the SALC all statements, reports, documents and/or other information requested by Wyeth in connection with any tax matters that arise related to the Seventh Amendment Security Fund. EXHIBIT C - 7 - ARTICLE III SEVENTH AMENDMENT SECURITY FUND Section 3.1 Establishment and Terms of Seventh Amendment Security Fund. (a) Establishment of Seventh Amendment Security Fund. The Security Fund Escrow Agent has established and shall maintain the Seventh Amendment Security Fund. (b) Deposits into the Seventh Amendment Security Fund. Within ten Business Days after the date of Trial Court Approval of the Seventh Amendment, Wyeth shall transfer to the Security Fund Escrow Agent for credit to the Seventh Amendment Security Fund cash and/or Permitted Assets in an amount that is equal to $1.275 billion minus the sum of Wyeth's Payment Obligations that have been paid as of such date. (c) Grant of Security. (i) Wyeth hereby pledges, assigns and grants to the Fund Administrator on behalf of the Supplemental Class Settlement Fund a security interest in all of Wyeth's right, title and interest in and to all cash, Permitted Assets and other financial assets from time to time standing to the credit of the Seventh Amendment Security Fund, all security entitlements with respect to such Seventh Amendment Security Fund and the proceeds of all of the foregoing (collectively, the "Collateral"). Wyeth also hereby pledges, assigns and grants to the Trustees on behalf of the Trust a security interest in all of Wyeth's right, title and interest in and to the Collateral, subject to subsection (c)(iii) below. (ii) The security interest in the Collateral granted hereby shall (A) in the case of the Supplemental Class Settlement Fund, secure Wyeth's Payment Obligations, and (B) in the case of the Trust, secure Wyeth's Seventh Amendment Matrix Obligations. (iii) The security interest in the Collateral granted to the Trustees on behalf of the Trust pursuant to subsection (c)(i) above shall be subordinate to the security interest granted to the Fund Administrator on behalf of the Supplemental Settlement Fund therein, and shall not be enforceable until such time as the Fund Administrator has substantially completed the distribution of amounts in the Supplemental Settlement Fund to Category One Class Members and delivered a certification thereof to the Court and the Security Fund Escrow Agent. Upon delivery of such certification to the Court, the Trust shall have the rights and remedies available to the Fund Administrator under Section 3.3(b). (iv) Wyeth will take all action which is reasonably necessary to ensure that the Fund Administrator and the Trust have a continuing perfected security interest in the Collateral, as their interests appear, while the Seventh Amendment Security Fund is in effect. In furtherance but without limitation of the foregoing, Wyeth hereby authorizes the Fund Administrator or the Trustees, as the case may be, at any time and from time to time to file in any filing office in any jurisdiction any initial financing statements, amendments thereto and continuation statements that (i) indicate the Collateral and (ii) provide any other information required by part 5 of Article 9 of the UCC. EXHIBIT C - 8 - (v) Except to the extent expressly provided herein, the security interest created hereby shall not apply to the Security Fund and the Collateral, as defined in the Security Agreement, and the Trust shall have no rights therein or claim thereto. (d) Withdrawals by Wyeth from the Seventh Amendment Security Fund. (i) Without limiting the transfer provisions of Section 3.2, Wyeth shall be entitled, from time to time, to withdraw income earned with respect to the Seventh Amendment Security Fund Amount and other amounts in excess of Wyeth's unpaid Payment Obligations pursuant to this subsection (d). If at any time the balance of the Seventh Amendment Security Fund exceeds 100% of the amount of Wyeth's Payment Obligations that are unpaid at such time, Wyeth may withdraw, at its option, free of any Lien, cash and/or Permitted Assets from the Seventh Amendment Security Fund, provided that: (A) The balance of the Seventh Amendment Security Fund taking into account such withdrawal must equal or exceed 100% of the amount of Wyeth's unpaid Payment Obligations; (B) Wyeth may make such withdrawals no more frequently than once monthly; and (C) At any time that the balance of the Seventh Amendment Security Fund is less than or equal to $255 million, no further withdrawals shall be permitted. (ii) The Security Fund Escrow Agent shall, from time to time, pay to Wyeth such excess amounts, within five days following delivery of a notice of withdrawal from Wyeth, to such account as directed by Wyeth. (iii) Notwithstanding the provisions of clause (d)(i) above, in the event the Seventh Amendment Security Fund Amount is less than $255 million then Wyeth shall, within 30 days following a written request from the Fund Administrator, pay to the Security Fund Escrow Agent for deposit into the Seventh Amendment Security Fund an amount equal to the difference between $255 million and such Seventh Amendment Security Fund Amount. (e) Termination of Seventh Amendment Security Fund. The Seventh Amendment Security Fund and the Liens granted pursuant to Section 3.1(c) shall terminate and be released on: (i) the date of delivery by Wyeth to the Settlement Fund Escrow Agent and the Security Fund Escrow Agent of a Notice of Walkaway or Non-approval stating that Final Judicial Approval of the Seventh Amendment has not occurred; or (ii) June 30, 2012, whichever date is earlier. Upon termination of the Seventh Amendment Security Fund pursuant to this Section, the Security Fund Escrow Agent shall pay to Wyeth the Seventh Amendment Security Fund EXHIBIT C - 9 - Amount, within five days of a notice from Wyeth to such effect, to such account as directed by Wyeth. Section 3.2 Payment of Settlement Fund Obligations. Wyeth shall be entitled to satisfy its Payment Obligations from funds and other property credited to the Seventh Amendment Security Fund from time to time. Upon written transfer instructions from Wyeth to the Security Fund Escrow Agent, delivered at least five days prior to a date on which Wyeth is required to make any deposit or payment in respect of its Payment Obligations and setting forth the amount of such deposit or payment, the Security Fund Escrow Agent is hereby authorized and directed to transfer to the Settlement Fund Escrow Agent for credit to the Supplemental Class Settlement Fund, on the date such deposit or payment is required to be made and to the extent funds are available in the Seventh Amendment Security Fund, cash in the amount of such required deposit or payment. Section 3.3 Remedies upon Default. If a Notice of Nonpayment shall have been delivered to Wyeth and the Security Fund Escrow Agent by the Fund Administrator and the payment default referred to therein shall be continuing after five days from the date of such Notice: (a) The Fund Administrator, prior to exercising its rights under Section XVI.A of the Seventh Amendment, shall request the Security Fund Escrow Agent to exercise the remedies of the Fund Administrator under Sections 3.3(b) and (c), and the Security Fund Escrow Agent shall exercise such remedies in order to cure the payment default specified in the Notice of Nonpayment. If the Security Fund Escrow Agent is unable to so exercise such remedies and cure such payment default, it shall notify the Fund Administrator, Class Counsel, the SALC and Wyeth thereof. In such event the Fund Administrator may but shall not be required to exercise its rights under Section XVI.B of the Seventh Amendment. (b) The Fund Administrator may exercise in respect of the Collateral, in addition to other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of a secured party upon default under the UCC, and the Security Fund Escrow Agent shall upon specific instructions from the Fund Administrator, without notice except as specified below, sell the Collateral or any part thereof in one or more parcels at public or private sale, at any exchange, broker's board or at any of the Fund Administrator's or the Security Fund Escrow Agent's offices or elsewhere, for cash, on credit or for future delivery, and upon such other terms as the Fund Administrator may deem commercially reasonable. Wyeth agrees that, to the extent notice of sale shall be required by law, at least ten days' notice to Wyeth of the time and place of any public sale or the time after which any private sale is to be made shall constitute reasonable notification. The Fund Administrator shall not be obligated to make any sale of Collateral regardless of notice of sale having been given. The Fund Administrator may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned. (c) Any cash held by the Security Fund Escrow Agent as Collateral and all cash proceeds received by the Security Fund Escrow Agent in respect of any sale of, collection from, EXHIBIT C - 10 - or other realization upon all or any part of the Collateral shall be transferred to the Supplemental Settlement Fund in an amount sufficient to cure the payment default referred to in the Notice of Nonpayment. Any surplus of such cash or cash proceeds held by the Security Fund Escrow Agent and remaining after payment in full shall be deposited into the Seventh Amendment Security Fund and held by the Security Fund Escrow Agent as Collateral pursuant to the terms of this Agreement. Section 3.4 Remedies Available to Trust. (a) Subject to Section 3.1(c)(iii), upon a default by Wyeth with respect to any of its Seventh Amendment Matrix Obligations, the Trustees shall deliver a notice of such default to Wyeth and the Security Fund Escrow Agent. Such notice shall specify the nature of the default and the amount of the deposit to the Trust required to be made by Wyeth in order to cure such default. (b) In the event Wyeth has not cured such default within ten days following its receipt of the notice described in subsection (a) above, the Trust shall have the rights and remedies of a secured party upon default under the U.C.C. and shall with specific written instructions request the Security Fund Escrow Agent to exercise, with respect to the Collateral, the rights of the Fund Administrator, as described in Section 3.3(b) and to cure such default, and the Security Fund Escrow Agent shall exercise such remedies in order to cure the payment default specified in the notice of default. Any cash held by the Security Fund Escrow Agent as Collateral and all cash proceeds received by the Security Fund Escrow Agent in respect of any sale of, collection from, or other realization upon all or any part of the Collateral shall be transferred to the Trust in an amount sufficient to cure the payment default referred to in the notice of default provided by the Trust pursuant to Section 3.4(a). Any surplus of such cash or cash proceeds held by the Security Fund Escrow Agent and remaining after payment in full of the defaulted amount shall be deposited into the Seventh Amendment Security Fund and held by the Security Fund Escrow Agent as Collateral pursuant to the terms of this Agreement. ARTICLE IV MISCELLANEOUS Section 4.1 Termination. This Agreement shall continue in effect until, but shall terminate on the date of the earliest to occur of the events referred to in Section 3.1(e). Upon such termination, the Fund Administrator shall execute and deliver to Wyeth such documents as Wyeth shall reasonably request to evidence the release of the Supplemental Settlement Fund and the release of the Seventh Amendment Security Fund from the security interest granted hereby. Section 4.2 Amendments. No amendment, modification or termination of this Agreement shall be binding on any party hereto unless it is in writing and is signed by each of the parties hereto, and any attempt to so amend, modify or terminate except pursuant to such a writing shall be null and void. No waiver of any rights hereunder shall be binding on any party hereto unless such waiver is in writing and signed by the party against whom enforcement is sought. EXHIBIT C - 11 - Section 4.3 Wyeth's Obligations Not Affected. The obligations of Wyeth under this Agreement shall remain in full force and effect without regard to, and shall not be impaired or affected by: (a) any amendment or modification of or addition or supplement to the Seventh Amendment, except to the extent Wyeth's obligations hereunder are modified or amended thereby; (b) any exercise or non-exercise by the Fund Administrator of any right, remedy, power or privilege under or in respect of this Agreement or the Seventh Amendment, or any waiver of any such right, remedy, power or privilege; (c) any waiver, consent, extension, indulgence or other action or inaction in respect of this Agreement or the Seventh Amendment; or (d) any bankruptcy, insolvency, reorganization, arrangement, readjustment, composition, liquidation or the like of Wyeth, whether or not the Security Fund Escrow Agent or the Fund Administrator shall have notice of any of the foregoing. Section 4.4 Severability. If any term or provision set forth in this Agreement shall be invalid or unenforceable, the remainder of this Agreement shall be construed in all respects as if such invalid or unenforceable term or provision were omitted. Section 4.5 Successors. The terms of this Agreement shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective corporate successors or heirs and personal representatives. Section 4.6 Notices. Except as otherwise expressly provided herein, any notice, order, instruction, request or other communication required or permitted to be given under this Agreement shall be in writing and deemed to have been properly given when delivered in person or when sent by telecopy or other electronic means and electronic confirmation of error free receipt is received or upon receipt of notice sent by certified or registered United States mail, return receipt requested, postage prepaid, addressed to the party at the address set forth on Annex A hereto (or such other address as may be specified in a notice in the manner set forth above). Section 4.7 Counterparts. This Agreement may be executed in any number of counterparts, all of which shall constitute one and the same instrument, and any party hereto may execute this Agreement by signing and delivering one or more counterparts. Counterparts may be exchanged by telecopier, with originals to be delivered promptly thereafter. Section 4.8 Choice of Law. This Agreement shall be governed by the law of the State of Delaware. EXHIBIT C - 12 - IN WITNESS WHEREOF, the parties hereto have duly executed this Seventh Amendment Security Fund Agreement as of the day and year first above written. WYETH By ________________________________ Title: HEFFLER, RADETICH AND SAITTA, L.L.P By ________________________________ Title: WILMINGTON TRUST COMPANY By ________________________________ Title: CLASS COUNSEL By ________________________________ Michael D. Fishbein, Esquire LEVIN, FISHBEIN, SEDRAN & BERMAN SEVENTH AMENDMENT LIAISON COMMITTEE By ________________________________ Wayne R. Spivey, Esquire SHRAGER, SPIVEY & SACHS EXHIBIT C - 13 - ANNEX A Addresses for Notices If to Wyeth: Wyeth Five Giralda Farms Madison, NJ 07940 Attn: Senior Vice President and General Counsel Telecopy: 973-660-7150 With copy to: Vice President and Treasurer Telecopy: 973-660-7174 If to the Fund Administrator: Heffler, Radetich and Saitta, L.L.P. 1515 Market Street, Suite 1700 Philadelphia, PA 19102 Attn.: Edward J. Radetich, Jr., CPA Telecopy: 215-665-0613 If to the Security Fund Escrow Agent: Wilmington Trust Company Rodney Square North 1100 North Market Street Wilmington, DE 19890 Attn.: Corporate Trust Custody Telecopy: 302-636-4149 If to the Settlement Fund Escrow Agent: PNC Advisors, N.A. [address] Attn.: Telecopy: If to the Trust: c/o Wolf, Block, Schorr & Solis-Cohen 1650 Arch Street, 22nd Floor Philadelphia, PA 19103 Attn.: Andrew A. Chirls, Esq. Telecopy: EXHIBIT C If to Class Counsel: Levin, Fishbein, Sedran & Berman 510 Walnut Street, Suite 500 Philadelphia, PA 19106 Attn.: Michael D. Fishbein, Esq. Telecopy: If to the SALC: Seventh Amendment Liaison Committee c/o Shrager, Spivey & Sachs Two Commerce Square, 32nd Floor 2001 Market Street Philadelphia, PA 19103 Attn. Wayne R. Spivey, Esq. Telecopy: EXHIBIT C [Claims Facility Header] [Date] Class Member Name Address RE: ____________ PAYMENT DIET DRUG RECIPIENT: [CLASS MEMBER NAME] CLAIM NUMBER: [DDR] Dear [Class Member Name]: You are a Category [One/Two] Class Member under the Nationwide Class Action Settlement Agreement, as amended by the Seventh Amendment, relating to the diet drugs Pondimin(R) and Redux(TM) (the "Diet Drugs"). The [Trust/Fund Administrator] has reviewed the documents you submitted and has determined at this time that you are eligible for a benefit under the Settlement Agreement in the amount provided for on the enclosed check. Capitalized terms in this letter have the meanings given them in the Settlement Agreement, as amended. As a Class Member, you are subject to all of the terms of the Settlement Agreement, regardless of whether you cash the enclosed check. As a result, you are entitled to the benefits provided to eligible Class Members under the Settlement Agreement, and are bound by all of its restrictions. You can refer to the Court-approved Notices previously mailed to you for more detail on those provisions. If you would like another copy of the most recent Notice, or of the entire Settlement Agreement, contact the AHP Settlement Trust at 1-800-386-2070, or visit the Trust's official website at www.settlementdietdrugs.com. As more specifically set out in the Settlement Agreement and in the Court-approved Notices, your endorsement and cashing of the enclosed check constitutes your confirmation that you: (a) release and forever discharge Wyeth and all Released Parties from: all Settled Claims; all claims arising from any acts or omissions of the Trust, its officers, agents, employees, attorneys and all other persons acting or purporting to act on the Trust's behalf; and all claims arising out of Wyeth's role in drafting, negotiating, obtaining approval of, or the administration of the Settlement Agreement; (b) reaffirm each and every release previously provided for the benefit of each and every Released Party from each and every Settled Claim, notwithstanding any event, act, transaction or thing prior to the execution of the Seventh Amendment, including, without limitation, the manner in which the Settlement Agreement was negotiated, the alleged inadequacy EXHIBIT D Page 2 of representation provided to Class Members in connection with the negotiation of the Settlement Agreement, the alleged inadequacy of notice provided to the Class in connection with the Settlement Agreement, the process by which the Settlement Agreement was approved, the payment of claims to Class Members not qualified to receive benefits under the Settlement Agreement, and any alleged inadequacy of funds available to the Trust to pay all claims for Matrix Compensation Benefits; (c) agree not to bring any legal action against any Trustee of the Trust or any officer or employee of the Trust arising from the performance of their duties under the Settlement Agreement as to which the Trustee and/or Trust officer or employee of the Trust may have a right of indemnity against the Trust, or against the Trust with respect to any such claims (neither this clause nor any other clause bars you from collecting benefits under the Settlement Agreement to which you are expressly entitled); (d) agree not to initiate, assert, maintain or prosecute any claim released by the foregoing clauses, seek to enforce any such right or claim, including by action, motion, appeal or any other manner, or attempt to establish a right not to be bound by the Settlement Agreement, and waive and relinquish any right under any applicable law not to be bound by the Settlement Agreement which might be established on behalf of Class Members by action taken by any other person; and (e) agree that you will satisfy from the funds provided to you with this letter, any lawful reimbursement or "subrogation" claims of private insurers or governmental agencies or programs (such as Medicare) that have provided medical services to you or paid for your medical care in connection with any health problem arising out of or relating to the Diet Drugs. You have _____ days to cash this check. If you do not do so by that deadline, you may lose your eligibility for this benefit. Under the Settlement Agreement and the Court's Orders approving it, the above terms apply to you regardless of whether you actually cash the enclosed check. If you have any questions regarding any of the above, consult your attorney or call 1-800-___-____ and refer to the Claim Number above, or contact us through our web site at [www.__________]. Sincerely, [Trust/Fund Administrator] EXHIBIT D CATEGORY TWO ELECTION FORM The purpose of this Form is to permit Category One Class Members to become Category Two Class Members and to receive the Minimum Payment Amount of $2,000, plus the Cash/Medical Services Benefit, without further medical review or audit of their claim, provided that they have appropriately documented Diet Drug use and a diagnosis of FDA Positive regurgitation after Diet Drug use and before the close of the Screening Period. INSTRUCTIONS 1. Complete this Form in its entirety. Print or type all information. 2. The Class Member and the Class Member's attorney, if the Class Member is represented, must read, sign, and date this Form. 3. Return the completed Form to: Fund Administrator [Address to be determined]. THE FORM MUST BE POSTMARKED NO LATER THAN [DATE] , OR IT IS NOT EFFECTIVE. 4. If the Seventh Amendment receives Final Judicial Approval, this Election is final and binding and cannot be retracted after it is transmitted to the Fund Administrator. IDENTIFYING INFORMATION - ------------------------------------------------------------------------------------------------------------------------------- NAME OF CLASS MEMBER | | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------- --------- ------------------------------ First Name MI Last Name - ------------------------------------------------------------------------------------------------------------------------------- ADDRESS OF CLASS MEMBER | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- Street Address | | | | | | | | | | | | | | | | | | | | | - | | | | ----------------------------------------------------- --------- ----------------------------- City State Zip Code - ------------------------------------------------------------------------------------------------------------------------------- SOCIAL SECURITY NUMBER | | | | - | | | - CLAIM NUMBER | | | | | | | | | | ------------------------------- (IF AVAILABLE) ------------------------------------- - ------------------------------------------------------------------------------------------------------------------------------- NAME OF ATTORNEY (IF ANY) | | | | | | | | | | | | | | | | | | | | | | | | --------------------------------------------------------- --------- --------------------- First Name MI Last Name - ------------------------------------------------------------------------------------------------------------------------------- NAME OF LAW FIRM | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- Law Firm - ------------------------------------------------------------------------------------------------------------------------------- ADDRESS OF LAW FIRM | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- Street Address | | | | | | | | | | | | | | | | | | | | | - | | | | ----------------------------------------------------- --------- ----------------------------- City State Zip Code - ------------------------------------------------------------------------------------------------------------------------------- ATTORNEY'S TELEPHONE NUMBER | | | | | | | | - | | | | | | | | | | | | | ---------- -------------------- ATTORNEY'S FACSIMILE ------------------------------------- Area Code Phone Number NUMBER Area Code Phone Number - ------------------------------------------------------------------------------------------------------------------------------- ATTORNEY'S EMAIL ADDRESS | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- E-mail - -------------------------------------------------------------------------------------------------------------------------------
ELECTION By my signature below, I hereby elect to withdraw the Matrix Claim that qualified me as a Category One Class Member, as described in Section III.A.1 of the Seventh Amendment to the Settlement Agreement. I wish to receive the $2,000 Matrix Election Payment described in Section VIII.C of the Seventh Amendment, the Cash/Medical Services Benefit if not previously paid to me (provided that I have appropriately documented Diet Drug use and a diagnosis of FDA Positive regurgitation before the close of the Screening Period), and other benefits as a Category Two Class Member for which I become eligible, provided that the Seventh Amendment receives Final Judicial Approval. I understand that I am giving up any rights and/or benefits that I may have had as a Category One Class Member. I further understand that this Election is final and binding, if the Seventh Amendment receives Final Judicial Approval, and that once it is transmitted to the Fund Administrator, it cannot be retracted. I have had the opportunity to consult with my attorney identified above, or to retain an attorney to advise me, and make this request voluntarily and with full knowledge of the consequences of my actions. SIGNATURE: __________________________________ DATE: ________/________/_________ Class Member (month) (day) (year) SIGNATURE: __________________________________ DATE: _________/________/________ Attorney (if any) (month) (day) (year) EXHIBIT E RELEASE AND COVENANT NOT TO SUE THE DIET DRUG RECIPIENT ("DDR") OR AUTHORIZED REPRESENTATIVE CLAIMANT MUST COMPLETE AND SIGN THIS RELEASE FORM AND RETURN IT TO THE FUND ADMINISTRATOR BEFORE THAT CATEGORY ONE CLASS MEMBER MAY RECEIVE ANY PORTION OF AN INDIVIDUAL PAYMENT AMOUNT FROM THE SUPPLEMENTAL CLASS SETTLEMENT FUND. AN ATTORNEY FOR THE DDR OR REPRESENTATIVE CLAIMANT MUST COMPLETE AND SIGN THE ATTORNEY SECTION OF THIS FORM. CLASS MEMBER IDENTIFYING INFORMATION (AN ATTORNEY MAY NOT SIGN THIS SECTION OF THIS FORM ON BEHALF OF A CLIENT, UNLESS THE ATTORNEY QUALIFIES AS A REPRESENTATIVE CLAIMANT PURSUANT TO THE SETTLEMENT AGREEMENT) - ------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | | | | | | | | | | | | | | | | | | NAME OF DDR ----------------------------------------- --------- ----------------------------------------- First Name MI Last Name - ------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- Street Address ADDRESS OF DDR | | | | | | | | | | | | | | | | | | | | - | | | | | -------------------------------------------------- --------- --------------------------------- City State Zip Code - ------------------------------------------------------------------------------------------------------------------------------- ( | ) | | | - | | | | DATE OF BIRTH OF DDR | | / | | | | | | ------------------------------------- --------------------------------- TELEPHONE NUMBER OF DDR Area Code Phone Number Date of Birth - MM/DD/YYYY) - ------------------------------------------------------------------------------------------------------------------------------- SOCIAL SECURITY NUMBER OF | | | | - | | | - | | | CLAIM NUMBER/DDR NUMBER (IF 18300 - | | | | | | DDR ------------------------------------- AVAILABLE) -------------------- - -------------------------------------------------------------------------------------------------------------------------------
IF YOU ARE COMPLETING THIS FORM AS THE REPRESENTATIVE CLAIMANT (I.E., ESTATE, ADMINISTRATOR, OR OTHER LEGAL REPRESENTATIVE, HEIR, OR BENEFICIARY OF A DIET DRUG RECIPIENT), YOU MUST COMPLETE ALL OF THE FOLLOWING. YOU ALSO MUST ATTACH A COPY OF THE ORDER OR DOCUMENT AUTHORIZING YOU TO ACT AS THE REPRESENTATIVE CLAIMANT OF THE DIET DRUG RECIPIENT IDENTIFIED ABOVE. - ------------------------------------------------------------------------------------------------------------------------------- NAME OF REPRESENTATIVE | | | | | | | | | | | | | | | | | | | | | | | | | CLAIMANT (IF ANY) ----------------------------------------- --------- ----------------------------------------- First Name MI Last Name - ------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | | | | | | | | | | | | | | | | | | ADDRESS OF REPRESENTATIVE ------------------------------------------------------------------------------------------------- CLAIMANT Street Address | | | | | | | | | | | | | | | | | | | | - | | | | | -------------------------------------------------- --------- --------------------------------- City State Zip Code - ------------------------------------------------------------------------------------------------------------------------------- TELEPHONE NUMBER OF ( | ) | | | - | | | | DATE OF BIRTH OF DDR | | / | | | | | | REPRESENTATIVE CLAIMANT ------------------------------------- REPRESENTATIVE CLAIMANT ------------------------------- Area Code Phone Number Date of Birth - MM/DD/YYYY) - ------------------------------------------------------------------------------------------------------------------------------- SOCIAL SECURITY NUMBER OF | | | | - | | | - | | | CLAIM NUMBER (IF AVAILABLE) 18300 - | | | | | | REPRESENTATIVE CLAIMANT ------------------------------------- OF REPRESENTATIVE CLAIMANT -------------------- - ------------------------------------------------------------------------------------------------------------------------------- RELATIONSHIP TO DDR | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------
CLASS MEMBER RELEASE AND COVENANT NOT TO SUE (SEE ATTACHMENT A FOR DEFINITIONS OF TERMS USED IN THIS FORM) I have received and had an opportunity to read Parts I and II of the "Official Court Notice of the Seventh Amendment to the Nationwide Class Action Settlement" relating to the Nationwide Class Action Settlement Agreement, as amended (the "Settlement Agreement"). I have executed and am submitting this Form to obtain the benefits available to me under the Seventh Amendment from the Supplemental Class Settlement Fund. However, I understand that the releases and other provisions of the Seventh Amendment apply to me, regardless of whether I sign and return to the Fund Administrator this Release and Covenant Not to Sue. I, individually and for my heirs, beneficiaries, agents, estate, executors, administrators, personal representatives, attorneys, successors and assigns, and/or if I am a legal representative of another person, then in that capacity (the "Releasing Parties"), accordingly hereby agree to and affirm all of the following: 1. The following claims of the Releasing Parties are hereby released and forever discharged: all Settled Claims against any Released Party; all claims against any Released Party arising from any acts or omissions of the Trust, its officers, agents, employees, attorneys and all other persons acting or purporting to act on the Trust's behalf; and all claims arising out of Wyeth's role in drafting, negotiating, obtaining approval of, or the administration of the Settlement Agreement. I reaffirm each and every release previously provided for the benefit of each and every Released Party from each and every Settled Claim, notwithstanding any event, act, transaction or thing from the beginning of the world until the Execution Date of the Seventh Amendment, including, without limitation, the manner in which the Settlement Agreement was negotiated, the alleged inadequacy of representation provided to Class Members in 1 EXHIBIT F connection with the negotiation of the Settlement Agreement, the alleged inadequacy of notice provided to the Class in connection with the Settlement Agreement, the process by which the Settlement Agreement was approved, the payment of claims to Class Members not qualified to receive benefits under the Settlement Agreement, and any alleged inadequacy of funds available to the Trust to pay all claims for Matrix Compensation Benefits. This Release and Covenant Not to Sue is solely for the benefit of the Released Parties. 2. I shall not initiate, assert, maintain or prosecute any legal action against any Trustee, officer or employee of the Trust arising from the performance of their duties under the Settlement Agreement, as to which the Trustee and/or Trust officer or employee may have a right of indemnity from the Settlement Fund or against the Trust with respect to any such claims; provided, however, that nothing contained herein shall preclude the Releasing Parties from recovering benefits due under the Settlement Agreement, as amended by the Seventh Amendment. 3. I shall not initiate, assert, maintain or prosecute any claim released by the foregoing clauses, seek to enforce any such right or claim, including by action, motion, appeal or any other manner, or attempt to establish a right not to be bound by the Settlement Agreement. I waive and relinquish any right under any applicable law not to be bound by the Settlement Agreement which might be established on behalf of Class Members by action taken by any other person. 4. Nothing in this Release and Covenant Not to Sue shall be interpreted as depriving me of the right to assert and/or enforce by appropriate legal action rights expressly provided to me by the Settlement Agreement, as amended by the Seventh Amendment. FURTHER COVENANTS RELATING TO THIRD PARTY CLAIMS I covenant that: 1. I shall satisfy any lawful outstanding liens or claims, whether currently asserted or unasserted, for reimbursement of medical expenses, including the cost of medical services, by any private subrogee or government entity ("Third Party Payors") that have paid for your medical care or provided medical services in connection with any health problem arising out of or relating to the Diet Drugs, including any claims for reimbursement of medical expenses paid or medical services provided by Medicare, after receipt of payment from the Fund Administrator or the Trust. 2. I shall indemnify and hold harmless the Fund Administrator, the Trust, and Wyeth from and against any claims, suits or demands asserted by any Third Party Payor arising out of or relating to the payment of medical expenses or provision of medical services by such Third Party Payor or the failure of the Fund Administrator or Wyeth to pay the Third Party Payor, including the cost of investigating and defending against such claims, suits or demands, and including any settlement thereof. I am obligated to cooperate as reasonably requested by the indemnitee in such investigation and defense. I acknowledge that the Medicare Secondary Payer Act, 42 U.S.C. Section 1395y(b)(2), may permit recovery of double the amount of such expenses paid by Medicare, and I agree that the foregoing indemnity includes the amount of any such double recovery or any other penalty or interest imposed. 3. The U.S. District Court for the Eastern District of Pennsylvania, in Philadelphia, Pennsylvania, shall have the power to enforce the obligations under this Release and Covenant Not to Sue pursuant to the Court's reserved power to enforce the Settlement Agreement. I HAVE CAREFULLY READ (OR HAVE HAD READ TO ME) THIS RELEASE AND COVENANT NOT TO SUE. I UNDERSTAND THE TERMS OF IT AND AGREE TO BE BOUND BY IT. SIGNATURE: ______________________________________________ DATE: _________/_________/_________ Diet Drug Recipient or Representative Claimant (month) (day) (year)
2 EXHIBIT F ATTORNEY FOR DDR OR REPRESENTATIVE CLAIMANT | | | | | | | | | | | | | | | | | | | | | | | | | NAME OF ATTORNEY ----------------------------------------- --------- ----------------------------------------- First Name MI Last Name - ------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | | | | | | | | | | | | | | | | | | NAME OF LAW FIRM ------------------------------------------------------------------------------------------------- Law Firm - ------------------------------------------------------------------------------------------------------------------------------- ADDRESS OF LAW FIRM | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- Street Address | | | | | | | | | | | | | | | | | | | | - | | | | | -------------------------------------------------- --------- --------------------------------- City State Zip Code - ------------------------------------------------------------------------------------------------------------------------------- ATTORNEY'S TELEPHONE NUMBER ( | ) | | | - | | | | ATTORNEY'S FACSIMILE | | | | - | | | | | ------------------------------------- NUMBER --------------------------------- Area Code Phone Number Area Code Phone Number - ------------------------------------------------------------------------------------------------------------------------------- ATTORNEY'S EMAIL ADDRESS | | | | | | | | | | | | | | | | | | | | | | | | | ------------------------------------------------------------------------------------------------- E-mail - -------------------------------------------------------------------------------------------------------------------------------
I ACKNOWLEDGE THAT I AM THE ATTORNEY FOR THE ABOVE NAMED DIET DRUG RECIPIENT OR REPRESENTATIVE CLAIMANT AND AGREE THAT I WILL COMPLY WITH THE TERMS OF THE SEVENTH AMENDMENT IN MAKING DISTRIBUTION OF THE INDIVIDUAL PAYMENT AMOUNT (OR ANY INTERIM DISTRIBUTION THEREOF) FOR SUCH DIET DRUG RECIPIENT OR REPRESENTATIVE CLAIMANT. SIGNATURE: ____________________________________________________________ DATE: _________/_________/_________ Attorney for DDR or Representative Claimant (month) (day) (year)
ATTACHMENT A 1. "RELEASED PARTIES" shall mean: a. Wyeth and each of its subsidiaries, affiliates, and divisions, including, but not limited to, Wyeth-Ayerst Laboratories Division, Wyeth-Ayerst Laboratories Co., Wyeth-Ayerst Pharmaceuticals Inc., and American Cyanamid Corporation, along with each of their respective current and former officers, directors, employees, attorneys, agents, and insurers; b. Any and all predecessors, successors, and/or shareholders of Wyeth and each of its subsidiaries, affiliates, and divisions; provided, however, that any such person or entity shall be considered a Released Party only to the extent that such person or entity is sued in its capacity as a predecessor, successor, and/or shareholder of Wyeth or its subsidiaries, affiliates, and divisions; c. Any and all suppliers of materials, components, and services used in the manufacture of Pondimin(R) and/or Redux((TM)), including the labeling and packaging thereof, along with each such person's or entity's predecessors, successors, parents, subsidiaries, affiliates, and divisions, and each of their respective current and former shareholders, officers, directors, employees, attorneys, agents, and insurers; provided, however, that no person or entity described in this subsection shall be a Released Party with respect to any claims based upon his, her or its own independent negligence or culpable conduct; d. All distributors of Pondimin(R) and/or Redux((TM)), including wholesale distributors, private label distributors, retail distributors, hospitals and clinics, and their respective predecessors, successors, parents, subsidiaries, affiliates, and divisions, and their respective current and former shareholders, officers, directors, employees, attorneys, agents, and insurers; provided that: (1) such persons and entities described in this section shall be a Released Party only as to claims as to which such persons would have a statutory or common-law right of indemnity against Wyeth; (2) no person or entity described in this section shall be a Released Party to the extent that any claim is based upon his, her or its own independent negligence or culpable conduct, including, without limitation, negligence or professional malpractice asserted against hospitals, clinics, and diet centers; and (3) no person or entity described in this section shall be a Released Party with respect to the manufacture, sale, or distribution of any Phentermine hydrochloride or Phentermine resin pharmaceutical product. e. All physicians who prescribed, and all pharmacists and pharmacies who dispensed, Pondimin(R) and/or Redux((TM)) to the extent that liability against such physicians, pharmacists or pharmacies is based on: (1) the prescription or dispensing of Pondimin(R) and/or Redux((TM)) in a manner consistent with the product labeling; and/or (2) the prescription or dispensing of Pondimin(R) for any period longer than a "few weeks"; and/or 3 EXHIBIT F (3) the prescription or dispensing of Pondimin(R) and/or Redux((TM)) for concomitant use with Phentermine hydrochloride or Phentermine resin; and/or (4) a claim that the physician's or pharmacist's liability stems solely from having prescribed or dispensed Pondimin(R) and/or Redux((TM)); and/or (5) a claim that the physician's or pharmacist's liability stems solely from the prescription or dispensing of a defective or unreasonably dangerous product. Physicians, pharmacists and pharmacies are not Released Parties with respect to any claims based on their independent negligence or culpable conduct, not consisting of the conduct described in paragraphs (1)-(5) of this Subsection 1.e. Notwithstanding the foregoing, manufacturers, sellers, wholesalers, or distributors of any Phentermine hydrochloride or Phentermine resin pharmaceutical product are not Released Parties with respect to the manufacture, sale, or distribution of any Phentermine hydrochloride or Phentermine resin pharmaceutical product, and Les Laboratoires Servier S.A. and all of its affiliates and subsidiaries, including, without limitation, Servier S.A.S., Oril, Orsem, Servier Amerique, Science Union et Cie, Institut de Recherches Internationales Servier, Servier Research (collectively hereinafter "Servier") and Interneuron Pharmaceuticals, Inc. (hereinafter "Interneuron") are not Released Parties. 2. "SETTLED CLAIMS" shall mean any and all claims, including assigned claims, whether known or unknown, asserted or unasserted, regardless of the legal theory, existing now or arising in the future by any or all members of the Settlement Class arising out of or relating to the purchase, use, manufacture, sale, dispensing, distribution, promotion, marketing, clinical investigation, administration, regulatory approval, prescription, ingestion, and labeling of Pondimin(R) and/or Redux((TM)), alone or in combination with any other substance, including, without limitation, any other drug, dietary supplement, herb, or botanical. These "Settled Claims" include, without limitation and by way of example, all claims for damages or remedies of whatever kind or character, known or unknown, that are now recognized by law or that may be created or recognized in the future by statute, regulation, judicial decision, or in any other manner, for: a. personal injury and/or bodily injury, damage, death, fear of disease or injury, mental or physical pain or suffering, emotional or mental harm, or loss of enjoyment of life; b. compensatory damages, punitive, exemplary, statutory and other multiple damages or penalties of any kind; c. loss of wages, income, earnings, and earning capacity, medical expenses, doctor, hospital, nursing, and drug bills; d. loss of support, services, consortium, companionship, society or affection, or damage to familial relations, by spouses, parents, children, other relatives or "significant others" of Settlement Class Members; e. consumer fraud, refunds, unfair business practices, deceptive trade practices, Unfair and Deceptive Acts and Practices ("UDAP"), and other similar claims whether arising under statute, regulation, or judicial decision; f. wrongful death and survival actions; g. medical screening and monitoring, injunctive and declaratory relief; h. economic or business losses or disgorgement of profits arising out of personal injury; and i. prejudgment or post-judgment interest. Notwithstanding the foregoing, Settled Claims do not include claims based on PPH, including claims for compensatory, punitive, exemplary or multiple damages based on PPH; provided, however, that if a Class Member receives Matrix Compensation Benefits or Seventh Amendment Matrix Compensation Benefits from the Settlement Fund and/or Individual Payment Amounts (including any Interim Distributions) from the Supplemental Class Settlement Fund, he/she may not bring a lawsuit based upon a claim for PPH, unless the Class Member was diagnosed with PPH before the Class Member had left-sided heart valve abnormalities (other than those which produce trivial, clinically insignificant left-sided regurgitation) or Endocardial Fibrosis. In addition, notwithstanding the foregoing, Settled Claims do not include claims arising from the exposure of unborn children, in utero, to Pondimin(R) or Redux(TM), and persons alleging exposure in utero to Pondimin(R) or Redux(TM) shall not be considered Diet Drug Recipients eligible for benefits under this Agreement. 4 EXHIBIT F SEVENTH AMENDMENT OPT-OUT FORM SEVENTH AMENDMENT OPT-OUT FORM IF YOU QUALIFY FOR AND WISH TO EXERCISE A SEVENTH AMENDMENT OPT-OUT UNDER THE SEVENTH AMENDMENT TO THE NATIONWIDE CLASS ACTION SETTLEMENT AGREEMENT, YOU MAY USE THIS FORM. YOU MUST BE A DIET DRUG RECIPIENT OR AN AUTHORIZED REPRESENTATIVE CLAIMANT OF A DIET DRUG RECIPIENT TO EXERCISE A SEVENTH AMENDMENT OPT-OUT. EXECUTING THIS SEVENTH AMENDMENT OPT-OUT FORM IS NOT EQUIVALENT TO OPTING-OUT OF THE CLASS OR OUT OF THE SETTLEMENT. USE THIS FORM ONLY IF YOU DO NOT WANT TO PARTICIPATE IN THE SEVENTH AMENDMENT, AND INSTEAD WANT TO REMAIN SUBJECT TO THE TERMS OF THE SETTLEMENT AGREEMENT IN EFFECT BEFORE THE SEVENTH AMENDMENT. TO OPT OUT OF THE SEVENTH AMENDMENT, COMPLETE FULLY ALL SECTIONS OF THIS FORM, SIGN IT, DATE IT, AND MAIL OR DELIVER IT TO WYETH AT THE ADDRESS SHOWN BELOW. YOUR MAILING MUST BE POSTMARKED OR DELIVERED TO WYETH NO LATER THAN [DATE] , OR IT WILL NOT BE EFFECTIVE. IF YOU WISH TO USE THIS FORM TO EXERCISE A SEVENTH AMENDMENT OPT-OUT, THE DIET DRUG RECIPIENT OR AUTHORIZED REPRESENTATIVE CLAIMANT WHO WISHES TO OPT OUT MUST SIGN THIS FORM PERSONALLY. ATTORNEYS MAY NOT SIGN THIS FORM ON BEHALF OF A CLIENT, UNLESS THE ATTORNEY QUALIFIES AS A REPRESENTATIVE CLAIMANT UNDER QUESTION 2 OF THIS FORM. 1. PROVIDE YOUR NAME, ADDRESS, SOCIAL SECURITY NUMBER, DATE OF BIRTH, TELEPHONE NUMBER, AND ANY DDR NUMBER ASSIGNED TO YOU BY THE AHP SETTLEMENT TRUST. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------- -------------------- --------------------------------------------- (First Name) (Middle Initial) (Last Name) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------- (Street Address) | | | | | | | | | | | | | | | | | | | | | | | | - | | | | | ------------------------------------------------------------- --------- ------------------------------------- (City) (State) (Zip Code) | | | | - | | | - | | | | 18300 - | | | | | | | | / | / | | | | ----------------------------------------- --------------------- --------------------------------- (Social Security Number) (Claim Number) (Date of Birth - MM/DD/YYYY) ( | | ) | | | - | | | | | ( | | ) | | | - | | | | | --------------------------------------------- --------------------------------------------- (Daytime Phone Number & Area Code) (Evening Phone Number & Area Code)
2. IF YOU ARE COMPLETING THIS FORM AS THE REPRESENTATIVE CLAIMANT (I.E., ESTATE, ADMINISTRATOR, OR OTHER LEGAL REPRESENTATIVE, HEIR, OR BENEFICIARY OF A DIET DRUG RECIPIENT), YOU MUST COMPLETE ALL OF THE FOLLOWING. YOU ALSO MUST ATTACH A COPY OF THE ORDER OR DOCUMENT AUTHORIZING YOU TO ACT AS THE REPRESENTATIVE CLAIMANT OF THE DIET DRUG RECIPIENT IDENTIFIED ABOVE. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------- -------------------- --------------------------------------------- (First Name) (Middle Initial) (Last Name) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------- (Street Address) | | | | | | | | | | | | | | | | | | | | | | | | - | | | | | ------------------------------------------------------------- --------- ------------------------------------- (City) (State) (Zip Code) | | | | - | | | - | | | | 18300 - | | | | | | | | / | / | | | | ----------------------------------------- --------------------- --------------------------------- (Social Security Number) (Claim Number) (Date of Birth - MM/DD/YYYY) ( | | ) | | | - | | | | | ( | | ) | | | - | | | | | --------------------------------------------- --------------------------------------------- (Daytime Phone Number & Area Code) (Evening Phone Number & Area Code) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------- (Your relationship to the Diet Drug Recipient)
EXHIBIT G Seventh Amendment Opt-Out Form - 1 SEVENTH AMENDMENT OPT-OUT FORM 3. IF YOU HAVE A LAWYER IN CONNECTION WITH THE DIET DRUG LITIGATION, LIST HIS/HER NAME, OFFICE ADDRESS, TELEPHONE NUMBER, FAX NUMBER, AND EMAIL ADDRESS, IF ANY. IF YOU DO NOT HAVE A LAWYER, CHECK HERE [] AND LEAVE THIS QUESTION 3 BLANK. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------- (Law Firm Name) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------- (Attorney's Name) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------- (Street Address) | | | | | | | | | | | | | | | | | | | | | | | | - | | | | | ------------------------------------------------------------- --------- ------------------------------------- (City) (State) (Zip Code) ( | | ) | | | - | | | | | ( | | ) | | | - | | | | | --------------------------------------------- --------------------------------------------- (Daytime Phone Number & Area Code) (Fax Number) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------- (E-mail Address, if any)
4. CERTIFICATION: I HAVE HAD AN OPPORTUNITY TO READ THE OFFICIAL COURT APPROVED NOTICE OF THE SEVENTH AMENDMENT TO THE NATIONWIDE CLASS ACTION SETTLEMENT AGREEMENT, AND TO CONSULT WITH PHYSICIANS AND ATTORNEYS CONCERNING THE TERMS AND CONDITIONS OF THE PROPOSED SEVENTH AMENDMENT. I HEREBY KNOWINGLY AND PERMANENTLY RELINQUISH, WAIVE, AND GIVE UP ALL OF THE RIGHTS THAT I WOULD OTHERWISE HAVE HAD UNDER THE SEVENTH AMENDMENT. I UNDERSTAND THAT BY SIGNING THIS FORM AND EXERCISING MY SEVENTH AMENDMENT OPT-OUT RIGHT, I REMAIN A MEMBER OF THE SETTLEMENT CLASS AND SUBJECT TO ALL THE TERMS OF THE SETTLEMENT AGREEMENT IN EFFECT BEFORE THE SEVENTH AMENDMENT, WITH SUCH RIGHTS, LIMITATIONS, RESTRICTIONS, AND OBLIGATIONS AS I WOULD HAVE OTHERWISE HAD IN THE ABSENCE OF THE SEVENTH AMENDMENT. I AFFIRMATIVELY AND FOREVER OPT OUT OF THE SEVENTH AMENDMENT, WITH FULL KNOWLEDGE OF THE LEGAL, FACTUAL AND MEDICAL CONSEQUENCES OF MY ACTIONS. Date: | | / | / | | | | _______________________________________________________________ ------------------------- (Signature of Diet Drug Recipient or Representative Claimant) (MM/DD/YYYY)
This Form must be mailed or delivered to Wyeth, at the address below, postmarked or delivered no later than [date] , or it will not be effective. Facsimiles are not accepted. BY MAIL BY DELIVERY WYETH WYETH C/O ORRAN L. BROWN C/O ORRAN L. BROWN ATTN: 7TH AMENDMENT OPT-OUTS ATTN: 7TH AMENDMENT OPT-OUTS P.O. BOX 85006 115 S. 15TH STREET, SUITE 400 RICHMOND, VA 23285-5006 RICHMOND, VA 23219-4209 EXHIBIT G Seventh Amendment Opt-Out Form - 2 MATTERS SUBJECT TO STAY IN DISTRICT COURT [AS OF 8/03/04]
DOCKET/ CASE DATE ITEM NUMBER FILED PROCEEDING SUBJECT MATTER - ------------------------------------------------------------------------------------------------------------------------------- 1. 1131 5/28/04 The AHP Settlement Trust's Motion to Enforce the Stay Against Claimant Matrix Benefits Grady Weiszbrod or, in the Alternative, the AHP Settlement Trust's Motion for Leave to File its Opposition to Grady Weiszbrod's Motion to Strike Application for Order to Show Cause 2. 1122 5/20/04 Motion to Strike Application of the AHP Settlement Trust as Untimely Matrix Benefits Filed, by Grady Weiszbrod. (B-II) 3. 1111 5/10/04 Memorandum by The Law Firm of Braunberger, Boud & Draper, P.C., in Matrix Benefits opposition to Wyeth's expedited motion for entry of Court approved procedure to preserve settlement funding and to address the pervasive abuse of the Matrix Claims process, in opposition to Wyeth's motion for temporary stay of processing and payment of "non-priority" Matrix Claims to preserve available settlement funding; in opposition to Wyeth's emergency motion for a temporary stay of processing and payment of Level I and II Matrix Claims to address the massive number of illegitimate claims filed with the Settlement Trust and agreeing in part with Class Counsels memo in responding to the points set forth abve 4. 1110 5/10/04 Sur-Reply in further support of Loncar & Associates' motion to deny The CIP AHP Settlement Trust's motion to stay payment of all post-audit claims where the Claimant relies upon A Green Form, CAP4 verification, or other document signed by John P. Orchard, M.D
EXHIBIT H MATTERS SUBJECT TO STAY IN DISTRICT COURT [AS OF 8/03/04]
DOCKET/ CASE DATE ITEM NUMBER FILED PROCEEDING SUBJECT MATTER - ------------------------------------------------------------------------------------------------------------------------------- 5. 205509 5/3/04 Almeda Nipper's Motion for an Order Directing the Trust to Pay her Matrix Matrix Benefits Claim that Received Final Post-Audit Determination (B-II) 6. 1081 4/30/04 Motion to Suspend Deadlines Set in Audit Rules 4,8,9,11,14,16 and 18 Audit Rules 7. 1078 4/28/04 Certain Class Members' Submission of Report of Expert And Memorandum: A. Matrix Benefits In Opposition to Wyeth's Expedited Motion for Entry of a Court Approved Procedure to Preserve Settlement Funding and to Address the Pervasive Abuse of the Matrix Claims Process; B. In Opposition to Wyeth's Motion for a Temporary Stay of Processing and Payment of "Non-Priority" Matrix Claims to Preserve Available Settlement Funding; C. In Response to Report by Wyeth on Matrix Claims and Fund A Benefits Processing by the AHP Settlement Trust; D. In Opposition to Wyeth's Emergency Motion for a Temporary Stay of Processing and Payment of Level I and II Matrix Claims to Address the Massive Number of Illegitimate Claims filed with the Settlement Trust; and E. In Response to Class Counsel's Memorandum in Partial Opposition to Wyeth's Emergency Motion for a Temporary Stay of Processing and Payment of Level I and II Matrix Claims to Address the Massive Number of Illegitimate Claims filed with the Settlement Trust 8. 1063 4/26/04 Will Pollard's Motion to Compel Payment and to Enforce the Settlement CIP/ Matrix Agreement and PTOs 1415 and 2807 Against the AHP Settlement Trust Benefits
EXHIBIT H 2 MATTERS SUBJECT TO STAY IN DISTRICT COURT [AS OF 8/03/04]
DOCKET/ CASE DATE ITEM NUMBER FILED PROCEEDING SUBJECT MATTER - ------------------------------------------------------------------------------------------------------------------------------- 9. 1057 4/23/04 AHP Settlement Trust's Motion to Dismiss Claims Filed by Barbara J. CIP Asbill, et al.(Leonard Claims) 10. 1044 4/16/04 AHP Settlement Trust's Motion to Dismiss Claims Filed by Mindy K. CIP Anderson, et al. (Liston Claims) 11. 1041 4/16/04 Claimant's Motion to Compel the Wyeth Settlement Trust to Process Their CIP Claims that were Attested to by Dr. Linda Crouse & Dr. Richard Mueller, but were not Among Claims Addressed in PTO 2640 12. 1040 4/16/04 Claimant Joseph Procopio's Motion to Compel Payment of Claim Matrix Benefits 13. 1038 4/15/04 Motion for Relief from Medical Practices Questionnaires (by Frances M. CIP Milligan). 14. 1029 4/14/04 Motion for Relief from Medical Practices Questionnaires (Michael L. Hodges) CIP 15. 1020 4/8/04 Certain Class Members' Emergency Motion for Order Directing the AHP Matrix Benefits Settlement Trust to Include Certain Data in its Report Regarding the Audit of Matrix Claims 16. 994 4/1/04 Certain Class Members' Motion to Compel the AHP Settlement Trust to Accept CIP Sworn Affidavits in Lieu of Medical Practices Questionnaires (Petroff & Associates, Shrager, Spivey & Sachs) 17. 990 3/31/04 Certain Class Members' Motion for Protective Order and to Compel Claims CIP Processing and Objections to Medical Practices Questionnaire (Baron & Budd)
EXHIBIT H 3 MATTERS SUBJECT TO STAY IN DISTRICT COURT [AS OF 8/03/04]
DOCKET/ CASE DATE ITEM NUMBER FILED PROCEEDING SUBJECT MATTER - ------------------------------------------------------------------------------------------------------------------------------- 18. 987 3/30/04 Wyeth's Emergency Motion for a Temporary Stay of Processing and Payment of Matrix Benefits Level I and Level II Matrix Claims to Address the Massive Number of Illegitimate Claims Filed With the Settlement 19. 974 3/26/04 John Bacon III's Motion to Compel the AHP Settlement Trust to Pay Matrix CIP/ Matrix Benefits upon the Trust Auditor's Findings Benefits 20. 971 3/24/04 AHP Settlement Trust's Motion to Stay Payment of all Post-Audit Claims CIP/ Matrix where the Claimant Relies upon a Green Form, CAP 4 Verification, or Other Benefits Document Signed by John P. Orchard 21. 943 3/10/04 AHP Settlement Trust's Motion to Compel the Production of Certain CIP Documents, and Responses to Certain Deposition Questions from Kip Petroff and Douglas Welmaker 22. USDC 3/3/04 Michael Hodge's Motion to Quash Subpoena, or, in the Alternative, Motion CIP District for Protective Order (Donna Dicken) of Kansas 23. USDC ND 3/1/04 Shawn Raver's Motion to Quash Subpoena and for Protective Order (Donna CIP of Texas Dicken) 24. 881 2/13/04 Wyeth's Joinder in the AHP Settlement Trust's Motion to Stay Payment of CIP All Claims with which George Fleming is or has been associated as Counsel 25. 858 2/2/04 Joinder by Wyeth in the Motion to Disqualify All Petroff and Associates' CIP Echocardiograms from Supporting Claims for Benefits and Motion to Stay Payment of All Claims submitted by Petroff and Associates as either Primary or Co-counsel and for Expedited Discovery
EXHIBIT H 4 MATTERS SUBJECT TO STAY IN DISTRICT COURT [AS OF 8/03/04]
DOCKET/ CASE DATE ITEM NUMBER FILED PROCEEDING SUBJECT MATTER - ------------------------------------------------------------------------------------------------------------------------------- 26. 848 1/27/04 AHP Settlement Trust's Motion to Stay Payment of all Claims with which CIP George Fleming is or has been associated as Counsel 27. 844 1/27/04 Wyeth's Expedited Motion for Entry of a CAP to Preserve Settlement Funding Matrix Benefits and to Address the Pervasive Abuse of the Matrix Claims Process 28. 843 1/27/04 Wyeth's Motion for a Temporary Stay of Processing of "Non-Priority" Matrix Matrix Benefits Claims to Preserve Settlement Funding 29. 814 1/16/04 AHP Settlement Trust's Motion to Disqualify all Petroff & Associates' CIP Echocardiograms from Supporting Claims for Benefits 30. 815 1/16/04 AHP Settlement Trust's Motion to Stay Payment of all Claims submitted by CIP Petroff & Associates as Primary Counsel or Co-Counsel and for Expedited Discovery 31. 807 1/16/04 Wyeth's Motion for Leave to take Discovery Regarding Echocardiogram CIP Companies 32. 791 1/14/04 F&A Claimant's Objections to the Trust's Global Discovery, Motion for Matrix Protective Order and Opposition to Claims Processing Stay Benefits/CIP 33. 746 12/29/03 Motion to Permit Discovery Regarding Additional Echocardiogram Companies CIP 34. 723 12/22/03 Claimant's Motion to Compel Class Counsel to Disclose Evidence Relating to Private the Independent Echocardiographic Reviews Allegedly Performed by their Echocardiograms/ Experts Deficiencies 35. 700 12/19/03 Certain Class Members' Motion to Compel Compliance with Court Order 3047 CIP/Trust Operations Plan
EXHIBIT H 5 MATTERS SUBJECT TO STAY IN DISTRICT COURT [AS OF 8/03/04]
DOCKET/ CASE DATE ITEM NUMBER FILED PROCEEDING SUBJECT MATTER - ------------------------------------------------------------------------------------------------------------------------------- 36. 701 12/19/03 Certain Class Members' Motion to Compel Production of Documents relating EchoMotion to Echocardiogram Screenings Echocardiograms 37. 601 11/19/03 Motion to Disqualify all EchoMotion Echocardiograms from Supporting Claims CIP for Benefits 38. 600 11/19/03 AHP Settlement Trust's Motion to Stay Payment of all Claims Supported by CIP EchoMotion Echocardiograms 39. 599 11/19/03 Class Member's Emergency Motion in Support of Approval of CAP 6 Matrix Benefits 40. 467 10/20/03 Claimant Linda Morales's Motion to Compel the AHP Settlement Trust to Pay Matrix Benefits Matrix Benefits (A-II) upon the Stipulation between the Parties and the Prior Orders of this Court 41. 357 9/22/03 Certain Class Members' Motion for Access to Court and Renewed Motion for CIP/Trust Reconsideration of PTO 2683 Operation Plan 42. 101 6/19/03 Motion to Enforce Settlement Agreement, filed on behalf of Darlene Nesbitt Matrix Benefits 43. 48 6/4/03 F&A Motion and Memorandum in Support to Change the Trust's Procedures to Ensure Timely Payment of Fund B Matrix Claims Matrix Benefits 44. Not 3/17/03 Motion of Claimant Samye Ellis for Specific Performance, Memorandum of Law Matrix Benefits Available and Form of Order 45. Not 3/19/03 Plaintiff's Motion to Compel Tentative Determination on Matrix Compensation Matrix Benefits Available Benefits Claim, filed on behalf of Nicole Fusco
EXHIBIT H 6 MATTERS SUBJECT TO STAY IN DISTRICT COURT [AS OF 8/03/04]
DOCKET/ CASE DATE ITEM NUMBER FILED PROCEEDING SUBJECT MATTER - ------------------------------------------------------------------------------------------------------------------------------- 46. 04-1388 3/31/04 Civil Complaint filed by Napoli, Kaiser, Bern & Associates on behalf of Mr. CIP Bacon against the Trust , the Trustees, and Richard L. Scheff captioned Bacon v. Overseth, et als. 47. 03-6163 11/10/03 Complaint alleging fraud and intentional misrepresentations captioned Castle CIP et als. v. Richard L. Mueller, M.D. 48. 03-5252 9/18/03 Complaint alleging violations of federal RICO statutes and fraud captioned CIP Castle et als. v. Linda J. Crouse, M.D.
EXHIBIT H 7 MATTERS SUBJECT TO STAY IN THE COURT OF APPEALS [AS OF 8/03/04]
ITEM APPEAL NUMBER(S) MATTER ON APPEAL - ---------------------------------------------------------------------------------------------------------------------- 1. 03-2025; 03-2063; 03-2072 PTO 2778, approving the Sixth Amendment to Settlement Agreement (final stay granted until 8/8/04). 2. 02-4502; 02-4614; 02-4615; 02-4617; 03-1007 PTO 2662, approving 100 % Audit of Matrix Claims (already stayed until 7/26/04). 3. 03-3650; 03-3741 PTO 2958, denying motions to discharge Class Counsel (already stayed until 7/24/04). 4. 02-4378 PTO 2640, consolidated with 03-3740, allows the Trust to audit all claims submitted by Hariton/Napoli and all claims involving echos attested to by Crouse/Mueller (already stayed until 7/26/04). 5. 04-2584 Crouse is appealing a protective order granted on 5/24/04 in favor of the Trustees.
EXHIBIT I IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA IN RE: DIET DRUGS (PHENTERMINE/FENFLURAMINE/DEXFENFLURAMINE) MDL DOCKET NO. 1203 PRODUCTS LIABILITY LITIGATION THIS DOCUMENT RELATES TO: SHEILA BROWN, ET AL., V. AMERICAN HOME CIVIL ACTION NO. 99-20593 PRODUCTS CORPORATION PRETRIAL ORDER NO. (MODIFICATION OF STAY RELATING TO MATRIX LEVEL I AND II CLAIMS) AND NOW, this ____________ day of ______, 2004, upon consideration of the Motion for relief with respect to claims that are subject to Post-Audit Payable Determinations and pursuant to the Court's authority under Sections VI.C.5 and VI.E.8 of the Settlement Agreement, it is hereby ORDERED, ADJUDGED AND DECREED: 1. For purposes of this Order, the term "Pre-Stay Payable PADL" refers to a Post-Audit Determination Letter issued pursuant to Rules 12 through 17 of the Rules for the Audit of Matrix Compensation Claims approved by the Court in Pretrial Order No. 2807 ("Audit Rules"), and/or a notice issued pursuant to paragraph 6 of Court Approved Procedure No. 4 ("CAP 4 Notice"), and/or a Post-Audit Determination Letter issued pursuant to Section IV.A or IV.B of the Policies and Procedures for Audit and Disposition of Matrix Compensation Claims in Audit approved by the Court in Pretrial Order No. 2457 that was: (a) issued by the Trust prior to May 6, 2004; (b) after a Trust Audit in which the Auditing Cardiologist determined that there was a reasonable medical basis for the Matrix claim that was the subject of the Post-Audit Determination Letter or CAP 4 Notice; (c) with respect to a claim for Matrix Level I or Matrix Level II benefits; and EXHIBIT J 1 (d) where the affected Class Member(s) has not received any payment, or full payment based on the Audit outcome with respect to the Matrix claim. 2. Except as otherwise provided in this Order, the Claims Integrity Program, all Show Cause proceedings, all "Enforcement Actions" (as defined in the proposed Seventh Amendment to the Nationwide Class Action Settlement Agreement) and all other actions by the Trust relating to any Pre-Stay Payable PADL are stayed until the earlier of the date that Wyeth exercises its Walkaway Right or the Court determines whether or not to approve the Seventh Amendment to the Nationwide Class Action Settlement Agreement ("Settlement Agreement"). 3. With respect to each Matrix claim that is the subject of a Pre-Stay Payable PADL, and for which the relevant deadlines set forth in Audit Rules 14, 16, and 18 had not run as of May 6, 2004, such deadlines are extended thirty (30) days from the date of this Order. 4. Notwithstanding the stay set forth in paragraph 2 of this Order, the Trust shall continue to (i) process any Matrix claim that is the subject of a Pre-Stay Payable PADL with reasonable diligence to determine the amount to be paid in connection with such claims in accordance with the Audit outcome relating to the claim or (ii) process and determine whether there was an intentional manipulation of the echocardiogram tape or disk submitted in connection with the claim that was not detected by the Trust before Audit or by the Auditing Cardiologist in the Audit of the claim and that amounts to a material misrepresentation of fact in connection with such a claim. For this purpose, claim "processing" is limited to steps that lead to a determination of the amount to be paid in connection with such claims and investigations into whether there was such a material misrepresentation of fact in connection with the claim. "Processing" does not include the re-Audit of a claim or any other court filings, motions, and/or discovery as to the claims subject to any Pre- EXHIBIT J 2 Stay Payable PADL, all of which shall remain subject to the stay contained in paragraph 2 of this Order. 5. Within the time period specified by paragraph 9 of this Order, the Trust shall categorize all Pre-Stay Payable PADL claims into one of the following three categories: (a) Pre-Stay Payable PADL claims where the Trust alleges that there was an intentional manipulation, as described in Paragraph 4 of this Order, in connection with the claim ("Paragraph 5(a) Claims"). (b) Other Pre-Stay Payable PADL claims, not included in Paragraph 5(a) of this Order, that the Trust does not consider to be presently payable ("Paragraph 5(b) Claims"). (c) Pre-Stay Payable PADL claims that the Trust considers to be presently payable ("Paragraph 5(c) Claims"). 6. The Trust shall pay all Paragraph 5(c) Claims and those that become payable pursuant to Paragraph 4 of this Order in accordance with the Audit outcome for each such claim, proof of Diet Drug use, and the information furnished in response to any CAP 4 Notice, within the applicable deadlines as extended by this Order. 7. If this Court approves the Seventh Amendment, the Trust shall pay all Paragraph 5(b) Claims in accordance with the Audit outcome for each such claim, proof of Diet Drug use and the information furnished in response to any CAP 4 Notice within thirty days of the date on which such "Trial Court Approval" occurs. 8. As to all claims subject to a Pre-Stay Payable PADL that are or become payable pursuant to this Order, the Trust shall consider the information furnished in response to any CAP 4 Notice to comply with CAP 4 if the materials are complete. With regard to Matrix Claims subject to CAP 4 Notices, "complete" shall mean that in response to the CAP 4 Notice issued by the Trust, the Diet Drug Recipient has furnished to the Trust a completed and signed Physician Verification Form EXHIBIT J 3 and/or all General Medical Records as required by paragraph 4 of the CAP 4 Notice, and proof of Diet Drug use greater than sixty (60) days. If the Class Member has submitted the aforementioned materials, the Trust shall not seek further proof and shall not delay payment for any reason whatsoever, except as provided herein. 9. As to any Matrix claim that is subject to a Pre-Stay Payable PADL and for which the Class Member has affirmatively accepted the Post-Audit Determination under Audit Rule 18(a), the time within which the Trust must pay the claim, determine and report that the claim is a Paragraph 5(a) Claim or determine and report that the claim is a Paragraph 5(b) Claim shall be no later than thirty (30) days from the date of this Order or thirty (30) days from the date of the Class Member's affirmative acceptance of the Post-Audit Determination, whichever is later. As to any Matrix claim that is subject to a Pre-Stay Payable PADL and for which the Class Member has initiated a timely contest pursuant to Audit Rule 18(b), or has failed to affirmatively accept the Trust's Post-Audit Determination within the time prescribed by Audit Rule 18(a), the time within which the Trust must pay the claim, determine and report that the claim is a Paragraph 5(a) Claim or determine and report that the claim is a Paragraph 5(b) Claim shall be no later than sixty (60) days from the date of this Order or ninety (90) days from the date of the Post-Audit Determination, whichever is later. The deadlines applicable to processing and payment of any Pre-Stay Payable PADL, as extended herein, shall be strictly adhered to by the Trust and strictly enforced. 10. The Trust shall promptly report each determination made pursuant to paragraph 5 of this Order to Wyeth, Class Counsel and the SALC and, within ten days of receiving a written request, shall provide them with a detailed explanation of the basis for each such determination. 11. In connection with any claim which the Trust determines is a Paragraph 5(a) Claim, the Trust shall, within forty-five days of making such a determination, furnish Wyeth, Class Counsel, the EXHIBIT J 4 SALC and the affected Class Member or the Class Member's attorney, if represented, with a copy of the echocardiogram tape or disk submitted in support of the claim, and a report stating with the specificity required by FED.R.CIV.P. 9(b) and Audit Rule 23(c) the specific factual basis for the Trust's assertion that there was a material misrepresentation in connection with the claim. To the extent that the Trust's claim of material misrepresentation is based on the opinion of an expert, the Trust shall, within ten days of making its determination that a claim is a Paragraph 5(a) Claim, furnish Wyeth, Class Counsel , the SALC, and the affected Class Member or the Class Member's attorney, if represented, with a report by such expert setting forth the material facts known to that expert and the opinions of that expert concerning the Paragraph 5(a) Claim and the basis for such opinions with the specificity required in FED.R.CIV.P. 26 (a)(2). The Trust may meet its expert disclosure obligations under this paragraph by submitting one or more generic reports describing the facts known to its expert(s) and the opinions of such expert(s) that are common to multiple claims, along with individual reports with all required case specific information for each claim. 12. The Trust shall establish and maintain a database that accurately and timely records the date of each and every post-Audit processing activity relevant to each Pre-Stay Payable PADL Claim, including the date on which a processing activity takes place, a description of the processing activity, and the results of that processing activity. The Trust shall furnish an electronic copy of this database to Class Counsel, Wyeth, and the SALC. 13. For purposes of the information disclosure requirements of this Order, the members of the SALC are "Authorized Persons" entitled to receive Confidential Information under Pretrial Order No. 2683 and in accordance with paragraph 19 of the Order Preliminarily Approving the Seventh Amendment. EXHIBIT J 5 14. This Order and any actions taken pursuant to this Order are without prejudice to and are not admissible in any proceeding relating to an opt-out from the Settlement Agreement. BY THE COURT: _________________________ HARVEY BARTLE, III, J. EXHIBIT J 6 PARALLEL PROCESSING OF HIGH LEVEL CLAIMS Citations are to the Nationwide Class Action Settlement Agreement, as Amended. Capitalized terms not otherwise defined in these Procedures have the meanings given them in that Agreement. 1. SCOPE. These Parallel Processing Procedures ("Procedures") apply to: (a) all claims for Matrix Compensation Benefits where the answers to Part II of the Green Form support a claim with a Matrix Level of Severity of III, IV and/or V, under Section IV.B.2.c(3)-(5) [pp.42-48] of the Settlement Agreement; and (b) all Supplemental Claims for Matrix Compensation Benefits on Matrix Level III, IV and/or V under Section IV.C.3 [p.54] of the Settlement Agreement, which the Trust: (a) Has not sent to Audit; or (b) Has sent to Audit but has not entered Auditing Cardiologist findings in its database; or (c) Has sent to Audit and has issued a Medical Status Letter or additional correspondence relating to a Medical Status Letter as the last correspondence on the claim. These claims are collectively referred to in these Procedures as "High Level Claims." These Procedures also apply to the Additional Cash or Medical Services claims under Section IV.A.1.c [pp. 32-33] of the Settlement Agreement that are associated with the High Level Claims processed under these Procedures. 2. APPLICABILITY TO SEVENTH AMENDMENT MATRIX COMPENSATION BENEFITS. If the Seventh Amendment to the Settlement Agreement attains Final Judicial Approval, these Procedures shall apply to claims for Seventh Amendment Matrix Compensation Benefits, as defined in the Seventh Amendment, which shall also be referred to in these Procedures as High Level Claims. 3. PARTIES IMPLEMENTING THESE PROCEDURES. Class Counsel shall designate one person to represent Class Counsel, and Wyeth shall designate one person to represent Wyeth in connection with these Procedures. Such persons shall serve as the PPP Committee. The PPP Committee shall designate such other support persons as are necessary to carry out these Procedures. Members of the SALC, as defined in the Seventh Amendment, may assist Class Counsel and the PPP Committee with the implementation of these Procedures. Any person assisting Class Counsel shall have access to all information concerning the Parallel Process and claims processed by the Parallel Process on a confidential basis as Authorized Persons pursuant to PTO 2683, including the limitation in Paragraph 5(d) of that Order. In connection with implementing these Procedures, the parties agree to proceed in good faith in the evaluation of the medical proof and determination of a Class Member's actual medical condition. 4. INTAKE AND INITIAL PROCESSING OF HIGH LEVEL CLAIMS. The AHP Settlement Trust ("Trust") shall perform the necessary tasks associated with the receipt, scanning, and data input into the Trust's claims database of all materials received by the Trust relating to High Level Claims. EXHIBIT K 1 5. CONTACT WITH CLASS MEMBERS. When these Procedures refer to any contact with Class Members, the contact shall be with counsel for Class Members shown as represented by counsel in the Trust's claims database, and directly with Class Members shown as unrepresented in the Trust's claims database. 6. INITIATION OF THE PROCESS. (a) IDENTIFICATION OF CLAIMANTS ASSERTING A HIGH LEVEL CLAIM. The Trust shall keep its database current on all claims processing steps taken, information received, and the current status of any High Level Claim. No later than 15 days after Trial Court Approval of these Procedures, the Trust shall identify each High Level Claim on file with the Trust and shall provide to the PPP Committee a report, in electronic form, listing the DDR, claimant name, Matrix Level of Severity supported by the answers in Part II of the Green Form, and the following information about the status of each such High Level claim: (1) Whether it has been paid and, if so, the date and amount of payment; (2) What determination letters, if any, have been sent to the claimant, and the dates of any such letter; (3) Whether the Trust considers the claim to be complete; (4) If the Trust considers the claim to be incomplete, identification of any missing information, the deficiency notices sent by the Trust on such claims, and the responses to such notices. The Trust shall continue to provide this report and all information required in this Section 6(a) to the PPP Committee no later than 15 days of its receipt of any High Level Claim. The PPP Committee shall have the right to identify additional claims that, upon information and belief, are High Level Claims, and such claims shall be processed in accordance with these Procedures. (b) ACCESS TO CLAIMS AND INFORMATION AT THE TRUST. The PPP Committee shall have complete access to all hard copy and electronic documents, echocardiogram tapes/disks, and other information in the possession, custody, and control of the Trust for all High Level Claims. The PPP Committee shall also have complete access to any spreadsheet or other database the Trust uses to record and track the receipt and location of all echocardiogram tapes and disks maintained by the Trust. In addition, the Class Counsel Claims Office shall have complete access to the Trust's claims database for all High Level Claims. The Trust shall provide Wyeth access to echocardiogram tapes/disks for copying on site at the Trust. If it is not possible to copy echocardiogram tapes/disks on site at the Trust, such disks may be copied off site, provided that procedures are established to ensure that a proper and documented chain of custody is followed. EXHIBIT K 2 (c) CLASS COUNSEL'S SUBMISSION OF ECHOCARDIOGRAM TAPES TO THE TRUST. Where Class Counsel receives a copy of an echocardiogram tape or disk directly from the claimant, Class Counsel shall send the tape or disk to the Trust. This transmission will be accompanied by a list that contains the names and DDR numbers of the claimants for whom tapes are being transmitted at that time. Class Counsel shall provide Wyeth with a copy of that list. The Trust shall enter the echocardiogram into the spreadsheet or database module it uses to track the receipt and location of all echocardiogram tapes and disks received and maintained by the Trust. 7. USE OF TRANSESOPHAGEAL ECHOCARDIOGRAMS AND CARDIAC CATHETERIZATIONS TO SUPPORT HIGH LEVEL CLAIMS. (a) WHERE RECORDS INDICATE EXISTENCE OF A TRANSTHORACIC ECHOCARDIOGRAM. If the claimant has submitted either a transesophageal echocardiogram or cardiac catheterization in support of a claim, but the medical records indicate that a transthoracic echocardiogram exists, Class Counsel shall attempt to obtain a copy of the transthoracic echocardiogram for inclusion in the claim materials to be transferred to Wyeth under Section 9 of these Procedures. (b) TRANSESOPHAGEAL ECHOCARDIOGRAMS. With respect to all High Level Claims, a transesophageal echocardiogram that provides satisfactory clinical evidence of the disease conditions that would otherwise support a claim shall be sufficient to complete a claim for determination of eligibility for Matrix Compensation Benefits and Additional Cash or Medical Services. (c) CARDIAC CATHETERIZATIONS. With respect to all High Level Claims based on surgery to repair or replace the aortic and/or mitral valve, a cardiac catheterization that provides satisfactory clinical evidence of FDA Positive regurgitation, or Mild Mitral regurgitation for claims based on Mild Mitral regurgitation and surgery, shall be sufficient to complete a claim for determination of eligibility for Matrix Compensation Benefits and Additional Cash or Medical Services. 8. DETERMINATION OF THE COMPLETENESS OF EACH CLAIM. (a) COMPLETENESS REVIEW. No later than 90 days after the PPP Committee's receipt of the list and report in Section 6(a) of these Procedures, Class Counsel shall review each claim to determine if it is sufficiently complete within the meaning of Section VI.C.2 [pp.90-94] and Section VI.C.4 [pp.103-111] of the Settlement Agreement to permit making a determination of eligibility for Matrix Compensation Benefits as a High Level Claim. Missing information shall be considered a deficiency that renders a claim incomplete only if material to making that determination. No claim submitted for Matrix A benefits will be sent to Wyeth under Section 9 of these Procedures unless and until the Class Member has complied with Court Approved Procedure No. 4 as approved by PTO No. 2805. EXHIBIT K 3 (b) STEPS TO BE TAKEN BY CLASS COUNSEL TO COMPLETE FILES. No later than 15 days after the determination of the deficiencies that are material to the completeness of claim, Class Counsel shall notify the Class Member in writing of all such deficiencies and shall provide each Class Member with three 30-day opportunities to supply the information. Class Counsel shall have the discretion to contact Class Members and subrogees by telephone as part of the deficiency process. Class Counsel shall document all telephone contact and identify the date and time of the call, as well as its content. If the claim remains incomplete after the conclusion of the third opportunity and the Class Member has informed Class Counsel of efforts taken to obtain the required information, Class Counsel shall continue to work with the Class Member to obtain the information until such time as Class Counsel determines that the information cannot be obtained and that it should not process the claim further. Upon Class Counsel's determination that the information cannot be obtained, or if the claim remains incomplete after the conclusion of the third opportunity and the Class Member has not notified Class Counsel of any attempt to obtain the information, Class Counsel shall not process the claim further and shall return the claim and its records of all written and oral contacts with the Class Member to the Trust. The Trust shall close the claim and not process it further, unless the Class Member establishes to the Trust good cause to reopen the claim. (c) RETENTION OF INFORMATION OBTAINED. Class Counsel shall provide a copy of all information obtained from the Claimant to Wyeth as provided in Section 8 of these Procedures, and to the Trust. The Trust shall scan the information into the Class Member's file in its claims database. (d) INFORMATION REGARDING POTENTIAL SUBROGEES: (1) For High Level Claims that are not claims for Seventh Amendment Matrix Compensation Benefits: a. Where the subrogation block on the Claim Form (GREEN Form, Part III, Question 5) is checked "Yes," Class Counsel will ensure that all necessary information appears on the Claim Form to enable the Trust to identify the potential subrogee. If the Class Member is unrepresented, Class Counsel will confirm all information contained in this question and will forward this information to the Trust. b. Where the subrogation block on the Claim Form (GREEN Form, Part III, Question 5) is not checked, Class Counsel will contact the Class Member's attorney to determine the appropriate response and receive written confirmation from the Class Member's attorney. If the Class Member is EXHIBIT K 4 unrepresented, Class Counsel will contact the Class Member, determine the appropriate response, obtain the information contained in this question and will forward that information to the Trust. c. Where the subrogation block on the Claim Form (GREEN Form, Part III, Question 5) is checked "No," the Trust will address the subrogation issue in the tentative Matrix Benefits determination letter and in a legend on any check to the Class Member. (2) When processing Seventh Amendment Matrix Compensation Benefits, Class Counsel shall take all steps necessary to obtain Class Member's compliance with the requirements of Section XV.W. of the Seventh Amendment, and the Trust shall process all Seventh Amendment Matrix Compensation Benefits in accordance with that Section. 9. TRANSMITTAL OF COMPLETE CLAIMS TO WYETH. (a) TRANSFER OF LIST OF COMPLETED CLAIMS TO WYETH AND THE TRUST. By noon each Wednesday, Class Counsel shall provide Wyeth with a list of the High Level Claims it determined to be sufficiently complete to make a High Level Claim determination during the preceding week ("the List"), as well as any documents newly-received from the Class Member for any claim appearing on the List. Class Counsel shall indicate its determination of duration of drug use and shall specify the valve of claim. (b) INCOMPLETE DESIGNATIONS BY WYETH. No later than 20 days after its receipt of the List, if Wyeth considers the claim incomplete, Wyeth shall notify Class Counsel and the Trust of the information needed. During this 20 day period, Wyeth and Class Counsel will confer to determine if the claim is complete. If Class Counsel agrees that the claim is incomplete, Class Counsel will take steps to obtain such information from the Class Member. If Wyeth and Class Counsel cannot agree on whether the claim is incomplete, the claim shall be referred to the Special Master (Gregory Miller) for a determination of whether the claim is complete. 10. CLAIMS DETERMINATIONS. After its review of the claim forms and Medical Information (including echocardiogram tape or disks or other applicable proof), and no later than 30 days after its determination that the claim is complete (i.e., agreed as complete by Wyeth, agreed as complete between Wyeth and Class Counsel, or ruled as complete by the Special Master), Wyeth will notify the Trust and Class Counsel as to each claim that the Matrix claim and/or its associated Additional Cash and Medical Services claim is designated by Wyeth as: (a) Payable; or, (b) Payability Disputed. EXHIBIT K 5 11. WYETH'S ACTIONS ON DESIGNATED CLAIMS. (a) PAYABLE DESIGNATIONS. With respect to each claim designated by Wyeth as Payable, Wyeth shall notify the Trust and Class Counsel of the benefit level and amount of the claim, based on the documentation and information reviewed by Wyeth. (b) PAYABILITY DISPUTED DESIGNATIONS. With respect to each claim designated by Wyeth as Payability Disputed, Wyeth shall notify the Trust and Class Counsel of the reasons why payability is disputed. (1) DEFICIENT PROOF. If Wyeth disputes the payability of a claim because of a non-evaluable echocardiogram tape (in whole or in part, where the non-evaluable echocardiogram tape prohibits an evaluation of the factor necessary to support the claim) Wyeth shall specify these reasons in its designation, and Class Counsel shall seek to cure those deficiencies as provided in Section 8(b) of these Procedures. If Class Counsel obtains a better copy of the tape, Class Counsel shall send it to the Trust and to Wyeth, and the processing of the claim will commence anew pursuant to Section 9(a) of these Procedures and will continue in accordance with all subsequent Sections. If Class Counsel is not able to obtain a better copy of the tape, Class Counsel shall notify the Trust and Wyeth, and the claim shall be processed as a Medical Disagreement pursuant to Section 11(b)(2) of these Procedures. (2) MEDICAL DISAGREEMENT. If Wyeth disputes the payability of a claim because it disagrees with the medical condition claimed on the Green Form, or disagrees with the evaluability of a tape as provided in Section 11(b)(1) of these Procedures, Wyeth shall specify which question(s) in Part II of the Green Form it disagrees with, and this question(s) will be the only question(s) submitted to the Auditing Cardiologist for review during Audit (the "Audit Question(s)"). 12. THE TRUST'S ACTIONS ON DESIGNATED MATRIX CLAIMS. After receipt of the response from Wyeth pursuant to Sections 10 and 11 above: (a) PAYABLE CLAIMS: With respect to each claim designated by Wyeth as payable, the Trust shall, as soon as possible, but no later than 30 days after the date of Wyeth's designation, perform a review of the claim to verify that the Class Member filed a Green Form and has the name and claim number of the claim included in Wyeth's designation. After this review and also within 30 days, the Trust shall issue a determination letter to the Class Member. This letter shall notify the claimant of the determination on the claim including the appropriate deductions for attorneys' fees and subrogation claims as required by EXHIBIT K 6 Section VI.C.4.n [p. 111] of the Settlement Agreement and shall provide the claimant an opportunity to accept the amount without prejudice to contest the Matrix or severity level of the claim. The Trust shall not run the Green Form algorithm, require additional completeness steps, or conduct any additional review of the claim, but instead shall process the claim at the level and amount specified in Wyeth's designation. Once a month, the Trust shall aggregate all claims designated as Payable by Wyeth during the preceding month and shall file the list with the Court, accompanied by a Motion for an Order authorizing the Trust to pay the claim(s) in accordance with the amount determined by Wyeth. The Trust shall pay the claims within five days of the Court's entry of the Order authorizing payment. To the extent that the claimant contests the Matrix or severity level of the claim, the claim will be deemed a Medical Disagreement under Section 11(b)(2) of these Procedures and shall be processed in accordance with Sections 11(b)(2), 12(b) and 13 of these Procedures. (b) PAYABILITY DISPUTED CLAIMS. With respect to each claim designated by Wyeth as Payability Disputed on the basis of a medical disagreement under Section 11(b)(2), the Trust shall, no later than 15 days after its receipt of Wyeth's designations, transmit any claim with a Payability Disputed designation for medical disagreement under Section 11(b)(2) to an Auditing Cardiologist. The Trust shall not conduct a completeness review of the claim prior to sending it to Audit. The Auditing Cardiologist shall decide whether there was a reasonable medical basis for the Attesting Physicians' answers to only those Audit Question(s) identified by Wyeth in Section 11(b)(2) of these Procedures. The Trust's processing of claims in Audit shall be governed by the Audit Rules approved by the Court in Pretrial Order No. 2807, except for Rules 3, 4, 5, 7, 8, (and any related Definitions in Rule 1), which are superseded by these Procedures. 13. CONTESTS FOLLOWING AUDIT. If the claimant contests an Audit finding in accordance with Audit Rule 18(b), the Trust shall forward all materials submitted by the claimant in contest to Class Counsel and Wyeth no later than five days of the Trust's receipt of such materials. Wyeth shall review the contest materials and shall notify the Trust and Class Counsel, in writing, no later than ten days following its receipt of the contest materials, whether the claim is Payable or remains Payability Disputed. If the claim is Payable, Wyeth shall provide the Trust with the information specified in Section 11(a) of these Procedures, and the Trust shall issue a Final Post-Audit Determination, in accordance with Audit Rule 18(c), that the claim is Payable. If, after review of the contest materials, Wyeth maintains that the claim is not payable, Wyeth shall provide the Trust with the information specified in Section 11(b) of these Procedures, which the Trust shall consider when deciding whether to issue a Final Post-Audit Determination in accordance with Audit Rule 18(c), denying the claim. EXHIBIT K 7 14. DERIVATIVE CLAIMS. The Trust shall process in accordance with Section IV.B.2 of the Settlement Agreement, as amended, all Derivative Claims associated with any claim of a Diet Drug Recipient included in this process. 15. PROCESSING OF UNDISPUTED BENEFITS. If the Trust determines that there exists a question or issue that may result in the need for further processing or inquiry into the validity or amount of a Derivative Claim or in the need to make legal determinations about a Derivative Claim, the pendency of that processing, inquiry or need for determination shall not delay the processing or payment of a claim for Matrix Benefits that may be payable to a Diet Drug Recipient or his or her Representative Claimant. 16. SUSPENSION OR CANCELLATION OF THIS PROCEDURE. Wyeth and/or Class Counsel have the right to cancel this Procedure upon thirty days' written notice to the Trust's Executive Director (or other chief executive officer), as to all High Level Claims that remain unpaid after the effective date of such notice. 17. DURATION OF THIS PROCEDURE. This procedure shall terminate upon the earlier of: (i) cancellation pursuant to Section 16 above; (ii) an order of the Trial Court directing relief differing from that stated in this Procedure, where such order has not been appealed or if appealed has not been stayed within fifteen days following the entry of the Order. AGREED: WYETH By: ___________________________________________ (signature) Name: _________________________________________ (printed or typed) Date: _________________________________________ CLASS COUNSEL By: ___________________________________________ (signature) Name: _________________________________________ (printed or typed) Date: _________________________________________ EXHIBIT K 8 SEVENTH AMENDMENT LIAISON COMMITTEE By: ___________________________________________ (signature) Name: _________________________________________ (printed or typed) Date: _________________________________________ By: ___________________________________________ (signature) Name: _________________________________________ (printed or typed) Date: _________________________________________ By: ___________________________________________ (signature) Name: _________________________________________ (printed or typed) Date: _________________________________________ By: ___________________________________________ (signature) Name: _________________________________________ (printed or typed) Date: _________________________________________ EXHIBIT K 9 By: ___________________________________________ (signature) Name: _________________________________________ (printed or typed) Date: _________________________________________ EXHIBIT K 10 PART I OF THE OFFICIAL COURT NOTICE: OVERVIEW OF THE SEVENTH AMENDMENT TO THE NATIONWIDE CLASS ACTION SETTLEMENT AGREEMENT EXHIBIT L THIS IS THE FORM OF PART I OF THE NOTICE, BUT IT WILL BE PRINTED FOR DISTRIBUTION, WITH APPROPRIATE DATES, PAGE REFERENCES AND BRACKETED UPDATE INFORMATION FILLED IN. IMPORTANT DEADLINES - - _______, 2004: deadline for filing written comments with the Court for or against approval of the Seventh Amendment. - - _______, 2004: deadline for electing not to be covered by the Seventh Amendment - - _______, 2004: date of Fairness Hearing TABLE OF CONTENTS 1. INTRODUCTION ............................................................................................. 1 2. OVERVIEW OF THE SETTLEMENT AGREEMENT ..................................................................... 1 3. THE SEVENTH AMENDMENT .................................................................................... 2 4. WHAT COULD HAPPEN IF THE PROPOSED SEVENTH AMENDMENT DOES NOT TAKE EFFECT? ................................ 2 5. WHO IS IN THE SEVENTH AMENDMENT? ......................................................................... 3 6. INITIAL, INTERMEDIATE AND BACK-END OPT-OUTS .............................................................. 5 7. WYETH'S GUARANTEED PAYMENT OF QUALIFYING FUTURE MATRIX LEVEL III, IV, AND V CLAIMS OF CATEGORY ONE AND CATEGORY TWO CLASS MEMBERS ........................................................... 5 8. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS UNDER THE SEVENTH AMENDMENT ............................. 6 a. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO PASS MEDICAL REVIEW ........................... 6 b. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO FAIL MEDICAL REVIEW ........................... 7 c. CATEGORY ONE CLASS MEMBERS WHO FAIL TO TIMELY COMPLY WITH FUND ADMINISTRATOR'S REQUIREMENTS ........ 7 d. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO ELECT TO MOVE TO CATEGORY TWO ................. 8 9. BENEFITS AVAILABLE TO CATEGORY TWO CLAIMANTS UNDER THE SEVENTH AMENDMENT ................................. 8 a. NOT ELIGIBLE FOR MEDICAL REVIEW .................................................................... 8 b. PAYMENT OF $2,000 .................................................................................. 8 c. ELIGIBLE FOR CASH/MED BENEFIT ...................................................................... 8 10. THE SUPPLEMENTAL FUND'S TREATMENT OF CERTAIN MEDICAL CONDITIONS .......................................... 10 a. HIGH AND LOW THRESHOLD CONDITIONS UNDER THE SEVENTH AMENDMENT ...................................... 10 b. ALTERNATIVE CAUSATION FACTORS ...................................................................... 10 11. NO LATER OPT-OUT RIGHTS FOR SEVENTH AMENDMENT PARTICIPANTS ................................................ 11 12. OTHER PROVISIONS OF THE SEVENTH AMENDMENT AFFECTING CLASS MEMBERS ......................................... 11 a. RELEASE OF CLAIMS AND COVENANT NOT TO SUE .......................................................... 11 b. TERMINATION OF TRUST LAWSUITS AGAINST CERTAIN PHYSICIANS AND PRECLUSION OF SIMILAR SUITS AGAINST CLAIMANTS, THEIR PHYSICIANS AND THEIR ATTORNEYS ...................................... 11 c. UNDERTAKINGS BY CERTAIN LAWYERS FOR CLASS MEMBERS .................................................. 12 d. EFFECT ON OTHER PROCEEDINGS ........................................................................ 12 e. AMOUNTS OWED TO MEDICARE OR HEALTH INSURANCE COMPANIES; CLASS MEMBER INDEMNITY ..................... 12 13. YOUR RIGHT TO DECIDE WHETHER TO PARTICIPATE IN THE SEVENTH AMENDMENT ..................................... 12 14. WYETH'S RIGHT TO TERMINATE THE SEVENTH AMENDMENT ......................................................... 13 15. SUMMARY OF YOUR OPTIONS UNDER THE SEVENTH AMENDMENT ...................................................... 13 16. ANSWERS TO SOME FREQUENTLY ASKED QUESTIONS ............................................................... 14-19
OVERVIEW OF THE SEVENTH AMENDMENT 1. INTRODUCTION. The Nationwide Class Action Settlement Agreement was created to resolve certain pending and potential legal claims against Wyeth arising from two diet drugs it marketed, Pondimin(R) and Redux(TM). The Settlement Agreement received the Court's final approval on January 3, 2002. Six amendments to the Settlement Agreement have been approved by the Court. A Seventh Amendment has now been submitted to the Court for approval. If the Seventh Amendment is approved by the Court, it will affect the rights of many Class Members. This Overview is Part I of a two-part Official Court Notice (the "Notice"). Part II contains a more complete summary of the Seventh Amendment. This Overview contains several charts summarizing sections of the Seventh Amendment. These charts are intended to serve as guides and are not complete descriptions of these sections. If there is any conflict between the Notice and the Seventh Amendment, the terms of the Seventh Amendment control. See Section 16 of this Overview for information on how to get a copy of the Seventh Amendment. 2. OVERVIEW OF THE SETTLEMENT AGREEMENT. The Settlement Agreement provides benefits for Class Members who used Pondimin(R) or Redux(TM) and who have specified medical conditions. For example, the Settlement Agreement provides money benefits called "Matrix" benefits for people who used the diet drugs and have been diagnosed with certain levels of heart valve regurgitation and other conditions. Class Members who qualify for Matrix benefits do so on one of five levels. Levels I and II generally are for Class Members who have not had surgery. Levels III, IV, and V are for Class Members who have had or needed heart-valve surgery, or who have experienced other conditions, such as a stroke or a post-surgical complication. These benefits are administered by the AHP Settlement Trust (the "Trust"). The Trust administers benefits to Class Members and determines whether a Class Member is eligible for benefits. There has been an overwhelming number of Matrix claims filed by Class Members, especially on Matrix Level II. This has led to significant delays and uncertainties in the payment of Matrix claims. The number of such claims was unanticipated by the parties or the Court when the Settlement Agreement was first approved. In addition, questions have arisen concerning the validity of Matrix claims. The Court ordered in November, 2002, that every seemingly-eligible Matrix claim be reviewed by the Trust's cardiologists to determine if the claim had a reasonable medical basis. These reviews are referred to as "audits." Approximately 60% of the Matrix Level I and II claims audited so far have been found not payable. The Trust now is also investigating many of the claims that were found eligible after audit. These further investigations are part of the Trust's "Claims Integrity Program." The Claims Integrity Program has stopped the processing and payment of many Matrix claims. This delay in paying Matrix claims and the Trust's handling of its audit and claims process have been the subject of numerous complaints and Court filings. In a filing dated August 17, 2004, the Trust asserted that the audit failure rate may be as high as 88% for Matrix Level I and II claims. This contention was based on the Trust's re-evaluation of 926 claims that had previously passed the Trust's medical audit. The Trust's contention has not been proven in any legal proceeding and would likely be contested in litigation that could take years to resolve. The Trust, Class Counsel, Wyeth, and individual Class Members, have spent considerable time and resources on various aspects of the Trust's administration of claims. See Part II of the Notice at [] for more information. These problems and unresolved disagreements create many uncertainties about the processing and payment of Matrix claims. Although the parties cannot predict exactly what will happen, IT IS LIKELY THAT THE TRUST WILL NOT HAVE ENOUGH MONEY TO PAY ALL SIGNIFICANT MAJORITY OF ELIGIBLE MATRIX CLAIMS IF IT PROCESSES ALL OF THESE CLAIMS UNDER THE CURRENT SETTLEMENT AGREEMENT. SEE PART II OF THE NOTICE AT []. 1 3. THE SEVENTH AMENDMENT. The Seventh Amendment is intended to reduce or avoid many of these problems. Under a new arrangement, Wyeth has agreed to pay an additional $1.275 billion to create a new fund with a new process for reviewing and paying claims. Claimants with unresolved Green Forms on file with the Trust that contain sufficient information to support a Claim on Matrix Level I and II will transfer their claims from the Trust to a new entity called the Supplemental Class Settlement Fund ("Supplemental Fund"). Neither Wyeth nor the Trust will be involved in the review and processing of claims by the Supplemental Fund or the payment to an individual claimant. The Supplemental Fund will be directed by a Fund Administrator appointed by the Court, who will work with Class Counsel and a committee of lawyers whose firms represent many Class Members under the Seventh Amendment (the "Seventh Amendment Liaison Committee" or "SALC"). See Part II of the Notice at pages [] for information about SALC. In addition, a medical committee of three cardiologists will help the Fund Administrator develop the rules, forms and procedures for reviewing claims. By freeing the Trust of its obligation to pay Matrix Level I and II claims, the Seventh Amendment also improves the chances that Class Members with claims on Matrix Level III, IV, and V will receive benefits from the existing Trust. Even if the Trust runs out of money, WYETH WILL GUARANTEE PAYMENT TO CLASS MEMBERS PARTICIPATING IN THE SEVENTH AMENDMENT WHO: 1) WERE DIAGNOSED WITH FDA POSITIVE OR MILD MITRAL REGURGITATION BETWEEN THE COMMENCEMENT OF DIET DRUG USE AND JANUARY 3, 2003, (OR BY A LATER DATE FOR THOSE CLASS MEMBERS WHO WERE UNABLE TO RECEIVE AN ECHOCARDIOGRAM FROM THE TRUST'S SCREENING PROGRAM BY JANUARY 3, 2003, AND WHO OBTAINED A COURT-APPROVED EXTENSION) ("THE SCREENING PERIOD"); AND, 2) WHO HAVE A MEDICAL CONDITION THAT QUALIFIES THEM FOR PAYMENT ON MATRIX LEVELS III, IV OR V, AS MODIFIED BY THE SEVENTH AMENDMENT, IF THOSE CONDITIONS OCCUR AND ARE DIAGNOSED BY THE EARLIER OF DECEMBER 31, 2011, OR 15 YEARS FROM THE DATE OF THEIR LAST DIET DRUG USE. Although the Seventh Amendment provides many benefits to participating Class Members, it also removes certain rights that they have under the existing Settlement Agreement. This Overview discusses the benefits the Seventh Amendment provides and those rights it eliminates. See Part II of the Notice for more detailed information. The Seventh Amendment will not take effect until it receives approval from the Court and any appeals from such approval are concluded. The Court will decide whether to approve the Seventh Amendment only after it holds a hearing. You have the right to object to the Seventh Amendment and participate in that hearing. You may decide to have your claim processed under the terms and conditions of the Seventh Amendment, or you may elect to remain in the existing Settlement Agreement. This Overview and Part II of the Notice describe each of these options and what may occur as a result of your decision. If you are an eligible Class Member who takes no action, you are covered by the Seventh Amendment. 4. WHAT COULD HAPPEN IF THE PROPOSED SEVENTH AMENDMENT DOES NOT TAKE EFFECT? Approximately $1.7 billion is available to the Trust as of June 30, 2004, to pay claims and administrative expenses under the Settlement Agreement. However, it has substantial obligations to pay in addition to the large number of pending claims for Matrix Level I and II compensation. If the Seventh Amendment does not take effect, it is likely that the Trust will run out of money. 2 If that happens, some Class Members may have other available options. These include the Sixth Amendment Opt-Out right, which gives certain Class Members the right to sue Wyeth in the tort system, although not for punitive damages. To be eligible for a Sixth Amendment Opt-Out, a Class Member must, among other things, have filed a Green Form by May 3, 2003, which the Trust finds payable after audit but does not pay because it does not have adequate funds, and which Wyeth does not voluntarily pay. The validity of the Sixth Amendment and its bar on punitive damages is presently on appeal. See page [] of Part II of the Notice for more information on the Sixth Amendment Opt-Out right and the appeal. Some Class Members may also qualify for the Back-End Opt-Out right (as described more fully in Part II of the Notice at pages []), regardless of whether the Trust's funds are exhausted. If the Trust runs out of money and none of these opt-out rights is available to you, and your claim is not paid before the Trust's money is exhausted, you would receive nothing from the Trust and would be barred by the terms of the Settlement Agreement from asserting any claim against Wyeth or certain others based on any injury arising out of your use of the diet drugs. However, Counsel for many Class Members have argued that, if claims are not paid, then claimants' rights would have been violated and they should not be precluded by the Settlement Agreement from suing Wyeth, including for punitive damages. Wyeth disputes that argument. The Courts have not decided this dispute and it would likely require many years of litigation, with an uncertain outcome, before those arguments could be finally decided. The Seventh Amendment is designed to resolve such disputes and to provide another option for eligible Class Members. 5. WHO IS IN THE SEVENTH AMENDMENT? The Seventh Amendment creates two groups of Class Members who are eligible to participate in the Seventh Amendment: Category One and Category Two. Whether you are in Category One or Two depends on your medical condition, which type of forms you have previously filed with the Trust, and how far the Trust has processed your claim. CATEGORY ONE AND CATEGORY TWO CLASS MEMBERS HAVE DIFFERENT RIGHTS UNDER THE SEVENTH AMENDMENT THAN THEY DO UNDER THE SETTLEMENT AGREEMENT. This Overview and Part II of the Notice explain these differences. Just because you have received the Notice does not mean that you are in either Category One or Category Two. The following table explains the factors that determine whether you are in Category One or Category Two. ALL of the factors listed for each Category must apply before you can be in either Category One or Category Two. 3 ARE YOU IN CATEGORY ONE OR CATEGORY TWO?
DETERMINING CATEGORY TWO CATEGORY ONE FACTORS YOU ARE NOT IN CATEGORY ONE, AND: - ------------------------------------------------------------------------------------------------------------------------------------ You filed a Pink, Blue or Green Form with the Trust on or REGISTRATION You filed a Pink, Blue, Green, and/or Gray Form with before May 3, 2003. the Trust on or before May 3, 2003, or you think you are timely registered AND the Court decides that you are timely registered. You have on file with the Trust by _____, 2004, a Green MEDICAL You had an echocardiogram performed and were Form, in which Part I is signed by you and Part II is signed CONDITIONS diagnosed with either mild mitral regurgitation or by a Board-Certified Cardiologist, whose answers contain FDA+ regurgitation between the commencement of diet sufficient information on medical conditions to support a drug use and January 3, 2003(or by a later date, for claim for Matrix Level I or II benefits in the current those Class Members who were unable to receive an Settlement. echocardiogram from the Trust's Screening Program by January 3, 2003, and who obtained a Court-approved extension). You have NOT been paid Matrix benefits from the current PRIOR PAYMENT You have NOT been paid Matrix benefits from the Trust. current Trust. You have NOT received a letter from the Trust advising you POST-AUDIT You have NOT received a letter from the Trust that a cardiologist working for the Trust has reviewed or DETERMINATION advising you that a cardiologist working for the audited your pending Green Form claim and that a decision LETTER Trust has reviewed or audited your claim and that a was made either denying Matrix benefits or finding you decision was made finding you eligible for Matrix eligible for Matrix benefits. benefits on Level I or II.* You do NOT have a Green Form Part II on file with the Trust HIGH LEVEL You do NOT have a Green Form Part II on file with signed by a Board-Certified Cardiologist whose answers CLAIMS the Trust signed by a Board-Certified Cardiologist contain sufficient information on medical conditions to whose answers contain sufficient information on support a claim for Matrix Level III, IV or V benefits. medical conditions to support a claim for any Matrix benefits. You have NOT signed an individual release of claims and/or RELEASE OR You have NOT signed an individual release of claims have not been the subject of a final court order dismissing DISMISSAL and/or have not been the subject of a final court with prejudice a legal action relating to injuries arising order dismissing with prejudice a legal action from your use of the diet drugs, unless that court order relating to injuries arising from your use of the allowed you to seek benefits under the Settlement Agreement. diet drugs, unless that court order allowed you to seek benefits under the Settlement Agreement. If you have previously filed an opt-out, special provisions PREVIOUSLY If you have previously filed an opt-out, special apply that affect your eligibility for Category One and FILED provisions apply that affect your eligibility for filing deadlines. See Section 6 below for further details. OPT-OUT Category Two and filing deadlines. See Section 6 below for further details.
*See Part II of the Notice at pages [] for certain cut-off dates. 4 Each person who has made a claim with the Trust has been assigned an individual claim number. If you do not know your claim number, contact the Trust. A list of the claim numbers for everyone believed to be in Category One has been compiled and is available on the Trust's official website at www.settlementdietdrugs.com. You should look at this list to see whether you are on it -- THIS IS YOUR RESPONSIBILITY. If you are not on this Initial Category One List and want to be included in Category One, you will have until _____, 2004, to submit or complete the necessary claim information with the Trust. If you otherwise qualify as a Category One Class Member and you comply with these steps, the list will be revised to include your claim number. See Section 16 below, at Question 10. . 6. INITIAL, INTERMEDIATE AND BACK-END OPT-OUTS. If you are on the Initial Category One Class Member List described above, and you previously submitted an Initial, Intermediate, or Back-End Opt-Out Form, THE SEVENTH AMENDMENT AUTOMATICALLY REVOKES YOUR INITIAL, INTERMEDIATE OR BACK-END OPT-OUT. This means that you will be in Category One, unless you elect not to participate in the Seventh Amendment. (See Section 13 for an explanation of how to elect not to participate in the Seventh Amendment). If you previously submitted an Initial, Intermediate, or Back-End Opt-Out Form and you do not qualify for Category One, but you do qualify for Category Two, you can participate in the Seventh Amendment if you ask Wyeth to revoke your opt-out and Wyeth consents to your request. You may obtain a copy of the Opt-Out Revocation Request Form on the Trust's official website at www.settlementdietdrugs.com. If you revoke your opt-out, you will be in Category Two, if you otherwise qualify for Category Two. See Part II of the Notice at [] for more information about these issues. 7. WYETH'S GUARANTEED PAYMENT OF QUALIFYING FUTURE MATRIX LEVEL III, IV, AND V CLAIMS OF CATEGORY ONE AND CATEGORY TWO CLASS MEMBERS. Any Category One or Category Two Class Member who was diagnosed as having FDA Positive or mild mitral regurgitation between the commencement of diet drug use and the end of the Screening Period and who develops medical conditions in the future that qualify on Matrix Level III, IV, or V, as modified by the Seventh Amendment, is entitled to receive payment from the Trust if those conditions are diagnosed and occur by the earlier of December 31, 2011, or 15 years from the Class Member's last use of diet drugs, and if it is determined after medical review or audit that the claim is payable. This is a change from the current Settlement Agreement. See Part II of the Notice at pages []. If the Trust does not have enough money to pay the claims of all such Category One and Category Two Class Members, Wyeth will guarantee payment of these claims and will deposit additional funds into the Trust to pay these claims. The Seventh Amendment does not change the amount payable to claimants at Matrix Levels III, IV or V. The Seventh Amendment has changed some of the medical criteria for Matrix Levels III, IV, and V for Seventh Amendment participants. For example, surgery-related claims will qualify for benefits on Matrix Level III only if surgery is actually performed. For more information on how the Seventh Amendment changes the specific medical criteria at Matrix Levels III, IV, and V, see Part II of the Notice at page [], and its Appendix F. Wyeth's guarantee of payment to claimants eligible under Levels III, IV, or V, as modified, applies only to Class Members who choose to participate in the Seventh Amendment. Class Members who do 5 not participate in the Seventh Amendment will not receive this benefit and will not receive payment from the Trust if the Trust runs out of money. See Part II of the Notice at pages []. 8. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS UNDER THE SEVENTH AMENDMENT. The benefits available to an eligible Category One Class Member depend on the outcome of the Supplemental Fund's Medical Review process. The Medical Review process will involve cardiologists who will review the echocardiograms and other specified information submitted with each claim to determine if the required medical conditions exist. This Medical Review is designed to be quicker and simpler than the Trust's current audit process. a. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO PASS MEDICAL REVIEW. (1) PARTICIPATION IN PRO RATA DISTRIBUTION OF THE $1.275 BILLION SUPPLEMENTAL FUND. Category One Class Members who pass Medical Review will share in the Supplemental Fund on a pro rata basis. A pro rata basis means that the Fund Administrator will divide $1.275 billion, plus any interest earned (after deducting the costs and expenses of the Fund Administrator, the $2,000 minimum payments discussed at Section 8.b. below, and certain credits as discussed in Part II of the Notice, page []), among Category One Class Members who pass Medical Review in a way that gives something to each such Class Member, distributing it proportionately to those with the same medical condition, age, and length of drug use. Payments will be subject to the 2% payment to Derivative Claimants, and applicable attorneys' fees, as described further in the answers to Questions 7 and 14, respectively, in Section 16 of this Overview and at pages [] of Part II of the Notice. The Fund Administrator's process will work like this: When the claim comes back from Medical Review with medical findings, the Fund Administrator will assign a "Relative Payment Value" to the claim. The Relative Payment Value will depend on how long the claimant used diet drugs, whether the claimant's medical condition falls into either a "High" or "Low" Threshold condition, how old the claimant was at the time of the diagnosis, and whether the claimant has an "Alternative Causation Factor." (For an explanation of High/Low Threshold and Alternative Causation Factors, see Section 10). Once claims of all Category One claimants have been processed through Medical Review and the Fund Administrator has assigned a Relative Payment Value to each claimant, the Fund Administrator will figure out how much each person will be paid, given: 1) the amount of money in the Supplemental Fund; 2) the Relative Payment Value of the claim; and 3) how many other claimants there are and the total of all their Relative Payment Values. See Part II of the Notice on page [] for more information on this subject. After the Fund Administrator has finished Medical Reviews for at least 50% of all Category One Class Members, the Fund Administrator may seek Court approval to make a partial payment to each such claimant. If there is a partial payment, it will be only a portion of the estimated final payment, but it will allow eligible claimants to receive money sooner than having to wait for all claimants to complete the Medical Review process. The partial payment may not exceed 40% of the estimated final payment. Also, before making any partial payment, the Fund Administrator must make sure that the partial payments will not put the Supplemental Fund at risk of not being able to pay all eligible claimants. The final payment will be paid once all of the claims have been reviewed. The Court must approve all partial and final payments. Neither the interim nor the final payment may be made before the Seventh Amendment has become final, with all required Court approvals. 6 Although the amount of money each Category One Class Member will receive from the Supplemental Fund cannot be known until the Fund Administrator has completed its Medical Review of all the claims, most, if not all, of those Class Members will receive less than they would have received under the Settlement Agreement, and most will receive substantially less. However, as discussed in Sections 2 and 4 of this Overview, it is very likely that the Trust will run out of money and will be unable to pay all claims that would otherwise be payable. The way Category One claimants who pass Medical Review get paid under the Seventh Amendment will make it certain that all these claimants will receive some money. (2) NO CASH/MEDICAL SERVICES BENEFIT FROM THE TRUST. The existing Settlement Agreement provides Class Members diagnosed as FDA Positive between the beginning of diet drug use and the end of the Screening Period the opportunity to receive $3,000 to $6,000 in cash or $5,000 to $10,000 worth of heart valve-related medical services. This benefit is called the "Cash/Med Benefit." The Seventh Amendment eliminates the Cash/Med Benefit to Category One Class Members who pass Medical Review and receive benefits from the Supplemental Fund. b. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO FAIL MEDICAL REVIEW. (1) PAYMENT OF $2,000. Category One Class Members who fail (or elect not to undergo) Medical Review will still receive $2,000 from the Supplemental Fund, less applicable attorney's fees if the Class Member is represented by an attorney. The Class Member will be required to prove diet drug use to obtain this benefit. (2) ELIGIBLE FOR CASH/MED BENEFIT. Category One Class Members who fail Medical Review but have an echocardiogram that is determined in the Medical Review process to show FDA Positive regurgitation between the beginning of diet drug use and the end of the Screening Period qualify for the Cash/Med Benefit, if they have not previously been paid or provided this benefit. The Trust will not audit these claims or require the claimant to submit to any additional medical review, but the claimant will be required to prove use of diet drugs to obtain this benefit from the Trust. c. CATEGORY ONE CLASS MEMBERS WHO FAIL TO TIMELY COMPLY WITH FUND ADMINISTRATOR'S REQUIREMENTS. The Fund Administrator will ask Category One Class Members to comply with certain filing deadlines and proof submissions before the claim is sent to Medical Review. Failure to comply with the Fund Administrator's requirements may disqualify Category One Class Members from receiving some benefits that they might otherwise be eligible to receive. (1) NOT ELIGIBLE FOR MEDICAL REVIEW. If a Category One Class Member fails to comply with the Fund Administrator's requirements for filing or completing a claim for Medical Review, the opportunity for Medical Review and its possible benefits will not be available to that Class Member. (2) PAYMENT OF $2,000. A Category One Class Member who fails to comply with the Fund Administrator's requirements will still be paid $2,000, less applicable attorney's fees if the Class Member is represented by an attorney. (3) NOT ELIGIBLE FOR CASH/MED BENEFIT. A Category One Class Member who does not comply with the Fund Administrator's requirements for filing or completing a claim will no longer have the right to the Cash/Med Benefit from the Trust, even if he or she has an echocardiogram report or claim form on file with the Trust showing FDA Positive regurgitation between the beginning of diet drug use and the end of the Screening Period. 7 d. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO ELECT TO MOVE TO CATEGORY TWO. Category One Class Members will have the option of electing to move to Category Two, but this election must occur by ____, which is 120 days after the deadline established by the Court for allowing Class Members to object or elect not to participate in the Seventh Amendment. If the Court extends that deadline, the 120 day deadline for a Category One Class Member to elect Category Two will also be extended. (1) ELIGIBLE FOR $2,000 PAYMENT. Category One Class Members who elect to move to Category Two will receive $2,000, less applicable attorney's fees if the Class Member is represented by an attorney, within 60 days after Final Judicial Approval. To receive this benefit, claimants must have been identified on the Initial Category One Class List or otherwise qualified for inclusion on that list and must have timely submitted a Category Two Election Form. (2) ELIGIBLE FOR CASH/MED BENEFIT. Category One Class Members who elect to move to Category Two and who qualify for the Cash/Med benefit will receive that benefit, if it has not previously been paid or provided to them. The Trust will not audit these claims for Cash/Med benefits or require the claimant to submit to any additional medical review, but the claimant must submit a properly completed Gray Form, echocardiogram tape or disk, and proof of diet drug use as required by the Settlement Agreement. 9. BENEFITS AVAILABLE TO CATEGORY TWO CLAIMANTS UNDER THE SEVENTH AMENDMENT. a. NOT ELIGIBLE FOR MEDICAL REVIEW. Category Two claimants cannot participate in the Supplemental Fund. Instead, their claims will be administered by the Trust. Because Category Two claimants do not participate in the Supplemental Fund, they are not eligible to participate in the Medical Review process and the pro rata distribution of the available money in the Supplemental Fund. b. PAYMENT OF $2,000. To receive a payment of $2,000, Category Two Class Members must have proof that they used the diet drugs, and they must have an echocardiogram between the commencement of diet drug use and the end of the Screening Period showing that they have FDA Positive or mild mitral regurgitation, and they must submit a Green or Gray Form documenting their FDA Positive or mild mitral diagnosis. No later than 60 days after Final Judicial Approval, the Trust will pay $2,000, less applicable attorney's fees if the Class Member is represented by an attorney, to eligible Category Two Class Members. Eligible Category Two Class Members will appear on a list within 30 days of Final Judicial Approval, which will be posted on the Trust's website. No later than 60 days after Final Judicial Approval, the Trust will notify each potential Category Two Class Member without complete submissions on file (and thus not appearing on the list) that they will not receive $2,000 unless they submit the necessary documentation to the Trust. Within 60 days after the Category Two Class Member submits the necessary materials, the Trust will pay the eligible Category Two Class Member $2,000, less applicable attorney's fees if the Class Member is represented by an attorney. ALL NECESSARY DOCUMENTATION MUST BE SUBMITTED TO THE TRUST NO LATER THAN SEVEN MONTHS AFTER FINAL JUDICIAL APPROVAL, OR THE CATEGORY TWO CLASS MEMBER WILL NOT BE ABLE TO RECEIVE THE $2,000. Although the Trust will process these claims for payment, Wyeth will deposit money into the Trust to make these $2,000 payments to Category Two Class Members, and these deposits will not reduce the amount of money Wyeth is obligated to pay under the original Settlement Agreement. c. ELIGIBLE FOR CASH/MED BENEFIT. Category Two Class Members will be eligible for the Cash/Med Benefit, if they have not previously been paid or provided this benefit and they have been diagnosed with FDA Positive regurgitation between the beginning of diet drug use and the end of the Screening Period. The claimant will be required to have all proof required by the Settlement Agreement, 8 including proof of diet drug use, and the Trust may audit 10% of these claims to ensure that they meet all of the requirements for this benefit. The following table summarizes the benefits available to Category One and Category Two Class Members. All citations in the table are to sections of this Overview. SEVENTH AMENDMENT BENEFIT REFERENCE GUIDE (ALL BENEFITS SUBJECT TO ELIGIBILITY REQUIREMENTS OF THE SETTLEMENT AGREEMENT AND SEVENTH AMENDMENT)
GUARANTEED PAYMENT STILL ELIGIBLE FOR CASH/MED OF MATRIX LEVEL III, BENEFIT FROM TRUST UNDER CATEGORY MONETARY PAYMENT IV OR V CLAIMS?* THE EXISTING SETTLEMENT? - ------------------------------------------------------------------------------------------------------------------------------------ Pro rata share of $1.275 billion, after expenses and other Yes No CLAIM PASSES payments and deductions. WITH MEDICAL MEDICAL REVIEW [See Section 8.a.(1)] [See Section 7] [See Section 8.a.(2)] REVIEW -------------------------------------------------------------------------------------------------------- Yes, if the Medical Review process finds FDA+ regurgitation on an $2,000 Yes echocardiogram taken between CLAIM FAILS the beginning of diet drug use MEDICAL REVIEW [See Section 8.b.(1)] [See Section 7] and the end of the Screening Period. [See Section 8.b.(2)] - ------------------------------------------------------------------------------------------------------------------------------------ FAILS TO COMPLY $2,000 Yes No WITH FUND ADMINISTRATOR'S REQUIREMENTS [See Section 8.c.(2)] [See Section 7] [See Section 8.c.(3)] - ------------------------------------------------------------------------------------------------------------------------------------ Yes, if FDA+ on an echocardiogram taken between the beginning of diet ELECT TO MOVE TO $2,000 Yes drug use and the end of the CATEGORY TWO Screening Period, which is supported by a Gray or Green CATEGORY [See Section 8.d.(1)] [See Section 7] Form. ONE [See Section 8.d.(2)] - ------------------------------------------------------------------------------------------------------------------------------------ Yes, if found FDA+ on an $2,000, if FDA+ or have Mild Mitral echocardiogram taken between Regurgitation on an echocardiogram taken the beginning of diet drug between the beginning of diet drug use and use and the end of the the end of the Screening Period, as supported Yes Screening Period, which is by a Gray or Green Form. supported by a Gray or Green Form. Ten percent of these claims will be subject to Trust audits. CATEGORY TWO [See Section 9.b] [See Section 7] [See Section 9.c] - ------------------------------------------------------------------------------------------------------------------------------------
9 *CLAIMANTS MUST MEET THE REQUIREMENTS FOR MATRIX III, IV, OR V CLAIMS, AS MODIFIED BY THE SEVENTH AMENDMENT, WHICH ARE BASED ON CONDITIONS THAT ARE DIAGNOSED AND OCCURRED BY THE EARLIER OF DECEMBER 31, 2011, OR 15 YEARS FROM THE CLASS MEMBER'S LAST DIET DRUG USE. SEE SECTION 7 AND PART II OF THE NOTICE AT PAGES [] FOR MORE INFORMATION. 10. THE SUPPLEMENTAL FUND'S TREATMENT OF CERTAIN MEDICAL CONDITIONS. a. HIGH AND LOW THRESHOLD CONDITIONS UNDER THE SEVENTH AMENDMENT. The Seventh Amendment takes the Matrix Level I and II medical criteria in the existing Settlement Agreement and divides them into "High Threshold" and "Low Threshold" conditions, recognizing that certain medical conditions on Levels I and II are more severe than others. People who are found during the Supplemental Fund's Medical Review process to have medical conditions on the High Threshold will receive more compensation from the Supplemental Fund than those on the Low Threshold. The following table describes generally what medical conditions qualify on the High Threshold and Low Threshold.
HIGH THRESHOLD CONDITIONS LOW THRESHOLD CONDITIONS - -------------------------------------------------------------------------------------------------------------------------------- REGURGITATION HIGH THRESHOLD COMPLICATING REGURGITATION LOW THRESHOLD COMPLICATING LEVEL/VALVE FACTOR LEVEL/VALVE FACTOR - -------------------------------------------------------------------------------------------------------------------------------- Severe Aortic With or Without High Threshold Severe Mitral No High Threshold Complicating Factors Complicating Factors FDA+ Moderate Aortic Abnormal Left Ventricular End- Valvular Bacterial Endocarditis Contracted After Commencement of Systolic or End Diastolic Dimension Regurgitation Diet Drug Use Moderate Aortic Ejection Fraction <50% Moderate Mitral Abnormal Left Atrial Size Severe Mitral Pulmonary Hypertension Moderate Mitral Pulmonary Hypertension Severe Mitral Abnormal Left Ventricular End- Moderate Mitral Abnormal Left Ventricular End-Systolic Dimension Systolic Dimension Severe Mitral Ejection Fraction <50% Moderate Mitral Ejection Fraction < or = 60%
b. ALTERNATIVE CAUSATION FACTORS. Alternative Causation Factors are medical factors that cause some of the same medical conditions as those claimed to have been caused by the diet drugs. As in the existing Settlement Agreement, an Alternative Causation Factor found during Medical Review in the Supplemental Fund will reduce the value of a claim. Many of the same Alternative Causation Factors from the Settlement Agreement exist in the Seventh Amendment, although some have been changed, and others have been eliminated. See Part II of the Notice, Appendix D. 10 11. NO LATER OPT-OUT RIGHTS FOR SEVENTH AMENDMENT PARTICIPANTS. The existing Settlement Agreement provided opportunities for certain people who met specific medical criteria and/or procedural requirements to opt-out and file a lawsuit against Wyeth. The time for submitting two of those opt-out rights - the Initial and Intermediate - has passed (except possibly for certain Class Members who received a late echocardiogram in the Screening Program). PEOPLE WHO PARTICIPATE IN THE SEVENTH AMENDMENT WILL NO LONGER HAVE ANY RIGHT TO OPT OUT UNDER THE INTERMEDIATE, BACK-END, SIXTH AMENDMENT AND FINANCIAL INSECURITY OPT-OUTS. For a discussion of these opt-out rights and their termination for persons participating in the Seventh Amendment, see Part II of the Notice at pages []. A Class Member who would have been eligible for these later opt-out rights but participates in the Seventh Amendment will no longer be able to exercise these opt-out rights and file suit against Wyeth. 12. OTHER PROVISIONS OF THE SEVENTH AMENDMENT AFFECTING CLASS MEMBERS. a. RELEASE OF CLAIMS AND COVENANT NOT TO SUE. The Seventh Amendment reiterates and reaffirms the Settlement Agreement's provisions releasing Wyeth and other people or entities called "Released Parties" arising from the use of diet drugs. "Released Parties" is defined more fully in Part II of the Notice at ________. The claims that are released are called "Settled Claims," and are explained more fully in Appendix D to Part II of the Notice. In addition to these releases, the Seventh Amendment releases Wyeth and all Released Parties for any acts or omissions of the Trust or its representatives, as well as all claims arising out of Wyeth's role in drafting, negotiating, obtaining approval of, or in the administration of the current Settlement Agreement. Class Members participating in the Seventh Amendment will be barred from asserting against Wyeth or other Released Parties that their rights were violated in connection with the original Settlement Agreement, including any argument relating to the Trust's not having enough money to pay valid claims. If someone else establishes a right not to be bound by the Settlement Agreement on behalf of Class Members or some group of them, Class Members participating in the Seventh Amendment will not have that right. In addition, participating Class Members will not be able to assert any claim against any Trustee, officer or employee of the Trust arising from the performance of their duties under the Settlement Agreement, as to which the Trustee and/or the Trust officer or employee may have a right of indemnity from the Settlement Fund or against the Trust with respect to any such claims. For more information on this subject, see Part II of the Notice at pages []. b. TERMINATION OF TRUST LAWSUITS AGAINST CERTAIN PHYSICIANS AND PRECLUSION OF SIMILAR SUITS AGAINST CLAIMANTS, THEIR PHYSICIANS AND THEIR ATTORNEYS. The Seventh Amendment bars the Trust or Wyeth from suing anyone to recover amounts paid by the Trust before July 21, 2004. It could be asserted that this bar benefits certain attorneys, apart from effects of the Seventh Amendment on their clients or on other Class Members because, among other things, Wyeth and the Trust have made allegations against some attorneys in connection with claims they have submitted on behalf of clients, as discussed at pages [] of Part II of the Notice. Those attorneys have denied those allegations. Neither Wyeth nor the Trust has made such allegations against most attorneys representing Class Members. No such allegations have been made against Class Counsel. Under these circumstances, Class Counsel does not have any financial stake in the Seventh Amendment's bar against this kind of lawsuit. Class Counsel has an independent fiduciary obligation to the class as a whole and has made an independent determination that this anti-lawsuit provision of the Seventh Amendment is in the best interests of the class because such lawsuits would likely lead to lengthy litigation, are likely to cost the Trust more than it will actually recover, and would create an environment not conducive to efficient claims resolution. Class Counsel has also made a determination that the Seventh Amendment as a whole is in the best interest of 11 the class. You may choose to rely on these determinations by Class Counsel or you may choose to seek independent legal advice in deciding whether to participate in the Seventh Amendment. c. UNDERTAKINGS BY CERTAIN LAWYERS FOR CLASS MEMBERS. Because Wyeth was not willing to proceed with negotiations of the Seventh Amendment without assurance that the amendment would receive substantial support from other Class Members, written support for the Seventh Amendment was obtained from law firms representing a large number of Class Members. Those law firms signed a term sheet stating that they believed the Seventh Amendment is in the best interests of their clients and committing that they would recommend to all their clients that they participate in it and not object to it. Those law firms have recognized that there is a conflict between representing some claimants who want to be part of the Seventh Amendment and some who do not. This is because clients who decide not to participate in or to object to the Amendment could lead to Wyeth's terminating the Seventh Amendment, to the detriment of those clients who wish to participate. See Section 14. Those law firms further stated in the term sheet that they would take all lawful measures to withdraw from representing any client who elects not to be covered by, or who objects to, the Seventh Amendment and would therefore forego an legal fees related to any such client's claims. Eligible Class Members who are represented by their own attorney may wish to discuss with an attorney the potential conflict described here and its impact on their decision-making regarding all issues relating to the Seventh Amendment. d. EFFECT ON OTHER PROCEEDINGS. A number of other legal proceedings and appeals have been stayed and would be dismissed and terminated if the Seventh Amendment becomes effective. For more information on this subject, see pages [] of Part II of the Notice. e. AMOUNTS OWED TO MEDICARE OR HEALTH INSURANCE COMPANIES; CLASS MEMBER INDEMNITY. If Medicare or any other governmental entity or private health insurance carrier has paid any of your medical expenses or has provided medical services relating to or arising from use of diet drugs, you might have certain obligations to satisfy their claims for subrogation or reimbursement. If you receive a pro rata share from the Supplemental Fund, you would also be required to pay Wyeth, the Trust, or the Fund Administrator, if they are sued by the entity that paid those expenses. For more information on this subject, see pages [] of Part II of the Notice. 13. YOUR RIGHT TO DECIDE WHETHER TO PARTICIPATE IN THE SEVENTH AMENDMENT. No Class Member receiving the Notice is required to participate in the Seventh Amendment. You may elect not to participate and continue to have whatever rights you may have under the existing Settlement Agreement. If you do not want to participate in the Seventh Amendment, you must notify Wyeth in a written statement that is postmarked or delivered no later than ____, 2004, that you clearly wish not to participate in the Seventh Amendment. This written statement must include your full name, your address, the claim number assigned to you by the Trust, your Social Security number, and the name of your attorney, if you have one. It must also state clearly that you do not wish to participate in the Seventh Amendment. YOU MUST PERSONALLY SIGN THIS WRITTEN STATEMENT. If your written statement does not include all of these requirements, and if it is not postmarked or delivered on or before ___, 2004, you will be part of the Seventh Amendment. For your convenience, you may use the Seventh Amendment Opt-Out Form available on the Trust's official website at www.settlementdietdrugs.com to make your election not to participate in the Seventh Amendment, or you may write your own statement that complies with these requirements. CLASS MEMBERS WHO ELECT NOT TO PARTICIPATE IN THE SEVENTH AMENDMENT WILL REMAIN SUBJECT TO THE EXISTING SETTLEMENT AGREEMENT AND ALSO RETAIN ANY OPT-OUT RIGHT, INCLUDING THE SIXTH AMENDMENT AND THE BACK-END OPT-OUT, IF THEY QUALIFY TO EXERCISE SUCH OPT-OUTS UNDER THE TERMS OF THE SETTLEMENT AGREEMENT. 12 Unless you elect not to participate in the Seventh Amendment, you will be accepting all of its terms. These terms include both the benefits the Seventh Amendment provides, as well as the elimination of certain rights under the existing Settlement Agreement, which are terminated by the Seventh Amendment, and the releases, and other matters discussed in Sections 11 and 12. 14. WYETH'S RIGHT TO TERMINATE THE SEVENTH AMENDMENT. Wyeth has the right to terminate the Seventh Amendment at any time before _____, 2004. Wyeth has stated that one factor it will consider in deciding whether to terminate the Seventh Amendment and, therefore, not pay the $1.275 billion, will be the extent of Class Members' participation in the Seventh Amendment. Wyeth has stated that unless there is a very high level of participation by eligible Class Members in the Seventh Amendment, it intends to walk away and terminate the Seventh Amendment. 15. SUMMARY OF YOUR OPTIONS UNDER THE SEVENTH AMENDMENT. Although Part II of the Notice provides more detail about your options under the Seventh Amendment, this table summarizes some options you have: YOUR OPTIONS IN THE SEVENTH AMENDMENT
OPTIONS EXPLANATION ACTION - ------------------------------------------------------------------------------------------------------------------------------------ You do not need to do anything at this time beyond checking to see if your claim is on the Category One Class Member List, unless you previously filed an Initial, Intermediate or Back-End opt-out and wish to be in the Seventh Amendment. However, to receive PARTICIPATE IN THE Be eligible to seek benefits in the Seventh Amendment, benefits under the Seventh Amendment, you must SEVENTH AMENDMENT and relinquish certain rights under the Settlement comply with deadlines established by the Fund Agreement. Administrator and/or the Trust, depending on whether you seek benefits as a Category One or Category Two Class Member. If you previously filed an Initial, Intermediate or Back-End opt-out, see Section 6 for details on what you must do, if anything, to participate in the Seventh Amendment - ------------------------------------------------------------------------------------------------------------------------------------ Send a written statement notifying Wyeth of your ELECT TO BE Remain in the existing Settlement Agreement to be clear intention not to participate, which you can do EXCLUDED processed by the Trust, subject to the Claims Integrity (but are not required to do) by completing, signing (OPT OUT OF Program and retaining opt-out rights, if you qualify for and timely submitting the Seventh Amendment Opt-Out THE SEVENTH them. Form, which is available for your convenience on the AMENDMENT) Trust's website at www.settlementdietdrugs.com. See Section 13. - ------------------------------------------------------------------------------------------------------------------------------------ Write, do not call, the Court if you do not like the OBJECT TO THE Tell the Court if you do not like the Seventh Amendment Seventh Amendment, and specify the reasons you SEVENTH AMENDMENT or any portion(s) of it and why. object. Your objection(s) must be accompanied by a memorandum of law explaining why you think the Seventh Amendment should not be approved. See Part II of the Notice, pages [] - ------------------------------------------------------------------------------------------------------------------------------------ File an objection as specified above and request in Speak to the Court in a formal hearing about the fairness writing a time to be heard by the Court, and specify GO TO A HEARING of the Seventh Amendment. whether you have an attorney and, if so, who that is. In your written request, summarize any grounds for any objections. - ------------------------------------------------------------------------------------------------------------------------------------
13 16. ANSWERS TO SOME FREQUENTLY ASKED QUESTIONS. 1. HOW DO I GET A COPY OF THE SEVENTH AMENDMENT? You may view a copy of the Seventh Amendment and the Settlement Agreement on the Trust's official website, at www.settlementdietdrugs.com. You may also request a copy by writing to the Trust at AHP Settlement Trust, P.O. Box 7939, Philadelphia, Pennsylvania, 19101, or by calling the Trust at 1-800-386-2070. Finally, you may inspect a copy of the Seventh Amendment at the Clerk's Office at the United States District Court for the Eastern District of Pennsylvania in Philadelphia, PA, during regular business hours, and may get copies by paying their copying costs. 2. WHAT MUST HAPPEN, AND ON WHAT TIMETABLE, FOR THE SEVENTH AMENDMENT TO BE APPROVED BY THE COURT? The Court has preliminarily approved the Seventh Amendment and has issued an Order that governs the steps that must now occur before the Seventh Amendment can be finally approved by the Court. The first thing that must happen is that Class Members deciding not to participate must file this election by ___, 2004. Class Members must also submit any objections to the Seventh Amendment by ___, 2004. After this deadline, Wyeth will have 60 days (which can be extended by the Court upon unanimous consent of Wyeth, the SALC, and Class Counsel) to decide whether to walk away from the Seventh Amendment. If Wyeth does not walk away, the Court will hold a Fairness Hearing on ___, to determine whether the proposed Seventh Amendment is fair, reasonable and adequate. During the Fairness Hearing, the Court will hear testimony and/or arguments for, and objections against, the Seventh Amendment. After the Fairness Hearing, the Court will decide whether to grant its approval to the Seventh Amendment. If the Court grants its approval, there will be a period of 30 days for persons who filed Objections to appeal the Court's decision. If there are no appeals, Final Judicial Approval will occur after the last day of the appeal period, or 31 days after this Court has granted its approval. If there are appeals, then Final Judicial Approval will not occur until all appeals are concluded, which could take a long time. 3. CAN ANY CLAIMS PROCESSING OCCUR BETWEEN THIS COURT'S APPROVAL AND FINAL JUDICIAL APPROVAL? Yes. The Fund Administrator may process claims of Category One Class Members, and the Trust may process claims of Category Two Class Members between this Court's approval and Final Judicial Approval to allow payment as promptly as possible to all eligible Category One and Category Two Class Members following Final Judicial Approval. No payments will be made until after Final Judicial Approval. The Trust's claims processing activity, including its audit, Claims Integrity Program, and payment of claims, may proceed for those claimants who elect not to participate in the Seventh Amendment after the end of the period when Wyeth can walk away from the Seventh Amendment. 4. WHAT ADMINISTRATIVE STEPS WILL THE FUND ADMINISTRATOR REQUIRE FOR SUBMITTING A CLAIM TO THE SUPPLEMENTAL FUND? If the Seventh Amendment is approved by the Court, the Fund Administrator will establish rules, forms, and procedures for submitting and processing claims by Category One Class Members. Generally, 14 the claims review process will be designed to be simpler and quicker than the current Matrix claim and audit process at the Trust. If you wish to be eligible for Category One benefits, the Fund Administrator must have your proof of diet drug use, a copy of the echocardiogram tape or disk that forms the basis of your claim, a sworn statement on a form provided by the Fund Administrator which states your date of birth, the date of the echocardiogram supporting your claim, and whether you previously received any payment of Matrix benefits from the Trust or received notice that the Trust denied your claim for Matrix benefits. The Fund Administrator may request additional information in support of a claim. If you do not meet the Fund Administrator's requirements, you may not obtain some benefits that you might otherwise have been eligible to receive. 5. HOW LONG WILL IT BE BEFORE MY CLAIM GETS PAID UNDER THE SEVENTH AMENDMENT? The timing of payments depends on how long it takes for the Seventh Amendment to receive Final Judicial Approval (see Question and Answer #2 above), and whether you are a Category One or Category Two Class Member. No payments can be made until the Seventh Amendment receives Final Judicial Approval. After Final Judicial Approval, the Court may authorize the Fund Administrator to make partial payments (not to exceed 40% of the expected final claim payment to Category One Class Members who pass Medical Review). The Fund Administrator will not decide whether to seek Court approval to make a partial payment until at least 50% of all eligible claims have gone through Medical Review. Final distributions will be made after all Category One participants have completed Medical Review. Category Two Class Members will receive any applicable $2,000 payment by the later of 60 days after Final Judicial Approval or 60 days after they have submitted all documentation necessary for Category Two participation. The Trust's claims processing activity, including its audit, Claims Integrity Program, and payment of claims, may proceed for those claimants who elect not to participate in the Seventh Amendment after the end of the period when Wyeth can walk away from the Seventh Amendment. 6. IS THERE A WAY UNDER THE SEVENTH AMENDMENT FOR ME TO AVOID GOING THROUGH MEDICAL REVIEW IN THE SUPPLEMENTAL FUND, BUT STILL BE PAID SOMETHING? Yes. Category One participants may elect to forego any Medical Review by switching to Category Two. Category One participants who switch to Category Two will not receive the pro rata share of the Settlement Fund, but will receive $2,000 and they will still be eligible for the Cash/Med benefit if they have an echocardiogram showing FDA Positive regurgitation between the beginning of diet drug use and the end of the Screening Program. If they have such a timely echocardiogram that shows FDA Positive regurgitation or mild mitral regurgitation, they also are still eligible to file a claim with the Trust seeking benefits on Matrix Level III, IV, or V, as modified by the Seventh Amendment, if the medical condition qualifying them on those Matrix levels is diagnosed and occurs by the earlier of December 31, 2011, or fifteen years from their last use of the diet drugs. Wyeth has agreed to deposit funds into the Trust to make sure that all qualifying Level III, IV or V claims, based on the modified criteria, are paid. The only other way to be paid without going through Medical Review is if you are one of the few people whose claim had already gone through audit at the Trust and was found payable by the Trust's doctors, but the Trust had not yet issued you a letter telling you the outcome of that audit. If you are one 15 of those people, you have received a special notice in this packet informing you of your status and how your claim will be processed in the Supplemental Fund. 7. WHAT HAPPENS TO THE CLAIMS OF DIET DRUG USERS' FAMILY MEMBERS UNDER THE SEVENTH AMENDMENT? The Settlement Agreement provides benefits to eligible spouses, significant others and/or children of diet drug users, who are called Derivative Claimants. Under the Seventh Amendment, Derivative Claimants do not receive any portion of a $2,000 payment amount received by Category One Class Members who fail Medical Review, switch to Category Two, or fail to comply with the Fund Administrator's requirements. Nor do they receive a portion of the $2,000 payment to Category Two Class Members. Derivative Claimants of Category One Class Members who pass Medical Review will receive an aggregate 2% share of the Category One Class Member's benefit. See Part II of the Notice, page [] for further information. 8. IS THERE A CHANCE THAT THE SEVENTH AMENDMENT WILL NOT TAKE EFFECT? Yes. The Seventh Amendment will not take effect if Wyeth decides to walk away or the Court decides not to approve it. Unless there is a very high level of participation by eligible Class Members in the Seventh Amendment, Wyeth has stated that it intends to terminate the Seventh Amendment and not deposit the additional $1.275 billion into the Supplemental Fund. Instead, its contractual funding obligations will end once its original funding obligations under the Settlement Agreement are satisfied. Wyeth will have no further contractual obligation to provide additional funds to the Trust for Matrix Compensation benefits if the Trust once it runs out of money. 9. DOES THE SEVENTH AMENDMENT CHANGE THE REQUIREMENTS FOR SURGERY CLAIMS? Yes. The existing Settlement Agreement provides Matrix Level III benefits for a Class Member who took the diet drugs and had heart-valve repair or replacement surgery on a valve that had been diagnosed between the commencement of diet drug use and the end of the Screening Period as having FDA Positive or mild mitral regurgitation. The Settlement Agreement also provides Matrix Level III benefits under certain circumstances for a Class Member who took the diet drugs and needed -- but did not have - heart-valve surgery on a valve with severe regurgitation, if he or she submits supporting medical records and a physician's statement. The Seventh Amendment provides Matrix Level III benefits for people who actually have surgery within specified deadlines, but it does not provide these benefits for people who did not have surgery. However, the Seventh Amendment does permit a person needing surgery, but whose doctor has advised against it, to make certain claims at Matrix Levels IV and V. 10. IF I AM NOT ON THE CATEGORY ONE LIST BUT WANT TO BE, WHAT CAN I DO TO BE A CATEGORY ONE CLASS MEMBER? If you are not on the Category One list, you may take steps to be included in Category One IF you have already done certain things. You must have submitted a signed Pink, Blue and/or Part I of a Green Form, and/or a substantially completed Green Form Part II signed by an attesting physician to the Trust on or before May 3, 2003. You must have had an echocardiogram after you used the diet drugs but before the end of the Screening Period that demonstrates mild mitral or FDA Positive regurgitation, and an echocardiogram after diet drug use that demonstrates a Matrix Level I or Matrix Level II condition. If you have satisfied these steps, you must submit to Wyeth and to the Fund Administrator, no later than ____, proof of diet drug use, a Green Form with Part I signed by you and Part II signed by an 16 attesting physician in which the answers contain sufficient information on medical conditions to support a claim on Matrix Level I or Matrix Level II. Finally, you must submit the echocardiogram(s) on which your claim is based. Within 120 days of ____, Wyeth, the SALC and the Fund Administrator will review these submissions and shall decide whether to include the Class Member as a Category One Class Member. This does not apply if you have previously filed an Initial, Intermediate or Back-End Opt-Out. The only way for a person who previously filed an Initial, Intermediate or Back-End Opt-Out to be included in Category One is if they filed a Green Form by May 6, 2004, in which the answers to Part II contain sufficient information on medical conditions to support a claim on Matrix Level I or Matrix Level II. Under those circumstances, your opt-out will be AUTOMATICALLY REVOKED unless you elect not to participate in the Seventh Amendment. If you previously filed an Initial, Intermediate or Back-End Opt-Out and you did not file such a Green Form by May 6, 2004, you can be in Category Two if you obtain Wyeth's consent to revoke your opt-out. If you obtain that consent, and if you otherwise qualify, you will be in Category Two. 11. WHAT IF I DID NOT KEEP A COPY OF MY ECHOCARDIOGRAM TAPE OR PROOF THAT I USED THE DIET DRUGS WHEN I SUBMITTED THEM TO THE TRUST? You may ask the Trust, in writing, to provide a copy of your echocardiogram tape and proof of diet drug use to the Fund Administrator. You will have to pay the Trust a service fee of $50.00 for providing copies of your diet drug use proof and $100.00 for providing a copy of your echocardiogram tape. 12. IF I DECIDE TO GO THROUGH MEDICAL REVIEW AND THE FUND ADMINISTRATOR'S DOCTOR DOES NOT THINK MY CLAIM QUALIFIES, IS THERE ANYTHING I CAN DO TO GET ANOTHER CHANCE? Yes. If your claim fails Medical Review, you will be able to ask the Fund Administrator to submit your claim to a different doctor for a second review. Your request must be in writing within whatever deadline the Fund Administrator sets, and you must pay a non-refundable fee, not to exceed $2,500, to help cover the cost of the second review. If the second doctor finds your claim payable, it will be processed by the Fund Administrator as a payable claim, with no regard to the first review. If you do not request a second review and/or if the second review also finds that your claim is not payable, the Fund Administrator's determination will be final and you will not be able to challenge or appeal that decision. 13. THIS OVERVIEW SAYS THAT IF A CLASS MEMBER GETS A $2,000 PAYMENT, IT IS "LESS APPLICABLE ATTORNEY'S FEES." HOW MUCH WILL BE TAKEN OUT OF THE $2,000 TO PAY MY ATTORNEY? This is a matter to discuss with your attorney, but the Seventh Amendment sets a maximum of $650 that your attorney can take out of your $2,000. 14. WILL ATTORNEYS' FEES BE DEDUCTED OUT OF OTHER PAYMENTS I MIGHT RECEIVE UNDER THE SEVENTH AMENDMENT? IF SO, HOW MUCH WILL BE DEDUCTED? This is a matter to discuss with your attorney, because this depends on the individual agreement you have with him or her. Subject to the Court's approval, the Court will determine whether a "common benefit" fee will be set aside out of the Supplemental Fund to pay attorneys for professional services that are found by the court to be of "common benefit" to Category One Class Members. Subject to the Court's approval, the persons who participate in that fee would include Class Counsel, members of SALC, and possibly others. If the Court awards this common benefit fee and you are represented by an 17 attorney, the fee will be taken out of your attorney's share and will not affect the amount you receive. If you are not represented by counsel, the amount will be deducted from your payment. For more information on the common benefit fee, see [] of Part II of the Notice. 15. THE SETTLEMENT AGREEMENT PROVIDES SPECIFIC DETAIL ABOUT HOW MUCH MONEY I WOULD RECEIVE IF MY CLAIM WAS FOUND PAYABLE BY THE TRUST, BUT I CANNOT FIND ANY INFORMATION ABOUT THE EXACT AMOUNT OF MONEY I WOULD GET AS A CATEGORY ONE CLASS MEMBER UNDER THE SEVENTH AMENDMENT. WHY? Many factors affect the actual amount of money a Category One Class Member may receive under the Seventh Amendment. Assuming your claim passes Medical Review in the Supplemental Fund, there is still no way to calculate or predict an actual amount until the Fund Administrator knows how many Category One Class Members pass Medical Review, and their ages, medical conditions and duration of diet drug use. The Fund Administrator will pay claims according to a grid, but for now, that grid can only show you the relative differences between Class Members based on their age, diet drug use, whether they have "High" or "Low" Threshold conditions, and whether they have any alternative causation factors. It is important to remember that one of the main goals of the Seventh Amendment is to pay all eligible Class Members something. The Fund Administrator will process and pay claims as quickly as it can, and may be able to make a partial payment to all eligible Class Members once at least 50% of the claims complete Medical Review. Although the Settlement Agreement specifies compensation levels corresponding to particular medical conditions, payment of such amounts is not guaranteed, and it is likely that many eligible claimants will receive nothing at all from the Trust if the current process continues without the Seventh Amendment, although they may have certain opt-out rights available to them. See Section 4 above. 16. DOES THE SEVENTH AMENDMENT CHANGE THE DEADLINES FOR ME IF MY HEALTH CONDITION WORSENS IN THE FUTURE AND I QUALIFY FOR MATRIX LEVEL III, IV OR V BENEFITS? Yes. Under the existing Settlement Agreement, a Class Member who is diagnosed as having FDA Positive or mild mitral regurgitation between the commencement of diet drug use and the end of the Screening Period and who initially develops a Matrix Level condition at any time through December 31, 2015, may be paid Matrix compensation benefits or may elect to be a Back-End Opt-Out. If such a Class Member does not opt-out and then progresses to a Level III, IV or V claim beyond 2015, he or she may receive compensation for that progression claim. Under the Seventh Amendment, Category One and Category Two Class Members must have been diagnosed with FDA Positive or mild mitral regurgitation between the commencement of diet drug use and the end of the Screening Period and progress to Level III, IV or V (as modified by the Seventh Amendment). The progression to Level III, IV or V must both be diagnosed and occur before December 31, 2011, or fifteen years from the last date of diet drug use, whichever is earlier. This is the new deadline. Although the deadline is shorter under the Seventh Amendment than under the Settlement Agreement, Wyeth guarantees of payment of these claims. That guarantee does not exist under the Settlement Agreement and will not apply to those who elect not to participate in the Seventh Amendment. Conditions that arise after the earlier of December 31, 2011, or fifteen years after the last diet drug use, will not qualify for payment. 18 17. IF I PARTICIPATE IN THE SEVENTH AMENDMENT, WILL THE TRUST'S CURRENT AUDIT AND CLAIMS INTEGRITY PROGRAM AFFECT MY CLAIM? If the Seventh Amendment becomes effective, the Trust's Claims Integrity Program and all related legal proceedings with respect to claims by Category One and Category Two Class Members will cease. Category One and Category Two Class Members who elect not to participate in the Seventh Amendment will be subject to the Trust's Audit process and Claims Integrity Program. A Category One or Category Two Class Member who seeks benefits from the Trust for the modified Matrix Level III, IV, or V benefits under the Seventh Amendment will be subject to the Trust's audit process, in which a Trust auditing cardiologist will review the echocardiogram and other material submitted in support of the claim to determine whether there is a reasonable medical basis for the medical conditions asserted in the Class Member's Green Form. The echocardiogram tape or disk must comply with the requirements of the Settlement Agreement, as amended by the Seventh Amendment, but it will be reviewed in audit regardless of whether it was allegedly obtained without adequate physician supervision, the identity of the person or entity that performed the echocardiogram, or the attorney representing the claim. The Trust will not pay any claim that it determines in the audit process has no reasonable medical basis. In addition to the audit process, the Trust still will review all Matrix Level III, IV or V claims of Category One or Two Class Members to ensure that there was no misrepresentation of material fact, and the Trust can contest the validity of an echocardiogram tape or disk where there is substantial evidence that the tape or disk constitutes or contains a material misrepresentation of fact. REMEMBER: THIS OVERVIEW IS INTENDED TO BE ONLY A SUMMARY OF YOUR RIGHTS AND OBLIGATIONS UNDER THE SEVENTH AMENDMENT. PART II OF THE NOTICE IS VERY IMPORTANT, AND YOU MUST READ IT CAREFULLY. IF THERE IS ANY CONFLICT BETWEEN THE TERMS OF THE NOTICE AND THE SEVENTH AMENDMENT, THE TERMS OF THE SEVENTH AMENDMENT CONTROL. YOU MAY GET A COPY OF THE SEVENTH AMENDMENT ON THE TRUST'S OFFICIAL WEBSITE, AT WWW.SETTLEMENTDIETDRUGS.COM 19 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA - ------------------------------------) IN RE DIET DRUGS ) (PHENTERMINE/FENFLURAMINE/ ) DEXFENFLURAMINE) PRODUCTS ) LIABILITY LITIGATION ) MDL No. 1203 ) - ------------------------------------) This document relates to: ) SHEILA BROWN, et al. v. AMERICAN ) Civil Action No. 99-20593 HOME PRODUCTS CORPORATION ) - ------------------------------------) PART II OF OFFICIAL COURT NOTICE OF SEVENTH AMENDMENT TO THE NATIONWIDE CLASS ACTION SETTLEMENT* This Notice Is Being Sent: - - To inform you of a proposed Seventh Amendment to the Nationwide Class Action Settlement Agreement (the "Settlement Agreement") between Wyeth and the certified class of which you are a member. Wyeth was formerly known as American Home Products Corporation. The Amendment affects certain Pondimin(R) and/or Redux(TM) users and their family members. The Amendment would only come into effect if this Court approves it. - - To alert you to these important dates: - ____________, 2004: deadline for filing written comments with this Court for or against approval of the Seventh Amendment. - ____________, 2004: deadline for electing not to participate in the Seventh Amendment. - ____________, 2004: date of this Court's hearing to consider whether to approve the Seventh Amendment as fair, reasonable and adequate. THIS NOTICE CONTAINS IMPORTANT INFORMATION CONCERNING A PROPOSED MATERIAL CHANGE IN YOUR RIGHTS UNDER THE SETTLEMENT AGREEMENT. PLEASE READ THIS NOTICE CAREFULLY AND DISCUSS IT WITH YOUR PERSONAL ATTORNEY IF YOU HAVE ONE. MORE DETAILED INFORMATION IS ALSO AVAILABLE. SEE "HOW CAN I GET ADDITIONAL INFORMATION?" BELOW. THE OFFICIAL COURT NOTICE CONSISTS OF TWO PARTS, BOTH INCLUDED IN THE SAME PACKAGE. THIS PART II SHOULD BE READ IN CONJUNCTION WITH PART I, THE OVERVIEW OF THE SEVENTH AMENDMENT. - -------------------------------- * [This is the form of Part II of the Notice, but it will be printed for distribution, with appropriate dates and bracketed update information filled in and page references added.] TABLE OF CONTENTS I. THE PARTIES HAVE PROPOSED TO CHANGE THE EXISTING SETTLEMENT AGREEMENT........................................ 1 II. THE CURRENT STATUS OF THE TRUST.............................................................................. 4 A. WHAT ARE THE MEDICAL CONDITIONS QUALIFYING FOR MATRIX COMPENSATION?................................. 4 B. WHY HAVE MANY MATRIX CLAIMS NOT YET BEEN DECIDED BY THE TRUST?...................................... 5 C. HOW MUCH MONEY IS LEFT IN THE TRUST?................................................................ 9 D. WHAT WILL HAPPEN TO YOUR MATRIX BENEFITS IF THE TRUST NO LONGER HAS FUNDS AND IF THE SEVENTH AMENDMENT DOES NOT BECOME EFFECTIVE?................................................................ 10 III. THE SEVENTH AMENDMENT ? GENERAL.............................................................................. 12 IV. HOW DO YOU KNOW IF THE PROPOSED SEVENTH AMENDMENT APPLIES TO YOU, AND IF SO, HOW WILL YOU BE CATEGORIZED FOR THAT PURPOSE?............................................................................................ 14 A. CATEGORY ONE........................................................................................ 14 B. CATEGORY TWO........................................................................................ 16 C. FAMILY MEMBERS...................................................................................... 16 D. IF YOU ARE ON THE CATEGORY ONE CLASS MEMBER LIST, YOU MAY ELECT TO BE TREATED AS A CATEGORY TWO PERSON INSTEAD...................................................................................... 17 E. PREVIOUS OPT-OUTS WHO ARE ALSO ON THE INITIAL CATEGORY ONE CLASS MEMBER LIST........................ 18 F. PREVIOUS OPT-OUTS WHO ARE NOT ON THE INITIAL CATEGORY ONE CLASS MEMBER LIST......................... 18 V. WHAT ARE THE BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS?............................................... 19 A. WYETH'S NEW FINANCIAL COMMITMENT AND ESTABLISHMENT OF A SUPPLEMENTAL FUND TO ADMINISTER CATEGORY ONE CLAIMS.......................................................................................... 19 B. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO PASS THE FUND ADMINISTRATOR'S MEDICAL REVIEW... 21
i ' (1) PARTICIPATION IN THE SUPPLEMENTAL FUND..................................................... 21 (A) THE DETERMINATION OF RELATIVE PAYMENT VALUES...................................... 24 (B) HOW WILL THE SUPPLEMENTAL FUND BE ADMINISTERED?................................... 25 (2) FURTHER BENEFITS FOR THOSE WHO PROGRESS TO HIGHER MATRIX LEVELS, AND WYETH'S GUARANTEE .... 26 (3) NO CASH/MEDICAL SERVICES BENEFIT FROM THE TRUST............................................ 29 C. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO FAIL MEDICAL REVIEW............................ 29 (1) PAYMENT OF $2,000.......................................................................... 30 (2) FURTHER BENEFITS FOR THOSE WHO PROGRESS TO HIGHER MATRIX LEVELS, AND WYETH'S GUARANTEE .... 30 (3) OPPORTUNITY TO RECEIVE TRUST'S CASH/MEDICAL SERVICES BENEFIT............................... 30 D. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO FAIL TO COMPLY WITH THE FUND ADMINISTRATOR'S PROCEDURAL REQUIREMENTS............................................................................. 31 (1) PAYMENT OF $2,000.......................................................................... 31 (2) FURTHER BENEFITS FOR THOSE WHO PROGRESS TO A HIGHER MATRIX LEVEL, AND WYETH'S GUARANTEE ... 31 (3) NO CASH/MEDICAL SERVICE BENEFIT FROM THE TRUST............................................. 32 E. FAMILY MEMBERS AND OTHER DERIVATIVE CLAIMANTS....................................................... 32 F. HOW TO MAKE A CLAIM FOR CATEGORY ONE BENEFITS....................................................... 32 VI. WHAT ARE THE BENEFITS AVAILABLE TO CATEGORY TWO CLASS MEMBERS?............................................... 34 A. PAYMENT OF $2,000................................................................................... 34 B. FURTHER BENEFITS FOR THOSE WHO PROGRESS TO A HIGHER MATRIX LEVEL, AND WYETH'S GUARANTEE............. 35 C. OPPORTUNITY TO RECEIVE TRUST'S CASH/MEDICAL SERVICES BENEFIT........................................ 35 D. HOW TO MAKE A CLAIM FOR CATEGORY TWO BENEFITS....................................................... 35
ii VII. WHAT ARE THE BENEFITS AVAILABLE FOR THOSE CATEGORY ONE CLASS MEMBERS WHO ELECT TO BE TREATED AS CATEGORY TWO CLASS MEMBERS?........................................................................................... 36 VIII. OTHER PROVISIONS OF THE SEVENTH AMENDMENT AFFECTING CLASS MEMBERS............................................ 37 A. TERMINATION OF FURTHER OPT-OUT RIGHTS............................................................... 37 B. RELEASE OF CLAIMS AND COVENANT NOT TO SUE........................................................... 40 C. TERMINATION OF TRUST LAWSUITS AGAINST CERTIFYING PHYSICIANS AND PRECLUSION OF OTHER SIMILAR SUITS AGAINST CLAIMANTS, THEIR PHYSICIANS OR THEIR ATTORNEYS BY WYETH OR THE TRUST; POSSIBLE EFFECT ON YOU................................................................................................. 43 D. UNDERTAKINGS BY CERTAIN LAWYERS FOR CLASS MEMBERS; POSSIBLE EFFECT ON YOU........................... 44 E. EFFECT ON CLAIMS INTEGRITY PROGRAM AND CERTAIN OTHER PROCEEDINGS.................................... 45 F. AMOUNTS OWED TO MEDICARE OR HEALTH INSURANCE COMPANIES; CLASS MEMBER INDEMNITY...................... 47 IX. ATTORNEYS' FEES.............................................................................................. 48 X. YOUR RIGHT TO ELECT NOT TO PARTICIPATE IN THE SEVENTH AMENDMENT AND WYETH'S WALK-AWAY RIGHT.................. 49 XI. CONSIDERATIONS RELATING TO THE TRUST......................................................................... 51 XII. FAIRNESS HEARING AND PROCEDURE FOR OBJECTING TO THE SEVENTH AMENDMENT -- WHEN IS THE FAIRNESS HEARING AND WHAT IS IT ABOUT?............................................................................................ 55 XIII. HOW CAN I GET ADDITIONAL INFORMATION?........................................................................ 56 CLASS COUNSEL......................................................................................................... 58 SEVENTH AMENDMENT LIAISON COMMITTEE................................................................................... 58 THE FUND ADMINISTRATOR................................................................................................ 59
iii I. THE PARTIES HAVE PROPOSED TO CHANGE THE EXISTING SETTLEMENT AGREEMENT The Settlement Agreement was approved by the Court on August 28, 2000, when the Court also certified the diet drug class action of which you are a member. The Settlement Agreement became effective on January 3, 2002. Under the terms of that Settlement, the Court appointed the AHP Settlement Trust (the "Trust") to administer benefits. This Notice and the Seventh Amendment relate primarily, although not entirely, to the portion of the Settlement Agreement which provides compensation and opt-out rights for Class Members who have been or might in the future be diagnosed with specified levels of regurgitation from the valves in the left side of the heart ("VHD") and other medical conditions (a "Matrix Level condition"). That compensation is referred to as "Matrix" compensation. The amount of Matrix compensation depends upon the claimant's medical condition and ranges from the lowest amounts for Matrix Level I to the highest amounts for Matrix Level V. The Trust has received many more claims for Matrix compensation than had been expected when the Settlement Agreement was approved in August 2000. Those expectations were based on expert testimony concerning the number of Class Members likely to qualify for and file such claims. In addition, medical audits of individual claim submissions have to date rejected approximately 60% of the claims filed for Matrix Levels I or II compensation. Those results have led to numerous disputes. In a filing dated August 17, 2004, the Trust asserted that the Audit Failure rate may be as high as 88% for Matrix Level I and II claims. This contention was based on the Trust's re-evaluation of 926 claims that had previously passed the Trust's medical audit. The Trust's contention has not been proven in any legal proceeding and would likely be contested in litigation that could take years to resolve. There are other disputes and court proceedings related to the validity of many of the claims filed and to the actions of the Trust in administering benefits. For these and other reasons, there have been lengthy delays in paying valid claims. DEPENDING ON HOW THOSE DISPUTES ARE RESOLVED AND THE RESULTS OF ADDITIONAL MEDICAL AUDITS OF CLAIMS, THERE IS A HIGH LIKELIHOOD THAT THERE WILL BE INSUFFICIENT FUNDS AVAILABLE TO THE TRUST TO PAY 1 ALL ELIGIBLE CLAIMANTS. Under the current Settlement Agreement, the Trust will pay Matrix benefits in full to those whose claims are found valid after audit. If the Trust runs out of money, however, all other claimants, even those with valid claims, would then receive nothing from the Trust. Neither the Court nor the parties are able to predict how those disputes and audits will be resolved. It is likely that many of those Matrix claimants would not be paid Matrix compensation under the Settlement Agreement in effect prior to the currently-proposed Seventh Amendment (the "Pre-Amendment Settlement Agreement"). Under those circumstances, some Class Members would have the right to sue Wyeth in the tort system (see discussion of "Sixth Amendment Opt-Out" right at pages __ and of "Back-End Opt-Out" right at pages __). Wyeth and Class Counsel, with the assistance of a liaison group of attorneys representing individual Class Members, have agreed to the Seventh Amendment. That Amendment is subject to this Court's approval. If the Amendment becomes effective, Wyeth would pay an additional $1.275 billion into a new fund (the "Supplemental Fund") to pay claims. The Amendment is intended to expedite payments and to allocate some part of the new $1.275 billion fund to all eligible Class Members, many of whom would otherwise be unlikely to receive any payment at all from the Trust under the Pre-Amendment Settlement Agreement. IT IS LIKELY, HOWEVER, THAT MOST, IF NOT ALL, OF THOSE QUALIFYING FOR EXISTING MATRIX LEVEL I AND II BENEFITS WILL RECEIVE LESS, AND MOST WILL RECEIVE SUBSTANTIALLY LESS, MONEY UNDER THE AMENDMENT THAN THEY WOULD HAVE RECEIVED IF THERE HAD BEEN ENOUGH MONEY TO PAY ALL CLAIMS UNDER THE CURRENT SETTLEMENT AGREEMENT. Wyeth also agrees in the Seventh Amendment to guarantee that there will be money available to pay eligible claimants who participate in the Amendment and who meet modified Matrix Levels III, IV or V criteria by a new deadline, even if the Trust runs out of money. 2 Matrix Levels III, IV and V apply to claimants who have had heart valve replacement or repair surgery or other comparable or greater levels of injury. See pages __. THE SEVENTH AMENDMENT ALSO PROVIDES THAT CLASS MEMBERS WILL GIVE UP SOME OF THE RIGHTS THEY CURRENTLY HAVE, INCLUDING THE RIGHTS THAT SOME CLASS MEMBERS WOULD HAVE TO OPT OUT OF THE SETTLEMENT AGREEMENT AND SUE WYETH IN THE TORT SYSTEM. SEE PAGES __. Each Class Member covered by the Seventh Amendment has the right to elect not to participate in the Seventh Amendment. ANY ELIGIBLE CLASS MEMBER WHO DOES NOT EXERCISE THAT ELECTION WILL AUTOMATICALLY BE COVERED BY THE SEVENTH AMENDMENT, WITHOUT TAKING ANY FURTHER ACTION. As described below, participating Class Members might need to take further steps to obtain benefits. Any Class Member who does elect not to participate in the Seventh Amendment, however, would remain in the class and would continue to be subject to the terms of the Pre-Amendment Settlement Agreement. See pages __. During a specified period of time in the future, Wyeth has the right to walk away from and terminate the Amendment. Wyeth has stated that it would exercise its walk-away right and not provide the $1.275 billion of new funds or the other Seventh Amendment benefits unless there is a very high level of participation by eligible Class Members. See page __. If you have previously exercised an opt-out right under the Settlement Agreement and would otherwise qualify to participate in the Seventh Amendment, you may, with Wyeth's consent, revoke your opt out at this time. IF YOU HAVE PREVIOUSLY EXERCISED AN INITIAL, INTERMEDIATE OR BACK-END OPT-OUT AND YOU ALSO FILED A GREEN FORM CLAIMING MATRIX BENEFITS BEFORE MAY 6, 2004 QUALIFYING YOU FOR INCLUSION IN THE SEVENTH AMENDMENT AND, AS A RESULT, YOU ARE INCLUDED IN A LIST OF CLASS MEMBERS DESCRIBED AT PAGE __, YOUR OPT-OUT WOULD BE CONSIDERED TO BE AUTOMATICALLY REVOKED AND YOU WILL BE CONSIDERED TO BE 3 PARTICIPATING IN THE SEVENTH AMENDMENT UNLESS YOU TAKE ACTION AND ELECT NOT TO PARTICIPATE. SEE PAGES __. This Court has preliminarily approved the Seventh Amendment, but it will not become effective unless finally approved by the Court after a hearing and any appeals have been concluded. Affected Class Members have the right to participate in that hearing. See page __. This Notice is being sent to more people than those known to qualify to participate in the Seventh Amendment. You are not necessarily eligible to participate merely because you receive this Notice. This document is Part II of that Notice, and it should be read in conjunction with Part I, the Overview of the Seventh Amendment. II. THE CURRENT STATUS OF THE TRUST A. WHAT ARE THE MEDICAL CONDITIONS QUALIFYING FOR MATRIX COMPENSATION? Under the Pre-Amendment Settlement Agreement, there are five defined levels of VHD that qualify for payment. Generally (although these conditions are defined at length in that Agreement), these can be described as: Matrix Level I: mild or greater aortic regurgitation and/or moderate or greater mitral regurgitation with a finding of bacterial endocarditis; and/or severe aortic and/or mitral VHD without other medical signs of injury to the heart or any infection in the heart; Matrix Level II: moderate to severe aortic and/or mitral VHD with medical signs of certain other conditions of the heart; Matrix Level III: cases where aortic and/or mitral heart valve repair or replacement surgery is performed or recommended or where an individual has suffered a stroke from particular complications of regurgitation; Matrix Level IV: serious complications of aortic and/or mitral VHD or valve-related surgery such as a serious stroke; and 4 Matrix Level V: very serious complications of aortic and/or mitral VHD or valve-related surgery, such as death or a heart transplant. To be eligible for Matrix Level compensation, Class Members must have been diagnosed by echocardiogram between the commencement of diet drug use and the end of the Trust's "screening period" as having "FDA Positive" regurgitation or as having mild regurgitation of the mitral heart valve. For most people, the end of the Trust's screening period was January 3, 2003. For certain Class Members who received echocardiograms provided by the Trust in its screening program but who could not obtain an echocardiogram by that date, the diagnosis must have occurred by July 3, 2003, unless extended by the Court. "FDA Positive" refers to regurgitation of the aortic heart valve which is either mild, moderate or severe and/or regurgitation of the mitral heart valve which is either moderate or severe. The Pre-Amendment Settlement Agreement specifies requirements for such a diagnosis. B. WHY HAVE MANY MATRIX CLAIMS NOT YET BEEN DECIDED BY THE TRUST? If you have filed a Matrix claim and it has not yet been decided, you are among a very large number of Class Members in the same situation. Here are some of the reasons why claims processing has taken so long. The number of claims for Matrix benefits, particularly on Matrix Level II, have significantly exceeded the estimates made when the Settlement Agreement was negotiated and approved. Those estimates were based upon expert advice and testimony at that time presented by each of counsel for the class and counsel for Wyeth. Wyeth's financial obligation under the Pre-Amendment Settlement Agreement is capped at a maximum amount. IF MORE THAN A SMALL FRACTION OF THE CLAIMS CURRENTLY ON FILE FOR MATRIX BENEFITS WERE DEEMED VALID (NO ONE 5 KNOWS PRECISELY HOW MANY), THE TRUST WOULD NOT HAVE ENOUGH MONEY TO PAY THE REMAINING CLAIMANTS UNDER THE PRE-AMENDMENT SETTLEMENT AGREEMENT. There are almost 70,000 claims for Matrix benefits currently on file with the Trust and not fully processed, according to its database. Of those, about 43,000 contain enough information to identify claims for Matrix Levels I through V. And of those, more than 40,000 assert eligibility for Matrix Levels I or II. In November 2002, this Court ordered that 100% of all Matrix claims be audited by cardiologists retained by the Trust to assess whether there is a reasonable medical basis for the claims. At this time, approximately 5,500 claims have been audited. Of the claims audited that assert eligibility for Matrix Level I or II benefits, approximately 60% have been found to be without a reasonable medical basis and therefore not payable. (See page one for a discussion of a recent trust filing related to Audit pass rates). Some claimants have asserted that the Trust's audit process is unfair, but there has been no court ruling on that assertion. Other claimants have disputed the Trust's conclusions on their individual claims. In addition, there have been appeals taken from the order to audit all claims. Those appeals have been put on hold without any decision [CHECK STATUS AT MAILING DATE]. On March 30, 2004, Wyeth filed an emergency motion, arguing that further measures were required to identify possibly invalid claims in light of the high audit failure rate. This motion was contested by counsel for claimants. The Court has deferred ruling on that motion pending consideration of the Seventh Amendment. Counsel for some claimants have asserted that the Trust's processing and payment of claims have not occurred with the speed and efficiency required by the Pre-Amendment Settlement Agreement. The Pre-Amendment Settlement Agreement sets several deadlines for the Trust's processing and payment of claims. In addition, the Court has issued audit rules that 6 set additional deadlines by which the Trust must act, particularly with regard to steps to be taken after it receives audit results from the cardiologists it hires to review Matrix claims. The Trust has filed several requests with the Court for deadline extensions. The Court granted those extensions in part and denied them in part. Motions were also filed on behalf of some claimants arguing that the Trust was failing timely to pay claims that had passed audit and asserting that that failure was a violation of the Pre-Amendment Settlement Agreement and the audit rules. The Court has not ruled on those motions. The Trust has initiated a "Claims Integrity Program" to identify possibly invalid claims, primarily for Matrix Levels I and II. A large number of disputes have arisen relating to that Claims Integrity Program, to the administration of claims processing by the Trust and to the outcome of particular audits, among other things. Those disputes are largely unresolved at this time. The Trust has sued two doctors alleging that they fraudulently certified claims submitted to the Trust, causing it to pay millions of dollars in benefits to persons who did not have the required levels of heart valve regurgitation necessary to qualify them for benefits. The doctors have denied those allegations, and one of the doctors has counter-sued the Trust. In one of its complaints, the Trust alleged that the attorneys for the claimants whose claims were certified by the defendant doctor had participated in a scheme with the doctor to submit medically unreasonable claims to the Trust. In addition, the Trust has raised the possibility that it might sue other doctors and some law firms by asking that they agree to extend the deadline for filing suits based on similar allegations of submitting improper claims to the Trust. The Trust has also put on hold further processing of claims certified by other doctors and/or submitted by some claimants' attorneys, moved to disqualify echocardiograms conducted by two echocardiogram 7 providers and sought the right to take discovery from other echocardiogram companies as to their processes. As a result of the Trust's Claims Integrity Program, many law firms - including some of those who helped in the discussions leading to the Seventh Amendment (see pages __) and/or many who have expressed active support for the proposed Seventh Amendment - have had claims submitted by them put on hold. Many of these law firms and claimants have challenged the Claims Integrity Program and the Trust's right to delay further processing of any claims or to conduct those other proceedings. Lawyers representing some claimants have also argued that the Trust has breached its duties to claimants and have asserted that claimants therefore have legal claims against the Trust. Disputes have also arisen as to the proper interpretation of the medical criteria for determining a Matrix Level condition under the Settlement Agreement. The stated purpose of the Trust's Claims Integrity Program was to "ensure the prompt payment of legitimate claims, [and t]o protect the Trust from paying illegitimate...claims in the future...." Many lawyers for claimants and Class Counsel have questioned whether the program has achieved these goals. Application of the Claims Integrity Program led to an announcement by the Trust on April 15, 2004, that it was indefinitely suspending the processing and payment of claims for Matrix Level I and Matrix Level II benefits, even for claims that had passed audit. Some attorneys have asserted that the program changed claims criteria for echocardiograms after key deadlines had passed. Counsel for some claimants have also objected to the amount of money spent by the Trust on administrative and legal expenses, including the Claims Integrity Program. Motions addressing all these issues from various viewpoints - Class Counsel, the Trust, Wyeth and counsel for claimants - are pending before the Court. 8 Some claimants' attorneys moved to replace the Trustees and to discharge Class Counsel. These motions were denied by the Court. An appeal has been taken from the denial of the motion to discharge Class Counsel, but that appeal is still pending. These disputes have delayed the resolution of claims and have caused the Trust to spend substantial resources on legal and claims auditing fees. DEPENDING ON HOW THOSE DISPUTES ARE RESOLVED AND THE RESULTS OF ADDITIONAL AUDITS, IT IS LIKELY THAT THERE WILL BE INSUFFICIENT FUNDS AVAILABLE TO THE TRUST TO PAY ALL PAYABLE CLAIMS. Neither the Court nor the parties are able to predict how those disputes and audits will be resolved. If the Seventh Amendment becomes effective, it would end these disputes, by, among other things, terminating the Trust's Claims Integrity Program as to participating Class Members (see pages __); ending the Trust's pending lawsuits against doctors and barring the Trust or Wyeth from bringing any suits against claimants, their attorneys or their doctors to recover amounts paid out as Matrix compensation (see pages __); barring participating Class Members from bringing any suits against the Trust's trustees, officers or employees arising out of the performance of their duties under the Pre-Amendment Settlement Agreement (see page __); and releasing Wyeth and confirming prior releases of Wyeth (see pages __). C. HOW MUCH MONEY IS LEFT IN THE TRUST? Approximately $1.7 billion remained available to the Trust as of June 30, 2004. This included both the funds actually in the hands of the Trust and the remaining amount Wyeth is required to pay into the Trust under the Pre-Amendment Settlement Agreement. In addition to the payment of pending Matrix Level I and II claims, that amount will also be used to pay a number of different types of claims and other expenses, including: (i) valid claims for Matrix Level III, IV and V benefits; (ii) Matrix compensation to at least some of those who have 9 received post-audit determination letters from the Trust prior to May 6, 2004 advising them that their Matrix Level I or II claims are payable ("Pre-May 6 Payable PADLs"); (iii) a $255 million reserve for Matrix benefits to those Class Members who have been paid Matrix compensation at one level but later progress to higher levels; and (iv) administrative expenses, including legal fees. It is likely that some part of this $1.7 billion would also be used to pay some refunds of the diet drug purchase price provided in the Pre-Amendment Settlement Agreement but not yet paid and cash or medical services benefits provided in the Pre-Amendment Settlement Agreement but not yet paid (see pages __). (Wyeth is obligated to contribute additional amounts, in excess of that $1.7 billion, if needed to pay unpaid cash or medical services benefits, subject to a limitation contained in the Pre-Amendment Settlement Agreement.) In light of these obligations and the large number of Matrix Level I or II claims on file, it is likely that only a small fraction of the pending Matrix Level I and II claims could be paid by the Trust. D. WHAT WILL HAPPEN TO YOUR MATRIX BENEFITS IF THE TRUST NO LONGER HAS FUNDS AND IF THE SEVENTH AMENDMENT DOES NOT BECOME EFFECTIVE? If you qualify for Matrix benefits, but the Trust does not have the money to pay them, your rights could depend on whether, at the time the Trust runs out of available money, you qualify to exercise a "Sixth Amendment Opt-Out" right or a "Back-End Opt-Out," or whether you do not qualify for any opt-out right. See pages __. Briefly, the Sixth Amendment Opt-Out right gives Matrix claimants who filed their claim by May 3, 2003 and whose claims are not paid because of the inadequacy of the Trust's resources and to whom Wyeth does not voluntarily make payment, the right to sue Wyeth in the tort system, although not for punitive damages. The Back-End Opt-Out right would be available to some Class Members who meet Matrix compensation criteria and who have not claimed Matrix benefits from the Trust, similarly 10 permitting them to sue Wyeth for compensatory damages. Persons who elected the Accelerated Implementation Option do not have any of these opt-out rights. Under the Pre-Amendment Settlement Agreement, the Trust will stop paying new Matrix claims when Wyeth's remaining obligation to the Trust has been reduced to $255 million. The only exception is for Class Members previously paid on a lower Matrix Level but whose medical condition has progressed to a higher Matrix Level. If the Trust ran out of money available to pay Matrix claimants who had not previously received any Matrix benefits, some of those claimants would then have the right to a Sixth Amendment Opt-Out, assuming that that right is not found invalid by the appellate court. See pages __. In addition, some Class Members would have the right under those circumstances to exercise a Back-End Opt-Out if they had not filed a claim for Matrix benefits. If none of these opt-out rights is available to you, and if your claim is not paid before the Trust's funds are exhausted, you would receive nothing from the Trust. The terms of the Pre-Amendment Settlement Agreement and the Court's injunction implementing that agreement provide that you may not assert any claim against Wyeth or any other "Released Party" (see Appendix A) based on any injury arising out of your use of Redux or Pondimin. It is therefore Wyeth's position that all such claims would be barred. It is likely that a large number of claimants would be in that position. However, counsel for many Class Members have argued that, if their claims are not paid, then claimants' rights would have been violated and they should not be precluded by the Pre-Amendment Settlement Agreement from suing Wyeth, including for punitive damages. Wyeth disputes that argument. The courts have not decided this dispute. It would likely require many years of litigation, with an uncertain outcome, before those arguments could be finally decided. See pages __. 11 III. THE SEVENTH AMENDMENT -- GENERAL The situation described above led to discussions involving Counsel for the Class (identified at page __), counsel for a number of individual Class Members (identified in the following paragraph), and counsel for Wyeth. Those discussions resulted in a proposal to create a new $1.275 billion fund, in which all qualifying Matrix Level I and II claimants would share, rather than, as under the Pre-Amendment Settlement Agreement, paying some claimants in full and leaving nothing with which to pay other similar claims. These discussions also focused on: providing a greater level of assurance that funds would be available for a significant period into the future to pay Class Members who progressed to meet modified Matrix Levels III, IV and V criteria; providing certain other benefits to Class Members who did not have Matrix Level medical conditions but who might develop those conditions in the future; ending the disputes described at pages __; eliminating rights some Class Members would have to sue Wyeth in the tort system by exercising Intermediate Opt-Out, Back-End Opt-Out or Sixth Amendment Opt-Out rights; releasing any right that Class Members might have to claim their rights were violated in connection with the Pre-Amendment Settlement Agreement, including in the event the Trust's resources are exhausted; barring the Trust or Wyeth from suing claimants, their attorneys or certifying physicians to recover amounts previously paid for Matrix benefits; reducing the cost and delay arising from the Trust's audit program and its Claims Integrity Program; compromising the disputes relating to the medical criteria applicable to Matrix Level conditions; eliminating claim-specific litigation; providing an expeditious administrative method to distinguish between payable Matrix claims and those claims that do not qualify for a matrix payment; and otherwise facilitating prompt review and disposition of claims. 12 Class Counsel, and particularly Michael D. Fishbein, participated in those discussions and negotiations on behalf of the class as a whole as its fiduciary. Wayne R. Spivey, of Shrager, Spivey & Sachs, Philadelphia, Pennsylvania, and Jerry Alexander of Alexander & Associates, Omaha, Nebraska, each of whom represents a number of Class Members, encouraged and facilitated those discussions and participated in negotiating a term sheet setting forth the principal terms of a proposed amendment. Because Wyeth was not willing to proceed with negotiations towards any amendment without assurances that it would receive substantial support from other Class Members, Class Counsel and Messrs. Alexander and Spivey, together with Jim Doyle of Fleming & Associates, Houston, Texas, Tony Martinez, of Martinez, Berrera & Martinez, Brownsville, Texas, and Ellen Presby, of Baron & Budd, Dallas, Texas, obtained written support from firms representing a large number of Class Members. See page __. The drafting and finalization of the Seventh Amendment then proceeded, in which Class Counsel participated on behalf of the class as a whole and in which Messrs. Spivey, Alexander, Doyle and Martinez and Ms. Presby also participated. Those attorneys for individual Class Members were subsequently approved by the Court as members of the Seventh Amendment Liaison Committee ("SALC") (see page __). What follows is a summary of some of the terms of the Seventh Amendment. You can get the complete text of the Amendment and of other relevant documents, as explained at page __. THE TERMS OF THE AMENDMENT, NOT ALL OF WHICH ARE SUMMARIZED HERE, ARE CONTROLLED BY THE FULL TEXT OF THE AMENDMENT RATHER THAN BY THIS SUMMARY. 13 IV. HOW DO YOU KNOW IF THE PROPOSED SEVENTH AMENDMENT APPLIES TO YOU, AND IF SO, HOW WILL YOU BE CATEGORIZED FOR THAT PURPOSE? Your rights would be significantly affected by the Seventh Amendment if you fall within one of the following two categories, unless you timely elect not to participate in the Amendment. IF YOU ARE IN ONE OF THOSE CATEGORIES AND YOU TAKE NO ACTION, YOU WILL BE BOUND BY THE SEVENTH AMENDMENT IF IT IS APPROVED BY THE COURT. (IF YOU HAVE PREVIOUSLY EXERCISED AN INITIAL, INTERMEDIATE OR BACK-END OPT-OUT, HOWEVER, SEE PAGES __.) Whether you are in Category One or in Category Two is important because the category will determine how you are treated in the Seventh Amendment, including how much money you might receive. A. CATEGORY ONE To be in Category One, a diet drug user must meet all of the following requirements: (1) you must have filed with the Trust on or before May 3, 2003 either a Pink Form (exercising an Accelerated Implementation Option ("AIO")), a Blue Form or Part I of a Green Form and/or on whose behalf a Green Form Part II was substantially completed and submitted to the Trust on or before that date by an attesting physician; and (2) you must have filed with the Trust Part II of a Green Form that was substantially completed and signed by an attesting physician and which contains sufficient information about your medical condition to support a claim for Matrix Level I or II compensation, but not a claim for Matrix Level III, IV or V compensation. If you had exercised any opt-out under the Pre-Amendment Settlement Agreement (see pages __), that Green Form filing must have been made before May 6, 2004. Any other Class Member must already have made that filing with the Trust or must do so by [DATE: END OF OBJECTION PERIOD]. In addition, you are not in Category One if any of the following applies to you: (1) you have received payment of any Matrix compensation from the Trust; or 14 (2) the Trust sent you a letter on or before July 21, 2004 telling you that a determination denying Matrix benefits had been made after audit on your Green Form described in section A(2) above; or (3) the Trust sent you a Pre-May 6 Payable PADL (see page __); or (4) you have signed an individual release of claims against Wyeth arising from the diet drugs or your claims against Wyeth have been dismissed with prejudice unless that dismissal expressly preserved your right to seek benefits under the Settlement Agreement. If you received a Pre-May 6 Payable PADL, you are not eligible to participate in the Seventh Amendment, and your claim will continue to be processed by the Trust. See page __. If the Trust's cardiologist found that you have a Matrix Level I or II condition, but that determination has not been subjected to the Trust's post-audit review processes and you were not issued a Pre-May 6 Payable PADL, you will be eligible for Category One benefits without any further medical review by the Fund Administrator; these claims, however, may be reviewed to ensure there was not a fraudulent manipulation of the echocardiogram tape or disk. Based on data obtained from the Trust's claims processing database, Wyeth and Class Counsel have preliminarily identified those believed to fall into Category One and have compiled a list of the claim numbers assigned by the Trust (the "DDR" number) to those persons (the "Initial Category One Class Member List"). There are approximately 40,500 Class Members on that list. THAT LIST IS PUBLISHED ON THE TRUST'S OFFICIAL WEBSITE, WWW.SETTLEMENTDIETDRUGS.COM. You should examine that list to determine whether or not you have been included in it. There are procedures available by which you could be added to that list if you qualify. You must do so prior to [INSERT DATE: END OF OBJECTION PERIOD]. If you are not on the list and you believe you should be, see Section [15], Question [10] of Part I of the Notice, the Overview of the Seventh Amendment. 15 B. CATEGORY TWO This category consists of all users of Pondimin or Redux who are not included in Category One and, with certain other exceptions, who registered or believed they registered with the Trust for benefits by May 3, 2003 and who were diagnosed between the commencement of diet drug use and the end of the Trust's screening period (see page __) either with FDA Positive regurgitation or mild mitral regurgitation. More specifically, to be in Category Two, a diet drug user must meet all of the following requirements: (1) you must have filed with the Trust on or before May 3, 2003 either a Pink Form (exercising the AIO), a Blue Form, a Gray Form or Part II of a Green Form or you must have a good faith belief at this time that you timely registered for benefits under the Pre-Amendment Settlement Agreement and the Court determines that you have timely registered for those benefits; and (2) you must have been diagnosed as having either mild mitral regurgitation or FDA Positive regurgitation after diet drug use and before the end of the Trust's screening period (see page __). In addition, you are not in Category Two if any of the following applies to you: (1) you have filed a Green Form before [DATE: END OF OBJECTION PERIOD] containing sufficient information about your medical condition to support a claim for any Matrix compensation benefits; or (2) you have received payment of any Matrix compensation from the Trust; or (3) you are included in Category One, as described above; or (4) you have signed an individual release of claims against Wyeth arising from the diet drugs or a court has dismissed your claims against Wyeth with prejudice unless that dismissal expressly preserved your right to seek benefits under the Settlement Agreement. C. FAMILY MEMBERS If you are a spouse or child or other "derivative" claimant of someone who used Pondimin and/or Redux, you will be in either Category One or Category Two if that diet drug user is in that category. Only the diet drug user may make an election not to participate in the 16 Seventh Amendment. That election, and other acts by the diet drug user under the Seventh Amendment, will apply to the diet drug user's spouse, other family members and other derivative claimants. D. IF YOU ARE ON THE CATEGORY ONE CLASS MEMBER LIST, YOU MAY ELECT TO BE TREATED AS A CATEGORY TWO PERSON INSTEAD Class Members on the Category One Class Member List may elect, rather than participating in the Supplemental Fund, to be treated as a Category Two Class Member. The benefits available to a person who exercises that election are described at pages __. A person exercising such an election would be entitled to all the benefits to which a Category Two Class Member would be entitled. The only exception is that a person electing to be treated as a Category Two rather than a Category One Class Member would have the right to receive any previously unpaid "Cash/Medical Services Benefits" (see pages __) without any medical review or audit if that person's claim documents indicate that he or she has FDA Positive regurgitation and he or she otherwise qualified under the Pre-Amendment Settlement Agreement for the benefit. You would give up your chance to receive any of the Category One benefits. If you wish to switch from Category One to Category Two, you must complete the Category Two election form and send it to the Fund Administrator. See page __ for that address. You may obtain a copy of the Category Two election form from the Fund Administrator or at the website www.settlementdietdrugs.com. The completed and executed form must be postmarked no later than [DATE: 120 DAYS AFTER END OF OBJECTION PERIOD]. If you exercise that election, your decision is final and binding, and it cannot be retracted. 17 E. PREVIOUS OPT-OUTS WHO ARE ALSO ON THE INITIAL CATEGORY ONE CLASS MEMBER LIST If you have previously sought both (a) to exercise any form of opt-out and (b) to claim Matrix benefits by filing a Green Form before May 6, 2004 which meets the requirements for your inclusion in Category One (see page __), your opt-out will be considered to be automatically revoked and you will be considered to be a Category One Class Member, without any further action on your part, unless you elect not to participate in the Seventh Amendment. IF YOU HAVE DONE BOTH (A) AND (B) IN THE PREVIOUS PARAGRAPH AND IF YOU WISH TO MAINTAIN YOUR STATUS AS AN OPT-OUT AND PURSUE CLAIMS IN THE TORT SYSTEM, YOU MUST ELECT NOT TO PARTICIPATE IN THE SEVENTH AMENDMENT. SEE PAGES __. OTHERWISE, IT WILL NO LONGER BE POSSIBLE FOR YOU TO CONTINUE TO PURSUE A CLAIM IN COURT. EVEN IF YOU DO ELECT NOT TO PARTICIPATE IN THE SEVENTH AMENDMENT, YOU SHOULD BE AWARE THAT WYETH'S POSITION IS THAT CLASS MEMBERS DO NOT HAVE THE RIGHT TO AN INTERMEDIATE OPT-OUT OR A BACK-END OPT-OUT WHEN THEY HAVE FILED A CLAIM WITH THE TRUST FOR MATRIX COMPENSATION. CLASS COUNSEL'S POSITION IS THAT CLASS MEMBERS WHO HAVE FILED A CLAIM WITH THE TRUST FOR MATRIX COMPENSATION NONETHELESS HAVE A RIGHT TO AN INTERMEDIATE OPT-OUT IF OTHERWISE TIMELY AND PROPER. F. PREVIOUS OPT-OUTS WHO ARE NOT ON THE INITIAL CATEGORY ONE CLASS MEMBER LIST If you have previously exercised any form of opt-out, and if you have not also claimed Matrix benefits by submitting a substantially completed Green Form to the Trust before May 6, 2004 in which the un-audited answers to Part II of the Form support a claim for Matrix Level I or II benefits, you may still participate in the Seventh Amendment as a Category Two Class Member if Wyeth consents to your revoking that opt-out. If you do revoke that opt-out, you will receive a $2,000 payment as a member of Category Two if you are eligible for that payment (see 18 pages __), and if eligible you will also be entitled to recover for any future actual surgery or other benefits available to Category Two Class Members. You would also have the benefit of Wyeth's guarantee that there would be sufficient funds to pay that compensation. Under some circumstances, you might also receive the "cash/medical services benefit" (see pages __). You would waive all further rights to seek any compensation against Wyeth in the tort system, and you will have no future right to opt out (see pages __). See also pages __ concerning certain medical expense reimbursements. If you wish to revoke such an opt-out, write to the following address and request Wyeth's consent to revoke your opt-out and participate in the Seventh Amendment as a Category Two person: Wyeth c/o Orran L. Brown BrownGreer PLC P.O. Box 85006 Richmond, VA 23285-5006 The letter must be postmarked no later than [FILL IN DATE], 2004. V. WHAT ARE THE BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS? The benefits available to Category One persons will depend on whether or not they are found to be eligible to share in the Supplemental Fund. A. WYETH'S NEW FINANCIAL COMMITMENT AND ESTABLISHMENT OF A SUPPLEMENTAL FUND TO ADMINISTER CATEGORY ONE CLAIMS Under the Seventh Amendment, Wyeth agrees to pay an additional $1.275 billion, which it is not required to pay under the Pre-Amendment Settlement Agreement, less certain credits. Wyeth will deposit those funds, not into the Trust, but into the newly established Supplemental 19 Fund to be administered by a Fund Administrator (see page __). Only Category One Class Members have the right to participate in the Supplemental Fund. One goal of the Supplemental Fund is to streamline the paying of claims. The Trust's audit program does not apply to these claims, and neither does its Claims Integrity Program. The Supplemental Fund will be administered by a Fund Administrator appointed by the Court (see page __). Prior to the Fund Administrator's determination of a Class Member's status, there will be a medical review of the Class Member's claim. The Fund Administrator will hire board-certified cardiologists to conduct that medical review in order to determine whether each Category One claim meets required injury levels. Those cardiologists will review each echocardiogram tape or disk. Unlike the Trust, the Fund Administrator will not rely on a certification from the claimant's physician. Nor will any audit be conducted of whether there is a "reasonable medical basis" for that certification. Instead, the cardiologists hired by the Fund Administrator will determine eligibility. If a claimant disputes the results of that review, the Class Member would be entitled, for a fee to be set by the Fund Administrator, to a second review by a different cardiologist conducted without knowledge of the outcome of the first review. If that cardiologist determines that the claim is valid, it will be paid. Class Members will have no right to challenge the Fund Administrator's actions or, after such a second review, its determination of any person's status, which will be final and binding. Such determination would not be subject to appeal, challenge, show cause orders or review of any kind before any court, agency, arbitrator, mediator or otherwise. 20 This is intended to be a more streamlined process than under the existing Trust. However, no payments will be made unless and until this Court has approved the Seventh Amendment and any appeals from such approval have been resolved. Under the Seventh Amendment, pending claims which contain sufficient information to support Matrix Level I or II benefits filed by Seventh Amendment participants would be shifted from the Trust to the Supplemental Fund. Accordingly, under the Seventh Amendment, all Class Members covered by the Amendment would give up forever any right to claim Matrix Level I or II benefits from the Trust. B. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO PASS THE FUND ADMINISTRATOR'S MEDICAL REVIEW If the Fund Administrator determines as a result of the medical review process that a Category One person has the medical condition required for a pro rata share of the Supplemental Fund, that person is eligible to receive the following benefits. See pages __ for information about how to claim these benefits, which will require among other things proof of diet drug use: (1) PARTICIPATION IN THE SUPPLEMENTAL FUND First, that person would receive a pro rata share of the $1.275 billion, less other expenses, credits and payments as described below. The amount of the payment each qualifying person would receive will vary and will depend on the number of people participating in the Supplemental Fund, the number of people who qualify for payment after medical review and their respective injury levels, duration of diet drug use and age at the time of diagnosis. It is not known at this time what the payment level will be for each qualifying claim. Here is how it will work: 21 The amount in the Supplemental Fund to be shared will be Wyeth's deposit of $1,275,000,000, plus interest earned on that money until it is disbursed from the Supplemental Fund, less (i) the costs and expenses incurred by the Fund Administrator, (ii) the amounts expended at $2,000 each for Category One Class Members who fail medical review or elect not to undergo that review (see pages __), (iii) a credit to which Wyeth will be entitled of $2,000 each for Category One Class Members who elect to become Category Two Class Members; (iv) a further credit to which Wyeth will be entitled if there are more than 6,400 diet drug users who make that election. The amount of the credit described in item (iv) will be determined by multiplying $5,500 for each person who shifts to Category Two in excess of 6,400 people. The Fund Administrator, as a result of the medical review process discussed above, will assign to each participating Category One Class Member a "Relative Payment Value." Each person's percentage share of the Supplemental Fund's balance will be the percentage his or her Relative Payment Value represents of the total of all the Relative Payment Values assigned by the Fund Administrator. See the following subsection. The latter number will depend on (1) the number of Class Members who submit materials to the Fund Administrator documenting a claim for a pro rata share of the Supplemental Fund, (2) the number and ages of claimants found eligible to share on a pro rata basis (which could be higher or lower than the approximately 40,500 claims referred to at page __), (3) the percentage of those found eligible who qualify for High Threshold as opposed to Low Threshold and (4) within each threshold category, the percentage of claimants who either are found to have Alternative Causation Factors or used the diet drugs 60 days or less. No one can predict at this time how much money will be paid to each qualifying Category One Class Member from the Supplemental Fund. However, most, if not all, of those 22 Class Members would receive less than the amount specified in the Pre-Amendment Settlement Agreement, and most Class Members would receive substantially less than that specified amount. On the other hand, all qualifying Category One Class Members will receive payment from the Supplemental Fund, while only a small fraction of claimants could receive the amounts specified in the Pre-Amendment Settlement Agreement before the Trust ran out of available funds. Appendix E sets forth the Matrix compensation amounts payable for each severity level and age group, with and without reduction factors, under the Pre-Amendment Settlement Agreement. THESE SPECIFIED AMOUNTS, HOWEVER, WILL ONLY BE PAID IF THERE ARE SUFFICIENT FUNDS IN THE TRUST TO PAY THEM. AS EXPLAINED ABOVE, IT IS HIGHLY LIKELY THAT THERE WILL NOT BE ENOUGH MONEY AVAILABLE IN THE TRUST TO PAY ALL ELIGIBLE CLAIMANTS. After the Fund Administrator has completed the medical review process for at least 50% of the claims of Category One Class Members and after the Seventh Amendment becomes effective, the Fund Administrator may distribute a portion (but no more than 40%) of each person's estimated share of the Supplemental Fund. The Fund Administrator is not required to do so, however, and will do so only after the Seventh Amendment is finally approved and only if the Court finds that such a partial distribution will not place at risk the Supplemental Fund's ability fully to pay all eligible Category One Class Members. After the medical review process has been completed as to all claims, each person found eligible will receive the balance of his or her share of the Supplemental Fund that is available for distribution, less any interim distribution that may have been made. The Court has the power to award legal fees to those attorneys who helped to create the benefits provided by the Seventh Amendment, including the Supplemental Fund, for the common benefit of all participating Class Members. See page __. If such an award is made 23 from the Supplemental Fund, it will be prorated among all persons receiving a pro rata distribution from the Supplemental Fund. If you are represented by a lawyer, your share of the "common benefit" fee will be deducted from your lawyer's share of the distribution. It will not affect the net amount that you are entitled to recover. If you are not represented by an attorney, your share of that fee will be deducted from your distribution. (a) THE DETERMINATION OF RELATIVE PAYMENT VALUES The Relative Payment Value will take into account whether the diet drugs were used for fewer than 61 days or for 61 days or more; whether the Fund Administrator's cardiologist concludes that the person has a "High Threshold Condition" or a "Low Threshold Condition"; whether the person has any "Alternative Causation Factor"; and the age of the person at time of first diagnosis. The Fund Administrator, based on those factors, will use a grid to determine each participating person's Relative Payment Value. A copy of the grid is in Appendix B. There are four columns in the grid: (1) High Threshold Condition with no Alternative Causation Factors and 61 or more days of diet drug use; (2) Low Threshold Condition with no Alternative Causation Factors and 61 or more days of use; (3) High Threshold Condition and either Alternative Causation Factors or 60 days or less of use; and (4) Low Threshold Condition and either Alternative Causation Factors or 60 days or less of use. The Seventh Amendment takes the Matrix Level I and II medical criteria in the Pre-Amendment Settlement Agreement and divides them into "High Threshold" and "Low Threshold" Conditions. That division recognizes that certain medical conditions on Levels I and II are more serious than others. The Amendment weights claims differently from the way they are weighted under the Pre-Amendment Settlement Agreement. Conditions on the High Threshold will be paid more than those on the Low Threshold. In addition, some changes have 24 been made in the criteria determining qualification for payment. See Appendix C for a summary of those changes. Relative Payment Values are also affected by the presence of medical factors that can cause some of the same health conditions as those claimed to have been caused by the diet drugs. These are referred to as "Alternative Causation Factors." Many of the same "Alternative Causation Factors" used in the Pre-Amendment Settlement Agreement are also used in determining the Relative Payment Values under the Amendment, but some have been changed and others have been eliminated. Those changes have been made primarily to streamline the review process. See Appendix D for a comparison of those factors under the Pre-Amendment Settlement Agreement and under the Seventh Amendment. For all these reasons, each Category One Class Member's pro rata share will be based on the benefits provided under the Seventh Amendment, not on the amounts of Matrix compensation they would have received under the Pre-Amendment Settlement Agreement. (b) HOW WILL THE SUPPLEMENTAL FUND BE ADMINISTERED? A Fund Administrator will administer the Supplemental Fund, in consultation with Class Counsel and SALC. See page __. All of the law firms to which the members of the SALC belong represent a large number of Class Members who would qualify as either Category One or Category Two Class Members. The SALC is to serve as a liaison between counsel for Category One Class Members and Category Two Class Members, on the one hand, and Class Counsel, Wyeth and the Court, on the other hand. See pages __. The Fund Administrator is to be appointed by the Court, and is to be nominated by Class Counsel and the SALC jointly. They have agreed to nominate Heffler, Radetich & Saitta, LLP, as Fund Administrator. In addition, a Medical Review Coordinating Committee ("MRCC") will, among other things, develop and 25 implement a protocol to train cardiologists to conduct medical reviews and assist the Fund Administrator in the development and implementation of quality control procedures to secure, to the extent reasonably possible, uniform application of the medical criteria specified in the Seventh Amendment. The members of the MRCC are to be nominated by Class Counsel and the SALC jointly, and they have agreed to nominate Dean Karalis, M.D.; Gregg Reis, M.D.; and Frank Silvestry, M.D., as the initial members. (2) FURTHER BENEFITS FOR THOSE WHO PROGRESS TO HIGHER MATRIX LEVELS, AND WYETH'S GUARANTEE Under the Seventh Amendment, Category One and Category Two persons who were diagnosed as having FDA Positive or mild mitral regurgitation before the end of the Trust's screening program have the right to claim compensation at Matrix Levels III, IV or V if their condition worsens to that level and if they meet modified criteria before a new deadline. This benefit will be administered by the Trust. For these Class Members, Wyeth guarantees that there will be sufficient funds available with which to pay those benefits. Those payments to Category One or Category Two Class Members would be reduced by any payment that person had previously received from the Supplemental Fund or the Trust. IF YOU ELECT NOT TO PARTICIPATE IN THE SEVENTH AMENDMENT, THEN WYETH DOES NOT GUARANTEE THIS PAYMENT. For those participating in the Seventh Amendment, there will be a new deadline for submitting a Matrix Level III, IV or V claim to the Trust. To meet the new deadline, the medical condition that qualifies you for Matrix Level III, IV or V benefits must both be diagnosed and also occur by the earlier of December 31, 2011, or fifteen years from the last date of diet drug use. Under the Pre-Amendment Settlement Agreement, the deadline for initially qualifying for Matrix benefits is December 31, 2015. Also, under the Pre-Amendment Settlement Agreement, 26 if a person qualifies for Matrix benefits by December 31, 2015, he or she may continue to receive higher amounts of Matrix compensation if the condition which qualified him or her for that payment progresses after that date to a more severe condition. For example, under the Pre-Amendment Settlement Agreement, if you receive compensation for Matrix Level I before December 31, 2015 and progress to Level III in 2016, you would be eligible for an additional payment. Under the Seventh Amendment, if you qualify for Matrix Level III in 2011 but progress to Level IV in 2012, you would not be eligible for a further payment in 2012 or thereafter. The medical criteria for Matrix Levels III, IV and V have been changed or clarified for persons covered by the Seventh Amendment. Appendix F summarizes the differences between the Pre-Amendment Settlement Agreement's criteria and those applicable under the Amendment. Briefly, under the Pre-Amendment Settlement Agreement, Matrix Level III included persons who were indicated for surgery to repair or replace a heart valve, but who did not have the surgery for specified reasons. Under the Seventh Amendment, that criterion no longer applies, and only actual surgery to repair or replace the aortic or mitral heart valve would qualify on Level III for persons covered by the Amendment. In addition, under the Seventh Amendment, for any claim based on complications of left atrial enlargement with chronic atrial fibrillation, a sworn statement must be submitted by an examining physician, along with contemporaneous medical records, that establishes to a reasonable degree of medical certainty and to the reasonable satisfaction of the Trust that the left atrial enlargement and chronic atrial fibrillation were a direct consequence of either moderate or severe mitral regurgitation. For this purpose, an examining physician must be a board-certified or board-eligible cardiologist or cardiothoracic surgeon who either (i) has treated the Class Member for the condition that forms 27 the basis for the Matrix claim or (ii) is as familiar with the Class Member's condition as one who has treated the Class Member. All claims seeking the modified Matrix Level III, IV, or V benefits are subject to the Trust's audit process, in which a Trust auditing cardiologist will review the echocardiogram and other material submitted in support of the claim to determine whether there is a reasonable medical basis for the medical conditions asserted in the Class Member's Green Form. The echocardiogram tape or disk must comply with the requirements of the Pre-Amendment Settlement Agreement, as amended by the Seventh Amendment, but will be reviewed in audit regardless of whether it was allegedly obtained without adequate physician supervision, regardless of the identity of the person or entity that performed the echocardiogram, or regardless of the attorney representing the claimant. See pages __. The Trust will not pay any claim that it determines in the audit process has no reasonable medical basis. As part of the audit process, the Trust still will review all Matrix claims to ensure there was no misrepresentation of material fact and can contest the validity of an echocardiogram tape or disk where there is substantial evidence that the tape or disk constitutes or contains a material representation of fact as to certain matters. If the Trust does not have enough money to pay the modified Matrix Levels III, IV or V benefits to persons covered by the Seventh Amendment, Wyeth will deposit in the Trust enough additional money to pay those benefits. THIS GUARANTEE IS ONLY APPLICABLE TO PERSONS PARTICIPATING IN THE SEVENTH AMENDMENT. Those who elect not to participate in it will not have the benefit of that guarantee. For people who elect not to participate in the Seventh Amendment and for those who are not eligible to participate in the Amendment, the Settlement Agreement's existing provisions will continue to apply. For people not covered by the Seventh 28 Amendment, the Trust will stop paying new Matrix claims when Wyeth's financial obligation has been reduced to $255 million. After that time, the Trust will only pay claims of persons who were previously paid Matrix compensation and whose medical condition has progressed to a higher level. Those who are not covered by the Seventh Amendment and who became eligible to claim Matrix benefits for the first time will continue to have the right to a Sixth Amendment Opt-Out or a Back-End Opt-Out, if they otherwise qualify for those rights (see pages __). (3) NO CASH/MEDICAL SERVICES BENEFIT FROM THE TRUST Under the Pre-Amendment Settlement Agreement, Class Members diagnosed as FDA Positive by the end of the Trust's screening period (see page __) and who had used the diet drugs for 61 or more days have the right to receive either $6,000 in cash or up to $10,000 in value of valve-related medical services to be provided by the Trust. Persons diagnosed as FDA Positive by the end of the Trust's screening period and who had used the diet drugs for fewer than 61 days have the right to receive either $3,000 in cash or up to $5,000 in value of valve-related medical services to be provided by the Trust. These benefits are referred to as the "Cash/Medical Services Benefits." Category One Class Members who receive a pro rata share of the Supplemental Fund after medical review will not receive an additional amount from the Trust under the Pre-Amendment Settlement Agreement for these Cash/Medical Services Benefits. C. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO FAIL MEDICAL REVIEW If the Fund Administrator determines as a result of its medical review process that a Category One Class Member does not have the medical condition required for a pro rata share of the Supplemental Fund, the benefits that person is eligible to receive are as follows. See 29 pages __ for information as to how to claim these benefits, which will require among other things proof of diet drug use. (1) PAYMENT OF $2,000 A Category One Class Member who fails to qualify for a share of the Supplemental Fund on medical grounds will nevertheless receive a payment of $2,000 from the Supplemental Fund, less attorneys' fees of up to $650 if he or she is represented by counsel. (2) FURTHER BENEFITS FOR THOSE WHO PROGRESS TO HIGHER MATRIX LEVELS, AND WYETH'S GUARANTEE A Category One Class Member who fails to pass the Fund Administrator's medical review but who was diagnosed as having FDA Positive or mild mitral regurgitation after diet drug use and before the end of the Trust's screening period would have the right to Matrix Levels III, IV or V compensation if the person's condition worsens so as to qualify at those levels, as modified by the Seventh Amendment, before December 31, 2011 or fifteen years after the last use of the diet drugs, whichever is earlier. See page __. Such a person would have the benefit of Wyeth's guarantee that there would be enough money available to pay such compensation if and when that person qualifies for it. See page __ for information about the new deadline applicable to qualification for Matrix Levels III, IV or V compensation under the Seventh Amendment. (3) OPPORTUNITY TO RECEIVE TRUST'S CASH/MEDICAL SERVICES BENEFIT If the medical review conducted by the Fund Administrator results in a finding that a Category One Class Member is not eligible for a pro rata share of the Supplemental Fund, but that he or she was diagnosed with FDA Positive regurgitation between the commencement of diet drug use and the end of the Trust's screening period, then the claim will be forwarded to the 30 Trust for payment of the Cash/Medical Services Benefit. In this case, the Trust will be required to pay that benefit without conducting any audit or further medical review. D. BENEFITS AVAILABLE TO CATEGORY ONE CLASS MEMBERS WHO FAIL TO COMPLY WITH THE FUND ADMINISTRATOR'S PROCEDURAL REQUIREMENTS The Fund Administrator will ask Category One Class Members to comply with certain filing deadlines and proof submissions before a claim is sent for medical review. Even if a Category One Class Member fails to comply with those requirements, he or she will continue to be eligible for certain benefits. Those benefits would not include participation in the pro rata distribution of the balance in the Supplemental Fund, but would include the following. See pages __ for information as to how to claim these benefits, which will require among other things proof of diet drug use. (1) PAYMENT OF $2,000 If a Category One Class Member does not timely complete the claims process, he or she will be eligible to receive $2,000 by the Fund Administrator, less attorneys' fees of up to $650 if he or she is represented by counsel. (2) FURTHER BENEFITS FOR THOSE WHO PROGRESS TO A HIGHER MATRIX LEVEL, AND WYETH'S GUARANTEE Even if a Class Member fails to comply with the Fund Administrator's requirements for obtaining medical review, he or she would continue to be eligible for Matrix Level III, IV or V compensation from the Trust if he or she was diagnosed as having FDA Positive or mild mitral regurgitation between the commencement of diet drug use and the end of the Trust's screening period and if his or her condition worsens within the Seventh Amendment's deadline to meet its requirements for compensation at those levels. See page __ for information about the new 31 deadline applicable to qualification for Matrix Levels III, IV or V compensation under the Seventh Amendment. (3) NO CASH/MEDICAL SERVICE BENEFIT FROM THE TRUST If a Category One person does not timely complete the Fund Administrator's claims process, he or she would no longer have the right to obtain any unpaid Cash/Medical Services Benefits from the Trust. E. FAMILY MEMBERS AND OTHER DERIVATIVE CLAIMANTS Family members of a diet drug user and others who have made a derivative claim for benefits, will have the right to receive a 2 percent share of the amount their diet drug user is to receive as a pro rata distribution from the Supplemental Fund. That amount will be deducted from the amount paid to the diet drug user. The 2 percent is an aggregate limitation describing THE TOTAL AMOUNT that ALL family members and other derivative claimants may recover in connection with a single claim. Thus, for example, if the amount to be distributed in connection with a single claim is $50,000, then the total amount to be paid to family members and derivative claimants will be $1,000. If there is one family member entitled to share in the distribution, he or she would receive $1,000. If there are four family members entitled to share in the distribution, they would each receive $250. Family members and other derivative claimants will not share in the $2,000 payments that their diet drug user receives. F. HOW TO MAKE A CLAIM FOR CATEGORY ONE BENEFITS There are deadlines for Category One benefits that do not apply in the existing Pre-Amendment Settlement Agreement. To be eligible for Category One benefits, you must have a 32 substantially completed Green Form in which the unaudited answers to Part II support a Matrix Level I or II claim on file with the Trust before [DATE: END OF THE OBJECTION PERIOD] (or May 6, 2004 if you have also exercised an Initial, Intermediate or Back-End Opt-Out right). If the Seventh Amendment receives Trial Court approval, the Fund Administrator will establish rules, forms and procedures that will be used in administering benefit claims by Category One Class Members under the Seventh Amendment. If you wish to be eligible for Category One benefits, then you will be required to submit the following proof in support of your claim to the Fund Administrator by a date to be set by the Fund Administrator: (1) Proof of diet drug use, as required in the Pre-Amendment Settlement Agreement and the Seventh Amendment. (2) A copy of the echocardiogram tape or disk that forms the basis of the claim for benefits which must comply with the criteria set forth in the Seventh Amendment. (3) In the case of a claim that is based in part on the medical condition of bacterial endocarditis, sufficient medical proof of the condition must be provided. (4) A sworn statement on a form provided by the Fund Administrator setting forth your date of birth, the date of the echocardiogram supporting your claim, and whether or not you previously received any payment of Matrix benefits from the Trust or received notice that your claim for Matrix benefits was denied by the Trust. All Category One Class Members will be required to submit this material, even if they previously submitted certain materials to the Trust. If necessary, the Fund Administrator may request additional information in support of a claim for benefits. The Fund Administrator's address is: Edward J. Radetich, Jr. Heffler, Radetich & Saitta L.L.P. P.O. Box ____ Philadelphia, PA [ZIP CODE] 33 If the Fund Administrator finds that there are technical deficiencies by a Class Member in compliance with any of the conditions to the processing or payment of claims under the Seventh Amendment, including deficiencies regarding the echocardiogram tape or disk supporting the claim, the Fund Administrator shall notify the Class Member or his/her counsel, if represented, of the technical deficiencies by a notice of deficiency and shall allow the otherwise eligible claimant 60 days from the date of receipt of that notice to correct the deficiencies. IF THE DEFICIENCIES ARE NOT CORRECTED WITHIN THE 60-DAY PERIOD, THE FUND ADMINISTRATOR SHALL REJECT THE CLAIM AND THE CLASS MEMBER WILL BE ENTITLED TO RECEIVE ONLY THE $2,000 MINIMUM PAYMENT FROM THE FUND ADMINISTRATOR. If such a Class Member later corrects those deficiencies and progresses to the modified Matrix Levels III, IV or V, that Class Member would receive the benefits attributable to those conditions and would have the benefit of Wyeth's guarantee that the Trust would have funds available with which to pay those benefits. VI. WHAT ARE THE BENEFITS AVAILABLE TO CATEGORY TWO CLASS MEMBERS? Category Two persons will not participate in the Supplemental Fund. Unless they elect not to participate in the Seventh Amendment, they will forego any right to claim Matrix Level I or II compensation from the Trust and future opt-out rights. However, they will be eligible for the following benefits. See page __ for information as to how to claim these benefits, which will require among other things proof of diet drug use. A. PAYMENT OF $2,000 Even though Category Two Class Members do not have a Matrix Level condition, they will be entitled to receive $2,000 from the Trust, unless they elect not to participate in the 34 Seventh Amendment. Attorneys' fees of up to $650 will be deducted for those represented by an attorney. B. FURTHER BENEFITS FOR THOSE WHO PROGRESS TO A HIGHER MATRIX LEVEL, AND WYETH'S GUARANTEE A Category Two Class Member whose condition worsens to Matrix Levels III, IV or V, as modified by the Seventh Amendment and within the Amendment's deadline, will have the right to the compensation attributable to those levels, unless they elect not to participate in the Seventh Amendment. See pages __. Those Matrix Level III, IV or V compensation benefits will be paid by the Trust, and Wyeth will guarantee that the Trust will have enough money to pay those benefits. C. OPPORTUNITY TO RECEIVE TRUST'S CASH/MEDICAL SERVICES BENEFIT Category Two Class Members who have not previously received a Cash/Medical Services Benefit from the Trust to which they are entitled would receive those benefits. Eligibility for that payment would depend upon the submission of proof of diet drug use, the submission of a Green Form Part II or a Gray Form documenting that the diet drug user had an echocardiogram performed after the commencement of diet drug use and before the end of the Trust's screening period (see page __) that demonstrated FDA Positive valvular regurgitation and a copy of the echocardiogram tape or disk - all in accordance with the provisions of the Pre-Amendment Settlement Agreement. Wyeth will continue to have the right to designate up to 10 percent of these claims for audit. D. HOW TO MAKE A CLAIM FOR CATEGORY TWO BENEFITS Within 30 days after the Seventh Amendment becomes effective, a list will be posted on the Trust's official website, www.settlementdietdrugs.com, which will contain the Trust's 35 identification numbers for the Class Members who appear to be eligible for Category Two benefits. If you are on that list, you need to do nothing further to collect Category Two benefits. If you are not on that list, but you are a potential Category Two Class Member, you will get a letter from the Trust telling you to submit the information it needs in order to provide you with Category Two benefits. You will be required to submit to the Trust, if not previously submitted, the following proof in support of your claims: (1) Proof of diet drug use, as required in the Pre-Amendment Settlement Agreement. (2) A copy of the echocardiogram tape or disk that forms the basis of the claim for benefits. (3) A Gray Form or Part II of a Green Form completed by a board-certified or board-eligible cardiologist who verifies on such form that you were diagnosed with mild mitral regurgitation or FDA Positive regurgitation based on an echocardiogram performed after the start of your use of Pondimin and/or Redux and before the close of the screening period, which for most Class Members was January 3, 2003. All of this information must be submitted to the Trust within seven months after the Seventh Amendment becomes effective or you will not receive Category Two benefits. The letter from the Trust will tell you either to send this required information to the Trust or to tell the Trust if you have provided that information to it previously. Within 60 days after you respond to that letter, the Trust will either pay you Category Two benefits or let you know why your claim is not eligible for those benefits. VII. WHAT ARE THE BENEFITS AVAILABLE FOR THOSE CATEGORY ONE CLASS MEMBERS WHO ELECT TO BE TREATED AS CATEGORY TWO CLASS MEMBERS? Class Members who qualify for Category One but who timely elect to be treated as being in Category Two will receive all the benefits that a Category Two Class Member would receive. 36 Those benefits include the $2,000 payment from the Trust and the Cash/Medical Services Benefit, if not previously paid to that person. The Trust will not audit or conduct a medical review of claims of such a person before providing the foregoing benefits, although proof of diet drug use will be required before the Cash/Medical Services Benefit can be paid. The benefits available to a Category One Class Member electing to become a Category Two Class Member will also include eligibility for Matrix compensation at Levels III, IV or V, as modified by the Seventh Amendment, if the person's medical condition worsens and qualifies for those benefits, as well as Wyeth's guarantee that there would be enough money available to the Trust to pay those Matrix benefits in the future. See page __ for information as to the steps you need to take. VIII. OTHER PROVISIONS OF THE SEVENTH AMENDMENT AFFECTING CLASS MEMBERS There are many other provisions of the Seventh Amendment, but here is a summary of some additional provisions affecting individual Class Members. A. TERMINATION OF FURTHER OPT-OUT RIGHTS The benefits provided to Category One and Category Two Class Members under the Seventh Amendment would constitute their exclusive opportunity to get compensation from Wyeth or any other "Released Party" (see Appendix A) as a result of their use of Pondimin and/or Redux, unless they elect not to participate in the Seventh Amendment. Therefore, four types of opt-out rights which would otherwise have given eligible Class Members opportunities in the future to sue Wyeth or any other Released Party are terminated for those participating in the Amendment: Intermediate Opt-Out rights, Back-End Opt-Out rights, Sixth Amendment Opt-Out rights and Financial Insecurity Opt-Out rights. The following is a summary of the rights and limitations relating to the terminated opt-outs, as relevant to Category One and Category Two 37 Class Members. The full text of the provisions governing these rights are set forth in the Pre-Amendment Settlement Agreement, and those terms are controlled by that agreement rather than by this summary. You may obtain a copy of that document, as explained at page __ below. (a) Intermediate Opt-Out Right: Class Members who did not exercise the Accelerated Implementation Option ("AIO") and who were first diagnosed as FDA Positive by an echocardiogram after September 30, 1999 but prior to the end of the screening period had the right until May 3, 2003 to exercise an Intermediate Opt-Out and sue Wyeth or other "Released Parties." That lawsuit would be subject to certain restrictions, including that they could only sue based on the heart valve diagnosed as FDA Positive and that they could not seek punitive, exemplary or any multiple damages. Intermediate Opt-Out rights not exercised by May 3, 2003 have already expired, with the exception of Class Members who timely registered, and were eligible, for the Trust's echocardiogram screening program but who were not provided an echocardiogram by the Trust on a timely basis. Those persons have the right (terminated for those who participate in the Seventh Amendment) to exercise an Intermediate Opt-Out for a period of 120 days after the date on which they were provided such an echocardiogram. (b) Back-End Opt-Out Right: Persons who have not filed a claim for Matrix benefits have the right to exercise a Back-End Opt-Out but only if they are diagnosed as FDA Positive or as having mild mitral regurgitation between the commencement of diet drug use and the end of the screening period and if they are first diagnosed with a Matrix Level condition after September 30, 1999. That right (terminated for those who participate in the Seventh Amendment) would permit such a person to sue Wyeth and any other "Released Party." The lawsuit would be subject to specified restrictions, including the restriction against seeking punitive, exemplary or any multiple damage, and it may only be based on the diagnosed Matrix Level condition. This right is only available to Class Members: - who did not elect the AIO; - who registered for settlement benefits, based on FDA Positive VHD or mild mitral regurgitation or endocardial fibrosis, by May 3, 2003; - who did not file a claim for Matrix benefits; and - who exercise the Back-End Opt-Out right either before May 3, 2003 or who do so within 120 days of the date on which the Class Member first knows or should reasonably have known of a Matrix Level condition. 38 (c) Sixth Amendment Opt-Out Right: Persons who filed a Green Form claim for Matrix benefits on or before May 3, 2003, but who do not receive them because of inadequate Trust funding, might be entitled to sue Wyeth and other "Released Parties" under what is known as the "Sixth Amendment Opt-Out" right. That lawsuit would be subject to certain restrictions, including all those applicable to Back-End Opt-Out suits. In addition, a Sixth Amendment Opt-Out may sue only Wyeth and may not join with any other plaintiff, among other restrictions. This right (terminated for those who participate in the Seventh Amendment) is only available to Class Members: - who have not received any Matrix Level benefits from the Trust; - who would have qualified to exercise a Back-End Opt-Out if they had not claimed Matrix benefits; - who did not elect the AIO; - who filed a claim for Matrix benefits on or before May 3, 2003; - who are determined by the Trust, after audit, to qualify for Matrix Level benefits; and - who do not receive such benefits because payment would reduce the Trust's financial resources to less than $255 million. But if Wyeth chooses voluntarily to pay that Class Member the amount of Matrix compensation which he/she would have received had the Trust had sufficient funds, the Sixth Amendment Opt-Out may not be exercised and the Class Member may not sue Wyeth. Some Class Members are appealing the Court's approval of the amendment of the Settlement Agreement that added the Sixth Amendment Opt-Out right. If the approval of that amendment were overturned by the appellate court, otherwise eligible claimants would have no right under the Pre-Amendment Settlement Agreement to sue Wyeth under the Sixth Amendment Opt-Out right. The appellants have sought a ruling, and therefore the appellate court could rule, that the Pre-Amendment Settlement Agreement does not preclude valid Matrix claimants who go without payment from suing Wyeth, including for punitive damages. See following section. No decision has been issued in that appeal and [DESCRIBE STATUS OF STAY]. (d) The Financial Insecurity Opt-Out Right: The Financial Insecurity Opt-Out provides that, if Wyeth defaults on a financial obligation to the Trust which is not cured and which the Court finds was either due to financial inability to pay or deliberate unwillingness to pay, and if this occurs more than once within a two-year period, and if the collateral for Wyeth's financial obligations has been depleted by more than 50% of the then-required amount and if the Court determines that the remaining collateral is not likely to be sufficient to pay remaining Matrix 39 compensation benefits, then all diet drug users who were diagnosed as FDA Positive or as having mild mitral regurgitation between the commencement of diet drug use and the end of the screening period and who have registered for settlement benefits or who are diagnosed as having endocardial fibrosis by specified dates, would have the right to opt out of the settlement and pursue any and all claims against Wyeth or other "Released Parties," without limitations. This right is terminated for those who participate in the Seventh Amendment. B. RELEASE OF CLAIMS AND COVENANT NOT TO SUE For participating Class Members, the Seventh Amendment would release and discharge (1) all "Settled Claims" against any "Released Party" arising out of or relating to the use of Pondimin or Redux (see Appendix A for an explanation of those defined terms); (2) all claims against any Released Party arising out of any acts or omissions of the Trust, its officers, agents, employees, attorneys and all other persons acting on its behalf; and (3) all claims against Wyeth and its affiliates arising out of Wyeth's role in drafting, negotiating, obtaining approval of or the administration of the Pre-Amendment Settlement Agreement. In addition, all releases from Settled Claims previously provided by participating Class Members to Released Parties are reaffirmed, notwithstanding any allegations about, for example, the manner in which the Pre-Amendment Settlement Agreement was negotiated, the alleged inadequacy of the representation provided to Class Members in connection with its negotiation, the alleged inadequacy of notice provided to the class in connection with the Pre-Amendment Settlement Agreement, the process by which it was approved, the payment of claims to Class Members not qualified for payment, or any alleged inadequacy of funds available to the Trust to pay Matrix compensation benefits. The Seventh Amendment bars participating Class Members from initiating, asserting, prosecuting or maintaining any claim, motion, appeal or other manner of seeking to enforce any of the released claims. 40 These releases and covenants not to sue, as an example, would preclude such Class Members from making the arguments that have been asserted in the appeal from the Court's approval of the Sixth Amendment Opt-Out right. In that appeal, some Class Members argue that they may not be precluded by the Settlement Agreement from suing Wyeth, including for punitive damages, because: it barred their tort claims but did not provide sufficient funds to pay all valid claims; the original class notice did not adequately disclose the risk to Class Members of the Trust's not having sufficient money to pay all valid claims; some or all of the Class Members were not adequately represented in negotiating the Settlement Agreement; and there was a mutual mistake of fact in entering into the Settlement Agreement because the parties were mistaken about the number of claims that would be filed against the Trust. Wyeth disputes those arguments. Similarly, the Seventh Amendment would bar participating Class Members from arguing that they should not be barred by the Settlement Agreement from suing Wyeth, including for punitive damages, because Class Counsel did not adequately represent a particular group of Class Members in negotiating the Settlement Agreement. Some Class Members argue in their appeal on behalf of Class Members with pulmonary hypertension not arising from valvular heart disease or primary pulmonary hypertension (see the following subsection) that that group of Class Members should not be barred from such a suit because they were allegedly not adequately represented. Other Class Members have claimed that they are in a group of Class Members not adequately represented because they were not diagnosed as having FDA Positive regurgitation by the applicable deadlines under the Pre-Amendment Settlement Agreement. In addition, if any other person establishes a right on behalf of Class Members, or some group of them, not to be bound by the Pre-Amendment Settlement Agreement, Class Members participating in the Seventh Amendment waive and relinquish any such right. 41 Category One and Category Two Class Members participating in the Seventh Amendment will not be able to assert any claim against any Trustee, officer or employee of the Trust arising from the performance of their duties under the Pre-Amendment Settlement Agreement as to which the Trustee and/or the Trust officer or employee may have a right of indemnity from the Trust or against the Trust with respect to any such claims. Of course, these releases and covenants not to sue would not deprive anyone covered by the Seventh Amendment from asserting or enforcing rights expressly given to them by the Settlement Agreement, as amended by the Seventh Amendment. To obtain a share of the Supplemental Fund, other than the minimum $2,000 payment, and to obtain Matrix compensation from the Trust at Matrix Levels III, IV or V, a person covered by the Seventh Amendment would be required to sign a document confirming these releases and agreements. In addition, distributions of $2,000 payments by the Fund Administrator or by the Trust to Category One and Category Two Class Members will be accompanied by a notice specifying that the cashing of those checks would constitute confirmation of these releases and covenants not to sue. However, all Category One and Category Two Class Members participating in the Seventh Amendment will be deemed to have provided these releases and covenants not to sue, regardless of whether or not they sign such a statement or cash such a check. The Seventh Amendment releases and covenants not to sue would not apply to any Category One or Category Two Class Member who elects not to participate in the Seventh Amendment. Class Members who elect not to participate in the Seventh Amendment will continue to be subject to the releases and covenants not to sue contained in the Pre-Amendment Settlement Agreement and the bar order entered by the Court when it approved the settlement in August 42 2000. That Bar order precluded Class Members from asserting Settled Claims against Wyeth and other Released Parties. C. TERMINATION OF TRUST LAWSUITS AGAINST CERTIFYING PHYSICIANS AND PRECLUSION OF OTHER SIMILAR SUITS AGAINST CLAIMANTS, THEIR PHYSICIANS OR THEIR ATTORNEYS BY WYETH OR THE TRUST; POSSIBLE EFFECT ON YOU The Seventh Amendment bars the Trust or Wyeth from asserting any civil claim against any person to recover amounts paid by the Trust before July 21, 2004. The Seventh Amendment also bars the Trust or Wyeth from asserting any civil claim against any person to recover amounts paid by the Trust after that date pursuant to a Pre-May 6 Payable PADL (see page __). This restriction will not apply to any lawsuit by Wyeth or the Trust arising out of a claim submitted by a Class Member who has elected not to be covered by the Seventh Amendment. If approved, therefore, the Seventh Amendment would end the lawsuits brought by the Trust against the doctors discussed at page __. The Trust would be barred from bringing such lawsuits against claimants, their attorneys or their certifying doctors. Wyeth would also be barred from bringing any such suits. It could be asserted that this bar against suits by the Trust or by Wyeth would be a benefit for certain attorneys, apart from the effects of the Seventh Amendment on their clients or on other Class Members, because, among other things, Wyeth and the Trust have made allegations against certain attorneys in connection with claims they have submitted on behalf of clients, as discussed at pages __. These attorneys have vigorously denied such allegations. Moreover, neither Wyeth nor the Trust has made such allegations against most attorneys representing Class Members. Specifically, there have been no such allegations against Class Counsel. Under these circumstances, Class Counsel does not have any financial stake in any Seventh Amendment term which precludes the kind of lawsuits described above. Class Counsel has an independent 43 fiduciary obligation to the class as a whole and has made an independent determination that the anti-lawsuit provisions of the Seventh Amendment are in the best interests of the class because such lawsuits would likely lead to protracted litigation, are likely to cost the Trust more than it will actually recover, and would create an environment that is not conducive to expeditious claims resolution. In addition, Class Counsel has made a determination that the Seventh Amendment as a whole is in the best interests of the class. You may choose to rely on these determinations by Class Counsel or you may choose to seek independent legal advice in deciding whether to participate in the Seventh Amendment. D. UNDERTAKINGS BY CERTAIN LAWYERS FOR CLASS MEMBERS; POSSIBLE EFFECT ON YOU Because Wyeth was not willing to proceed with negotiations towards any amendment to the Settlement Agreement without assurances that the amendment would receive substantial support from other Class Members, Messrs. Alexander, Spivey, Doyle and Martinez and Ms. Presby (see pages __) obtained written support from firms representing a large number of Class Members. In the negotiations, Wyeth stated that unless there was a very high level of participation by eligible Class Members in the Seventh Amendment, Wyeth would exercise its right to terminate the Amendment. Lawyers representing many claimants have signed a term sheet (the form of which is attached to the Seventh Amendment) stating that they believe the Seventh Amendment is in the best interests of their clients and committing that they will recommend to all their clients that they participate in it and not object to it. These law firms have recognized that there is a conflict between representing some claimants who want to be part of the Seventh Amendment and some who do not. This is because clients who decide not to participate, or to object to the Amendment, could lead to Wyeth's terminating the Seventh Amendment to the detriment of those clients who wish to participate. Those law firms further 44 stated that they would take all lawful measures to withdraw from representing any client who elected not to be covered by, or who objects to, the Seventh Amendment. All eligible Class Members who are represented by their own attorney may wish to discuss with their attorney the potential conflict described here and its impact on your decision-making regarding all issues relating to the Seventh Amendment. E. EFFECT ON CLAIMS INTEGRITY PROGRAM AND CERTAIN OTHER PROCEEDINGS This Court has stayed, or put on hold, the processing, auditing and payment of claims for Matrix Level I or II benefits, except claims for which a post-audit determination letter had been issued by May 6, 2004 finding a claim either payable or not payable. In addition, the Court has stayed the Trust's Claims Integrity Program. Those stays will continue until the Seventh Amendment is approved or disapproved by the Court or Wyeth exercises its "walk-away" right. If the Seventh Amendment becomes effective, the Trust's Claims Integrity Program discussed at pages __ and all related legal proceedings with respect to claims by Category One and Category Two Class Members will cease. This will not affect the Trust's audit program as to Matrix claims that are not transferred to the Supplemental Fund and processed by the Fund Administrator. For such claims, the Trust will continue to review in its audit process all Matrix claims of all Class Members to determine whether there is a reasonable medical basis for the claim, before it can be paid. In addition, the Trust may determine whether any material misrepresentation of fact has been made in connection with any claim for Matrix compensation at Matrix Levels III, IV, or V by Category One or Category Two Class Members and may bring legal challenges to those claims on that ground. For this purpose, however, an allegation of material misrepresentation may not be based solely on (i) whether an echocardiogram tape or disk was allegedly obtained without adequate physician supervision, (ii) the identity of the 45 person or entity that performed the echocardiogram, or (iii) the identity of the attorneys representing the claimant. The Trust's existing audit and Claims Integrity programs will resume, however, for all Class Members who elect not to participate in the Seventh Amendment. In addition, appeals from some orders entered by this Court have been stayed while the Seventh Amendment approval process is completed and will be dismissed if the Amendment is approved. Specifically, (1) some Class Members have argued on appeal that this Court's order refusing to discharge Class Counsel was in error; (2) some Class Members have argued on appeal that this Court's order directing that all claims for Matrix benefits be audited was in error; (3) some Class Members have argued on appeal that this Court's order approving the Sixth Amendment was in error (see pages __); and (4) some Class Members have argued that this Court was in error when it directed that 78 claims submitted by one law firm should not be paid based upon the record at that time. [DESCRIBE STATUS AT TIME OF MAILING IF NOT STAYED.] Two other appeals by Class Members are pending as to which there is no stay. In one of those appeals, some Class Members assert that persons who exercised Intermediate Opt-Out or Back-End Opt-Out rights were not adequately represented in the negotiation of the Settlement Agreement. In the other appeal, the Class Members assert that persons having pulmonary hypertension not arising from VHD and not meeting the Settlement Agreement's definition of primary pulmonary hypertension ("PPH") were not adequately represented in the negotiation of the Settlement Agreement. Both groups of Class Members argue that their rights were violated and that the Settlement Agreement does not bind them or others similarly situated and does not bar them from asserting claims against Wyeth or from the types of claims they may assert. Wyeth vigorously disputes the validity of those arguments. Those two appeals have not yet been argued and no decision has been issued. 46 F. AMOUNTS OWED TO MEDICARE OR HEALTH INSURANCE COMPANIES; CLASS MEMBER INDEMNITY If any of your diet drug-related medical expenses were paid by Medicare or any other governmental entity or by a private health insurance carrier, or you received medical services from them for any diet drug-related condition, the Seventh Amendment requires participating Category One and Category Two Class Members to reimburse those third parties for those medical expenses or services out of payments under the Amendment from either the Supplemental Fund or the Trust to the extent that such governmental entity or private health insurance carrier has a lawful right to such reimbursement. Distributions to Class Members represented by an attorney will be paid in the first instance to that attorney, who will be obligated to make that reimbursement out of the distribution before making payment to the Class Member. If Medicare or the other governmental entity or the private insurance carrier, with an asserted legal right to reimbursement of medical expenses as described above, sues Wyeth, the Fund Administrator or the Trust for any of those medical expenses not paid, participating Class Members who receive a pro rata share of the Supplemental Fund and participating Class Members who receive Matrix compensation from the Trust for Matrix Level III, IV or V will be required to indemnify Wyeth, the Fund Administrator and the Trust against any claim such a governmental entity or private insurer asserts against them. A statute relating to Medicare's rights provides that the agency which administers it may seek twice the amount of the reimbursement to which it is entitled, together with other penalties. If Medicare obtains such double recovery or other penalties, the Class Member's indemnity obligation will include that double payment and those penalties. The indemnity also includes the costs incurred by those indemnified for investigation and defense. This Court will have jurisdiction to determine any claims for such indemnification. 47 For those Class Members participating in the Seventh Amendment who are represented by counsel, the provisions of the Pre-Amendment Settlement Agreement relating to claims for reimbursement of medical expenses will no longer apply. Those provisions would, however, continue to apply for persons covered by the Seventh Amendment but not represented by an attorney. Under those provisions, if the Trust is aware of a claim by any governmental or private party who has paid any such medical expenses, the Trust is to determine the payability of the claim and to deduct any amount found payable to such a party from the Matrix compensation payable to the Class Member. The Trust's determinations in this regard may be reviewed on appeal by a member of a board of arbitrators appointed by the Court and ultimately by the Court on an appeal from the decision of the arbitrator. IX. ATTORNEYS' FEES From the $2,000 payments to be made by either the Fund Administrator or the Trust under the Seventh Amendment to Class Members represented by their own counsel, an amount not to exceed $650 will be deducted for attorneys' fees. No such deduction would be made from those payments in the case of unrepresented Class Members. The Seventh Amendment provides that the Court shall determine whether and to what extent a "common benefit percentage" of the Supplemental Fund should be set aside to pay attorneys for professional services that are found by the Court to be of "common benefit" to Category One Class Members. Subject to the Court's approval, the persons who could participate in that "common benefit" fee would include Class Counsel, members of the SALC and possibly other attorneys. If the Court awards a "common benefit" fee payable from the Supplemental Fund, that award will be prorated among all of those who receive a pro rata share 48 of the Supplemental Fund. If you are represented by counsel, your share of that "common benefit" fee will be deducted from your attorney's share of the recovery and will not affect the net amount you receive. If you are not represented by counsel, your share of the "common benefit" fee will be deducted from your distribution. No such "common benefit" fee deduction will be made from any minimum $2,000 payment from the Supplemental Fund. The Pre-Amendment Settlement Agreement provides that the payment of Matrix compensation by the Trust will be subject to a 9 percent deduction for common benefit attorneys' fees, which may be reduced when the Court makes a final determination of the amount of "common benefit" fees to award in connection with this settlement. That provision will continue to apply to Matrix Level III, IV or V compensation payable to Class Members participating in the Seventh Amendment. X. YOUR RIGHT TO ELECT NOT TO PARTICIPATE IN THE SEVENTH AMENDMENT AND WYETH'S WALK-AWAY RIGHT You may elect not to participate in the Seventh Amendment and to continue instead to be covered by the Pre-Amendment Settlement Agreement. This election right is referred to in the Seventh Amendment as the "Seventh Amendment Opt-Out." IF YOU ARE ELIGIBLE TO PARTICIPATE IN THE SEVENTH AMENDMENT BUT TAKE NO ACTION, YOU WILL BE COVERED BY AND BOUND BY THE SEVENTH AMENDMENT. If you exercised any opt-out right under the Pre-Amendment Settlement Agreement and have not claimed Matrix benefits by submitting a substantially complete Green Form to the Trust in which the un-audited answered to Part II support a claim for Matrix benefits, you would need to obtain Wyeth's consent to revoke your opt-out in order to participate 49 in Category Two under the Seventh Amendment. You might need to supply additional information in order to claim your benefits, however. Wyeth has the right, in its sole discretion, to terminate and "walk away" from the Amendment before [date]. Wyeth has stated that an important factor in its decision whether to terminate the Amendment will be the extent of Class Members' participation in the Seventh Amendment. Wyeth has stated that it would walk away unless there is a very high level of participation by eligible Class Members in the Seventh Amendment. THE EXERCISE OF AN ELECTION NOT TO BE COVERED BY THE SEVENTH AMENDMENT IS NOT THE EQUIVALENT OF OPTING OUT OF THE CLASS OR OPTING OUT OF THE SETTLEMENT AGREEMENT. IF YOU ELECT NOT TO PARTICIPATE IN THE AMENDMENT, YOU WILL REMAIN A MEMBER OF THE CLASS AND YOU WILL CONTINUE TO BE SUBJECT TO THE PRE-AMENDMENT SETTLEMENT AGREEMENT WITH SUCH RIGHTS, LIMITATIONS, RESTRICTIONS AND OBLIGATIONS AS YOU WOULD HAVE OTHERWISE HAD IN THE ABSENCE OF THE SEVENTH AMENDMENT. IF YOU ELECT NOT TO BE COVERED BY THE AMENDMENT, THAT ELECTION WILL HAVE NO IMPACT ON YOUR COVERAGE BY ANY FUTURE AMENDMENTS TO THE SETTLEMENT AGREEMENT. The deadline for electing not to be covered by the Seventh Amendment is [DATE]. To exercise that election, an eligible Class Member who had used the diet drugs must send a written statement that he or she is exercising that election, either postmarked or delivered by that deadline, to the following address: If by mail: If by delivery: Wyeth Wyeth c/o Orran L. Brown c/o Orran L. Brown Attn: Seventh Amendment Opt-Outs Attn: Seventh Amendment Opt-Outs P.O. Box 85006 BrownGreer PLC Richmond, VA 23285-5006 115 South 15th Street Suite 400 Richmond, VA 23219-4209 50 That document must clearly identify (1) the name of the Class Member making that election, (2) the "DDR" claim number that has been assigned by the Trust to that Class Member's claim, (3) the Class Member's address, (4) the Class Member's Social Security number and (5) the name of the attorney for the Class Member, if any. The document must be personally signed by the Class Member who used the diet drugs, and not by his or her attorney or by any family member or by anyone else. A form is available for your use in exercising this election, although there is no requirement that you use that form. If you wish to receive a copy of the form, it is available to you on the Trust's website, www.settlementdietdrugs.com. XI. CONSIDERATIONS RELATING TO THE TRUST The Trust will be affected by the terms and operation of the Seventh Amendment in a number of ways other than those specifically applicable to Class Members who participate. The following are among the ways in which the Trust will be affected. The most significant impact on the Trust will be in the shifting of Matrix Level I and II claims from the Trust to the Supplemental Fund. The effect of that shift on the Trust is that the number of Matrix compensation claims which it must process, audit and possibly pay will be very substantially reduced. The Trust's remaining financial resources will then be available to a much greater extent for the payment of its other obligations. The effect of that shift on the Trust will depend upon the number of Category One Class Members who elect not to participate in the Seventh Amendment, assuming Wyeth does not walk away and terminate it. The Trust will be required under the Seventh Amendment to process and pay $2,000 to each Category Two Class Member and to each person who qualifies for Category One but elects 51 to shift to Category Two. However, apart from the cost of processing and making those payments, the Trust will not be adversely affected. Wyeth is obligated by the Seventh Amendment to deposit into the Trust the amount required to make those $2,000 payments. Those deposits will not reduce the amount of Wyeth's remaining obligation to the Trust under the Pre-Amendment Settlement Agreement. To the extent those $2,000 payments are for Category One persons who elect to shift to Category Two, Wyeth will receive a credit against its $1.275 billion obligation to the Supplemental Fund. The Fund Administrator, the MRCC, the escrow agent which will hold the Supplemental Fund's money and participating cardiologists will be indemnified by the Supplemental Fund for any costs of defending against, and for any liability based on, any claim arising from an act, omission or transaction by them in good faith under the Seventh Amendment and/or any procedure, document, rule or agreement arising from the Seventh Amendment. If the Fund Administrator, after using its best efforts, is unable to procure and maintain commercially reasonable amounts and types of insurance against such liabilities and if the Supplemental Fund has insufficient money to satisfy its indemnity obligation, the Court for good cause may authorize the Trust to indemnify the Fund Administrator, the MRCC, the escrow agent and participating physicians for the same liabilities for which the Supplemental Fund would otherwise have indemnified them. The Trust is obligated by the Seventh Amendment to pay the costs of the printing and mailing of this Notice. Under the terms of the Pre-Amendment Settlement Agreement, Wyeth is entitled to receive certain credits against its financial obligation to the Trust based on amounts Wyeth pays 52 as a result of a claim asserted by an Initial or Back-End Opt-Out person. The Seventh Amendment terminates Wyeth's right to those credits. In order to expedite the Trust's processing of Matrix Levels III, IV and V claims, the parties sought, and the Court has ordered, the resumption of a "Party Assisted Processing" procedure for those claims. Under that order, on receipt of such a claim, whether by persons covered by the Seventh Amendment or by other persons, the Trust is to forward the claim to Class Counsel. Class Counsel will determine if the claims are properly documented and, if not, will contact the claimant to explain what is missing and otherwise assist the Class Members in completing the claim. If the claim cannot be made complete, Class Counsel will return it to the Trust, which will close the file and not process the claim further. If Class Counsel determines that a claim is complete, the claim will be forwarded to Wyeth for its review. If Wyeth believes that the claim is payable, Wyeth will notify the Trust of that belief and the Trust will not conduct any further review or audit of the claim, but will seek approval from the Court for payment of the claim. If Wyeth believes that the claim is not payable, Wyeth will notify the Trust that the claim is disputed, specifying the dispute, and the Trust will send that dispute to a cardiologist for audit. Members of the SALC may assist in the implementation of these procedures and will have access to information about the process and the claims to which it relates, on a confidential basis. The parties have also sought, and the Court has entered, an order relating to the manner in which the Trust is to process Pre-May 6 Payable PADLs (see page __). There are the approximately 900 claims which the Trust has determined after audit are payable and has sent the claimant a letter to that effect on or before May 6, 2004. The new order directs the Trust to segregate those claims into one of the following three categories: (1) claims where, despite the issuance of the Pre-May 6 Payable PADL, the Trust now asserts that there was an intentional 53 manipulation of the echocardiogram tape or disk submitted in connection with the claim but not detected by the Trust until after the completion of the audit on the claim; (2) claims which the Trust has placed on hold because the echocardiogram supporting the claim was allegedly acquired without physician supervision or because the claimant's attesting physician was subject to an unanswered medical practices questionnaire issued by the Trust as part of its Claims Integrity Program; and (3) claims that are complete and ready to be paid. The Trust must pay all claims in the third category within 30 days after the entry of the new order. The Trust must continue processing the second category of claims and pay these claims, to the extent found payable, within 30 days after the date on which the Seventh Amendment is approved by this Court. For claims in the first category, the Trust must notify Wyeth, Class Counsel, the SALC and the claimant or claimant's counsel, if represented, and provide a specific factual basis for the assertion of intentional manipulation of the echocardiogram. Thereafter, such claims will be subject to further procedures in accordance with the Pre-Amendment Settlement Agreement. The parties have also proposed to the Court for its approval, separately from the Seventh Amendment, a proposed Eighth Amendment to the Pre-Amendment Settlement Agreement. The proposed Eighth Amendment will not become effective unless and until approved by the Court. The Eighth Amendment relates to the "Show Cause" process that Class Members may follow to appeal any denial by the Trust of a Matrix claim. The Eighth Amendment, if approved by the Court, would authorize a mediation program for claims that are subject to Show Cause proceedings. Under that program, the Trust, Wyeth and the claimant could participate in a non-binding mediation, presided over by a mediator appointed by the Court. Currently, a Matrix compensation claim must either be denied in full or paid in full by the Trust. Under the Eighth Amendment, however, the Trust would be permitted to resolve a claim by compromise, either at 54 or below the level of compensation provided for in the Pre-Amendment Settlement Agreement, if the claimant and Wyeth agree. XII. FAIRNESS HEARING AND PROCEDURE FOR OBJECTING TO THE SEVENTH AMENDMENT--WHEN IS THE FAIRNESS HEARING AND WHAT IS IT ABOUT? The Court will hold a Fairness Hearing in Courtroom __ at the United States Courthouse, 601 Market Street, Philadelphia, PA 19106 on ____________ 2004 at ____________, to determine whether the proposed Seventh Amendment is fair, reasonable and adequate and to consider any other matters deemed appropriate by the Court. The Court may, without further notice to Class Members, continue the hearing to another or additional dates. The Seventh Amendment will become effective only if the Court approves it and if any appeals from that approval are resolved without change in that approval. Any Class Member may object to the proposed Seventh Amendment, either on his or her own or through counsel. In order to do so, such Class Members must file specific and detailed written objections and a memorandum of law in support of those objections with the Clerk of the Court and serve them on Wyeth and Class Counsel at the following addresses: Clerk of the Court United States District Court for the Eastern District of Pennsylvania 601 Market Street Philadelphia, PA 19106 With copies to: Arnold Levin, Esq. Levin, Fishbein, Sedran & Berman 510 Walnut Street - Suite 500 Philadelphia, PA 19106-3875 and 55 Orran L. Brown, Esq. BrownGreer PLC P.O. Box 85006 Richmond, VA 23285-5006 OBJECTIONS MUST BE FILED NO LATER THAN [DATE: END OF OBJECTION PERIOD]. ANY OBJECTIONS TO THE SEVENTH AMENDMENT MUST BE DETAILED AND MUST EXPRESS SPECIFIC OBJECTIONS AND MUST BE ACCOMPANIED BY A MEMORANDUM OF LAW IN SUPPORT OF THOSE OBJECTIONS. You may, but are not required to, appear at the hearing to voice your objection to the Seventh Amendment. You may have your own attorney appear on your behalf at the fairness hearing if you wish. Persons wishing to speak at the hearing are required to file written objections in the manner and within the time described above and must request in writing time to speak at the hearing, specifying their interest and whether or not they are represented by counsel. Those requests should be mailed to the Clerk, with copies to the attorneys identified above. DO NOT CALL THE COURT. ALL REQUESTS MUST BE IN WRITING. REQUESTS FOR TIME TO SPEAK AT THE HEARING MUST BE POSTMARKED NO LATER THAN [DATE]. Those who do not wish to object to the proposed Seventh Amendment do not need to appear at the Fairness Hearing or file any papers. THIS IS THE ONLY OPPORTUNITY CLASS MEMBERS WILL HAVE TO OBJECT TO THE SEVENTH AMENDMENT. IT IS IMPORTANT FOR YOU TO UNDERSTAND THAT IF YOU DO NOT OBJECT IN THE MANNER DESCRIBED ABOVE, WITHIN THE DEADLINE SPECIFIED, YOU WILL BE VIEWED AS HAVING WAIVED YOUR RIGHT TO OBJECT TO THIS SEVENTH AMENDMENT AT ANY TIME IN THE FUTURE. XIII. HOW CAN I GET ADDITIONAL INFORMATION? This Official Court Notice is just a summary of the proposed Seventh Amendment and of the existing Settlement Agreement, as it has been amended previously. If there is any conflict 56 between this Notice and the Settlement Agreement, the terms of the Settlement Agreement will govern. If you would like to receive a copy of the Seventh Amendment and the Settlement Agreement, you may write to the Trust at P.O. Box 7939, Philadelphia, Pennsylvania 19101, or you may call the Trust at 1-800-386-2070. You also may view a copy of the Seventh Amendment and the Settlement Agreement on the Trust's website at the following address: www.settlementdietdrugs.com. You may inspect documents on file with the Court, including the Seventh Amendment and the Settlement Agreement, at the Clerk's Office at the United States District Court for the Eastern District of Pennsylvania, during regular business hours, and may obtain copies of documents by payment of the prescribed charges. The Clerk's Office is not permitted to give legal advice. If you have any questions about the Seventh Amendment, you may also consult your own counsel or, if you are not already represented, at your own expense, an attorney of your choice who is familiar with handling diet drug claims. * * * This Notice was approved on [date], by the United States District Court for the Eastern District of Pennsylvania for distribution to Class Members as an Official Notice of the Court. YOU SHOULD SAVE THIS NOTICE FOR REFERENCE CONCERNING YOUR RIGHTS AND BENEFITS AND THE IMPORTANT DEADLINES. 57 CLASS COUNSEL Arnold Levin, Esq. Gene Locks, Esq. Levin, Fishbein, Sedran & Berman Locks Law Firm 510 Walnut Street, Suite 500 1500 Walnut Street Philadelphia, PA 19106 Philadelphia, PA 19102 (215) 592-1500 (215) 893-0100 Michael D. Fishbein, Esq. Sol H. Weiss, Esq. Levin, Fishbein, Sedran & Berman Anapol, Schwartz, Weiss, Cohan, 510 Walnut Street, Suite 500 Feldman & Smalley, P.C. Philadelphia, PA 19106 1900 Delancey Place (215) 592-1500 Philadelphia, PA 19103 (215) 735-1130 Stanley Chesley, Esq. Charles R. Parker, Esq. Waite, Schneider, Bayless & Chesley Locke, Liddell & Sapp, LLP 1513 Central Trust Tower 3400 JP Morgan Chase Tower Fourth & Vine Sts. 600 Travis Cincinnati, OH 45202 Houston, TX 77002 (513) 621-0267 (713) 226-1200 John J. Cummings, Esq. Cummings, Cummings & Dudenhefer 416 Gravier Street New Orleans, LA 70130 (504) 586-0000
SEVENTH AMENDMENT LIAISON COMMITTEE Wayne Spivey, Esq., Chairman Jerry Alexander, Esq. Shrager, Spivey & Sachs Alexander & Associates, P.C. Two Commerce Square, 32nd Floor Historic Inns of Court Building 2001 Market Street 619 North 90th Street Philadelphia, PA 19103 Omaha, NE 68114 (215) 568-7771 (402) 390-9339
58 James Doyle, Esq. Tony Martinez, Esq. Fleming & Associates, LLP Martinez, Barrera & Martinez, LLP 1330 Post Oak Boulevard 1201 East Van Buren Suite 3030 Brownsville, TX 78520 Houston, TX 77056 (956) 546-7159 (713) 621-7944 Ellen Presby, Esq. Baron & Budd, PC The Centrum 3102 Oaklawn Avenue Suite 1100 Dallas, RX 75215 (214) 521-3605
THE FUND ADMINISTRATOR Edward J. Radetich, Jr. Heffler, Radetich & Saitta L.L.P. P.O. Box ____ Philadelphia, PA [ZIP CODE] [TELEPHONE NUMBER]( ) INDEX TO APPENDICES Appendix A Certain Definitions in Pre-Amendment Settlement Agreement Appendix B Relative Payment Values Under the Seventh Amendment Appendix C Comparison of Existing Level I and II Matrix Compensation Requirements with High Threshold and Low Threshold Criteria Appendix D Comparison of Existing Reduction Factors with Seventh Amendment Alternative Causation Factors Appendix E Pre-Amendment Settlement Agreement Matrix Benefit Payment Amounts Appendix F Matrix Level III-V Requirements in Pre-Amendment Settlement Agreement which are Modified Under the Seventh Amendment APPENDIX A CERTAIN DEFINITIONS IN PRE-AMENDMENT SETTLEMENT AGREEMENT 1. "RELEASED PARTIES" means: a. Wyeth and each of its subsidiaries, affiliates, and divisions, along with each of their respective current and former officers, directors, employees, attorneys, agents, and insurers; b. Any and all predecessors, successors, and/or shareholders of Wyeth and each of its subsidiaries, affiliates, and divisions; provided, however, that any such person or entity shall be considered a Released Party only to the extent that such person or entity is sued in its capacity as a predecessor, successor, and/or shareholder of Wyeth or its subsidiaries, affiliates, and divisions; c. Any and all suppliers of materials, components, and services used in the manufacture of Pondimin(R) and/or Redux((TM)), including the labeling and packaging thereof, along with each such person's or entity's predecessors, successors, parents, subsidiaries, affiliates, and divisions, and each of their respective current and former shareholders, officers, directors, employees, attorneys, agents, and insurers; provided, however, that no person or entity described in this subsection shall be a Released Party with respect to any claims based upon his, her or its own independent negligence or culpable conduct; d. All distributors of Pondimin(R) and/or Redux((TM)), including wholesale distributors, private label distributors, retail distributors, hospitals and clinics, and their respective predecessors, successors, parents, subsidiaries, affiliates, and divisions, and their respective current and former shareholders, officers, directors, employees, attorneys, agents, and insurers; provided that: (1) such persons and entities described in this section shall be a Released Party only as to claims as to which such persons would have a statutory or common-law right of indemnity against Wyeth; (2) no person or entity described in this section shall be a Released Party to the extent that any claim is based upon his, her or its own independent negligence or culpable conduct, including, without limitation, negligence or professional malpractice asserted against hospitals, clinics, and diet centers; and (3) no person or entity described in this section shall be a Released Party with respect to the manufacture, sale, or distribution of any Phentermine hydrochloride or Phentermine resin pharmaceutical product. e. All physicians who prescribed, and all pharmacists and pharmacies who dispensed, Pondimin(R) and/or Redux((TM)) to the extent that liability against such physicians, pharmacists or pharmacies is based on: (1) the prescription or dispensing of Pondimin(R) and/or Redux((TM)) in a manner consistent with the product labeling; and/or (2) the prescription or dispensing of Pondimin(R) for any period longer than a "few weeks"; and/or (3) the prescription or dispensing of Pondimin(R) and/or Redux((TM)) for concomitant use with Phentermine hydrochloride or Phentermine resin; and/or (4) a claim that the physician's or pharmacist's liability stems solely from having prescribed or dispensed Pondimin(R) and/or Redux((TM)); and/or (5) a claim that the physician's or pharmacist's liability stems solely from the prescription or dispensing of a defective or unreasonably dangerous product. Physicians, pharmacists and pharmacies are not Released Parties with respect to any claims based on their independent negligence or culpable conduct, not consisting of the conduct described in paragraphs (1)-(5) above. Notwithstanding the foregoing, manufacturers, sellers, wholesalers, or distributors of any Phentermine hydrochloride or Phentermine resin pharmaceutical product are not Released Parties with respect to the manufacture, sale, or distribution of any Phentermine hydrochloride or Phentermine resin pharmaceutical product, and Les Laboratoires Servier S.A. and all of its affiliates and subsidiaries, including, without limitation, Servier S.A.S., Oril, Orsem, Servier Amerique, Science Union et Cie, Institut de Recherches Internationales Servier, Servier Research and Interneuron Pharmaceuticals, Inc. are not Released Parties. 2. "SETTLED CLAIMS" means any and all claims, including assigned claims, whether known or unknown, asserted or unasserted, regardless of the legal theory, existing now or arising in the future by any or all members of the Settlement Class arising out of or relating to the purchase, use, manufacture, sale, dispensing, distribution, promotion, marketing, clinical investigation, administration, regulatory approval, prescription, ingestion, and labeling of Pondimin(R) and/or Redux((TM)), alone or in combination with any other substance, including, without limitation, any other drug, dietary supplement, herb, or botanical. These "Settled Claims" include, without limitation and by way of example, all claims for damages or remedies of whatever kind or character, known or unknown, that are now recognized by law or that may be created or recognized in the future by statute, regulation, judicial decision, or in any other manner, for: a. personal injury and/or bodily injury, damage, death, fear of disease or injury, mental or physical pain or suffering, emotional or mental harm, or loss of enjoyment of life; b. compensatory damages, punitive, exemplary, statutory and other multiple damages or penalties of any kind; c. loss of wages, income, earnings, and earning capacity, medical expenses, doctor, hospital, nursing, and drug bills; d. loss of support, services, consortium, companionship, society or affection, or damage to familial relations, by spouses, parents, children, other relatives or "significant others" of Settlement Class Members; e. consumer fraud, refunds, unfair business practices, deceptive trade practices, Unfair and Deceptive Acts and Practices ("UDAP"), and other similar claims whether arising under statute, regulation, or judicial decision; f. wrongful death and survival actions; g. medical screening and monitoring, injunctive and declaratory relief; h. economic or business losses or disgorgement of profits arising out of personal injury; and i. prejudgment or post-judgment interest. Notwithstanding the foregoing, Settled Claims do not include claims based on primary pulmonary hypertension ("PPH") (another defined term), including claims for compensatory, punitive, exemplary or multiple damages based on PPH; provided, however, that if a Class Member receives settlement benefits from Fund B, he/she may not bring a lawsuit based upon a claim for PPH, unless the Class Member was diagnosed with PPH before the Class Member had left-sided heart valve abnormalities (other than those which produce trivial, clinically insignificant left-sided regurgitation) or Endocardial Fibrosis. In addition, notwithstanding the foregoing, Settled Claims do not include claims arising from the exposure of unborn children, in utero, to Pondimin(R) or Redux(TM), and persons alleging exposure in utero to Pondimin(R) or Redux(TM) shall not be considered Diet Drug Recipients eligible for benefits under the Pre-Amendment Settlement Agreement. * * * The Seventh Amendment provides that receipt of a pro rata share of the Supplemental Fund or any Matrix compensation from the Trust would have the same effect as to claims based on PPH as receipt of "settlement benefits from Fund B" in the Pre-Amendment Settlement Agreement quoted above. APPENDIX B RELATIVE PAYMENT VALUES UNDER THE SEVENTH AMENDMENT The following grid provides the Relative Payment Values, or weightings, of claims for purpose of determining their pro rata shares of the Supplemental Fund under the Seventh Amendment. The "Alpha" column provides the Relative Payment Value in each age range for persons with a High Threshold Condition, no Alternative Causation Factors and 61 days or more of diet drug use. Column "Beta" provides in each age range the Relative Payment Value for persons with a Low Threshold Condition, no Alternative Causation Factors and 61 or more days of diet drug use. The "Delta" column provides the Relative Payment Value in each age range for persons with a High Threshold Condition and either Alternative Causation Factors or 60 days or less of diet drug use. The "Epsilon" column sets forth the Relative Payment Value of persons in each age range with a Low Threshold Condition and either Alternative Causation Factors or 60 days or less of diet drug use.
61 + DAYS OF DIET DRUG USE; NO < OR = 60 DAYS OF DIET DRUG USE AND/OR A ALTERNATIVE CAUSATION FACTORS ALTERNATIVE CAUSATION FACTORS G ------------------------------------------------------------------------------- E HIGH THRESHOLD LOW THRESHOLD HIGH THRESHOLD LOW THRESHOLD A GRID LEVEL GRID LEVEL GRID LEVEL GRID LEVEL T ALPHA BETA DELTA EPSILON ----------------------------------------------------------------------------------------- F < OR = 24 100.00 33.54 20.00 6.71 I ----------------------------------------------------------------------------------------- R 25-29 95.00 31.87 19.00 6.37 S ----------------------------------------------------------------------------------------- T 30-34 90.25 30.27 18.05 6.05 ----------------------------------------------------------------------------------------- D 35-39 85.74 28.76 17.15 5.75 I ----------------------------------------------------------------------------------------- A 40-44 81.45 27.32 16.29 5.46 G ----------------------------------------------------------------------------------------- N 45-49 77.38 25.95 15.48 5.19 O ----------------------------------------------------------------------------------------- S 50-54 73.51 24.66 14.70 4.93 I ----------------------------------------------------------------------------------------- S 55-59 69.83 23.42 13.97 4.68 ----------------------------------------------------------------------------------------- 60-64 66.34 22.25 13.27 4.45 ----------------------------------------------------------------------------------------- 65-69 59.71 20.03 11.94 4.01 ----------------------------------------------------------------------------------------- 70-79 29.85 10.01 5.97 2.00 =========================================================================================
APPENDIX C COMPARISON OF EXISTING LEVEL I AND II MATRIX COMPENSATION REQUIREMENTS WITH HIGH THRESHOLD AND LOW THRESHOLD CRITERIA
EXISTING SETTLEMENT AGREEMENT MEDICAL CONDITIONS FOR LEVEL I AND SEVENTH AMENDMENT II BENEFITS CLASSIFICATION - -------------------------------------------------------------------------------------------------------------- L Severe Aortic Regurgitation And No Complicating Factors. High Threshold Condition E V ---------------------------------------------------------------------------------------------------- E Severe Mitral Regurgitation And No Complicating Factors. Low Threshold Condition L ---------------------------------------------------------------------------------------------------- I FDA Positive Aortic or Mitral Regurgitation With Bacterial Low Threshold Condition Endocarditis. - -------------------------------------------------------------------------------------------------------------- Severe Aortic Regurgitation And Pulmonary Hypertension. High Threshold Condition ---------------------------------------------------------------------------------------------------- Severe Aortic Regurgitation And Abnormal Left Ventricular High Threshold Condition Dimension. ---------------------------------------------------------------------------------------------------- Moderate Aortic Regurgitation And Abnormal Left Ventricular High Threshold Condition Dimension. ---------------------------------------------------------------------------------------------------- Severe Aortic Regurgitation And Low Ejection Fraction (< High Threshold Condition 50%). ---------------------------------------------------------------------------------------------------- L Moderate Aortic Regurgitation And Low Ejection Fraction (< High Threshold Condition E 50%). V ---------------------------------------------------------------------------------------------------- E Severe Mitral Regurgitation And Pulmonary Hypertension. High Threshold Condition L ---------------------------------------------------------------------------------------------------- Moderate Mitral Regurgitation And Pulmonary Hypertension. Low Threshold Condition II ---------------------------------------------------------------------------------------------------- Severe Mitral Regurgitation And Abnormal Left Atrial Size. Low Threshold Condition ---------------------------------------------------------------------------------------------------- Moderate Mitral Regurgitation And Abnormal Left Atrial Size. Low Threshold Condition ---------------------------------------------------------------------------------------------------- Severe Mitral Regurgitation And Abnormal Left Ventricular High Threshold Condition End-Systolic Dimension. ---------------------------------------------------------------------------------------------------- Moderate Mitral Regurgitation And Abnormal Left Ventricular Low Threshold Condition End-Systolic Dimension. ---------------------------------------------------------------------------------------------------- Severe Mitral Regurgitation And Low Ejection Fraction (< or = High Threshold Condition (Ejection 60%). Fraction < 50%) ---------------------------------------------------------------------------------------------------- Low Threshold Condition (Ejection Fraction 50% or greater) ---------------------------------------------------------------------------------------------------- Moderate Mitral Regurgitation And Low Ejection Fraction (< or = Low Threshold Condition 60%). ---------------------------------------------------------------------------------------------------- Severe Mitral Regurgitation And Arrhythmias With An Low Threshold Condition Enlarged Left Atrial Size. ---------------------------------------------------------------------------------------------------- Moderate Mitral Regurgitation And Arrhythmias With An Low Threshold Condition Enlarged Left Atrial Size. ----------------------------------------------------------------------------------------------------
APPENDIX D COMPARISON OF EXISTING REDUCTION FACTORS WITH SEVENTH AMENDMENT ALTERNATIVE CAUSATION FACTORS
EXISTING SETTLEMENT AGREEMENT SEVENTH AMENDMENT ALTERNATIVE REDUCTION FACTORS CAUSATION FACTORS - ----------------------------------------------------------------------------------------------------------------------- A The following congenital aortic valve abnormalities: unicuspid, Same O bicuspid or quadricuspid aortic valve, ventricular septal defect R associated with aortic regurgitation. T ---------------------------------------------------------------------------------------------------------------- I Aortic dissection involving the aortic root and/or aortic valve. Same C ---------------------------------------------------------------------------------------------------------------- Aortic sclerosis in people who are > or = 60 years old as of the time Same V they are first diagnosed as having FDA Positive aortic or mitral A regurgitation. L ---------------------------------------------------------------------------------------------------------------- V Aortic root dilatation > 5.0 cm. Same E ---------------------------------------------------------------------------------------------------------------- Aortic stenosis with an aortic valve area < 1.0 square centimeter Same by the Continuity Equation. - ----------------------------------------------------------------------------------------------------------------------- The following congenital mitral valve abnormalities: parachute Same M valve, cleft of the mitral valve associated with atrial septal I defect. T ---------------------------------------------------------------------------------------------------------------- R Mitral Valve Prolapse. Same A ---------------------------------------------------------------------------------------------------------------- L Chordae tendineae rupture or papillary muscle rupture; or acute Same myocardial infarction associated with acute mitral regurgitation. V ---------------------------------------------------------------------------------------------------------------- A Mitral annular calcification. Same L ---------------------------------------------------------------------------------------------------------------- V M-Mode and 2-D echocardiographic evidence of rheumatic mitral valves Same, except that exception for review E (doming of the anterior leaflet and/or anterior motion of the by Board-Certified Pathologist is not posterior leaflet and/or commissural fusion), except where a included Board-Certified Pathologist has examined mitral valve tissue and determined that there was no evidence of rheumatic valve disease. ---------------------------------------------------------------------------------------------------------------- Diagnosis of Mild Mitral Regurgitation and not Moderate Mitral Same Regurgitation or Severe Mitral Regurgitation by an Echocardiogram performed between the commencement of Diet Drug use and the end of the Screening Period. - ----------------------------------------------------------------------------------------------------------------------- Heart valve surgery prior to Pondimin(R) and/or Redux((TM)) use on Same B the valve that is the basis of claim. O ---------------------------------------------------------------------------------------------------------------- T Bacterial endocarditis prior to Pondimin(R) and/or Redux((TM)) use. Not Included H ---------------------------------------------------------------------------------------------------------------- FDA Positive Aortic or Mitral regurgitation (confirmed by Not Included V Echocardiogram) prior to Pondimin(R) and/or Redux((TM)) use for the A valve that is the basis of claim. L ---------------------------------------------------------------------------------------------------------------- V A diagnosis of Systemic Lupus Erythematosus or a diagnosis of Not Included E Rheumatoid Arthritis and valvular abnormalities of a type associated S with those conditions. ---------------------------------------------------------------------------------------------------------------- Carcinoid tumor of a type associated with aortic and/or mitral Not Included valve lesions. ---------------------------------------------------------------------------------------------------------------- History of daily use of methysergide or ergotamines for a continuous Not Included period of longer than 120 days. ---------------------------------------------------------------------------------------------------------------- Diet Drug Ingested for 60 days or less. Although not an "Alternative Causation Factor" under the Seventh Amendment, Diet Drug-Use for 60 days or less does reduce benefit levels the same as the Alternative Causation Factors - -----------------------------------------------------------------------------------------------------------------------
APPENDIX E PRE-AMENDMENT SETTLEMENT AGREEMENT MATRIX BENEFIT PAYMENT AMOUNTS The tables below set forth the Matrix compensation benefits provided in the Pre-Amendment Settlement Agreement, inflation adjusted for the year 2004, for Matrix levels I and II. The application of each Matrix depends on factors contained in Section IV.B.2 of the Pre-Amendment Settlement Agreement. FOR PERSONS WHO USED THE DIET DRUGS FOR 61 OR MORE DAYS AND HAVE NO ALTERNATIVE CAUSATION FACTORS
AGE AT DIAGNOSIS MATRIX SEVERITY ------------------------------------------------------------------------------------------------------------- LEVEL < or = 24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-79 - --------------------------------------------------------------------------------------------------------------------------------- A-1 I $128,750 $122,313 $116,197 $110,386 $104,867 $ 99,624 $ 94,642 $ 89,910 $ 85,415 $ 76,873 $ 38,437 ----------------------------------------------------------------------------------------------------------------------- II $669,497 $636,023 $604,222 $574,011 $545,310 $518,044 $492,142 $467,536 $444,159 $399,744 $199,872 - ---------------------------------------------------------------------------------------------------------------------------------
FOR FAMILY MEMBERS AND OTHER DERIVATIVE CLAIMANTS OF THOSE ON MATRIX A-1
AGE AT DIAGNOSIS MATRIX SEVERITY ---------------------------------------------------------------------------------------------- LEVEL < or = 24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-79 - ------------------------------------------------------------------------------------------------------------------- A-2 I $1,301 $1,235 $1,174 $1,115 $1,059 $1,006 $ 956 $ 908 $ 862 $ 769 $ 520 ---------------------------------------------------------------------------------------------------------- II $6,763 $6,424 $6,103 $5,798 $5,508 $5,233 $4,971 $4,722 $4,486 $3,997 $1,999 - --------------------------------------------------------------------------------------------------------------------
FOR PERSONS WHO USED THE DIET DRUGS FOR 60 DAYS OR LESS AND/OR HAVE ALTERNATIVE CAUSATION FACTORS
AGE AT DIAGNOSIS MATRIX SEVERITY -------------------------------------------------------------------------------------------------------------- LEVEL < or = 24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-79 - ---------------------------------------------------------------------------------------------------------------------------------- B-1 I $ 25,750 $ 24,463 $ 23,239 $ 22,078 $ 20,973 $ 19,926 $18,929 $17,982 $17,083 $15,375 $ 7,688 ------------------------------------------------------------------------------------------------------------------------- II $133,899 $127,205 $120,845 $114,802 $109,062 $103,609 $98,428 $93,507 $88,832 $79,948 $39,974 - ----------------------------------------------------------------------------------------------------------------------------------
FOR FAMILY MEMBERS AND OTHER DERIVATIVE CLAIMANTS OF THOSE ON MATRIX B-1
AGE AT DIAGNOSIS MATRIX SEVERITY ------------------------------------------------------------------------------------------------- LEVEL < or = 24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-79 - --------------------------------------------------------------------------------------------------------------------- B-2 I $ 520 $ 520 $ 520 $ 520 $ 520 $ 520 $520 $520 $520 $520 $520 II $1,353 $1,285 $1,220 $1,160 $1,102 $1,047 $995 $945 $897 $799 $520 - ---------------------------------------------------------------------------------------------------------------------
APPENDIX F MATRIX LEVEL III - V REQUIREMENTS IN PRE-AMENDMENT SETTLEMENT AGREEMENT WHICH ARE MODIFIED UNDER THE SEVENTH AMENDMENT(2)
PRE-AMENDMENT SETTLEMENT AGREEMENT SEVENTH AMENDMENT MODIFICATIONS - ------------------------------------------------------------------------------------------------------------------------------------ L Severe Mitral or Aortic Regurgitation and ACC/AHA Class I Class Member has to have actual surgery performed. Valve E indications for surgery to repair or replace the involved surgery that is medically recommended, but not performed, V valve(s) and surgery not performed and a statement from the whether because of medical contraindications or because of E attending Cardiologist or Cardiothoracic Surgeon, supported by patient choice, will not qualify for Level III Matrix L medical records, regarding the recommendations made to the Compensation Benefits. patient regarding valve surgery and the reason why surgery was III not performed. ----------------------------------------------------------------------------------------------------------------------------- Moderate or Severe Mitral Regurgitation and a stroke, as a Basic criteria for a stroke-based claim are the same as consequence of chronic atrial fibrillation with left atrial under existing Settlement Agreement, but Seventh enlargement, that results in a permanent condition that meets Amendment, in addition, requires a statement under penalty the criteria of AHA Stroke Outcome Classification Functional of perjury from an examining physician, along with Level II, as determined six months after the stroke. supporting contemporaneous medical records, establishing that the claimant had chronic atrial fibrillation with left atrial enlargement as a direct consequence of moderate or severe mitral regurgitation. - ------------------------------------------------------------------------------------------------------------------------------------ Moderate or Severe Mitral Regurgitation and a stroke, as a Basic criteria for a stroke-based claim are the same as consequence of chronic atrial fibrillation with left atrial under existing Settlement Agreement, but Seventh enlargement, that results in a permanent condition that meets Amendment, in addition, requires a statement under penalty the criteria of AHA Stroke Outcome Classification Functional of perjury from an examining physician, along with Level III, as determined six months after the stroke. supporting contemporaneous medical records, establishing that the claimant had chronic atrial fibrillation with left atrial enlargement as a direct consequence of moderate or severe mitral regurgitation. ----------------------------------------------------------------------------------------------------------------------------- L Mild, Moderate or Severe Aortic Regurgitation or Moderate or Basic criteria are the same as under existing Settlement E Severe Mitral Regurgitation, in addition to a peripheral Agreement but, in the case of a peripheral embolus caused V embolus due to either (i) bacterial endocarditis contracted by atrial fibrillation with left atrial enlargement, E after use of Pondimin(R) and/or Redux(TM), or to (ii) atrial Seventh Amendment also requires a statement under penalty L fibrillation with left atrial enlargement, that results in of perjury from an examining physician, along with severe permanent impairment to the kidneys, abdominal organs, supporting contemporaneous medical records, establishing IV or extremities. that the claimant had chronic atrial fibrillation with left atrial enlargement as a direct consequence of moderate or severe mitral regurgitation. ----------------------------------------------------------------------------------------------------------------------------- Mild, Moderate or Severe Mitral or Aortic Regurgitation and (i) Basic criteria are the same as under existing Settlement New York Heart Association Functional Class I or Class II Agreement, but in the case of ineligibility for surgery Symptoms, and (ii) either (a) valvular repair or replacement due to medical reasons, the individual must have ACC/AHA surgery on the valve or valves with the required level of Class I indications for surgery and the medical reasons regurgitation or (b) ineligibility for such surgery due to that make him or her eligible for surgery have to be documented medical reasons and (iii) significant damage to the documented contemporaneously in the Diet Drug Recipient's heart muscle, defined as (a) an ejection fraction <30% with medical records by the attending Board-Certified aortic regurgitation or <35% with mitral regurgitation in Cardiothoracic Surgeon or Board-Certified Cardiologist and individuals who have not had valve surgery or (b) an ejection certified to under penalty of perjury by an Examining fraction of <40% six months after valvular repair or Physician, and such medical reasons have to be more than replacement surgery. acute conditions requiring a postponement of surgery. - ------------------------------------------------------------------------------------------------------------------------------------
- ------------- (2) Modifications apply only to Category One and Category Two persons. - ------------------------------------------------------------------------------------------------------------------------------------ Moderate or Severe Mitral Regurgitation and a stroke, as a Basic criteria for a stroke-based claim are the same as consequence of chronic atrial fibrillation with left atrial under existing Settlement Agreement, but Seventh enlargement, that results in a permanent condition that meets Amendment, in addition, requires a statement under penalty the criteria of AHA Stroke Outcome Classification Functional of perjury from an examining physician, along with Level IV or V, as determined six months after the stroke. supporting contemporaneous medical records, establishing that the claimant had chronic atrial fibrillation with left atrial enlargement as a direct consequence of moderate or severe mitral regurgitation. ----------------------------------------------------------------------------------------------------------------------------- L Mild, Moderate or Severe Mitral or Aortic Regurgitation and (i) Basic criteria are the same as under existing Settlement E New York Heart Association Functional Class III or Class IV Agreement, but in the case of ineligibility for surgery V Symptoms, and (ii) either (a) valvular repair or replacement due to medical reasons, the individual must have ACC/AHA E surgery on the valve or valves with the required level of Class I indications for surgery and the medical reasons L regurgitation or (b) ineligibility for such surgery due to that make him or her ineligible for surgery have to be documented medical reasons and (iii) significant damage to the documented contemporaneously in the Diet Drug Recipient's V heart muscle, defined as (a) an ejection fraction <30% with medical records by the attending Board-Certified aortic regurgitation or <35% with mitral regurgitation in Cardiothoracic Surgeon or Board-Certified Cardiologist and individuals who have not had valve surgery or (b) an ejection certified to under penalty of perjury by an Examining fraction of <40% six months after valvular repair or Physician, and such medical reasons have to be more than replacement surgery. acute conditions requiring a postponement of surgery. ----------------------------------------------------------------------------------------------------------------------------- Death resulting from a condition caused by valvular heart Basic criteria are the same as under existing Settlement disease or valvular repair or replacement surgery that occurred Agreement, but Seventh Amendment requires prior or after the use of Pondimin(R) and/or Redux(TM), supported by a simultaneous eligibility for benefits under Matrix Levels statement from the attending Board-Certified Cardiothoracic I or II, as defined in the existing Settlement Agreement, Surgeon or Board-Certified Cardiologist, supported by medical or prior or simultaneous eligibility for benefits based records. upon High Matrix Level Qualifying Factors, as defined in the Seventh Amendment. ----------------------------------------------------------------------------------------------------------------------------- Mild, Moderate or Severe Valvular regurgitation, and Basic criteria are the same as under existing Settlement qualification for benefits under Matrix Levels II, III or IV, Agreement, but in the case of a supporting Matrix Level as defined in the Settlement Agreement, and ventricular claim based upon ineligibility for surgery due to medical fibrillation or sustained ventricular tachycardia, which reasons, the individual must have ACC/AHA Class I results in hemodynamic compromise. indications for surgery and the medical reasons that make him or her ineligible for surgery have to be documented contemporaneously in the Diet Drug Recipient's medical records by the attending Board-Certified Cardiothoracic Surgeon or Board-Certified Cardiologist and certified to under penalty of perjury by an Examining Physician, and such medical reasons have to be more than acute conditions requiring a postponement of surgery. - ------------------------------------------------------------------------------------------------------------------------------------
NOS. 03-2025,03-2063 AND 03-2072 UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT IN RE DIET DRUGS (PHENTERMINE/FENFLURAMINE/DEXFENFLURAMINE) PRODUCTS LIABILITY LITIGATION, MDL NO. 1203 FLEMING & ASSOCIATES, L.L.P. APPELLANT IN NO. 03-2025 JOEL ZUCKERBERG APPELLANTS IN NO. 03-2063 HARITON & D'ANGELO, LLP., ET AL. APPELLANTS IN NO. 03-2072 APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA -------------------------- THE HON. HARVEY BARTLE III MOTION TO EXTEND STAY The above appeals relate to an order entered by the District Court approving the Sixth Amendment to the diet drug Nationwide Class Action Settlement Agreement (the "Settlement Agreement"). By this Motion, the undersigned parties-all of the parties to those appeals-hereby request an order extending the stay of these consolidated appeals that was issued by this Court on June 9, 2004. The parties to all of these appeals had previously requested a stay from this Court while a further amendment (the "Seventh Amendment") to the Settlement Agreement was negotiated. Since that initial stay was issued, the Seventh Amendment agreement has been signed by the parties to that agreement and has been placed in escrow pending EXHIBIT M satisfaction of specified conditions. On Wednesday, August 4, 2004, most of those conditions were satisfied. After the filing of this motion, the parties have only a few minor conforming changes to make in the documents and they expect that the Seventh Amendment would therefore be released from escrow very shortly. All of the parties to the instant appeals request that this Court extend the stay of these appeals. All parties believe that the Seventh Amendment is highly relevant to the issues in the instant appeals and that these appeals should not be decided based on the record as it existed at the time these appeals were argued. For this reason among others, the Appellants have agreed to dismiss these appeals upon final judicial approval of the Seventh Amendment. The Sixth Amendment, the approval of which is at issue in the instant appeals, addressed what would happen if the AHP Settlement Trust (the "Trust"), which is administering the $3.75 billion committed by Wyeth under the Settlement Agreement, were to run out of money to pay valid claimants. The Seventh Amendment, however, provides that Wyeth would increase the amount it is committing to the Settlement Agreement by depositing an additional $1.275 billion into a new fund, which would be allocated among all claimants eligible to share in that fund. The Seventh Amendment, if effectuated, will likely moot the issues raised in the instant appeals and will dramatically change the factual premises upon which these appeals were briefed and argued. The undersigned therefore request the Court to extend the stay of these appeals pending judicial approval of the Seventh Amendment. 2 BACKGROUND AND PROCEDURAL HISTORY I. THE SIXTH AMENDMENT AND THE SEVENTH AMENDMENT The Sixth Amendment to the Settlement Agreement, which is the subject of the instant appeals, provided Class Members with certain rights and benefits in the event that the funds available to the Trust proved insufficient to pay all claimants otherwise eligible for compensation. Specifically, the Sixth Amendment provided qualifying claimants with the right to sue Wyeth, subject to specified restrictions, if their valid claim was not paid by the Trust because it had exhausted its available financial resources. Some Class Members appealed the District Court's approval of the Sixth Amendment, arguing that, if the Trust was left with no money to pay their benefits, their rights would have been violated, in part because they had received insufficient notice of that risk at the time they chose not to opt out of the settlement class. The Sixth Amendment had been adopted to address concerns about the ability of the Trust to function in the face of the tens of thousands of claims for compensation that had been filed with the Trust. The number of such claims has substantially exceeded the estimates of the experts who testified at the fairness hearing leading to the approval of the Settlement Agreement. Many of these claims are subject to disputes about their validity. These disputes have led to protracted and contentious motions practice that has imposed a heavy burden on the District Court. The sheer volume of claims and the many disputes concerning validity have delayed resolution and payment of claims. More recently, in order to resolve the many issues concerning administration of the multitude of claims, including the possibility that the Trust would have insufficient funds to pay those claims, Class Counsel and counsel for a number of individual Class 3 Members have engaged in lengthy discussions with Wyeth regarding a proposed Seventh Amendment to the Settlement Agreement. That Seventh Amendment, if effectuated, would provide greater certainty to Class Members, provide them a fair and equitable opportunity for more expeditious compensation, minimize the transaction costs of processing claims, and reduce the burden on the District Court in resolving contested motions practice. The counsel for individual Class Members who, along with Wyeth and Class Counsel, have participated in the negotiation of the Seventh Amendment have secured support for that Amendment from lawyers who together represent a large proportion of the tens of thousands of claims for compensation benefits in the current Trust. The proposed Seventh Amendment addresses more comprehensively the very concerns about the possibility that the Trust would have insufficient funds to pay all legitimate claims that had earlier led to the Sixth Amendment. The Seventh Amendment would create a Supplemental Fund with a new administrative structure. If the Seventh Amendment is ultimately approved, Wyeth would deposit a total of $1.275 billion into this Fund. Claims for Matrix Level I and II benefits - i.e., compensation benefits for certain heart valve conditions other than the most serious kinds, such as those requiring valve surgery-would be shifted from the Trust to the Supplemental Fund. Those claims for Matrix Level I and II benefits constitute more than 95% of the claims on file with the Trust that contain sufficient information to assess the Matrix Level asserted. To the extent that such claims for benefits are shifted to the new Supplemental Fund, there would be an enormous decrease in the claims against the Trust corpus. Meanwhile, the Supplemental Fund would review all the claims transferred to it and would allocate to all 4 claimants with valid claims a portion of the $1,275 billion, depending upon the claimant's medical condition, age and certain other factors specified in the Seventh Amendment. Claims for other conditions as set forth in the proposed Seventh Amendment (e.g., heart valve surgery), whether currently pending or arising in the future, would be submitted to the existing Trust. Because the creation of the Supplemental Fund would free the Trust from the overwhelming number of current claims for benefits, it is more likely that the Trust would have adequate funds to pay these claimants. However, even if the existing Trust were to run out of funds, under the proposed Seventh Amendment Wyeth would guarantee that there would be money available to pay these more serious claims by participants in the Seventh Amendment. All eligible Class Members would have the right to elect not to participate in the Seventh Amendment and to remain subject to the terms of the Settlement Agreement prior to the Seventh Amendment. All Class Members participating in the Seventh Amendment would give up any future rights to sue Wyeth in the tort system, including as provided in the Sixth Amendment, and the right to collaterally attack the Settlement Agreement. II. PROCEDURAL HISTORY On May 4, 2004, Wyeth and Class Counsel (who are Appellees here) and counsel for a number of individual Class Members filed a Joint Motion for Stay with the District Court, requesting it to stay numerous disputed matters pending before that court that 5 would be resolved by the effect of the Seventh Amendment. By order of May 6, 2004, the District Court granted that motion. See Exhibit A hereto.(1) When the parties requested the stay of the District Court proceedings, they also sought stays of a number of appeals pending before this Court, including the three instant consolidated appeals involving approval of the Sixth Amendment to the Settlement Agreement. All Appellants agreed to that stay motion. See Exhibit E hereto. That motion stated that "[i]n the event the proposed amendment to the Settlement Agreement is executed and finally approved by the District Court, after appropriate notice and a fairness hearing, the moving parties will move to dismiss these appeals." Exhibit E at 2. The Court granted a sixty-day stay, expiring on August 9, 2004. At the time, the Court stated that no further extension of the stay would be granted. Due to the changed circumstances outlined in this motion, however, the undersigned are requesting the Court to reconsider its prior order and extend the current stay. ARGUMENT The moving parties agree that the Seventh Amendment, if effectuated and ultimately approved, would likely moot the instant appeals relating to the Sixth Amendment. Accordingly, under the terms of the proposed Seventh Amendment, the moving parties here agreed to move to dismiss the instant appeals following final judicial approval of the Seventh Amendment. See Exhibit E at 2 ("In the event the proposed amendment to the Settlement Agreement is executed and finally approved by the District - ------------------------- (1) The District Court's stay was scheduled to expire on July 9, 2004. However, the District Court extended that stay, permitting the negotiation and drafting of the Seventh Amendment to continue during the pendency of the stay. See Exhibits B, C, and D hereto. 6 Court, after appropriate notice and a fairness hearing, the moving parties will move to dismiss these appeals."). All Appellants and Appellees continue to agree that the instant appeals should be dismissed upon final approval of the Seventh Amendment. The effectuation of the Seventh Amendment would dramatically change the factual basis upon which the instant appeals were briefed and argued. To address the concern that the existing funding of the Trust is likely to be inadequate to pay all claims, Wyeth would deposit an additional $1.275 billion into a new Supplemental Fund to pay many of the existing claimants, although in an amount likely to be less than they would have received under the original Settlement Agreement had there been enough money to pay them all. Wyeth would guarantee the availability of money to pay certain more serious claims relating to valve surgery and other serious medical conditions. In return, those Class Members who participate in the Seventh Amendment would give up any right to sue Wyeth in the tort system. Class Members who participate in the Seventh Amendment will, among other things, relinquish the Sixth Amendment Opt-Out right, which is the subject of the instant appeals, and also relinquish their rights to collateral challenges to the Settlement Agreement. In addition, because Wyeth would deposit additional money into a Supplemental Fund for those eligible Class Members who participate in the Seventh Amendment, the existing Trust would be relieved of the responsibility of paying those participating Class Members' pending claims. This would significantly reduce the likelihood that the existing Trust would run out of money before other claims could be paid. The prospect of a "funding insufficiency" - the only circumstance under which Sixth Amendment Opt- 7 Out rights could become available to Class Members-will therefore be substantially diminished. The factual circumstances underlying the Sixth Amendment - and these appeals - would be radically changed by the effectuation of the Seventh Amendment. For example, the parties disputed in their briefs and at oral argument whether or not the Appellants' collateral attack on the Settlement Agreement was ripe for decision in the context of these appeals. The Seventh Amendment significantly changes that dynamic, because its implementation would eliminate or at least materially reduce the prospect of a funding insufficiency on which those collateral attack arguments were based. In addition, the parties disputed whether or not the Class Notice adequately addressed the risk of a funding insufficiency, but again that argument is essentially mooted by the Seventh Amendment for the same reason. Although the Court has stated that it would not further extend the stay of the instant appeals, the moving parties accordingly urge the Court to reconsider that decision now that the Seventh Amendment has been signed and placed in escrow and now that the Seventh Amendment's release from escrow is imminent. The undersigned request that such a stay continue until the Seventh Amendment is approved by the District Court and all appeals of that approval have been exhausted-at which time the undersigned will move to dismiss the instant appeals. Such a stay order could also provide that, in the event that the Seventh Amendment does not become effective or is not approved by the District Court, the parties must notify the Court so that the stay can be lifted. 8 All of the undersigned parties have agreed to this motion and have accordingly executed the attached separate signature pages. Respectfully submitted, The Following Counsel August 9, 2004 9 ATTORNEYS FOR WYETH, APPELLEE IN NOS. 03-2025, 03-2063, 03-2072 ARNOLD & PORTER LLP Robert D. Rosenbaum 399 Park Avenue ARNOLD & PORTER LLP New York, NY 10022 555 Twelfth Street, N.W. (212) 715-1010 Washington, D.C. 20004 (202) 942-5862 Michael T. Scott Paul B. Kerrigan REED SMITH LLP 2500 One Liberty Place Philadelphia, PA 19103 (215) 851-8248 By: /s/ Peter L. Zimroth ------------------------------------ Peter L. Zimroth 9 ATTORNEYS FOR APPELLANTS IN 03-2025 George M. Fleming Jonathan S. Massey Sylvia Davidow JONATHAN MASSEY, P.C. Rand P. Nolen 3920 Northampton Street. N.W. FLEMING & ASSOCIATES, LLP Washington, D.C. 20015 1330 Post Oak Boulevard, Suite 3030 (202) 686-0457 Houston, TX 77056 (713) 621-7944 Mike O'Brien MIKE O'BRIEN, P.C. 1330 Post Oak Boulevard, Suite 2960 Houston, TX 77056 (713) 222-0088 By:/s/ Sylvia Davidow ------------------------------------- 11 CLASS COUNSEL, APPELLEE IN NOS. 03-2025, 03-2063, 03-2072 Arnold Levin Charles R. Parker Michael D. Fishbein John Roberson Fred S. Longer HILL & PARKER, P.C. LEVIN, FISHBEIN, SEDRAN & BERMAN 5300 Memorial Drive, Suite 700 510 Walnut Street- Suite 500 Houston, TX 77007 Philadelphia, PA 19106 (713) 868-5581 (215) 592-1500 By: /s/ [ILLEGIBLE] ------------------ 10 ATTORNEY FOR APPELLANT IN NO. 03-2063 N. Albert Bacharach, Jr. 115 Northeast 6th Avenue Gainesville, FL 32601-3416 (352) 378-9859 By: /s/ N. Albert Bacharach, Jr. -------------------------------- 12 ATTORNEYS FOR APPELLANTS IN NO. 02-2072 Pan. J. Napoli Mario D' Angelo Deise A. Rubin HARITON & D' ANGELO NAIOLI, KAISER, BERN & ASSOCIATES 3500 Sunrise Highway, Suite T207 114 Old Country Road, Suite 116A Great River, NY 11737 Mircola, NY 11501 (631) 224-1133 [ILLEGIBLE] 73-8918 By: /s/ [ILLEGIBLE] ------------------ 14 CERTIFICATE OF SERVICE I, Milind M. Shah, hereby certify that one true and correct copy of the foregoing Motion to Extend Stay was served this 10th day of August, 2004, upon the following, by first class mail: Arnold Levin, Esq. Charles R. Parker, Esq. Michael D. Fishbein, Esq. John Roberson, Esq. Fred S. Longer, Esq. Hill & Parker, P.C. Levin, Fishbein, Sedran & Berman 5300 Memorial Drive, Suite 700 510 Walnut Street Houston, TX 77007 Suite 500 Philadelphia, PA 19106 George M. Fleming, Esq. Jonathan Massey, Esq. Sylvia Davidow, Esq. Jonathan Massey, P.C. Rand P. Nolen, Esq. 3920 Northampton Street, N.W. Scott A. Love, Esq. Washington, DC 20015 Fleming & Associates, L.L.P. 1330 Post Oak Boulevard, Suite 3030 Houston, TX 77056 Mike O'Brien, Esq. N. Albert Bacharach, Jr., Esq. Mike O'Brien, P.C. 115 Northeast 6th Avenue 1330 Post Oak Boulevard, Gainesville, FL 32601-3416 Suite 2960 Houston, TX 77056 Paul J. Napoli, Esq. Mario D'Angelo, Esq. Denise A. Rubin, Esq. Hariton & D'Angelo Napoli, Kaiser, Bern & Associates 3500 Sunrise Highway, Suite T207 114 Old Country Road, Suite 116A Great River, NY 11737 Mincola, NY 11501 By: /s/ Milind M. Shah ---------------------------- Milind M. Shah NOS. 02-4502, 02-4614, 02-4615, 02-4617, 03-1007, 02-4378, AND 03-3740 UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT IN RE DIET DRUGS (PHENTERMINE/FENFLURAMINE/DEXFENFLURAMINE) PRODUCTS LIABILITY LITIGATION, MDL NO. 1203 HARITON & D'ANGELO, LLP, et al. APPELLANTS IN NOS. 02-4502, 02-4378, AND 03-3740 FLEMING & ASSOCIATES, L.L.P. APPELLANT IN NO. 02-4614 CLASS MEMBERS APPELLANTS IN NO. 02-4615 WILLIAMS BAILEY LAW FIRM, et al. APPELLANTS IN NO. 02-4617 LYNETTE TAYLOR, et al. APPELLANTS IN NO. 03-1007 APPEALS FROM THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA THE HON. HARVEY BARTLE III MOTION TO EXTEND STAY The above appeals relate to orders entered by the District Court in connection with the processing of claims for "Matrix" compensation under the diet drug Nationwide Class Action Settlement Agreement (the "Settlement Agreement"). ("Matrix" level compensation is that compensation, sometimes substantial, for those with specified medical conditions.) By this Motion, Appellees Wyeth and Class Counsel and all Appellants request an order extending the stay of these appeals that was issued by this Court on May 27, 2004. (The other Appellee, the AHP Settlement Trust (the "Trust"), does not oppose the relief requested herein.) The parties to these appeals (except for the Trust, which did not oppose the relief requested) had previously requested a stay from this Court while an amendment (the "Seventh Amendment") to the Settlement Agreement was negotiated. Since that initial stay was issued, the Seventh Amendment agreement has been signed by the parties to that agreement and has been placed in escrow pending satisfaction of specified conditions. On Wednesday, August 4, 2004, most of these conditions were satisfied. After the filing of this motion, the parties have only a few minor conforming changes to make in the documents, and they expect that the Seventh Amendment will therefore be released from escrow very shortly. The moving parties to the instant appeals request that this Court extend the stay of these appeals. The parties believe that the Seventh Amendment is highly relevant to the issues in the instant appeals and that these appeals should not be decided based on the record as it existed at the time these appeals were argued. For this reason among others, the Appellants have agreed to dismiss these appeals upon final judicial approval of the Seventh Amendment. The instant appeals involve the Trust's administration of claims from the $3.75 billion fund committed by Wyeth under the Settlement Agreement. The Seventh Amendment provides that Wyeth would increase the amount it is committing to the Settlement Agreement by depositing an additional $1.275 billion into a new fund, which would be allocated among all claimants eligible to share in that fund. The Seventh Amendment, if effectuated, will likely moot the issues raised in the instant appeals and 2 will dramatically change the factual premises upon which these appeals were briefed and argued. The undersigned therefore request the Court to extend the stay of these appeals pending judicial approval of the Seventh Amendment. BACKGROUND AND PROCEDURAL HISTORY I. BACKGROUND REGARDING THE SEVENTH AMENDMENT Class Counsel, Wyeth, and counsel for many individual Class Members have had concerns about the ability of the AHP Settlement Trust (the "Trust") to function in the face of the tens of thousands of claims for compensation that have been filed with the Trust. The number of such claims has substantially exceeded the estimates of the experts who testified at the fairness hearing leading to the approval of the Settlement Agreement. Many of these claims are subject to disputes about their validity. These disputes have led to protracted and contentious motions practice that has imposed a heavy burden on the District Court. The sheer volume of claims and the many disputes concerning validity have delayed resolution and payment of claims. The instant appeals arise from such proceedings concerning the multitude of claims filed with the Trust. Specifically, the five consolidated appeals at Docket Nos. 02-4502, 02-4614, 02-4615, 02-4617, and 03-1007 arise from an order of the District Court requiring all Matrix claims for compensation benefits filed with the Trust to be "audited," i.e., reviewed by cardiologists retained by the Trust. The other set of appeals (Docket Nos. 02-4378 and 03-3740) arise from an evidentiary hearing concerning certain claims that were submitted by a consortium of law firms and that were certified by two doctors working with the law firms. Following that hearing, the District Court ordered, among 3 other things, that the Trust had the authority to audit all claims filed by the law firms or certified by doctors subject to the hearing. More recently, in order to resolve the many issues concerning administration of the multitude of claims, including the possibility that the Trust would have insufficient funds to pay those claims, Class Counsel and counsel for a number of individual Class Members have engaged in lengthy discussions with Wyeth regarding a proposed Seventh Amendment to the Settlement Agreement. That Seventh Amendment, if effectuated, would provide greater certainty to Class Members, provide them a fair and equitable opportunity for more expeditious compensation, minimize the transaction costs of processing claims, and reduce the burden on the District Court in resolving contested motions practice. The counsel for individual Class Members who, along with Wyeth and Class Counsel, have participated in the negotiation of the Seventh Amendment have secured support for that Amendment from lawyers who together represent a large proportion of the tens of thousands of claims for compensation benefits in the current Trust. Most significantly for the instant appeals, the proposed Seventh Amendment would create a Supplemental Fund with a new administrative structure. If the Seventh Amendment is ultimately approved, Wyeth would deposit a total of $1.275 billion into this Fund. Claims for Matrix Level I and II benefits - i.e., compensation benefits for certain heart valve conditions other than the most serious kinds, such as those requiring valve surgery - would be shifted from the Trust to the Supplemental Fund. Those claims for Matrix Level I and II benefits constitute more than 95% of the remaining Matrix claims on file with the Trust that contain sufficient information to assess the Matrix Level 4 asserted. To the extent that such claims for benefits are shifted to the new Supplemental Fund, there will be an enormous decrease in claims against the Trust corpus. Meanwhile, the Supplemental Fund would review all of the claims transferred to it and would allocate to all claimants with valid claims a portion of the $1.275 billion, depending upon the claimant's medical condition, age, and certain other factors specified in the Seventh Amendment. Level I and Level II claims by Class Members participating in the Seventh Amendment would not be subject to the Trust's audit but would instead be subject to the processes of the new Fund set forth in the Seventh Amendment. Claims for other conditions as set forth in the proposed Seventh Amendment (e.g. heart valve surgery), whether currently pending or arising in the future, would be submitted to the existing Trust. Because the creation of the Supplemental Fund would free the Trust from the overwhelming number of current claims for benefits, it is more likely that the Trust would have adequate funds to pay these claimants. However, even if the existing Trust were to run out of funds, under the proposed Seventh Amendment, Wyeth would guarantee that there would be money available to pay those more serious claims by participants in the Seventh Amendment. All eligible Class Members would have the right to elect not to participate in the Seventh Amendment and to remain subject to the terms of the Settlement Agreement prior to the Seventh Amendment. All Class Members participating in the Seventh Amendment would give up any rights to sue Wyeth in the tort system and the right to collaterally attack the Settlement Agreement. 5 II. PROCEDURAL HISTORY On May 4.2004, Wyeth and Class Counsel (who are Appellees here) and counsel for a number of individual Class Members filed a Joint Motion for Stay with the District Court, requesting it to stay numerous disputed matters pending before that court that would be resolved by effect of the Seventh Amendment. By order of May 6, 2004, the District Court granted that motion. See Exhibit A hereto.(1) When the parties requested the stay of the District Court proceedings, they also sought stays of a number of appeals pending before this Court, including the appeals here involving the audit of claims for Matrix compensation. All Appellants agreed to that stay motion. See Exhibit E hereto. That motion stated that "[i]n the event the proposed amendment to the Settlement Agreement is executed and finally approved by the District Court, after appropriate notice and a fairness hearing, the moving parties will move to dismiss their respective appeals." Exhibit E at 2. The Court granted a sixty-day stay, expiring on July 26, 2004. The parties respectfully request that the Court extend that stay. ARGUMENT The moving parties agree that the Seventh Amendment, if effectuated and ultimately approved, would likely resolve the concerns of the parties to the instant appeals. Accordingly, under the terms of the proposed Seventh Amendment, the moving parties here agreed to move to dismiss the instant appeals following final judicial - ---------------------------- (1) The District Court's stay was scheduled to expire on July 9, 2004. However, the District Court extended that stay, permitting the negotiation and drafting of the Seventh Amendment to continue during the pendency of the stay. See Exhibits B, C, and D hereto. 6 approval of the Seventh Amendment. See Exhibit E at 2 ("In the event the proposed amendment to the Settlement Agreement is executed and finally approved by the District Court, after appropriate notice and a fairness hearing, the moving parties will move to dismiss their respective appeals."). All Appellants and Appellees Wyeth and Class Counsel continue to agree that the instant appeals should be dismissed upon final approval of the Seventh Amendment.(2) The effectuation of the Seventh Amendment would dramatically change the factual basis upon which the instant appeals were briefed and argued. The claims of Class Members participating in the Seventh Amendment and who are asserting "Matrix Level I and II" claims (the types of claims that comprise the vast majority of the claims for Matrix benefits submitted to the Trust) would be processed by a new claims facility under new procedures. These claims will no longer be subject to the audit procedures used by the existing Trust and that are at issue in the instant appeals. The parties accordingly urge the Court to extend its previous stay now that the Seventh Amendment has been signed and placed in escrow. The parties request that such a stay continue until the Seventh Amendment is approved by the District Court and all appeals of that approval have been exhausted - at which time the parties will move to dismiss the instant appeals. Such a stay order could also provide that, in the event that the Seventh Amendment does not become effective or is not approved by the District Court, the parties must notify the Court so that the stay can be lifted. - --------------------------- (2) Although the other Appellee, the AHP Settlement Trust, has not joined in this motion, they do not oppose the relief requested, as reflected on their signature page. 7 All of the parties have agreed to this motion and have accordingly executed the attached separate signature pages. Respectfully submitted, The Following Counsel August 10, 2004 8 ATTORNEYS FOR WYETH, APPELLEE IN NOS. 02-4502, 02-4614, 02-461.5, 02-4617, 03-1007, 02-4378, 03-3740 Peter L. Zimroth Robert D. Rosenbaum ARNOLD & PORTER LLP ARNOLD & PORTER LLP 399 Park Avenue 555 Twelfth Street, N.W. New York, NY 10022 Washington, D.C. 20004 (212) 715-1010 (202) 942-5862 Michael T. Scott Paul B. Kerrigan REED SMITH LLP 2500 One Liberty Place Philadelphia, PA 19103 (215) 851-8248 By: /s/ Peter L. Zimroth ---------------------------- 8 CLASS COUNSEL, APPELLEE IN NOS. 02-4502, 02-4614, 02-4615, 02-4617, 03-1007, 02-4378, 03-3740 Arnold Levin Michael D. Fishbein Fred S. Longer LEVIN, FISHBEIN, SEDRAN & BERMAN 510 Walnut Street - Suite 500 Philadelphia, PA 19106 (215) 592-1500 By: [ILLEGIBLE] --------------------------- 9 ATTORNEYS FOR AHP SETTLEMENT TRUST, APPELLEE IN NOS. 02-4502, 02-4614, 02-4615, 02-4617, 03-1007, 02-4378, 03-3740 DOES NOT OPPOSE THE RELIEF REQUESTED: Andrew A. Chirls Abbe F. Fletman Deena B. Beard WOLF, BLOCK, SCHORR AND SOLIS-COHEN LLP 1650 Arch Street 22nd Floor Philadelphia, PA 19103 (215) 977-2472 By: /s/ Abbe F. Fletman -------------------------- 10 ATTORNEYS FOR APPELLANTS IN NO. 02-4614 George M. Fleming Jonathan Massey Sylvia Davidow JONATHAN MASSEY, P.C. Rand P. Nolen 3920 Northampton Street. N.W. FLEMING & ASSOCIATES, LLP Washington, D.C. 20015 1330 Post Oak Boulevard, Suite 3030 (202) 686-0457 Houston, TX 77056 (713)621-7944 Mike O'Brien MIKE O'BRIEN, P.C. 1330 Post Oak Boulevard, Suite 2960 Houston, TX 77056 (713) 222-0088 By: /s/ Sylvia Davidow ------------------------- 11 ATTORNEYS FOR APPELLANTS IN NO. 02-4615 Thomas E. Mellon, Jr. Jonathan Massey John A. Corr JONATHAN MASSEY, P. C. Steven A. Corr 3920 Northampton Street. N.W. MELLON, WEBSTER & SHELLY Washington, D.C. 20015 87 North Broad Street (202) 686-0457 Doylestown, PA 18901 (215) 348-7700 C.L. ("Mike") Schmidt L. Kent Clay THE SCHMIDT FIRM CLAY & CROW, L.L.P. 8401 N. Central Expressway, Suite 880 12222 Merit Drive, Suite 1490 Dallas, TX 75225 Dallas, TX 75251 (214) 521-4898 (972) 980-409 Michael P. McGartland MCGARTLAND & BORCHARDT 1300 South University Drive, Suite 500 Fort Worth, TX 76107 (817) 332-9300 By: /s/ Thomas E. Mellon, Jr. --------------------------------- 12 ATTORNEYS FOR APPELLANTS IN NO. 02-4617 Robert E.J. Curran John Eddie Williams, Jr. CURRAN & BYRNE John Boundas 606 East Baltimore Pike Avram J.Blair P.O. Box 30 G. Erick Rosemond Media, PA 19063 WILLIAMS BAILEY LAW FIRM, L.L.P. (610)565-4322 8441 Gulf Freeway, Suite 600 Houston, TX 77017 (713) 230-2200 Edward F. Blizzard Jonathan Massey BLIZZARD, MCCARTHY & NABERS, L.L.P. JONATHAN MASSEY, P.C. 440 Louisiana, Suite 1700 3920 Northampton Street. N.W. Houston, TX 77002 Washington, D.C. 20015 (713) 844-3750 (202) 686-0457 By: /s/ Robert E.J. Curran --------------------------- 13 ATTORNEYS FOR APPELLANTS IN NO. 02-4502,02-4378,03-3740 Paul J. Napoli Mario D'Angelo Denise A. Rubin HARITON & D'ANGELO NAPOLI, KAISER, BERN & ASSOCIATES 3500 Sunrise Highway, Suite T207 3500 Sunrise Highway, Suite T-207 Great River, NY 11737 Great River, NY 11739 (631) 224-1133 (212)267-3700 Arlin M. Adams Jonathan Massey SCHNADER HARRISON SEGAL & LEWIS, JONATHAN MASSEY, P.C. LLP 3920 Northampton Street. N.W. 1600 Market Street, Suite 3600 Washington, D.C. 20015 Philadelphia, PA 19103 (202) 686-0457 (215)751-2000 Abraham C. Reich Brian Isaac Fox ROTHSCHILD POLLACK, POLLACK, ISAAC & DECicco 2000 Market Street 225 Broadway 10th Floor New York, NY 10007 Philadelphia, PA 19103 (212) 233-8100 (215) 233-8100 By: (ILLEGIBLE) ------------------------- 12 ATTORNEYS FOR APPELLANTS IN NO. 03-1007 Michael J. Miller Jonathan Massey MILLER & ASSOCIATES JONATHAN MASSEY, P.C. 105 North Alfred Street 3920 Northampton Street. N.W. Alexandria, VA 22314 Washington, D.C. 20015 (703)519-8080 (202) 686-0457 Michele A. DiMartino Christopher A. Gomez MILLER & ASSOCIATES 555 East City Line Ave. Suite 910 Bala Cynwyd, PA 19004 (610) 660-0622 By: /s/ [ILLEGIBLE] ------------------------- 15 CERTIFICATE OF SERVICE I, Milind M. Shah, hereby certify that one true and correct copy of the foregoing Motion to Extend Stay was served this 10th day of August, 2004, upon the following, by first class mail: Arnold Levin, Esq. George M. Fleming, Esq. Michael D. Fishbein, Esq. Sylvia Davidow, Esq. Fred S. Longer, Esq. Rand P. Nolen, Esq. Levin, Fishbein, Sedran & Berman Scott A. Love, Esq. 510 Walnut Street Fleming & Associates, L.L.P. Suite 500 1330 Post Oak Boulevard, Philadelphia, PA 19106 Suite 3030 Fax: (215) 592-4663 Houston, TX 77056 Fax: (713) 621-9638 Mike O'Brien, Esq. Jonathan Massey, Esq. Mike O'Brien, P.C. Jonathan Massey, P.C. 1330 Post Oak Boulevard, 3920 Northampton Street, N.W. Suite 2960 Washington, DC 20015 Houston, TX 77056 Fax: (202) 686-0497 Fax: (713) 222-0888 Abraham C. Reich Mario D'Angelo Fox Rothschild Hariton & D'Angelo 2000 Market Street 3500 Sunrise Highway, Suite T207 10th Floor Great River, NY 11737 Philadelphia, PA 19103 Fax:(631) 224-4774 Fax: (215) 299-2150 Paul J. Napoli Arlin M. Adams Denise A. Rubin Schnader Harrison Segal & Lewis, LLP Napoli, Kaiser, Bern & Associates 1600 Market Street, Suite 3600 114 Old Country Road, Suite 116A Philadelphia, PA 19103 Mineola,NY 11501 Fax: (215) 751-2205 Fax:(212) 587-0031 Brian Isaac Thomas E. Mellon, Jr. Pollack, Pollack, Isaac & DeCicco John A. Corr 225 Broadway Steven A. Corr New York, NY 10007 Mellon, Webster & Shelly Fax: (212) 766-4380 87 North Broad Street Doylestown, PA 18901 Fax: (215) 348-0171 C.L. ("Mike") Schmidt L. Kent Clay The Schmidt Firm Clay & Crow, L.L.P. 8401 N. Central Expressway, Suite 880 12222 Merit Drive, Suite 1490 Dallas, TX 75225 Dallas, TX 75251 Fax: (214) 521-9995 Fax:(972) 980-4099 Michael P. McGartland Robert E.J. Curran McGartland & Borchardt Curran & Byrne 1300 South University Drive, Suite 500 606 East Baltimore Pike Fort Worth, TX 76107 P.O. Box 30 Fax: (817) 332-9301 Media, PA 19063 Fax:(610) 565-9531 John Eddie Williams, Jr. Edward F. Blizzard John Boundas Blizzard, McCarthy & Nabers, L.P.P. Avram J. Blair 440 Louisiana, Suite 1700 G. Erick Rosemond Houston, TX 77002 Williams Bailey Law Firm, L.L.P. Fax:(713) 844-3755 8441 GulfFreeway, Suite 600 Houston, TX 77017 Fax: (713) 643-6226 Michael J. Miller, Esq. Michele A. DiMartino Miller & Associates Christopher A. Gomez 809 Cameron Street Miller & Associates Alexandria, VA 22314 555 East City Line Ave. Fax:(703) 519-8084 Suite 910 Bala Cynwyd, PA 19004 Andrew A. Chirls Fax:(610) 660-0628 Abbe F. Fletman Robyn D. Levitan AHP SETTLEMENT TRUST Wolf, Block, Schorr & Solis- Cohen 1650 Arch Street 22nd Floor Philadelphia, PA 19103 Fax:(215) 405-2572 By: /s/ Milind M. Shah ------------------------------- Milind M. Shah NOS. 03-3650 AND 03-3741 UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT IN RE DIET DRUGS (PHENTERMINE/FENFLURAMINE/DEXFENFLURAMINE) PRODUCTS LIABILITY LITIGATION, MDL NO. 1203 CLARA CLARK, ET AL., APPELLANTS IN 03-3650 HARITON & D'ANGELO, LLP, ET AL., APPELLANTS IN 03-3741 APPEALS FROM THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA THE HON. HARVEY BARTLE III MOTION TO EXTEND STAY These appeals relate to an order entered by the District Court denying a motion to discharge the Class Counsel who negotiated the diet drug Nationwide Class Action Settlement Agreement (the "Settlement Agreement") with Wyeth. By this Motion, all Appellants and all Appellees request an order extending the stay of these appeals that was issued by the Court on May 25, 2004. The parties to these appeals had previously requested a stay from this Court during the negotiation of an amendment (the "Seventh Amendment") to the Settlement Agreement. Since that initial stay was issued, the Seventh Amendment agreement has been signed by the parties to that agreement and has been placed in escrow pending satisfaction of specified conditions. On Wednesday, August 4, 2004, most of these conditions were satisfied. After the filing of this motion, the parties have only a few minor conforming changes to make in the documents, and they expect that the Seventh Amendment will therefore be released from escrow very shortly. The moving parties to the instant appeals request that this Court extend the stay of these appeals. The parties believe that the Seventh Amendment is highly relevant to the issues in the instant appeals and that these appeals should not be decided based on the record as it existed at the time these appeals were argued. For this reason among others, the Appellants have agreed to dismiss these appeals upon final judicial approval of the Seventh Amendment. The instant appeals involve the denial of certain Class Members' request to remove the Class Counsel who negotiated the Settlement Agreement, which included in its terms a $3.75 billion fund committed by Wyeth. The Seventh Amendment provides that Wyeth would increase the amount it is committing to the Settlement Agreement by depositing an additional $1.275 billion into a new fund, which would be allocated among all claimants eligible to share in the new fund. The Seventh Amendment, if effectuated, will likely moot the issues raised in the instant appeals and will dramatically change the factual premises upon which these appeals were briefed and argued. The undersigned therefore request the Court to extend the stay of these appeals pending judicial approval of the Seventh Amendment. BACKGROUND AND PROCEDURAL HISTORY I. BACKGROUND REGARDING THE SEVENTH AMENDMENT Class Counsel, Wyeth, and counsel for many individual Class Members have had concerns about the ability of the AHP Settlement Trust (the "Trust") to function in the 2 face of the tens of thousands of claims for compensation that have been filed with the Trust. The number of such claims has substantially exceeded the estimates of the experts who testified at the fairness hearing leading to the approval of the Settlement Agreement. Many of these claims are subject to disputes about their validity. These disputes have led to protracted and contentious motions practice that has imposed a heavy burden on the District Court. The sheer volume of the claims and the many disputes concerning validity have delayed resolution and payment of claims. The instant appeals arose from a contentious dispute before the District Court regarding the Class Counsel who had negotiated the Settlement Agreement with Wyeth. Appellants sought to discharge Class Counsel, arguing that Class Counsel had not properly represented the Class. More recently, in order to resolve the many issues concerning administration of the multitude of claims, including the possibility that the Trust would have insufficient funds to pay those claims, Class Counsel and counsel for a number of individual Class Members have engaged in lengthy discussions with Wyeth regarding a proposed Seventh Amendment to the Settlement Agreement. That Seventh Amendment, if effectuated, would provide greater certainty to Class Members, provide them a fair and equitable opportunity for more expeditious compensation, minimize the transaction costs of processing claims, and reduce the burden on the District Court in resolving contested motions practice. The counsel for individual Class Members who, along with Wyeth and Class Counsel, have participated in the negotiation of the Seventh Amendment have secured support for that Amendment from lawyers who together represent a large 3 proportion of the tens of thousands of claims for compensation benefits in the current Trust. The proposed Seventh Amendment would create a Supplemental Fund with a new administrative structure. If the Seventh Amendment is ultimately approved, Wyeth would deposit a total of $1.275 billion into this Fund. Claims for Matrix Level I and II benefits - i.e., compensation benefits for certain heart valve conditions other than the most serious kinds, such as those requiring valve surgery - would be shifted from the Trust to the Supplemental Fund. Those claims for Matrix Level I and II benefits constitute more than 95% of the remaining Matrix claims on file with the Trust that contain sufficient information to assess the Matrix Level asserted. To the extent that such claims for benefits are shifted to the new Supplemental Fund, there will be an enormous decrease in claims against the Trust corpus. Meanwhile, the Supplemental Fund would review all of the claims transferred to it and would allocate to all claimants with valid claims a portion of the $1.275 billion, depending upon the claimant's medical condition, age, and certain other factors specified in the Seventh Amendment. Claims for other conditions as set forth in the proposed Seventh Amendment (e.g. heart valve surgery), whether currently pending or arising in the future, would be submitted to the existing Trust. Because the creation of the Supplemental Fund would free the Trust from the overwhelming number of current claims for benefits, it is more likely that the Trust would have adequate funds to pay these claimants. However, even if the existing Trust were to ran out of funds, under the proposed Seventh Amendment, Wyeth would guarantee that there would be money available to pay those more serious claims by participants in the Seventh Amendment. 4 All eligible Class Members would have the right to elect not to participate in the Seventh Amendment and to remain subject to the terms of the Settlement Agreement prior to the Seventh Amendment. All Class Members participating in the Seventh Amendment would give up any rights to sue Wyeth in the tort system and the right to collaterally attack the Settlement Agreement. II. PROCEDURAL HISTORY On May 4, 2004, Wyeth and Class Counsel (who are Appellees here) and counsel for a number of individual Class Members filed a Joint Motion for Stay with the District Court, requesting it to stay numerous disputed matters pending before that court that would be resolved by effect of the Seventh Amendment. By order of May 6, 2004, the District Court granted that motion. See Exhibit A hereto.(1) When the parties requested the stay of the District Court proceedings, they also sought stays of a number of appeals pending before this Court, including the appeals here involving the District Court's order denying a motion to discharge Class Counsel. All Appellants agreed to that stay motion. See Exhibit E hereto. That motion stated that "[i]n the event the proposed amendment to the Settlement Agreement is executed and finally approved by the District Court, after appropriate notice and a fairness hearing, the moving parties will move to dismiss these appeals." Exhibit E at 2. This Court granted a sixty-day stay, expiring on July 26, 2004. The parties respectfully request that the Court extend that stay. - ---------------------------- (1) The District Court's stay was scheduled to expire on July 9, 2004. However, the District Court extended that stay, permitting the negotiation and drafting of the Seventh Amendment to continue during the pendency of the stay. See Exhibits B, C, and D hereto. 5 ARGUMENT The moving parties agree that the Seventh Amendment, if effectuated and ultimately approved, would resolve the concerns of the parties to the instant appeals. Accordingly, under the terms of the proposed Seventh Amendment, the moving parties here agreed to move to dismiss the instant appeals following final judicial approval of the Seventh Amendment. See Exhibit E at 2 ("In the event the proposed amendment to the Settlement Agreement is executed and finally approved by the District Court, after appropriate notice and a fairness hearing, the moving parties will move to dismiss these appeals."). All Appellants and all Appellees continue to agree that the instant appeals should be dismissed upon final approval of the Seventh Amendment. The parties accordingly urge the Court to extend its previous stay now that the Seventh Amendment has been signed and placed in escrow. The parties request that such a stay continue until the Seventh Amendment is approved by the District Court and all appeals of that approval have been exhausted - at which time the parties to these appeals will move to dismiss the instant appeals. Such a stay order could also provide that, in the event that the Seventh Amendment does not become effective or is not approved by the District Court, the parties must notify the Court so that the stay can be lifted. All of the parties have agreed to this motion and have accordingly executed the attached separate signature pages. Respectfully submitted, The Following Counsel August 10, 2004 6 ATTORNEYS FOR WYETH, APPELLEE IN NOS. 03-3650, 03-3741 Peter L. Zimroth Robert D. Rosenbaum ARNOLD & PORTER LLP ARNOLD & PORTER LLP 399 Park Avenue 555 Twelfth Street, N.W. New York, NY 10022 Washington, D.C. 20004 (212) 715-1010 (202) 942-5862 Michael T. Scott Paul B. Kerrigan REED SMITH LLP 2500 One Liberty Place Philadelphia, PA 19103 (215) 851-8248 By: /s/ Peter L. Zimroth -------------------------------- 8 CLASS COUNSEL, APPELLEE IN NOS. 03-3650, 03-3741 Arnold Levin Samuel Issacharoff Michael D. Fishbein 435 West 116th Street Fred S. Longer New York, NY 10027 LEVIN, FISHBEIN, SEDRAN & BERMAN (212) 854-2527 510 Walnut Street - Suite 500 Philadelphia, PA 19106 (215) 592-1500 By: [ILLEGIBLE] --------------------------- 9 ATTORNEYS FOR APPELLANTS IN 03-3650 George M. Fleming Jonathan S. Massey Sylvia Davidow JONATHAN MASSEY, P.C. Rand P. Nolen 3920 Northampton Street. N.W. FLEMING & ASSOCIATES, LLP Washington, D.C. 20015 1330 Post Oak Boulevard, Suite 3030 (202) 686-0457 Houston, TX 77056 (713) 621-7944 Mike O'Brien Thomas C. Goldstein MIKE O'BRIEN, P.C. GOLDSTEIN & HOWE, P.C. 1330 Post Oak Boulevard, Suite 2960 4607 Asbury Place N.W. Houston, TX 77056 Washington, DC 20026-4324 (713) 222-0088 (202) 237-7543 By: /s/ Sylvia Davidow ------------------------------- 10 ATTORNEYS FOR APPELLANTS IN NO. 03-3741 Paul J. Napoli Mario D'Angelo Denise A. Rubin HARITON & D'ANGELO NAPOLI, KAISER, BERN & ASSOCIATES 3500 Sunrise Highway, Suite T207 114 Old Country Road, Suite 116A Great River, NY 11737 Mineola, NY 11501 (631) 224-1133 (516) 873-8918 By: [ILLEGIBLE] --------------------------------- 10 Certificate of Service I, Milind M. Shah, hereby certify that one true and correct copy of the foregoing Motion to Extend Stay was served this 10th day of August, 2004, upon the following, by first class mail: Arnold Levin, Esq. Samuel Issacharoff, Esq. Michael D. Fishbein, Esq. 435 West 116th Street Fred S. Longer, Esq. New York, NY 10027 Levin, Fishbein, Sedran & Berman 510 Walnut Street Suite 500 Philadelphia, PA 19106 George M. Fleming, Esq. Thomas C. Goldstein, Esq. Sylvia Davidow, Esq. Goldstein & Howe, P.C. Rand P. Nolen, Esq. 4607 Asbury Place, N.W. Scott A. Love, Esq. Washington, DC 20026-4324 Fleming & Associates, L.L.P. 1330 Post Oak Boulevard, Suite 3030 Houston, TX 77056 Mike O'Brien, Esq. Jonathan Massey, Esq. Mike O'Brien, P.C. Jonathan Massey, P.C. 1330 Post Oak Boulevard, 3920 Northampton Street, N.W. Suite 2960 Washington, DC 20015 Houston, TX 77056 Paul J. Napoli, Esq. Mario D'Angelo, Esq. Denise A. Rubin, Esq. Hariton & D'Angelo Napoli, Kaiser, Bern & Associates 3500 Sunrise Highway, Suite T207 114 Old Country Road, Suite 116A Great River, NY 11737 Mineola, NY 11501 By: /s/ Milind M. Shah ------------------------------ Milind M. Shah EX-99 3 y00311exv99.txt PRESS RELEASE Exhibit 99 [Wyeth Logo] N E W S R E L E A S E IMMEDIATE RELEASE Media Contact: Investor Contact: Natalie de Vane Justin Victoria Wyeth Wyeth (484) 865-5139 (973) 660-5340 Douglas Petkus Wyeth Pharmaceuticals (484) 865-5140 Wyeth Confirms Support for Proposed Seventh Amendment to National Diet Drug Settlement Amendment Must Still Undergo Judicial Review Madison, N.J., January 10, 2005 - Wyeth (NYSE: WYE) today confirmed that it would support the proposed Seventh Amendment to the National Diet Drug Settlement, clearing the way for a fairness hearing on the Amendment scheduled for January 18 before Judge Harvey Bartle III of the Eastern District of Pennsylvania. Wyeth's deadline for exercising its walkaway right to the Amendment was January 8. Executed in May 2004, the Seventh Amendment to the Settlement Agreement would create a new claims processing structure, funding arrangement and payment schedule for Matrix Level I or II claims, the least serious but most numerous claims in the Settlement. The Court granted preliminary approval of the Amendment on August 26, 2004, and directed that notice be provided to the class. Class members had until November 9, 2004 to decide whether to be subject to the Amendment or to opt out and remain bound by the terms of the original Settlement Agreement. Class members who have pending more serious claims (Matrix Level III-V) are not affected by the Seventh Amendment and would remain eligible to have those claims processed under the existing Settlement Agreement and receive the current Matrix amounts, if those claims are found to be valid. The Settlement Trust is a separate legal entity and operates completely independently of Wyeth. "Although the proposed Amendment must undergo further judicial review, we are encouraged by the greater than 95 percent level of participation by class members in the Settlement," says Lawrence V. Stein, Senior Vice President and General Counsel of Wyeth. "The proposed Amendment ensures that the large majority of class members who have less serious claims will receive compensation on a streamlined basis. And it preserves funds in the existing Trust for the more serious claims. It also would help resolve much of the uncertainty that has surrounded the diet drug settlement - for both class members and for Wyeth." If approved by the courts, the proposed Seventh Amendment would include the following key terms: o The Amendment would create a new Supplemental Fund, to be administered by a Fund Administrator appointed by the District Court. Following approval by the federal court overseeing the Settlement and any appellate courts, the Company would ultimately deposit a total of $1,275.0 million, net of certain credits, into the Supplemental Fund; Page 1 o All current matrix Level I and II claimants who qualify under the Seventh Amendment, who pass the supplemental Fund's medical review and who otherwise satisfy the requirements of the Settlement, would receive a pro rata share of the $1,275.0 million Supplemental Fund, after deduction of certain expenses and other amounts from the Supplemental Fund. The pro rata amount would vary depending upon the number of claimants who pass medical review, the nature of their claims, their age and other factors. A Seventh Amendment participant who does not qualify for a payment after such medical review would be paid $2,000 from the Supplemental Fund; o The Amendment would preclude future Level I and Level II matrix claims. Participating class members who in the future may have become eligible to file Level I and Level II matrix claims would receive a $2,000 payment from the Settlement Trust; such payments would be funded by the Company apart from its other funding obligations under the national settlement; o If the participants in the Seventh Amendment have heart valve surgery or certain other more serious medical conditions by December 31, 2011, they would remain eligible to submit claims to the existing Settlement Trust and be paid the current matrix amounts if they qualify for such payments under terms modified by the Seventh Amendment. In the event the existing Settlement Trust is unable to pay those claims, the Company would guarantee payment; and o All class members who participate in the Seventh Amendment would give up any further opt-out rights. Approval of the Seventh Amendment would also preclude any lawsuits by the Trust or the Company to recover any amounts previously paid to class members by the Trust, as well as terminate the Claims Integrity Program as to all claimants who participate in the Seventh Amendment. The Company is evaluating potential additional charges relating to the diet drug litigation in connection with the preparation of its year-end financial statements. Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and nonprescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. ###### Page 2 -----END PRIVACY-ENHANCED MESSAGE-----